page_no,line,is_paragraph_end,is_heading,is_header,is_footer,is_bullet_head,is_bullet_body,is_image_caption,is_table_caption,is_table_content,is_toc,is_toc_heading,is_page_no,is_doc_title,pdf_attribute
1,"See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/340608951",0,0,0,0,0,0,0,0,0,0,0,0,0,"('See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/340608951', 'SourceSansPro-Regular', 6.708657698472621, (39.75500858354123, 761.1490626559092, 335.1501225948452, 767.8577203543819), True, False, 1, 840.95996, 594.95996)"
1,Coronavirus Disease 2019 - COVID-19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus Disease 2019 - COVID-19', 'Martel-Regular', 15.859297808095903, (39.75500858354123, 728.8306476709882, 288.7026325529398, 744.6899454790841), True, False, 1, 840.95996, 594.95996)"
1,Preprint * April 2020,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprint * April 2020', 'SourceSansPro-Regular', 7.454064109413935, (39.75500858354123, 705.9003418257677, 95.18231642593663, 713.487052033013), False, False, 1, 840.95996, 594.95996)"
1,DOI: 10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('DOI: 10.20944/preprints202003.0001.v2', 'SourceSansPro-Regular', 5.217844876589766, (39.75500858354123, 696.7244665486108, 115.32996591990707, 701.9423114252006), True, False, 1, 840.95996, 594.95996)"
1,CITATIONS,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CITATIONS', 'SourceSansPro-Regular', 5.963251287531193, (39.75500858354123, 664.0035839158094, 63.47860292493643, 669.9668352033406), True, False, 1, 840.95996, 594.95996)"
1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,"('5', 'SourceSansPro-Regular', 8.94487693129679, (39.75500858354123, 652.3850791352271, 43.7033331565577, 661.3299560665239), True, False, 1, 840.95996, 594.95996)"
1,"10 authors, including:",0,0,0,0,0,0,0,0,0,0,0,0,0,"('10 authors, including:', 'SourceSansPro-Regular', 7.454064109413935, (39.75500858354123, 627.7154916114699, 100.48363131609854, 635.3022018187153), False, False, 1, 840.95996, 594.95996)"
1,Kuldeep Dhama,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Kuldeep Dhama', 'SourceSansPro-Regular', 7.454064109413935, (66.2583476392354, 609.8257377488763, 110.49420638443286, 617.2798018582903), True, False, 1, 840.95996, 594.95996)"
1,Indian Veterinary Research Institute,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Indian Veterinary Research Institute', 'SourceSansPro-Regular', 7.454064109413935, (66.2583476392354, 599.2244021265988, 164.90499144520825, 606.6784662360127), True, False, 1, 840.95996, 594.95996)"
1,"811 PUBLICATIONS   9,506 CITATIONS",0,0,0,0,0,0,0,0,0,0,0,0,0,"('811 PUBLICATIONS   9,506 CITATIONS', 'SourceSansPro-Regular', 7.454064109413935, (66.2583476392354, 587.2978995515364, 156.94104934068935, 594.7519636609503), False, False, 1, 840.95996, 594.95996)"
1,SEE PROFILE,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SEE PROFILE', 'SourceSansPro-Regular', 5.963251287531193, (73.54676587955129, 571.9044806972721, 102.05338467790213, 577.8677319848033), True, False, 1, 840.95996, 594.95996)"
1,Shubhankar Sircar,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Shubhankar Sircar', 'SourceSansPro-Regular', 7.454064109413935, (66.2583476392354, 546.8803074916028, 117.56974377594378, 554.3343716010168), True, False, 1, 840.95996, 594.95996)"
1,Indian Veterinary Research Institute,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Indian Veterinary Research Institute', 'SourceSansPro-Regular', 7.454064109413935, (66.2583476392354, 536.2789718693251, 164.90499144520825, 543.733035978739), True, False, 1, 840.95996, 594.95996)"
1,41 PUBLICATIONS   364 CITATIONS,0,0,0,0,0,0,0,0,0,0,0,0,0,"('41 PUBLICATIONS   364 CITATIONS', 'SourceSansPro-Regular', 7.454064109413935, (66.2583476392354, 524.3524692942627, 149.18675540645245, 531.8065334036767), False, False, 1, 840.95996, 594.95996)"
1,SEE PROFILE,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SEE PROFILE', 'SourceSansPro-Regular', 5.96325128753125, (73.54676587955129, 508.9590504399985, 102.05338467790213, 514.9223017275298), True, False, 1, 840.95996, 594.95996)"
1,READS,0,0,0,0,0,0,0,0,0,0,0,0,0,"('READS', 'SourceSansPro-Regular', 5.963251287531193, (297.4999809001669, 664.0035839158094, 312.34081549792546, 669.9668352033406), True, False, 1, 840.95996, 594.95996)"
1,"41,071",0,0,0,0,0,0,0,0,0,0,0,0,0,"('41,071', 'SourceSansPro-Regular', 8.94487693129679, (297.4999809001669, 652.3850791352271, 319.2177072490716, 661.3299560665239), True, False, 1, 840.95996, 594.95996)"
1,Sharun Khan,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sharun Khan', 'SourceSansPro-Regular', 7.454064109413935, (324.00331995586106, 609.8257377488763, 359.84688605277074, 617.2798018582903), True, False, 1, 840.95996, 594.95996)"
1,Indian Veterinary Research Institute,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Indian Veterinary Research Institute', 'SourceSansPro-Regular', 7.454064109413935, (324.00331995586106, 599.2244021265988, 422.649963761834, 606.6784662360127), True, False, 1, 840.95996, 594.95996)"
1,101 PUBLICATIONS   515 CITATIONS,0,0,0,0,0,0,0,0,0,0,0,0,0,"('101 PUBLICATIONS   515 CITATIONS', 'SourceSansPro-Regular', 7.454064109413935, (324.00331995586106, 587.2978995515364, 409.9858201216568, 594.7519636609503), False, False, 1, 840.95996, 594.95996)"
1,SEE PROFILE,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SEE PROFILE', 'SourceSansPro-Regular', 5.963251287531193, (331.291738196177, 571.9044806972721, 359.7983569945278, 577.8677319848033), True, False, 1, 840.95996, 594.95996)"
1,Some of the authors of this publication are also working on these related projects:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Some of the authors of this publication are also working on these related projects:', 'SourceSansPro-Semibold', 7.512298968704215, (39.75500858354123, 472.7453693742003, 272.62980628694913, 480.25766834290454), True, False, 1, 840.95996, 594.95996)"
1,Corona virus pandemic View project,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Corona virus pandemic View project', 'SourceSansPro-Regular', 7.4540641094139914, (81.49776759625954, 445.65903450081265, 181.1622319198493, 454.6039114321094), True, False, 1, 840.95996, 594.95996)"
1,Evaluation of Bone marrow derived Mesenchymal Stem Cell (BM-MSC) in managing spinal cord injuries in canines View project,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Evaluation of Bone marrow derived Mesenchymal Stem Cell (BM-MSC) in managing spinal cord injuries in canines View project', 'SourceSansPro-Regular', 7.4540641094139914, (81.49776759625954, 415.84277806315674, 428.5336316842072, 424.7876549944535), True, False, 1, 840.95996, 594.95996)"
1,All content following this page was uploaded by Alfonso J. Rodriguez-Morales on 15 April 2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('All content following this page was uploaded by Alfonso J. Rodriguez-Morales on 15 April 2020.', 'SourceSansPro-Regular', 7.454064109413981, (43.06792596550301, 29.40261242917438, 302.3282992455287, 36.85667653858836), True, False, 1, 840.95996, 594.95996)"
1,The user has requested enhancement of the downloaded file.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The user has requested enhancement of the downloaded file.', 'SourceSansPro-Regular', 5.963251287531186, (43.06792596550301, 14.671777051302477, 178.11072084048135, 20.635028338833663), True, False, 1, 840.95996, 594.95996)"
2,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 2, 841.92, 595.32)"
2,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 750.148, 75.024, 760.864), True, False, 2, 841.92, 595.32)"
2,Coronavirus Disease 2019 - COVID-19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus Disease 2019 - COVID-19', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 729.028, 275.81, 739.744), True, False, 2, 841.92, 595.32)"
2,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 707.788, 75.024, 718.504), True, False, 2, 841.92, 595.32)"
2,"Kuldeep  Dhama,a  Khan  Sharun,b  Ruchi  Tiwari,c Shubhankar  Sircar,d Sudipta  Bhat,d Yashpal",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Kuldeep  Dhama,a  Khan  Sharun,b  Ruchi  Tiwari,c Shubhankar  Sircar,d Sudipta  Bhat,d Yashpal', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 686.668, 526.396, 699.3917200000001), True, False, 2, 841.92, 595.32)"
2,"Singh  Malik,d*  Karam  Pal  Singh,a  Wanpen  Chaicumpa,e  D.  Katterine  Bonilla-Aldana,f,g,h",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Singh  Malik,d*  Karam  Pal  Singh,a  Wanpen  Chaicumpa,e  D.  Katterine  Bonilla-Aldana,f,g,h', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 671.428, 526.42, 684.1517200000001), True, False, 2, 841.92, 595.32)"
2,"Alfonso J Rodriguez-Morales,g,h,i*",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Alfonso J Rodriguez-Morales,g,h,i*', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 656.308, 240.89, 669.0317200000001), True, False, 2, 841.92, 595.32)"
2,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 7.308359999999993, (72.024, 640.4833600000001, 74.034, 647.79172), True, False, 2, 841.92, 595.32)"
2,Affiliations:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Affiliations:', 'TimesNewRomanPS-BoldMT', 7.179719999999975, (72.024, 618.76336, 114.95, 625.94308), True, False, 2, 841.92, 595.32)"
2,"aDivision  of  Pathology,  ICAR-Indian  Veterinary  Research  Institute,  Izatnagar,  Bareilly-  243  122,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('aDivision  of  Pathology,  ICAR-Indian  Veterinary  Research  Institute,  Izatnagar,  Bareilly-  243  122,', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 593.75536, 526.16176, 604.92328), True, False, 2, 841.92, 595.32)"
2,"Uttar Pradesh, India.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Uttar Pradesh, India.', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 579.83536, 165.85999999999999, 589.87072), True, False, 2, 841.92, 595.32)"
2,"bDivision  of  Surgery,  ICAR-Indian  Veterinary  Research  Institute,  Izatnagar,  Bareilly-  243  122,  Uttar",0,0,0,0,0,0,0,0,0,0,0,0,0,"('bDivision  of  Surgery,  ICAR-Indian  Veterinary  Research  Institute,  Izatnagar,  Bareilly-  243  122,  Uttar', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 559.88536, 526.1584, 571.05328), True, False, 2, 841.92, 595.32)"
2,"Pradesh, India.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Pradesh, India.', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 545.96536, 137.42, 556.00072), True, False, 2, 841.92, 595.32)"
2,"cDepartment  of  Veterinary  Microbiology  and  Immunology, College  of  Veterinary  Sciences,  Uttar",0,0,0,0,0,0,0,0,0,0,0,0,0,"('cDepartment  of  Veterinary  Microbiology  and  Immunology, College  of  Veterinary  Sciences,  Uttar', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 526.04536, 526.16368, 537.2132799999999), True, False, 2, 841.92, 595.32)"
2,Pradesh  Pandit  Deen  Dayal  Upadhyaya  Pashu  Chikitsa  Vigyan  Vishwavidyalaya  Evam  Go,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Pradesh  Pandit  Deen  Dayal  Upadhyaya  Pashu  Chikitsa  Vigyan  Vishwavidyalaya  Evam  Go', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 512.12536, 526.02392, 522.16072), True, False, 2, 841.92, 595.32)"
2,"Anusandhan Sansthan (DUVASU), Mathura, India -281001, India.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Anusandhan Sansthan (DUVASU), Mathura, India -281001, India.', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 498.20536, 371.11, 508.24071999999995), True, False, 2, 841.92, 595.32)"
2,"dDivision  of  Biological  Standardization,  ICAR-Indian  Veterinary  Research  Institute,  Izatnagar,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('dDivision  of  Biological  Standardization,  ICAR-Indian  Veterinary  Research  Institute,  Izatnagar,', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 478.28536, 525.9778399999999, 489.45328), True, False, 2, 841.92, 595.32)"
2,"Bareilly- 243 122, Uttar Pradesh, India.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Bareilly- 243 122, Uttar Pradesh, India.', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 464.36536, 248.92999999999998, 474.40072), True, False, 2, 841.92, 595.32)"
2,"eCenter  of  Research  Excellence  on  Therapeutic  Proteins  and  Antibody  Engineering,  Department  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('eCenter  of  Research  Excellence  on  Therapeutic  Proteins  and  Antibody  Engineering,  Department  of', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 444.56536, 525.8078399999996, 455.73328000000004), True, False, 2, 841.92, 595.32)"
2,"Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 430.64536, 509.62, 440.68071999999995), True, False, 2, 841.92, 595.32)"
2,"fSemillero de Zoonosis, Grupo de Investigación BIOECOS, Fundación Universitaria Autónoma de las",0,0,0,0,0,0,0,0,0,0,0,0,0,"('fSemillero de Zoonosis, Grupo de Investigación BIOECOS, Fundación Universitaria Autónoma de las', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 410.72536, 525.8951999999996, 421.89328), True, False, 2, 841.92, 595.32)"
2,"Américas, Sede Pereira, Pereira, Risaralda, Colombia.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Américas, Sede Pereira, Pereira, Risaralda, Colombia.', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 396.80536, 313.01, 406.84072), True, False, 2, 841.92, 595.32)"
2,"gPublic  Health  and  Infection  Research  Group,  Faculty  of  Health  Sciences,  Universidad  Tecnologica",0,0,0,0,0,0,0,0,0,0,0,0,0,"('gPublic  Health  and  Infection  Research  Group,  Faculty  of  Health  Sciences,  Universidad  Tecnologica', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 376.86536, 526.1799599999999, 388.03328), True, False, 2, 841.92, 595.32)"
2,"de Pereira, Pereira, Colombia.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('de Pereira, Pereira, Colombia.', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 362.94536, 207.41, 372.98071999999996), True, False, 2, 841.92, 595.32)"
2,"hLatin  American  Network  of  Coronavirus  Disease  2019-COVID-19  Research  (LANCOVID-19),",0,0,0,0,0,0,0,0,0,0,0,0,0,"('hLatin  American  Network  of  Coronavirus  Disease  2019-COVID-19  Research  (LANCOVID-19),', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 343.02536000000003, 526.16944, 354.19328), True, False, 2, 841.92, 595.32)"
2,"Pereira, Risaralda, Colombia.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Pereira, Risaralda, Colombia.', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 329.10536, 204.64999999999998, 339.14072), True, False, 2, 841.92, 595.32)"
2,"iGrupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las",0,0,0,0,0,0,0,0,0,0,0,0,0,"('iGrupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 309.18536, 526.1430399999999, 320.35328), True, False, 2, 841.92, 595.32)"
2,"Americas, Pereira, Risaralda, Colombia.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Americas, Pereira, Risaralda, Colombia.', 'TimesNewRomanPSMT', 10.035359999999969, (72.024, 295.26536, 252.29, 305.30071999999996), True, False, 2, 841.92, 595.32)"
2,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 6.326639999999998, (72.024, 280.18664, 73.764, 286.51328), True, False, 2, 841.92, 595.32)"
2,Corresponding Author(s):,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Corresponding Author(s):', 'TimesNewRomanPS-BoldMT', 9.858720000000005, (72.024, 255.42536, 203.45, 265.28408), True, False, 2, 841.92, 595.32)"
2,"Yashpal  Singh  Malik,  PhD  (malikyps@gmail.com),  Division  of  Biological  Standardization,  ICAR-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Yashpal  Singh  Malik,  PhD  (malikyps@gmail.com),  Division  of  Biological  Standardization,  ICAR-', 'TimesNewRomanPSMT', 10.035359999999997, (72.024, 235.50536, 523.54, 245.54072), True, False, 2, 841.92, 595.32)"
2,"Indian Veterinary Research Institute, Izatnagar 243122, Bareilly, Uttar Pradesh, India.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Indian Veterinary Research Institute, Izatnagar 243122, Bareilly, Uttar Pradesh, India.', 'TimesNewRomanPSMT', 10.035359999999997, (72.024, 221.58536, 454.3, 231.62072), True, False, 2, 841.92, 595.32)"
2,"Alfonso  J  Rodriguez-Morales,  HonDSc  (arodriguezm@utp.edu.co),  Public  Health  and  Infection",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Alfonso  J  Rodriguez-Morales,  HonDSc  (arodriguezm@utp.edu.co),  Public  Health  and  Infection', 'TimesNewRomanPSMT', 10.035359999999997, (72.024, 201.63536000000002, 526.078, 211.67072000000002), True, False, 2, 841.92, 595.32)"
2,"Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia.', 'TimesNewRomanPSMT', 10.035359999999997, (72.024, 187.71536, 521.38, 197.75072), True, False, 2, 841.92, 595.32)"
2,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 9.858720000000005, (72.024, 167.79536000000002, 74.784, 177.65408000000002), True, False, 2, 841.92, 595.32)"
2,Short title: COVID-19.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Short title: COVID-19.', 'TimesNewRomanPS-BoldMT', 10.908000000000015, (72.024, 146.82799999999997, 190.7, 157.736), False, False, 2, 841.92, 595.32)"
2,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 125.70800000000001, 75.024, 136.616), True, False, 2, 841.92, 595.32)"
2,"Words Count: 18,301 | Summary: 249 | References: 330 | Tables:2 | Figures: 7",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Words Count: 18,301 | Summary: 249 | References: 330 | Tables:2 | Figures: 7', 'TimesNewRomanPS-BoldMT', 10.715999999999994, (72.024, 104.468, 471.7, 115.184), True, False, 2, 841.92, 595.32)"
2,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 2, 841.92, 595.32)"
2,(c)  2020 by the author(s). Distributed under a Creative Commons CC BY license.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(c)  2020 by the author(s). Distributed under a Creative Commons CC BY license.', 'Helvetica', 10.404, (65.0, 7.377, 385.752, 17.781), True, False, 2, 841.92, 595.32)"
2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"('1', 'BCDEEE+Calibri', 11.04, (517.9, 48.864000000000004, 525.91504, 59.904), True, False, 2, 841.92, 595.32)"
3,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 3, 841.92, 595.32)"
3,Summary,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Summary', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (272.33, 750.148, 325.99, 760.864), True, False, 3, 841.92, 595.32)"
3,"In  the  past  decades,  several  new  diseases  have  emerged  in  new  geographical  areas,  with",0,0,0,0,0,0,0,0,0,0,0,0,0,"('In  the  past  decades,  several  new  diseases  have  emerged  in  new  geographical  areas,  with', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 729.028, 526.0559999999998, 739.936), True, False, 3, 841.92, 595.32)"
3,"pathogens including Ebola, Zika, Nipah, and coronaviruses (CoVs). Recently, a new type of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('pathogens including Ebola, Zika, Nipah, and coronaviruses (CoVs). Recently, a new type of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 713.068, 526.246, 723.976), True, False, 3, 841.92, 595.32)"
3,"viral infection has emerged in Wuhan City, China, and initial genomic sequencing data of this",0,0,0,0,0,0,0,0,0,0,0,0,0,"('viral infection has emerged in Wuhan City, China, and initial genomic sequencing data of this', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 697.2280000000001, 526.1999999999999, 708.1360000000001), True, False, 3, 841.92, 595.32)"
3,"virus does not match with previously sequenced CoVs, suggesting a novel CoV strain (2019-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus does not match with previously sequenced CoVs, suggesting a novel CoV strain (2019-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 681.388, 523.456, 692.296), True, False, 3, 841.92, 595.32)"
3,"nCoV),  which  has  now  been  termed  as  severe  acute  respiratory  syndrome  CoV-2  (SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('nCoV),  which  has  now  been  termed  as  severe  acute  respiratory  syndrome  CoV-2  (SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 665.548, 523.456, 676.456), True, False, 3, 841.92, 595.32)"
3,CoV-2). Although  Coronavirus disease 2019 (COVID-19) is  suspected to originate from  an,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2). Although  Coronavirus disease 2019 (COVID-19) is  suspected to originate from  an', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 649.588, 526.2940000000001, 660.496), True, False, 3, 841.92, 595.32)"
3,"animal  host  (zoonotic  origin)  followed  by  human-to-human  transmission,  the  possibility  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('animal  host  (zoonotic  origin)  followed  by  human-to-human  transmission,  the  possibility  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 633.748, 526.2940000000001, 644.6560000000001), True, False, 3, 841.92, 595.32)"
3,other routes such as food-borne transmission should not be ruled out. Compared to diseases,0,0,0,0,0,0,0,0,0,0,0,0,0,"('other routes such as food-borne transmission should not be ruled out. Compared to diseases', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 617.908, 526.354, 628.816), True, False, 3, 841.92, 595.32)"
3,"caused  by  previously  known  human  CoVs,  COVID-19  shows  less  severe  pathogenesis  but",0,0,0,0,0,0,0,0,0,0,0,0,0,"('caused  by  previously  known  human  CoVs,  COVID-19  shows  less  severe  pathogenesis  but', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 602.068, 526.258, 612.976), True, False, 3, 841.92, 595.32)"
3,"higher  transmission  competence,  as  is  evident  from  the  continuously  increasing  number  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('higher  transmission  competence,  as  is  evident  from  the  continuously  increasing  number  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 586.1080000000001, 526.0920000000001, 597.0160000000001), True, False, 3, 841.92, 595.32)"
3,"confirmed  cases  globally.  Compared  to  other  emerging  viruses  such  as  Ebola  virus,  avian",0,0,0,0,0,0,0,0,0,0,0,0,0,"('confirmed  cases  globally.  Compared  to  other  emerging  viruses  such  as  Ebola  virus,  avian', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 570.238, 526.33, 581.1460000000001), True, False, 3, 841.92, 595.32)"
3,"H7N9,  SARS-CoV,  or  MERS-CoV,  SARS-CoV-2  has  shown  relatively  low  pathogenicity",0,0,0,0,0,0,0,0,0,0,0,0,0,"('H7N9,  SARS-CoV,  or  MERS-CoV,  SARS-CoV-2  has  shown  relatively  low  pathogenicity', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 554.398, 526.306, 565.306), True, False, 3, 841.92, 595.32)"
3,and  moderate  transmissibility.  Codon  usage  studies  suggest  that  this  novel  virus  may  have,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  moderate  transmissibility.  Codon  usage  studies  suggest  that  this  novel  virus  may  have', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 538.558, 526.2260000000001, 549.466), True, False, 3, 841.92, 595.32)"
3,been transferred from  an animal  source such  as bats.  Early diagnosis by real-time PCR and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('been transferred from  an animal  source such  as bats.  Early diagnosis by real-time PCR and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 522.5980000000001, 526.348, 533.5060000000001), True, False, 3, 841.92, 595.32)"
3,next-generation sequencing has facilitated the identification of the pathogen at an early stage.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('next-generation sequencing has facilitated the identification of the pathogen at an early stage.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 506.75800000000004, 526.0440000000001, 517.666), True, False, 3, 841.92, 595.32)"
3,"Since,  no  antiviral  drug  or  vaccine  exists  to  treat  or  prevent  SARS-CoV-2,  potential",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Since,  no  antiviral  drug  or  vaccine  exists  to  treat  or  prevent  SARS-CoV-2,  potential', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 490.918, 526.408, 501.82599999999996), True, False, 3, 841.92, 595.32)"
3,therapeutic  strategies  that  are  currently  being  evaluated  predominantly  stem  from  previous,0,0,0,0,0,0,0,0,0,0,0,0,0,"('therapeutic  strategies  that  are  currently  being  evaluated  predominantly  stem  from  previous', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 475.07800000000003, 526.2620000000001, 485.986), True, False, 3, 841.92, 595.32)"
3,"experience with treating SARS-CoV, MERS-CoV, and other emerging viral diseases. In this",0,0,0,0,0,0,0,0,0,0,0,0,0,"('experience with treating SARS-CoV, MERS-CoV, and other emerging viral diseases. In this', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 459.118, 526.25, 470.02599999999995), True, False, 3, 841.92, 595.32)"
3,"review,  we  address  epidemiological,  diagnostic,  clinical,  and  therapeutic  aspects,  including",0,0,0,0,0,0,0,0,0,0,0,0,0,"('review,  we  address  epidemiological,  diagnostic,  clinical,  and  therapeutic  aspects,  including', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 443.278, 526.128, 454.186), True, False, 3, 841.92, 595.32)"
3,perspectives  of  vaccines  and  preventive  measures  that  have  already  been  globally,0,0,0,0,0,0,0,0,0,0,0,0,0,"('perspectives  of  vaccines  and  preventive  measures  that  have  already  been  globally', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 427.438, 526.2260000000001, 438.34599999999995), True, False, 3, 841.92, 595.32)"
3,recommended.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('recommended.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 411.598, 145.94, 422.506), True, False, 3, 841.92, 595.32)"
3,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 389.618, 75.024, 400.334), True, False, 3, 841.92, 595.32)"
3,KEYWORDS:  Emerging  coronavirus;  2019-nCoV;  SARS-CoV-2;  COVID-19;  diagnosis;,0,0,0,0,0,0,0,0,0,0,0,0,0,"('KEYWORDS:  Emerging  coronavirus;  2019-nCoV;  SARS-CoV-2;  COVID-19;  diagnosis;', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 368.498, 526.42, 379.40599999999995), False, False, 3, 841.92, 595.32)"
3,vaccines; therapy; one health,0,0,0,0,0,0,0,0,0,0,0,0,0,"('vaccines; therapy; one health', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 353.37800000000004, 214.73, 364.286), True, False, 3, 841.92, 595.32)"
3,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 332.13800000000003, 75.024, 342.85400000000004), True, False, 3, 841.92, 595.32)"
3,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 3, 841.92, 595.32)"
3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2', 'BCDEEE+Calibri', 11.04, (517.9, 48.864000000000004, 525.91504, 59.904), True, False, 3, 841.92, 595.32)"
4,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 4, 841.92, 595.32)"
4,TABLE OF CONTENTS,0,0,0,0,0,0,0,0,0,0,0,0,0,"('TABLE OF CONTENTS', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (232.97, 750.148, 365.35, 760.864), True, False, 4, 841.92, 595.32)"
4,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 735.028, 75.024, 745.744), True, False, 4, 841.92, 595.32)"
4,INTRODUCTION......................................................................................4,0,0,0,0,0,0,0,0,0,0,0,0,0,"('INTRODUCTION......................................................................................4', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 721.2280000000001, 519.1, 731.9440000000001), True, False, 4, 841.92, 595.32)"
4,THE VIRUS..............................................................................................5,0,0,0,0,0,0,0,0,0,0,0,0,0,"('THE VIRUS..............................................................................................5', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 707.428, 518.74, 718.144), True, False, 4, 841.92, 595.32)"
4,Spike glycoprotein 'S.'..................................................................................7,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""Spike glycoprotein 'S.'..................................................................................7"", 'TimesNewRomanPS-BoldMT', 10.908000000000015, (72.024, 693.628, 516.7, 704.5360000000001), False, False, 4, 841.92, 595.32)"
4,M protein..................................................................................................8,0,0,0,0,0,0,0,0,0,0,0,0,0,"('M protein..................................................................................................8', 'TimesNewRomanPS-BoldMT', 10.908000000000015, (72.024, 679.828, 518.74, 690.736), False, False, 4, 841.92, 595.32)"
4,E protein...................................................................................................8,0,0,0,0,0,0,0,0,0,0,0,0,0,"('E protein...................................................................................................8', 'TimesNewRomanPS-BoldMT', 10.908000000000015, (72.024, 666.028, 521.38, 676.936), False, False, 4, 841.92, 595.32)"
4,N protein...................................................................................................8,0,0,0,0,0,0,0,0,0,0,0,0,0,"('N protein...................................................................................................8', 'TimesNewRomanPS-BoldMT', 10.908000000000015, (72.024, 652.2280000000001, 522.82, 663.1360000000001), False, False, 4, 841.92, 595.32)"
4,NSPs and accessory proteins............................................................................8,0,0,0,0,0,0,0,0,0,0,0,0,0,"('NSPs and accessory proteins............................................................................8', 'TimesNewRomanPS-BoldMT', 10.908000000000015, (72.024, 638.428, 519.46, 649.336), False, False, 4, 841.92, 595.32)"
4,SARS-CoV-2 spike glycoprotein gene analysis......................................................9,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2 spike glycoprotein gene analysis......................................................9', 'TimesNewRomanPSMT', 10.716000000000008, (72.024, 624.628, 520.06, 635.5360000000001), False, False, 4, 841.92, 595.32)"
4,i. Sequence percent similarity analysis.............................................................9,0,0,0,0,0,0,0,0,0,0,0,0,0,"('i. Sequence percent similarity analysis.............................................................9', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 610.828, 516.1, 621.544), True, False, 4, 841.92, 595.32)"
4,ii. Splits-Tree phylogeny analysis.....................................................................9,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ii. Splits-Tree phylogeny analysis.....................................................................9', 'TimesNewRomanPS-BoldMT', 10.908000000000015, (72.024, 597.028, 519.82, 607.936), False, False, 4, 841.92, 595.32)"
4,CURRENT WORLDWIDE SCENARIO OF SARS-CoV-2...................................9,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CURRENT WORLDWIDE SCENARIO OF SARS-CoV-2...................................9', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 583.2280000000001, 518.38, 593.9440000000001), True, False, 4, 841.92, 595.32)"
4,"VIEWPOINT ON SARS-CoV-2 TRANSMISSION, SPREAD, AND EMERGENCE....10",0,0,0,0,0,0,0,0,0,0,0,0,0,"('VIEWPOINT ON SARS-CoV-2 TRANSMISSION, SPREAD, AND EMERGENCE....10', 'TimesNewRomanPS-BoldMT', 10.908000000000015, (72.024, 569.398, 525.82, 580.306), False, False, 4, 841.92, 595.32)"
4,"CORONAVIRUSES (CoV) IN HUMANS - SARS, MERS, AND COVID-19.............13",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CORONAVIRUSES (CoV) IN HUMANS - SARS, MERS, AND COVID-19.............13', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 555.5980000000001, 524.98, 566.3140000000001), True, False, 4, 841.92, 595.32)"
4,CLINICAL PATHOLOGY OF SARS-CoV-2 (COVID-19)....................................15,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CLINICAL PATHOLOGY OF SARS-CoV-2 (COVID-19)....................................15', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 541.798, 523.66, 552.514), True, False, 4, 841.92, 595.32)"
4,CORONAVIRUSES  (CoV)  IN  ANIMALS  AND  ZOONOTIC  LINKS-  A  BRIEF,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CORONAVIRUSES  (CoV)  IN  ANIMALS  AND  ZOONOTIC  LINKS-  A  BRIEF', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 527.998, 526.396, 538.714), True, False, 4, 841.92, 595.32)"
4,VIEWPOINT...........................................................................................17,0,0,0,0,0,0,0,0,0,0,0,0,0,"('VIEWPOINT...........................................................................................17', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 514.198, 521.5, 524.914), True, False, 4, 841.92, 595.32)"
4,DIAGNOSIS OF SARS-CoV-2 (COVID-19).....................................................19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('DIAGNOSIS OF SARS-CoV-2 (COVID-19).....................................................19', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 500.398, 522.1, 511.11400000000003), True, False, 4, 841.92, 595.32)"
4,"VACCINES, THERAPEUTICS AND DRUGS..................................................23",0,0,0,0,0,0,0,0,0,0,0,0,0,"('VACCINES, THERAPEUTICS AND DRUGS..................................................23', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 486.598, 522.46, 497.314), True, False, 4, 841.92, 595.32)"
4,Vaccines...................................................................................................24,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Vaccines...................................................................................................24', 'TimesNewRomanPS-BoldMT', 10.907999999999959, (72.024, 472.798, 524.14, 483.70599999999996), False, False, 4, 841.92, 595.32)"
4,Therapeutics and drugs.................................................................................26,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Therapeutics and drugs.................................................................................26', 'TimesNewRomanPS-BoldMT', 10.907999999999959, (72.024, 458.998, 523.06, 469.90599999999995), False, False, 4, 841.92, 595.32)"
4,Antiviral drugs...........................................................................................28,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Antiviral drugs...........................................................................................28', 'TimesNewRomanPS-BoldMT', 10.907999999999959, (72.024, 445.19800000000004, 523.06, 456.106), False, False, 4, 841.92, 595.32)"
4,"Passive immunization, Antibody therapy, Monoclonal antibodies (mAb).......................30",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Passive immunization, Antibody therapy, Monoclonal antibodies (mAb).......................30', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 431.398, 524.5, 442.306), False, False, 4, 841.92, 595.32)"
4,Potential therapeutic agents............................................................................31,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Potential therapeutic agents............................................................................31', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 417.598, 522.82, 428.506), False, False, 4, 841.92, 595.32)"
4,Animal models and cell cultures.......................................................................33,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Animal models and cell cultures.......................................................................33', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 403.798, 524.38, 414.70599999999996), False, False, 4, 841.92, 595.32)"
4,"PREVENTION, CONTROL, AND MANAGEMENT..........................................33",0,0,0,0,0,0,0,0,0,0,0,0,0,"('PREVENTION, CONTROL, AND MANAGEMENT..........................................33', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 389.978, 524.5, 400.694), True, False, 4, 841.92, 595.32)"
4,CONCLUDING REMARKS........................................................................36,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CONCLUDING REMARKS........................................................................36', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 376.178, 522.82, 386.894), True, False, 4, 841.92, 595.32)"
4,ACKNOWLEDGMENTS............................................................................37,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ACKNOWLEDGMENTS............................................................................37', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 362.37800000000004, 523.42, 373.09400000000005), True, False, 4, 841.92, 595.32)"
4,REFERENCES.........................................................................................38,0,0,0,0,0,0,0,0,0,0,0,0,0,"('REFERENCES.........................................................................................38', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 348.57800000000003, 521.74, 359.29400000000004), True, False, 4, 841.92, 595.32)"
4,AUTHOR BIOGRAPHIES..........................................................................63,0,0,0,0,0,0,0,0,0,0,0,0,0,"('AUTHOR BIOGRAPHIES..........................................................................63', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 334.778, 521.38, 345.494), True, False, 4, 841.92, 595.32)"
4,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 314.978, 75.024, 325.694), True, False, 4, 841.92, 595.32)"
4,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 4, 841.92, 595.32)"
4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"('3', 'BCDEEE+Calibri', 11.04, (517.9, 48.864000000000004, 525.91504, 59.904), True, False, 4, 841.92, 595.32)"
5,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 5, 841.92, 595.32)"
5,INTRODUCTION,0,0,0,0,0,0,0,0,0,0,0,0,0,"('INTRODUCTION', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 750.148, 174.02, 760.864), True, False, 5, 841.92, 595.32)"
5,"Over  the  past  two  decades,  coronaviruses  (CoVs)  have  been  associated  with",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Over  the  past  two  decades,  coronaviruses  (CoVs)  have  been  associated  with', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 729.028, 526.1, 739.936), True, False, 5, 841.92, 595.32)"
5,significant disease outbreaks in East Asia and the Middle East. The severe acute respiratory,0,0,0,0,0,0,0,0,0,0,0,0,0,"('significant disease outbreaks in East Asia and the Middle East. The severe acute respiratory', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 713.788, 526.1039999999997, 724.696), True, False, 5, 841.92, 595.32)"
5,syndrome  (SARS)  and  the  Middle  East  respiratory  syndromes  (MERS)  began  to  emerge  in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('syndrome  (SARS)  and  the  Middle  East  respiratory  syndromes  (MERS)  began  to  emerge  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 698.668, 526.1399999999999, 709.576), True, False, 5, 841.92, 595.32)"
5,"2002  and  2012,  respectively.  At  present,  a  novel  coronavirus,  the  severe  acute  respiratory",0,0,0,0,0,0,0,0,0,0,0,0,0,"('2002  and  2012,  respectively.  At  present,  a  novel  coronavirus,  the  severe  acute  respiratory', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 683.428, 526.258, 694.336), True, False, 5, 841.92, 595.32)"
5,"syndrome coronavirus 2 (SARS-CoV-2), causing the Coronavirus Disease 2019 (COVID-19),",0,0,0,0,0,0,0,0,0,0,0,0,0,"('syndrome coronavirus 2 (SARS-CoV-2), causing the Coronavirus Disease 2019 (COVID-19),', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 668.308, 529.42, 679.216), True, False, 5, 841.92, 595.32)"
5,"has emerged in late 2019, which has posed a global health threat with its ongoing pandemic",0,0,0,0,0,0,0,0,0,0,0,0,0,"('has emerged in late 2019, which has posed a global health threat with its ongoing pandemic', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 653.068, 526.42, 663.976), True, False, 5, 841.92, 595.32)"
5,in many countries and territories (1).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in many countries and territories (1).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 637.948, 253.97, 648.856), True, False, 5, 841.92, 595.32)"
5,Health  workers  worldwide  are  currently  making  efforts  to  control  further  disease,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Health  workers  worldwide  are  currently  making  efforts  to  control  further  disease', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 622.708, 526.1359999999999, 633.616), True, False, 5, 841.92, 595.32)"
5,outbreaks caused by the novel CoV (originally named 2019-nCoV) that was first identified in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('outbreaks caused by the novel CoV (originally named 2019-nCoV) that was first identified in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 607.828, 526.3299999999999, 618.736), True, False, 5, 841.92, 595.32)"
5,"Wuhan  City,  Hubei  Province,  China,  on  December  12th,  2019.  On  February  11th,  2020,  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Wuhan  City,  Hubei  Province,  China,  on  December  12th,  2019.  On  February  11th,  2020,  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 592.948, 526.396, 605.67172), True, False, 5, 841.92, 595.32)"
5,World Health Organization (WHO) announced the official designation for this current CoV-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('World Health Organization (WHO) announced the official designation for this current CoV-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 578.068, 523.216, 588.976), True, False, 5, 841.92, 595.32)"
5,"associated  disease  to  be  'COVID-19',  caused  by  the  SARS-CoV-2.  The  primary  cluster  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""associated  disease  to  be  'COVID-19',  caused  by  the  SARS-CoV-2.  The  primary  cluster  of"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 563.158, 526.318, 574.066), True, False, 5, 841.92, 595.32)"
5,patients was found to be connected with the Huanan South China Seafood Market in Wuhan,0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients was found to be connected with the Huanan South China Seafood Market in Wuhan', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 548.278, 526.282, 559.186), True, False, 5, 841.92, 595.32)"
5,"(2).  CoVs  belong  to  the  family  Coronaviridae  (subfamily  Coronavirinae),  the  members  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(2).  CoVs  belong  to  the  family  Coronaviridae  (subfamily  Coronavirinae),  the  members  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 533.398, 526.33, 544.318), False, False, 5, 841.92, 595.32)"
5,"which  infect  a  broad  range  of  hosts,  producing  symptoms  and  diseases  ranging  from  a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('which  infect  a  broad  range  of  hosts,  producing  symptoms  and  diseases  ranging  from  a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 518.398, 526.116, 529.306), True, False, 5, 841.92, 595.32)"
5,"common cold to severe and ultimately fatal illnesses such as SARS, MERS, and, as of present,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('common cold to severe and ultimately fatal illnesses such as SARS, MERS, and, as of present,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 503.51800000000003, 529.1880000000001, 514.426), True, False, 5, 841.92, 595.32)"
5,COVID-19.  The  SARS-CoV-2  (formerly  2019-nCoV)  is  considered  as  one  of  the  seven,0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19.  The  SARS-CoV-2  (formerly  2019-nCoV)  is  considered  as  one  of  the  seven', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 488.63800000000003, 526.2940000000001, 499.546), True, False, 5, 841.92, 595.32)"
5,"members  of  the  CoV  family  that  infect  humans  (3),  and  it  belongs  to  the  same  lineage  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('members  of  the  CoV  family  that  infect  humans  (3),  and  it  belongs  to  the  same  lineage  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 473.75800000000004, 526.3299999999999, 484.666), True, False, 5, 841.92, 595.32)"
5,"CoVs  that  causes  SARS;  however,  this  novel  virus  is  genetically  distinct.  Until  2020,  six",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoVs  that  causes  SARS;  however,  this  novel  virus  is  genetically  distinct.  Until  2020,  six', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 458.87800000000004, 526.42, 469.786), True, False, 5, 841.92, 595.32)"
5,"CoVs  were  known  to  infect  humans  include  HCoV-229E,  HCoV-NL63,  HCoV-OC43,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoVs  were  known  to  infect  humans  include  HCoV-229E,  HCoV-NL63,  HCoV-OC43,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 443.998, 526.408, 454.90599999999995), True, False, 5, 841.92, 595.32)"
5,"HCoV-HKU1,  SARS-CoV,  and  MERS-CoV.  Though  SARS-CoV  and  MERS-CoV  have",0,0,0,0,0,0,0,0,0,0,0,0,0,"('HCoV-HKU1,  SARS-CoV,  and  MERS-CoV.  Though  SARS-CoV  and  MERS-CoV  have', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 429.118, 526.396, 440.02599999999995), True, False, 5, 841.92, 595.32)"
5,"resulted  in  outbreaks  with  high  mortality,  others  remain  associated  with  mild  upper-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('resulted  in  outbreaks  with  high  mortality,  others  remain  associated  with  mild  upper-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 414.238, 523.216, 425.14599999999996), True, False, 5, 841.92, 595.32)"
5,respiratory tract illnesses (4).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory tract illnesses (4).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 399.358, 215.09, 410.26599999999996), True, False, 5, 841.92, 595.32)"
5,Newly evolved CoVs are thus posing a significant threat to global public health. Over,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Newly evolved CoVs are thus posing a significant threat to global public health. Over', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 376.418, 526.0520000000001, 387.32599999999996), True, False, 5, 841.92, 595.32)"
5,"the  past  two  decades,  the  current  emergence  of  COVID-19  is  the  third  CoV  outbreak  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  past  two  decades,  the  current  emergence  of  COVID-19  is  the  third  CoV  outbreak  in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 361.178, 526.258, 372.08599999999996), True, False, 5, 841.92, 595.32)"
5,humans (5). It is no coincidence that Fan et al. predicted potential SARS- or MERS-like CoV,0,0,0,0,0,0,0,0,0,0,0,0,0,"('humans (5). It is no coincidence that Fan et al. predicted potential SARS- or MERS-like CoV', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 346.058, 526.4200000000001, 356.96599999999995), True, False, 5, 841.92, 595.32)"
5,outbreaks  in  China  following  pathogen  transmission  from  bats  (6).  The  COVID-19  that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('outbreaks  in  China  following  pathogen  transmission  from  bats  (6).  The  COVID-19  that', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 330.81800000000004, 526.408, 341.726), True, False, 5, 841.92, 595.32)"
5,emerged in China spread rapidly throughout the country and subsequently to other countries.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('emerged in China spread rapidly throughout the country and subsequently to other countries.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 315.69800000000004, 526.116, 326.606), True, False, 5, 841.92, 595.32)"
5,"Due to the severity of this outbreak and the potential of spreading on an international scale,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Due to the severity of this outbreak and the potential of spreading on an international scale,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 300.458, 526.366, 311.366), True, False, 5, 841.92, 595.32)"
5,"the  WHO  declared  a  'global  health  emergency'  on  January  31st,  2020.  Subsequently,  on",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""the  WHO  declared  a  'global  health  emergency'  on  January  31st,  2020.  Subsequently,  on"", 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 285.338, 526.4200000000001, 298.06172000000004), True, False, 5, 841.92, 595.32)"
5,"March 11th, 2020, a pandemic situation was declared. At present, we are not in a position to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('March 11th, 2020, a pandemic situation was declared. At present, we are not in a position to', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 270.098, 526.234, 282.82172), True, False, 5, 841.92, 595.32)"
5,effectively  treat  COVID-19  since  neither  approved  vaccines  nor  specific  antiviral  drugs  for,0,0,0,0,0,0,0,0,0,0,0,0,0,"('effectively  treat  COVID-19  since  neither  approved  vaccines  nor  specific  antiviral  drugs  for', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 254.97799999999998, 526.294, 265.88599999999997), True, False, 5, 841.92, 595.32)"
5,treating human CoV infections are available (7-9). Most nations are currently making efforts,0,0,0,0,0,0,0,0,0,0,0,0,0,"('treating human CoV infections are available (7-9). Most nations are currently making efforts', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 239.85799999999998, 526.384, 250.766), True, False, 5, 841.92, 595.32)"
5,to prevent further spreading of this potentially deadly virus by implementing preventive and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('to prevent further spreading of this potentially deadly virus by implementing preventive and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 224.618, 526.226, 235.526), True, False, 5, 841.92, 595.32)"
5,control strategies.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('control strategies.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 209.468, 160.34, 220.376), True, False, 5, 841.92, 595.32)"
5,"In  domestic  animals,  infections  with  CoVs  are  associated  with  a  broad  spectrum  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('In  domestic  animals,  infections  with  CoVs  are  associated  with  a  broad  spectrum  of', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 188.22799999999998, 526.0519999999999, 199.136), True, False, 5, 841.92, 595.32)"
5,"pathological conditions. Apart from infectious bronchitis virus, canine respiratory CoV, and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('pathological conditions. Apart from infectious bronchitis virus, canine respiratory CoV, and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 172.38799999999998, 526.408, 183.296), True, False, 5, 841.92, 595.32)"
5,"mouse  hepatitis  virus,  all  other  CoVs  are  predominantly  associated  with  gastrointestinal",0,0,0,0,0,0,0,0,0,0,0,0,0,"('mouse  hepatitis  virus,  all  other  CoVs  are  predominantly  associated  with  gastrointestinal', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 156.54799999999997, 526.104, 167.456), True, False, 5, 841.92, 595.32)"
5,diseases (10). The emergence of novel CoVs may have become possible because of multiple,0,0,0,0,0,0,0,0,0,0,0,0,0,"('diseases (10). The emergence of novel CoVs may have become possible because of multiple', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 140.588, 526.0999999999999, 151.496), True, False, 5, 841.92, 595.32)"
5,"CoVs  being  maintained  in  their  natural  host,  which  could  have  favored  the  probability  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoVs  being  maintained  in  their  natural  host,  which  could  have  favored  the  probability  of', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 124.748, 526.42, 135.656), True, False, 5, 841.92, 595.32)"
5,genetic  recombination  (10).  High  genetic  diversity  and  the  ability  to  infect  multiple  host,0,0,0,0,0,0,0,0,0,0,0,0,0,"('genetic  recombination  (10).  High  genetic  diversity  and  the  ability  to  infect  multiple  host', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 108.908, 526.1660000000002, 119.816), True, False, 5, 841.92, 595.32)"
5,"species  are  a  result  of  high-frequency  mutations  in  CoVs,  which  occur  due  to  instability  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('species  are  a  result  of  high-frequency  mutations  in  CoVs,  which  occur  due  to  instability  of', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 93.072, 526.19, 103.98), True, False, 5, 841.92, 595.32)"
5,RNA-dependent  RNA  polymerases  along  with  higher  rates  of  homologous  RNA,0,0,0,0,0,0,0,0,0,0,0,0,0,"('RNA-dependent  RNA  polymerases  along  with  higher  rates  of  homologous  RNA', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 77.112, 526.384, 88.02), True, False, 5, 841.92, 595.32)"
5,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 5, 841.92, 595.32)"
5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,"('4', 'BCDEEE+Calibri', 11.04, (517.9, 48.864000000000004, 525.91504, 59.904), True, False, 5, 841.92, 595.32)"
6,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 6, 841.92, 595.32)"
6,"recombination (10, 11). Identifying the origin of SARS-CoV-2 and the pathogen's evolution",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""recombination (10, 11). Identifying the origin of SARS-CoV-2 and the pathogen's evolution"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.318, 767.076), True, False, 6, 841.92, 595.32)"
6,"will  be  helpful  for  disease  surveillance  (12),  development  of  new  targeted  drugs,  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('will  be  helpful  for  disease  surveillance  (12),  development  of  new  targeted  drugs,  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 740.308, 526.274, 751.216), True, False, 6, 841.92, 595.32)"
6,prevention of further epidemics (13). The most common symptoms associated with COVID-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('prevention of further epidemics (13). The most common symptoms associated with COVID-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 724.468, 523.456, 735.376), True, False, 6, 841.92, 595.32)"
6,"19 were fever, cough, dyspnea, expectoration, headache, and myalgia or fatigue.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('19 were fever, cough, dyspnea, expectoration, headache, and myalgia or fatigue.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 708.508, 461.02, 719.416), True, False, 6, 841.92, 595.32)"
6,"In  contrast,  less  common  signs  at  the  time  of  hospital  admission  included  diarrhea,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('In  contrast,  less  common  signs  at  the  time  of  hospital  admission  included  diarrhea,', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 686.668, 526.1120000000001, 697.576), True, False, 6, 841.92, 595.32)"
6,"hemoptysis, and shortness of breath (14). Recently, individuals with asymptomatic infections",0,0,0,0,0,0,0,0,0,0,0,0,0,"('hemoptysis, and shortness of breath (14). Recently, individuals with asymptomatic infections', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 670.828, 526.2260000000001, 681.736), True, False, 6, 841.92, 595.32)"
6,"were  also  suspected  of  potentially  transmitting  infections,  which  further  add  to  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('were  also  suspected  of  potentially  transmitting  infections,  which  further  add  to  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 654.988, 526.318, 665.8960000000001), True, False, 6, 841.92, 595.32)"
6,complexity of disease transmission dynamics in COVID-19 infections (1). The current status,0,0,0,0,0,0,0,0,0,0,0,0,0,"('complexity of disease transmission dynamics in COVID-19 infections (1). The current status', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 639.028, 526.306, 649.936), True, False, 6, 841.92, 595.32)"
6,suggests that the COVID-19 outbreak in China may progress as a severe epidemic or even a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('suggests that the COVID-19 outbreak in China may progress as a severe epidemic or even a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 623.188, 526.106, 634.096), True, False, 6, 841.92, 595.32)"
6,pandemic  if  proper  emergency  response  procedures  or  preventive  and  control  measures  are,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pandemic  if  proper  emergency  response  procedures  or  preventive  and  control  measures  are', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 607.3480000000001, 526.282, 618.2560000000001), True, False, 6, 841.92, 595.32)"
6,"not  applied  (15).  Such  efficient  responses  require  in-depth  knowledge  regarding  the  virus,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('not  applied  (15).  Such  efficient  responses  require  in-depth  knowledge  regarding  the  virus,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 591.508, 526.318, 602.416), True, False, 6, 841.92, 595.32)"
6,"which currently is a novel agent; consequently, further studies are required.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('which currently is a novel agent; consequently, further studies are required.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 575.548, 439.99, 586.456), True, False, 6, 841.92, 595.32)"
6,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 553.678, 75.024, 564.586), True, False, 6, 841.92, 595.32)"
6,Comparing the genome of SARS-CoV-2 with that of the closely related SARS/SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Comparing the genome of SARS-CoV-2 with that of the closely related SARS/SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 553.678, 523.576, 564.586), True, False, 6, 841.92, 595.32)"
6,"like CoV revealed that the sequence coding for the spike protein with a total length of 1,273",0,0,0,0,0,0,0,0,0,0,0,0,0,"('like CoV revealed that the sequence coding for the spike protein with a total length of 1,273', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.838, 526.0680000000002, 548.746), True, False, 6, 841.92, 595.32)"
6,amino acids showed 27 amino acid substitutions. Six of these substitutions are in the region,0,0,0,0,0,0,0,0,0,0,0,0,0,"('amino acids showed 27 amino acid substitutions. Six of these substitutions are in the region', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 521.998, 526.0319999999999, 532.9060000000001), True, False, 6, 841.92, 595.32)"
6,"of  the  receptor-binding  domain,  and  another  six  substitutions  are  in  the  underpinning",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  the  receptor-binding  domain,  and  another  six  substitutions  are  in  the  underpinning', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 506.038, 526.2260000000001, 516.946), True, False, 6, 841.92, 595.32)"
6,subdomain  (SD) (16). Phylogenetic analyses have revealed that the  SARS-CoV-2 is  closely,0,0,0,0,0,0,0,0,0,0,0,0,0,"('subdomain  (SD) (16). Phylogenetic analyses have revealed that the  SARS-CoV-2 is  closely', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 490.19800000000004, 526.396, 501.106), True, False, 6, 841.92, 595.32)"
6,related  (88%  similarity)  to  two  SARS-like  CoVs  derived  from  bats  (bat-SL-CoVZC45  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('related  (88%  similarity)  to  two  SARS-like  CoVs  derived  from  bats  (bat-SL-CoVZC45  and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 474.358, 526.3960000000001, 485.26599999999996), True, False, 6, 841.92, 595.32)"
6,"bat-SL-CoVZXC21). Furthermore, the SARS-CoV-2 is genetically distinct from SARS-CoV",0,0,0,0,0,0,0,0,0,0,0,0,0,"('bat-SL-CoVZXC21). Furthermore, the SARS-CoV-2 is genetically distinct from SARS-CoV', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 458.51800000000003, 526.408, 469.426), True, False, 6, 841.92, 595.32)"
6,(79% similarity) and MERS-CoV (50%) (17). The COVID-19is associated with afflictions of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(79% similarity) and MERS-CoV (50%) (17). The COVID-19is associated with afflictions of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 442.558, 526.42, 453.46599999999995), True, False, 6, 841.92, 595.32)"
6,"the lungs in all cases and generated characteristic chest computer-tomography findings, such",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the lungs in all cases and generated characteristic chest computer-tomography findings, such', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 426.718, 526.3420000000001, 437.626), True, False, 6, 841.92, 595.32)"
6,as  the  presence  of  multiple  lesions  in  lung  lobes  that  appear  as  dense  ground-glass  opaque,0,0,0,0,0,0,0,0,0,0,0,0,0,"('as  the  presence  of  multiple  lesions  in  lung  lobes  that  appear  as  dense  ground-glass  opaque', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 410.87800000000004, 526.408, 421.786), True, False, 6, 841.92, 595.32)"
6,structures and occasionally co-exist with consolidation shadows (18).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('structures and occasionally co-exist with consolidation shadows (18).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 395.038, 411.31, 405.94599999999997), True, False, 6, 841.92, 595.32)"
6,Some  therapeutic  options  for  treating  COVID-19  have  shown  efficacy  at  in  vitro,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Some  therapeutic  options  for  treating  COVID-19  have  shown  efficacy  at  in  vitro', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 373.178, 526.42, 384.09799999999996), False, False, 6, 841.92, 595.32)"
6,"studies;  however,  these  treatments  have  to  date  not  undergone  any  randomized  animal  or",0,0,0,0,0,0,0,0,0,0,0,0,0,"('studies;  however,  these  treatments  have  to  date  not  undergone  any  randomized  animal  or', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 357.218, 526.2460000000001, 368.126), True, False, 6, 841.92, 595.32)"
6,"human  clinical  trials,  which  limit  their  practical  applicability  in  the  current  pandemic  (7,  9,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('human  clinical  trials,  which  limit  their  practical  applicability  in  the  current  pandemic  (7,  9,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 341.37800000000004, 526.42, 352.286), True, False, 6, 841.92, 595.32)"
6,19-21).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('19-21).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 325.538, 110.06, 336.44599999999997), True, False, 6, 841.92, 595.32)"
6,The  present  comprehensive  review  describes  the  various  features  of  the  COVID-19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  present  comprehensive  review  describes  the  various  features  of  the  COVID-19', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 303.69800000000004, 526.42, 314.606), True, False, 6, 841.92, 595.32)"
6,"(caused  by  the  SARS-CoV-2)  causing  the  current  disease  outbreaks,  advances  in  diagnosis",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(caused  by  the  SARS-CoV-2)  causing  the  current  disease  outbreaks,  advances  in  diagnosis', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 288.458, 526.19, 299.366), True, False, 6, 841.92, 595.32)"
6,"and  developing  vaccines  and  therapeutics,  a  brief  comparison  with  the  earlier  SARS  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  developing  vaccines  and  therapeutics,  a  brief  comparison  with  the  earlier  SARS  and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 273.338, 526.116, 284.246), True, False, 6, 841.92, 595.32)"
6,"MERS CoVs, the veterinary perspective of CoVs and this emerging novel pathogen as well",0,0,0,0,0,0,0,0,0,0,0,0,0,"('MERS CoVs, the veterinary perspective of CoVs and this emerging novel pathogen as well', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 258.098, 526.342, 269.006), True, False, 6, 841.92, 595.32)"
6,as evaluate the zoonotic potential of similar coronaviruses and to provide feasible one health,0,0,0,0,0,0,0,0,0,0,0,0,0,"('as evaluate the zoonotic potential of similar coronaviruses and to provide feasible one health', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 242.97799999999998, 526.294, 253.886), True, False, 6, 841.92, 595.32)"
6,strategies for the management of this fatal virus (22-330).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('strategies for the management of this fatal virus (22-330).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 227.738, 352.03, 238.64600000000002), True, False, 6, 841.92, 595.32)"
6,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 206.588, 75.024, 217.304), True, False, 6, 841.92, 595.32)"
6,THE VIRUS (SARS-CoV-2),0,0,0,0,0,0,0,0,0,0,0,0,0,"('THE VIRUS (SARS-CoV-2)', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 185.34799999999998, 219.77, 196.064), True, False, 6, 841.92, 595.32)"
6,Coronaviruses are positive-sense RNA viruses having an extensive and promiscuous,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronaviruses are positive-sense RNA viruses having an extensive and promiscuous', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 164.22799999999998, 526.2380000000002, 175.136), True, False, 6, 841.92, 595.32)"
6,"wide  range  of  natural  hosts  and  affect  multiple  systems  (23,  24).  Coronaviruses  can  cause",0,0,0,0,0,0,0,0,0,0,0,0,0,"('wide  range  of  natural  hosts  and  affect  multiple  systems  (23,  24).  Coronaviruses  can  cause', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 148.988, 526.342, 159.89600000000002), True, False, 6, 841.92, 595.32)"
6,clinical diseases in humans that may extend from the common cold to more severe respiratory,0,0,0,0,0,0,0,0,0,0,0,0,0,"('clinical diseases in humans that may extend from the common cold to more severe respiratory', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 133.868, 526.384, 144.776), True, False, 6, 841.92, 595.32)"
6,"diseases  like  SARS  and  MERS  (17,  284).  The  recently  emerging  SARS-CoV-2  has  caused",0,0,0,0,0,0,0,0,0,0,0,0,0,"('diseases  like  SARS  and  MERS  (17,  284).  The  recently  emerging  SARS-CoV-2  has  caused', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 118.628, 526.396, 129.536), True, False, 6, 841.92, 595.32)"
6,"havoc  in  China,  and  pandemic  situation  to  the  worldwide  population,  leading  to  current",0,0,0,0,0,0,0,0,0,0,0,0,0,"('havoc  in  China,  and  pandemic  situation  to  the  worldwide  population,  leading  to  current', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 103.508, 526.396, 114.416), True, False, 6, 841.92, 595.32)"
6,disease outbreaks that have not been controlled to date through high efforts are being put in to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('disease outbreaks that have not been controlled to date through high efforts are being put in to', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 88.272, 526.33, 99.18), True, False, 6, 841.92, 595.32)"
6,"counter this virus. More  recently, the    WHO announced an official name  for this disease as",0,0,0,0,0,0,0,0,0,0,0,0,0,"('counter this virus. More  recently, the    WHO announced an official name  for this disease as', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 73.152, 526.27, 84.06), True, False, 6, 841.92, 595.32)"
6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,"('5', 'BCDEEE+Calibri', 11.04, (517.9, 48.864000000000004, 525.91504, 59.904), True, False, 6, 841.92, 595.32)"
6,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 6, 841.92, 595.32)"
7,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 7, 841.92, 595.32)"
7,"COVID-19.  For the time being, earlier, the  WHO named  this currently  emerging  virus  as  a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19.  For the time being, earlier, the  WHO named  this currently  emerging  virus  as  a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.42, 767.076), True, False, 7, 841.92, 595.32)"
7,"2019-novel  coronavirus  (2019-nCoV)  and  later  the  disease  as  COVID-19  (25).  Later,  this",0,0,0,0,0,0,0,0,0,0,0,0,0,"('2019-novel  coronavirus  (2019-nCoV)  and  later  the  disease  as  COVID-19  (25).  Later,  this', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.396, 751.936), True, False, 7, 841.92, 595.32)"
7,virus  has  been  proposed  to  be  designated/named  as  'severe  acute  respiratory  syndrome,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""virus  has  been  proposed  to  be  designated/named  as  'severe  acute  respiratory  syndrome"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.306, 736.696), True, False, 7, 841.92, 595.32)"
7,coronavirus  2'  (SARS-CoV-2)  by  the International  Committee  on  Taxonomy  of  Viruses,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""coronavirus  2'  (SARS-CoV-2)  by  the International  Committee  on  Taxonomy  of  Viruses"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 526.238, 721.576), True, False, 7, 841.92, 595.32)"
7,(ICTV) Coronaviridae Study  Group  that  determined  the  virus  belongs  to  the  existing,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(ICTV) Coronaviridae Study  Group  that  determined  the  virus  belongs  to  the  existing', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 526.1720000000001, 706.348), False, False, 7, 841.92, 595.32)"
7,"species, Severe acute respiratory syndrome-related coronavirus, and found this virus related",0,0,0,0,0,0,0,0,0,0,0,0,0,"('species, Severe acute respiratory syndrome-related coronavirus, and found this virus related', 'TimesNewRomanPS-ItalicMT', 10.908000000000015, (72.024, 680.308, 526.408, 691.228), False, False, 7, 841.92, 595.32)"
7,"to  SARS-CoVs  (26). The  SARS-CoV-2  is  a  member  of  the  order  Nidovirales,  family",0,0,0,0,0,0,0,0,0,0,0,0,0,"('to  SARS-CoVs  (26). The  SARS-CoV-2  is  a  member  of  the  order  Nidovirales,  family', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 665.068, 526.408, 675.9879999999999), False, False, 7, 841.92, 595.32)"
7,"Coronaviridae,  sub-family  Orthocoronavirinae,  which  is  sub-divided  into  four  genera,  viz.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronaviridae,  sub-family  Orthocoronavirinae,  which  is  sub-divided  into  four  genera,  viz.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 649.948, 526.318, 660.8679999999999), False, False, 7, 841.92, 595.32)"
7,"Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus (3, 27). The",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus (3, 27). The', 'TimesNewRomanPS-ItalicMT', 10.908000000000015, (72.024, 634.708, 526.384, 645.6279999999999), False, False, 7, 841.92, 595.32)"
7,"genera  Alphacoronavirus  and  Betacoronavirus  originate  from  bats,  while  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('genera  Alphacoronavirus  and  Betacoronavirus  originate  from  bats,  while  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 619.588, 526.408, 630.5079999999999), False, False, 7, 841.92, 595.32)"
7,"Gammacoronavirus and Deltacoronavirus have evolved from birds and swine gene pools (24,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Gammacoronavirus and Deltacoronavirus have evolved from birds and swine gene pools (24,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 604.3480000000001, 529.42, 615.268), False, False, 7, 841.92, 595.32)"
7,"28, 29, 280).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('28, 29, 280).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 589.2280000000001, 135.98, 600.1360000000001), True, False, 7, 841.92, 595.32)"
7,"Coronaviruses  possess  an  unsegmented,  single-stranded  (ss)  positive-sense  RNA",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronaviruses  possess  an  unsegmented,  single-stranded  (ss)  positive-sense  RNA', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 567.958, 526.384, 578.866), True, False, 7, 841.92, 595.32)"
7,"genome of around 30 kb, enclosed by a 5'-cap and 3'-poly-A tail (30). The genome of SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""genome of around 30 kb, enclosed by a 5'-cap and 3'-poly-A tail (30). The genome of SARS-"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 552.838, 523.456, 563.746), True, False, 7, 841.92, 595.32)"
7,"CoV-2 is 29.891 kb long, with a G + C content of 38% (31). These viruses are encircled with",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2 is 29.891 kb long, with a G + C content of 38% (31). These viruses are encircled with', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.5980000000001, 526.27, 548.5060000000001), True, False, 7, 841.92, 595.32)"
7,an envelope containing viral nucleocapsid. The nucleocapsids in CoVs are arranged in helical,0,0,0,0,0,0,0,0,0,0,0,0,0,"('an envelope containing viral nucleocapsid. The nucleocapsids in CoVs are arranged in helical', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 522.4780000000001, 526.0439999999999, 533.3860000000001), True, False, 7, 841.92, 595.32)"
7,"symmetry,  which  reflects  an  atypical  attribute  in  positive-sense  RNA  viruses  (30).  The",0,0,0,0,0,0,0,0,0,0,0,0,0,"('symmetry,  which  reflects  an  atypical  attribute  in  positive-sense  RNA  viruses  (30).  The', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 507.238, 526.396, 518.146), True, False, 7, 841.92, 595.32)"
7,electron  micrographs  of  SARS-CoV-2  revealed  a  divulging  spherical  outline  with  some,0,0,0,0,0,0,0,0,0,0,0,0,0,"('electron  micrographs  of  SARS-CoV-2  revealed  a  divulging  spherical  outline  with  some', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 492.118, 526.2860000000002, 503.02599999999995), True, False, 7, 841.92, 595.32)"
7,"degree of pleomorphism, virion diameter varying from 60 to 140 nm, and distinct spikes of 9",0,0,0,0,0,0,0,0,0,0,0,0,0,"('degree of pleomorphism, virion diameter varying from 60 to 140 nm, and distinct spikes of 9', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 476.87800000000004, 526.33, 487.786), True, False, 7, 841.92, 595.32)"
7,"to 12 nm, giving the virus an appearance of a solar corona (3). The CoVs genome is arranged",0,0,0,0,0,0,0,0,0,0,0,0,0,"('to 12 nm, giving the virus an appearance of a solar corona (3). The CoVs genome is arranged', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 461.75800000000004, 526.294, 472.666), True, False, 7, 841.92, 595.32)"
7,linearly  as  5'-leader-UTR-replicase-structural  genes-(S-E-M-N)-3'  UTR-poly  (A)  (32).,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""linearly  as  5'-leader-UTR-replicase-structural  genes-(S-E-M-N)-3'  UTR-poly  (A)  (32)."", 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 446.51800000000003, 526.408, 457.426), True, False, 7, 841.92, 595.32)"
7,"Accessory  genes  such  as  3a/b,  4a/b,  hemagglutinin-esterase  gene  (HE)  are  also  seen",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Accessory  genes  such  as  3a/b,  4a/b,  hemagglutinin-esterase  gene  (HE)  are  also  seen', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 431.398, 526.294, 442.306), True, False, 7, 841.92, 595.32)"
7,intermingled  within  the  structural  genes  (30).  The  SARS-CoV-2  has  also  been  found  to  be,0,0,0,0,0,0,0,0,0,0,0,0,0,"('intermingled  within  the  structural  genes  (30).  The  SARS-CoV-2  has  also  been  found  to  be', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 416.158, 526.3299999999999, 427.066), True, False, 7, 841.92, 595.32)"
7,"arranged similarly and encodes several accessory proteins, although it lacks the HE, which is",0,0,0,0,0,0,0,0,0,0,0,0,0,"('arranged similarly and encodes several accessory proteins, although it lacks the HE, which is', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 401.038, 526.306, 411.94599999999997), True, False, 7, 841.92, 595.32)"
7,characteristic of some Betacoronaviruses (31). The positive-sense genome of CoVs serves as,0,0,0,0,0,0,0,0,0,0,0,0,0,"('characteristic of some Betacoronaviruses (31). The positive-sense genome of CoVs serves as', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 385.778, 526.2940000000001, 396.698), False, False, 7, 841.92, 595.32)"
7,mRNA  and  is  translated  to  polyprotein  1a/1ab  (pp  1a/1ab)  (33).  A  replication-transcription,0,0,0,0,0,0,0,0,0,0,0,0,0,"('mRNA  and  is  translated  to  polyprotein  1a/1ab  (pp  1a/1ab)  (33).  A  replication-transcription', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 370.658, 526.396, 381.566), True, False, 7, 841.92, 595.32)"
7,complex  (RTC)  is  formed  in  double-membrane  vesicles  (DMVs)  by  non-structural  proteins,0,0,0,0,0,0,0,0,0,0,0,0,0,"('complex  (RTC)  is  formed  in  double-membrane  vesicles  (DMVs)  by  non-structural  proteins', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 355.418, 526.342, 366.32599999999996), True, False, 7, 841.92, 595.32)"
7,"(nsps),  encoded  by  the  polyprotein  (34).  Subsequently,  the  RTC  synthesizes  a  nested  set  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(nsps),  encoded  by  the  polyprotein  (34).  Subsequently,  the  RTC  synthesizes  a  nested  set  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 340.298, 526.202, 351.20599999999996), True, False, 7, 841.92, 595.32)"
7,subgenomic RNAs (sgRNAs) via discontinuous transcription (35).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('subgenomic RNAs (sgRNAs) via discontinuous transcription (35).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 325.058, 397.63, 335.96599999999995), True, False, 7, 841.92, 595.32)"
7,"Based  on  molecular  characterization,  the  SARS-CoV-2  is  considered  as  a  new",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Based  on  molecular  characterization,  the  SARS-CoV-2  is  considered  as  a  new', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 303.938, 526.294, 314.84599999999995), True, False, 7, 841.92, 595.32)"
7,Betacoronavirus  belonging  to  the  subgenus  Sarbecovirus  (3).  Few  other  critical  zoonotic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Betacoronavirus  belonging  to  the  subgenus  Sarbecovirus  (3).  Few  other  critical  zoonotic', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 288.69800000000004, 526.396, 299.618), False, False, 7, 841.92, 595.32)"
7,viruses  (MERS-related-CoV  and  SARS-related-CoV)  also  belong  to  the  same  genus.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('viruses  (MERS-related-CoV  and  SARS-related-CoV)  also  belong  to  the  same  genus.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 273.57800000000003, 526.42, 284.486), True, False, 7, 841.92, 595.32)"
7,"However,  the  SARS-CoV-2  was  identified  as  a  distinct  virus  based  on  the  percent  identity",0,0,0,0,0,0,0,0,0,0,0,0,0,"('However,  the  SARS-CoV-2  was  identified  as  a  distinct  virus  based  on  the  percent  identity', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 258.338, 526.384, 269.246), True, False, 7, 841.92, 595.32)"
7,with  other  Betacoronavirus;  conserved  ORF  1ab  is  below  90%  (3).  An  overall  80%,0,0,0,0,0,0,0,0,0,0,0,0,0,"('with  other  Betacoronavirus;  conserved  ORF  1ab  is  below  90%  (3).  An  overall  80%', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 243.218, 526.384, 254.138), False, False, 7, 841.92, 595.32)"
7,nucleotide identity was observed between SARS-CoV-2 and original SARS-CoV along with,0,0,0,0,0,0,0,0,0,0,0,0,0,"('nucleotide identity was observed between SARS-CoV-2 and original SARS-CoV along with', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 227.97799999999998, 526.384, 238.886), True, False, 7, 841.92, 595.32)"
7,"89% identity with ZC45 and ZXC21 SARS related CoVsof bats (2, 31, 36). In addition to this,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('89% identity with ZC45 and ZXC21 SARS related CoVsof bats (2, 31, 36). In addition to this,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 212.82799999999997, 529.42, 223.736), True, False, 7, 841.92, 595.32)"
7,82%  identity  has  been  observed  between  SARS-CoV-2  and  human  SARS-CoV  Tor2  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('82%  identity  has  been  observed  between  SARS-CoV-2  and  human  SARS-CoV  Tor2  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 197.588, 526.384, 208.496), True, False, 7, 841.92, 595.32)"
7,human  SARS-CoV  BJ01  2003  (31).  A  sequence  identity  of  only  51.8%  was  observed,0,0,0,0,0,0,0,0,0,0,0,0,0,"('human  SARS-CoV  BJ01  2003  (31).  A  sequence  identity  of  only  51.8%  was  observed', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 182.468, 526.306, 193.376), True, False, 7, 841.92, 595.32)"
7,between  MERS-related-CoV  and  the  recently  emerged  SARS-CoV-2  (37).  Phylogenetic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('between  MERS-related-CoV  and  the  recently  emerged  SARS-CoV-2  (37).  Phylogenetic', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 167.22799999999998, 526.3720000000001, 178.136), True, False, 7, 841.92, 595.32)"
7,analysis  of  the  structural  genes  also  made  known  that  SARS-CoV-2  is  closer  to  bat  SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('analysis  of  the  structural  genes  also  made  known  that  SARS-CoV-2  is  closer  to  bat  SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 152.10799999999998, 523.576, 163.016), True, False, 7, 841.92, 595.32)"
7,"related-CoV. Therefore, SARS-CoV-2 might have originated from bats, while other amplifier",0,0,0,0,0,0,0,0,0,0,0,0,0,"('related-CoV. Therefore, SARS-CoV-2 might have originated from bats, while other amplifier', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 136.868, 526.3720000000001, 147.776), True, False, 7, 841.92, 595.32)"
7,"hosts might have played a possible role for this disease transmission to humans (31). Of note,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('hosts might have played a possible role for this disease transmission to humans (31). Of note,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 121.748, 526.42, 132.656), True, False, 7, 841.92, 595.32)"
7,the  other  two  zoonotic  CoVs  (MERS-related-CoV  and  SARS-related-CoV)  have  also,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  other  two  zoonotic  CoVs  (MERS-related-CoV  and  SARS-related-CoV)  have  also', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 106.508, 526.42, 117.416), True, False, 7, 841.92, 595.32)"
7,"originated from bats (38, 39). Nevertheless, for SARS and MERS, civet cat and camels act as",0,0,0,0,0,0,0,0,0,0,0,0,0,"('originated from bats (38, 39). Nevertheless, for SARS and MERS, civet cat and camels act as', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 91.392, 526.396, 102.3), True, False, 7, 841.92, 595.32)"
7,"amplifier hosts, respectively (40, 41).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('amplifier hosts, respectively (40, 41).', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 76.152, 254.69, 87.06), True, False, 7, 841.92, 595.32)"
7,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 7, 841.92, 595.32)"
7,6,0,0,0,0,0,0,0,0,0,0,0,0,0,"('6', 'BCDEEE+Calibri', 11.04, (517.9, 48.864000000000004, 525.91504, 59.904), True, False, 7, 841.92, 595.32)"
8,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 8, 841.92, 595.32)"
8,Coronaviruses genome and subgenome encode six open reading frames (ORFs) (31).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronaviruses genome and subgenome encode six open reading frames (ORFs) (31).', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 756.168, 526.3960000000001, 767.076), True, False, 8, 841.92, 595.32)"
8,"The  majority  of  the  5'  end  is  occupied  by  ORF1a/b,  which  produces  16  nsps.  The  two",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""The  majority  of  the  5'  end  is  occupied  by  ORF1a/b,  which  produces  16  nsps.  The  two"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.3960000000001, 751.936), True, False, 8, 841.92, 595.32)"
8,"polyproteins,  pp1a  and  pp1ab,  are  initially  produced  from  ORF1a/b  by  a  -1  frameshift",0,0,0,0,0,0,0,0,0,0,0,0,0,"('polyproteins,  pp1a  and  pp1ab,  are  initially  produced  from  ORF1a/b  by  a  -1  frameshift', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.3960000000001, 736.696), True, False, 8, 841.92, 595.32)"
8,between  ORF1a  and  ORF1b  (32).  The  viral  encoded  proteases  cleave  polyproteins  into,0,0,0,0,0,0,0,0,0,0,0,0,0,"('between  ORF1a  and  ORF1b  (32).  The  viral  encoded  proteases  cleave  polyproteins  into', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 526.366, 721.576), True, False, 8, 841.92, 595.32)"
8,"individual  nsps  [Main  protease  (Mpro),  chymotrypsin-like  protease  (3CLpro),  and  papain-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('individual  nsps  [Main  protease  (Mpro),  chymotrypsin-like  protease  (3CLpro),  and  papain-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 523.336, 706.336), True, False, 8, 841.92, 595.32)"
8,"like  protease  (PLPs)]  (42).  The  SARS-CoV-2  also  encodes  these  nsps,  and  their  functions",0,0,0,0,0,0,0,0,0,0,0,0,0,"('like  protease  (PLPs)]  (42).  The  SARS-CoV-2  also  encodes  these  nsps,  and  their  functions', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 680.308, 526.318, 691.216), True, False, 8, 841.92, 595.32)"
8,"have  been  elucidated  recently  (31).  Remarkably,  a  difference  between  SARS-CoV-2  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('have  been  elucidated  recently  (31).  Remarkably,  a  difference  between  SARS-CoV-2  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 665.068, 526.42, 675.976), True, False, 8, 841.92, 595.32)"
8,other CoVsis the identification of a novel short putative protein within ORF3 band a secreted,0,0,0,0,0,0,0,0,0,0,0,0,0,"('other CoVsis the identification of a novel short putative protein within ORF3 band a secreted', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 649.948, 526.36, 660.856), True, False, 8, 841.92, 595.32)"
8,protein with an alpha helix and beta-sheet with six strands encoded by the ORF8 (31).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein with an alpha helix and beta-sheet with six strands encoded by the ORF8 (31).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 634.708, 488.02, 645.616), True, False, 8, 841.92, 595.32)"
8,"Coronaviruses  encode  four  major  structural  proteins,  namely  Spike  (S),  Membrane",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronaviruses  encode  four  major  structural  proteins,  namely  Spike  (S),  Membrane', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 613.588, 526.318, 624.496), True, False, 8, 841.92, 595.32)"
8,"(M), Envelope (E), and Nucleocapsid (N), which are described in detail as below.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(M), Envelope (E), and Nucleocapsid (N), which are described in detail as below.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 598.3480000000001, 467.02, 609.2560000000001), True, False, 8, 841.92, 595.32)"
8,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 577.2280000000001, 75.024, 587.9440000000001), True, False, 8, 841.92, 595.32)"
8,Spike glycoprotein 'S',0,0,0,0,0,0,0,0,0,0,0,0,0,"(""Spike glycoprotein 'S'"", 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 561.958, 188.42, 572.674), True, False, 8, 841.92, 595.32)"
8,Coronavirus S protein is a large multifunctional class I viral transmembrane protein.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus S protein is a large multifunctional class I viral transmembrane protein.', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 540.838, 526.088, 551.746), True, False, 8, 841.92, 595.32)"
8,"The size of this abundant S protein varies from 1160 amino acids (IBV, Infectious Bronchitis",0,0,0,0,0,0,0,0,0,0,0,0,0,"('The size of this abundant S protein varies from 1160 amino acids (IBV, Infectious Bronchitis', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 525.5980000000001, 526.246, 536.5060000000001), True, False, 8, 841.92, 595.32)"
8,"Virus in poultry) to 1400 amino acids (FCoV, Feline Coronavirus) (43). It lies as a trimer on",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Virus in poultry) to 1400 amino acids (FCoV, Feline Coronavirus) (43). It lies as a trimer on', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 510.47800000000007, 526.318, 521.3860000000001), True, False, 8, 841.92, 595.32)"
8,"the  virion  surface,  giving  the  virion  a  'corona'  or  crown-like  appearance.  Functionally  it  is",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""the  virion  surface,  giving  the  virion  a  'corona'  or  crown-like  appearance.  Functionally  it  is"", 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 495.238, 526.384, 506.14599999999996), True, False, 8, 841.92, 595.32)"
8,required for the entry of the infectious virion particles inside the cell through interaction with,0,0,0,0,0,0,0,0,0,0,0,0,0,"('required for the entry of the infectious virion particles inside the cell through interaction with', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 480.118, 526.0040000000001, 491.02599999999995), True, False, 8, 841.92, 595.32)"
8,various host cellular receptors (44).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('various host cellular receptors (44).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 464.87800000000004, 245.33, 475.786), True, False, 8, 841.92, 595.32)"
8,"Furthermore, it acts as a critical factor for tissue tropism and the determination of host",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Furthermore, it acts as a critical factor for tissue tropism and the determination of host', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 443.75800000000004, 526.33, 454.666), True, False, 8, 841.92, 595.32)"
8,"range (45). Notably, S protein is one of the vital immunodominant proteins of CoVs capable",0,0,0,0,0,0,0,0,0,0,0,0,0,"('range (45). Notably, S protein is one of the vital immunodominant proteins of CoVs capable', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 428.51800000000003, 526.408, 439.426), True, False, 8, 841.92, 595.32)"
8,of  inducing  host  immune  response  (45).  The  ectodomain  in  all  CoVs  S  protein  shows  a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  inducing  host  immune  response  (45).  The  ectodomain  in  all  CoVs  S  protein  shows  a', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 413.398, 526.342, 424.306), True, False, 8, 841.92, 595.32)"
8,"similar domain organization, divided into two domains (43). The first one, S1, helps in host",0,0,0,0,0,0,0,0,0,0,0,0,0,"('similar domain organization, divided into two domains (43). The first one, S1, helps in host', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 398.158, 526.2700000000001, 409.066), True, False, 8, 841.92, 595.32)"
8,"receptor binding while the latter one, S2, accounts for the fusion. The former (S1) is further",0,0,0,0,0,0,0,0,0,0,0,0,0,"('receptor binding while the latter one, S2, accounts for the fusion. The former (S1) is further', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 383.01800000000003, 526.2940000000001, 393.926), True, False, 8, 841.92, 595.32)"
8,"divided into two subdomains, namely the N- terminal domain (NTD) and C- terminal domain",0,0,0,0,0,0,0,0,0,0,0,0,0,"('divided into two subdomains, namely the N- terminal domain (NTD) and C- terminal domain', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 367.778, 526.3960000000001, 378.686), True, False, 8, 841.92, 595.32)"
8,(CTD).  Both  these  subdomains  act  as  the  receptor-binding  domains  interacting  efficiently,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(CTD).  Both  these  subdomains  act  as  the  receptor-binding  domains  interacting  efficiently', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 352.658, 526.2940000000001, 363.566), True, False, 8, 841.92, 595.32)"
8,with various host receptors (45). The S1 CTD contains the receptor-binding motif (RBM). In,0,0,0,0,0,0,0,0,0,0,0,0,0,"('with various host receptors (45). The S1 CTD contains the receptor-binding motif (RBM). In', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 337.418, 526.306, 348.32599999999996), True, False, 8, 841.92, 595.32)"
8,"each  coronavirus  spike  protein,  the  trimeric  S1  locates  itself  on  top  of  the  trimeric  S2  stalk",0,0,0,0,0,0,0,0,0,0,0,0,0,"('each  coronavirus  spike  protein,  the  trimeric  S1  locates  itself  on  top  of  the  trimeric  S2  stalk', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 322.298, 526.2819999999999, 333.20599999999996), True, False, 8, 841.92, 595.32)"
8,"(45).  Lately,  the  structural  analyses  of  the  S  proteins  of  COVID-19have  revealed  27  amino",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(45).  Lately,  the  structural  analyses  of  the  S  proteins  of  COVID-19have  revealed  27  amino', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 307.058, 526.306, 317.96599999999995), True, False, 8, 841.92, 595.32)"
8,acid  substitutions  within  a  length  of  1273  amino  acid  stretch  (16).  Among  the  six,0,0,0,0,0,0,0,0,0,0,0,0,0,"('acid  substitutions  within  a  length  of  1273  amino  acid  stretch  (16).  Among  the  six', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 291.938, 526.342, 302.84599999999995), True, False, 8, 841.92, 595.32)"
8,"substitutions, located in the RBD (aa 357-528) while four substitutions in RBM at the CTD of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('substitutions, located in the RBD (aa 357-528) while four substitutions in RBM at the CTD of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 276.69800000000004, 526.39, 287.606), True, False, 8, 841.92, 595.32)"
8,"the  S1  domain  (16).  To  the  note,  no  amino  acid  change  is  seen  in  the  RBM,  which  binds",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  S1  domain  (16).  To  the  note,  no  amino  acid  change  is  seen  in  the  RBM,  which  binds', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 261.57800000000003, 526.408, 272.486), True, False, 8, 841.92, 595.32)"
8,"directly to the Angiotensin-converting enzyme-2 (ACE2) receptor in SARS-CoV (16, 46). At",0,0,0,0,0,0,0,0,0,0,0,0,0,"('directly to the Angiotensin-converting enzyme-2 (ACE2) receptor in SARS-CoV (16, 46). At', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 246.338, 526.3960000000001, 257.246), True, False, 8, 841.92, 595.32)"
8,"present,  the  main  emphasis  is  to  know  about  how  many  differences  would  be  required  to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('present,  the  main  emphasis  is  to  know  about  how  many  differences  would  be  required  to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 231.218, 526.25, 242.126), True, False, 8, 841.92, 595.32)"
8,change the host tropism. Sequence comparison revealed 17 non-synonymous changes in the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('change the host tropism. Sequence comparison revealed 17 non-synonymous changes in the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 215.97799999999998, 526.42, 226.886), True, False, 8, 841.92, 595.32)"
8,early  sequence  of  SARS-CoV-2  than  the  later  isolates  of  SARS-CoV.  The  changes  were,0,0,0,0,0,0,0,0,0,0,0,0,0,"('early  sequence  of  SARS-CoV-2  than  the  later  isolates  of  SARS-CoV.  The  changes  were', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 200.82799999999997, 526.306, 211.736), True, False, 8, 841.92, 595.32)"
8,found  scattered  over  the  genome  of  the  virus  with  nine  substitutions  in  the  open  reading,0,0,0,0,0,0,0,0,0,0,0,0,0,"('found  scattered  over  the  genome  of  the  virus  with  nine  substitutions  in  the  open  reading', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 185.588, 526.396, 196.496), True, False, 8, 841.92, 595.32)"
8,"frame  (ORF)  1ab,  ORF8  (4  substitutions),  spike  gene  (3  substitutions),  and  ORF7a  (single",0,0,0,0,0,0,0,0,0,0,0,0,0,"('frame  (ORF)  1ab,  ORF8  (4  substitutions),  spike  gene  (3  substitutions),  and  ORF7a  (single', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 170.468, 526.396, 181.376), True, False, 8, 841.92, 595.32)"
8,"substitution) (4). Notably, the same non-synonymous changes were found in a familial cluster,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('substitution) (4). Notably, the same non-synonymous changes were found in a familial cluster,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 155.22799999999998, 529.42, 166.136), True, False, 8, 841.92, 595.32)"
8,indicating that the viral evolution might have happened during person-to-person transmission,0,0,0,0,0,0,0,0,0,0,0,0,0,"('indicating that the viral evolution might have happened during person-to-person transmission', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 140.10799999999998, 526.342, 151.016), True, False, 8, 841.92, 595.32)"
8,"(4,  47).  Such  adaptive  evolutions  are  frequent  and  constitute  a  constantly  ongoing  process",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(4,  47).  Such  adaptive  evolutions  are  frequent  and  constitute  a  constantly  ongoing  process', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 124.868, 526.318, 135.77599999999998), True, False, 8, 841.92, 595.32)"
8,once the virus spreads among new hosts (47). Even though no functional changes occur in the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('once the virus spreads among new hosts (47). Even though no functional changes occur in the', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 109.748, 526.384, 120.656), True, False, 8, 841.92, 595.32)"
8,"virus  associated  with  this  adaptive  evolution,  close  monitoring  of  the  viral  mutations  that",0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus  associated  with  this  adaptive  evolution,  close  monitoring  of  the  viral  mutations  that', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 94.512, 526.1280000000003, 105.42), True, False, 8, 841.92, 595.32)"
8,occurs during subsequent human-to-human transmission is warranted.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('occurs during subsequent human-to-human transmission is warranted.', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 79.392, 411.43, 90.3), True, False, 8, 841.92, 595.32)"
8,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 8, 841.92, 595.32)"
8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,"('7', 'BCDEEE+Calibri', 11.04, (517.9, 48.864000000000004, 525.91504, 59.904), True, False, 8, 841.92, 595.32)"
9,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 9, 841.92, 595.32)"
9,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 756.168, 111.02, 767.076), True, False, 9, 841.92, 595.32)"
9,M protein,0,0,0,0,0,0,0,0,0,0,0,0,0,"('M protein', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 735.028, 126.74, 745.744), True, False, 9, 841.92, 595.32)"
9,"The M protein is the most abundant viral protein present in the virion particle, gives a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('The M protein is the most abundant viral protein present in the virion particle, gives a', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 713.788, 526.0760000000001, 724.696), True, False, 9, 841.92, 595.32)"
9,definite  shape  to  the  viral  envelope  (48).  It  binds  to  nucleocapsid  and  acts  as  a  central,0,0,0,0,0,0,0,0,0,0,0,0,0,"('definite  shape  to  the  viral  envelope  (48).  It  binds  to  nucleocapsid  and  acts  as  a  central', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 698.668, 526.226, 709.576), True, False, 9, 841.92, 595.32)"
9,organizer  of  the  coronavirus  assembly  (49).  Coronaviruses  M  proteins  are  highly  diverse,0,0,0,0,0,0,0,0,0,0,0,0,0,"('organizer  of  the  coronavirus  assembly  (49).  Coronaviruses  M  proteins  are  highly  diverse', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 683.428, 526.2260000000001, 694.336), True, False, 9, 841.92, 595.32)"
9,concerning  amino  acid  contents  but  maintain  overall  structural  similarity  within  different,0,0,0,0,0,0,0,0,0,0,0,0,0,"('concerning  amino  acid  contents  but  maintain  overall  structural  similarity  within  different', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 668.308, 526.1480000000001, 679.216), True, False, 9, 841.92, 595.32)"
9,"general  (50).  The  M  protein  has  three  transmembrane  domains,  flanked  by  short  amino-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('general  (50).  The  M  protein  has  three  transmembrane  domains,  flanked  by  short  amino-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 653.068, 523.336, 663.976), True, False, 9, 841.92, 595.32)"
9,"terminal  outside  the  virion,  and  a  long  carboxy-terminal  inside  the  virion  (50).  Overall,  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('terminal  outside  the  virion,  and  a  long  carboxy-terminal  inside  the  virion  (50).  Overall,  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 637.948, 526.348, 648.856), True, False, 9, 841.92, 595.32)"
9,"viral scaffold is maintained by M-M interaction. To the note, the M protein of SARS-CoV-2",0,0,0,0,0,0,0,0,0,0,0,0,0,"('viral scaffold is maintained by M-M interaction. To the note, the M protein of SARS-CoV-2', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 622.708, 526.42, 633.616), True, False, 9, 841.92, 595.32)"
9,does not have an amino acid substitution in comparison to the SARS-CoV (16).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('does not have an amino acid substitution in comparison to the SARS-CoV (16).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 607.588, 460.42, 618.496), True, False, 9, 841.92, 595.32)"
9,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 586.3480000000001, 75.024, 597.0640000000001), True, False, 9, 841.92, 595.32)"
9,E protein,0,0,0,0,0,0,0,0,0,0,0,0,0,"('E protein', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 565.198, 123.38, 575.914), True, False, 9, 841.92, 595.32)"
9,The  coronaviruses  E  protein  is  the  most  enigmatic  and  smallest  among  the  major,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  coronaviruses  E  protein  is  the  most  enigmatic  and  smallest  among  the  major', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 543.958, 526.124, 554.866), True, False, 9, 841.92, 595.32)"
9,"structural  proteins  (51).  It  plays  a  multifunctional  role  in  the  pathogenesis,  assembly,  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('structural  proteins  (51).  It  plays  a  multifunctional  role  in  the  pathogenesis,  assembly,  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 528.838, 526.19, 539.746), True, False, 9, 841.92, 595.32)"
9,release  of  the  virus  (52).  It  is  a  small  integral  membrane  polypeptide  that  acts  as  viroporin,0,0,0,0,0,0,0,0,0,0,0,0,0,"('release  of  the  virus  (52).  It  is  a  small  integral  membrane  polypeptide  that  acts  as  viroporin', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 513.5980000000001, 526.306, 524.5060000000001), True, False, 9, 841.92, 595.32)"
9,(ion-channel)  (53).  Inactivation  or  absence  of  this  protein  is  related  to  altered  virulence  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(ion-channel)  (53).  Inactivation  or  absence  of  this  protein  is  related  to  altered  virulence  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 498.478, 526.124, 509.38599999999997), True, False, 9, 841.92, 595.32)"
9,coronaviruses due to changes in morphology and tropism (54). The E protein consists of three,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronaviruses due to changes in morphology and tropism (54). The E protein consists of three', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 483.238, 526.318, 494.14599999999996), True, False, 9, 841.92, 595.32)"
9,"domains,  namely  short  hydrophilic  amino-terminal,  a  large  hydrophobic  transmembrane",0,0,0,0,0,0,0,0,0,0,0,0,0,"('domains,  namely  short  hydrophilic  amino-terminal,  a  large  hydrophobic  transmembrane', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 468.118, 526.2620000000001, 479.02599999999995), True, False, 9, 841.92, 595.32)"
9,"domain,  and  an  excellent  C  terminal  domain  (51).  The  SARS-CoV-2  E  protein  reveals  a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('domain,  and  an  excellent  C  terminal  domain  (51).  The  SARS-CoV-2  E  protein  reveals  a', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 452.87800000000004, 526.42, 463.786), True, False, 9, 841.92, 595.32)"
9,similar amino acid constitution without any substitution (16).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('similar amino acid constitution without any substitution (16).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 437.75800000000004, 369.07, 448.666), True, False, 9, 841.92, 595.32)"
9,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 422.51800000000003, 111.02, 433.426), True, False, 9, 841.92, 595.32)"
9,N protein,0,0,0,0,0,0,0,0,0,0,0,0,0,"('N protein', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 401.63800000000003, 126.98, 412.35400000000004), True, False, 9, 841.92, 595.32)"
9,"The N protein of coronavirus is multipurpose. Among several functions, it plays a role",0,0,0,0,0,0,0,0,0,0,0,0,0,"('The N protein of coronavirus is multipurpose. Among several functions, it plays a role', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 380.498, 526.396, 391.40599999999995), True, False, 9, 841.92, 595.32)"
9,"in  complex  formation  with  viral  genome,  facilitates  M  protein  interaction  needed  during",0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  complex  formation  with  viral  genome,  facilitates  M  protein  interaction  needed  during', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 365.25800000000004, 526.282, 376.166), True, False, 9, 841.92, 595.32)"
9,"virion assembly, and enhances transcription efficiency of the virus (55, 56). It contains three",0,0,0,0,0,0,0,0,0,0,0,0,0,"('virion assembly, and enhances transcription efficiency of the virus (55, 56). It contains three', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 350.13800000000003, 526.384, 361.046), True, False, 9, 841.92, 595.32)"
9,"highly conserved and distinct domains, namely an N-terminal domain (NTD), RNA-binding",0,0,0,0,0,0,0,0,0,0,0,0,0,"('highly conserved and distinct domains, namely an N-terminal domain (NTD), RNA-binding', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 334.898, 526.396, 345.806), True, False, 9, 841.92, 595.32)"
9,"domain or a linker region (LKR), and a C-terminal domain (CTD) (57). The NTD binds with",0,0,0,0,0,0,0,0,0,0,0,0,0,"('domain or a linker region (LKR), and a C-terminal domain (CTD) (57). The NTD binds with', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 319.778, 526.318, 330.686), True, False, 9, 841.92, 595.32)"
9,"the 3' end of the viral  genome, perhaps via electrostatic interactions, and is  highly diverged",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""the 3' end of the viral  genome, perhaps via electrostatic interactions, and is  highly diverged"", 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 304.538, 526.342, 315.44599999999997), True, False, 9, 841.92, 595.32)"
9,both in length as well as sequence (58). The charged LKR is serine and arginine-rich and also,0,0,0,0,0,0,0,0,0,0,0,0,0,"('both in length as well as sequence (58). The charged LKR is serine and arginine-rich and also', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 289.418, 526.384, 300.32599999999996), True, False, 9, 841.92, 595.32)"
9,known  as  SR  (Serine  and  Arginine)  domain  (59).  The  LKR  region  is  capable  of  direct,0,0,0,0,0,0,0,0,0,0,0,0,0,"('known  as  SR  (Serine  and  Arginine)  domain  (59).  The  LKR  region  is  capable  of  direct', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 274.178, 526.2460000000001, 285.08599999999996), True, False, 9, 841.92, 595.32)"
9,"interaction with in vitro RNA interaction and is also responsible for cell signaling (60, 61). It",0,0,0,0,0,0,0,0,0,0,0,0,0,"('interaction with in vitro RNA interaction and is also responsible for cell signaling (60, 61). It', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 259.058, 526.4200000000001, 269.97799999999995), False, False, 9, 841.92, 595.32)"
9,also  modulates the antiviral  response  of the host  by  working as  an antagonist for interferon,0,0,0,0,0,0,0,0,0,0,0,0,0,"('also  modulates the antiviral  response  of the host  by  working as  an antagonist for interferon', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 243.81799999999998, 526.2819999999999, 254.726), True, False, 9, 841.92, 595.32)"
9,"and  RNA  interference  (62).  In  comparison  to  SARS-CoV,  the  N  protein  of  SARS-CoV-2",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  RNA  interference  (62).  In  comparison  to  SARS-CoV,  the  N  protein  of  SARS-CoV-2', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 228.69799999999998, 526.42, 239.606), True, False, 9, 841.92, 595.32)"
9,"possess  five  amino  acid  mutations,  where  the  two  are  in  the  intrinsically  dispersed  region",0,0,0,0,0,0,0,0,0,0,0,0,0,"('possess  five  amino  acid  mutations,  where  the  two  are  in  the  intrinsically  dispersed  region', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 213.428, 526.1120000000001, 224.336), True, False, 9, 841.92, 595.32)"
9,"(IDR, 25 & 26 positions), one each in the NTD (103 position), LKR (217 position) and CTD",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(IDR, 25 & 26 positions), one each in the NTD (103 position), LKR (217 position) and CTD', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 198.308, 525.9720000000002, 209.216), True, False, 9, 841.92, 595.32)"
9,(334 position) (16).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(334 position) (16).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 183.06799999999998, 171.74, 193.976), True, False, 9, 841.92, 595.32)"
9,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldItalicMT', 10.716000000000008, (72.024, 161.94799999999998, 75.024, 172.664), True, False, 9, 841.92, 595.32)"
9,NSPs and accessory proteins,0,0,0,0,0,0,0,0,0,0,0,0,0,"('NSPs and accessory proteins', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 140.708, 224.45, 151.424), True, False, 9, 841.92, 595.32)"
9,"Besides  the  important  structural  proteins,  SARS-CoV-2genome  contains  15  nsps,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Besides  the  important  structural  proteins,  SARS-CoV-2genome  contains  15  nsps,', 'TimesNewRomanPSMT', 10.908000000000001, (108.02, 119.58800000000001, 526.3420000000001, 130.496), True, False, 9, 841.92, 595.32)"
9,"nsp1-nsp10  and  nsp12-16  and  8  accessory  proteins  (3a,  3b,  p6,  7a,  7b,  8b,  9b,  and  orf  14)",0,0,0,0,0,0,0,0,0,0,0,0,0,"('nsp1-nsp10  and  nsp12-16  and  8  accessory  proteins  (3a,  3b,  p6,  7a,  7b,  8b,  9b,  and  orf  14)', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 104.348, 526.456, 115.256), True, False, 9, 841.92, 595.32)"
9,(16). All these proteins play a specific role in viral replication (27). The difference in respect,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(16). All these proteins play a specific role in viral replication (27). The difference in respect', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 89.232, 526.306, 100.14), True, False, 9, 841.92, 595.32)"
9,"to  the  accessory  proteins  with  SARS-CoV,  SARS-CoV-2  does  not  contain  8a  protein  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('to  the  accessory  proteins  with  SARS-CoV,  SARS-CoV-2  does  not  contain  8a  protein  and', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 73.992, 526.318, 84.9), True, False, 9, 841.92, 595.32)"
9,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 9, 841.92, 595.32)"
9,8,0,0,0,0,0,0,0,0,0,0,0,0,0,"('8', 'BCDEEE+Calibri', 11.04, (517.9, 48.864000000000004, 525.91504, 59.904), True, False, 9, 841.92, 595.32)"
10,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 10, 841.92, 595.32)"
10,"longer  8b,  and  shorter  3b  proteins  (16).  The  nsp7,  nsp13,  envelope,  matrix,  or  accessory",0,0,0,0,0,0,0,0,0,0,0,0,0,"('longer  8b,  and  shorter  3b  proteins  (16).  The  nsp7,  nsp13,  envelope,  matrix,  or  accessory', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.3100000000002, 767.076), True, False, 10, 841.92, 595.32)"
10,proteins p6 and 8b have not been detected with any amino acid substitutions in comparison to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('proteins p6 and 8b have not been detected with any amino acid substitutions in comparison to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.19, 751.936), True, False, 10, 841.92, 595.32)"
10,coronaviruses (16).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronaviruses (16).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 167.66, 736.696), True, False, 10, 841.92, 595.32)"
10,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 75.024, 721.576), True, False, 10, 841.92, 595.32)"
10,The virus structure of SARS-CoV-2 is depicted in Fig. 1.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The virus structure of SARS-CoV-2 is depicted in Fig. 1.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 696.868, 350.11, 707.7760000000001), False, False, 10, 841.92, 595.32)"
10,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 677.068, 111.02, 687.976), True, False, 10, 841.92, 595.32)"
10,SARS-CoV-2 spike glycoprotein gene analysis,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2 spike glycoprotein gene analysis', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 661.828, 309.77, 672.544), True, False, 10, 841.92, 595.32)"
10,i. Sequence percent similarity analysis,0,0,0,0,0,0,0,0,0,0,0,0,0,"('i. Sequence percent similarity analysis', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 638.908, 270.05, 649.624), True, False, 10, 841.92, 595.32)"
10,We  assessed  the  nucleotide  (NT)  percent  similarity  using  the  MegAlign  software,0,0,0,0,0,0,0,0,0,0,0,0,0,"('We  assessed  the  nucleotide  (NT)  percent  similarity  using  the  MegAlign  software', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 616.1080000000001, 526.342, 627.0160000000001), True, False, 10, 841.92, 595.32)"
10,"program, where the similarity in between the current novel SARS-CoV-2 isolates was found",0,0,0,0,0,0,0,0,0,0,0,0,0,"('program, where the similarity in between the current novel SARS-CoV-2 isolates was found', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 601.1080000000001, 526.33, 612.0160000000001), True, False, 10, 841.92, 595.32)"
10,"in  the  range  of  99.4  to  100  %.  Among  the  other  Serbecovirus  CoV  sequences,  the  novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  the  range  of  99.4  to  100  %.  Among  the  other  Serbecovirus  CoV  sequences,  the  novel', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 586.2280000000001, 526.294, 597.148), False, False, 10, 841.92, 595.32)"
10,SARS-CoV-2 sequences showed the highest similarity with Bat-SL-CoV with the NT percent,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2 sequences showed the highest similarity with Bat-SL-CoV with the NT percent', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 571.318, 526.306, 582.226), True, False, 10, 841.92, 595.32)"
10,"identity  ranges  between  78.2  to  78.8%.  Meanwhile,  earlier  reported  SARS-CoVs  showed",0,0,0,0,0,0,0,0,0,0,0,0,0,"('identity  ranges  between  78.2  to  78.8%.  Meanwhile,  earlier  reported  SARS-CoVs  showed', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 556.438, 526.396, 567.346), True, False, 10, 841.92, 595.32)"
10,"70.6 to 74.9 % similarity at NT levels with SARS-CoV-2. Further, the NT percent similarity",0,0,0,0,0,0,0,0,0,0,0,0,0,"('70.6 to 74.9 % similarity at NT levels with SARS-CoV-2. Further, the NT percent similarity', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 541.558, 526.282, 552.466), True, False, 10, 841.92, 595.32)"
10,"was  55.4%,  45.5%  to  47.9%,  46.2%  to  46.6%,  and  45.0%  to  46.3%  with  the  other  four",0,0,0,0,0,0,0,0,0,0,0,0,0,"('was  55.4%,  45.5%  to  47.9%,  46.2%  to  46.6%,  and  45.0%  to  46.3%  with  the  other  four', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 526.678, 526.396, 537.586), True, False, 10, 841.92, 595.32)"
10,"subgenera, namely Hibecovirus, Nobecovirus, Merbecovirus, and Embecovirus, respectively.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('subgenera, namely Hibecovirus, Nobecovirus, Merbecovirus, and Embecovirus, respectively.', 'TimesNewRomanPS-ItalicMT', 10.908000000000015, (72.024, 511.798, 526.36, 522.718), False, False, 10, 841.92, 595.32)"
10,The  percent  similarity  index  of  current  outbreak  isolates  signposts  a  close  relationship  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  percent  similarity  index  of  current  outbreak  isolates  signposts  a  close  relationship  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 496.918, 526.104, 507.82599999999996), True, False, 10, 841.92, 595.32)"
10,"SARS-CoV-2  isolates  to  Bat-SL-CoV,  indicating  a  common  origin.  However,  particular",0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  isolates  to  Bat-SL-CoV,  indicating  a  common  origin.  However,  particular', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 482.038, 526.42, 492.94599999999997), True, False, 10, 841.92, 595.32)"
10,pieces  of  evidence  based  on  further  complete  genomic  analysis  of  current  isolates  are,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pieces  of  evidence  based  on  further  complete  genomic  analysis  of  current  isolates  are', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 467.158, 526.1, 478.066), True, False, 10, 841.92, 595.32)"
10,"necessary to draw any supposition. Though, it was ascertained that the current novel SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('necessary to draw any supposition. Though, it was ascertained that the current novel SARS-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 452.158, 523.456, 463.066), True, False, 10, 841.92, 595.32)"
10,CoV-2  isolates  belong  to  the  subgenus  of  Sarbecovirus  falling  inside  the  diverse  range  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2  isolates  belong  to  the  subgenus  of  Sarbecovirus  falling  inside  the  diverse  range  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 437.278, 526.4200000000001, 448.198), False, False, 10, 841.92, 595.32)"
10,Betacoronaviruses.  Their  possible  ancestor  was  hypothesized  to  be  of  bat  CoV  strains,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Betacoronaviruses.  Their  possible  ancestor  was  hypothesized  to  be  of  bat  CoV  strains', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 422.398, 526.1780000000001, 433.318), False, False, 10, 841.92, 595.32)"
10,wherein bats might have played a crucial part in harboring this class of viruses.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('wherein bats might have played a crucial part in harboring this class of viruses.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 407.51800000000003, 454.9, 418.426), True, False, 10, 841.92, 595.32)"
10,ii. Splits-Tree phylogeny analysis,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ii. Splits-Tree phylogeny analysis', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 384.57800000000003, 243.77, 395.29400000000004), True, False, 10, 841.92, 595.32)"
10,In  the  unrooted  phylogenetic  tree  of  different  betacoronaviruses  based  on  the  S,0,0,0,0,0,0,0,0,0,0,0,0,0,"('In  the  unrooted  phylogenetic  tree  of  different  betacoronaviruses  based  on  the  S', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 361.778, 526.42, 372.686), True, False, 10, 841.92, 595.32)"
10,"protein, virus sequences from different subgenera grouped into separate clusters. SARS-CoV-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein, virus sequences from different subgenera grouped into separate clusters. SARS-CoV-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 346.898, 523.576, 357.806), True, False, 10, 841.92, 595.32)"
10,2 sequences from Wuhan and other countries exhibited a close relationship and appeared in a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2 sequences from Wuhan and other countries exhibited a close relationship and appeared in a', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 332.01800000000003, 526.0799999999999, 342.926), True, False, 10, 841.92, 595.32)"
10,single  cluster  (Fig.  2).  The  CoVs  from  the  subgenus  Sarbecovirus  appeared  jointly  in  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('single  cluster  (Fig.  2).  The  CoVs  from  the  subgenus  Sarbecovirus  appeared  jointly  in  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 317.01800000000003, 526.384, 327.938), False, False, 10, 841.92, 595.32)"
10,"splits-tree  and  divided  into  three  sub-clusters,  namely  SARS-CoV-2,  Bat-SARS-like-CoV",0,0,0,0,0,0,0,0,0,0,0,0,0,"('splits-tree  and  divided  into  three  sub-clusters,  namely  SARS-CoV-2,  Bat-SARS-like-CoV', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 302.13800000000003, 526.432, 313.046), True, False, 10, 841.92, 595.32)"
10,"(Bat-SL-CoV) and SARS-CoVs (Fig. 2). In the case of other subgenera like Merbecoviruses,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(Bat-SL-CoV) and SARS-CoVs (Fig. 2). In the case of other subgenera like Merbecoviruses,', 'TimesNewRomanPSMT', 10.919999999999959, (72.024, 287.25800000000004, 526.384, 298.178), False, False, 10, 841.92, 595.32)"
10,all  the  sequences  grouped  in  a  single  cluster  whereas  in  Embecovirus  different  species,0,0,0,0,0,0,0,0,0,0,0,0,0,"('all  the  sequences  grouped  in  a  single  cluster  whereas  in  Embecovirus  different  species', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 272.37800000000004, 526.3720000000001, 283.298), False, False, 10, 841.92, 595.32)"
10,"comprising of canine  respiratory CoVs, bovine CoVs, equine CoVs, and  human CoV strain",0,0,0,0,0,0,0,0,0,0,0,0,0,"('comprising of canine  respiratory CoVs, bovine CoVs, equine CoVs, and  human CoV strain', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 257.498, 526.116, 268.40599999999995), True, False, 10, 841.92, 595.32)"
10,(OC43)  grouped  inside  a  common  cluster.  Isolates  in  the  subgenus  Nobecovorus  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(OC43)  grouped  inside  a  common  cluster.  Isolates  in  the  subgenus  Nobecovorus  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 242.618, 526.42, 253.538), False, False, 10, 841.92, 595.32)"
10,Hibecovirus were found placed separately away from other reported SARS-CoVs but share a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Hibecovirus were found placed separately away from other reported SARS-CoVs but share a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 227.738, 526.318, 238.65800000000002), False, False, 10, 841.92, 595.32)"
10,common origin from bats.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('common origin from bats.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 212.82799999999997, 200.33, 223.736), True, False, 10, 841.92, 595.32)"
10,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 189.908, 75.024, 200.624), True, False, 10, 841.92, 595.32)"
10,CURRENT WORLDWIDE SCENARIO OF SARS-CoV-2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CURRENT WORLDWIDE SCENARIO OF SARS-CoV-2', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 168.66799999999998, 377.35, 179.384), True, False, 10, 841.92, 595.32)"
10,"This  novel  virus,  SARS-CoV-2,  comes  under  the  subgenus  Sarbecovirus  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('This  novel  virus,  SARS-CoV-2,  comes  under  the  subgenus  Sarbecovirus  of', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 147.54799999999997, 526.408, 158.468), False, False, 10, 841.92, 595.32)"
10,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 147.54799999999997, 75.024, 158.456), True, False, 10, 841.92, 595.32)"
10,Orthocoronavirinae  subfamily  and  is  entirely  different  from  the  viruses  responsible  for,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Orthocoronavirinae  subfamily  and  is  entirely  different  from  the  viruses  responsible  for', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 132.428, 529.42, 143.348), False, False, 10, 841.92, 595.32)"
10,MERS-CoV and SARS-CoV (3). The newly emerged  SARS-CoV-2 comes under the group,0,0,0,0,0,0,0,0,0,0,0,0,0,"('MERS-CoV and SARS-CoV (3). The newly emerged  SARS-CoV-2 comes under the group', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 117.188, 526.42, 128.096), True, False, 10, 841.92, 595.32)"
10,2B coronavirus (2). The genome sequences of SARS-CoV-2 obtained from the patients share,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2B coronavirus (2). The genome sequences of SARS-CoV-2 obtained from the patients share', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 102.068, 526.33, 112.976), True, False, 10, 841.92, 595.32)"
10,a 79.5% sequence similarity to that of SARS-CoV (63).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('a 79.5% sequence similarity to that of SARS-CoV (63).', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 86.83200000000001, 342.43, 97.74000000000001), True, False, 10, 841.92, 595.32)"
10,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 10, 841.92, 595.32)"
10,9,0,0,0,0,0,0,0,0,0,0,0,0,0,"('9', 'BCDEEE+Calibri', 11.04, (517.9, 48.864000000000004, 525.91504, 59.904), True, False, 10, 841.92, 595.32)"
11,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 11, 841.92, 595.32)"
11,"As on April 2, 2020, a total number of 8,96,450 confirmed cases of COVID-19 (with",0,0,0,0,0,0,0,0,0,0,0,0,0,"('As on April 2, 2020, a total number of 8,96,450 confirmed cases of COVID-19 (with', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 756.168, 526.396, 767.076), True, False, 11, 841.92, 595.32)"
11,"45,526 deaths) were reported in 203 countries worldwide (WHO situation report, 73) (Fig. 3).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('45,526 deaths) were reported in 203 countries worldwide (WHO situation report, 73) (Fig. 3).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 740.308, 525.94, 751.216), False, False, 11, 841.92, 595.32)"
11,"Initially,  the  epicenter  of  the  SARS-CoV-2  pandemic  was  China,  which  reported  a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Initially,  the  epicenter  of  the  SARS-CoV-2  pandemic  was  China,  which  reported  a', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 716.428, 526.2700000000001, 727.336), True, False, 11, 841.92, 595.32)"
11,"maximum of deaths associated with COVID-19, with 82,724 laboratory-confirmed cases with",0,0,0,0,0,0,0,0,0,0,0,0,0,"('maximum of deaths associated with COVID-19, with 82,724 laboratory-confirmed cases with', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 700.588, 526.33, 711.496), True, False, 11, 841.92, 595.32)"
11,"3,327 deaths on April 2, 2020 (Fig. 4). The SARS-CoV-2 confirmed cases were reported in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('3,327 deaths on April 2, 2020 (Fig. 4). The SARS-CoV-2 confirmed cases were reported in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 684.628, 526.42, 695.5360000000001), True, False, 11, 841.92, 595.32)"
11,"more  than  203  countries  apart  from  China  till  April  2,  2020  (Fig.  3,  Fig.  4).  (25,  64).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('more  than  203  countries  apart  from  China  till  April  2,  2020  (Fig.  3,  Fig.  4).  (25,  64).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 668.788, 526.42, 679.696), True, False, 11, 841.92, 595.32)"
11,"Currently,  all  the  continents  in  the  world,  except  Antarctica,  have  COVID-19.  For  many",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Currently,  all  the  continents  in  the  world,  except  Antarctica,  have  COVID-19.  For  many', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 652.948, 526.384, 663.856), True, False, 11, 841.92, 595.32)"
11,"weeks,  Italy  was  the  focus  of  concerns  regarding  the  high  number  of  cases,  with  1,10,574",0,0,0,0,0,0,0,0,0,0,0,0,0,"('weeks,  Italy  was  the  focus  of  concerns  regarding  the  high  number  of  cases,  with  1,10,574', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 637.1080000000001, 526.42, 648.0160000000001), True, False, 11, 841.92, 595.32)"
11,"cases  and  13,157  deaths  (1°),  but  now,  the  United  States  is  the  country  with  the  highest",0,0,0,0,0,0,0,0,0,0,0,0,0,"('cases  and  13,157  deaths  (1°),  but  now,  the  United  States  is  the  country  with  the  highest', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 621.148, 526.0760000000001, 632.056), True, False, 11, 841.92, 595.32)"
11,"number of cases, 1,87,302 and 3,846 deaths. Spain, the third country with the highest number",0,0,0,0,0,0,0,0,0,0,0,0,0,"('number of cases, 1,87,302 and 3,846 deaths. Spain, the third country with the highest number', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 605.308, 526.172, 616.216), True, False, 11, 841.92, 595.32)"
11,"of cases, 1,02,136, is second in the number of deaths, 9,053. A John Hopkins University web",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of cases, 1,02,136, is second in the number of deaths, 9,053. A John Hopkins University web', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 589.468, 526.342, 600.376), True, False, 11, 841.92, 595.32)"
11,platform  has  provided  daily  updates  on  the  basic  epidemiology  of  the  COVID-19  outbreak,0,0,0,0,0,0,0,0,0,0,0,0,0,"('platform  has  provided  daily  updates  on  the  basic  epidemiology  of  the  COVID-19  outbreak', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 573.628, 526.42, 584.5360000000001), True, False, 11, 841.92, 595.32)"
11,(https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 557.638, 520.488, 568.546), True, False, 11, 841.92, 595.32)"
11,467b48e9ecf6) (238).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('467b48e9ecf6) (238).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 541.798, 178.94, 552.706), True, False, 11, 841.92, 595.32)"
11,The COVID-19 has also been confirmed on a cruise ship named 'Diamond Princess',0,0,0,0,0,0,0,0,0,0,0,0,0,"(""The COVID-19 has also been confirmed on a cruise ship named 'Diamond Princess'"", 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 517.918, 526.408, 528.826), True, False, 11, 841.92, 595.32)"
11,"quarantined  in  the  Japanese  water  territory  (Port  of  Yokohama),  as  well  as  on  other  cruise",0,0,0,0,0,0,0,0,0,0,0,0,0,"('quarantined  in  the  Japanese  water  territory  (Port  of  Yokohama),  as  well  as  on  other  cruise', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 502.07800000000003, 526.384, 512.986), True, False, 11, 841.92, 595.32)"
11,"ships  in  the  world  (239)  (Fig.3,  Fig.4).  The  significant  events  occurred  during  the  SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('ships  in  the  world  (239)  (Fig.3,  Fig.4).  The  significant  events  occurred  during  the  SARS-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 486.238, 523.456, 497.14599999999996), False, False, 11, 841.92, 595.32)"
11,"CoV-2/COVID-19 virus outbreak from 8th Dec. 2019 and till April 2, 2020, are presented as a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2/COVID-19 virus outbreak from 8th Dec. 2019 and till April 2, 2020, are presented as a', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 470.398, 526.342, 483.12172000000004), True, False, 11, 841.92, 595.32)"
11,timeline depiction in Fig. 5.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('timeline depiction in Fig. 5.', 'TimesNewRomanPSMT', 10.716000000000008, (72.024, 454.438, 209.09, 465.34599999999995), False, False, 11, 841.92, 595.32)"
11,China at the beginning bears the majority of the burden associated with COVID-19 in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('China at the beginning bears the majority of the burden associated with COVID-19 in', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 430.558, 526.384, 441.46599999999995), True, False, 11, 841.92, 595.32)"
11,"the form of disease morbidity and mortality compared to other countries (65), but with time",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the form of disease morbidity and mortality compared to other countries (65), but with time', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 415.438, 526.372, 426.34599999999995), True, False, 11, 841.92, 595.32)"
11,"passing there was an evident displacement to Europe, particularly Italy and Spain, while the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('passing there was an evident displacement to Europe, particularly Italy and Spain, while the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 400.19800000000004, 526.42, 411.106), True, False, 11, 841.92, 595.32)"
11,United States is now having the highest number of confirmed cases. The COVID-19 outbreak,0,0,0,0,0,0,0,0,0,0,0,0,0,"('United States is now having the highest number of confirmed cases. The COVID-19 outbreak', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 385.058, 526.396, 395.96599999999995), True, False, 11, 841.92, 595.32)"
11,has also been associated with severe economic impact globally due to the sudden interruption,0,0,0,0,0,0,0,0,0,0,0,0,0,"('has also been associated with severe economic impact globally due to the sudden interruption', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 369.938, 526.342, 380.84599999999995), True, False, 11, 841.92, 595.32)"
11,of  global  trade  and  supply  chains  that  forced  the  multinational  companies  to  make  hard,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  global  trade  and  supply  chains  that  forced  the  multinational  companies  to  make  hard', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 354.69800000000004, 526.068, 365.606), True, False, 11, 841.92, 595.32)"
11,decisions that lead to significant economic losses (66). The recent increase in the number of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('decisions that lead to significant economic losses (66). The recent increase in the number of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 339.57800000000003, 526.408, 350.486), True, False, 11, 841.92, 595.32)"
11,confirmed  critically  ill  patients  with  COVID-19  has  already  surpassed  the  intensive  care,0,0,0,0,0,0,0,0,0,0,0,0,0,"('confirmed  critically  ill  patients  with  COVID-19  has  already  surpassed  the  intensive  care', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 324.338, 526.2260000000001, 335.246), True, False, 11, 841.92, 595.32)"
11,"supplies,  thus  limiting the  intensive  care  services  only  to  a  small  proportion  of  critically  ill",0,0,0,0,0,0,0,0,0,0,0,0,0,"('supplies,  thus  limiting the  intensive  care  services  only  to  a  small  proportion  of  critically  ill', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 309.218, 526.04, 320.126), True, False, 11, 841.92, 595.32)"
11,patients (67). This might have also contributed to the increased case fatality rate observed in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients (67). This might have also contributed to the increased case fatality rate observed in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 293.978, 526.3720000000001, 304.88599999999997), True, False, 11, 841.92, 595.32)"
11,the COVID-19 outbreak.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the COVID-19 outbreak.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 278.858, 194.69, 289.76599999999996), True, False, 11, 841.92, 595.32)"
11,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 257.618, 75.024, 268.52599999999995), True, False, 11, 841.92, 595.32)"
11,"VIEWPOINT ON SARS-CoV-2 TRANSMISSION, SPREAD, and EMERGENCE",0,0,0,0,0,0,0,0,0,0,0,0,0,"('VIEWPOINT ON SARS-CoV-2 TRANSMISSION, SPREAD, and EMERGENCE', 'TimesNewRomanPS-BoldMT', 10.908000000000015, (72.024, 236.498, 495.22, 247.406), False, False, 11, 841.92, 595.32)"
11,The  novel  coronavirus  was  identified  within  one  month  (28  days)  of  the  outbreak.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  novel  coronavirus  was  identified  within  one  month  (28  days)  of  the  outbreak.', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 215.22799999999998, 526.384, 226.136), True, False, 11, 841.92, 595.32)"
11,This is impressively fast when compared to the time taken to identify SARS-CoV reported in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('This is impressively fast when compared to the time taken to identify SARS-CoV reported in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 200.10799999999998, 526.3720000000001, 211.016), True, False, 11, 841.92, 595.32)"
11,"Foshan, Guangdong Province, China (125 days) (68). Immediately after the confirmation of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Foshan, Guangdong Province, China (125 days) (68). Immediately after the confirmation of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 184.868, 526.354, 195.776), True, False, 11, 841.92, 595.32)"
11,"viral etiology, the Chinese virologists rapidly released the genomic sequence of SARS-CoV-2",0,0,0,0,0,0,0,0,0,0,0,0,0,"('viral etiology, the Chinese virologists rapidly released the genomic sequence of SARS-CoV-2', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 169.748, 526.42, 180.656), True, False, 11, 841.92, 595.32)"
11,to the public. This bold move will play a crucial role in controlling the spread of this newly,0,0,0,0,0,0,0,0,0,0,0,0,0,"('to the public. This bold move will play a crucial role in controlling the spread of this newly', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 154.50799999999998, 526.0919999999999, 165.416), True, False, 11, 841.92, 595.32)"
11,emerged novel coronavirus to other parts of the world (69). The possible origin of this novel,0,0,0,0,0,0,0,0,0,0,0,0,0,"('emerged novel coronavirus to other parts of the world (69). The possible origin of this novel', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 139.38799999999998, 526.246, 150.296), True, False, 11, 841.92, 595.32)"
11,virus  and  the  first  mode  of  disease  transmission  are  not  yet  identified  (70).  Analysis  of  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus  and  the  first  mode  of  disease  transmission  are  not  yet  identified  (70).  Analysis  of  the', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 124.148, 526.36, 135.05599999999998), True, False, 11, 841.92, 595.32)"
11,initial  cluster  of  infections  suggests  that  the  infected  individuals  had  a  common  exposure,0,0,0,0,0,0,0,0,0,0,0,0,0,"('initial  cluster  of  infections  suggests  that  the  infected  individuals  had  a  common  exposure', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 109.028, 526.342, 119.936), True, False, 11, 841.92, 595.32)"
11,"point, the seafood market in Wuhan, Hubei Province, China (Fig.  6). The restaurants of this",0,0,0,0,0,0,0,0,0,0,0,0,0,"('point, the seafood market in Wuhan, Hubei Province, China (Fig.  6). The restaurants of this', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 93.792, 526.306, 104.7), False, False, 11, 841.92, 595.32)"
11,market  are  famous  for  serving  different  types  of  wild  animals  for  human  consumption,0,0,0,0,0,0,0,0,0,0,0,0,0,"('market  are  famous  for  serving  different  types  of  wild  animals  for  human  consumption', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 78.672, 526.42, 89.58), True, False, 11, 841.92, 595.32)"
11,"(71).The Huanan South  China Seafood Market also  sells live animals  such as poultry, bats,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(71).The Huanan South  China Seafood Market also  sells live animals  such as poultry, bats,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 63.432, 526.028, 74.34), True, False, 11, 841.92, 595.32)"
11,10,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 11, 841.92, 595.32)"
11,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 11, 841.92, 595.32)"
12,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 12, 841.92, 595.32)"
12,"snakes,  and  marmots  (72).  This  might  be  the  point  where  zoonotic  (animal-to-human)",0,0,0,0,0,0,0,0,0,0,0,0,0,"('snakes,  and  marmots  (72).  This  might  be  the  point  where  zoonotic  (animal-to-human)', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.408, 767.076), True, False, 12, 841.92, 595.32)"
12,transmission  might  have  occurred  (71). Although  the  SARS-CoV-2  is  suspected  to  be,0,0,0,0,0,0,0,0,0,0,0,0,0,"('transmission  might  have  occurred  (71). Although  the  SARS-CoV-2  is  suspected  to  be', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.318, 751.936), True, False, 12, 841.92, 595.32)"
12,originating  from  an  animal  host  (zoonotic  origin)  with  the  further  human-to-human,0,0,0,0,0,0,0,0,0,0,0,0,0,"('originating  from  an  animal  host  (zoonotic  origin)  with  the  further  human-to-human', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.396, 736.696), True, False, 12, 841.92, 595.32)"
12,"transmission  (Fig.  6),  the  possibility  of  food-borne  transmission  should  be  ruled  out  with",0,0,0,0,0,0,0,0,0,0,0,0,0,"('transmission  (Fig.  6),  the  possibility  of  food-borne  transmission  should  be  ruled  out  with', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 526.25, 721.576), False, False, 12, 841.92, 595.32)"
12,"further investigations, since it is a latent possibility (1). Additionally, to that, other potential",0,0,0,0,0,0,0,0,0,0,0,0,0,"('further investigations, since it is a latent possibility (1). Additionally, to that, other potential', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 526.3180000000001, 706.336), True, False, 12, 841.92, 595.32)"
12,"and expected routes would be associated with the transmission, as in other respiratory viruses,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and expected routes would be associated with the transmission, as in other respiratory viruses,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 680.308, 529.2740000000001, 691.216), True, False, 12, 841.92, 595.32)"
12,"by  direct  contact,  shaking  contaminated  hands,  or  by  direct  contact  with  contaminated",0,0,0,0,0,0,0,0,0,0,0,0,0,"('by  direct  contact,  shaking  contaminated  hands,  or  by  direct  contact  with  contaminated', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 665.068, 526.408, 675.976), True, False, 12, 841.92, 595.32)"
12,"surfaces (Fig. 6). Still, to be better defined, yet need to be answered if blood transfusion and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('surfaces (Fig. 6). Still, to be better defined, yet need to be answered if blood transfusion and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 649.948, 526.342, 660.856), False, False, 12, 841.92, 595.32)"
12,"organ transplantation (281), as well as transplacental and perinatal routes, would be possible",0,0,0,0,0,0,0,0,0,0,0,0,0,"('organ transplantation (281), as well as transplacental and perinatal routes, would be possible', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 634.708, 526.354, 645.616), True, False, 12, 841.92, 595.32)"
12,for SARS-CoV-2 transmission (Fig. 6).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('for SARS-CoV-2 transmission (Fig. 6).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 619.588, 265.01, 630.496), False, False, 12, 841.92, 595.32)"
12,"From  experience  with  several  outbreaks  associated  with  known  emerging  viruses,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('From  experience  with  several  outbreaks  associated  with  known  emerging  viruses,', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 598.3480000000001, 526.16, 609.2560000000001), True, False, 12, 841.92, 595.32)"
12,higher pathogenicity of the virus is often associated with lower transmissibility. Compared to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('higher pathogenicity of the virus is often associated with lower transmissibility. Compared to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 583.2280000000001, 526.1400000000002, 594.1360000000001), True, False, 12, 841.92, 595.32)"
12,"the  emerging  viruses  like  Ebola  virus,  Avian  H7N9,  SARS-CoV,  and  MERS-CoV,  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  emerging  viruses  like  Ebola  virus,  Avian  H7N9,  SARS-CoV,  and  MERS-CoV,  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 567.958, 526.4200000000001, 578.866), True, False, 12, 841.92, 595.32)"
12,SARS-CoV-2  have  relatively  lower  pathogenicity  and  moderate  transmissibility  (15).  The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  have  relatively  lower  pathogenicity  and  moderate  transmissibility  (15).  The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 552.838, 526.42, 563.746), True, False, 12, 841.92, 595.32)"
12,risk of death among the individuals infected with COVID-19 was calculated using infection,0,0,0,0,0,0,0,0,0,0,0,0,0,"('risk of death among the individuals infected with COVID-19 was calculated using infection', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.5980000000001, 526.306, 548.5060000000001), True, False, 12, 841.92, 595.32)"
12,fatality risk (IFR). The IFR was found to be in the range of 0.3% to 0.6% that is comparable,0,0,0,0,0,0,0,0,0,0,0,0,0,"('fatality risk (IFR). The IFR was found to be in the range of 0.3% to 0.6% that is comparable', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 522.4780000000001, 526.0079999999999, 533.3860000000001), True, False, 12, 841.92, 595.32)"
12,"to previously occurred Asian influenza pandemic (1957-1958) (73, 282).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('to previously occurred Asian influenza pandemic (1957-1958) (73, 282).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 507.238, 424.39, 518.146), True, False, 12, 841.92, 595.32)"
12,"Notably, the re-analysis of the COVID-19 pandemic curve from the initial cluster of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Notably, the re-analysis of the COVID-19 pandemic curve from the initial cluster of', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 492.118, 526.33, 503.02599999999995), True, False, 12, 841.92, 595.32)"
12,cases pointed out  a substantial human-to-human  transmission.  It  is  opined  that the common,0,0,0,0,0,0,0,0,0,0,0,0,0,"('cases pointed out  a substantial human-to-human  transmission.  It  is  opined  that the common', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 477.238, 526.354, 488.14599999999996), True, False, 12, 841.92, 595.32)"
12,SARS-CoV-2 exposure history at the Wuhan seafood market might have originated from the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2 exposure history at the Wuhan seafood market might have originated from the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 462.238, 526.3299999999999, 473.14599999999996), True, False, 12, 841.92, 595.32)"
12,"human-to-human  transmission  rather  than  animal-to-human  transmission  (74).  Meanwhile,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('human-to-human  transmission  rather  than  animal-to-human  transmission  (74).  Meanwhile,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 447.358, 526.408, 458.26599999999996), True, False, 12, 841.92, 595.32)"
12,pointing out the zoonotic spillover in COVID-19 is too early to fully endorse (1). Following,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pointing out the zoonotic spillover in COVID-19 is too early to fully endorse (1). Following', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 432.478, 526.396, 443.38599999999997), True, False, 12, 841.92, 595.32)"
12,"the initial infection, human-to-human transmission has been documented with a preliminary",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the initial infection, human-to-human transmission has been documented with a preliminary', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 417.598, 526.33, 428.506), True, False, 12, 841.92, 595.32)"
12,"reproduction  number  (R0)  estimate  of  1.4  to  2.5  (70,75),  and  recently  it  is  estimated  to  be",0,0,0,0,0,0,0,0,0,0,0,0,0,"('reproduction  number  (R0)  estimate  of  1.4  to  2.5  (70,75),  and  recently  it  is  estimated  to  be', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 402.61336, 526.246, 413.626), True, False, 12, 841.92, 595.32)"
12,"2.24 to 3.58 (76). In another study, the average reproductive number (R0) of COVID-19 was",0,0,0,0,0,0,0,0,0,0,0,0,0,"('2.24 to 3.58 (76). In another study, the average reproductive number (R0) of COVID-19 was', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 387.71335999999997, 526.3960000000001, 398.726), True, False, 12, 841.92, 595.32)"
12,"found  to  be  3.28,  which  is  significantly  higher  than  the  initial  WHO  estimate  of  1.4  to  2.5",0,0,0,0,0,0,0,0,0,0,0,0,0,"('found  to  be  3.28,  which  is  significantly  higher  than  the  initial  WHO  estimate  of  1.4  to  2.5', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 372.938, 526.056, 383.84599999999995), True, False, 12, 841.92, 595.32)"
12,(77).  It  is  too  early  to  obtain  the  exact  R0  value  since  there  is  a  possibility  of  bias  due  to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(77).  It  is  too  early  to  obtain  the  exact  R0  value  since  there  is  a  possibility  of  bias  due  to', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 357.95336, 526.2260000000001, 368.96599999999995), True, False, 12, 841.92, 595.32)"
12,insufficient  data.  The  higher  R0  value  is  indicative  of  the  more  significant  potential  of  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('insufficient  data.  The  higher  R0  value  is  indicative  of  the  more  significant  potential  of  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 343.07336, 526.3960000000001, 354.08599999999996), True, False, 12, 841.92, 595.32)"
12,SARS-CoV-2  transmission  in  a  susceptible  population.  That  is  not  the  first  time  where  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  transmission  in  a  susceptible  population.  That  is  not  the  first  time  where  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 328.298, 526.306, 339.20599999999996), True, False, 12, 841.92, 595.32)"
12,culinary practices of China have been blamed for the origin of novel coronavirus infection in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('culinary practices of China have been blamed for the origin of novel coronavirus infection in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 313.418, 526.1780000000001, 324.32599999999996), True, False, 12, 841.92, 595.32)"
12,humans.  Previously  the  animals  present  in  the  live-animal  market  were  identified  to  be  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('humans.  Previously  the  animals  present  in  the  live-animal  market  were  identified  to  be  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 298.418, 526.384, 309.32599999999996), True, False, 12, 841.92, 595.32)"
12,intermediate hosts of the SARS outbreak in China (78). Several wildlife species were found,0,0,0,0,0,0,0,0,0,0,0,0,0,"('intermediate hosts of the SARS outbreak in China (78). Several wildlife species were found', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 283.538, 526.408, 294.44599999999997), True, False, 12, 841.92, 595.32)"
12,to harbor potentially evolving coronavirus strains that can overcome the species barrier (79).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('to harbor potentially evolving coronavirus strains that can overcome the species barrier (79).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 268.658, 526.42, 279.566), True, False, 12, 841.92, 595.32)"
12,One  of  the  main  principles  of  Chinese  food  culture  is  that  live-slaughtered  animals  are,0,0,0,0,0,0,0,0,0,0,0,0,0,"('One  of  the  main  principles  of  Chinese  food  culture  is  that  live-slaughtered  animals  are', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 253.778, 526.33, 264.686), True, False, 12, 841.92, 595.32)"
12,considered to be more nutritious (5).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('considered to be more nutritious (5).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 238.898, 253.37, 249.806), True, False, 12, 841.92, 595.32)"
12,After passing of struggling last four months from December 2019 to March 2020 now,0,0,0,0,0,0,0,0,0,0,0,0,0,"('After passing of struggling last four months from December 2019 to March 2020 now', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 215.97799999999998, 526.2620000000001, 226.886), True, False, 12, 841.92, 595.32)"
12,"as COVID-19 conditions seem to be under control in China, again wet animal markets have",0,0,0,0,0,0,0,0,0,0,0,0,0,"('as COVID-19 conditions seem to be under control in China, again wet animal markets have', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 201.06799999999998, 526.1479999999999, 211.976), True, False, 12, 841.92, 595.32)"
12,"been started, and people are enthusiastically buying bats, dogs, cats, birds, scorpions, badgers,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('been started, and people are enthusiastically buying bats, dogs, cats, birds, scorpions, badgers,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 186.188, 529.354, 197.096), True, False, 12, 841.92, 595.32)"
12,"rabbits, pangolins (scaly anteaters), minks, a soup made from palm civet, ostriches, hamsters,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('rabbits, pangolins (scaly anteaters), minks, a soup made from palm civet, ostriches, hamsters,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 171.308, 526.342, 182.216), True, False, 12, 841.92, 595.32)"
12,"snapping turtles, ducks, fishes, Siamese crocodiles and other animal meat available there but",0,0,0,0,0,0,0,0,0,0,0,0,0,"('snapping turtles, ducks, fishes, Siamese crocodiles and other animal meat available there but', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 156.428, 526.258, 167.336), True, False, 12, 841.92, 595.32)"
12,without taking any precautions. The Chinese government is encouraging people to feel their,0,0,0,0,0,0,0,0,0,0,0,0,0,"('without taking any precautions. The Chinese government is encouraging people to feel their', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 141.54799999999997, 526.2740000000001, 152.456), True, False, 12, 841.92, 595.32)"
12,routine back to normalcy. However this could be a risk when it is mentioned in the advisory,0,0,0,0,0,0,0,0,0,0,0,0,0,"('routine back to normalcy. However this could be a risk when it is mentioned in the advisory', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 126.66799999999999, 526.396, 137.576), True, False, 12, 841.92, 595.32)"
12,to  avoid  contact  with  live-dead  animals  as  for  as  possible  as  SARS-CoV-2  has  shown,0,0,0,0,0,0,0,0,0,0,0,0,0,"('to  avoid  contact  with  live-dead  animals  as  for  as  possible  as  SARS-CoV-2  has  shown', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 111.788, 526.384, 122.696), True, False, 12, 841.92, 595.32)"
12,"zoonotic spillover, and we can not rule out the probability of any new mutation in the same",0,0,0,0,0,0,0,0,0,0,0,0,0,"('zoonotic spillover, and we can not rule out the probability of any new mutation in the same', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 96.912, 526.2500000000001, 107.82000000000001), True, False, 12, 841.92, 595.32)"
12,virus  being  closely  in  contact  with  both  animal  and  humans  at  the  market  (289).  A  few,0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus  being  closely  in  contact  with  both  animal  and  humans  at  the  market  (289).  A  few', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 81.912, 526.396, 92.82000000000001), True, False, 12, 841.92, 595.32)"
12,"months back, China imposed a temporary ban on the sale of live-dead animals in wet markets.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('months back, China imposed a temporary ban on the sale of live-dead animals in wet markets.', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 67.032, 529.42, 77.94), True, False, 12, 841.92, 595.32)"
12,11,0,0,0,0,0,0,0,0,0,0,0,0,0,"('11', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 12, 841.92, 595.32)"
12,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 12, 841.92, 595.32)"
13,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 13, 841.92, 595.32)"
13,"However, now again, more than hundreds of such wet markets have been re-opened without",0,0,0,0,0,0,0,0,0,0,0,0,0,"('However, now again, more than hundreds of such wet markets have been re-opened without', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.408, 767.076), True, False, 13, 841.92, 595.32)"
13,optimizing any standard food safety and sanitation practices (291).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('optimizing any standard food safety and sanitation practices (291).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.268, 395.35, 752.176), True, False, 13, 841.92, 595.32)"
13,Being  the  largest  populated  country  in  the  world  and  due  to  its  domestic  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Being  the  largest  populated  country  in  the  world  and  due  to  its  domestic  and', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 718.3480000000001, 526.1000000000001, 729.2560000000001), True, False, 13, 841.92, 595.32)"
13,"international  food  exportation  policies,  now  the  whole  world  is  in  the  face  of  menace,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('international  food  exportation  policies,  now  the  whole  world  is  in  the  face  of  menace,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 702.508, 526.42, 713.416), True, False, 13, 841.92, 595.32)"
13,including China itself. Wet markets of live-dead animals do not maintain strict food hygienic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('including China itself. Wet markets of live-dead animals do not maintain strict food hygienic', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 686.668, 526.2380000000002, 697.576), True, False, 13, 841.92, 595.32)"
13,"practices, fresh blood splashes are present everywhere, on the floor, and the tabletop and such",0,0,0,0,0,0,0,0,0,0,0,0,0,"('practices, fresh blood splashes are present everywhere, on the floor, and the tabletop and such', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 670.708, 526.3420000000001, 681.616), True, False, 13, 841.92, 595.32)"
13,"food  customaries  could  encourage  many  pathogens  to  adapt,  mutate  and  jump  the  species",0,0,0,0,0,0,0,0,0,0,0,0,0,"('food  customaries  could  encourage  many  pathogens  to  adapt,  mutate  and  jump  the  species', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 654.868, 526.2620000000001, 665.7760000000001), True, False, 13, 841.92, 595.32)"
13,"barrier.  As  a  result,  the  whole  world  is  suffering  now  with  novel  SARS-CoV-2  with  more",0,0,0,0,0,0,0,0,0,0,0,0,0,"('barrier.  As  a  result,  the  whole  world  is  suffering  now  with  novel  SARS-CoV-2  with  more', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 639.028, 526.42, 649.936), True, False, 13, 841.92, 595.32)"
13,"than  10,00,000  morbidity  and  approximately  50,000  mortality  across  the  globe.  There  is  an",0,0,0,0,0,0,0,0,0,0,0,0,0,"('than  10,00,000  morbidity  and  approximately  50,000  mortality  across  the  globe.  There  is  an', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 623.188, 526.408, 634.096), True, False, 13, 841.92, 595.32)"
13,urgent  need  of  rationale  international  campaign  enforcing  penalty  against  such  unhealthy,0,0,0,0,0,0,0,0,0,0,0,0,0,"('urgent  need  of  rationale  international  campaign  enforcing  penalty  against  such  unhealthy', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 607.2280000000001, 526.0679999999999, 618.1360000000001), True, False, 13, 841.92, 595.32)"
13,food  practices  of  China  to  encourage  the  sellers  regarding  the  upliftment  of  hygienic  food,0,0,0,0,0,0,0,0,0,0,0,0,0,"('food  practices  of  China  to  encourage  the  sellers  regarding  the  upliftment  of  hygienic  food', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 591.388, 526.42, 602.296), True, False, 13, 841.92, 595.32)"
13,"practices or/else close the crude live-dead animal wet markets, and to modify its food policies",0,0,0,0,0,0,0,0,0,0,0,0,0,"('practices or/else close the crude live-dead animal wet markets, and to modify its food policies', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 575.548, 526.2260000000001, 586.456), True, False, 13, 841.92, 595.32)"
13,in order to avoid further life and the economical threat of any new emerging or re-emerging,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in order to avoid further life and the economical threat of any new emerging or re-emerging', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 559.678, 526.42, 570.586), True, False, 13, 841.92, 595.32)"
13,pandemic due to animal-human close interaction (290).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pandemic due to animal-human close interaction (290).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 543.838, 343.63, 554.746), True, False, 13, 841.92, 595.32)"
13,This  will  increase  the  possibility  of  zoonotic  disease  transmission  to  humans.  Even,0,0,0,0,0,0,0,0,0,0,0,0,0,"('This  will  increase  the  possibility  of  zoonotic  disease  transmission  to  humans.  Even', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 527.878, 526.42, 538.7860000000001), True, False, 13, 841.92, 595.32)"
13,"though individuals of all ages and sexes are susceptible to COVID-19, older people with an",0,0,0,0,0,0,0,0,0,0,0,0,0,"('though individuals of all ages and sexes are susceptible to COVID-19, older people with an', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 512.758, 526.384, 523.666), True, False, 13, 841.92, 595.32)"
13,"underlying  chronic  disease  are  more  likely  to  become  severely  infected  (80).  Recently,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('underlying  chronic  disease  are  more  likely  to  become  severely  infected  (80).  Recently,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 497.51800000000003, 526.384, 508.426), True, False, 13, 841.92, 595.32)"
13,individuals with asymptomatic infection were also considered as a source of infection to the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('individuals with asymptomatic infection were also considered as a source of infection to the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 482.398, 526.396, 493.306), True, False, 13, 841.92, 595.32)"
13,other  susceptible  individuals  (81).  Both  the  asymptomatic  and  symptomatic  patients  secrete,0,0,0,0,0,0,0,0,0,0,0,0,0,"('other  susceptible  individuals  (81).  Both  the  asymptomatic  and  symptomatic  patients  secrete', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 467.158, 526.408, 478.066), True, False, 13, 841.92, 595.32)"
13,"similar  viral  load,  which  indicates  that  the  transmission  capacity  of  asymptomatic  or",0,0,0,0,0,0,0,0,0,0,0,0,0,"('similar  viral  load,  which  indicates  that  the  transmission  capacity  of  asymptomatic  or', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 452.038, 526.0319999999999, 462.94599999999997), True, False, 13, 841.92, 595.32)"
13,minimally  symptomatic  patients  is  very  high.  This  reflects  that  the  transmission  of  SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('minimally  symptomatic  patients  is  very  high.  This  reflects  that  the  transmission  of  SARS-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 436.798, 523.456, 447.70599999999996), True, False, 13, 841.92, 595.32)"
13,CoV-2 may occur early in the course of infection (82). Atypical clinical manifestations have,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2 may occur early in the course of infection (82). Atypical clinical manifestations have', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 421.678, 526.306, 432.58599999999996), True, False, 13, 841.92, 595.32)"
13,also  been  reported  in  COVID-19  in  which  the  only  reporting  symptom  was  fatigue.  Such,0,0,0,0,0,0,0,0,0,0,0,0,0,"('also  been  reported  in  COVID-19  in  which  the  only  reporting  symptom  was  fatigue.  Such', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 406.438, 526.3299999999999, 417.34599999999995), True, False, 13, 841.92, 595.32)"
13,"patients  may  lack  respiratory  signs  such  as  fever,  cough,  and  sputum  (83).  Hence,  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients  may  lack  respiratory  signs  such  as  fever,  cough,  and  sputum  (83).  Hence,  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 391.298, 526.444, 402.20599999999996), True, False, 13, 841.92, 595.32)"
13,clinicians  must  be  on  the  look-out  for  the  possible  occurrence  of  atypical  clinical,0,0,0,0,0,0,0,0,0,0,0,0,0,"('clinicians  must  be  on  the  look-out  for  the  possible  occurrence  of  atypical  clinical', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 376.058, 526.2020000000001, 386.96599999999995), True, False, 13, 841.92, 595.32)"
13,manifestations to avoid the possibility of missed diagnosis. The early transmission ability of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('manifestations to avoid the possibility of missed diagnosis. The early transmission ability of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 360.938, 526.306, 371.84599999999995), True, False, 13, 841.92, 595.32)"
13,"SARS-CoV-2 was found to be similar to or slightly higher than the SARS-CoV, reflecting it a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2 was found to be similar to or slightly higher than the SARS-CoV, reflecting it a', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 345.69800000000004, 526.396, 356.606), True, False, 13, 841.92, 595.32)"
13,controllable disease with moderate to high transmissibility (84).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('controllable disease with moderate to high transmissibility (84).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 330.57800000000003, 381.67, 341.486), True, False, 13, 841.92, 595.32)"
13,"Hence, the COVID-19 pandemic does not have any novel factors in it other than the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Hence, the COVID-19 pandemic does not have any novel factors in it other than the', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 309.338, 526.306, 320.246), True, False, 13, 841.92, 595.32)"
13,new  genetically  unique  pathogen  and  a  new  possible  reservoir.  The  cause  and  the  possible,0,0,0,0,0,0,0,0,0,0,0,0,0,"('new  genetically  unique  pathogen  and  a  new  possible  reservoir.  The  cause  and  the  possible', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 294.218, 526.306, 305.126), True, False, 13, 841.92, 595.32)"
13,future  outcome  are  just  the  repetitions  of  our  previous  interaction  with  these  fatal,0,0,0,0,0,0,0,0,0,0,0,0,0,"('future  outcome  are  just  the  repetitions  of  our  previous  interaction  with  these  fatal', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 278.978, 526.3720000000001, 289.88599999999997), True, False, 13, 841.92, 595.32)"
13,coronaviruses. The only  difference is  the time of occurrence and the genetic distinctness  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronaviruses. The only  difference is  the time of occurrence and the genetic distinctness  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 263.858, 526.2220000000002, 274.76599999999996), True, False, 13, 841.92, 595.32)"
13,the  pathogen  involved.  Mutations  on  the  receptor-binding  domain  (RBD)  of  CoV  allowed,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  pathogen  involved.  Mutations  on  the  receptor-binding  domain  (RBD)  of  CoV  allowed', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 248.618, 526.396, 259.526), True, False, 13, 841.92, 595.32)"
13,"them  to  infect  newer  hosts,  thereby  expanding  their  reach  to  all  corners  of  the  world  (85).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('them  to  infect  newer  hosts,  thereby  expanding  their  reach  to  all  corners  of  the  world  (85).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 233.498, 526.408, 244.406), True, False, 13, 841.92, 595.32)"
13,This is a potential threat to both animal and public health. Advanced studies using Bayesian,0,0,0,0,0,0,0,0,0,0,0,0,0,"('This is a potential threat to both animal and public health. Advanced studies using Bayesian', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 218.25799999999998, 526.27, 229.166), True, False, 13, 841.92, 595.32)"
13,phylogeographic  reconstruction  identified  the  most  probable  origin  of  the  SARS-CoV-2  is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('phylogeographic  reconstruction  identified  the  most  probable  origin  of  the  SARS-CoV-2  is', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 203.10799999999998, 526.42, 214.016), True, False, 13, 841.92, 595.32)"
13,"from the Bat SARS-like Coronavirus, circulating in the Rhinolophus bat family (86).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('from the Bat SARS-like Coronavirus, circulating in the Rhinolophus bat family (86).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 187.988, 482.74, 198.89600000000002), True, False, 13, 841.92, 595.32)"
13,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 166.748, 75.024, 177.656), True, False, 13, 841.92, 595.32)"
13,Phylogenetic  analysis  of  10  whole-genome  sequences  of  SARS-CoV-2  showed  that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Phylogenetic  analysis  of  10  whole-genome  sequences  of  SARS-CoV-2  showed  that', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 166.748, 526.408, 177.656), True, False, 13, 841.92, 595.32)"
13,"they are related to two CoVs of bat origin, namely bat-SL-CoVZC45 and bat-SL-CoVZXC21",0,0,0,0,0,0,0,0,0,0,0,0,0,"('they are related to two CoVs of bat origin, namely bat-SL-CoVZC45 and bat-SL-CoVZXC21', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 151.628, 526.396, 162.536), True, False, 13, 841.92, 595.32)"
13,which were reported during 2018 in China (17). It was reported that SARS-CoV-2 had been,0,0,0,0,0,0,0,0,0,0,0,0,0,"('which were reported during 2018 in China (17). It was reported that SARS-CoV-2 had been', 'TimesNewRomanPSMT', 10.716000000000008, (72.024, 136.38799999999998, 526.42, 147.296), False, False, 13, 841.92, 595.32)"
13,confirmed to use ACE-2 as an entry receptor while exhibiting similar RBD with SARS-CoV,0,0,0,0,0,0,0,0,0,0,0,0,0,"('confirmed to use ACE-2 as an entry receptor while exhibiting similar RBD with SARS-CoV', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 121.268, 526.42, 132.176), True, False, 13, 841.92, 595.32)"
13,"(17, 87, 256-257). Several countries have provided recommendations to their people traveling",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(17, 87, 256-257). Several countries have provided recommendations to their people traveling', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 106.028, 526.2500000000001, 116.936), True, False, 13, 841.92, 595.32)"
13,"to China (88, 89). Compared to the previous coronavirus outbreak caused by SARS-CoV and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('to China (88, 89). Compared to the previous coronavirus outbreak caused by SARS-CoV and', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 90.912, 526.3960000000001, 101.82000000000001), True, False, 13, 841.92, 595.32)"
13,"MERS-CoV, the efficiency of human-to-human transmission in SARS-CoV-2 was thought to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('MERS-CoV, the efficiency of human-to-human transmission in SARS-CoV-2 was thought to', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 75.672, 526.372, 86.58), True, False, 13, 841.92, 595.32)"
13,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 13, 841.92, 595.32)"
13,12,0,0,0,0,0,0,0,0,0,0,0,0,0,"('12', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 13, 841.92, 595.32)"
14,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 14, 841.92, 595.32)"
14,be  less.  This  was  based  on  the  assumption  that  the  health  workers  were  affected  the  least,0,0,0,0,0,0,0,0,0,0,0,0,0,"('be  less.  This  was  based  on  the  assumption  that  the  health  workers  were  affected  the  least', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.0919999999999, 767.076), True, False, 14, 841.92, 595.32)"
14,compared  to  the  previous  outbreaks  of  fatal  coronaviruses  (2).  Super-spreading  events  are,0,0,0,0,0,0,0,0,0,0,0,0,0,"('compared  to  the  previous  outbreaks  of  fatal  coronaviruses  (2).  Super-spreading  events  are', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.318, 751.936), True, False, 14, 841.92, 595.32)"
14,"considered to be the main culprit for the extensive transmission of SARS and MERS (90, 91).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('considered to be the main culprit for the extensive transmission of SARS and MERS (90, 91).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.4200000000001, 736.696), True, False, 14, 841.92, 595.32)"
14,Almost  half  of  the  MERS-CoV  cases  reported  in  Saudi  Arabia  are  of  secondary  origin  that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Almost  half  of  the  MERS-CoV  cases  reported  in  Saudi  Arabia  are  of  secondary  origin  that', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 526.1659999999999, 721.576), True, False, 14, 841.92, 595.32)"
14,occurs  through  contact  with  infected-asymptomatic  or  symptomatic  individuals  through,0,0,0,0,0,0,0,0,0,0,0,0,0,"('occurs  through  contact  with  infected-asymptomatic  or  symptomatic  individuals  through', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 526.42, 706.336), True, False, 14, 841.92, 595.32)"
14,human-to-human transmission (92). The occurrence of super-spreading events in the COVID-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('human-to-human transmission (92). The occurrence of super-spreading events in the COVID-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 680.308, 523.336, 691.216), True, False, 14, 841.92, 595.32)"
14,"19 outbreak cannot be ruled out until its possibility is evaluated. Similar to SARS and MERS,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('19 outbreak cannot be ruled out until its possibility is evaluated. Similar to SARS and MERS,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 665.068, 526.42, 675.976), True, False, 14, 841.92, 595.32)"
14,the  COVID-19  can  also  infect  the  lower  respiratory  tract  with  milder  symptoms  (27).  The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  COVID-19  can  also  infect  the  lower  respiratory  tract  with  milder  symptoms  (27).  The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 649.948, 526.42, 660.856), True, False, 14, 841.92, 595.32)"
14,basic  reproduction  number  of  COVID-19  was  found  to  be  in  the  range  of  2.8-3.3  based  on,0,0,0,0,0,0,0,0,0,0,0,0,0,"('basic  reproduction  number  of  COVID-19  was  found  to  be  in  the  range  of  2.8-3.3  based  on', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 634.708, 526.384, 645.616), True, False, 14, 841.92, 595.32)"
14,real-time reports and 3.2-3.9 based on predicted infected cases (84).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('real-time reports and 3.2-3.9 based on predicted infected cases (84).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 619.588, 400.99, 630.496), True, False, 14, 841.92, 595.32)"
14,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 598.3480000000001, 75.024, 609.2560000000001), True, False, 14, 841.92, 595.32)"
14,"CORONAVIRUSES (CoV) IN HUMANS - SARS, MERS, and COVID-19",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CORONAVIRUSES (CoV) IN HUMANS - SARS, MERS, and COVID-19', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 577.2280000000001, 461.26, 587.9440000000001), True, False, 14, 841.92, 595.32)"
14,Coronavirus  infection  in  humans  is  commonly  associated  with  mild  to  severe,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus  infection  in  humans  is  commonly  associated  with  mild  to  severe', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 555.958, 526.2620000000002, 566.866), True, False, 14, 841.92, 595.32)"
14,"respiratory  diseases  that  are  characterized  by  high  fever,  severe  inflammation,  cough,  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory  diseases  that  are  characterized  by  high  fever,  severe  inflammation,  cough,  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 540.838, 526.1780000000001, 551.746), True, False, 14, 841.92, 595.32)"
14,internal  organs  dysfunction  that  can  even  lead  to  death  (92).  Most  of  the  identified,0,0,0,0,0,0,0,0,0,0,0,0,0,"('internal  organs  dysfunction  that  can  even  lead  to  death  (92).  Most  of  the  identified', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 525.5980000000001, 526.3299999999999, 536.5060000000001), True, False, 14, 841.92, 595.32)"
14,"coronaviruses cause common cold in humans. However, this changed when SARS-CoV was",0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronaviruses cause common cold in humans. However, this changed when SARS-CoV was', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 510.47800000000007, 526.384, 521.3860000000001), True, False, 14, 841.92, 595.32)"
14,"identified,  paving  the  way  for  severe  forms  of  the  disease  in  humans  (22).  Our  previous",0,0,0,0,0,0,0,0,0,0,0,0,0,"('identified,  paving  the  way  for  severe  forms  of  the  disease  in  humans  (22).  Our  previous', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 495.238, 526.396, 506.14599999999996), True, False, 14, 841.92, 595.32)"
14,experience with the outbreaks of other coronaviruses like SARS and MERS suggests that the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('experience with the outbreaks of other coronaviruses like SARS and MERS suggests that the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 480.118, 526.432, 491.02599999999995), True, False, 14, 841.92, 595.32)"
14,mode  of  transmission  in  COVID-19  can  be  mainly  human-to-human  transmission  occurs,0,0,0,0,0,0,0,0,0,0,0,0,0,"('mode  of  transmission  in  COVID-19  can  be  mainly  human-to-human  transmission  occurs', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 464.87800000000004, 526.4440000000001, 475.786), True, False, 14, 841.92, 595.32)"
14,"through direct contact, droplets, and fomites (25). Recent studies on the aerosol and surface",0,0,0,0,0,0,0,0,0,0,0,0,0,"('through direct contact, droplets, and fomites (25). Recent studies on the aerosol and surface', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 449.75800000000004, 526.2940000000001, 460.666), True, False, 14, 841.92, 595.32)"
14,stability of SARS-CoV demonstrated that aerosol and fomite transmission of SARS-CoV-2 is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('stability of SARS-CoV demonstrated that aerosol and fomite transmission of SARS-CoV-2 is', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 434.51800000000003, 526.372, 445.426), True, False, 14, 841.92, 595.32)"
14,"feasible, as the virus can remain viable in aerosols for multiple hours and on surfaces up to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('feasible, as the virus can remain viable in aerosols for multiple hours and on surfaces up to', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 419.398, 526.0439999999999, 430.306), True, False, 14, 841.92, 595.32)"
14,days (259).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('days (259).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 404.158, 129.01999999999998, 415.066), True, False, 14, 841.92, 595.32)"
14,The  immune  response  against  Coronavirus  is  vital  to  control  and  get  rid  of  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  immune  response  against  Coronavirus  is  vital  to  control  and  get  rid  of  the', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 383.01800000000003, 526.444, 393.926), True, False, 14, 841.92, 595.32)"
14,"infection.  However,  maladjusted  immune  responses,  as  such,  may  contribute  to  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('infection.  However,  maladjusted  immune  responses,  as  such,  may  contribute  to  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 367.778, 526.342, 378.686), True, False, 14, 841.92, 595.32)"
14,immunopathology  of  the  disease  resulting  in  impairment  of  pulmonary  gas  exchange.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('immunopathology  of  the  disease  resulting  in  impairment  of  pulmonary  gas  exchange.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 352.658, 526.1279999999999, 363.566), True, False, 14, 841.92, 595.32)"
14,Understanding the interaction between CoVs and the host innate immune systems may throw,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Understanding the interaction between CoVs and the host innate immune systems may throw', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 337.418, 526.42, 348.32599999999996), True, False, 14, 841.92, 595.32)"
14,light on our understanding of the lung inflammation associated with this infection (24).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('light on our understanding of the lung inflammation associated with this infection (24).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 322.298, 493.3, 333.20599999999996), True, False, 14, 841.92, 595.32)"
14,SARS  is  a  viral  respiratory  disease  caused  by  a  formerly  unrecognized  animal,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS  is  a  viral  respiratory  disease  caused  by  a  formerly  unrecognized  animal', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 301.058, 526.318, 311.96599999999995), True, False, 14, 841.92, 595.32)"
14,coronavirus that originated from the 'wet markets' in southern China after getting adapted to,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""coronavirus that originated from the 'wet markets' in southern China after getting adapted to"", 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 285.938, 526.396, 296.84599999999995), True, False, 14, 841.92, 595.32)"
14,"the  human  host,  thereby  enabling  transmission  between  humans  (90).  The  SARS  outbreak",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  human  host,  thereby  enabling  transmission  between  humans  (90).  The  SARS  outbreak', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 270.69800000000004, 526.306, 281.606), True, False, 14, 841.92, 595.32)"
14,reported in the year 2002-03 has identified 8098 confirmed cases with 774 total deaths (9.6%),0,0,0,0,0,0,0,0,0,0,0,0,0,"('reported in the year 2002-03 has identified 8098 confirmed cases with 774 total deaths (9.6%)', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 255.578, 530.1380000000001, 266.486), True, False, 14, 841.92, 595.32)"
14,"(93). The outbreak has severely affected the Asia Pacific region, especially mainland China",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(93). The outbreak has severely affected the Asia Pacific region, especially mainland China', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 240.338, 526.3299999999999, 251.246), True, False, 14, 841.92, 595.32)"
14,(94). Even though the case fatality rate of SARS-CoV-2 (COVID-19) is comparatively lower,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(94). Even though the case fatality rate of SARS-CoV-2 (COVID-19) is comparatively lower', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 225.218, 526.318, 236.126), True, False, 14, 841.92, 595.32)"
14,"than  SARS-CoV,  there  exists  a  severe  concern  linked  to  this  outbreak  due  to  its",0,0,0,0,0,0,0,0,0,0,0,0,0,"('than  SARS-CoV,  there  exists  a  severe  concern  linked  to  this  outbreak  due  to  its', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 209.94799999999998, 526.2260000000001, 220.856), True, False, 14, 841.92, 595.32)"
14,"epidemiological  similarity  to  influenza  viruses  (95,  284).  This  can  fail  the  public  health",0,0,0,0,0,0,0,0,0,0,0,0,0,"('epidemiological  similarity  to  influenza  viruses  (95,  284).  This  can  fail  the  public  health', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 194.82799999999997, 526.372, 205.736), True, False, 14, 841.92, 595.32)"
14,"system, thus resulting in a pandemic (96).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('system, thus resulting in a pandemic (96).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 179.588, 275.69, 190.496), True, False, 14, 841.92, 595.32)"
14,The MERS is also a respiratory disease that was first reported in Saudi Arabia during,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The MERS is also a respiratory disease that was first reported in Saudi Arabia during', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 158.468, 526.4200000000001, 169.376), True, False, 14, 841.92, 595.32)"
14,the  year  2012.  The  disease  was  found  to  have  a  case  fatality  rate  of  around  35%  (97).  The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  year  2012.  The  disease  was  found  to  have  a  case  fatality  rate  of  around  35%  (97).  The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 143.22799999999998, 526.408, 154.136), True, False, 14, 841.92, 595.32)"
14,"analysis  of  available  datasets  suggests  that  the  incubation  period  of  SARS-CoV-2,  SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('analysis  of  available  datasets  suggests  that  the  incubation  period  of  SARS-CoV-2,  SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 128.10799999999998, 523.576, 139.016), True, False, 14, 841.92, 595.32)"
14,"CoV, and MERS-CoV, is almost in the same range. The longest predicted incubation time of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV, and MERS-CoV, is almost in the same range. The longest predicted incubation time of', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 112.868, 526.1300000000001, 123.776), True, False, 14, 841.92, 595.32)"
14,"SARS-CoV-2 (COVID-19) is 14 days. Hence, suspected individuals are isolated for 14 days",0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2 (COVID-19) is 14 days. Hence, suspected individuals are isolated for 14 days', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 97.748, 526.342, 108.656), True, False, 14, 841.92, 595.32)"
14,to  avoid  the  risk  of  further  spread  (98).  Even  though  a  high  similarity  has  been  reported,0,0,0,0,0,0,0,0,0,0,0,0,0,"('to  avoid  the  risk  of  further  spread  (98).  Even  though  a  high  similarity  has  been  reported', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 82.512, 526.2020000000001, 93.42), True, False, 14, 841.92, 595.32)"
14,"between the genome sequence of new coronavirus (SARS-CoV-2) and SARS-like CoVs, the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('between the genome sequence of new coronavirus (SARS-CoV-2) and SARS-like CoVs, the', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 67.392, 526.444, 78.3), True, False, 14, 841.92, 595.32)"
14,13,0,0,0,0,0,0,0,0,0,0,0,0,0,"('13', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 14, 841.92, 595.32)"
14,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 14, 841.92, 595.32)"
15,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 15, 841.92, 595.32)"
15,comparative analysis identified a furin-like cleavage site in the SARS-CoV-2 S protein that is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('comparative analysis identified a furin-like cleavage site in the SARS-CoV-2 S protein that is', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.294, 767.076), True, False, 15, 841.92, 595.32)"
15,missing in other SARS-like CoVs (99). The furin-like cleavage site is expected to playa role,0,0,0,0,0,0,0,0,0,0,0,0,0,"('missing in other SARS-like CoVs (99). The furin-like cleavage site is expected to playa role', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.42, 751.936), True, False, 15, 841.92, 595.32)"
15,"in  the  viral  life  cycle,  disease  pathogenicity,  and  might  even  act  as  a  therapeutic  target  for",0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  the  viral  life  cycle,  disease  pathogenicity,  and  might  even  act  as  a  therapeutic  target  for', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.2260000000001, 736.696), True, False, 15, 841.92, 595.32)"
15,furin inhibitors. The highly contagious nature of SARS-CoV-2 compared to its predecessors,0,0,0,0,0,0,0,0,0,0,0,0,0,"('furin inhibitors. The highly contagious nature of SARS-CoV-2 compared to its predecessors', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 526.33, 721.576), True, False, 15, 841.92, 595.32)"
15,SARS might be the result of a stabilizing mutation that occurred in the endosome-associated-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS might be the result of a stabilizing mutation that occurred in the endosome-associated-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 523.336, 706.336), True, False, 15, 841.92, 595.32)"
15,protein-like domain of nsp2 protein.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein-like domain of nsp2 protein.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 680.308, 248.69, 691.216), True, False, 15, 841.92, 595.32)"
15,"Similarly, the destabilizing mutation near to the phosphatase domain of nsp3 proteins",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Similarly, the destabilizing mutation near to the phosphatase domain of nsp3 proteins', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 659.068, 526.124, 669.976), True, False, 15, 841.92, 595.32)"
15,in  SARS-CoV-2  could  put  forward  a  potential  mechanism  that  differentiates  from  SARS,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  SARS-CoV-2  could  put  forward  a  potential  mechanism  that  differentiates  from  SARS', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.2020000000002, 654.856), True, False, 15, 841.92, 595.32)"
15,(100). Even though the case fatality rates reported in COVID-19 is meager compared to the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(100). Even though the case fatality rates reported in COVID-19 is meager compared to the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 526.36, 639.616), True, False, 15, 841.92, 595.32)"
15,"previous  SARS  and  MERS  outbreaks,  it  has  so  far  caused  more  death  than  the  SARS  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('previous  SARS  and  MERS  outbreaks,  it  has  so  far  caused  more  death  than  the  SARS  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 613.588, 526.0640000000001, 624.496), True, False, 15, 841.92, 595.32)"
15,MERS combined (101). Possibly related to the viral pathogenesis is the recent finding of an,0,0,0,0,0,0,0,0,0,0,0,0,0,"('MERS combined (101). Possibly related to the viral pathogenesis is the recent finding of an', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 598.3480000000001, 526.202, 609.2560000000001), True, False, 15, 841.92, 595.32)"
15,"832-nt deletion in the ORF8, which appears to reduce replicative fitness of the virus and lead",0,0,0,0,0,0,0,0,0,0,0,0,0,"('832-nt deletion in the ORF8, which appears to reduce replicative fitness of the virus and lead', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 583.2280000000001, 526.2020000000002, 594.1360000000001), True, False, 15, 841.92, 595.32)"
15,to attenuated phenotypes of SARS-CoV-2 (258).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('to attenuated phenotypes of SARS-CoV-2 (258).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 567.958, 309.05, 578.866), True, False, 15, 841.92, 595.32)"
15,Coronavirus  is  the  most  prominent  example  of  a  virus  that  has  crossed  the  species,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus  is  the  most  prominent  example  of  a  virus  that  has  crossed  the  species', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 546.838, 526.282, 557.746), True, False, 15, 841.92, 595.32)"
15,"barrier twice from  wild  animals to humans, SARS, and MERS (79, 102). The possibility of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('barrier twice from  wild  animals to humans, SARS, and MERS (79, 102). The possibility of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 531.5980000000001, 526.342, 542.5060000000001), True, False, 15, 841.92, 595.32)"
15,crossing the species barrier for the third time cannot be ruled out in the case of SARS-CoV-2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('crossing the species barrier for the third time cannot be ruled out in the case of SARS-CoV-2', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 516.4780000000001, 526.42, 527.3860000000001), True, False, 15, 841.92, 595.32)"
15,(COVID-19).  Bats  are  recognized  as  the  possible  natural  reservoir  host  of  both  SARS-CoV,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(COVID-19).  Bats  are  recognized  as  the  possible  natural  reservoir  host  of  both  SARS-CoV', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 501.238, 526.408, 512.146), True, False, 15, 841.92, 595.32)"
15,"and MERS-CoV infection. In contrast, the possible intermediary host is Palm civet in SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and MERS-CoV infection. In contrast, the possible intermediary host is Palm civet in SARS-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 486.118, 523.576, 497.02599999999995), True, False, 15, 841.92, 595.32)"
15,CoV  and  Dromedary  camel  for  MERS-CoV  infection  (102).  Bats  are  considered  as  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV  and  Dromedary  camel  for  MERS-CoV  infection  (102).  Bats  are  considered  as  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 470.87800000000004, 526.27, 481.786), True, False, 15, 841.92, 595.32)"
15,ancestral hosts in both SARS and MERS (103). Bats are also considered as the reservoir host,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ancestral hosts in both SARS and MERS (103). Bats are also considered as the reservoir host', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 455.75800000000004, 526.238, 466.666), True, False, 15, 841.92, 595.32)"
15,"of human coronaviruses like HCoV-229E and HCoV-NL63 (104). In the case of COVID-19,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of human coronaviruses like HCoV-229E and HCoV-NL63 (104). In the case of COVID-19,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 440.51800000000003, 526.42, 451.426), True, False, 15, 841.92, 595.32)"
15,there  are  two  possibilities  for  primary  transmission;  either  it  can  be  transmitted  through,0,0,0,0,0,0,0,0,0,0,0,0,0,"('there  are  two  possibilities  for  primary  transmission;  either  it  can  be  transmitted  through', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 425.398, 526.42, 436.306), True, False, 15, 841.92, 595.32)"
15,intermediate  hosts  similar  to  that  of  SARS  and  MERS  or  directly  from  bats  (103).  The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('intermediate  hosts  similar  to  that  of  SARS  and  MERS  or  directly  from  bats  (103).  The', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 410.158, 526.42, 421.066), True, False, 15, 841.92, 595.32)"
15,emergence  paradigm  put  forward  in  the  SARS  outbreak  suggests  that  the  SARS-CoV,0,0,0,0,0,0,0,0,0,0,0,0,0,"('emergence  paradigm  put  forward  in  the  SARS  outbreak  suggests  that  the  SARS-CoV', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 395.038, 526.408, 405.94599999999997), True, False, 15, 841.92, 595.32)"
15,originated  from  the  bats  (reservoir  host)  and  later  jumped  to  civet  (intermediate  host)  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('originated  from  the  bats  (reservoir  host)  and  later  jumped  to  civet  (intermediate  host)  and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 379.778, 526.1160000000001, 390.686), True, False, 15, 841.92, 595.32)"
15,incorporated changes within the receptor-binding domain (RBD) to improve binding to civet,0,0,0,0,0,0,0,0,0,0,0,0,0,"('incorporated changes within the receptor-binding domain (RBD) to improve binding to civet', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 364.658, 526.408, 375.566), True, False, 15, 841.92, 595.32)"
15,"ACE2. This civet-adapted virus, during their subsequent exposure to humans at live-markets,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('ACE2. This civet-adapted virus, during their subsequent exposure to humans at live-markets,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 349.418, 526.42, 360.32599999999996), True, False, 15, 841.92, 595.32)"
15,promoted further adaptations that resulted in the epidemic strain (104). Transmission can also,0,0,0,0,0,0,0,0,0,0,0,0,0,"('promoted further adaptations that resulted in the epidemic strain (104). Transmission can also', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 334.298, 526.27, 345.20599999999996), True, False, 15, 841.92, 595.32)"
15,occur  directly  from  the  reservoir  host  to  humans  without  RBD  adaptations.  The  bat,0,0,0,0,0,0,0,0,0,0,0,0,0,"('occur  directly  from  the  reservoir  host  to  humans  without  RBD  adaptations.  The  bat', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 319.058, 526.318, 329.96599999999995), True, False, 15, 841.92, 595.32)"
15,coronavirus  that  is  currently  in  circulation  maintains  specific  'poised'  spike  proteins  that,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""coronavirus  that  is  currently  in  circulation  maintains  specific  'poised'  spike  proteins  that"", 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 303.938, 526.3299999999999, 314.84599999999995), True, False, 15, 841.92, 595.32)"
15,facilitate  human  infection  without  the  requirement  of  any  mutations  or  adaptations  (105).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('facilitate  human  infection  without  the  requirement  of  any  mutations  or  adaptations  (105).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 288.69800000000004, 526.408, 299.606), True, False, 15, 841.92, 595.32)"
15,Different  species  of  bats  carry  a  massive  number  of  coronaviruses  around  the  world  (106),0,0,0,0,0,0,0,0,0,0,0,0,0,"('Different  species  of  bats  carry  a  massive  number  of  coronaviruses  around  the  world  (106)', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 273.57800000000003, 526.4200000000001, 284.486), True, False, 15, 841.92, 595.32)"
15,altogether.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('altogether.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 258.338, 129.01999999999998, 269.246), True, False, 15, 841.92, 595.32)"
15,"The high  plasticity in receptor usage, along  with  the  feasibility  of adaptive mutation",0,0,0,0,0,0,0,0,0,0,0,0,0,"('The high  plasticity in receptor usage, along  with  the  feasibility  of adaptive mutation', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 237.218, 526.342, 248.126), True, False, 15, 841.92, 595.32)"
15,"and recombination, may result in frequent interspecies transmission of coronavirus from bats",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and recombination, may result in frequent interspecies transmission of coronavirus from bats', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 221.97799999999998, 526.1000000000001, 232.886), True, False, 15, 841.92, 595.32)"
15,"to  animals  and  humans  (106).  The  pathogenesis  of  most  bat  coronaviruses  is  unknown,  as",0,0,0,0,0,0,0,0,0,0,0,0,0,"('to  animals  and  humans  (106).  The  pathogenesis  of  most  bat  coronaviruses  is  unknown,  as', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 206.82799999999997, 526.408, 217.736), True, False, 15, 841.92, 595.32)"
15,these viruses are not isolated and studied (4). In the year to the already available coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('these viruses are not isolated and studied (4). In the year to the already available coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 191.588, 526.396, 202.496), True, False, 15, 841.92, 595.32)"
15,"hedgehog coronavirus HKU31, a Betacoronavirus has been identified from Amur hedgehogs",0,0,0,0,0,0,0,0,0,0,0,0,0,"('hedgehog coronavirus HKU31, a Betacoronavirus has been identified from Amur hedgehogs', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 176.468, 526.318, 187.388), False, False, 15, 841.92, 595.32)"
15,"in  China.  Study  shows  that  hedgehogs  are  the  reservoir  of  Betacoronavirus,  and  there  is",0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  China.  Study  shows  that  hedgehogs  are  the  reservoir  of  Betacoronavirus,  and  there  is', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 161.22799999999998, 526.3720000000001, 172.148), False, False, 15, 841.92, 595.32)"
15,evidence of recombination (107).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('evidence of recombination (107).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 146.10799999999998, 235.01, 157.016), True, False, 15, 841.92, 595.32)"
15,The  current  scientific  evidence  available  on  MERS  infection  suggests  that  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  current  scientific  evidence  available  on  MERS  infection  suggests  that  the', 'TimesNewRomanPSMT', 10.907999999999987, (108.02, 124.868, 526.16, 135.77599999999998), True, False, 15, 841.92, 595.32)"
15,"significant reservoir host, as well as the animal source of MERS infection in humans, are the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('significant reservoir host, as well as the animal source of MERS infection in humans, are the', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 109.748, 526.3960000000001, 120.656), True, False, 15, 841.92, 595.32)"
15,dromedary  camels  (97).  The  infected  dromedary  camels  may  not  show  any  visible  signs  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('dromedary  camels  (97).  The  infected  dromedary  camels  may  not  show  any  visible  signs  of', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 94.512, 526.36, 105.42), True, False, 15, 841.92, 595.32)"
15,"infection,  making  it  challenging  to  identify  animals  actively  excreting  MERS-CoV  that  has",0,0,0,0,0,0,0,0,0,0,0,0,0,"('infection,  making  it  challenging  to  identify  animals  actively  excreting  MERS-CoV  that  has', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 79.392, 526.384, 90.3), True, False, 15, 841.92, 595.32)"
15,"the  potential  to  infect  humans.  However,  they  may  shed  MERS-CoV  through  milk,  urine,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  potential  to  infect  humans.  However,  they  may  shed  MERS-CoV  through  milk,  urine,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 64.152, 526.318, 75.06), True, False, 15, 841.92, 595.32)"
15,14,0,0,0,0,0,0,0,0,0,0,0,0,0,"('14', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 15, 841.92, 595.32)"
15,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 15, 841.92, 595.32)"
16,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 16, 841.92, 595.32)"
16,"feces,  nasal,  and  eye  discharge  and  can  also  be  found  in  the  raw  organs  (108).  In  a  study",0,0,0,0,0,0,0,0,0,0,0,0,0,"('feces,  nasal,  and  eye  discharge  and  can  also  be  found  in  the  raw  organs  (108).  In  a  study', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.372, 767.076), True, False, 16, 841.92, 595.32)"
16,"conducted  to  evaluate  the  susceptibility  of  animal  species  to  MERS-CoV  infection,  llamas",0,0,0,0,0,0,0,0,0,0,0,0,0,"('conducted  to  evaluate  the  susceptibility  of  animal  species  to  MERS-CoV  infection,  llamas', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.342, 751.936), True, False, 16, 841.92, 595.32)"
16,"and pigs were found to be susceptible, indicating the possibility of MERS-CoV circulation in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and pigs were found to be susceptible, indicating the possibility of MERS-CoV circulation in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.33, 736.696), True, False, 16, 841.92, 595.32)"
16,animal species other than dromedary camels (109).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('animal species other than dromedary camels (109).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 319.99, 721.576), True, False, 16, 841.92, 595.32)"
16,"Following  the  outbreak  of  SARS  in  China,  SARS-CoV  like  viruses  were  isolated",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Following  the  outbreak  of  SARS  in  China,  SARS-CoV  like  viruses  were  isolated', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 689.428, 526.2940000000001, 700.336), True, False, 16, 841.92, 595.32)"
16,from Himalayan palm civets (Paguma larvata) and Raccoon dog (Nyctereutes procyonoides),0,0,0,0,0,0,0,0,0,0,0,0,0,"('from Himalayan palm civets (Paguma larvata) and Raccoon dog (Nyctereutes procyonoides)', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 674.308, 526.4200000000001, 685.228), False, False, 16, 841.92, 595.32)"
16,"found  in  a  live-animal  market  in  Guangdong,  China.  The  animal  isolates  obtained  from  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('found  in  a  live-animal  market  in  Guangdong,  China.  The  animal  isolates  obtained  from  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 659.068, 526.1719999999999, 669.976), True, False, 16, 841.92, 595.32)"
16,live-animal  market  retained  a  29-nucleotide  sequence  that  was  not  found  in  most  of  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('live-animal  market  retained  a  29-nucleotide  sequence  that  was  not  found  in  most  of  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.2260000000001, 654.856), True, False, 16, 841.92, 595.32)"
16,human isolates (78). These findings were critical in identifying the possibility of interspecies,0,0,0,0,0,0,0,0,0,0,0,0,0,"('human isolates (78). These findings were critical in identifying the possibility of interspecies', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 526.282, 639.616), True, False, 16, 841.92, 595.32)"
16,transmission in SARS-CoV. The higher diversity and prevalence of bat coronaviruses in this,0,0,0,0,0,0,0,0,0,0,0,0,0,"('transmission in SARS-CoV. The higher diversity and prevalence of bat coronaviruses in this', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 613.588, 526.1360000000001, 624.496), True, False, 16, 841.92, 595.32)"
16,region  compared  to  the  previous  reports  indicate  a  host/pathogen  coevolution.  SARS-like,0,0,0,0,0,0,0,0,0,0,0,0,0,"('region  compared  to  the  previous  reports  indicate  a  host/pathogen  coevolution.  SARS-like', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 598.3480000000001, 526.408, 609.2560000000001), True, False, 16, 841.92, 595.32)"
16,coronaviruses  have  also  been  found  circulating  in  the  Chinese  horseshoe  bat  (Rhinolophus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronaviruses  have  also  been  found  circulating  in  the  Chinese  horseshoe  bat  (Rhinolophus', 'TimesNewRomanPSMT', 10.919999999999959, (72.024, 583.2280000000001, 526.42, 594.148), False, False, 16, 841.92, 595.32)"
16,sinicus)  populations.  The  in  vitro  and  in  vivo  studies  carried  out  on  the  isolated  virus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('sinicus)  populations.  The  in  vitro  and  in  vivo  studies  carried  out  on  the  isolated  virus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 567.958, 526.3299999999999, 578.8779999999999), False, False, 16, 841.92, 595.32)"
16,confirmed that there is a potential risk for the re-emergence of SARS-CoV infection from the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('confirmed that there is a potential risk for the re-emergence of SARS-CoV infection from the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 552.838, 526.306, 563.746), True, False, 16, 841.92, 595.32)"
16,viruses that are currently being circulated in the bat population (105).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('viruses that are currently being circulated in the bat population (105).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.5980000000001, 407.95, 548.5060000000001), True, False, 16, 841.92, 595.32)"
16,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 516.4780000000001, 75.024, 527.3860000000001), True, False, 16, 841.92, 595.32)"
16,CLINICAL PATHOLOGY OF SARS-CoV-2 (COVID-19),0,0,0,0,0,0,0,0,0,0,0,0,0,"('CLINICAL PATHOLOGY OF SARS-CoV-2 (COVID-19)', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 495.238, 373.63, 505.954), True, False, 16, 841.92, 595.32)"
16,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 474.118, 75.024, 485.02599999999995), True, False, 16, 841.92, 595.32)"
16,The disease caused by SARS-CoV-2 is also named as the Severe Specific Contagious,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The disease caused by SARS-CoV-2 is also named as the Severe Specific Contagious', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 474.118, 526.2260000000001, 485.02599999999995), True, False, 16, 841.92, 595.32)"
16,"Pneumonia  (SSCP),  Wuhan  pneumonia,  and  recently  named  as  Coronavirus  Disease  2019,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Pneumonia  (SSCP),  Wuhan  pneumonia,  and  recently  named  as  Coronavirus  Disease  2019,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 458.87800000000004, 526.33, 469.786), True, False, 16, 841.92, 595.32)"
16,"COVID-19,  by  WHO  (110).  Compared  to  the  SARS-CoV,  SARS-CoV-2  has  less  severe",0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19,  by  WHO  (110).  Compared  to  the  SARS-CoV,  SARS-CoV-2  has  less  severe', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 443.75800000000004, 526.372, 454.666), True, False, 16, 841.92, 595.32)"
16,pathogenesis but has superior transmission competence that is evident from the continuously,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pathogenesis but has superior transmission competence that is evident from the continuously', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 428.51800000000003, 526.1280000000002, 439.426), True, False, 16, 841.92, 595.32)"
16,increasing confirmed cases (111). The incubation period of SARS-CoV-2 in familial clusters,0,0,0,0,0,0,0,0,0,0,0,0,0,"('increasing confirmed cases (111). The incubation period of SARS-CoV-2 in familial clusters', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 413.398, 526.42, 424.306), True, False, 16, 841.92, 595.32)"
16,was found to be 3 to 6 days (112). The mean incubation period of COVID-19 was estimated,0,0,0,0,0,0,0,0,0,0,0,0,0,"('was found to be 3 to 6 days (112). The mean incubation period of COVID-19 was estimated', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 398.158, 526.384, 409.066), True, False, 16, 841.92, 595.32)"
16,to be 6.4 days and ranging from 2.1-11.1 days (113). Among the early affected people of 425,0,0,0,0,0,0,0,0,0,0,0,0,0,"('to be 6.4 days and ranging from 2.1-11.1 days (113). Among the early affected people of 425', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 383.01800000000003, 526.258, 393.926), True, False, 16, 841.92, 595.32)"
16,"patients,  59  years  was  the  median  age  group  affected,  of  which  more  males  were  affected",0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients,  59  years  was  the  median  age  group  affected,  of  which  more  males  were  affected', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 367.778, 526.33, 378.686), True, False, 16, 841.92, 595.32)"
16,"(114).  Similar  to  SARS  and  MERS,  the  severity  of  this  nCoV  is  high  in  age  group  people",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(114).  Similar  to  SARS  and  MERS,  the  severity  of  this  nCoV  is  high  in  age  group  people', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 352.658, 526.2260000000001, 363.566), True, False, 16, 841.92, 595.32)"
16,"above 50 years (2, 115). Symptoms of COVID-19 include fever, cough, myalgia, or fatigue,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('above 50 years (2, 115). Symptoms of COVID-19 include fever, cough, myalgia, or fatigue,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 337.418, 526.384, 348.32599999999996), True, False, 16, 841.92, 595.32)"
16,"less  commonly  headache,  hemoptysis  and  diarrhea  (116;  287).  Compared  to  the  patients",0,0,0,0,0,0,0,0,0,0,0,0,0,"('less  commonly  headache,  hemoptysis  and  diarrhea  (116;  287).  Compared  to  the  patients', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 322.298, 526.33, 333.20599999999996), True, False, 16, 841.92, 595.32)"
16,"infected  with  SARS-Cov-2  in  Wuhan  during  the  initial  stages  of  the  outbreak,  only  mild",0,0,0,0,0,0,0,0,0,0,0,0,0,"('infected  with  SARS-Cov-2  in  Wuhan  during  the  initial  stages  of  the  outbreak,  only  mild', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 307.058, 526.1660000000002, 317.96599999999995), True, False, 16, 841.92, 595.32)"
16,symptoms were noticed  in  those patients  that are infected by human-to-human transmission,0,0,0,0,0,0,0,0,0,0,0,0,0,"('symptoms were noticed  in  those patients  that are infected by human-to-human transmission', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 291.938, 526.342, 302.84599999999995), True, False, 16, 841.92, 595.32)"
16,(14).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(14).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 276.69800000000004, 98.064, 287.606), True, False, 16, 841.92, 595.32)"
16,The  initial  trends  suggested  that  the  mortality  associated  with  COVID-19  is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  initial  trends  suggested  that  the  mortality  associated  with  COVID-19  is', 'TimesNewRomanPSMT', 10.907999999999987, (108.02, 255.578, 526.408, 266.486), True, False, 16, 841.92, 595.32)"
16,comparatively lesser than the previous outbreaks of SARS (101). The updates obtained from,0,0,0,0,0,0,0,0,0,0,0,0,0,"('comparatively lesser than the previous outbreaks of SARS (101). The updates obtained from', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 240.338, 526.342, 251.246), True, False, 16, 841.92, 595.32)"
16,"the  countries  like  China,  Japan,  Thailand,  and  Korea  indicate  that  the  COVID-19  infection",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  countries  like  China,  Japan,  Thailand,  and  Korea  indicate  that  the  COVID-19  infection', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 225.218, 526.384, 236.126), True, False, 16, 841.92, 595.32)"
16,appears to be having relatively mild manifestations as compared with SARS and MERS (4).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('appears to be having relatively mild manifestations as compared with SARS and MERS (4).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 209.94799999999998, 526.42, 220.856), True, False, 16, 841.92, 595.32)"
16,"Regardless  of  the  coronavirus  type,  immune  cells  like  mast  cells  that  are  present  in  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Regardless  of  the  coronavirus  type,  immune  cells  like  mast  cells  that  are  present  in  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 194.82799999999997, 526.306, 205.736), True, False, 16, 841.92, 595.32)"
16,submucosa  of  the  respiratory  tract  and  nasal  cavity  are  considered  as  the  primary  barrier,0,0,0,0,0,0,0,0,0,0,0,0,0,"('submucosa  of  the  respiratory  tract  and  nasal  cavity  are  considered  as  the  primary  barrier', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 179.588, 526.076, 190.496), True, False, 16, 841.92, 595.32)"
16,against this virus (92). Advanced in-depth  analysis of the genome has identified 380 amino,0,0,0,0,0,0,0,0,0,0,0,0,0,"('against this virus (92). Advanced in-depth  analysis of the genome has identified 380 amino', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 164.468, 526.2020000000001, 175.376), True, False, 16, 841.92, 595.32)"
16,acid substitutions between the amino acid sequences of SARS-CoV-2 and the SARS/SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('acid substitutions between the amino acid sequences of SARS-CoV-2 and the SARS/SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 149.22799999999998, 523.576, 160.136), True, False, 16, 841.92, 595.32)"
16,like coronaviruses. This difference in the amino acid sequence might have contributed to the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('like coronaviruses. This difference in the amino acid sequence might have contributed to the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 134.10799999999998, 526.104, 145.016), True, False, 16, 841.92, 595.32)"
16,difference in the pathogenic divergence of SARS-CoV-2 (16). Further researches are required,0,0,0,0,0,0,0,0,0,0,0,0,0,"('difference in the pathogenic divergence of SARS-CoV-2 (16). Further researches are required', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 118.868, 526.2940000000001, 129.77599999999998), True, False, 16, 841.92, 595.32)"
16,"to  evaluate  the  possible  difference  in  tropism,  pathogenesis,  and  transmission  of  this  novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('to  evaluate  the  possible  difference  in  tropism,  pathogenesis,  and  transmission  of  this  novel', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 103.748, 526.0800000000002, 114.656), True, False, 16, 841.92, 595.32)"
16,agent  associated  with  this change in  the amino acid  sequence.  With the  current  outbreak of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('agent  associated  with  this change in  the amino acid  sequence.  With the  current  outbreak of', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 88.512, 526.384, 99.42), True, False, 16, 841.92, 595.32)"
16,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 16, 841.92, 595.32)"
16,15,0,0,0,0,0,0,0,0,0,0,0,0,0,"('15', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 16, 841.92, 595.32)"
17,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 17, 841.92, 595.32)"
17,"COVID-19,  there  is  an  expectancy  of  a  significant  increase  in  the  number  of  published",0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19,  there  is  an  expectancy  of  a  significant  increase  in  the  number  of  published', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.226, 767.076), True, False, 17, 841.92, 595.32)"
17,"studies about this emerging coronavirus, as occurred with SARS and MERS (117).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('studies about this emerging coronavirus, as occurred with SARS and MERS (117).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 472.66, 751.936), True, False, 17, 841.92, 595.32)"
17,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 719.788, 75.024, 730.696), True, False, 17, 841.92, 595.32)"
17,The  2019-n-CoV  invades  the  lung  parenchyma  resulting  in  severe  interstitial,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  2019-n-CoV  invades  the  lung  parenchyma  resulting  in  severe  interstitial', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 719.788, 526.238, 730.696), True, False, 17, 841.92, 595.32)"
17,inflammation of the lungs. This will be evident on CT images as ground-glass opacity in the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('inflammation of the lungs. This will be evident on CT images as ground-glass opacity in the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 704.668, 526.408, 715.576), True, False, 17, 841.92, 595.32)"
17,"lungs. This lesion, even though initially, involves a single lobe but later expands to multiple",0,0,0,0,0,0,0,0,0,0,0,0,0,"('lungs. This lesion, even though initially, involves a single lobe but later expands to multiple', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 689.428, 526.2700000000001, 700.336), True, False, 17, 841.92, 595.32)"
17,lung  lobes  (118).  The  histological  examination  of  lung  biopsy  samples  obtained  from,0,0,0,0,0,0,0,0,0,0,0,0,0,"('lung  lobes  (118).  The  histological  examination  of  lung  biopsy  samples  obtained  from', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 674.308, 526.396, 685.216), True, False, 17, 841.92, 595.32)"
17,"COVID-19 infected patient showed diffuse alveolar damage, cellular fibromyxoid exudates,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19 infected patient showed diffuse alveolar damage, cellular fibromyxoid exudates,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 659.068, 526.2140000000002, 669.976), True, False, 17, 841.92, 595.32)"
17,"hyaline  membrane  formation,  and  desquamation  of  pneumocytes,  indicative  of  acute",0,0,0,0,0,0,0,0,0,0,0,0,0,"('hyaline  membrane  formation,  and  desquamation  of  pneumocytes,  indicative  of  acute', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.33, 654.856), True, False, 17, 841.92, 595.32)"
17,respiratory  distress  syndrome  (119).  It  has  also  been  found  that  the  SARS-CoV-2  infected,0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory  distress  syndrome  (119).  It  has  also  been  found  that  the  SARS-CoV-2  infected', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 526.444, 639.616), True, False, 17, 841.92, 595.32)"
17,patients  often  have  lymphocytopenia  along  with/  without  leukocyte  abnormalities.  The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients  often  have  lymphocytopenia  along  with/  without  leukocyte  abnormalities.  The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 613.588, 526.1599999999999, 624.496), True, False, 17, 841.92, 595.32)"
17,degree of lymphocytopenia gives an idea about the disease prognosis as it is found positively,0,0,0,0,0,0,0,0,0,0,0,0,0,"('degree of lymphocytopenia gives an idea about the disease prognosis as it is found positively', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 598.3480000000001, 526.1240000000003, 609.2560000000001), True, False, 17, 841.92, 595.32)"
17,correlated  with  the  disease  severity  (118).  Pregnant  women  are  considered  to  be  having  a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('correlated  with  the  disease  severity  (118).  Pregnant  women  are  considered  to  be  having  a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 583.2280000000001, 526.42, 594.1360000000001), True, False, 17, 841.92, 595.32)"
17,higher risk of getting infected by COVID-19. The coronaviruses can cause adverse outcomes,0,0,0,0,0,0,0,0,0,0,0,0,0,"('higher risk of getting infected by COVID-19. The coronaviruses can cause adverse outcomes', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 567.958, 526.354, 578.866), True, False, 17, 841.92, 595.32)"
17,"for the fetus, such as intrauterine growth restriction, spontaneous abortion, preterm delivery,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('for the fetus, such as intrauterine growth restriction, spontaneous abortion, preterm delivery,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 552.838, 526.1600000000001, 563.746), True, False, 17, 841.92, 595.32)"
17,and perinatal death.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and perinatal death.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.5980000000001, 169.34, 548.5060000000001), True, False, 17, 841.92, 595.32)"
17,"Nevertheless,  the  possibility  of  intrauterine  maternal-fetal  transmission  (vertical",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Nevertheless,  the  possibility  of  intrauterine  maternal-fetal  transmission  (vertical', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 516.4780000000001, 526.306, 527.3860000000001), True, False, 17, 841.92, 595.32)"
17,"transmission) of CoVs is low, and it is not reported in either SARS or MERS (120). However,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('transmission) of CoVs is low, and it is not reported in either SARS or MERS (120). However,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 501.238, 529.42, 512.146), True, False, 17, 841.92, 595.32)"
17,there has been concern regarding the impact of SARS-CoV-2/COVID-19 on the pregnancy.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('there has been concern regarding the impact of SARS-CoV-2/COVID-19 on the pregnancy.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 486.118, 515.74, 497.02599999999995), True, False, 17, 841.92, 595.32)"
17,Researchers have mentioned the probability of in utero transmission of novel SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Researchers have mentioned the probability of in utero transmission of novel SARS-', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 464.87800000000004, 523.576, 475.798), False, False, 17, 841.92, 595.32)"
17,CoV-2  from  COVID-19  infected  mothers  to  their  neonates  in  China  based  upon  the  rise  in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2  from  COVID-19  infected  mothers  to  their  neonates  in  China  based  upon  the  rise  in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 449.75800000000004, 526.408, 460.666), True, False, 17, 841.92, 595.32)"
17,"IgM, IgG antibody levels and cytokine values in the blood obtained from newly borne infants",0,0,0,0,0,0,0,0,0,0,0,0,0,"('IgM, IgG antibody levels and cytokine values in the blood obtained from newly borne infants', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 434.51800000000003, 526.032, 445.426), True, False, 17, 841.92, 595.32)"
17,"immediately post-birth; however, reverse transcriptase-polymerase chain  reaction (RT-PCR)",0,0,0,0,0,0,0,0,0,0,0,0,0,"('immediately post-birth; however, reverse transcriptase-polymerase chain  reaction (RT-PCR)', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 419.398, 526.4200000000001, 430.306), True, False, 17, 841.92, 595.32)"
17,did not confirm the presence of SARS-CoV-2 genetic material in the infants (288).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('did not confirm the presence of SARS-CoV-2 genetic material in the infants (288).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 404.158, 472.66, 415.066), True, False, 17, 841.92, 595.32)"
17,"Recent  studies  show  that  at  least,  in  some  cases,  preterm  delivery  and  its",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Recent  studies  show  that  at  least,  in  some  cases,  preterm  delivery  and  its', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 383.01800000000003, 526.1239999999999, 393.926), True, False, 17, 841.92, 595.32)"
17,"consequences,  are  associated.  Nevertheless,  some  cases  have  raised  doubts  regarding  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('consequences,  are  associated.  Nevertheless,  some  cases  have  raised  doubts  regarding  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 367.778, 526.1879999999999, 378.686), True, False, 17, 841.92, 595.32)"
17,possibility of vertical transmission (240-243).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('possibility of vertical transmission (240-243).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 352.658, 294.65, 363.566), True, False, 17, 841.92, 595.32)"
17,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 331.418, 75.024, 342.32599999999996), True, False, 17, 841.92, 595.32)"
17,"The COVID-19 infection was associated with pneumonia, and some developed acute",0,0,0,0,0,0,0,0,0,0,0,0,0,"('The COVID-19 infection was associated with pneumonia, and some developed acute', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 331.418, 526.408, 342.32599999999996), True, False, 17, 841.92, 595.32)"
17,"respiratory  distress  syndrome  (ARDS).  The  blood  biochemistry  indexes  such  as  albumin,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory  distress  syndrome  (ARDS).  The  blood  biochemistry  indexes  such  as  albumin,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 316.298, 526.1780000000001, 327.20599999999996), True, False, 17, 841.92, 595.32)"
17,"lactate  dehydrogenase,  C-reactive  protein,  lymphocytes  (%),  and  neutrophils  (%)  gives  an",0,0,0,0,0,0,0,0,0,0,0,0,0,"('lactate  dehydrogenase,  C-reactive  protein,  lymphocytes  (%),  and  neutrophils  (%)  gives  an', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 301.058, 526.1540000000001, 311.96599999999995), True, False, 17, 841.92, 595.32)"
17,"idea  about  the  disease  severity  in  COVID-19  infection  (121).  During  COVID-19,  patients",0,0,0,0,0,0,0,0,0,0,0,0,0,"('idea  about  the  disease  severity  in  COVID-19  infection  (121).  During  COVID-19,  patients', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 285.938, 526.36, 296.84599999999995), True, False, 17, 841.92, 595.32)"
17,"may  present  leukocytosis,  leukopenia  with  lymphopenia  (244),  also  hypoalbuminemia,  an",0,0,0,0,0,0,0,0,0,0,0,0,0,"('may  present  leukocytosis,  leukopenia  with  lymphopenia  (244),  also  hypoalbuminemia,  an', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 270.69800000000004, 526.42, 281.606), True, False, 17, 841.92, 595.32)"
17,"increase  of  LDH,  AST,  ALT,  bilirubin,  and  especially  D-dime  (244).  Middle-aged  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('increase  of  LDH,  AST,  ALT,  bilirubin,  and  especially  D-dime  (244).  Middle-aged  and', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 255.578, 526.3960000000001, 266.486), True, False, 17, 841.92, 595.32)"
17,"elderly  patients  with  primary  chronic  diseases,  especially  high  blood  pressure  and  diabetes,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('elderly  patients  with  primary  chronic  diseases,  especially  high  blood  pressure  and  diabetes,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 240.338, 526.42, 251.246), True, False, 17, 841.92, 595.32)"
17,were found to be more susceptible to respiratory failure and thereby having poorer prognosis.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('were found to be more susceptible to respiratory failure and thereby having poorer prognosis.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 225.218, 526.116, 236.126), True, False, 17, 841.92, 595.32)"
17,Providing  respiratory  support  at  early  stages  improved  the  disease  prognosis  and  facilitated,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Providing  respiratory  support  at  early  stages  improved  the  disease  prognosis  and  facilitated', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 209.94799999999998, 526.2340000000002, 220.856), True, False, 17, 841.92, 595.32)"
17,recovery  (18).  The  ARDS  in  COVID-19  is  due  to  the  occurrence  of  cytokine  storms  that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('recovery  (18).  The  ARDS  in  COVID-19  is  due  to  the  occurrence  of  cytokine  storms  that', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 194.82799999999997, 526.1780000000001, 205.736), True, False, 17, 841.92, 595.32)"
17,"results in exaggerated immune response, immune regulatory network imbalance, and, finally,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('results in exaggerated immune response, immune regulatory network imbalance, and, finally,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 179.588, 526.42, 190.496), True, False, 17, 841.92, 595.32)"
17,can  even  lead  to  multiple  organ  failure  (122).  In  addition  to  the  exaggerated  inflammatory,0,0,0,0,0,0,0,0,0,0,0,0,0,"('can  even  lead  to  multiple  organ  failure  (122).  In  addition  to  the  exaggerated  inflammatory', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 164.468, 526.2260000000001, 175.376), True, False, 17, 841.92, 595.32)"
17,"response  seen  in  patients  with  COVID-19  pneumonia,  the  bile  duct  epithelial  cell-derived",0,0,0,0,0,0,0,0,0,0,0,0,0,"('response  seen  in  patients  with  COVID-19  pneumonia,  the  bile  duct  epithelial  cell-derived', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 149.22799999999998, 526.396, 160.136), True, False, 17, 841.92, 595.32)"
17,hepatocytes  up-regulate  the  ACE2  expression  in  liver  tissue  by  compensatory  proliferation,0,0,0,0,0,0,0,0,0,0,0,0,0,"('hepatocytes  up-regulate  the  ACE2  expression  in  liver  tissue  by  compensatory  proliferation', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 134.10799999999998, 526.1, 145.016), True, False, 17, 841.92, 595.32)"
17,that might result in hepatic tissue injury (123).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('that might result in hepatic tissue injury (123).', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 118.868, 297.65, 129.77599999999998), True, False, 17, 841.92, 595.32)"
17,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.715999999999994, (72.024, 97.748, 75.024, 108.464), True, False, 17, 841.92, 595.32)"
17,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 17, 841.92, 595.32)"
17,16,0,0,0,0,0,0,0,0,0,0,0,0,0,"('16', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 17, 841.92, 595.32)"
18,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 18, 841.92, 595.32)"
18,CORONAVIRUSES  (CoV)  IN  ANIMALS  AND  ZOONOTIC  LINKS-  A  BRIEF,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CORONAVIRUSES  (CoV)  IN  ANIMALS  AND  ZOONOTIC  LINKS-  A  BRIEF', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 756.168, 526.396, 766.884), True, False, 18, 841.92, 595.32)"
18,VIEWPOINT,0,0,0,0,0,0,0,0,0,0,0,0,0,"('VIEWPOINT', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 741.028, 149.42, 751.744), True, False, 18, 841.92, 595.32)"
18,"Coronavirus  can  cause  disease  in  several  species  of  domestic  and  wild  animals,  as",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus  can  cause  disease  in  several  species  of  domestic  and  wild  animals,  as', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 719.788, 526.1000000000001, 730.696), True, False, 18, 841.92, 595.32)"
18,"well as humans (23). The different animal species that are infected with CoV include horses,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('well as humans (23). The different animal species that are infected with CoV include horses,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 704.668, 526.396, 715.576), True, False, 18, 841.92, 595.32)"
18,"camels, cattle, swine, dogs, cats, rodents, birds, ferrets, mink, bats, rabbits, snake, and several",0,0,0,0,0,0,0,0,0,0,0,0,0,"('camels, cattle, swine, dogs, cats, rodents, birds, ferrets, mink, bats, rabbits, snake, and several', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 689.428, 526.42, 700.336), True, False, 18, 841.92, 595.32)"
18,"other  wild  animals  (20,  30,  79,  93,  124,  125;  Dhama  et  al.,  2020).  Coronavirus  infection  is",0,0,0,0,0,0,0,0,0,0,0,0,0,"('other  wild  animals  (20,  30,  79,  93,  124,  125;  Dhama  et  al.,  2020).  Coronavirus  infection  is', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 674.308, 526.282, 685.216), True, False, 18, 841.92, 595.32)"
18,associated with  a wide variety  of  clinical  manifestations ranging  from  enteritis  in  cows and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('associated with  a wide variety  of  clinical  manifestations ranging  from  enteritis  in  cows and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 659.068, 526.124, 669.976), True, False, 18, 841.92, 595.32)"
18,"pigs,  upper  respiratory  disease  in  chickens,  and  potentially  fatal  respiratory  infections  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('pigs,  upper  respiratory  disease  in  chickens,  and  potentially  fatal  respiratory  infections  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.2740000000001, 654.856), True, False, 18, 841.92, 595.32)"
18,humans (30).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('humans (30).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 138.38, 639.616), True, False, 18, 841.92, 595.32)"
18,"Among  the  CoVs  genera,  Alphacoronavirus  and  Betacoronavirus  infect  mammals.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Among  the  CoVs  genera,  Alphacoronavirus  and  Betacoronavirus  infect  mammals.', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 607.588, 526.384, 618.5079999999999), False, False, 18, 841.92, 595.32)"
18,"While Gammacoronavirus and Deltacoronavirus  mainly  infect  birds, fishes, and sometimes",0,0,0,0,0,0,0,0,0,0,0,0,0,"('While Gammacoronavirus and Deltacoronavirus  mainly  infect  birds, fishes, and sometimes', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 592.3480000000001, 526.384, 603.268), False, False, 18, 841.92, 595.32)"
18,"also  mammals  (27,  29,  106).  Several  novel  coronaviruses  that  come  under  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('also  mammals  (27,  29,  106).  Several  novel  coronaviruses  that  come  under  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 577.2280000000001, 526.2500000000001, 588.1360000000001), True, False, 18, 841.92, 595.32)"
18,genusDeltacoronavirus have been discovered in the past from birds like Wigeon coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('genusDeltacoronavirus have been discovered in the past from birds like Wigeon coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 561.958, 526.1600000000001, 572.8779999999999), False, False, 18, 841.92, 595.32)"
18,"HKU20,  Bulbul  coronavirus  HKU11,  Munia  coronavirus  HKU13,  White-eye  coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('HKU20,  Bulbul  coronavirus  HKU11,  Munia  coronavirus  HKU13,  White-eye  coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 546.838, 526.396, 557.746), True, False, 18, 841.92, 595.32)"
18,"HKU16, Night-heron coronavirus HKU19, Common moorhen coronavirus HKU21 and from",0,0,0,0,0,0,0,0,0,0,0,0,0,"('HKU16, Night-heron coronavirus HKU19, Common moorhen coronavirus HKU21 and from', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 531.5980000000001, 526.25, 542.5060000000001), True, False, 18, 841.92, 595.32)"
18,"pigs also (porcine coronavirus HKU15) (6, 29). Transmissible gastroenteritis virus (TGEV),",0,0,0,0,0,0,0,0,0,0,0,0,0,"('pigs also (porcine coronavirus HKU15) (6, 29). Transmissible gastroenteritis virus (TGEV),', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 516.4780000000001, 526.42, 527.3860000000001), True, False, 18, 841.92, 595.32)"
18,"porcine  epidemic  diarrhea  virus  (PEDV),  and  porcine  hemagglutinating  encephalomyelitis",0,0,0,0,0,0,0,0,0,0,0,0,0,"('porcine  epidemic  diarrhea  virus  (PEDV),  and  porcine  hemagglutinating  encephalomyelitis', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 501.238, 526.2620000000001, 512.146), True, False, 18, 841.92, 595.32)"
18,"virus (PHEV) are some of the coronaviruses of swine. Among them, TGEV and PEDV cause",0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus (PHEV) are some of the coronaviruses of swine. Among them, TGEV and PEDV cause', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 486.118, 526.08, 497.02599999999995), True, False, 18, 841.92, 595.32)"
18,severe  gastroenteritis  in  young  piglets  leading  to  noteworthy  morbidity  and  mortality.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('severe  gastroenteritis  in  young  piglets  leading  to  noteworthy  morbidity  and  mortality.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 470.87800000000004, 526.342, 481.786), True, False, 18, 841.92, 595.32)"
18,Infection  with  PHEV  also  cause  enteric  infection  but  can  cause  encephalitis  due  to  its,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infection  with  PHEV  also  cause  enteric  infection  but  can  cause  encephalitis  due  to  its', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 455.75800000000004, 526.1660000000002, 466.666), True, False, 18, 841.92, 595.32)"
18,capability to infect the nervous system (30).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('capability to infect the nervous system (30).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 440.51800000000003, 286.01, 451.426), True, False, 18, 841.92, 595.32)"
18,Bovine  coronaviruses  (BoCoVs)  are  known  to  infect  several  domestic  and  wild,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Bovine  coronaviruses  (BoCoVs)  are  known  to  infect  several  domestic  and  wild', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 419.398, 526.214, 430.306), True, False, 18, 841.92, 595.32)"
18,"ruminants  (126).  BoCoVinflicts  neonatal  calf  diarrhea,  in  adult  cattle,  leads  to  bloody",0,0,0,0,0,0,0,0,0,0,0,0,0,"('ruminants  (126).  BoCoVinflicts  neonatal  calf  diarrhea,  in  adult  cattle,  leads  to  bloody', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 404.158, 526.396, 415.066), True, False, 18, 841.92, 595.32)"
18,"diarrhea (winter dysentery), and respiratory disease complex (shipping fever) in cattle of all",0,0,0,0,0,0,0,0,0,0,0,0,0,"('diarrhea (winter dysentery), and respiratory disease complex (shipping fever) in cattle of all', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 389.01800000000003, 526.372, 399.926), True, False, 18, 841.92, 595.32)"
18,age  groups  (126).  BoCoV-like  viruses  have  been  noted  in  humans  suggesting  its  zoonotic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('age  groups  (126).  BoCoV-like  viruses  have  been  noted  in  humans  suggesting  its  zoonotic', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 373.778, 526.384, 384.686), True, False, 18, 841.92, 595.32)"
18,potential  as  well  (127).  Feline  enteric  and  feline  infectious  peritonitis  (FIP)  viruses  are  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('potential  as  well  (127).  Feline  enteric  and  feline  infectious  peritonitis  (FIP)  viruses  are  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 358.658, 526.384, 369.566), True, False, 18, 841.92, 595.32)"
18,"two  major  feline  CoVs  (128).  Where  feline  CoVs  can  affect  GIT,  abdominal  cavity",0,0,0,0,0,0,0,0,0,0,0,0,0,"('two  major  feline  CoVs  (128).  Where  feline  CoVs  can  affect  GIT,  abdominal  cavity', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 343.418, 526.2460000000001, 354.32599999999996), True, False, 18, 841.92, 595.32)"
18,"(peritonitis),  respiratory  tract,  and  CNS  (128).  Canines  are  also  affected  by  CoVsand  fall",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(peritonitis),  respiratory  tract,  and  CNS  (128).  Canines  are  also  affected  by  CoVsand  fall', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 328.298, 526.396, 339.20599999999996), True, False, 18, 841.92, 595.32)"
18,"under  different  genera,  namely  canine  enteric  coronavirus  in  Alphacoronavirus  and  canine",0,0,0,0,0,0,0,0,0,0,0,0,0,"('under  different  genera,  namely  canine  enteric  coronavirus  in  Alphacoronavirus  and  canine', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 313.058, 526.408, 323.97799999999995), False, False, 18, 841.92, 595.32)"
18,"respiratory  coronavirus  in  Betaacoronavirus  affecting  the  enteric  and  respiratory  tract,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory  coronavirus  in  Betaacoronavirus  affecting  the  enteric  and  respiratory  tract,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 297.938, 526.42, 308.85799999999995), False, False, 18, 841.92, 595.32)"
18,"respectively  (129,130).  The  infectious  bronchitis  virus  (IBV)  under  Gammacoronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('respectively  (129,130).  The  infectious  bronchitis  virus  (IBV)  under  Gammacoronavirus', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 282.69800000000004, 526.42, 293.618), False, False, 18, 841.92, 595.32)"
18,"causes  diseases  of  respiratory,  urinary,  and  reproductive  systems  with  substantial  economic",0,0,0,0,0,0,0,0,0,0,0,0,0,"('causes  diseases  of  respiratory,  urinary,  and  reproductive  systems  with  substantial  economic', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 267.57800000000003, 526.408, 278.486), True, False, 18, 841.92, 595.32)"
18,"losses  in  chickens  (131,132).  In  small  laboratory  animals,  mouse  hepatitis  virus,  rat",0,0,0,0,0,0,0,0,0,0,0,0,0,"('losses  in  chickens  (131,132).  In  small  laboratory  animals,  mouse  hepatitis  virus,  rat', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 252.338, 526.33, 263.246), True, False, 18, 841.92, 595.32)"
18,"sialodacryoadenitis  coronavirus,  guinea  pig,  and  rabbit  coronaviruses  are  the  major  CoVs",0,0,0,0,0,0,0,0,0,0,0,0,0,"('sialodacryoadenitis  coronavirus,  guinea  pig,  and  rabbit  coronaviruses  are  the  major  CoVs', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 237.218, 526.42, 248.126), True, False, 18, 841.92, 595.32)"
18,"associated  with  the  disease  manifestations  like  enteritis,  hepatitis  and  respiratory  infections",0,0,0,0,0,0,0,0,0,0,0,0,0,"('associated  with  the  disease  manifestations  like  enteritis,  hepatitis  and  respiratory  infections', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 221.97799999999998, 526.396, 232.886), True, False, 18, 841.92, 595.32)"
18,"(10, 133).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(10, 133).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 206.82799999999997, 122.06, 217.736), True, False, 18, 841.92, 595.32)"
18,Swine  acute  diarrhea  syndrome  coronavirus  (SADS-CoV)  was  first  identified  in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Swine  acute  diarrhea  syndrome  coronavirus  (SADS-CoV)  was  first  identified  in', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 185.588, 526.3299999999999, 196.496), True, False, 18, 841.92, 595.32)"
18,suckling piglets with severe enteritis and belonged to the genus Alphacoronavirus (106). The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('suckling piglets with severe enteritis and belonged to the genus Alphacoronavirus (106). The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 170.468, 526.396, 181.388), False, False, 18, 841.92, 595.32)"
18,"outbreak  was  associated  with  considerable  scale  mortality  of  piglets  (24,693  deaths)  across",0,0,0,0,0,0,0,0,0,0,0,0,0,"('outbreak  was  associated  with  considerable  scale  mortality  of  piglets  (24,693  deaths)  across', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 155.22799999999998, 526.238, 166.136), True, False, 18, 841.92, 595.32)"
18,four farms in China (134). The virus isolated from the piglets was almost identical and had a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('four farms in China (134). The virus isolated from the piglets was almost identical and had a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 140.10799999999998, 526.42, 151.016), True, False, 18, 841.92, 595.32)"
18,95% genomic similarity with horseshoe bat (Rhinolophus sp.) coronavirus HKU2 suggesting,0,0,0,0,0,0,0,0,0,0,0,0,0,"('95% genomic similarity with horseshoe bat (Rhinolophus sp.) coronavirus HKU2 suggesting', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 124.868, 526.33, 135.78799999999998), False, False, 18, 841.92, 595.32)"
18,"bat origin of the pig virus (106, 134, 135). It is also imperative to note that the SADS-CoV",0,0,0,0,0,0,0,0,0,0,0,0,0,"('bat origin of the pig virus (106, 134, 135). It is also imperative to note that the SADS-CoV', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 109.748, 526.408, 120.656), True, False, 18, 841.92, 595.32)"
18,"outbreak started in Guangdong province, near to  the location of  the  SARS pandemic origin",0,0,0,0,0,0,0,0,0,0,0,0,0,"('outbreak started in Guangdong province, near to  the location of  the  SARS pandemic origin', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 94.512, 526.306, 105.42), True, False, 18, 841.92, 595.32)"
18,"(134). Before this outbreak, pigs were not known to be infected with bat-origin coronaviruses.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(134). Before this outbreak, pigs were not known to be infected with bat-origin coronaviruses.', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 79.392, 529.366, 90.3), True, False, 18, 841.92, 595.32)"
18,This  indicates  that  the  bat-origin  coronavirus  might  have  jumped  to  pig  by  breaking  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('This  indicates  that  the  bat-origin  coronavirus  might  have  jumped  to  pig  by  breaking  the', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 64.152, 526.202, 75.06), True, False, 18, 841.92, 595.32)"
18,17,0,0,0,0,0,0,0,0,0,0,0,0,0,"('17', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 18, 841.92, 595.32)"
18,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 18, 841.92, 595.32)"
19,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 19, 841.92, 595.32)"
19,species  barrier.  The  next  step  of  this  'jump'  might  not  end  up  in  good  since  the  pigs  are,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""species  barrier.  The  next  step  of  this  'jump'  might  not  end  up  in  good  since  the  pigs  are"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.0080000000002, 767.076), True, False, 19, 841.92, 595.32)"
19,considered as the mixing vessel for influenza A viruses due to their ability to get infected by,0,0,0,0,0,0,0,0,0,0,0,0,0,"('considered as the mixing vessel for influenza A viruses due to their ability to get infected by', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.0400000000001, 751.936), True, False, 19, 841.92, 595.32)"
19,both human and avian influenza A viruses (136).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('both human and avian influenza A viruses (136).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 309.65, 736.696), True, False, 19, 841.92, 595.32)"
19,"Similarly,  they  can  act  as  the  mixing  vessel  for  coronaviruses  since  they  are  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Similarly,  they  can  act  as  the  mixing  vessel  for  coronaviruses  since  they  are  in', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 704.668, 526.064, 715.576), True, False, 19, 841.92, 595.32)"
19,"frequent contact with both humans and multiple wildlife species. Additionally, pigs are also",0,0,0,0,0,0,0,0,0,0,0,0,0,"('frequent contact with both humans and multiple wildlife species. Additionally, pigs are also', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 689.428, 526.2140000000002, 700.336), True, False, 19, 841.92, 595.32)"
19,"found  to  be  susceptible  to  infection  with  human  SARS-CoV  and  MERS-CoV,  thus  making",0,0,0,0,0,0,0,0,0,0,0,0,0,"('found  to  be  susceptible  to  infection  with  human  SARS-CoV  and  MERS-CoV,  thus  making', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 674.308, 526.396, 685.216), True, False, 19, 841.92, 595.32)"
19,"this  scenario  a  nightmare  (109,  137).  It  is  only  a  matter  of  time  that  another  zoonotic",0,0,0,0,0,0,0,0,0,0,0,0,0,"('this  scenario  a  nightmare  (109,  137).  It  is  only  a  matter  of  time  that  another  zoonotic', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 659.068, 526.1780000000001, 669.976), True, False, 19, 841.92, 595.32)"
19,coronavirus results in an epidemic by 'jumping' the so-called species barrier (292).,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""coronavirus results in an epidemic by 'jumping' the so-called species barrier (292)."", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 477.22, 654.856), True, False, 19, 841.92, 595.32)"
19,The  host  spectrum  of  coronavirus  got  increased  when  a  novel  coronavirus  named,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  host  spectrum  of  coronavirus  got  increased  when  a  novel  coronavirus  named', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 622.708, 526.0999999999999, 633.616), True, False, 19, 841.92, 595.32)"
19,SW1  was  identified  in  the  liver  tissue  of  the  captive  beluga  whale  (Delphinapterus  leucas),0,0,0,0,0,0,0,0,0,0,0,0,0,"('SW1  was  identified  in  the  liver  tissue  of  the  captive  beluga  whale  (Delphinapterus  leucas)', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 607.588, 526.4200000000001, 618.5079999999999), False, False, 19, 841.92, 595.32)"
19,"(138). In the past decades, several novel coronaviruses were identified from different animal",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(138). In the past decades, several novel coronaviruses were identified from different animal', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 592.3480000000001, 526.178, 603.2560000000001), True, False, 19, 841.92, 595.32)"
19,species. Bats can harbor these viruses without manifesting any clinical disease by persistently,0,0,0,0,0,0,0,0,0,0,0,0,0,"('species. Bats can harbor these viruses without manifesting any clinical disease by persistently', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 577.2280000000001, 526.1120000000001, 588.1360000000001), True, False, 19, 841.92, 595.32)"
19,infected (30). They are the only mammals with capacity for a power-driven flight that enables,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infected (30). They are the only mammals with capacity for a power-driven flight that enables', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 561.958, 526.42, 572.866), True, False, 19, 841.92, 595.32)"
19,them  to  migrate  long  distances  compared  to  land  mammals.  Bats  are  distributed  worldwide,0,0,0,0,0,0,0,0,0,0,0,0,0,"('them  to  migrate  long  distances  compared  to  land  mammals.  Bats  are  distributed  worldwide', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 546.838, 526.116, 557.746), True, False, 19, 841.92, 595.32)"
19,and  also  accounts  for  about  a  fifth  of  all  the  mammalian  species  (6).  This  makes  them  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  also  accounts  for  about  a  fifth  of  all  the  mammalian  species  (6).  This  makes  them  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 531.5980000000001, 526.366, 542.5060000000001), True, False, 19, 841.92, 595.32)"
19,"ideal reservoir host, for many viral agents, and also the source of novel coronaviruses that are",0,0,0,0,0,0,0,0,0,0,0,0,0,"('ideal reservoir host, for many viral agents, and also the source of novel coronaviruses that are', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 516.4780000000001, 526.342, 527.3860000000001), True, False, 19, 841.92, 595.32)"
19,yet to be identified. It has become a necessity to study the diversity of coronavirus in the bat,0,0,0,0,0,0,0,0,0,0,0,0,0,"('yet to be identified. It has become a necessity to study the diversity of coronavirus in the bat', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 501.238, 526.008, 512.146), True, False, 19, 841.92, 595.32)"
19,population to prevent future outbreaks that could jeopardize livestock and public health. The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('population to prevent future outbreaks that could jeopardize livestock and public health. The', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 486.118, 526.408, 497.02599999999995), True, False, 19, 841.92, 595.32)"
19,repeated outbreaks caused by bat origin coronaviruses calls for the development of efficient,0,0,0,0,0,0,0,0,0,0,0,0,0,"('repeated outbreaks caused by bat origin coronaviruses calls for the development of efficient', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 470.87800000000004, 526.2500000000001, 481.786), True, False, 19, 841.92, 595.32)"
19,"molecular  surveillance  strategies  for  studying  the  Betacoronavirus  among  animals  (12),",0,0,0,0,0,0,0,0,0,0,0,0,0,"('molecular  surveillance  strategies  for  studying  the  Betacoronavirus  among  animals  (12),', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 455.75800000000004, 526.42, 466.678), False, False, 19, 841.92, 595.32)"
19,especially in the Rhinolophus bat family (86). Chinese bats had high commercial value since,0,0,0,0,0,0,0,0,0,0,0,0,0,"('especially in the Rhinolophus bat family (86). Chinese bats had high commercial value since', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 440.51800000000003, 526.3180000000001, 451.438), False, False, 19, 841.92, 595.32)"
19,"they are used in Traditional Chinese Medicine (TCM). Therefore, handling of bats for trading",0,0,0,0,0,0,0,0,0,0,0,0,0,"('they are used in Traditional Chinese Medicine (TCM). Therefore, handling of bats for trading', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 425.398, 526.294, 436.306), True, False, 19, 841.92, 595.32)"
19,purposes poses considerable risk of transmitting zoonotic CoV epidemics (139).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('purposes poses considerable risk of transmitting zoonotic CoV epidemics (139).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 410.158, 459.7, 421.066), True, False, 19, 841.92, 595.32)"
19,Due to the possible role played by farm and wild animals in SARS-CoV-2 (COVID-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Due to the possible role played by farm and wild animals in SARS-CoV-2 (COVID-', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 389.01800000000003, 523.336, 399.926), True, False, 19, 841.92, 595.32)"
19,"19)  infection,  the  WHO  in  their  Novel  Coronavirus  (COVID-19)  situation  report  has",0,0,0,0,0,0,0,0,0,0,0,0,0,"('19)  infection,  the  WHO  in  their  Novel  Coronavirus  (COVID-19)  situation  report  has', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 373.778, 526.294, 384.686), True, False, 19, 841.92, 595.32)"
19,recommended to altogether avoid unprotected contact with both farm and wild animals (25).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('recommended to altogether avoid unprotected contact with both farm and wild animals (25).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 358.658, 526.456, 369.566), True, False, 19, 841.92, 595.32)"
19,"The  live-animal  markets,  like  the  one  in  Guangdong,  China,  will  provide  a  venue  for  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  live-animal  markets,  like  the  one  in  Guangdong,  China,  will  provide  a  venue  for  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 343.418, 526.318, 354.32599999999996), True, False, 19, 841.92, 595.32)"
19,animal coronaviruses to amplify and to get transmitted to new hosts like humans (78). Such,0,0,0,0,0,0,0,0,0,0,0,0,0,"('animal coronaviruses to amplify and to get transmitted to new hosts like humans (78). Such', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 328.298, 526.384, 339.20599999999996), True, False, 19, 841.92, 595.32)"
19,markets  can  be  considered  as  a  critical  place  for  the  origin  of  novel  zoonotic  diseases  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('markets  can  be  considered  as  a  critical  place  for  the  origin  of  novel  zoonotic  diseases  and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 313.058, 526.142, 323.96599999999995), True, False, 19, 841.92, 595.32)"
19,have enormous public health significance in the event of an outbreak. Bats are the reservoirs,0,0,0,0,0,0,0,0,0,0,0,0,0,"('have enormous public health significance in the event of an outbreak. Bats are the reservoirs', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 297.938, 526.396, 308.84599999999995), True, False, 19, 841.92, 595.32)"
19,"for  several  viruses,  and  hence  the  role  is  bats  in  the  present  outbreak  cannot  be  ruled  out",0,0,0,0,0,0,0,0,0,0,0,0,0,"('for  several  viruses,  and  hence  the  role  is  bats  in  the  present  outbreak  cannot  be  ruled  out', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 282.69800000000004, 526.25, 293.606), True, False, 19, 841.92, 595.32)"
19,(140).  In  a  qualitative  study  conducted  for  evaluating  the  zoonotic  risk  factors  among  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(140).  In  a  qualitative  study  conducted  for  evaluating  the  zoonotic  risk  factors  among  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 267.57800000000003, 526.378, 278.486), True, False, 19, 841.92, 595.32)"
19,"rural communities of southern China, the frequent human-animal interactions along with the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('rural communities of southern China, the frequent human-animal interactions along with the', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 252.338, 526.306, 263.246), True, False, 19, 841.92, 595.32)"
19,low  levels  of  environmental  biosecurity  were  identified  as  the  significant  risks  for  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('low  levels  of  environmental  biosecurity  were  identified  as  the  significant  risks  for  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 237.218, 526.408, 248.126), True, False, 19, 841.92, 595.32)"
19,"emergence of zoonotic disease in the local communities (141, 142).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('emergence of zoonotic disease in the local communities (141, 142).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 221.97799999999998, 399.31, 232.886), True, False, 19, 841.92, 595.32)"
19,The comprehensive sequence analysis performed on the SARS-CoV-2 RNA genome,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The comprehensive sequence analysis performed on the SARS-CoV-2 RNA genome', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 200.82799999999997, 526.3720000000001, 211.736), True, False, 19, 841.92, 595.32)"
19,identified that the CoV from Wuhan is a recombinant virus of the bat coronavirus and another,0,0,0,0,0,0,0,0,0,0,0,0,0,"('identified that the CoV from Wuhan is a recombinant virus of the bat coronavirus and another', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 185.588, 526.22, 196.496), True, False, 19, 841.92, 595.32)"
19,origin-unknown coronavirus. The recombination was found to have happened within the viral,0,0,0,0,0,0,0,0,0,0,0,0,0,"('origin-unknown coronavirus. The recombination was found to have happened within the viral', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 170.468, 526.36, 181.376), True, False, 19, 841.92, 595.32)"
19,spike  glycoprotein  that  recognizes  the  cell  surface  receptor.  Further  analysis  of  the  genome,0,0,0,0,0,0,0,0,0,0,0,0,0,"('spike  glycoprotein  that  recognizes  the  cell  surface  receptor.  Further  analysis  of  the  genome', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 155.22799999999998, 526.0799999999998, 166.136), True, False, 19, 841.92, 595.32)"
19,based  on  codon  usage  identified  that  the  snake  is  the  most  probable  animal  reservoir  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('based  on  codon  usage  identified  that  the  snake  is  the  most  probable  animal  reservoir  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 140.10799999999998, 526.1660000000002, 151.016), True, False, 19, 841.92, 595.32)"
19,"SARS-CoV-2  (143).  Contrary  to  these  findings,  another  genome  analysis  proposed  that  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  (143).  Contrary  to  these  findings,  another  genome  analysis  proposed  that  the', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 124.868, 526.2740000000001, 135.77599999999998), True, False, 19, 841.92, 595.32)"
19,"genome  of  SARS-CoV-2  is  96%  identical  to  the  bat  coronavirus,  reflecting  its  origin  to  be",0,0,0,0,0,0,0,0,0,0,0,0,0,"('genome  of  SARS-CoV-2  is  96%  identical  to  the  bat  coronavirus,  reflecting  its  origin  to  be', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 109.748, 526.3720000000001, 120.656), True, False, 19, 841.92, 595.32)"
19,from the bats (63). The involvement of bat-derived materials in causing the current outbreak,0,0,0,0,0,0,0,0,0,0,0,0,0,"('from the bats (63). The involvement of bat-derived materials in causing the current outbreak', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 94.512, 526.396, 105.42), True, False, 19, 841.92, 595.32)"
19,cannot be ruled out. High risk is involved in the production of bat-derived materials for TCM,0,0,0,0,0,0,0,0,0,0,0,0,0,"('cannot be ruled out. High risk is involved in the production of bat-derived materials for TCM', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 79.392, 526.294, 90.3), True, False, 19, 841.92, 595.32)"
19,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 19, 841.92, 595.32)"
19,18,0,0,0,0,0,0,0,0,0,0,0,0,0,"('18', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 19, 841.92, 595.32)"
20,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 20, 841.92, 595.32)"
20,practices involving the handling of wild bats. The use of bats for TCM practices will remain a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('practices involving the handling of wild bats. The use of bats for TCM practices will remain a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.3420000000001, 767.076), True, False, 20, 841.92, 595.32)"
20,severe risk for the occurrence of future zoonotic coronavirus epidemics (139).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('severe risk for the occurrence of future zoonotic coronavirus epidemics (139).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 449.26, 751.936), True, False, 20, 841.92, 595.32)"
20,"Furthermore,  the  pangolins  are  endangered  species  of  animals  that  harbor  a  wide",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Furthermore,  the  pangolins  are  endangered  species  of  animals  that  harbor  a  wide', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 719.788, 526.408, 730.696), True, False, 20, 841.92, 595.32)"
20,"variety  of  viruses,  including  coronaviruses  (144).  The  coronavirus  isolated  from  Malayan",0,0,0,0,0,0,0,0,0,0,0,0,0,"('variety  of  viruses,  including  coronaviruses  (144).  The  coronavirus  isolated  from  Malayan', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 704.668, 526.2260000000001, 715.576), True, False, 20, 841.92, 595.32)"
20,Pangolins  (Manis  javanica)  showed  a  very  high  amino  acid  identity  with  COVID-19  at  E,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Pangolins  (Manis  javanica)  showed  a  very  high  amino  acid  identity  with  COVID-19  at  E', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 689.428, 526.3960000000001, 700.348), False, False, 20, 841.92, 595.32)"
20,"(100%), M (98.2%), N (96.7%) and S genes (90.4%). The RBD of S protein in CoV isolated",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(100%), M (98.2%), N (96.7%) and S genes (90.4%). The RBD of S protein in CoV isolated', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 674.308, 526.056, 685.216), True, False, 20, 841.92, 595.32)"
20,from  Pangolin was almost  identical  (one amino  acid  difference) to  that of  SARS-CoV-2. A,0,0,0,0,0,0,0,0,0,0,0,0,0,"('from  Pangolin was almost  identical  (one amino  acid  difference) to  that of  SARS-CoV-2. A', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 659.068, 526.42, 669.976), True, False, 20, 841.92, 595.32)"
20,comparison of the genomes suggests the possibility of recombination between Pangolin-CoV-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('comparison of the genomes suggests the possibility of recombination between Pangolin-CoV-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 523.216, 654.856), True, False, 20, 841.92, 595.32)"
20,like  viruses  with  that  of  the  Bat-CoV-RaTG13-like  virus.  All  this  suggests  pangolins',0,0,0,0,0,0,0,0,0,0,0,0,0,"(""like  viruses  with  that  of  the  Bat-CoV-RaTG13-like  virus.  All  this  suggests  pangolins'"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 526.42, 639.616), True, False, 20, 841.92, 595.32)"
20,potential to act as the intermediate host of COVID-19 (145).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('potential to act as the intermediate host of COVID-19 (145).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 613.588, 367.99, 624.496), True, False, 20, 841.92, 595.32)"
20,"The  human-wildlife  interactions,  even  more  in  the  context  of  climate  change  (142),",0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  human-wildlife  interactions,  even  more  in  the  context  of  climate  change  (142),', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 592.3480000000001, 526.42, 603.2560000000001), True, False, 20, 841.92, 595.32)"
20,are  further  considered  high-risk  and  responsible  for  the  emergence  of  SARS-CoV.  The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('are  further  considered  high-risk  and  responsible  for  the  emergence  of  SARS-CoV.  The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 577.2280000000001, 526.384, 588.1360000000001), True, False, 20, 841.92, 595.32)"
20,"COVID-19  is  also  suspected  of  having  a  similar  mode  of  origin.  Hence,  to  prevent  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19  is  also  suspected  of  having  a  similar  mode  of  origin.  Hence,  to  prevent  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 561.958, 526.42, 572.866), True, False, 20, 841.92, 595.32)"
20,"occurrence  of  another  zoonotic  spillover  (1),  exhaustive  coordinated  efforts  are  needed  to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('occurrence  of  another  zoonotic  spillover  (1),  exhaustive  coordinated  efforts  are  needed  to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 546.838, 526.408, 557.746), True, False, 20, 841.92, 595.32)"
20,"identify  the  high-risk  pathogens  harbored  by  the  wild  animal  populations,  conducting",0,0,0,0,0,0,0,0,0,0,0,0,0,"('identify  the  high-risk  pathogens  harbored  by  the  wild  animal  populations,  conducting', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 531.5980000000001, 526.274, 542.5060000000001), True, False, 20, 841.92, 595.32)"
20,surveillance among the people who are susceptible for zoonotic spillover events  (12) and to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('surveillance among the people who are susceptible for zoonotic spillover events  (12) and to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 516.4780000000001, 526.384, 527.3860000000001), True, False, 20, 841.92, 595.32)"
20,improve  the  biosecurity  measures  associated  with  wildlife  trade  (146).  The  serological,0,0,0,0,0,0,0,0,0,0,0,0,0,"('improve  the  biosecurity  measures  associated  with  wildlife  trade  (146).  The  serological', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 501.238, 526.384, 512.146), True, False, 20, 841.92, 595.32)"
20,surveillance  study  conducted  in  people  living  in  the  proximity  to  bat  caves  has  earlier,0,0,0,0,0,0,0,0,0,0,0,0,0,"('surveillance  study  conducted  in  people  living  in  the  proximity  to  bat  caves  has  earlier', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 486.118, 526.3180000000001, 497.02599999999995), True, False, 20, 841.92, 595.32)"
20,identified the serological evidence of SARS-related CoVs in humans. The people living at the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('identified the serological evidence of SARS-related CoVs in humans. The people living at the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 470.87800000000004, 526.3420000000001, 481.786), True, False, 20, 841.92, 595.32)"
20,"wildlife-human  interface,  mainly  in  rural  China,  are  regularly  exposed  to  SARS-related",0,0,0,0,0,0,0,0,0,0,0,0,0,"('wildlife-human  interface,  mainly  in  rural  China,  are  regularly  exposed  to  SARS-related', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 455.75800000000004, 526.408, 466.666), True, False, 20, 841.92, 595.32)"
20,coronaviruses  (147).  These  findings  will  not  have  any  significance  until  a  significant,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronaviruses  (147).  These  findings  will  not  have  any  significance  until  a  significant', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 440.51800000000003, 526.42, 451.426), True, False, 20, 841.92, 595.32)"
20,outbreak occurs due to a virus-like SARS-CoV-2.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('outbreak occurs due to a virus-like SARS-CoV-2.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 425.398, 313.97, 436.306), True, False, 20, 841.92, 595.32)"
20,"Further studies are required to identify the possible animal reservoirs of SARS-CoV-2,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Further studies are required to identify the possible animal reservoirs of SARS-CoV-2,', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 404.158, 529.42, 415.066), True, False, 20, 841.92, 595.32)"
20,and  the  seasonal  variation  in  the  circulation  of  these  viruses  in  the  animal  population.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  the  seasonal  variation  in  the  circulation  of  these  viruses  in  the  animal  population.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 389.01800000000003, 526.318, 399.926), True, False, 20, 841.92, 595.32)"
20,Research collaboration between human and animal health sectors is becoming a necessity to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Research collaboration between human and animal health sectors is becoming a necessity to', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 373.778, 526.384, 384.686), True, False, 20, 841.92, 595.32)"
20,evaluate and identify the possible risk factors of transmission between animals and humans.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('evaluate and identify the possible risk factors of transmission between animals and humans.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 358.658, 526.104, 369.566), True, False, 20, 841.92, 595.32)"
20,Such  collaboration  will  help  to  devise  efficient  strategies  for  the  management  of  emerging,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Such  collaboration  will  help  to  devise  efficient  strategies  for  the  management  of  emerging', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 343.418, 526.116, 354.32599999999996), True, False, 20, 841.92, 595.32)"
20,zoonotic diseases (12).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('zoonotic diseases (12).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 328.298, 184.7, 339.20599999999996), True, False, 20, 841.92, 595.32)"
20,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 307.058, 75.024, 317.774), True, False, 20, 841.92, 595.32)"
20,DIAGNOSIS OF SARS-CoV-2 (COVID-19),0,0,0,0,0,0,0,0,0,0,0,0,0,"('DIAGNOSIS OF SARS-CoV-2 (COVID-19)', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 285.938, 300.05, 296.654), True, False, 20, 841.92, 595.32)"
20,RNA  tests  can  confirm  the  diagnosis  of  SARS-CoV-2  cases  (COVID-19)  with  real-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('RNA  tests  can  confirm  the  diagnosis  of  SARS-CoV-2  cases  (COVID-19)  with  real-', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 264.69800000000004, 523.456, 275.606), True, False, 20, 841.92, 595.32)"
20,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 264.69800000000004, 75.024, 275.606), True, False, 20, 841.92, 595.32)"
20,"time  RT-PCR  or  next-generation  sequencing  (148,  149,  245,  246).  At  present  nucleic  acid",0,0,0,0,0,0,0,0,0,0,0,0,0,"('time  RT-PCR  or  next-generation  sequencing  (148,  149,  245,  246).  At  present  nucleic  acid', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 249.57799999999997, 526.318, 260.486), True, False, 20, 841.92, 595.32)"
20,detection  techniques  like  reverse  transcription-polymerase  chain  reaction  (RT-PCR)  are,0,0,0,0,0,0,0,0,0,0,0,0,0,"('detection  techniques  like  reverse  transcription-polymerase  chain  reaction  (RT-PCR)  are', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 234.338, 526.42, 245.246), True, False, 20, 841.92, 595.32)"
20,considered as an effective method for confirming the diagnosis in clinical cases of  COVID-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('considered as an effective method for confirming the diagnosis in clinical cases of  COVID-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 219.218, 523.336, 230.126), True, False, 20, 841.92, 595.32)"
20,19  (148).  Several  companies  across  the  world  are  currently  focusing  on  developing  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('19  (148).  Several  companies  across  the  world  are  currently  focusing  on  developing  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 203.94799999999998, 526.16, 214.856), True, False, 20, 841.92, 595.32)"
20,"marketing  SARS-CoV-2  specific  nucleic  acid  detection  kits.  Also,  multiple  laboratories  are",0,0,0,0,0,0,0,0,0,0,0,0,0,"('marketing  SARS-CoV-2  specific  nucleic  acid  detection  kits.  Also,  multiple  laboratories  are', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 188.82799999999997, 526.342, 199.736), True, False, 20, 841.92, 595.32)"
20,developing  their  own  in-house  RT-PCR.  One  of  them  is  the  SARS-CoV-2nucleic  acid,0,0,0,0,0,0,0,0,0,0,0,0,0,"('developing  their  own  in-house  RT-PCR.  One  of  them  is  the  SARS-CoV-2nucleic  acid', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 173.588, 526.372, 184.496), True, False, 20, 841.92, 595.32)"
20,detection kit produced by Shuoshi Biotechnology (double fluorescence PCR method) (150).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('detection kit produced by Shuoshi Biotechnology (double fluorescence PCR method) (150).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 158.468, 526.42, 169.376), True, False, 20, 841.92, 595.32)"
20,"Up to March 30, 2020, the US Food and Drug Administration (FDA) has granted 22 in vitro",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Up to March 30, 2020, the US Food and Drug Administration (FDA) has granted 22 in vitro', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 143.22799999999998, 526.42, 154.148), False, False, 20, 841.92, 595.32)"
20,"diagnostics EUAs, including the RT-PCR Diagnostic Panel for universal detection of SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('diagnostics EUAs, including the RT-PCR Diagnostic Panel for universal detection of SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 128.10799999999998, 523.456, 139.016), True, False, 20, 841.92, 595.32)"
20,like  betacoronaviruses  and  specific  detection  of  SARS-CoV-2  that  developed  the  US  CDC,0,0,0,0,0,0,0,0,0,0,0,0,0,"('like  betacoronaviruses  and  specific  detection  of  SARS-CoV-2  that  developed  the  US  CDC', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 112.868, 526.294, 123.776), True, False, 20, 841.92, 595.32)"
20,"(Table 1) (260, 261).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(Table 1) (260, 261).', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 97.748, 177.38, 108.656), False, False, 20, 841.92, 595.32)"
20,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 20, 841.92, 595.32)"
20,19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('19', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 20, 841.92, 595.32)"
21,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 21, 841.92, 595.32)"
21,"In  a  recent  study,  95  full-length  genomic  sequences  of  SARAS-CoV-2  strains  were",0,0,0,0,0,0,0,0,0,0,0,0,0,"('In  a  recent  study,  95  full-length  genomic  sequences  of  SARAS-CoV-2  strains  were', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 756.168, 526.36, 767.076), True, False, 21, 841.92, 595.32)"
21,retrieved  from  the  National  Center  for  Biotechnology  Information  and  GISAID  databases,0,0,0,0,0,0,0,0,0,0,0,0,0,"('retrieved  from  the  National  Center  for  Biotechnology  Information  and  GISAID  databases', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.068, 751.936), True, False, 21, 841.92, 595.32)"
21,(262).  These  allow  to  establish  the  reference  sequence  by  conducting  multiple  sequence,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(262).  These  allow  to  establish  the  reference  sequence  by  conducting  multiple  sequence', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.112, 736.696), True, False, 21, 841.92, 595.32)"
21,"alignment  and  phylogenetic  analyses,  and  analyzed  sequence  variations  along  the  SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('alignment  and  phylogenetic  analyses,  and  analyzed  sequence  variations  along  the  SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 523.576, 721.576), True, False, 21, 841.92, 595.32)"
21,"CoV-2  genome.  The  homology  among  all  viral  strains  was  generally  high,  among  them,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2  genome.  The  homology  among  all  viral  strains  was  generally  high,  among  them,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 526.104, 706.336), True, False, 21, 841.92, 595.32)"
21,99.99% (99.91%-100%) at the nucleotide level and 99.99% (99.79%-100%) at the amino acid,0,0,0,0,0,0,0,0,0,0,0,0,0,"('99.99% (99.91%-100%) at the nucleotide level and 99.99% (99.79%-100%) at the amino acid', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 680.308, 526.306, 691.216), True, False, 21, 841.92, 595.32)"
21,"level. Although overall variation in ORF regions is low, 13 variation sites in 1a, 1b, S, 3a, M,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('level. Although overall variation in ORF regions is low, 13 variation sites in 1a, 1b, S, 3a, M,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 665.068, 526.1540000000001, 675.976), True, False, 21, 841.92, 595.32)"
21,"8,  and  N  regions  were  identified,  among  which  positions  nt28144  in  ORF  8  and  nt8782  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('8,  and  N  regions  were  identified,  among  which  positions  nt28144  in  ORF  8  and  nt8782  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 649.948, 526.0320000000002, 660.856), True, False, 21, 841.92, 595.32)"
21,"ORF  1a  showed  mutation  rate  of  30.53%  (29/95)  and  29.47%  (28/95),  respectively.  These",0,0,0,0,0,0,0,0,0,0,0,0,0,"('ORF  1a  showed  mutation  rate  of  30.53%  (29/95)  and  29.47%  (28/95),  respectively.  These', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 634.708, 526.1039999999999, 645.616), True, False, 21, 841.92, 595.32)"
21,"findings suggested that there may be selective mutations in SARS-COV-2, and it is necessary",0,0,0,0,0,0,0,0,0,0,0,0,0,"('findings suggested that there may be selective mutations in SARS-COV-2, and it is necessary', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 619.588, 526.342, 630.496), True, False, 21, 841.92, 595.32)"
21,to  avoid  certain  regions when designing primers and probes. Establishment  of the reference,0,0,0,0,0,0,0,0,0,0,0,0,0,"('to  avoid  certain  regions when designing primers and probes. Establishment  of the reference', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 604.3480000000001, 526.1399999999998, 615.2560000000001), True, False, 21, 841.92, 595.32)"
21,sequence for SARS-CoV-2 could benefit not only the biological study of this virus but also,0,0,0,0,0,0,0,0,0,0,0,0,0,"('sequence for SARS-CoV-2 could benefit not only the biological study of this virus but also', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 589.2280000000001, 526.408, 600.1360000000001), True, False, 21, 841.92, 595.32)"
21,"diagnosis, clinical monitoring, and intervention of SARS-CoV-2 infection in the future (262).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('diagnosis, clinical monitoring, and intervention of SARS-CoV-2 infection in the future (262).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 573.988, 524.38, 584.8960000000001), True, False, 21, 841.92, 595.32)"
21,"Nucleic  acids  of  SARS-CoV-2can  be  detected  from  the  samples  (64),  such  as",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Nucleic  acids  of  SARS-CoV-2can  be  detected  from  the  samples  (64),  such  as', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 552.838, 526.396, 563.746), True, False, 21, 841.92, 595.32)"
21,"bronchoalveolar  lavage  fluid,  sputum,  nasal  swabs,  fiber  bronchoscope  brush  biopsy,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('bronchoalveolar  lavage  fluid,  sputum,  nasal  swabs,  fiber  bronchoscope  brush  biopsy,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.5980000000001, 526.408, 548.5060000000001), True, False, 21, 841.92, 595.32)"
21,"pharyngeal  swabs,  feces,  blood,  and  urine,  with  different  levels  of  diagnostic  performances",0,0,0,0,0,0,0,0,0,0,0,0,0,"('pharyngeal  swabs,  feces,  blood,  and  urine,  with  different  levels  of  diagnostic  performances', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 522.4780000000001, 526.1159999999998, 533.3860000000001), True, False, 21, 841.92, 595.32)"
21,"(Table 2) (80, 238, 245, 246). The viral loads of SARS-CoV-2 were measured using N-gene-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(Table 2) (80, 238, 245, 246). The viral loads of SARS-CoV-2 were measured using N-gene-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 507.238, 523.336, 518.146), False, False, 21, 841.92, 595.32)"
21,specific  quantitative  RT-PCR  assay  in  the  throat  swab  and  sputum  samples  collected  from,0,0,0,0,0,0,0,0,0,0,0,0,0,"('specific  quantitative  RT-PCR  assay  in  the  throat  swab  and  sputum  samples  collected  from', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 492.118, 526.178, 503.02599999999995), True, False, 21, 841.92, 595.32)"
21,COVID-19 infected individuals. The result indicated that the viral load peaked at around 5-6,0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19 infected individuals. The result indicated that the viral load peaked at around 5-6', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 476.87800000000004, 526.42, 487.786), True, False, 21, 841.92, 595.32)"
21,"days following the onset of symptoms, and it ranged from  104 to  107 copies/mL during this",0,0,0,0,0,0,0,0,0,0,0,0,0,"('days following the onset of symptoms, and it ranged from  104 to  107 copies/mL during this', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 461.75800000000004, 526.33, 474.48172000000005), True, False, 21, 841.92, 595.32)"
21,"time (151). In another study, the viral load was found to be higher in the nasal swabs rather",0,0,0,0,0,0,0,0,0,0,0,0,0,"('time (151). In another study, the viral load was found to be higher in the nasal swabs rather', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 446.51800000000003, 526.1119999999997, 457.426), True, False, 21, 841.92, 595.32)"
21,than the throat swabs obtained from COVID-19 symptomatic patients (82). Although initially,0,0,0,0,0,0,0,0,0,0,0,0,0,"('than the throat swabs obtained from COVID-19 symptomatic patients (82). Although initially', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 431.398, 526.366, 442.306), True, False, 21, 841.92, 595.32)"
21,"was thought that viral load would be associated with poor outcomes, some case reports have",0,0,0,0,0,0,0,0,0,0,0,0,0,"('was thought that viral load would be associated with poor outcomes, some case reports have', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 416.158, 526.16, 427.066), True, False, 21, 841.92, 595.32)"
21,"shown asymptomatic individuals with high viral loads (247). In a recent study, analyzing the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('shown asymptomatic individuals with high viral loads (247). In a recent study, analyzing the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 401.038, 526.396, 411.94599999999997), True, False, 21, 841.92, 595.32)"
21,viral  load  in  nasal  and  throat  swabs  obtained  from  the  17  symptomatic  patients  concerning,0,0,0,0,0,0,0,0,0,0,0,0,0,"('viral  load  in  nasal  and  throat  swabs  obtained  from  the  17  symptomatic  patients  concerning', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 385.778, 526.42, 396.686), True, False, 21, 841.92, 595.32)"
21,"the day of onset of any symptoms, higher viral loads were detected soon after symptom onset,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the day of onset of any symptoms, higher viral loads were detected soon after symptom onset,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 370.658, 526.176, 381.566), True, False, 21, 841.92, 595.32)"
21,with higher viral loads detected in the nose than in the throat. Authors suggest that the viral,0,0,0,0,0,0,0,0,0,0,0,0,0,"('with higher viral loads detected in the nose than in the throat. Authors suggest that the viral', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 355.418, 526.1519999999998, 366.32599999999996), True, False, 21, 841.92, 595.32)"
21,nucleic  acid  shedding  pattern  of  patients  infected  with  SARS-CoV-2  resembles  that  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('nucleic  acid  shedding  pattern  of  patients  infected  with  SARS-CoV-2  resembles  that  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 340.298, 526.33, 351.20599999999996), True, False, 21, 841.92, 595.32)"
21,patients with influenza and appears different from that seen in patients infected with SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients with influenza and appears different from that seen in patients infected with SARS-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 325.058, 523.456, 335.96599999999995), True, False, 21, 841.92, 595.32)"
21,"CoV. In this study from  China, the viral load that was detected in the asymptomatic patient",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV. In this study from  China, the viral load that was detected in the asymptomatic patient', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 309.938, 526.0439999999999, 320.84599999999995), True, False, 21, 841.92, 595.32)"
21,"was similar to that in the symptomatic patients, which suggests the transmission potential of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('was similar to that in the symptomatic patients, which suggests the transmission potential of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 294.69800000000004, 526.2620000000001, 305.606), True, False, 21, 841.92, 595.32)"
21,"asymptomatic or minimally symptomatic patients (248). In South Korea, studies on viral load",0,0,0,0,0,0,0,0,0,0,0,0,0,"('asymptomatic or minimally symptomatic patients (248). In South Korea, studies on viral load', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 279.57800000000003, 526.282, 290.486), True, False, 21, 841.92, 595.32)"
21,"of  SARS-CoV-2,  suggests  that  their  kinetics  may  be  significantly  different  from  that  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  SARS-CoV-2,  suggests  that  their  kinetics  may  be  significantly  different  from  that  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 264.338, 526.1479999999999, 275.246), True, False, 21, 841.92, 595.32)"
21,previously reported other coronavirus infections such as SARS-CoV (255). Such findings are,0,0,0,0,0,0,0,0,0,0,0,0,0,"('previously reported other coronavirus infections such as SARS-CoV (255). Such findings are', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 249.218, 526.354, 260.126), True, False, 21, 841.92, 595.32)"
21,in concordance with reports that transmission may occur early in the course of infection and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in concordance with reports that transmission may occur early in the course of infection and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 233.97799999999998, 526.2260000000001, 244.886), True, False, 21, 841.92, 595.32)"
21,suggest that case detection and isolation may require strategies different from those required,0,0,0,0,0,0,0,0,0,0,0,0,0,"('suggest that case detection and isolation may require strategies different from those required', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 218.85799999999998, 526.14, 229.766), True, False, 21, 841.92, 595.32)"
21,for  the  control  of  SARS-CoV.  How  the  SARS-CoV-2  viral  load  correlates  with  culturable,0,0,0,0,0,0,0,0,0,0,0,0,0,"('for  the  control  of  SARS-CoV.  How  the  SARS-CoV-2  viral  load  correlates  with  culturable', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 203.588, 526.2940000000001, 214.496), True, False, 21, 841.92, 595.32)"
21,virus needs to be determined?. Identification of patients with few or no symptoms and with,0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus needs to be determined?. Identification of patients with few or no symptoms and with', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 188.468, 526.1300000000001, 199.376), True, False, 21, 841.92, 595.32)"
21,modest levels of detectable viral RNA in the oropharynx for at least  five days suggests that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('modest levels of detectable viral RNA in the oropharynx for at least  five days suggests that', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 173.22799999999998, 526.354, 184.136), True, False, 21, 841.92, 595.32)"
21,we need better data to  determine transmission dynamics and inform  our screening  practices,0,0,0,0,0,0,0,0,0,0,0,0,0,"('we need better data to  determine transmission dynamics and inform  our screening  practices', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 158.10799999999998, 526.0559999999998, 169.016), True, False, 21, 841.92, 595.32)"
21,(248).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(248).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 142.868, 107.06, 153.776), True, False, 21, 841.92, 595.32)"
21,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 121.748, 75.024, 132.656), True, False, 21, 841.92, 595.32)"
21,The studies on viral load of SARS-CoV-2 show that this virus can actively replicate in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The studies on viral load of SARS-CoV-2 show that this virus can actively replicate in', 'TimesNewRomanPSMT', 10.908000000000001, (108.02, 121.748, 526.2980000000001, 132.656), True, False, 21, 841.92, 595.32)"
21,"the upper respiratory tract, and is shed for a prolonged time after symptoms end, including in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the upper respiratory tract, and is shed for a prolonged time after symptoms end, including in', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 106.508, 526.0800000000002, 117.416), True, False, 21, 841.92, 595.32)"
21,stool. These findings suggest adjustments of current case definitions and re-evaluation of the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('stool. These findings suggest adjustments of current case definitions and re-evaluation of the', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 91.392, 526.372, 102.3), True, False, 21, 841.92, 595.32)"
21,"prospects of outbreak containment (249). In some cases, the viral load studies of SARS-CoV-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('prospects of outbreak containment (249). In some cases, the viral load studies of SARS-CoV-', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 76.152, 523.456, 87.06), True, False, 21, 841.92, 595.32)"
21,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 21, 841.92, 595.32)"
21,20,0,0,0,0,0,0,0,0,0,0,0,0,0,"('20', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 21, 841.92, 595.32)"
22,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 22, 841.92, 595.32)"
22,2  have  also  been  useful  to  recommend  precautionary  measures  when  handling  certain,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2  have  also  been  useful  to  recommend  precautionary  measures  when  handling  certain', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.1, 767.076), True, False, 22, 841.92, 595.32)"
22,"samples,  e.g.,  feces.  In  a  recent  study,  from  17  confirmed  cases  of  SARS-CoV-2  infection",0,0,0,0,0,0,0,0,0,0,0,0,0,"('samples,  e.g.,  feces.  In  a  recent  study,  from  17  confirmed  cases  of  SARS-CoV-2  infection', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.396, 751.936), True, False, 22, 841.92, 595.32)"
22,"with available data (representing days 0-13 after onset), stool samples from nine (53%; days",0,0,0,0,0,0,0,0,0,0,0,0,0,"('with available data (representing days 0-13 after onset), stool samples from nine (53%; days', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.1780000000001, 736.696), True, False, 22, 841.92, 595.32)"
22,0-11 after onset) were positive on RT-PCR analysis. Although the viral loads were less than,0,0,0,0,0,0,0,0,0,0,0,0,0,"('0-11 after onset) were positive on RT-PCR analysis. Although the viral loads were less than', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 526.2260000000001, 721.576), True, False, 22, 841.92, 595.32)"
22,"those of respiratory samples (range 550 copies per mL to 1*21 × 105 copies per mL), this has",0,0,0,0,0,0,0,0,0,0,0,0,0,"('those of respiratory samples (range 550 copies per mL to 1*21 × 105 copies per mL), this has', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 526.1780000000001, 706.336), True, False, 22, 841.92, 595.32)"
22,essential biosafety implications (250).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('essential biosafety implications (250).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 680.308, 257.69, 691.216), True, False, 22, 841.92, 595.32)"
22,The samples from 18 SARS-CoV-2 positive patients in Singapore who traveled from,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The samples from 18 SARS-CoV-2 positive patients in Singapore who traveled from', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 659.068, 526.27, 669.976), True, False, 22, 841.92, 595.32)"
22,Wuhan to Singapore showed the presence of viral RNA in stool and whole blood but not in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Wuhan to Singapore showed the presence of viral RNA in stool and whole blood but not in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.2020000000001, 654.856), True, False, 22, 841.92, 595.32)"
22,"urine  by  real-time  reverse  transcriptase-polymerase  chain  reaction  (293).  Further,  novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('urine  by  real-time  reverse  transcriptase-polymerase  chain  reaction  (293).  Further,  novel', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 526.384, 639.616), True, False, 22, 841.92, 595.32)"
22,SARS-CoV-2  infections  have  been  detected  in  a  variety  of  clinical  specimens  like,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  infections  have  been  detected  in  a  variety  of  clinical  specimens  like', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 613.588, 526.2940000000001, 624.496), True, False, 22, 841.92, 595.32)"
22,"bronchoalveolar  lavage  fluid,  sputum,  nasal  swabs,  fibro-bronchoscope  brush  biopsy,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('bronchoalveolar  lavage  fluid,  sputum,  nasal  swabs,  fibro-bronchoscope  brush  biopsy,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 598.3480000000001, 526.318, 609.2560000000001), True, False, 22, 841.92, 595.32)"
22,"pharyngeal swabs, feces, and blood (246).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('pharyngeal swabs, feces, and blood (246).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 583.2280000000001, 277.01, 594.1360000000001), True, False, 22, 841.92, 595.32)"
22,The  findings  of  SARS-CoV-2  on  fecal  samples  have  raised  concerns  and  multiple,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  findings  of  SARS-CoV-2  on  fecal  samples  have  raised  concerns  and  multiple', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 561.958, 526.372, 572.866), True, False, 22, 841.92, 595.32)"
22,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 561.958, 75.024, 572.866), True, False, 22, 841.92, 595.32)"
22,"questions.  Although  direct  droplet  transmission  is  an  essential  route  of  transmission,  fecal",0,0,0,0,0,0,0,0,0,0,0,0,0,"('questions.  Although  direct  droplet  transmission  is  an  essential  route  of  transmission,  fecal', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 546.838, 526.282, 557.746), True, False, 22, 841.92, 595.32)"
22,"excretion,  environmental  contamination,  and  fomites  might  contribute  to  viral  transmission",0,0,0,0,0,0,0,0,0,0,0,0,0,"('excretion,  environmental  contamination,  and  fomites  might  contribute  to  viral  transmission', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 531.5980000000001, 526.1520000000002, 542.5060000000001), True, False, 22, 841.92, 595.32)"
22,"(251-254). Considering the evidence of fecal excretion for both SARS-CoV and MERS-CoV,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(251-254). Considering the evidence of fecal excretion for both SARS-CoV and MERS-CoV,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 516.4780000000001, 526.396, 527.3860000000001), True, False, 22, 841.92, 595.32)"
22,"and their ability to remain viable in conditions that could facilitate fecal-oral transmission, it",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and their ability to remain viable in conditions that could facilitate fecal-oral transmission, it', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 501.238, 526.318, 512.146), True, False, 22, 841.92, 595.32)"
22,is possible that SARS-CoV-2 could also be transmitted via this route. The possibility of fecal-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('is possible that SARS-CoV-2 could also be transmitted via this route. The possibility of fecal-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 486.118, 523.216, 497.02599999999995), True, False, 22, 841.92, 595.32)"
22,"oral transmission of SARS-CoV-2 has implications, especially in areas with poor sanitation.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('oral transmission of SARS-CoV-2 has implications, especially in areas with poor sanitation.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 470.87800000000004, 526.2260000000001, 481.786), True, False, 22, 841.92, 595.32)"
22,"Coronaviruses are susceptible to  antiseptics containing ethanol, and disinfectants containing",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronaviruses are susceptible to  antiseptics containing ethanol, and disinfectants containing', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 455.75800000000004, 526.128, 466.666), True, False, 22, 841.92, 595.32)"
22,chlorine or bleach (251-254). Strict precautions must be observed when handling the stools of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('chlorine or bleach (251-254). Strict precautions must be observed when handling the stools of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 440.51800000000003, 526.238, 451.426), True, False, 22, 841.92, 595.32)"
22,"patients  infected  with  coronavirus,  and  sewage  from  hospitals  should  also  be  adequately",0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients  infected  with  coronavirus,  and  sewage  from  hospitals  should  also  be  adequately', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 425.398, 526.408, 436.306), True, False, 22, 841.92, 595.32)"
22,disinfected. The importance of frequent and proper hand hygiene should be emphasized (251-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('disinfected. The importance of frequent and proper hand hygiene should be emphasized (251-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 410.158, 523.456, 421.066), True, False, 22, 841.92, 595.32)"
22,254).  Future  research  on  the  possibility  of  fecal-oral  transmission  of  SARS-CoV-2  should,0,0,0,0,0,0,0,0,0,0,0,0,0,"('254).  Future  research  on  the  possibility  of  fecal-oral  transmission  of  SARS-CoV-2  should', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 395.038, 526.42, 405.94599999999997), True, False, 22, 841.92, 595.32)"
22,include  environmental  studies  to  determine  whether  the  virus  remains  viable  in  conditions,0,0,0,0,0,0,0,0,0,0,0,0,0,"('include  environmental  studies  to  determine  whether  the  virus  remains  viable  in  conditions', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 379.778, 526.0920000000001, 390.686), True, False, 22, 841.92, 595.32)"
22,that would favor such transmission. Study  of the enteric involvement and viral  excretion of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('that would favor such transmission. Study  of the enteric involvement and viral  excretion of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 364.658, 526.0679999999999, 375.566), True, False, 22, 841.92, 595.32)"
22,SARS-CoV-2 in feces is required to investigate whether fecal concentrations of SARS-CoV-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2 in feces is required to investigate whether fecal concentrations of SARS-CoV-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 349.418, 523.336, 360.32599999999996), True, False, 22, 841.92, 595.32)"
22,2 RNA correlate with the severity of the disease and presence or absence of gastrointestinal,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2 RNA correlate with the severity of the disease and presence or absence of gastrointestinal', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 334.298, 526.0439999999998, 345.20599999999996), True, False, 22, 841.92, 595.32)"
22,symptoms  and  whether  fecal  SARS-CoV-2  RNA  can  also  be  detected  in  the  incubation  or,0,0,0,0,0,0,0,0,0,0,0,0,0,"('symptoms  and  whether  fecal  SARS-CoV-2  RNA  can  also  be  detected  in  the  incubation  or', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 319.058, 526.2260000000001, 329.96599999999995), True, False, 22, 841.92, 595.32)"
22,convalescence phases of COVID-19 (251-254).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('convalescence phases of COVID-19 (251-254).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 303.938, 303.29, 314.84599999999995), True, False, 22, 841.92, 595.32)"
22,The  lower  respiratory  tract  sampling  techniques  like  bronchoalveolar  lavage  fluid,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  lower  respiratory  tract  sampling  techniques  like  bronchoalveolar  lavage  fluid', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 288.69800000000004, 526.33, 299.606), True, False, 22, 841.92, 595.32)"
22,(BALF) aspirate is considered to be the ideal clinical material than the throat swab due to its,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(BALF) aspirate is considered to be the ideal clinical material than the throat swab due to its', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 273.81800000000004, 526.0200000000002, 284.726), True, False, 22, 841.92, 595.32)"
22,higher positive rate of the nucleic acid test (148). The diagnosis of COVID-19 can be made,0,0,0,0,0,0,0,0,0,0,0,0,0,"('higher positive rate of the nucleic acid test (148). The diagnosis of COVID-19 can be made', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 258.938, 526.408, 269.84599999999995), True, False, 22, 841.92, 595.32)"
22,by using upper respiratory tract specimens collected using nasopharyngeal and oropharyngeal,0,0,0,0,0,0,0,0,0,0,0,0,0,"('by using upper respiratory tract specimens collected using nasopharyngeal and oropharyngeal', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 244.058, 526.0919999999999, 254.966), True, False, 22, 841.92, 595.32)"
22,"swabs.  However,  these  techniques  are  associated  with  unnecessary  risks  to  healthcare",0,0,0,0,0,0,0,0,0,0,0,0,0,"('swabs.  However,  these  techniques  are  associated  with  unnecessary  risks  to  healthcare', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 229.178, 526.1039999999998, 240.086), True, False, 22, 841.92, 595.32)"
22,"workers due to close contact with patients (152). Similarly, a single patient with a high viral",0,0,0,0,0,0,0,0,0,0,0,0,0,"('workers due to close contact with patients (152). Similarly, a single patient with a high viral', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 214.268, 526.258, 225.17600000000002), True, False, 22, 841.92, 595.32)"
22,"load  reported  contaminating  an  entire  endoscopy  room  by  shedding  the  virus,  which  may",0,0,0,0,0,0,0,0,0,0,0,0,0,"('load  reported  contaminating  an  entire  endoscopy  room  by  shedding  the  virus,  which  may', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 199.38799999999998, 526.42, 210.296), True, False, 22, 841.92, 595.32)"
22,remain viable for at least three days and considered as a great risk for uninfected patients and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('remain viable for at least three days and considered as a great risk for uninfected patients and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 184.50799999999998, 526.318, 195.416), True, False, 22, 841.92, 595.32)"
22,"healthcare  workers  (294).  Recently,  it  was  found  that  the  anal  swabs  gave  more  positive",0,0,0,0,0,0,0,0,0,0,0,0,0,"('healthcare  workers  (294).  Recently,  it  was  found  that  the  anal  swabs  gave  more  positive', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 169.628, 526.226, 180.536), True, False, 22, 841.92, 595.32)"
22,"results  compared  to  the  oral  swabs  in  the  later  stages  of  the  infection  (153).  Hence,  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('results  compared  to  the  oral  swabs  in  the  later  stages  of  the  infection  (153).  Hence,  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 154.628, 526.408, 165.536), True, False, 22, 841.92, 595.32)"
22,clinicians  have  to  be  cautious  while  discharging  any  COVID-19  infected  patient  based  on,0,0,0,0,0,0,0,0,0,0,0,0,0,"('clinicians  have  to  be  cautious  while  discharging  any  COVID-19  infected  patient  based  on', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 139.748, 526.306, 150.656), True, False, 22, 841.92, 595.32)"
22,negative oral swab test results due to the possibility of fecal-oral transmission. Even though,0,0,0,0,0,0,0,0,0,0,0,0,0,"('negative oral swab test results due to the possibility of fecal-oral transmission. Even though', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 124.868, 526.384, 135.77599999999998), True, False, 22, 841.92, 595.32)"
22,"the viral loads in stool samples were found to be less than that of respiratory samples, strict",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the viral loads in stool samples were found to be less than that of respiratory samples, strict', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 109.988, 526.4200000000001, 120.896), True, False, 22, 841.92, 595.32)"
22,precautionary measures have to be followed while handling the stool samples of COVID-19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('precautionary measures have to be followed while handling the stool samples of COVID-19', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 95.112, 526.42, 106.02), True, False, 22, 841.92, 595.32)"
22,suspected  or  infected  patients  (151).  The  children  infected  with  SARS-CoV-2  experience,0,0,0,0,0,0,0,0,0,0,0,0,0,"('suspected  or  infected  patients  (151).  The  children  infected  with  SARS-CoV-2  experience', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 80.232, 526.3720000000001, 91.14), True, False, 22, 841.92, 595.32)"
22,only  a mild  form of illness  and  recovers immediately after treatment.  It  was recently  found,0,0,0,0,0,0,0,0,0,0,0,0,0,"('only  a mild  form of illness  and  recovers immediately after treatment.  It  was recently  found', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 65.352, 526.0199999999998, 76.26), True, False, 22, 841.92, 595.32)"
22,21,0,0,0,0,0,0,0,0,0,0,0,0,0,"('21', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 22, 841.92, 595.32)"
22,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 22, 841.92, 595.32)"
23,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 23, 841.92, 595.32)"
23,that  the  stool  samples  of  SARS-CoV-2  infected  children  that  gave  negative  throat  swab,0,0,0,0,0,0,0,0,0,0,0,0,0,"('that  the  stool  samples  of  SARS-CoV-2  infected  children  that  gave  negative  throat  swab', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.33, 767.076), True, False, 23, 841.92, 595.32)"
23,results were found to be positive within ten days of a negative result. That could result in the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('results were found to be positive within ten days of a negative result. That could result in the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.268, 526.3960000000001, 752.176), True, False, 23, 841.92, 595.32)"
23,"fecal-oral  transmission  of  SARS-CoV-2  infections,  especially  in  children  (295).  Hence,  to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('fecal-oral  transmission  of  SARS-CoV-2  infections,  especially  in  children  (295).  Hence,  to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 526.3720000000001, 737.296), True, False, 23, 841.92, 595.32)"
23,"prevent the fecal-oral transmission of SARS-CoV-2, infected COVID-19 patients should only",0,0,0,0,0,0,0,0,0,0,0,0,0,"('prevent the fecal-oral transmission of SARS-CoV-2, infected COVID-19 patients should only', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.318, 722.416), True, False, 23, 841.92, 595.32)"
23,be considered as negative when they are tested negative for SARS-CoV-2 in the stool sample.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('be considered as negative when they are tested negative for SARS-CoV-2 in the stool sample.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 696.628, 525.94, 707.5360000000001), True, False, 23, 841.92, 595.32)"
23,A  suspected  case  of  COVID-19  infection  is  said  to  be  confirmed  if  the  respiratory,0,0,0,0,0,0,0,0,0,0,0,0,0,"('A  suspected  case  of  COVID-19  infection  is  said  to  be  confirmed  if  the  respiratory', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 673.708, 526.2020000000002, 684.616), True, False, 23, 841.92, 595.32)"
23,tract  aspirate  or  blood  samples  are  tested  positive  for  SARS-CoV-2  nucleic  acid  using  RT-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('tract  aspirate  or  blood  samples  are  tested  positive  for  SARS-CoV-2  nucleic  acid  using  RT-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 658.828, 523.456, 669.736), True, False, 23, 841.92, 595.32)"
23,PCR or by the identification of SARS-CoV-2 genetic sequence in respiratory tract aspirate or,0,0,0,0,0,0,0,0,0,0,0,0,0,"('PCR or by the identification of SARS-CoV-2 genetic sequence in respiratory tract aspirate or', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.1900000000002, 654.856), True, False, 23, 841.92, 595.32)"
23,blood samples tested (80). The patient will be confirmed as cured when two subsequent oral,0,0,0,0,0,0,0,0,0,0,0,0,0,"('blood samples tested (80). The patient will be confirmed as cured when two subsequent oral', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 629.068, 526.1179999999999, 639.976), True, False, 23, 841.92, 595.32)"
23,"swabs  results  become  negative  (153).  Recently,  the  live  virus  was  detected  in  the  self-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('swabs  results  become  negative  (153).  Recently,  the  live  virus  was  detected  in  the  self-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 614.068, 523.336, 624.976), True, False, 23, 841.92, 595.32)"
23,collected  saliva  of  patients  infected  with  COVID-19.  These  findings  were  confirmative  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('collected  saliva  of  patients  infected  with  COVID-19.  These  findings  were  confirmative  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 599.188, 526.366, 610.096), True, False, 23, 841.92, 595.32)"
23,using  saliva  as  a  non-invasive  specimen  for  the  diagnosis  of  COVID-19  infection  in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('using  saliva  as  a  non-invasive  specimen  for  the  diagnosis  of  COVID-19  infection  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 584.308, 526.384, 595.216), True, False, 23, 841.92, 595.32)"
23,suspected individuals (152). It has also been observed that the initial screening of COVID-19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('suspected individuals (152). It has also been observed that the initial screening of COVID-19', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 569.398, 526.42, 580.306), True, False, 23, 841.92, 595.32)"
23,patients infected with RT-PCR may give negative results even if they have chest CT findings,0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients infected with RT-PCR may give negative results even if they have chest CT findings', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 554.518, 526.42, 565.426), True, False, 23, 841.92, 595.32)"
23,"that  are  suggestive  of  infection.  Hence,  for  the  accurate  diagnosis  of  COVID-19,  a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('that  are  suggestive  of  infection.  Hence,  for  the  accurate  diagnosis  of  COVID-19,  a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 539.638, 526.396, 550.546), True, False, 23, 841.92, 595.32)"
23,combination of repeated swab tests using RT-PCR and CT scanning is required to prevent the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('combination of repeated swab tests using RT-PCR and CT scanning is required to prevent the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 524.758, 526.2260000000001, 535.666), True, False, 23, 841.92, 595.32)"
23,possibility of false-negative results during the disease screening  (154). RT-PCR is  the most,0,0,0,0,0,0,0,0,0,0,0,0,0,"('possibility of false-negative results during the disease screening  (154). RT-PCR is  the most', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 509.87800000000004, 526.3480000000001, 520.7860000000001), True, False, 23, 841.92, 595.32)"
23,"widely used method of diagnosing COVID-19. However, it has some significant limitations",0,0,0,0,0,0,0,0,0,0,0,0,0,"('widely used method of diagnosing COVID-19. However, it has some significant limitations', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 494.998, 526.384, 505.90599999999995), True, False, 23, 841.92, 595.32)"
23,in  the  clinical  perspective  since  it  will  not  give  any  idea  regarding  the  disease  progression.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  the  clinical  perspective  since  it  will  not  give  any  idea  regarding  the  disease  progression.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 480.118, 526.396, 491.02599999999995), True, False, 23, 841.92, 595.32)"
23,Droplet digital PCR (ddPCR) can be used for the quantification of viral load in the samples,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Droplet digital PCR (ddPCR) can be used for the quantification of viral load in the samples', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 465.238, 525.9839999999998, 476.14599999999996), True, False, 23, 841.92, 595.32)"
23,"obtained  from  lower  respiratory  tracts.  Hence,  based  on  the  viral  load,  we  can  quickly",0,0,0,0,0,0,0,0,0,0,0,0,0,"('obtained  from  lower  respiratory  tracts.  Hence,  based  on  the  viral  load,  we  can  quickly', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 450.238, 526.408, 461.14599999999996), True, False, 23, 841.92, 595.32)"
23,"evaluate  the  progression  of  infection  (296).  In  addition  to  all  the  above,  sequencing  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('evaluate  the  progression  of  infection  (296).  In  addition  to  all  the  above,  sequencing  and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 435.358, 526.2260000000001, 446.26599999999996), True, False, 23, 841.92, 595.32)"
23,phylogenetics  are  critical  in  the  correct  identification  and  confirmation  of  the  causing  viral,0,0,0,0,0,0,0,0,0,0,0,0,0,"('phylogenetics  are  critical  in  the  correct  identification  and  confirmation  of  the  causing  viral', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 420.478, 526.214, 431.38599999999997), True, False, 23, 841.92, 595.32)"
23,"agent, and useful in order to establish relationships with previous isolates and sequences, as",0,0,0,0,0,0,0,0,0,0,0,0,0,"('agent, and useful in order to establish relationships with previous isolates and sequences, as', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 405.598, 526.1279999999998, 416.506), True, False, 23, 841.92, 595.32)"
23,"well  to  know,  especially  during  an  epidemic,  the  nucleotide,  amino  acid  mutation  as  well",0,0,0,0,0,0,0,0,0,0,0,0,0,"('well  to  know,  especially  during  an  epidemic,  the  nucleotide,  amino  acid  mutation  as  well', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 390.69800000000004, 526.1780000000001, 401.606), True, False, 23, 841.92, 595.32)"
23,molecular  divergence.  Rapid  development  and  implementation  of  diagnostic  tests  against,0,0,0,0,0,0,0,0,0,0,0,0,0,"('molecular  divergence.  Rapid  development  and  implementation  of  diagnostic  tests  against', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 375.81800000000004, 526.1600000000001, 386.726), True, False, 23, 841.92, 595.32)"
23,emerging  novel  diseases  like  COVID-19  pose  a  significant  challenge  due  to  the  lack  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('emerging  novel  diseases  like  COVID-19  pose  a  significant  challenge  due  to  the  lack  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 360.938, 526.444, 371.84599999999995), True, False, 23, 841.92, 595.32)"
23,enough resources and logistical limitations associated with an outbreak (155).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('enough resources and logistical limitations associated with an outbreak (155).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 346.058, 448.3, 356.96599999999995), True, False, 23, 841.92, 595.32)"
23,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 323.13800000000003, 75.024, 334.046), True, False, 23, 841.92, 595.32)"
23,The  SARS-CoV-2  infection  can  also  be  confirmed  by  isolation  and  culturing.  The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  SARS-CoV-2  infection  can  also  be  confirmed  by  isolation  and  culturing.  The', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 323.13800000000003, 526.214, 334.046), True, False, 23, 841.92, 595.32)"
23,"human airway epithelial cell culture was found to be useful in isolating the novel coronavirus,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('human airway epithelial cell culture was found to be useful in isolating the novel coronavirus,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 308.25800000000004, 526.33, 319.166), True, False, 23, 841.92, 595.32)"
23,SARS-CoV-2 (3). The efficient control of an outbreak is dependent upon the rapid diagnosis,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2 (3). The efficient control of an outbreak is dependent upon the rapid diagnosis', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 293.37800000000004, 526.1000000000001, 304.286), True, False, 23, 841.92, 595.32)"
23,"of the disease. Recently, in response to the COVID-19 outbreak, 1-step quantitative real-time",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of the disease. Recently, in response to the COVID-19 outbreak, 1-step quantitative real-time', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 278.498, 526.432, 289.40599999999995), True, False, 23, 841.92, 595.32)"
23,reverse-transcription PCR assays were developed that detect the ORF1b and N regions of the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('reverse-transcription PCR assays were developed that detect the ORF1b and N regions of the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 263.618, 526.1000000000001, 274.52599999999995), True, False, 23, 841.92, 595.32)"
23,SARS-CoV-2 genome (156). That developed assay was found to achieve the rapid detection,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2 genome (156). That developed assay was found to achieve the rapid detection', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 248.738, 526.384, 259.646), True, False, 23, 841.92, 595.32)"
23,of  SARS-CoV-2.  Nucleic  acid-based  assays  offer  high  accuracy  in  the  diagnosis  of  SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  SARS-CoV-2.  Nucleic  acid-based  assays  offer  high  accuracy  in  the  diagnosis  of  SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 233.738, 523.456, 244.64600000000002), True, False, 23, 841.92, 595.32)"
23,"CoV-2, but the current rate of spread limits its usage due to the lack of diagnostic assay kits.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2, but the current rate of spread limits its usage due to the lack of diagnostic assay kits.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 218.85799999999998, 525.9920000000002, 229.766), True, False, 23, 841.92, 595.32)"
23,That  will  further  result  in  the  extensive  transmission  of  COVID-19  since  only  a  portion  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('That  will  further  result  in  the  extensive  transmission  of  COVID-19  since  only  a  portion  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 203.94799999999998, 526.366, 214.856), True, False, 23, 841.92, 595.32)"
23,"suspected  cases  can  be  diagnosed.  In  such  situations,  conventional  serological  assays  like",0,0,0,0,0,0,0,0,0,0,0,0,0,"('suspected  cases  can  be  diagnosed.  In  such  situations,  conventional  serological  assays  like', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 189.06799999999998, 526.2260000000001, 199.976), True, False, 23, 841.92, 595.32)"
23,ELISA  that  are  specific  to  COVID-19  IgM  and  IgG  antibodies  can  be  used  as  a  high-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ELISA  that  are  specific  to  COVID-19  IgM  and  IgG  antibodies  can  be  used  as  a  high-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 174.188, 523.576, 185.096), True, False, 23, 841.92, 595.32)"
23,"throughput alternative (149). At present, there is no diagnostic kit available for detecting the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('throughput alternative (149). At present, there is no diagnostic kit available for detecting the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 159.308, 526.444, 170.216), True, False, 23, 841.92, 595.32)"
23,SARS-CoV-2  antibody  (150).  The  specific  antibody  profiles  of  COVID-19  patients  were,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  antibody  (150).  The  specific  antibody  profiles  of  COVID-19  patients  were', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 144.428, 526.318, 155.336), True, False, 23, 841.92, 595.32)"
23,"analyzed  and  found  that  the  IgM  level  lasted  more  than  one  month,  indicating  a  prolonged",0,0,0,0,0,0,0,0,0,0,0,0,0,"('analyzed  and  found  that  the  IgM  level  lasted  more  than  one  month,  indicating  a  prolonged', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 129.54799999999997, 526.342, 140.456), True, False, 23, 841.92, 595.32)"
23,stage  of  virus  replication  in  SARS-CoV-2  infected  patients.  The  IgG  levels  were  found  to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('stage  of  virus  replication  in  SARS-CoV-2  infected  patients.  The  IgG  levels  were  found  to', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 114.668, 526.214, 125.57600000000001), True, False, 23, 841.92, 595.32)"
23,increase  only  in  the  later  stages  of  the  disease.  These  findings  indicate  that  the  specific,0,0,0,0,0,0,0,0,0,0,0,0,0,"('increase  only  in  the  later  stages  of  the  disease.  These  findings  indicate  that  the  specific', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 99.788, 526.0559999999998, 110.696), True, False, 23, 841.92, 595.32)"
23,antibody profile of both SARS-CoV-2 and SARS-CoV was similar (330). These findings can,0,0,0,0,0,0,0,0,0,0,0,0,0,"('antibody profile of both SARS-CoV-2 and SARS-CoV was similar (330). These findings can', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 84.912, 526.342, 95.82000000000001), True, False, 23, 841.92, 595.32)"
23,be  utilized  for  the  development  of  specific  diagnostic  tests  against  COVID-19  and  can  be,0,0,0,0,0,0,0,0,0,0,0,0,0,"('be  utilized  for  the  development  of  specific  diagnostic  tests  against  COVID-19  and  can  be', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 69.912, 526.36, 80.82000000000001), True, False, 23, 841.92, 595.32)"
23,22,0,0,0,0,0,0,0,0,0,0,0,0,0,"('22', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 23, 841.92, 595.32)"
23,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 23, 841.92, 595.32)"
24,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 24, 841.92, 595.32)"
24,used for rapid screening. Even though diagnostic test kits are already available that can detect,0,0,0,0,0,0,0,0,0,0,0,0,0,"('used for rapid screening. Even though diagnostic test kits are already available that can detect', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.396, 767.076), True, False, 24, 841.92, 595.32)"
24,"the genetic sequences of SARS-CoV-2 (95), their availability is a concern as the number of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the genetic sequences of SARS-CoV-2 (95), their availability is a concern as the number of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.268, 526.2500000000001, 752.176), True, False, 24, 841.92, 595.32)"
24,"COVID-19 cases are skyrocketing (155, 157) major problem associated with this diagnostic",0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19 cases are skyrocketing (155, 157) major problem associated with this diagnostic', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 526.2740000000001, 737.296), True, False, 24, 841.92, 595.32)"
24,kit is that it works only when the test subject has an active infection thus limiting its use in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('kit is that it works only when the test subject has an active infection thus limiting its use in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.0880000000002, 722.416), True, False, 24, 841.92, 595.32)"
24,the  early  stages  of  infection.  Several  labs  around  the  world  are  currently  on  the  quest  for,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  early  stages  of  infection.  Several  labs  around  the  world  are  currently  on  the  quest  for', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 696.628, 526.2020000000001, 707.5360000000001), True, False, 24, 841.92, 595.32)"
24,developing antibody-based diagnostic tests against SARS-CoV-2 (157).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('developing antibody-based diagnostic tests against SARS-CoV-2 (157).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 681.748, 420.07, 692.6560000000001), True, False, 24, 841.92, 595.32)"
24,Chest CT is an ideal diagnostic tool for identifying viral pneumonia. The sensitivity of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chest CT is an ideal diagnostic tool for identifying viral pneumonia. The sensitivity of', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 658.828, 526.2800000000002, 669.736), True, False, 24, 841.92, 595.32)"
24,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 658.828, 75.024, 669.736), True, False, 24, 841.92, 595.32)"
24,chest CT is far more superior to the X-ray. The chest CT findings associated with COVID-19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('chest CT is far more superior to the X-ray. The chest CT findings associated with COVID-19', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.408, 654.856), True, False, 24, 841.92, 595.32)"
24,infected  patients  include  characteristic  patchy  infiltration  that  later  progresses  into  ground-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infected  patients  include  characteristic  patchy  infiltration  that  later  progresses  into  ground-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 629.068, 523.336, 639.976), True, False, 24, 841.92, 595.32)"
24,glass opacities (158). Early manifestations of COVID-19 pneumonia might not be evident in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('glass opacities (158). Early manifestations of COVID-19 pneumonia might not be evident in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 614.068, 526.27, 624.976), True, False, 24, 841.92, 595.32)"
24,"the X-ray chest radiography. In such situations, a chest CT examination can be performed as",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the X-ray chest radiography. In such situations, a chest CT examination can be performed as', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 599.188, 526.19, 610.096), True, False, 24, 841.92, 595.32)"
24,it is considered to be highly specific for COVID-19 pneumonia (118). Those patients having,0,0,0,0,0,0,0,0,0,0,0,0,0,"('it is considered to be highly specific for COVID-19 pneumonia (118). Those patients having', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 584.308, 526.33, 595.216), True, False, 24, 841.92, 595.32)"
24,COVID-19 pneumonia will exhibit the typical ground-glass opacity in their chest CT images,0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19 pneumonia will exhibit the typical ground-glass opacity in their chest CT images', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 569.398, 526.2460000000001, 580.306), True, False, 24, 841.92, 595.32)"
24,(154). The patients infected with COVID-19 had elevated plasma Angiotensin 2 levels. The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(154). The patients infected with COVID-19 had elevated plasma Angiotensin 2 levels. The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 554.518, 526.396, 565.426), True, False, 24, 841.92, 595.32)"
24,"level of Angiotensin 2 was found to be linearly associated with the viral load and lung injury,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('level of Angiotensin 2 was found to be linearly associated with the viral load and lung injury,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 539.638, 526.42, 550.546), True, False, 24, 841.92, 595.32)"
24,indicating its potential as a diagnostic biomarker (121). The chest CT imaging abnormalities,0,0,0,0,0,0,0,0,0,0,0,0,0,"('indicating its potential as a diagnostic biomarker (121). The chest CT imaging abnormalities', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 524.758, 526.2460000000001, 535.666), True, False, 24, 841.92, 595.32)"
24,associated  with  COVID-19  pneumonia  have  also  been  observed  even  in  asymptomatic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('associated  with  COVID-19  pneumonia  have  also  been  observed  even  in  asymptomatic', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 509.87800000000004, 526.282, 520.7860000000001), True, False, 24, 841.92, 595.32)"
24,patients.  These  abnormalities  progress  from  the  initial  focal  unilateral  to  diffuse  bilateral,0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients.  These  abnormalities  progress  from  the  initial  focal  unilateral  to  diffuse  bilateral', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 494.998, 526.384, 505.90599999999995), True, False, 24, 841.92, 595.32)"
24,ground-glass  opacities  and  will  further  progress  to  or  co-exist  with  lung  consolidations,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ground-glass  opacities  and  will  further  progress  to  or  co-exist  with  lung  consolidations', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 480.118, 526.408, 491.02599999999995), True, False, 24, 841.92, 595.32)"
24,changes  within  1-3  weeks  (159).  The  role  played  by  radiologists  in  the  current  scenario  is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('changes  within  1-3  weeks  (159).  The  role  played  by  radiologists  in  the  current  scenario  is', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 465.238, 526.282, 476.14599999999996), True, False, 24, 841.92, 595.32)"
24,very high. Radiologists can help in the early diagnosis of lung abnormalities associated with,0,0,0,0,0,0,0,0,0,0,0,0,0,"('very high. Radiologists can help in the early diagnosis of lung abnormalities associated with', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 450.238, 526.342, 461.14599999999996), True, False, 24, 841.92, 595.32)"
24,"COVID-19 pneumonia.  They can also help in the evaluation of disease severity, identifying",0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19 pneumonia.  They can also help in the evaluation of disease severity, identifying', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 435.358, 526.2260000000001, 446.26599999999996), True, False, 24, 841.92, 595.32)"
24,"its progression to acute respiratory distress syndrome, and the presence of secondary bacterial",0,0,0,0,0,0,0,0,0,0,0,0,0,"('its progression to acute respiratory distress syndrome, and the presence of secondary bacterial', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 420.478, 526.1039999999998, 431.38599999999997), True, False, 24, 841.92, 595.32)"
24,infections (160). Even though chest CT is considered an essential diagnostic tool for COVID-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infections (160). Even though chest CT is considered an essential diagnostic tool for COVID-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 405.598, 523.336, 416.506), True, False, 24, 841.92, 595.32)"
24,"19,  the  extensive  use  of  CT  for  screening  purposes  in  suspected  individuals  might  be",0,0,0,0,0,0,0,0,0,0,0,0,0,"('19,  the  extensive  use  of  CT  for  screening  purposes  in  suspected  individuals  might  be', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 390.69800000000004, 526.33, 401.606), True, False, 24, 841.92, 595.32)"
24,associated  with  a  disproportionate  risk-benefit  ratio  due  to  increased  radiation  exposure  as,0,0,0,0,0,0,0,0,0,0,0,0,0,"('associated  with  a  disproportionate  risk-benefit  ratio  due  to  increased  radiation  exposure  as', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 375.81800000000004, 526.2140000000002, 386.726), True, False, 24, 841.92, 595.32)"
24,"well as increased risk of cross-infection. Hence, the use of CT for early diagnosis of SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('well as increased risk of cross-infection. Hence, the use of CT for early diagnosis of SARS-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 360.938, 523.456, 371.84599999999995), True, False, 24, 841.92, 595.32)"
24,CoV-2 infection in high-risk groups should be done with great caution (297).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2 infection in high-risk groups should be done with great caution (297).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 346.058, 445.06, 356.96599999999995), True, False, 24, 841.92, 595.32)"
24,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 323.13800000000003, 75.024, 334.046), True, False, 24, 841.92, 595.32)"
24,"VACCINES, THERAPEUTICS, AND DRUGS",0,0,0,0,0,0,0,0,0,0,0,0,0,"('VACCINES, THERAPEUTICS, AND DRUGS', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 302.01800000000003, 318.43, 312.73400000000004), True, False, 24, 841.92, 595.32)"
24,"The recently emerged viruses, such as Zika, Ebola, and Nipah viruses and their high threats to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('The recently emerged viruses, such as Zika, Ebola, and Nipah viruses and their high threats to', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 286.778, 526.3420000000001, 297.686), True, False, 24, 841.92, 595.32)"
24,"humans,  have  paved  race  in  exploring  of  designing  and  developing  advanced  vaccines,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('humans,  have  paved  race  in  exploring  of  designing  and  developing  advanced  vaccines,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 271.898, 526.0999999999999, 282.806), True, False, 24, 841.92, 595.32)"
24,"prophylactics, therapeutics, and drugs regimens to counter emergency viruses (161-163, 285).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('prophylactics, therapeutics, and drugs regimens to counter emergency viruses (161-163, 285).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 257.01800000000003, 526.408, 267.926), True, False, 24, 841.92, 595.32)"
24,"Several attempts are being made to design and develop vaccines against coronavirus infection,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Several attempts are being made to design and develop vaccines against coronavirus infection,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 242.13799999999998, 529.42, 253.046), True, False, 24, 841.92, 595.32)"
24,"mostly by targeting the Spike glycoprotein. Nevertheless, owing to the extensive diversity in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('mostly by targeting the Spike glycoprotein. Nevertheless, owing to the extensive diversity in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 227.25799999999998, 526.3299999999999, 238.166), True, False, 24, 841.92, 595.32)"
24,"antigenic  variants,  cross-protection  rendered  by  the  vaccines  is  significantly  limited  even",0,0,0,0,0,0,0,0,0,0,0,0,0,"('antigenic  variants,  cross-protection  rendered  by  the  vaccines  is  significantly  limited  even', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 212.34799999999998, 526.348, 223.256), True, False, 24, 841.92, 595.32)"
24,within  the  strains  of  a  phylogenetic  sub-cluster  (104).  Due  to  the  lack  of  effective  antiviral,0,0,0,0,0,0,0,0,0,0,0,0,0,"('within  the  strains  of  a  phylogenetic  sub-cluster  (104).  Due  to  the  lack  of  effective  antiviral', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 197.34799999999998, 526.282, 208.256), True, False, 24, 841.92, 595.32)"
24,"therapy  and  vaccines  in  the  present  scenario,  we  have  to  rely  exclusively  on  enforcing",0,0,0,0,0,0,0,0,0,0,0,0,0,"('therapy  and  vaccines  in  the  present  scenario,  we  have  to  rely  exclusively  on  enforcing', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 182.468, 526.408, 193.376), True, False, 24, 841.92, 595.32)"
24,infection  control  measures  to  minimize  the  risk  of  possible  nosocomial  transmission  (68).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infection  control  measures  to  minimize  the  risk  of  possible  nosocomial  transmission  (68).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 167.588, 526.42, 178.496), True, False, 24, 841.92, 595.32)"
24,"Recently, the receptor for SARS-CoV-2 was confirmed as the human angiotensin-converting",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Recently, the receptor for SARS-CoV-2 was confirmed as the human angiotensin-converting', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 152.708, 526.408, 163.616), True, False, 24, 841.92, 595.32)"
24,"enzyme 2 (hACE2), and the virus was found to enter the host cell mainly through endocytosis.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('enzyme 2 (hACE2), and the virus was found to enter the host cell mainly through endocytosis.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 137.82799999999997, 529.1960000000001, 148.736), True, False, 24, 841.92, 595.32)"
24,It was also found that the major components that have a critical role in the viral entry include,0,0,0,0,0,0,0,0,0,0,0,0,0,"('It was also found that the major components that have a critical role in the viral entry include', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 122.94800000000001, 526.282, 133.856), True, False, 24, 841.92, 595.32)"
24,"PIKfyve, TPC2, and cathepsin L. These findings are critical since the components described",0,0,0,0,0,0,0,0,0,0,0,0,0,"('PIKfyve, TPC2, and cathepsin L. These findings are critical since the components described', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 108.068, 526.408, 118.976), True, False, 24, 841.92, 595.32)"
24,above  might  act  as  a  potential  candidate  for  vaccines  or  therapeutic  drugs  against  SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('above  might  act  as  a  potential  candidate  for  vaccines  or  therapeutic  drugs  against  SARS-', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 93.19200000000001, 523.576, 104.10000000000001), True, False, 24, 841.92, 595.32)"
24,CoV-2 (298).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2 (298).', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 78.312, 142.7, 89.22), True, False, 24, 841.92, 595.32)"
24,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 24, 841.92, 595.32)"
24,23,0,0,0,0,0,0,0,0,0,0,0,0,0,"('23', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 24, 841.92, 595.32)"
25,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 25, 841.92, 595.32)"
25,The majority of the therapeutic options and strategies that we are evaluating in SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The majority of the therapeutic options and strategies that we are evaluating in SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 756.168, 523.456, 767.076), True, False, 25, 841.92, 595.32)"
25,"CoV-2 (COVID-19) are taken from our previous experiences in treating SARS-CoV, MERS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2 (COVID-19) are taken from our previous experiences in treating SARS-CoV, MERS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 523.456, 751.936), True, False, 25, 841.92, 595.32)"
25,"CoV,  and  other  emerging  viral  diseases.  Several  therapeutic  and  preventive  strategies,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV,  and  other  emerging  viral  diseases.  Several  therapeutic  and  preventive  strategies,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.42, 736.696), True, False, 25, 841.92, 595.32)"
25,"including vaccines, immunotherapeutics, and antiviral drugs, have been explored against the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('including vaccines, immunotherapeutics, and antiviral drugs, have been explored against the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 526.3960000000001, 721.576), True, False, 25, 841.92, 595.32)"
25,"previous  coronavirus  outbreaks  caused  by  SARS-CoV  and  MERS-CoV  (8,  104,  164-167).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('previous  coronavirus  outbreaks  caused  by  SARS-CoV  and  MERS-CoV  (8,  104,  164-167).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 526.456, 706.336), True, False, 25, 841.92, 595.32)"
25,"These  valuable  options  have  already  been  evaluated  for  their  potency,  efficacy,  and  safety",0,0,0,0,0,0,0,0,0,0,0,0,0,"('These  valuable  options  have  already  been  evaluated  for  their  potency,  efficacy,  and  safety', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 680.308, 526.384, 691.216), True, False, 25, 841.92, 595.32)"
25,along with several other ongoing types of research will fuel our search for ideal therapeutic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('along with several other ongoing types of research will fuel our search for ideal therapeutic', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 665.068, 526.2460000000001, 675.976), True, False, 25, 841.92, 595.32)"
25,"agent  against  COVID-19  (7,  9,  19,  21,  36).  The  main  reason  for  the  lack  of  approved  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('agent  against  COVID-19  (7,  9,  19,  21,  36).  The  main  reason  for  the  lack  of  approved  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 649.948, 526.1780000000001, 660.856), True, False, 25, 841.92, 595.32)"
25,commercially available vaccines or therapeutic agents against the previous coronaviruses like,0,0,0,0,0,0,0,0,0,0,0,0,0,"('commercially available vaccines or therapeutic agents against the previous coronaviruses like', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 634.708, 526.104, 645.616), True, False, 25, 841.92, 595.32)"
25,SARS-CoV and MERS-CoV might be due to the lack of interest among the pharmaceutical,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV and MERS-CoV might be due to the lack of interest among the pharmaceutical', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 619.588, 526.142, 630.496), True, False, 25, 841.92, 595.32)"
25,companies  (19).  These  are  outbreak  scenarios:  the  demand  for  drugs  or  vaccines  lasts  for  a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('companies  (19).  These  are  outbreak  scenarios:  the  demand  for  drugs  or  vaccines  lasts  for  a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 604.3480000000001, 526.202, 615.2560000000001), True, False, 25, 841.92, 595.32)"
25,period until the outbreak lasts. The number of people affected will also be a small proportion,0,0,0,0,0,0,0,0,0,0,0,0,0,"('period until the outbreak lasts. The number of people affected will also be a small proportion', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 589.2280000000001, 526.1780000000001, 600.1360000000001), True, False, 25, 841.92, 595.32)"
25,"of the global drug and vaccine market. So, by the time a new drug or vaccine is developed,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of the global drug and vaccine market. So, by the time a new drug or vaccine is developed,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 573.988, 526.2740000000001, 584.8960000000001), True, False, 25, 841.92, 595.32)"
25,"there would not be any patients for clinical trials, and also there would not be any market for",0,0,0,0,0,0,0,0,0,0,0,0,0,"('there would not be any patients for clinical trials, and also there would not be any market for', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 558.838, 526.214, 569.746), True, False, 25, 841.92, 595.32)"
25,"the  newly  discovered  drugs  to  be  sold.  At  present,  there  is  no  vaccine  or  therapeutic  drugs",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  newly  discovered  drugs  to  be  sold.  At  present,  there  is  no  vaccine  or  therapeutic  drugs', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 543.5980000000001, 526.1039999999998, 554.5060000000001), True, False, 25, 841.92, 595.32)"
25,available for treating COVID-19 infection.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('available for treating COVID-19 infection.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 528.4780000000001, 283.73, 539.3860000000001), True, False, 25, 841.92, 595.32)"
25,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.715999999999951, (72.024, 507.238, 75.024, 517.954), True, False, 25, 841.92, 595.32)"
25,Vaccines,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Vaccines', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 486.118, 123.38, 496.834), True, False, 25, 841.92, 595.32)"
25,The S protein plays a significant role in the induction of protective immunity against,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The S protein plays a significant role in the induction of protective immunity against', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 464.87800000000004, 526.2500000000001, 475.786), True, False, 25, 841.92, 595.32)"
25,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 464.87800000000004, 75.024, 475.786), True, False, 25, 841.92, 595.32)"
25,SARS-CoV by mediating T-cell responses and neutralizing-antibody production (168). In the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV by mediating T-cell responses and neutralizing-antibody production (168). In the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 449.75800000000004, 526.396, 460.666), True, False, 25, 841.92, 595.32)"
25,"past  few  decades,  we  have  seen  several  attempts  to  develop  a  vaccine  against  human",0,0,0,0,0,0,0,0,0,0,0,0,0,"('past  few  decades,  we  have  seen  several  attempts  to  develop  a  vaccine  against  human', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 434.51800000000003, 526.318, 445.426), True, False, 25, 841.92, 595.32)"
25,"coronaviruses by using  S protein as the target (168, 169). However, the developed vaccines",0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronaviruses by using  S protein as the target (168, 169). However, the developed vaccines', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 419.398, 526.33, 430.306), True, False, 25, 841.92, 595.32)"
25,have  minimal  application  even  among  closely  related  strains  of  the  virus  due  to  a  lack  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('have  minimal  application  even  among  closely  related  strains  of  the  virus  due  to  a  lack  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 404.158, 526.444, 415.066), True, False, 25, 841.92, 595.32)"
25,cross-protection.  That  is  mainly  because  of  the  extensive  diversity  existing  among  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('cross-protection.  That  is  mainly  because  of  the  extensive  diversity  existing  among  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 389.01800000000003, 526.342, 399.926), True, False, 25, 841.92, 595.32)"
25,different antigenic variants of the virus (104). The contributions of the structural proteins like,0,0,0,0,0,0,0,0,0,0,0,0,0,"('different antigenic variants of the virus (104). The contributions of the structural proteins like', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 373.778, 526.2620000000002, 384.686), True, False, 25, 841.92, 595.32)"
25,"a spike (S), matrix (M), small envelope (E), and nucleocapsid (N) proteins of SARS-CoV to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('a spike (S), matrix (M), small envelope (E), and nucleocapsid (N) proteins of SARS-CoV to', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 358.658, 526.408, 369.566), True, False, 25, 841.92, 595.32)"
25,induce  protective  immunity  has  been  evaluated  by  expressing  them  in  a  recombinant,0,0,0,0,0,0,0,0,0,0,0,0,0,"('induce  protective  immunity  has  been  evaluated  by  expressing  them  in  a  recombinant', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 343.418, 526.2940000000001, 354.32599999999996), True, False, 25, 841.92, 595.32)"
25,"parainfluenza virus type 3 vector called BHPIV3. Of the note, the result was conclusive that",0,0,0,0,0,0,0,0,0,0,0,0,0,"('parainfluenza virus type 3 vector called BHPIV3. Of the note, the result was conclusive that', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 328.298, 526.318, 339.20599999999996), True, False, 25, 841.92, 595.32)"
25,"the expression of M, E, or N proteins without the presence of S protein would not confer any",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the expression of M, E, or N proteins without the presence of S protein would not confer any', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 313.058, 526.396, 323.96599999999995), True, False, 25, 841.92, 595.32)"
25,detectable  protection  with  the  absence  of  detectable  serum  SARS-CoV-neutralizing,0,0,0,0,0,0,0,0,0,0,0,0,0,"('detectable  protection  with  the  absence  of  detectable  serum  SARS-CoV-neutralizing', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 297.938, 526.384, 308.84599999999995), True, False, 25, 841.92, 595.32)"
25,antibodies  (170).  Antigenic  determinant  sites  present  over  S  and  N  structural  proteins  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('antibodies  (170).  Antigenic  determinant  sites  present  over  S  and  N  structural  proteins  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 282.69800000000004, 526.1719999999999, 293.606), True, False, 25, 841.92, 595.32)"
25,SARS-CoV-2  can  be  well  explored  as  a  suitable  vaccine  candidate  (299).  In  the  Asian,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  can  be  well  explored  as  a  suitable  vaccine  candidate  (299).  In  the  Asian', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 267.57800000000003, 526.3960000000001, 278.486), True, False, 25, 841.92, 595.32)"
25,"population,  S,  E,  M,  and  N  proteins  of  novel-SARS-CoV-2  can  be  tested  for  developing",0,0,0,0,0,0,0,0,0,0,0,0,0,"('population,  S,  E,  M,  and  N  proteins  of  novel-SARS-CoV-2  can  be  tested  for  developing', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 252.338, 526.306, 263.246), True, False, 25, 841.92, 595.32)"
25,subunit vaccines against COVID-19 (300).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('subunit vaccines against COVID-19 (300).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 237.218, 280.73, 248.126), True, False, 25, 841.92, 595.32)"
25,Identification  of  the  immunodominant  region  among  the  subunits  and  domains  of  S,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Identification  of  the  immunodominant  region  among  the  subunits  and  domains  of  S', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 215.97799999999998, 526.0880000000001, 226.886), True, False, 25, 841.92, 595.32)"
25,protein  is  critical  while  developing  an  effective  vaccine  against  the  coronavirus.  The  C-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein  is  critical  while  developing  an  effective  vaccine  against  the  coronavirus.  The  C-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 200.82799999999997, 523.456, 211.736), True, False, 25, 841.92, 595.32)"
25,terminal  domain  of  the  S1  subunit  is  considered  as  the  immunodominant  region  of  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('terminal  domain  of  the  S1  subunit  is  considered  as  the  immunodominant  region  of  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 185.588, 526.238, 196.496), True, False, 25, 841.92, 595.32)"
25,"porcine deltacoronavirus S protein (171). Similarly, further studies are required to determine",0,0,0,0,0,0,0,0,0,0,0,0,0,"('porcine deltacoronavirus S protein (171). Similarly, further studies are required to determine', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 170.468, 526.27, 181.376), True, False, 25, 841.92, 595.32)"
25,the immunodominant regions of SARS-CoV-2 for facilitating vaccine development.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the immunodominant regions of SARS-CoV-2 for facilitating vaccine development.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 155.22799999999998, 478.66, 166.136), True, False, 25, 841.92, 595.32)"
25,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 134.10799999999998, 75.024, 145.016), True, False, 25, 841.92, 595.32)"
25,"However,  our  previous  attempts  to  develop  a  universal  vaccine  that  is  effective",0,0,0,0,0,0,0,0,0,0,0,0,0,"('However,  our  previous  attempts  to  develop  a  universal  vaccine  that  is  effective', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 134.10799999999998, 526.0519999999999, 145.016), True, False, 25, 841.92, 595.32)"
25,against both SARS-CoV and MERS-CoV based on T cell epitopes similarity pointed out the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('against both SARS-CoV and MERS-CoV based on T cell epitopes similarity pointed out the', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 118.868, 526.282, 129.77599999999998), True, False, 25, 841.92, 595.32)"
25,possibility  of  cross-reactivity  among  coronaviruses  (172).  That  can  be  made  possible  by,0,0,0,0,0,0,0,0,0,0,0,0,0,"('possibility  of  cross-reactivity  among  coronaviruses  (172).  That  can  be  made  possible  by', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 103.748, 526.3299999999999, 114.656), True, False, 25, 841.92, 595.32)"
25,selected potential vaccine targets that  are common to both the viruses. The SARS-CoV-2 is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('selected potential vaccine targets that  are common to both the viruses. The SARS-CoV-2 is', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 88.512, 526.384, 99.42), True, False, 25, 841.92, 595.32)"
25,"found  to  be  closely  related  to  the  SARS-CoV  (173,174).  Hence,  the  knowledge  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('found  to  be  closely  related  to  the  SARS-CoV  (173,174).  Hence,  the  knowledge  and', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 73.392, 526.306, 84.3), True, False, 25, 841.92, 595.32)"
25,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 25, 841.92, 595.32)"
25,24,0,0,0,0,0,0,0,0,0,0,0,0,0,"('24', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 25, 841.92, 595.32)"
26,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 26, 841.92, 595.32)"
26,understanding of the S protein-based vaccine development in SARS-CoV will help to identify,0,0,0,0,0,0,0,0,0,0,0,0,0,"('understanding of the S protein-based vaccine development in SARS-CoV will help to identify', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.432, 767.076), True, False, 26, 841.92, 595.32)"
26,"potential  S  protein  vaccine  candidates  in  SARS-CoV-2.  Therefore,  vaccine  strategies  based",0,0,0,0,0,0,0,0,0,0,0,0,0,"('potential  S  protein  vaccine  candidates  in  SARS-CoV-2.  Therefore,  vaccine  strategies  based', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.306, 751.936), True, False, 26, 841.92, 595.32)"
26,"on the whole S protein, S protein subunits, or specific potential epitopes of S protein appear",0,0,0,0,0,0,0,0,0,0,0,0,0,"('on the whole S protein, S protein subunits, or specific potential epitopes of S protein appear', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.42, 736.696), True, False, 26, 841.92, 595.32)"
26,most promising vaccine candidates against coronaviruses shortly. The RBD of the S1 subunit,0,0,0,0,0,0,0,0,0,0,0,0,0,"('most promising vaccine candidates against coronaviruses shortly. The RBD of the S1 subunit', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 526.2460000000001, 721.576), True, False, 26, 841.92, 595.32)"
26,of S protein has a superior capacity to induce neutralizing antibodies. This property of RBD,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of S protein has a superior capacity to induce neutralizing antibodies. This property of RBD', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 526.318, 706.336), True, False, 26, 841.92, 595.32)"
26,can be utilized for developing effective SARS-CoV vaccines either by using RBD containing,0,0,0,0,0,0,0,0,0,0,0,0,0,"('can be utilized for developing effective SARS-CoV vaccines either by using RBD containing', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 680.308, 526.2020000000001, 691.216), True, False, 26, 841.92, 595.32)"
26,"recombinant  proteins  or  recombinant  vectors  that  encode  RBD  (175).  Hence,  the  superior",0,0,0,0,0,0,0,0,0,0,0,0,0,"('recombinant  proteins  or  recombinant  vectors  that  encode  RBD  (175).  Hence,  the  superior', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 665.068, 526.3299999999999, 675.976), True, False, 26, 841.92, 595.32)"
26,genetic  similarity  existing  between  SARS-CoV-2  and  SARS-CoV  can  be  utilized  to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('genetic  similarity  existing  between  SARS-CoV-2  and  SARS-CoV  can  be  utilized  to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 649.948, 526.33, 660.856), True, False, 26, 841.92, 595.32)"
26,repurpose  vaccines  that  have  proven  in  vitro  efficacy  against  SARS-CoV  to  be  utilized  for,0,0,0,0,0,0,0,0,0,0,0,0,0,"('repurpose  vaccines  that  have  proven  in  vitro  efficacy  against  SARS-CoV  to  be  utilized  for', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 634.708, 526.282, 645.6279999999999), False, False, 26, 841.92, 595.32)"
26,SARS-CoV-2. The possibility of cross-protection in COVID-19 was evaluated by comparing,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2. The possibility of cross-protection in COVID-19 was evaluated by comparing', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 619.588, 526.3299999999999, 630.496), True, False, 26, 841.92, 595.32)"
26,the S protein  sequences  of  SARS-CoV-2with  that of SARS-CoV. The comparative analysis,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the S protein  sequences  of  SARS-CoV-2with  that of SARS-CoV. The comparative analysis', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 604.3480000000001, 526.306, 615.2560000000001), True, False, 26, 841.92, 595.32)"
26,"confirmed that the variable residues were found concentrated on the S1 subunit of S protein,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('confirmed that the variable residues were found concentrated on the S1 subunit of S protein,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 589.2280000000001, 526.0560000000002, 600.1360000000001), True, False, 26, 841.92, 595.32)"
26,"an important vaccine target of the virus (150). Hence, the possibility of SARS-CoV specific",0,0,0,0,0,0,0,0,0,0,0,0,0,"('an important vaccine target of the virus (150). Hence, the possibility of SARS-CoV specific', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 573.988, 526.396, 584.8960000000001), True, False, 26, 841.92, 595.32)"
26,neutralizing  antibodies  providing  cross-protection  to  COVID-19  might  be  less.  Further,0,0,0,0,0,0,0,0,0,0,0,0,0,"('neutralizing  antibodies  providing  cross-protection  to  COVID-19  might  be  less.  Further', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 558.838, 526.306, 569.746), True, False, 26, 841.92, 595.32)"
26,genetic  analysis  is  required  between  COVID-19  and  different  strains  of  SARS-CoV  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('genetic  analysis  is  required  between  COVID-19  and  different  strains  of  SARS-CoV  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 543.5980000000001, 526.396, 554.5060000000001), True, False, 26, 841.92, 595.32)"
26,SARS-like  (SL)  coronaviruses  to  evaluate  the  possibility  of  repurposed  vaccines  against,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-like  (SL)  coronaviruses  to  evaluate  the  possibility  of  repurposed  vaccines  against', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 528.4780000000001, 526.214, 539.3860000000001), True, False, 26, 841.92, 595.32)"
26,COVID-19. This strategy will be helpful in the scenario of an outbreak since much time can,0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19. This strategy will be helpful in the scenario of an outbreak since much time can', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 513.238, 526.3059999999999, 524.1460000000001), True, False, 26, 841.92, 595.32)"
26,"be saved because preliminary evaluation, including in vitro studies, would be already over in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('be saved because preliminary evaluation, including in vitro studies, would be already over in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 498.118, 526.318, 509.03799999999995), False, False, 26, 841.92, 595.32)"
26,such vaccine candidates.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('such vaccine candidates.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 482.87800000000004, 193.37, 493.786), True, False, 26, 841.92, 595.32)"
26,Identifying epitopes that have the potential to become a vaccine candidate is critical to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Identifying epitopes that have the potential to become a vaccine candidate is critical to', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 461.75800000000004, 526.1719999999999, 472.666), True, False, 26, 841.92, 595.32)"
26,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 461.75800000000004, 75.024, 472.666), True, False, 26, 841.92, 595.32)"
26,developing an effective vaccine against COVID-19. Immuno-informatics approach has been,0,0,0,0,0,0,0,0,0,0,0,0,0,"('developing an effective vaccine against COVID-19. Immuno-informatics approach has been', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 446.51800000000003, 526.42, 457.426), True, False, 26, 841.92, 595.32)"
26,used  for  the  identification  of  essential  epitopes  of  cytotoxic  T  lymphocyte  and  B  cell  from,0,0,0,0,0,0,0,0,0,0,0,0,0,"('used  for  the  identification  of  essential  epitopes  of  cytotoxic  T  lymphocyte  and  B  cell  from', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 431.398, 526.154, 442.306), True, False, 26, 841.92, 595.32)"
26,"surface  glycoprotein  of  SARS-CoV-2.  Recently,  a  few  epitopes  have  been  recognized  from",0,0,0,0,0,0,0,0,0,0,0,0,0,"('surface  glycoprotein  of  SARS-CoV-2.  Recently,  a  few  epitopes  have  been  recognized  from', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 416.158, 526.396, 427.066), True, False, 26, 841.92, 595.32)"
26,the  SARS-CoV-2surface  glycoprotein.  The  selected  epitopes  explored  targeting  molecular,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  SARS-CoV-2surface  glycoprotein.  The  selected  epitopes  explored  targeting  molecular', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 401.038, 526.3960000000001, 411.94599999999997), True, False, 26, 841.92, 595.32)"
26,dynamic simulations evaluating their interaction with corresponding MHC class I molecules.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('dynamic simulations evaluating their interaction with corresponding MHC class I molecules.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 385.778, 526.42, 396.686), True, False, 26, 841.92, 595.32)"
26,They potentially induce immune responses (176). The recombinant vaccine can be designed,0,0,0,0,0,0,0,0,0,0,0,0,0,"('They potentially induce immune responses (176). The recombinant vaccine can be designed', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 370.658, 526.306, 381.566), True, False, 26, 841.92, 595.32)"
26,by using rabies virus (RV) as a viral vector. The RV can be made to express MERS-CoV S1,0,0,0,0,0,0,0,0,0,0,0,0,0,"('by using rabies virus (RV) as a viral vector. The RV can be made to express MERS-CoV S1', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 355.418, 526.384, 366.32599999999996), True, False, 26, 841.92, 595.32)"
26,protein  on  its  surface  so  that  an  immune  response  is  induced  against  MERS-CoV.  The  RV,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein  on  its  surface  so  that  an  immune  response  is  induced  against  MERS-CoV.  The  RV', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 340.298, 526.408, 351.20599999999996), True, False, 26, 841.92, 595.32)"
26,vector-based  vaccines  against  MERS-CoV  can  induce  faster  antibody  response  as  well  as,0,0,0,0,0,0,0,0,0,0,0,0,0,"('vector-based  vaccines  against  MERS-CoV  can  induce  faster  antibody  response  as  well  as', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 325.058, 526.214, 335.96599999999995), True, False, 26, 841.92, 595.32)"
26,higher degrees of cellular immunity compared to the Gram-positive enhancer matrix (GEM),0,0,0,0,0,0,0,0,0,0,0,0,0,"('higher degrees of cellular immunity compared to the Gram-positive enhancer matrix (GEM)', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 309.938, 526.2819999999999, 320.84599999999995), True, False, 26, 841.92, 595.32)"
26,"particles  vector-based  vaccine.  However,  the  latter  can  induce  a  very  higher  antibody",0,0,0,0,0,0,0,0,0,0,0,0,0,"('particles  vector-based  vaccine.  However,  the  latter  can  induce  a  very  higher  antibody', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 294.69800000000004, 526.318, 305.606), True, False, 26, 841.92, 595.32)"
26,"response at  lower doses  (167). Hence, the degree of humoral  and cellular immune response",0,0,0,0,0,0,0,0,0,0,0,0,0,"('response at  lower doses  (167). Hence, the degree of humoral  and cellular immune response', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 279.57800000000003, 526.19, 290.486), True, False, 26, 841.92, 595.32)"
26,produced by such vaccines depends upon the vector used.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('produced by such vaccines depends upon the vector used.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 264.338, 352.03, 275.246), True, False, 26, 841.92, 595.32)"
26,"Dual  vaccines  are  getting  more  popular  recently.  Among  them,  the  rabies  virus-based",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Dual  vaccines  are  getting  more  popular  recently.  Among  them,  the  rabies  virus-based', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 243.218, 526.396, 254.126), True, False, 26, 841.92, 595.32)"
26,vectored vaccine platform  is  used to develop  vaccines against emerging  infectious diseases.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('vectored vaccine platform  is  used to develop  vaccines against emerging  infectious diseases.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 227.97799999999998, 526.318, 238.886), True, False, 26, 841.92, 595.32)"
26,The  dual  vaccine  developed  from  inactivated  rabies  virus  particles  that  express  the  MERS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  dual  vaccine  developed  from  inactivated  rabies  virus  particles  that  express  the  MERS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 212.82799999999997, 523.456, 223.736), True, False, 26, 841.92, 595.32)"
26,CoV  S1  domain  of  S  protein  was  found  to  induce  immune  responses  against  both  MERS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV  S1  domain  of  S  protein  was  found  to  induce  immune  responses  against  both  MERS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 197.588, 523.456, 208.496), True, False, 26, 841.92, 595.32)"
26,CoV and rabies virus. The vaccinated mice were found to be completely protected from the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV and rabies virus. The vaccinated mice were found to be completely protected from the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 182.468, 526.282, 193.376), True, False, 26, 841.92, 595.32)"
26,MERS-CoV  challenge  (169).  The  intranasal  administration  of  the  recombinant  adenovirus-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('MERS-CoV  challenge  (169).  The  intranasal  administration  of  the  recombinant  adenovirus-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 167.22799999999998, 523.336, 178.136), True, False, 26, 841.92, 595.32)"
26,based  vaccine  in  BALB/c  mice  was  found  to  induce  long-lasting  neutralizing  immunity,0,0,0,0,0,0,0,0,0,0,0,0,0,"('based  vaccine  in  BALB/c  mice  was  found  to  induce  long-lasting  neutralizing  immunity', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 152.10799999999998, 526.318, 163.016), True, False, 26, 841.92, 595.32)"
26,"against  MERS  spike  pseudotyped  virus  characterized  by  the  induction  of  systemic  IgG,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('against  MERS  spike  pseudotyped  virus  characterized  by  the  induction  of  systemic  IgG,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 136.868, 526.092, 147.776), True, False, 26, 841.92, 595.32)"
26,"secretory  IgA,  and  lung  resident  memory  T  cell  responses  (177).  Immuno-informatics",0,0,0,0,0,0,0,0,0,0,0,0,0,"('secretory  IgA,  and  lung  resident  memory  T  cell  responses  (177).  Immuno-informatics', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 121.748, 526.432, 132.656), True, False, 26, 841.92, 595.32)"
26,methods are employed for the genome-wide screening of potential vaccine targets among the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('methods are employed for the genome-wide screening of potential vaccine targets among the', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 106.508, 526.2020000000001, 117.416), True, False, 26, 841.92, 595.32)"
26,"different  immunogens  of  MERS-CoV  (178).  The  N  protein,  as  well  as  the  potential  B  cell",0,0,0,0,0,0,0,0,0,0,0,0,0,"('different  immunogens  of  MERS-CoV  (178).  The  N  protein,  as  well  as  the  potential  B  cell', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 91.392, 526.2460000000001, 102.3), True, False, 26, 841.92, 595.32)"
26,"epitopes  of  the  E  protein  of  the  MERS-CoV,  have  been  suggested  as  probable",0,0,0,0,0,0,0,0,0,0,0,0,0,"('epitopes  of  the  E  protein  of  the  MERS-CoV,  have  been  suggested  as  probable', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 76.152, 526.3180000000001, 87.06), True, False, 26, 841.92, 595.32)"
26,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 26, 841.92, 595.32)"
26,25,0,0,0,0,0,0,0,0,0,0,0,0,0,"('25', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 26, 841.92, 595.32)"
27,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 27, 841.92, 595.32)"
27,"immunoprotective  targets  inducing  both  T-cell  and  neutralizing  antibody  responses  (178,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('immunoprotective  targets  inducing  both  T-cell  and  neutralizing  antibody  responses  (178,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.42, 767.076), True, False, 27, 841.92, 595.32)"
27,179).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('179).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 102.984, 751.936), True, False, 27, 841.92, 595.32)"
27,The collaborative effort of the scientists of Rocky Mountain Laboratories and Oxford,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The collaborative effort of the scientists of Rocky Mountain Laboratories and Oxford', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 719.788, 526.3960000000001, 730.696), True, False, 27, 841.92, 595.32)"
27,University is on the way for designing a chimpanzee adenovirus-vectored vaccine candidate,0,0,0,0,0,0,0,0,0,0,0,0,0,"('University is on the way for designing a chimpanzee adenovirus-vectored vaccine candidate', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 704.668, 526.33, 715.576), True, False, 27, 841.92, 595.32)"
27,to  counter  COVID-19  (180).  The  Coalition  for  Epidemic  Preparedness  Innovations  (CEPI),0,0,0,0,0,0,0,0,0,0,0,0,0,"('to  counter  COVID-19  (180).  The  Coalition  for  Epidemic  Preparedness  Innovations  (CEPI)', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 689.428, 526.2500000000001, 700.336), True, False, 27, 841.92, 595.32)"
27,has  initiated  three  programs  to  develop  SARS-CoV-2  vaccines  (181).  CEPI  has  a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('has  initiated  three  programs  to  develop  SARS-CoV-2  vaccines  (181).  CEPI  has  a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 674.308, 526.42, 685.216), True, False, 27, 841.92, 595.32)"
27,collaborative  project  with  Inovio  for  designing  the  MERS  CoV  DNA  vaccine  that  could,0,0,0,0,0,0,0,0,0,0,0,0,0,"('collaborative  project  with  Inovio  for  designing  the  MERS  CoV  DNA  vaccine  that  could', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 659.068, 526.396, 669.976), True, False, 27, 841.92, 595.32)"
27,potentiate  effective  immunity.  CEPI  and  the  University  of  Queensland  are  designing  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('potentiate  effective  immunity.  CEPI  and  the  University  of  Queensland  are  designing  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.408, 654.856), True, False, 27, 841.92, 595.32)"
27,"molecular  clamp  vaccine  platform  for  MERS-CoV  and  other  pathogens,  which  could  assist",0,0,0,0,0,0,0,0,0,0,0,0,0,"('molecular  clamp  vaccine  platform  for  MERS-CoV  and  other  pathogens,  which  could  assist', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 526.36, 639.616), True, False, 27, 841.92, 595.32)"
27,an  easier  recognition  of  antigens  by  the  immune  system  (181).  CEPI  has  also  funded,0,0,0,0,0,0,0,0,0,0,0,0,0,"('an  easier  recognition  of  antigens  by  the  immune  system  (181).  CEPI  has  also  funded', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 613.588, 526.396, 624.496), True, False, 27, 841.92, 595.32)"
27,Moderna  to  develop  a  vaccine  against  COVID-19  in  collaboration  with  Vaccine  Research,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Moderna  to  develop  a  vaccine  against  COVID-19  in  collaboration  with  Vaccine  Research', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 598.3480000000001, 526.318, 609.2560000000001), True, False, 27, 841.92, 595.32)"
27,"Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), a part of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), a part of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 583.2280000000001, 526.0559999999998, 594.1360000000001), True, False, 27, 841.92, 595.32)"
27,"National Institutes of Health (NIH) (182). By employing mRNA vaccine platform technology,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('National Institutes of Health (NIH) (182). By employing mRNA vaccine platform technology,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 567.958, 529.238, 578.866), True, False, 27, 841.92, 595.32)"
27,a vaccine candidate expressing SARS-CoV-2 spike protein is expected to go through clinical,0,0,0,0,0,0,0,0,0,0,0,0,0,"('a vaccine candidate expressing SARS-CoV-2 spike protein is expected to go through clinical', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 552.838, 526.384, 563.746), True, False, 27, 841.92, 595.32)"
27,"testing  in  the coming months (180). On March 16th, Jennifer Haller became the first  person",0,0,0,0,0,0,0,0,0,0,0,0,0,"('testing  in  the coming months (180). On March 16th, Jennifer Haller became the first  person', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.5980000000001, 526.354, 550.32172), True, False, 27, 841.92, 595.32)"
27,outside of China to receive an experimental vaccine that was developed by Moderna against,0,0,0,0,0,0,0,0,0,0,0,0,0,"('outside of China to receive an experimental vaccine that was developed by Moderna against', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 522.4780000000001, 526.0920000000001, 533.3860000000001), True, False, 27, 841.92, 595.32)"
27,"the  pandemic  virus.  Moderna,  along  with  China's  CanSino  Biologics,  became  the  first",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""the  pandemic  virus.  Moderna,  along  with  China's  CanSino  Biologics,  became  the  first"", 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 507.238, 526.33, 518.146), True, False, 27, 841.92, 595.32)"
27,research  group  that  launched  small  clinical  trials  of  vaccines  against  COVID-19.  The  study,0,0,0,0,0,0,0,0,0,0,0,0,0,"('research  group  that  launched  small  clinical  trials  of  vaccines  against  COVID-19.  The  study', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 492.118, 526.384, 503.02599999999995), True, False, 27, 841.92, 595.32)"
27,was conducted to evaluate the vaccine's safety and ability to trigger immune responses (301).,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""was conducted to evaluate the vaccine's safety and ability to trigger immune responses (301)."", 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 476.87800000000004, 522.46, 487.786), True, False, 27, 841.92, 595.32)"
27,Scientists  from  all  over  the  world  are  trying  hard  to  develop  working  vaccines  with,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Scientists  from  all  over  the  world  are  trying  hard  to  develop  working  vaccines  with', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 461.75800000000004, 526.1359999999999, 472.666), True, False, 27, 841.92, 595.32)"
27,robust protective immunity against COVID-19. Vaccine candidates like mRNA-1273 SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('robust protective immunity against COVID-19. Vaccine candidates like mRNA-1273 SARS-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 446.87800000000004, 523.576, 457.786), True, False, 27, 841.92, 595.32)"
27,"CoV-2 Vaccine, INO-4800 DNA coronavirus vaccine and Adenovirus type 5 vector vaccine",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2 Vaccine, INO-4800 DNA coronavirus vaccine and Adenovirus type 5 vector vaccine', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 431.998, 526.396, 442.90599999999995), True, False, 27, 841.92, 595.32)"
27,"candidate (Ad5-nCoV) are few examples under Phase-I clinical trials, while Self-amplifying",0,0,0,0,0,0,0,0,0,0,0,0,0,"('candidate (Ad5-nCoV) are few examples under Phase-I clinical trials, while Self-amplifying', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 416.998, 526.396, 427.90599999999995), True, False, 27, 841.92, 595.32)"
27,"RNA  vaccine,  Oral  recombinant  COVID-19  vaccine,  BNT162,  Plant-based  COVID-19",0,0,0,0,0,0,0,0,0,0,0,0,0,"('RNA  vaccine,  Oral  recombinant  COVID-19  vaccine,  BNT162,  Plant-based  COVID-19', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 402.118, 526.408, 413.02599999999995), True, False, 27, 841.92, 595.32)"
27,vaccine  and  Ii-Key  peptide  COVID-19  vaccine  are  under  preclinical  trial  mode  (302).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('vaccine  and  Ii-Key  peptide  COVID-19  vaccine  are  under  preclinical  trial  mode  (302).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 387.218, 526.42, 398.126), True, False, 27, 841.92, 595.32)"
27,"Similarly,  the  WHO,  on  its  official  website,  has  mentioned  a  detailed  list  of  COVID-19",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Similarly,  the  WHO,  on  its  official  website,  has  mentioned  a  detailed  list  of  COVID-19', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 372.338, 526.408, 383.246), True, False, 27, 841.92, 595.32)"
27,vaccine  agents  that  are  under  consideration.  Different  phases  of  trials  like  live  attenuated,0,0,0,0,0,0,0,0,0,0,0,0,0,"('vaccine  agents  that  are  under  consideration.  Different  phases  of  trials  like  live  attenuated', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 357.458, 526.2020000000001, 368.366), True, False, 27, 841.92, 595.32)"
27,"virus  vaccines,  formaldehyde  alum  inactivated  vaccine,  Adenovirus  type  5  vector  vaccine,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus  vaccines,  formaldehyde  alum  inactivated  vaccine,  Adenovirus  type  5  vector  vaccine,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 342.57800000000003, 526.1719999999999, 353.486), True, False, 27, 841.92, 595.32)"
27,"LNP-encapsulated  mRNA,  DNA  plasmid  vaccine,  S  protein,  S-trimer,  Ii-Key  peptide  as",0,0,0,0,0,0,0,0,0,0,0,0,0,"('LNP-encapsulated  mRNA,  DNA  plasmid  vaccine,  S  protein,  S-trimer,  Ii-Key  peptide  as', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 327.69800000000004, 526.3480000000001, 338.606), True, False, 27, 841.92, 595.32)"
27,"subunit protein vaccine, among others (303).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('subunit protein vaccine, among others (303).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 312.81800000000004, 289.97, 323.726), True, False, 27, 841.92, 595.32)"
27,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 289.898, 111.02, 300.806), True, False, 27, 841.92, 595.32)"
27,Therapeutics and drugs,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Therapeutics and drugs', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 266.978, 200.09, 277.694), True, False, 27, 841.92, 595.32)"
27,There is no currently licensed specific anti-viral treatment for the MERS and SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('There is no currently licensed specific anti-viral treatment for the MERS and SARS-', 'TimesNewRomanPSMT', 10.907999999999987, (108.02, 245.85799999999998, 523.576, 256.76599999999996), True, False, 27, 841.92, 595.32)"
27,"CoV infections, and the primary measure in the clinical management is focused on alleviating",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV infections, and the primary measure in the clinical management is focused on alleviating', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 230.618, 526.2140000000002, 241.526), True, False, 27, 841.92, 595.32)"
27,clinical symptoms and supportive cares (183-186). The first therapeutic drugs that might be,0,0,0,0,0,0,0,0,0,0,0,0,0,"('clinical symptoms and supportive cares (183-186). The first therapeutic drugs that might be', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 215.468, 526.294, 226.376), True, False, 27, 841.92, 595.32)"
27,"effective  in  managing  COVID-19  include  remdesivir,  lopinavir/ritonavir  alone  or  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('effective  in  managing  COVID-19  include  remdesivir,  lopinavir/ritonavir  alone  or  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 200.22799999999998, 526.2380000000002, 211.136), True, False, 27, 841.92, 595.32)"
27,"combination  with  interferon-β,  convalescent  plasma,  and  mAbs  (187,  286).  Nevertheless,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('combination  with  interferon-β,  convalescent  plasma,  and  mAbs  (187,  286).  Nevertheless,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 185.10799999999998, 526.384, 196.016), True, False, 27, 841.92, 595.32)"
27,"before  utilizing  these  drugs  for  COVID-19  pneumonia  patients,  efficacy  and  safety  studies",0,0,0,0,0,0,0,0,0,0,0,0,0,"('before  utilizing  these  drugs  for  COVID-19  pneumonia  patients,  efficacy  and  safety  studies', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 169.868, 526.2500000000001, 180.776), True, False, 27, 841.92, 595.32)"
27,should be conducted by further clinical trials. Although a controlled trial of ritonavir-boosted,0,0,0,0,0,0,0,0,0,0,0,0,0,"('should be conducted by further clinical trials. Although a controlled trial of ritonavir-boosted', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 154.748, 526.408, 165.656), True, False, 27, 841.92, 595.32)"
27,lopinavir  and  interferon-alpha  2b  therapy  has  been  registered  for  hospitalized  patients  with,0,0,0,0,0,0,0,0,0,0,0,0,0,"('lopinavir  and  interferon-alpha  2b  therapy  has  been  registered  for  hospitalized  patients  with', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 139.50799999999998, 526.142, 150.416), True, False, 27, 841.92, 595.32)"
27,"COVID-19  (ChiCTR2000029308)  (188).  Besides,  the  use  of  hydroxychloroquine  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19  (ChiCTR2000029308)  (188).  Besides,  the  use  of  hydroxychloroquine  and', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 124.388, 526.318, 135.296), True, False, 27, 841.92, 595.32)"
27,"tocilizumab  and  their  potential  role  in  modulating  inflammatory  response  in  the  lungs,  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('tocilizumab  and  their  potential  role  in  modulating  inflammatory  response  in  the  lungs,  in', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 109.148, 526.0760000000002, 120.056), True, False, 27, 841.92, 595.32)"
27,"addition to the potential of antiviral of the first, has been proposed and discussed in multiple",0,0,0,0,0,0,0,0,0,0,0,0,0,"('addition to the potential of antiviral of the first, has been proposed and discussed in multiple', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 94.032, 526.1400000000001, 104.94), True, False, 27, 841.92, 595.32)"
27,"papers,  but  so  far,  not  available  good-quality  clinical  trials  have  been  published  (263-277).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('papers,  but  so  far,  not  available  good-quality  clinical  trials  have  been  published  (263-277).', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 78.792, 526.42, 89.7), True, False, 27, 841.92, 595.32)"
27,"Shortly, evidence will be available regarding the use of these drugs. Recently, also, a clinical",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Shortly, evidence will be available regarding the use of these drugs. Recently, also, a clinical', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 63.672, 526.032, 74.58), True, False, 27, 841.92, 595.32)"
27,26,0,0,0,0,0,0,0,0,0,0,0,0,0,"('26', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 27, 841.92, 595.32)"
27,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 27, 841.92, 595.32)"
28,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 28, 841.92, 595.32)"
28,trial  was  published  showing  the  comparison  of  lopinavir/ritonavir  versus  standard  case  but,0,0,0,0,0,0,0,0,0,0,0,0,0,"('trial  was  published  showing  the  comparison  of  lopinavir/ritonavir  versus  standard  case  but', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.1279999999999, 767.076), True, False, 28, 841.92, 595.32)"
28,"showed  that  in  hospitalized  adult  patients  with  severe  COVID-19,  no  benefit  was  observed",0,0,0,0,0,0,0,0,0,0,0,0,0,"('showed  that  in  hospitalized  adult  patients  with  severe  COVID-19,  no  benefit  was  observed', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.306, 751.936), True, False, 28, 841.92, 595.32)"
28,with lopinavir-ritonavir treatment beyond standard care (278).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('with lopinavir-ritonavir treatment beyond standard care (278).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 373.27, 736.696), True, False, 28, 841.92, 595.32)"
28,The guidance to the control of the COVID-19 infection might be based on the existing,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The guidance to the control of the COVID-19 infection might be based on the existing', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 704.668, 526.2940000000001, 715.576), True, False, 28, 841.92, 595.32)"
28,measures  for  MERS  and  SARS  and  with  some  further  precautions  because  of  the  widely,0,0,0,0,0,0,0,0,0,0,0,0,0,"('measures  for  MERS  and  SARS  and  with  some  further  precautions  because  of  the  widely', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 689.428, 526.396, 700.336), True, False, 28, 841.92, 595.32)"
28,"unknown nature of this new coronavirus (36, 189). Currently, the primary treatment strategy,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('unknown nature of this new coronavirus (36, 189). Currently, the primary treatment strategy,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 674.308, 526.42, 685.216), True, False, 28, 841.92, 595.32)"
28,"such  as  mechanical  ventilation,  ICU  admission,  and  symptomatic  and  supportive  care,  are",0,0,0,0,0,0,0,0,0,0,0,0,0,"('such  as  mechanical  ventilation,  ICU  admission,  and  symptomatic  and  supportive  care,  are', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 659.068, 526.408, 669.976), True, False, 28, 841.92, 595.32)"
28,"commonly recommended for severe cases. Furthermore, RNA synthesis inhibitors (like 3TC,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('commonly recommended for severe cases. Furthermore, RNA synthesis inhibitors (like 3TC,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.1040000000002, 654.856), True, False, 28, 841.92, 595.32)"
28,"TDF), remdesivir, neuraminidase inhibitors, peptide (EK1), anti-inflammatory drugs, abidol,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('TDF), remdesivir, neuraminidase inhibitors, peptide (EK1), anti-inflammatory drugs, abidol,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 526.396, 639.616), True, False, 28, 841.92, 595.32)"
28,"Chinese traditional medicine, such as Lianhuaqingwen and ShuFengJieDu Capsules, could be",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chinese traditional medicine, such as Lianhuaqingwen and ShuFengJieDu Capsules, could be', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 613.588, 526.092, 624.496), True, False, 28, 841.92, 595.32)"
28,"the promising drug treatment for COVID-19 (7). However, further clinical trials are required",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the promising drug treatment for COVID-19 (7). However, further clinical trials are required', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 598.3480000000001, 526.2020000000001, 609.2560000000001), True, False, 28, 841.92, 595.32)"
28,for  confirming  their  safety  and  efficacy  in  managing  the  COVID-19  infection.  The  major,0,0,0,0,0,0,0,0,0,0,0,0,0,"('for  confirming  their  safety  and  efficacy  in  managing  the  COVID-19  infection.  The  major', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 583.2280000000001, 526.342, 594.1360000000001), True, False, 28, 841.92, 595.32)"
28,limiting factor in the quest for identifying an ideal vaccine or therapeutic agent is time. It may,0,0,0,0,0,0,0,0,0,0,0,0,0,"('limiting factor in the quest for identifying an ideal vaccine or therapeutic agent is time. It may', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 567.958, 526.1399999999999, 578.866), True, False, 28, 841.92, 595.32)"
28,"take months to even several years for researchers to develop, produce, standardize, evaluate,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('take months to even several years for researchers to develop, produce, standardize, evaluate,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 552.838, 526.116, 563.746), True, False, 28, 841.92, 595.32)"
28,"approve, and commercialize specific therapeutic agents against COVID-19 infection. Hence,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('approve, and commercialize specific therapeutic agents against COVID-19 infection. Hence,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.5980000000001, 526.354, 548.5060000000001), True, False, 28, 841.92, 595.32)"
28,our  current  efforts  should  be  directed  towards  identifying  and  evaluating  therapeutic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('our  current  efforts  should  be  directed  towards  identifying  and  evaluating  therapeutic', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 522.4780000000001, 526.116, 533.3860000000001), True, False, 28, 841.92, 595.32)"
28,drugs/immunotherapeutic  agents  that  have  proven  efficacy  against  viral  agents  that  are,0,0,0,0,0,0,0,0,0,0,0,0,0,"('drugs/immunotherapeutic  agents  that  have  proven  efficacy  against  viral  agents  that  are', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 507.238, 526.1519999999998, 518.146), True, False, 28, 841.92, 595.32)"
28,"similar  toCOVID-19.  The  time  required  for  a  drug  discovery  program  to  develop,  evaluate,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('similar  toCOVID-19.  The  time  required  for  a  drug  discovery  program  to  develop,  evaluate,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 492.118, 526.42, 503.02599999999995), True, False, 28, 841.92, 595.32)"
28,and  obtain  approval  for  a  new  potent  antiviral  agent  against  COVID-19  should  take  more,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  obtain  approval  for  a  new  potent  antiviral  agent  against  COVID-19  should  take  more', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 476.87800000000004, 526.354, 487.786), True, False, 28, 841.92, 595.32)"
28,"than ten years (9). In the present scenario, the development of a new therapeutic agent against",0,0,0,0,0,0,0,0,0,0,0,0,0,"('than ten years (9). In the present scenario, the development of a new therapeutic agent against', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 461.75800000000004, 526.318, 472.666), True, False, 28, 841.92, 595.32)"
28,COVID-19 is not a feasible option for the available time.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19 is not a feasible option for the available time.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 446.51800000000003, 352.03, 457.426), True, False, 28, 841.92, 595.32)"
28,The COVID-19 patients showing severe signs are treated symptomatically along with,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The COVID-19 patients showing severe signs are treated symptomatically along with', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 425.398, 526.1000000000001, 436.306), True, False, 28, 841.92, 595.32)"
28,oxygen  therapy.  In  cases  where  the  patients  progress  to  respiratory  failure  and  become,0,0,0,0,0,0,0,0,0,0,0,0,0,"('oxygen  therapy.  In  cases  where  the  patients  progress  to  respiratory  failure  and  become', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 410.158, 526.42, 421.066), True, False, 28, 841.92, 595.32)"
28,"refractory  to  oxygen  therapy,  mechanical  ventilation  is  initiated.  The  COVID-19  induced",0,0,0,0,0,0,0,0,0,0,0,0,0,"('refractory  to  oxygen  therapy,  mechanical  ventilation  is  initiated.  The  COVID-19  induced', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 395.038, 526.384, 405.94599999999997), True, False, 28, 841.92, 595.32)"
28,septic  shock  can  be  managed  by  providing  adequate  hemodynamic  support  (304).  Several,0,0,0,0,0,0,0,0,0,0,0,0,0,"('septic  shock  can  be  managed  by  providing  adequate  hemodynamic  support  (304).  Several', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 379.778, 526.384, 390.686), True, False, 28, 841.92, 595.32)"
28,classes  of  drugs  are  currently  being  evaluated  for  their  potential  therapeutic  action  against,0,0,0,0,0,0,0,0,0,0,0,0,0,"('classes  of  drugs  are  currently  being  evaluated  for  their  potential  therapeutic  action  against', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 364.658, 526.384, 375.566), True, False, 28, 841.92, 595.32)"
28,"SARS-CoV-2. However, therapeutic agents that are having anti-SARS-CoV-2 activity can be",0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2. However, therapeutic agents that are having anti-SARS-CoV-2 activity can be', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 349.418, 526.336, 360.32599999999996), True, False, 28, 841.92, 595.32)"
28,broadly  classified into three categories;  drugs that  block the entry of  the  virus into  the host,0,0,0,0,0,0,0,0,0,0,0,0,0,"('broadly  classified into three categories;  drugs that  block the entry of  the  virus into  the host', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 334.298, 526.408, 345.20599999999996), True, False, 28, 841.92, 595.32)"
28,"cell, drugs that  block viral  replication as  well as  its  survival  within the host  cell, and drugs",0,0,0,0,0,0,0,0,0,0,0,0,0,"('cell, drugs that  block viral  replication as  well as  its  survival  within the host  cell, and drugs', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 319.058, 526.258, 329.96599999999995), True, False, 28, 841.92, 595.32)"
28,that attenuate the exaggerated host immune response (305).  Inflammatory cytokine storm  is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('that attenuate the exaggerated host immune response (305).  Inflammatory cytokine storm  is', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 303.938, 526.306, 314.84599999999995), True, False, 28, 841.92, 595.32)"
28,"commonly  seen in  critically ill  COVID-19 patients.  Hence, they may be benefited from  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('commonly  seen in  critically ill  COVID-19 patients.  Hence, they may be benefited from  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 288.69800000000004, 526.1780000000001, 299.606), True, False, 28, 841.92, 595.32)"
28,use  of  timely  anti-inflammation  treatment.  Anti-inflammatory  therapy  using  drug-like,0,0,0,0,0,0,0,0,0,0,0,0,0,"('use  of  timely  anti-inflammation  treatment.  Anti-inflammatory  therapy  using  drug-like', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 273.57800000000003, 526.408, 284.486), True, False, 28, 841.92, 595.32)"
28,"glucocorticoids,  cytokine  inhibitors,  JAK  inhibitors,  and  chloroquine/hydroxychloroquine",0,0,0,0,0,0,0,0,0,0,0,0,0,"('glucocorticoids,  cytokine  inhibitors,  JAK  inhibitors,  and  chloroquine/hydroxychloroquine', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 258.338, 526.408, 269.246), True, False, 28, 841.92, 595.32)"
28,should  be  done  only  after  analyzing  the  risk  and  benefit  ratio  in  COVID-19  patients  (306).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('should  be  done  only  after  analyzing  the  risk  and  benefit  ratio  in  COVID-19  patients  (306).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 243.218, 526.42, 254.126), True, False, 28, 841.92, 595.32)"
28,There have not been any studies regarding the use of non-steroidal anti-inflammatory drugs,0,0,0,0,0,0,0,0,0,0,0,0,0,"('There have not been any studies regarding the use of non-steroidal anti-inflammatory drugs', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 227.97799999999998, 526.378, 238.886), True, False, 28, 841.92, 595.32)"
28,"(NSAID)  among  COVID-19  infected  patients.  However,  reasonable  pieces  of  evidence  are",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(NSAID)  among  COVID-19  infected  patients.  However,  reasonable  pieces  of  evidence  are', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 212.82799999999997, 526.3960000000001, 223.736), True, False, 28, 841.92, 595.32)"
28,available that link NSAID uses with the occurrence of respiratory and cardiovascular adverse,0,0,0,0,0,0,0,0,0,0,0,0,0,"('available that link NSAID uses with the occurrence of respiratory and cardiovascular adverse', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 197.588, 526.178, 208.496), True, False, 28, 841.92, 595.32)"
28,"effects. Hence, as a cautionary approach, it is better to recommend the use of NSAIDs as the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('effects. Hence, as a cautionary approach, it is better to recommend the use of NSAIDs as the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 182.468, 526.282, 193.376), True, False, 28, 841.92, 595.32)"
28,first-line  option  for  managing  COVID-19  symptoms  (307).  The  use  of  corticosteroids  in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('first-line  option  for  managing  COVID-19  symptoms  (307).  The  use  of  corticosteroids  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 167.22799999999998, 526.294, 178.136), True, False, 28, 841.92, 595.32)"
28,COVID-19  patients  is  still  a  matter  of  controversy  and  requires  further  systematic  clinical,0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19  patients  is  still  a  matter  of  controversy  and  requires  further  systematic  clinical', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 152.10799999999998, 526.342, 163.016), True, False, 28, 841.92, 595.32)"
28,studies.  The  guideline  that  was  put  forward  to  manage  critically  ill  adults  with  COVID-19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('studies.  The  guideline  that  was  put  forward  to  manage  critically  ill  adults  with  COVID-19', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 136.868, 526.4200000000001, 147.776), True, False, 28, 841.92, 595.32)"
28,suggests  the  use  of  systemic  corticosteroids  in  mechanically  ventilated  adults  with  acute,0,0,0,0,0,0,0,0,0,0,0,0,0,"('suggests  the  use  of  systemic  corticosteroids  in  mechanically  ventilated  adults  with  acute', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 121.748, 526.25, 132.656), True, False, 28, 841.92, 595.32)"
28,respiratory  distress  syndrome  (ARDS)  (308).  The  generalized  use  of  corticosteroids  is  not,0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory  distress  syndrome  (ARDS)  (308).  The  generalized  use  of  corticosteroids  is  not', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 106.508, 526.396, 117.416), True, False, 28, 841.92, 595.32)"
28,indicated  in  COVID-19  since  there  are  some  concerns  associated  with  the  use  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('indicated  in  COVID-19  since  there  are  some  concerns  associated  with  the  use  of', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 91.392, 526.1, 102.3), True, False, 28, 841.92, 595.32)"
28,corticosteroids in viral pneumonia. Stem cell therapy using mesenchymal stem cells (MSCs),0,0,0,0,0,0,0,0,0,0,0,0,0,"('corticosteroids in viral pneumonia. Stem cell therapy using mesenchymal stem cells (MSCs)', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 76.152, 526.2260000000001, 87.06), True, False, 28, 841.92, 595.32)"
28,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 28, 841.92, 595.32)"
28,27,0,0,0,0,0,0,0,0,0,0,0,0,0,"('27', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 28, 841.92, 595.32)"
29,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 29, 841.92, 595.32)"
29,is  another  promising  strategy  that  can  be  used  in  the  clinical  cases  of  COVID-19  owing  to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('is  another  promising  strategy  that  can  be  used  in  the  clinical  cases  of  COVID-19  owing  to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.384, 767.076), True, False, 29, 841.92, 595.32)"
29,their  potential  immunomodulatory  capacity.  It  may  have  a  beneficial  role  in  attenuating  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('their  potential  immunomodulatory  capacity.  It  may  have  a  beneficial  role  in  attenuating  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.2940000000001, 751.936), True, False, 29, 841.92, 595.32)"
29,"cytokine  storm  that  is  observed  in  the  severe  cases  of  SARS-CoV-2  infection,  thereby",0,0,0,0,0,0,0,0,0,0,0,0,0,"('cytokine  storm  that  is  observed  in  the  severe  cases  of  SARS-CoV-2  infection,  thereby', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.396, 736.696), True, False, 29, 841.92, 595.32)"
29,"reducing  the  mortality.  Among  the  different  types  of  MSCs,  expanded  umbilical  cord",0,0,0,0,0,0,0,0,0,0,0,0,0,"('reducing  the  mortality.  Among  the  different  types  of  MSCs,  expanded  umbilical  cord', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 526.2860000000001, 721.576), True, False, 29, 841.92, 595.32)"
29,mesenchymal  stem  cells  can  be  considered  as  a  potential  therapeutic  agent  that  requires,0,0,0,0,0,0,0,0,0,0,0,0,0,"('mesenchymal  stem  cells  can  be  considered  as  a  potential  therapeutic  agent  that  requires', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 526.1279999999998, 706.336), True, False, 29, 841.92, 595.32)"
29,further validation for managing critically ill COVID-19 patients (309).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('further validation for managing critically ill COVID-19 patients (309).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 680.308, 414.07, 691.216), True, False, 29, 841.92, 595.32)"
29,Another option is to repurpose broadly acting anti-viral drugs that have already been,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Another option is to repurpose broadly acting anti-viral drugs that have already been', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 659.068, 526.408, 669.976), True, False, 29, 841.92, 595.32)"
29,"used  for  other  viral  infections.  Such  drugs  have  the  advantage  of  easy  availability,  known",0,0,0,0,0,0,0,0,0,0,0,0,0,"('used  for  other  viral  infections.  Such  drugs  have  the  advantage  of  easy  availability,  known', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.1039999999999, 654.856), True, False, 29, 841.92, 595.32)"
29,"pharmacokinetic and pharmacodynamic properties, solubility, stability, side effects, and also",0,0,0,0,0,0,0,0,0,0,0,0,0,"('pharmacokinetic and pharmacodynamic properties, solubility, stability, side effects, and also', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 526.3720000000001, 639.616), True, False, 29, 841.92, 595.32)"
29,well-established dosing regimens (9). Repurposed drugs are potential therapeutic options for,0,0,0,0,0,0,0,0,0,0,0,0,0,"('well-established dosing regimens (9). Repurposed drugs are potential therapeutic options for', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 613.588, 526.2140000000002, 624.496), True, False, 29, 841.92, 595.32)"
29,the management of coronavirus infections. The repurposed drugs like lopinavir/ritonavir and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the management of coronavirus infections. The repurposed drugs like lopinavir/ritonavir and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 598.3480000000001, 526.0920000000001, 609.2560000000001), True, False, 29, 841.92, 595.32)"
29,interferon-1β  possess  in  vitro  anti-MERS-CoV  activity.  The  in  vivo  study  conducted  in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('interferon-1β  possess  in  vitro  anti-MERS-CoV  activity.  The  in  vivo  study  conducted  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 583.2280000000001, 526.342, 594.148), False, False, 29, 841.92, 595.32)"
29,common  marmosets  (non-human  primate  model)  identified  that  the  animals  treated  with,0,0,0,0,0,0,0,0,0,0,0,0,0,"('common  marmosets  (non-human  primate  model)  identified  that  the  animals  treated  with', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 567.958, 526.202, 578.866), True, False, 29, 841.92, 595.32)"
29,lopinavir/ritonavir and interferon-beta had better outcomes compared to the untreated animals,0,0,0,0,0,0,0,0,0,0,0,0,0,"('lopinavir/ritonavir and interferon-beta had better outcomes compared to the untreated animals', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 552.838, 526.282, 563.746), True, False, 29, 841.92, 595.32)"
29,(190). The combination of lopinavir-ritonavir and interferon-beta is currently being evaluated,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(190). The combination of lopinavir-ritonavir and interferon-beta is currently being evaluated', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.5980000000001, 526.2940000000001, 548.5060000000001), True, False, 29, 841.92, 595.32)"
29,for  the  treatment  of  MERS  in  humans  (MIRACLE  trial)  (191).  The  same  two  protease,0,0,0,0,0,0,0,0,0,0,0,0,0,"('for  the  treatment  of  MERS  in  humans  (MIRACLE  trial)  (191).  The  same  two  protease', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 522.4780000000001, 526.318, 533.3860000000001), True, False, 29, 841.92, 595.32)"
29,"inhibitors lopinavir and ritonavir, when combined with another drug ribavirin, were found to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('inhibitors lopinavir and ritonavir, when combined with another drug ribavirin, were found to', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 507.238, 526.396, 518.146), True, False, 29, 841.92, 595.32)"
29,be  associated  with  favorable  clinical  response  in  SARS  patients  indicating  therapeutic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('be  associated  with  favorable  clinical  response  in  SARS  patients  indicating  therapeutic', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 492.118, 526.112, 503.02599999999995), True, False, 29, 841.92, 595.32)"
29,"efficacy (165). However, in the present scenario, due to the lack of specific therapeutic agents",0,0,0,0,0,0,0,0,0,0,0,0,0,"('efficacy (165). However, in the present scenario, due to the lack of specific therapeutic agents', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 476.87800000000004, 526.42, 487.786), True, False, 29, 841.92, 595.32)"
29,"against  SARS-CoV-2,  the  hospitalized  patients  confirmed  for  the  disease  will  receive",0,0,0,0,0,0,0,0,0,0,0,0,0,"('against  SARS-CoV-2,  the  hospitalized  patients  confirmed  for  the  disease  will  receive', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 461.75800000000004, 526.1599999999999, 472.666), True, False, 29, 841.92, 595.32)"
29,supportive  care  like  oxygen  therapy  and  fluid  therapy  along  with  the  antibiotic  therapy  for,0,0,0,0,0,0,0,0,0,0,0,0,0,"('supportive  care  like  oxygen  therapy  and  fluid  therapy  along  with  the  antibiotic  therapy  for', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 446.51800000000003, 526.0999999999999, 457.426), True, False, 29, 841.92, 595.32)"
29,managing secondary bacterial infections (192).Patients with novel coronavirus or COVID-19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('managing secondary bacterial infections (192).Patients with novel coronavirus or COVID-19', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 431.398, 526.408, 442.306), True, False, 29, 841.92, 595.32)"
29,"pneumonia  who  are  mechanically  ventilated  often  require  sedatives,  analgesics,  and  even",0,0,0,0,0,0,0,0,0,0,0,0,0,"('pneumonia  who  are  mechanically  ventilated  often  require  sedatives,  analgesics,  and  even', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 416.158, 526.342, 427.066), True, False, 29, 841.92, 595.32)"
29,muscle  relaxation  drugs  to  prevent  ventilator-related  lung  injury  associated  with  human-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('muscle  relaxation  drugs  to  prevent  ventilator-related  lung  injury  associated  with  human-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 401.038, 523.336, 411.94599999999997), True, False, 29, 841.92, 595.32)"
29,machine  incoordination  (122).  The  result  obtained  from  a  clinical  study  containing  four,0,0,0,0,0,0,0,0,0,0,0,0,0,"('machine  incoordination  (122).  The  result  obtained  from  a  clinical  study  containing  four', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 385.778, 526.2260000000001, 396.686), True, False, 29, 841.92, 595.32)"
29,"patients infected with COVID-19 claimed that combination therapy using lopinavir/ritonavir,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients infected with COVID-19 claimed that combination therapy using lopinavir/ritonavir,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 370.658, 526.2740000000001, 381.566), True, False, 29, 841.92, 595.32)"
29,"arbidol, and ShufengJiedu Capsule (Traditional Chinese medicine) was found to be effective",0,0,0,0,0,0,0,0,0,0,0,0,0,"('arbidol, and ShufengJiedu Capsule (Traditional Chinese medicine) was found to be effective', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 355.418, 526.056, 366.32599999999996), True, False, 29, 841.92, 595.32)"
29,in managing COVID-19 pneumonia (193). It is difficult to evaluate the therapeutic potential,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in managing COVID-19 pneumonia (193). It is difficult to evaluate the therapeutic potential', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 340.298, 526.1900000000002, 351.20599999999996), True, False, 29, 841.92, 595.32)"
29,of a drug or a combination of drugs for managing a disease based on such a low and limited,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of a drug or a combination of drugs for managing a disease based on such a low and limited', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 325.058, 526.1120000000001, 335.96599999999995), True, False, 29, 841.92, 595.32)"
29,"sample size. Before choosing the ideal therapeutic agent for the management of COVID-19,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('sample size. Before choosing the ideal therapeutic agent for the management of COVID-19,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 309.938, 526.42, 320.84599999999995), True, False, 29, 841.92, 595.32)"
29,randomized clinical control studies should be performed with a sufficient study population.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('randomized clinical control studies should be performed with a sufficient study population.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 294.69800000000004, 513.1, 305.606), True, False, 29, 841.92, 595.32)"
29,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 273.57800000000003, 75.024, 284.29400000000004), True, False, 29, 841.92, 595.32)"
29,Antiviral drugs,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Antiviral drugs', 'TimesNewRomanPS-BoldMT', 10.716000000000037, (72.024, 252.338, 153.98, 263.05400000000003), True, False, 29, 841.92, 595.32)"
29,Several  classes  of  routinely  used  antiviral  drugs  like  oseltamivir  (neuraminidase,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Several  classes  of  routinely  used  antiviral  drugs  like  oseltamivir  (neuraminidase', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 231.218, 526.148, 242.126), True, False, 29, 841.92, 595.32)"
29,"inhibitors), acyclovir, ganciclovir, and ribavirin does not have any effect on  COVID-19 and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('inhibitors), acyclovir, ganciclovir, and ribavirin does not have any effect on  COVID-19 and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 215.97799999999998, 526.408, 226.886), True, False, 29, 841.92, 595.32)"
29,hence  not  recommended  (187).  Oral  administration  of  neuraminidase  inhibitors  such  as,0,0,0,0,0,0,0,0,0,0,0,0,0,"('hence  not  recommended  (187).  Oral  administration  of  neuraminidase  inhibitors  such  as', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 200.82799999999997, 526.2260000000001, 211.736), True, False, 29, 841.92, 595.32)"
29,oseltamivir has been widely used as an experimental drug for COVID-19 suspected cases in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('oseltamivir has been widely used as an experimental drug for COVID-19 suspected cases in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 185.588, 526.33, 196.496), True, False, 29, 841.92, 595.32)"
29,"the hospitals of China even though  there is  no evidence of its efficacy  (7). Recently, the in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the hospitals of China even though  there is  no evidence of its efficacy  (7). Recently, the in', 'TimesNewRomanPSMT', 10.920000000000016, (72.024, 170.468, 526.408, 181.388), False, False, 29, 841.92, 595.32)"
29,"vitro  antiviral  efficacy  of  FAD-approved  drugs  such  as  ribavirin,  penciclovir,  nitazoxanide,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('vitro  antiviral  efficacy  of  FAD-approved  drugs  such  as  ribavirin,  penciclovir,  nitazoxanide,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 155.22799999999998, 526.2620000000001, 166.148), False, False, 29, 841.92, 595.32)"
29,"nafamostat,  and  chloroquine  were  compared  with  that  of  the  two  broad-spectrum  antiviral",0,0,0,0,0,0,0,0,0,0,0,0,0,"('nafamostat,  and  chloroquine  were  compared  with  that  of  the  two  broad-spectrum  antiviral', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 140.10799999999998, 526.3539999999999, 151.016), True, False, 29, 841.92, 595.32)"
29,"drugs remdesivir and favipiravir against the SARS-CoV-2. Among the evaluated drugs, both",0,0,0,0,0,0,0,0,0,0,0,0,0,"('drugs remdesivir and favipiravir against the SARS-CoV-2. Among the evaluated drugs, both', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 124.868, 526.384, 135.77599999999998), True, False, 29, 841.92, 595.32)"
29,remdesivir  and  chloroquine  were  found  to  be  highly  effective  in  controlling  COVID-19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('remdesivir  and  chloroquine  were  found  to  be  highly  effective  in  controlling  COVID-19', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 109.748, 526.42, 120.656), True, False, 29, 841.92, 595.32)"
29,infection in vitro (194). The study also pointed out that the three nucleoside analogs such as,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infection in vitro (194). The study also pointed out that the three nucleoside analogs such as', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 94.512, 526.3960000000001, 105.432), False, False, 29, 841.92, 595.32)"
29,"ribavirin, penciclovir, and favipiravir may not have significant in vivo antiviral effects against",0,0,0,0,0,0,0,0,0,0,0,0,0,"('ribavirin, penciclovir, and favipiravir may not have significant in vivo antiviral effects against', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 79.392, 526.306, 90.312), False, False, 29, 841.92, 595.32)"
29,SARS-CoV-2 since higher concentrations were required to reduce the viral infection in vitro.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2 since higher concentrations were required to reduce the viral infection in vitro.', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 64.152, 526.42, 75.072), False, False, 29, 841.92, 595.32)"
29,28,0,0,0,0,0,0,0,0,0,0,0,0,0,"('28', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 29, 841.92, 595.32)"
29,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 29, 841.92, 595.32)"
30,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 30, 841.92, 595.32)"
30,Both  remdesivir  and  chloroquine  are  currently  being  used  in  humans  for  the  treatment  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Both  remdesivir  and  chloroquine  are  currently  being  used  in  humans  for  the  treatment  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.1640000000001, 767.076), True, False, 30, 841.92, 595.32)"
30,"other  diseases.  They  also  have  a  well-defined  safety  profile  in  human  beings.  Hence,  such",0,0,0,0,0,0,0,0,0,0,0,0,0,"('other  diseases.  They  also  have  a  well-defined  safety  profile  in  human  beings.  Hence,  such', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.214, 751.936), True, False, 30, 841.92, 595.32)"
30,drugs can be used for evaluating their efficacy in patients of novel coronavirus infections.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('drugs can be used for evaluating their efficacy in patients of novel coronavirus infections.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 505.66, 736.696), True, False, 30, 841.92, 595.32)"
30,"Although no antiviral drugs have been approved for the treatment, several therapeutic",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Although no antiviral drugs have been approved for the treatment, several therapeutic', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 704.668, 526.0879999999999, 715.576), True, False, 30, 841.92, 595.32)"
30,"agents  such  as  lopinavir/ritonavir,  chloroquine,  and  hydroxychloroquine  are  being  proposed",0,0,0,0,0,0,0,0,0,0,0,0,0,"('agents  such  as  lopinavir/ritonavir,  chloroquine,  and  hydroxychloroquine  are  being  proposed', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 689.428, 526.408, 700.336), True, False, 30, 841.92, 595.32)"
30,for the clinical management of COVID-19 (304). The molecular docking study conducted in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('for the clinical management of COVID-19 (304). The molecular docking study conducted in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 674.308, 526.282, 685.216), True, False, 30, 841.92, 595.32)"
30,the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 using different commercially,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 using different commercially', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 659.068, 526.2940000000001, 669.976), True, False, 30, 841.92, 595.32)"
30,"available  anti-polymerase  drugs  identified  that  the  drugs  such  as  Ribavirin,  Remdesivir,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('available  anti-polymerase  drugs  identified  that  the  drugs  such  as  Ribavirin,  Remdesivir,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.1840000000001, 654.856), True, False, 30, 841.92, 595.32)"
30,"Galidesivir,  Tenofovir,  and  Sofosbuvir  were  found  to  bind  RdRp  tightly  indicating  a  great",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Galidesivir,  Tenofovir,  and  Sofosbuvir  were  found  to  bind  RdRp  tightly  indicating  a  great', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 526.384, 639.616), True, False, 30, 841.92, 595.32)"
30,potential  to  be  used  as  a  therapeutic  agent  against  COVID-19  (310).  The  broad-spectrum,0,0,0,0,0,0,0,0,0,0,0,0,0,"('potential  to  be  used  as  a  therapeutic  agent  against  COVID-19  (310).  The  broad-spectrum', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 613.588, 526.396, 624.496), True, False, 30, 841.92, 595.32)"
30,"antiviral drug that was developed in the USA, Tilorone dihydrochloride (Tilorone), has been",0,0,0,0,0,0,0,0,0,0,0,0,0,"('antiviral drug that was developed in the USA, Tilorone dihydrochloride (Tilorone), has been', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 598.3480000000001, 526.384, 609.2560000000001), True, False, 30, 841.92, 595.32)"
30,"previously  found  to  possess  potent  antiviral  activity  against  MERS,  Marburg,  Ebola,  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('previously  found  to  possess  potent  antiviral  activity  against  MERS,  Marburg,  Ebola,  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 583.2280000000001, 526.202, 594.1360000000001), True, False, 30, 841.92, 595.32)"
30,"Chikungunya  (311).  Even  though  it  had  broad-spectrum  activity,  it  was  neglected  for  an",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chikungunya  (311).  Even  though  it  had  broad-spectrum  activity,  it  was  neglected  for  an', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 567.958, 526.42, 578.866), True, False, 30, 841.92, 595.32)"
30,extended  period.  Tilorone  is  another  antiviral  drug  that  might  have  activity  against  SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('extended  period.  Tilorone  is  another  antiviral  drug  that  might  have  activity  against  SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 552.838, 523.696, 563.746), True, False, 30, 841.92, 595.32)"
30,CoV-2.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.5980000000001, 110.66, 548.5060000000001), True, False, 30, 841.92, 595.32)"
30,"Remdesivir,  a  novel  nucleotide  analog  prodrug,  was  developed  for  the  treatment  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Remdesivir,  a  novel  nucleotide  analog  prodrug,  was  developed  for  the  treatment  of', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 516.4780000000001, 526.2620000000002, 527.3860000000001), True, False, 30, 841.92, 595.32)"
30,"Ebola  virus  disease  (EVD),  and  it  was  also  found  to  inhibit  replication  of  SARS-CoV  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Ebola  virus  disease  (EVD),  and  it  was  also  found  to  inhibit  replication  of  SARS-CoV  and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 501.238, 526.396, 512.146), True, False, 30, 841.92, 595.32)"
30,"MERS-CoV in primary human airway epithelial cell culture system (195). Recently, in vitro",0,0,0,0,0,0,0,0,0,0,0,0,0,"('MERS-CoV in primary human airway epithelial cell culture system (195). Recently, in vitro', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 486.118, 526.42, 497.03799999999995), False, False, 30, 841.92, 595.32)"
30,study  has  proven  that  remdesivir  has  superior  antiviral  activity  than lopinavir  and  ritonavir.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('study  has  proven  that  remdesivir  has  superior  antiviral  activity  than lopinavir  and  ritonavir.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 470.87800000000004, 526.1399999999999, 481.786), True, False, 30, 841.92, 595.32)"
30,"Further,  in  vivo  studies  conducted  in  mice  also  identified  that  treatment  with  remdesivir",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Further,  in  vivo  studies  conducted  in  mice  also  identified  that  treatment  with  remdesivir', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 455.75800000000004, 526.184, 466.678), False, False, 30, 841.92, 595.32)"
30,improved  pulmonary  function  and  reduced  viral  loads  and  lung  pathology  both  in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('improved  pulmonary  function  and  reduced  viral  loads  and  lung  pathology  both  in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 440.51800000000003, 526.408, 451.426), True, False, 30, 841.92, 595.32)"
30,prophylactic  and  therapeutic  regimens  compared  to  lopinavir/ritonavir-IFN-γ  treatment  in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('prophylactic  and  therapeutic  regimens  compared  to  lopinavir/ritonavir-IFN-γ  treatment  in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 425.398, 526.36, 436.306), True, False, 30, 841.92, 595.32)"
30,"MERS-CoV  infection  (8).  Remdesivir  also  inhibits  a  diverse  range  of  coronaviruses,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('MERS-CoV  infection  (8).  Remdesivir  also  inhibits  a  diverse  range  of  coronaviruses,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 410.158, 526.42, 421.066), True, False, 30, 841.92, 595.32)"
30,"including circulating human CoV, zoonotic bat CoV, and pre-pandemic zoonotic CoV (195).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('including circulating human CoV, zoonotic bat CoV, and pre-pandemic zoonotic CoV (195).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 395.038, 526.408, 405.94599999999997), True, False, 30, 841.92, 595.32)"
30,Remdesivir  is  also  considered  as  the  only  therapeutic  drug  that  significantly  reduces,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Remdesivir  is  also  considered  as  the  only  therapeutic  drug  that  significantly  reduces', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 379.778, 526.0799999999999, 390.686), True, False, 30, 841.92, 595.32)"
30,pulmonary  pathology  (8).  All  these  findings  indicate  that  the  drug  remdesivir  has  to  be,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pulmonary  pathology  (8).  All  these  findings  indicate  that  the  drug  remdesivir  has  to  be', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 364.658, 526.226, 375.566), True, False, 30, 841.92, 595.32)"
30,further  evaluated  for  its  efficacy  in  the  treatment  of  COVID-19  infection  in  humans.  The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('further  evaluated  for  its  efficacy  in  the  treatment  of  COVID-19  infection  in  humans.  The', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 349.418, 526.306, 360.32599999999996), True, False, 30, 841.92, 595.32)"
30,broad-spectrum activity exhibited by remdesivir will help control the spread of disease in the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('broad-spectrum activity exhibited by remdesivir will help control the spread of disease in the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 334.298, 526.282, 345.20599999999996), True, False, 30, 841.92, 595.32)"
30,event of a new coronavirus outbreak.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('event of a new coronavirus outbreak.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 319.058, 253.01, 329.96599999999995), True, False, 30, 841.92, 595.32)"
30,Chloroquine  is  an  anti-malarial  drug  known  to  possess  antiviral  activity  due  to  its,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chloroquine  is  an  anti-malarial  drug  known  to  possess  antiviral  activity  due  to  its', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 297.938, 526.1780000000002, 308.84599999999995), True, False, 30, 841.92, 595.32)"
30,ability  to  block  virus-cell  fusion  by  raising  the  endosomal  pH  necessary  for  fusion.  It  also,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ability  to  block  virus-cell  fusion  by  raising  the  endosomal  pH  necessary  for  fusion.  It  also', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 282.69800000000004, 526.342, 293.606), True, False, 30, 841.92, 595.32)"
30,interferes  with  the  virus-receptor  binding  by  interfering  with  the  terminal  glycosylation  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('interferes  with  the  virus-receptor  binding  by  interfering  with  the  terminal  glycosylation  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 267.57800000000003, 526.1900000000002, 278.486), True, False, 30, 841.92, 595.32)"
30,"SARS-CoV  cellular  receptors,  angiotensin-converting  enzyme  2  (ACE2)  (196).  In  a  recent",0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV  cellular  receptors,  angiotensin-converting  enzyme  2  (ACE2)  (196).  In  a  recent', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 252.338, 526.396, 263.246), True, False, 30, 841.92, 595.32)"
30,"multicentre  clinical  trial  that  was  conducted  in  China,  chloroquine  phosphate  was  found  to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('multicentre  clinical  trial  that  was  conducted  in  China,  chloroquine  phosphate  was  found  to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 237.218, 526.1279999999999, 248.126), True, False, 30, 841.92, 595.32)"
30,exhibit  both  efficacy  and  safety  in  the  therapeutic  management  of  SARS-CoV-2  associated,0,0,0,0,0,0,0,0,0,0,0,0,0,"('exhibit  both  efficacy  and  safety  in  the  therapeutic  management  of  SARS-CoV-2  associated', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 221.97799999999998, 526.4440000000001, 232.886), True, False, 30, 841.92, 595.32)"
30,pneumonia  (197).  This  drug  is  already  included  in  the  treatment  guidelines  issued  by  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pneumonia  (197).  This  drug  is  already  included  in  the  treatment  guidelines  issued  by  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 206.82799999999997, 526.2940000000001, 217.736), True, False, 30, 841.92, 595.32)"
30,National  Health  Commission  of  the  People's  Republic  of  China.  The  preliminary  clinical,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""National  Health  Commission  of  the  People's  Republic  of  China.  The  preliminary  clinical"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 191.588, 526.306, 202.496), True, False, 30, 841.92, 595.32)"
30,"trials  using  hydroxychloroquine,  another  aminoquinoline  drug,  gave  promising  results.  The",0,0,0,0,0,0,0,0,0,0,0,0,0,"('trials  using  hydroxychloroquine,  another  aminoquinoline  drug,  gave  promising  results.  The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 176.468, 526.294, 187.376), True, False, 30, 841.92, 595.32)"
30,COVID-19 patients received 600 mg of hydroxychloroquine daily along with azithromycin as,0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19 patients received 600 mg of hydroxychloroquine daily along with azithromycin as', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 161.22799999999998, 526.42, 172.136), True, False, 30, 841.92, 595.32)"
30,a single-arm protocol. This protocol was found to be associated with  a significant reduction,0,0,0,0,0,0,0,0,0,0,0,0,0,"('a single-arm protocol. This protocol was found to be associated with  a significant reduction', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 146.10799999999998, 526.354, 157.016), True, False, 30, 841.92, 595.32)"
30,"in the viral load. Finally, it resulted in a complete cure (275) --however, the study comprised",0,0,0,0,0,0,0,0,0,0,0,0,0,"('in the viral load. Finally, it resulted in a complete cure (275) --however, the study comprised', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 130.868, 526.378, 141.776), True, False, 30, 841.92, 595.32)"
30,"a small population and hence the possibility of a misinterpretation. However, in another case",0,0,0,0,0,0,0,0,0,0,0,0,0,"('a small population and hence the possibility of a misinterpretation. However, in another case', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 115.748, 526.1, 126.656), True, False, 30, 841.92, 595.32)"
30,"study, the authors had raised concerns over the efficacy of hydroxychloroquine-azithromycin",0,0,0,0,0,0,0,0,0,0,0,0,0,"('study, the authors had raised concerns over the efficacy of hydroxychloroquine-azithromycin', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 100.508, 526.396, 111.416), True, False, 30, 841.92, 595.32)"
30,in the treatment of COVID-19 patients since no observable effect was seen when they were,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in the treatment of COVID-19 patients since no observable effect was seen when they were', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 85.392, 526.2019999999999, 96.3), True, False, 30, 841.92, 595.32)"
30,"used.  In  some  cases,  the  treatment  was  discontinued  due  to  the  prolongation  of  the  QT",0,0,0,0,0,0,0,0,0,0,0,0,0,"('used.  In  some  cases,  the  treatment  was  discontinued  due  to  the  prolongation  of  the  QT', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 70.152, 526.136, 81.06), True, False, 30, 841.92, 595.32)"
30,29,0,0,0,0,0,0,0,0,0,0,0,0,0,"('29', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 30, 841.92, 595.32)"
30,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 30, 841.92, 595.32)"
31,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 31, 841.92, 595.32)"
31,interval  (312).  Hence  further  randomized  clinical  trials  are  required  before  concluding  this,0,0,0,0,0,0,0,0,0,0,0,0,0,"('interval  (312).  Hence  further  randomized  clinical  trials  are  required  before  concluding  this', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.408, 767.076), True, False, 31, 841.92, 595.32)"
31,matter.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('matter.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 108.62, 751.936), True, False, 31, 841.92, 595.32)"
31,"Recently,  another  FDA  approved  drug  ivermectin  was  found  to  inhibit  the  in  vitro",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Recently,  another  FDA  approved  drug  ivermectin  was  found  to  inhibit  the  in  vitro', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 719.788, 526.432, 730.696), True, False, 31, 841.92, 595.32)"
31,replication of SARS-CoV-2.  The findings from this study indicate that a single treatment of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('replication of SARS-CoV-2.  The findings from this study indicate that a single treatment of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 704.668, 526.154, 715.576), True, False, 31, 841.92, 595.32)"
31,this drug was able to induce a ~5000-fold reduction in the viral RNA at 48h in cell culture.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('this drug was able to induce a ~5000-fold reduction in the viral RNA at 48h in cell culture.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 689.116, 526.19, 701.116), False, False, 31, 841.92, 595.32)"
31,"(313). In the coming days, further, in vivo studies will give an insight into the clinical utility",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(313). In the coming days, further, in vivo studies will give an insight into the clinical utility', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 673.948, 526.3299999999999, 684.8679999999999), False, False, 31, 841.92, 595.32)"
31,of this wonder drug.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of this wonder drug.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 658.828, 172.34, 669.736), True, False, 31, 841.92, 595.32)"
31,Nafamostat  is  a  potent  inhibitor  of  MERS-CoV  that  acts  by  preventing  membrane,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Nafamostat  is  a  potent  inhibitor  of  MERS-CoV  that  acts  by  preventing  membrane', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 637.588, 526.294, 648.496), True, False, 31, 841.92, 595.32)"
31,"fusion.  Nevertheless,  it  does  not  have  any  sorts  of  inhibitory  action  against  SARS-CoV-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('fusion.  Nevertheless,  it  does  not  have  any  sorts  of  inhibitory  action  against  SARS-CoV-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 622.468, 523.456, 633.376), True, False, 31, 841.92, 595.32)"
31,"2infection (194). Recently, several newly synthesized halogenated triazole compounds were",0,0,0,0,0,0,0,0,0,0,0,0,0,"('2infection (194). Recently, several newly synthesized halogenated triazole compounds were', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 607.2280000000001, 526.0759999999999, 618.1360000000001), True, False, 31, 841.92, 595.32)"
31,evaluated  using  fluorescence  resonance  energy  transfer  (FRET)  based  helicase  assays  for,0,0,0,0,0,0,0,0,0,0,0,0,0,"('evaluated  using  fluorescence  resonance  energy  transfer  (FRET)  based  helicase  assays  for', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 592.1080000000001, 526.1039999999998, 603.0160000000001), True, False, 31, 841.92, 595.32)"
31,their ability to inhibit helicase activity.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('their ability to inhibit helicase activity.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 576.868, 264.05, 587.7760000000001), True, False, 31, 841.92, 595.32)"
31,Among,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Among', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 555.718, 147.01999999999998, 566.626), True, False, 31, 841.92, 595.32)"
31,"the  evaluated  compounds,  4-(cyclopent-1-en-3-ylamino)-5-(2-(4-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  evaluated  compounds,  4-(cyclopent-1-en-3-ylamino)-5-(2-(4-', 'TimesNewRomanPSMT', 10.908000000000015, (162.728, 555.718, 523.216, 566.626), True, False, 31, 841.92, 595.32)"
31,"iodophenyl)hydrazinyl)-4H-1,2,4-triazole-3-thiol  and  4-(cyclopent-1-en-3-ylamino)-5-[2-(4-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('iodophenyl)hydrazinyl)-4H-1,2,4-triazole-3-thiol  and  4-(cyclopent-1-en-3-ylamino)-5-[2-(4-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 540.4780000000001, 523.456, 551.3860000000001), True, False, 31, 841.92, 595.32)"
31,"chlorophenyl)hydrazinyl]-4H-1,2,4-triazole-3-thiolwere  found  to  be  the  most  potent.  These",0,0,0,0,0,0,0,0,0,0,0,0,0,"('chlorophenyl)hydrazinyl]-4H-1,2,4-triazole-3-thiolwere  found  to  be  the  most  potent.  These', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 525.3580000000001, 526.2620000000001, 536.2660000000001), True, False, 31, 841.92, 595.32)"
31,"compounds were used for in silico studies, and molecular docking was accomplished into the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('compounds were used for in silico studies, and molecular docking was accomplished into the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 510.11800000000005, 526.282, 521.0260000000001), True, False, 31, 841.92, 595.32)"
31,active  binding  site  of  MERS-CoV  helicase  nsp13  (21).  Further  studies  are  required  for,0,0,0,0,0,0,0,0,0,0,0,0,0,"('active  binding  site  of  MERS-CoV  helicase  nsp13  (21).  Further  studies  are  required  for', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 494.998, 526.2700000000001, 505.90599999999995), True, False, 31, 841.92, 595.32)"
31,evaluating the therapeutic potential of these newly identified compounds in the management,0,0,0,0,0,0,0,0,0,0,0,0,0,"('evaluating the therapeutic potential of these newly identified compounds in the management', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 479.75800000000004, 526.152, 490.666), True, False, 31, 841.92, 595.32)"
31,of COVID-19 infection.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of COVID-19 infection.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 464.63800000000003, 193.73, 475.546), True, False, 31, 841.92, 595.32)"
31,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 443.398, 75.024, 454.11400000000003), True, False, 31, 841.92, 595.32)"
31,Passive immunization/ Antibody therapy/ Monoclonal antibody (mAb),0,0,0,0,0,0,0,0,0,0,0,0,0,"('Passive immunization/ Antibody therapy/ Monoclonal antibody (mAb)', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 422.278, 435.67, 432.994), True, False, 31, 841.92, 595.32)"
31,Monoclonal antibodies (mAbs) may be helpful in the intervention of disease in CoV,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Monoclonal antibodies (mAbs) may be helpful in the intervention of disease in CoV', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 401.038, 526.294, 411.94599999999997), True, False, 31, 841.92, 595.32)"
31,exposed  individuals.  Patients  recovering  from  SARS  showed  robust  neutralizing  antibodies,0,0,0,0,0,0,0,0,0,0,0,0,0,"('exposed  individuals.  Patients  recovering  from  SARS  showed  robust  neutralizing  antibodies', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 385.898, 526.14, 396.806), True, False, 31, 841.92, 595.32)"
31,against this CoV infection (164). A set of mAbs functionally targetting the specific domains,0,0,0,0,0,0,0,0,0,0,0,0,0,"('against this CoV infection (164). A set of mAbs functionally targetting the specific domains', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 370.658, 526.2140000000002, 381.566), True, False, 31, 841.92, 595.32)"
31,"of the MERS-CoV S protein, including six specific epitope groups interacting with receptor",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of the MERS-CoV S protein, including six specific epitope groups interacting with receptor', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 355.538, 526.25, 366.44599999999997), True, False, 31, 841.92, 595.32)"
31,"binding, membrane fusion, and sialic acid-binding sites which constitute vital entry functions",0,0,0,0,0,0,0,0,0,0,0,0,0,"('binding, membrane fusion, and sialic acid-binding sites which constitute vital entry functions', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 340.298, 526.2260000000001, 351.20599999999996), True, False, 31, 841.92, 595.32)"
31,"of  S  protein  (198,  199).  Passive  immunization  with  poorly  and  potently  neutralizing",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  S  protein  (198,  199).  Passive  immunization  with  poorly  and  potently  neutralizing', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 325.178, 526.214, 336.08599999999996), True, False, 31, 841.92, 595.32)"
31,antibodies provided substantial protection in mice after a lethal challenge with MERS-CoV.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('antibodies provided substantial protection in mice after a lethal challenge with MERS-CoV.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 309.938, 526.408, 320.84599999999995), True, False, 31, 841.92, 595.32)"
31,Such  antibodies  may  play  a  crucial  role  in  enhancing  humoral  protection  against  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Such  antibodies  may  play  a  crucial  role  in  enhancing  humoral  protection  against  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 294.81800000000004, 526.1780000000001, 305.726), True, False, 31, 841.92, 595.32)"
31,emerging  CoVs  by  targeting  important  epitopes  and  roles  of  the  S  protein.  The  cross-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('emerging  CoVs  by  targeting  important  epitopes  and  roles  of  the  S  protein.  The  cross-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 279.57800000000003, 523.456, 290.486), True, False, 31, 841.92, 595.32)"
31,neutralization ability of  SARS-CoV RBD-specific neutralizing  mAbs considerably  relies on,0,0,0,0,0,0,0,0,0,0,0,0,0,"('neutralization ability of  SARS-CoV RBD-specific neutralizing  mAbs considerably  relies on', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 264.458, 526.2620000000002, 275.366), True, False, 31, 841.92, 595.32)"
31,"the  similarity  between  their  RBDs,  therefore  SARS-CoV  RBD-specific  antibodies  could",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  similarity  between  their  RBDs,  therefore  SARS-CoV  RBD-specific  antibodies  could', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 249.218, 526.318, 260.126), True, False, 31, 841.92, 595.32)"
31,"cross-neutralized  SARS-like  (SL)  CoVs,  i.e.,  bat-SL-CoV  strain  WIV1  (RBD  with  eight",0,0,0,0,0,0,0,0,0,0,0,0,0,"('cross-neutralized  SARS-like  (SL)  CoVs,  i.e.,  bat-SL-CoV  strain  WIV1  (RBD  with  eight', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 234.09799999999998, 526.2940000000001, 245.006), True, False, 31, 841.92, 595.32)"
31,"amino acids-difference to SARS-CoV), but not bat-SL-CoV strain SHC014 (24 amino acids-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('amino acids-difference to SARS-CoV), but not bat-SL-CoV strain SHC014 (24 amino acids-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 218.85799999999998, 523.336, 229.766), True, False, 31, 841.92, 595.32)"
31,difference) (200).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('difference) (200).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 203.708, 162.62, 214.616), True, False, 31, 841.92, 595.32)"
31,Suitable RBD-specific mAbs can be identified by a comparative analysis of COVID-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Suitable RBD-specific mAbs can be identified by a comparative analysis of COVID-', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 182.468, 523.336, 193.376), True, False, 31, 841.92, 595.32)"
31,"19  RBD  with  that  of  SARS-CoV,  and  cross-neutralizing  SARS-CoV  RBD-specific  mAbs",0,0,0,0,0,0,0,0,0,0,0,0,0,"('19  RBD  with  that  of  SARS-CoV,  and  cross-neutralizing  SARS-CoV  RBD-specific  mAbs', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 167.34799999999998, 526.42, 178.256), True, False, 31, 841.92, 595.32)"
31,could be explored for their effectiveness against COVID-19 and further need to be assessed,0,0,0,0,0,0,0,0,0,0,0,0,0,"('could be explored for their effectiveness against COVID-19 and further need to be assessed', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 152.10799999999998, 526.294, 163.016), True, False, 31, 841.92, 595.32)"
31,clinically. The U.S. Biotech Regeneron is attempting to recognize mAbs specific and potent,0,0,0,0,0,0,0,0,0,0,0,0,0,"('clinically. The U.S. Biotech Regeneron is attempting to recognize mAbs specific and potent', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 136.988, 526.1039999999998, 147.89600000000002), True, False, 31, 841.92, 595.32)"
31,to combat COVID-19. A perfect therapeutic option suggested for SARS-CoV-2 (COVID-19),0,0,0,0,0,0,0,0,0,0,0,0,0,"('to combat COVID-19. A perfect therapeutic option suggested for SARS-CoV-2 (COVID-19)', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 121.748, 526.456, 132.656), True, False, 31, 841.92, 595.32)"
31,is the combination therapy comprising of mAbs and the drug remdesivir (COVID-19) (201).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('is the combination therapy comprising of mAbs and the drug remdesivir (COVID-19) (201).', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 106.628, 526.42, 117.536), True, False, 31, 841.92, 595.32)"
31,The SARS-CoV specific human monoclonal antibody CR3022 is found to bind with SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The SARS-CoV specific human monoclonal antibody CR3022 is found to bind with SARS-', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 91.392, 523.456, 102.3), True, False, 31, 841.92, 595.32)"
31,"CoV-2  RBD,  indicating  its  potential  to  develop  a  therapeutic  agent  in  the  management  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2  RBD,  indicating  its  potential  to  develop  a  therapeutic  agent  in  the  management  of', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 76.272, 526.378, 87.18), True, False, 31, 841.92, 595.32)"
31,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 31, 841.92, 595.32)"
31,30,0,0,0,0,0,0,0,0,0,0,0,0,0,"('30', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 31, 841.92, 595.32)"
32,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 32, 841.92, 595.32)"
32,COVID-19.  It  can  be  either  used  alone  or  in  combination  with  other  effective  neutralizing,0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19.  It  can  be  either  used  alone  or  in  combination  with  other  effective  neutralizing', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.064, 767.076), True, False, 32, 841.92, 595.32)"
32,antibodies for the treatment and prevention of COVID-19 (202). It was further observed that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('antibodies for the treatment and prevention of COVID-19 (202). It was further observed that', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.4200000000001, 751.936), True, False, 32, 841.92, 595.32)"
32,the  other  SARS-CoV-specific  neutralizing  antibodies  like  m396  and  CR3014  failed  to  bind,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  other  SARS-CoV-specific  neutralizing  antibodies  like  m396  and  CR3014  failed  to  bind', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.0999999999999, 736.696), True, False, 32, 841.92, 595.32)"
32,"the  S  protein  of  SARS-CoV-2,  indicating  that  a  particular  level  of  similarity  is  mandatory",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  S  protein  of  SARS-CoV-2,  indicating  that  a  particular  level  of  similarity  is  mandatory', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 526.2260000000002, 721.576), True, False, 32, 841.92, 595.32)"
32,between the RBD's of SARS-CoV and SARS-CoV-2 for the cross-reactivity to occur.,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""between the RBD's of SARS-CoV and SARS-CoV-2 for the cross-reactivity to occur."", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 488.38, 706.336), True, False, 32, 841.92, 595.32)"
32,"Further,  assessment  is  necessary  before  confirming  the  effectiveness  of  such",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Further,  assessment  is  necessary  before  confirming  the  effectiveness  of  such', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 674.308, 526.408, 685.216), True, False, 32, 841.92, 595.32)"
32,"combination  therapy.  Besides,  the  post-procedure  risk  management  program  should  not  be",0,0,0,0,0,0,0,0,0,0,0,0,0,"('combination  therapy.  Besides,  the  post-procedure  risk  management  program  should  not  be', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 659.068, 526.2380000000002, 669.976), True, False, 32, 841.92, 595.32)"
32,neglected in order to prevent further community and nosocomial spread of COVID-19 (314).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('neglected in order to prevent further community and nosocomial spread of COVID-19 (314).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.408, 654.856), True, False, 32, 841.92, 595.32)"
32,Development  of  broad-spectrum  inhibitors  against  the  often  human  coronaviral  pathogens,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Development  of  broad-spectrum  inhibitors  against  the  often  human  coronaviral  pathogens', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 526.354, 639.616), True, False, 32, 841.92, 595.32)"
32,will help to facilitate clinical trials on the effectiveness of such inhibitors against the endemic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('will help to facilitate clinical trials on the effectiveness of such inhibitors against the endemic', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 613.588, 526.056, 624.496), True, False, 32, 841.92, 595.32)"
32,and  other  emerging  coronaviruses  (203).  A  promising  animal  study  revealed  the  protective,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  other  emerging  coronaviruses  (203).  A  promising  animal  study  revealed  the  protective', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 598.3480000000001, 526.2700000000001, 609.2560000000001), True, False, 32, 841.92, 595.32)"
32,effect  of passive immunotherapy with  immune serum from  MERS-immune camels on mice,0,0,0,0,0,0,0,0,0,0,0,0,0,"('effect  of passive immunotherapy with  immune serum from  MERS-immune camels on mice', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 583.2280000000001, 526.318, 594.1360000000001), True, False, 32, 841.92, 595.32)"
32,infected  with  MERS-CoV  (204).  Passive  immunotherapy  using  convalescent  plasma  is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infected  with  MERS-CoV  (204).  Passive  immunotherapy  using  convalescent  plasma  is', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 567.958, 526.2260000000001, 578.866), True, False, 32, 841.92, 595.32)"
32,another strategy that can be used for treating COVID-19 infected critically ill patients (205).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('another strategy that can be used for treating COVID-19 infected critically ill patients (205).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 552.838, 518.26, 563.746), True, False, 32, 841.92, 595.32)"
32,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 531.5980000000001, 75.024, 542.5060000000001), True, False, 32, 841.92, 595.32)"
32,Inhibition  of  virus  replication  can  be  achieved  by  exploiting  fully  human  antibodies,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Inhibition  of  virus  replication  can  be  achieved  by  exploiting  fully  human  antibodies', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 531.5980000000001, 526.052, 542.5060000000001), True, False, 32, 841.92, 595.32)"
32,(human  single-chain  antibodies;  HuscFvs)  or  humanized-nanobodies  (single-domain,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(human  single-chain  antibodies;  HuscFvs)  or  humanized-nanobodies  (single-domain', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 516.4780000000001, 526.4200000000001, 527.3860000000001), True, False, 32, 841.92, 595.32)"
32,"antibodies, sdAb, VH/VHH) which can traverse across the membrane of virus-infected cells",0,0,0,0,0,0,0,0,0,0,0,0,0,"('antibodies, sdAb, VH/VHH) which can traverse across the membrane of virus-infected cells', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 501.238, 526.384, 512.146), True, False, 32, 841.92, 595.32)"
32,(transbodies) and  could  bind  to-/interfere with- biological  properties of the replicating virus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(transbodies) and  could  bind  to-/interfere with- biological  properties of the replicating virus', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 486.118, 526.238, 497.02599999999995), True, False, 32, 841.92, 595.32)"
32,"proteins. Like transbodies to the influenza virus, hepatitis C virus, Ebola virus, and Dengue",0,0,0,0,0,0,0,0,0,0,0,0,0,"('proteins. Like transbodies to the influenza virus, hepatitis C virus, Ebola virus, and Dengue', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 470.87800000000004, 526.076, 481.786), True, False, 32, 841.92, 595.32)"
32,virus (206). Hence generating transbodies directed against CoV intracellular proteins such as,0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus (206). Hence generating transbodies directed against CoV intracellular proteins such as', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 455.75800000000004, 526.064, 466.666), True, False, 32, 841.92, 595.32)"
32,"papain-like  proteases  (PLpro),  cysteine-like  protease  (3CLpro)  or  other  non-structural",0,0,0,0,0,0,0,0,0,0,0,0,0,"('papain-like  proteases  (PLpro),  cysteine-like  protease  (3CLpro)  or  other  non-structural', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 440.51800000000003, 526.384, 451.426), True, False, 32, 841.92, 595.32)"
32,"proteins  (nsp)  that  are  pivotal  for  virus  replication  and  transcription,  could  be  a  useful",0,0,0,0,0,0,0,0,0,0,0,0,0,"('proteins  (nsp)  that  are  pivotal  for  virus  replication  and  transcription,  could  be  a  useful', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 425.398, 526.42, 436.306), True, False, 32, 841.92, 595.32)"
32,"approach  for  safe,  broadly  effective  passive  immunization  virus  exposed  subjects  and  as",0,0,0,0,0,0,0,0,0,0,0,0,0,"('approach  for  safe,  broadly  effective  passive  immunization  virus  exposed  subjects  and  as', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 410.158, 526.0319999999999, 421.066), True, False, 32, 841.92, 595.32)"
32,therapeutics for infected patients.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('therapeutics for infected patients.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 395.038, 235.01, 405.94599999999997), True, False, 32, 841.92, 595.32)"
32,In  a  case  study  based  on  five  grimly  sick  patients  having  symptoms  of  severe,0,0,0,0,0,0,0,0,0,0,0,0,0,"('In  a  case  study  based  on  five  grimly  sick  patients  having  symptoms  of  severe', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 373.778, 526.33, 384.686), True, False, 32, 841.92, 595.32)"
32,"pneumonia  due  to  COVID-19,  convalescent  plasma  administration  was  found  helpful  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('pneumonia  due  to  COVID-19,  convalescent  plasma  administration  was  found  helpful  in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 358.658, 526.27, 369.566), True, False, 32, 841.92, 595.32)"
32,recovering  these  patients  successfully.  The  convalescent  plasma  containing  SARS-CoV-2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('recovering  these  patients  successfully.  The  convalescent  plasma  containing  SARS-CoV-2', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 343.418, 526.42, 354.32599999999996), True, False, 32, 841.92, 595.32)"
32,specific ELISA (serum) antibody titer higher than 1:1000 and neutralizing antibody titer more,0,0,0,0,0,0,0,0,0,0,0,0,0,"('specific ELISA (serum) antibody titer higher than 1:1000 and neutralizing antibody titer more', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 328.298, 526.408, 339.20599999999996), True, False, 32, 841.92, 595.32)"
32,significant than 40 was collected from the recovered patients and used for plasma transfusion,0,0,0,0,0,0,0,0,0,0,0,0,0,"('significant than 40 was collected from the recovered patients and used for plasma transfusion', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 313.058, 526.2260000000001, 323.96599999999995), True, False, 32, 841.92, 595.32)"
32,"twice in the volume of 200-250 ml on the same day of collection (315). At present, treatment",0,0,0,0,0,0,0,0,0,0,0,0,0,"('twice in the volume of 200-250 ml on the same day of collection (315). At present, treatment', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 297.938, 526.396, 308.84599999999995), True, False, 32, 841.92, 595.32)"
32,"for  sepsis  and  ARDS  mainly  involves  antimicrobial  therapy,  source  control,  and  supportive",0,0,0,0,0,0,0,0,0,0,0,0,0,"('for  sepsis  and  ARDS  mainly  involves  antimicrobial  therapy,  source  control,  and  supportive', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 282.69800000000004, 526.1639999999999, 293.606), True, False, 32, 841.92, 595.32)"
32,care.  Hence  the  use  of  therapeutic  plasma  exchange  can  be  considered  as  an  option  in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('care.  Hence  the  use  of  therapeutic  plasma  exchange  can  be  considered  as  an  option  in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 267.57800000000003, 525.9599999999998, 278.486), True, False, 32, 841.92, 595.32)"
32,managing such severe conditions. Further randomized trials can be designed to investigate its,0,0,0,0,0,0,0,0,0,0,0,0,0,"('managing such severe conditions. Further randomized trials can be designed to investigate its', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 252.338, 526.306, 263.246), True, False, 32, 841.92, 595.32)"
32,efficacy (316).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('efficacy (316).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 237.218, 145.7, 248.126), True, False, 32, 841.92, 595.32)"
32,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 215.97799999999998, 111.02, 226.886), True, False, 32, 841.92, 595.32)"
32,Potential therapeutic agents,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Potential therapeutic agents', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 194.82799999999997, 218.33, 205.54399999999998), True, False, 32, 841.92, 595.32)"
32,Therapeutic  options  that  could  be  evaluated  and  utilized  for  against  SARS-CoV-2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Therapeutic  options  that  could  be  evaluated  and  utilized  for  against  SARS-CoV-2', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 173.588, 526.42, 184.496), True, False, 32, 841.92, 595.32)"
32,"infection  comprise  of  molecules  binding  to  the  virus,  molecules  or  inhibitors  targetting",0,0,0,0,0,0,0,0,0,0,0,0,0,"('infection  comprise  of  molecules  binding  to  the  virus,  molecules  or  inhibitors  targetting', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 158.468, 526.2580000000002, 169.376), True, False, 32, 841.92, 595.32)"
32,"specific  enzymes  implicated  in  viral  replication  and  transcription,  small-molecule  inhibitors",0,0,0,0,0,0,0,0,0,0,0,0,0,"('specific  enzymes  implicated  in  viral  replication  and  transcription,  small-molecule  inhibitors', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 143.22799999999998, 526.366, 154.136), True, False, 32, 841.92, 595.32)"
32,"of the helicase, essential proteases or other proteins of the virus, host cell protease inhibitors",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of the helicase, essential proteases or other proteins of the virus, host cell protease inhibitors', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 128.10799999999998, 526.318, 139.016), True, False, 32, 841.92, 595.32)"
32,"and  endocytosis  inhibitors,  siRNA,  neutralizing  antibodies,  mAbs  targeting  host  receptor,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  endocytosis  inhibitors,  siRNA,  neutralizing  antibodies,  mAbs  targeting  host  receptor,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 112.868, 526.172, 123.776), True, False, 32, 841.92, 595.32)"
32,"mAbs interfering with S1 RBD, anti-viral peptide targeting S2, and natural products (7, 166,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('mAbs interfering with S1 RBD, anti-viral peptide targeting S2, and natural products (7, 166,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 97.748, 526.42, 108.656), True, False, 32, 841.92, 595.32)"
32,186). The S protein acts as the critical target for developing CoVs antiviral therapies such as,0,0,0,0,0,0,0,0,0,0,0,0,0,"('186). The S protein acts as the critical target for developing CoVs antiviral therapies such as', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 82.512, 526.42, 93.42), True, False, 32, 841.92, 595.32)"
32,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 32, 841.92, 595.32)"
32,31,0,0,0,0,0,0,0,0,0,0,0,0,0,"('31', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 32, 841.92, 595.32)"
33,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 33, 841.92, 595.32)"
33,"S  protein  inhibitors,  S  cleavage  inhibitors,  neutralizing  antibodies,  RBD-ACE2  blockers,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('S  protein  inhibitors,  S  cleavage  inhibitors,  neutralizing  antibodies,  RBD-ACE2  blockers,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.3960000000001, 767.076), True, False, 33, 841.92, 595.32)"
33,"siRNAs, fusion core blockers, and protease inhibitors (168).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('siRNAs, fusion core blockers, and protease inhibitors (168).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 366.67, 751.936), True, False, 33, 841.92, 595.32)"
33,All  these  therapeutic  approaches  have  revealed  both  in  vitro  and  in  vivo  anti-CoV,0,0,0,0,0,0,0,0,0,0,0,0,0,"('All  these  therapeutic  approaches  have  revealed  both  in  vitro  and  in  vivo  anti-CoV', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 719.788, 526.432, 730.708), False, False, 33, 841.92, 595.32)"
33,potentials.  Although  in  vitro  researches  were  carried  out  with  these  therapeutics  showing,0,0,0,0,0,0,0,0,0,0,0,0,0,"('potentials.  Although  in  vitro  researches  were  carried  out  with  these  therapeutics  showing', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 704.668, 526.214, 715.588), False, False, 33, 841.92, 595.32)"
33,"efficacy,  however,  mostly  need  appropriate  support  of  randomized  animal  or  human  trials.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('efficacy,  however,  mostly  need  appropriate  support  of  randomized  animal  or  human  trials.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 689.428, 526.42, 700.336), True, False, 33, 841.92, 595.32)"
33,Therefore  they  might  be  of  limited  applicability  and  require  trials  against  SARS-CoV-2  to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Therefore  they  might  be  of  limited  applicability  and  require  trials  against  SARS-CoV-2  to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 674.308, 526.42, 685.216), True, False, 33, 841.92, 595.32)"
33,gain practical usefulness. The binding of SARS-CoV-2 with ACE2 leads to exacerbation of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('gain practical usefulness. The binding of SARS-CoV-2 with ACE2 leads to exacerbation of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 659.068, 526.258, 669.976), True, False, 33, 841.92, 595.32)"
33,pneumonia  as  a  consequence  of  the  imbalance  in  the  renin-angiotensin  system  (RAS).  The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pneumonia  as  a  consequence  of  the  imbalance  in  the  renin-angiotensin  system  (RAS).  The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.948, 526.33, 654.856), True, False, 33, 841.92, 595.32)"
33,virus-induced  pulmonary  inflammatory  responses  may  be  reduced  by  the  administration  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus-induced  pulmonary  inflammatory  responses  may  be  reduced  by  the  administration  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 628.708, 526.164, 639.616), True, False, 33, 841.92, 595.32)"
33,ACE-Inhibitors (ACEI) and angiotensin type-1 receptor (AT1R) (207).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ACE-Inhibitors (ACEI) and angiotensin type-1 receptor (AT1R) (207).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 613.588, 416.47, 624.496), True, False, 33, 841.92, 595.32)"
33,Several  investigations  have  suggested  the  use  of  small  molecular  inhibitors  for  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Several  investigations  have  suggested  the  use  of  small  molecular  inhibitors  for  the', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 592.3480000000001, 526.0760000000001, 603.2560000000001), True, False, 33, 841.92, 595.32)"
33,potential control of SARS-CoV infections. The drugs of the FDA-approved compound library,0,0,0,0,0,0,0,0,0,0,0,0,0,"('potential control of SARS-CoV infections. The drugs of the FDA-approved compound library', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 577.2280000000001, 526.342, 588.1360000000001), True, False, 33, 841.92, 595.32)"
33,"were  screened  to  identify  four  small  molecular  inhibitors  of  MERS-CoV  (chlorpromazine,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('were  screened  to  identify  four  small  molecular  inhibitors  of  MERS-CoV  (chlorpromazine,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 561.958, 526.396, 572.866), True, False, 33, 841.92, 595.32)"
33,"chloroquine, loperamide, and lopinavir) that inhibited the viral replication. These compounds",0,0,0,0,0,0,0,0,0,0,0,0,0,"('chloroquine, loperamide, and lopinavir) that inhibited the viral replication. These compounds', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 546.838, 526.0920000000001, 557.746), True, False, 33, 841.92, 595.32)"
33,also hinder the SARS CoV and human CoVs (208). Therapeutic strategies involving the use,0,0,0,0,0,0,0,0,0,0,0,0,0,"('also hinder the SARS CoV and human CoVs (208). Therapeutic strategies involving the use', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 531.5980000000001, 526.2940000000001, 542.5060000000001), True, False, 33, 841.92, 595.32)"
33,of specific antibodies or compounds that neutralize cytokines and their receptors will help to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of specific antibodies or compounds that neutralize cytokines and their receptors will help to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 516.4780000000001, 526.408, 527.3860000000001), True, False, 33, 841.92, 595.32)"
33,restrain  the  host  inflammatory  responses.  Such  drugs  acting  specifically  in  the  respiratory,0,0,0,0,0,0,0,0,0,0,0,0,0,"('restrain  the  host  inflammatory  responses.  Such  drugs  acting  specifically  in  the  respiratory', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 501.238, 526.42, 512.146), True, False, 33, 841.92, 595.32)"
33,tract  will  help  to  reduce  virus-triggered  immune-pathologies  in  COVID-19  (209).  The  later,0,0,0,0,0,0,0,0,0,0,0,0,0,"('tract  will  help  to  reduce  virus-triggered  immune-pathologies  in  COVID-19  (209).  The  later', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 486.118, 526.396, 497.02599999999995), True, False, 33, 841.92, 595.32)"
33,stages of coronavirus induced inflammatory cascade are characterized by the release of pro-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('stages of coronavirus induced inflammatory cascade are characterized by the release of pro-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 470.87800000000004, 523.336, 481.786), True, False, 33, 841.92, 595.32)"
33,"inflammatory IL-1 family members such as IL-1 and IL-33. Hence, there exists a possibility",0,0,0,0,0,0,0,0,0,0,0,0,0,"('inflammatory IL-1 family members such as IL-1 and IL-33. Hence, there exists a possibility', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 455.75800000000004, 526.384, 466.666), True, False, 33, 841.92, 595.32)"
33,that  the  inflammation  associated  with  coronavirus  can  be  inhibited  by  utilizing  anti-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('that  the  inflammation  associated  with  coronavirus  can  be  inhibited  by  utilizing  anti-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 440.51800000000003, 523.336, 451.426), True, False, 33, 841.92, 595.32)"
33,inflammatory cytokines that belongs to the IL-1 family (92). It has also been suggested that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('inflammatory cytokines that belongs to the IL-1 family (92). It has also been suggested that', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 425.398, 526.384, 436.306), True, False, 33, 841.92, 595.32)"
33,the actin protein  is  the host  factor that is  involved in  cell  entry  and pathogenesis of  SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the actin protein  is  the host  factor that is  involved in  cell  entry  and pathogenesis of  SARS-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 410.158, 523.456, 421.066), True, False, 33, 841.92, 595.32)"
33,"CoV-2. Hence, those drugs that modulate the biological activity of this protein, like ibuprofen,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2. Hence, those drugs that modulate the biological activity of this protein, like ibuprofen,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 395.038, 529.42, 405.94599999999997), True, False, 33, 841.92, 595.32)"
33,might  have  some  therapeutic  application  in  managing  the  disease  (174).  The  plasma,0,0,0,0,0,0,0,0,0,0,0,0,0,"('might  have  some  therapeutic  application  in  managing  the  disease  (174).  The  plasma', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 379.778, 526.384, 390.686), True, False, 33, 841.92, 595.32)"
33,Angiotensin  II  level  was  found  to  be  markedly  elevated  in  COVID-19  infection  and  was,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Angiotensin  II  level  was  found  to  be  markedly  elevated  in  COVID-19  infection  and  was', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 364.658, 526.396, 375.566), True, False, 33, 841.92, 595.32)"
33,"correlated  to  viral  load  and  lung  injury.  Hence,  drugs  that  block  angiotensin  receptors  may",0,0,0,0,0,0,0,0,0,0,0,0,0,"('correlated  to  viral  load  and  lung  injury.  Hence,  drugs  that  block  angiotensin  receptors  may', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 349.418, 526.408, 360.32599999999996), True, False, 33, 841.92, 595.32)"
33,have the potential for treating COVID-19 infection (121). A scientist from Germany named,0,0,0,0,0,0,0,0,0,0,0,0,0,"('have the potential for treating COVID-19 infection (121). A scientist from Germany named', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 334.298, 526.3180000000001, 345.20599999999996), True, False, 33, 841.92, 595.32)"
33,Rolf  Hilgenfeld  has  been  working  on  the  identification  of  drugs  for  the  treatment  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Rolf  Hilgenfeld  has  been  working  on  the  identification  of  drugs  for  the  treatment  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 319.058, 526.432, 329.96599999999995), True, False, 33, 841.92, 595.32)"
33,coronaviral infection from the time of SARS. He has now planned to visit Wuhan and test the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronaviral infection from the time of SARS. He has now planned to visit Wuhan and test the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 303.938, 526.068, 314.84599999999995), True, False, 33, 841.92, 595.32)"
33,drug  molecules  he  has  in  animals.  If  they  are  found  useful  can  be  a  cure  to  the  current,0,0,0,0,0,0,0,0,0,0,0,0,0,"('drug  molecules  he  has  in  animals.  If  they  are  found  useful  can  be  a  cure  to  the  current', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 288.69800000000004, 526.384, 299.606), True, False, 33, 841.92, 595.32)"
33,problem caused by the novel virus (19).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('problem caused by the novel virus (19).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 273.57800000000003, 266.09, 284.486), True, False, 33, 841.92, 595.32)"
33,The  SARS-CoV  S2  subunit  plays  a  significant  role  in  mediating  virus  fusion  that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  SARS-CoV  S2  subunit  plays  a  significant  role  in  mediating  virus  fusion  that', 'TimesNewRomanPSMT', 10.907999999999987, (108.02, 252.338, 526.4200000000001, 263.246), True, False, 33, 841.92, 595.32)"
33,provides entry into the host cell. The heptad repeat 1 (HR1) and heptad repeat 2 (HR2)  can,0,0,0,0,0,0,0,0,0,0,0,0,0,"('provides entry into the host cell. The heptad repeat 1 (HR1) and heptad repeat 2 (HR2)  can', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 237.218, 526.42, 248.126), True, False, 33, 841.92, 595.32)"
33,"interact  and  form  a  six-helical  bundle  that  brings  the  viral  and  cellular  membranes  nearby,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('interact  and  form  a  six-helical  bundle  that  brings  the  viral  and  cellular  membranes  nearby,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 221.97799999999998, 526.42, 232.886), True, False, 33, 841.92, 595.32)"
33,facilitating  its  fusion.  The  sequence  alignment  study  conducted  between  COVID-19  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('facilitating  its  fusion.  The  sequence  alignment  study  conducted  between  COVID-19  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 206.82799999999997, 526.408, 217.736), True, False, 33, 841.92, 595.32)"
33,SARS-CoV identified that the S2 subunits are highly conserved in these CoVs. TheHR1 and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV identified that the S2 subunits are highly conserved in these CoVs. TheHR1 and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 191.588, 526.33, 202.496), True, False, 33, 841.92, 595.32)"
33,"HR2  domains  showed  92.6%  and  100%  overall  identity,  respectively  (210).  From  these",0,0,0,0,0,0,0,0,0,0,0,0,0,"('HR2  domains  showed  92.6%  and  100%  overall  identity,  respectively  (210).  From  these', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 176.468, 526.408, 187.376), True, False, 33, 841.92, 595.32)"
33,"findings,  we  can  confirm  the  significance  of  COVID-19  HR1  and  HR2  and  its  vital  role  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('findings,  we  can  confirm  the  significance  of  COVID-19  HR1  and  HR2  and  its  vital  role  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 161.22799999999998, 526.384, 172.136), True, False, 33, 841.92, 595.32)"
33,"host  cell  entry.  Hence,  fusion  inhibitors  target  the  HR1  domain  of  S  protein,  thereby",0,0,0,0,0,0,0,0,0,0,0,0,0,"('host  cell  entry.  Hence,  fusion  inhibitors  target  the  HR1  domain  of  S  protein,  thereby', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 146.10799999999998, 526.396, 157.016), True, False, 33, 841.92, 595.32)"
33,preventing viral fusion and entry into the host cell. It is another potential therapeutic strategy,0,0,0,0,0,0,0,0,0,0,0,0,0,"('preventing viral fusion and entry into the host cell. It is another potential therapeutic strategy', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 130.868, 526.0320000000002, 141.776), True, False, 33, 841.92, 595.32)"
33,that can be used in  the management of  COVID-19. Other than the specific therapy directed,0,0,0,0,0,0,0,0,0,0,0,0,0,"('that can be used in  the management of  COVID-19. Other than the specific therapy directed', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 115.748, 526.306, 126.656), True, False, 33, 841.92, 595.32)"
33,"against COVID-19, general  treatments  play  a vital role in  the enhancement of host immune",0,0,0,0,0,0,0,0,0,0,0,0,0,"('against COVID-19, general  treatments  play  a vital role in  the enhancement of host immune', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 100.508, 526.3180000000001, 111.416), True, False, 33, 841.92, 595.32)"
33,response against the viral agent. Inadequate nutrition is associated with the weakening of the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('response against the viral agent. Inadequate nutrition is associated with the weakening of the', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 85.392, 526.444, 96.3), True, False, 33, 841.92, 595.32)"
33,"host immune response, making the individual more susceptible. The role played by nutrition",0,0,0,0,0,0,0,0,0,0,0,0,0,"('host immune response, making the individual more susceptible. The role played by nutrition', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 70.152, 526.1840000000001, 81.06), True, False, 33, 841.92, 595.32)"
33,32,0,0,0,0,0,0,0,0,0,0,0,0,0,"('32', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 33, 841.92, 595.32)"
33,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 33, 841.92, 595.32)"
34,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 34, 841.92, 595.32)"
34,in  disease  susceptibility  should  be  measured  by  evaluating  the  nutritional  status  of  patients,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  disease  susceptibility  should  be  measured  by  evaluating  the  nutritional  status  of  patients', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.238, 767.076), True, False, 34, 841.92, 595.32)"
34,with COVID-19 (205).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('with COVID-19 (205).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 185.3, 751.936), True, False, 34, 841.92, 595.32)"
34,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 719.788, 75.024, 730.504), True, False, 34, 841.92, 595.32)"
34,Animal models and cell cultures,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Animal models and cell cultures', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 698.668, 241.97, 709.384), True, False, 34, 841.92, 595.32)"
34,"For  studying  the  pathogenesis  and  evaluation  of  vaccines  and  therapeutics  against  CoVs,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('For  studying  the  pathogenesis  and  evaluation  of  vaccines  and  therapeutics  against  CoVs,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 677.428, 526.42, 688.336), True, False, 34, 841.92, 595.32)"
34,"including  SARS,  MERS-CoVs,  and  the  presently  emerging  SARS-CoV-2,  suitable  animal",0,0,0,0,0,0,0,0,0,0,0,0,0,"('including  SARS,  MERS-CoVs,  and  the  presently  emerging  SARS-CoV-2,  suitable  animal', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 662.308, 526.408, 673.216), True, False, 34, 841.92, 595.32)"
34,"models  that  could  mimic  the  clinical  disease  are  needed  (211,212).  Various  animal  models",0,0,0,0,0,0,0,0,0,0,0,0,0,"('models  that  could  mimic  the  clinical  disease  are  needed  (211,212).  Various  animal  models', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 647.068, 526.318, 657.976), True, False, 34, 841.92, 595.32)"
34,"have been assessed for SARS- and MERS-CoVs such as a mouse, guinea pigs, golden Syrian",0,0,0,0,0,0,0,0,0,0,0,0,0,"('have been assessed for SARS- and MERS-CoVs such as a mouse, guinea pigs, golden Syrian', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 631.948, 526.396, 642.856), True, False, 34, 841.92, 595.32)"
34,"hamsters, ferrets, rabbits, non-human primates like rhesus macaques and marmosets, and cats",0,0,0,0,0,0,0,0,0,0,0,0,0,"('hamsters, ferrets, rabbits, non-human primates like rhesus macaques and marmosets, and cats', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 616.708, 526.2140000000002, 627.616), True, False, 34, 841.92, 595.32)"
34,"(185, 213-218). The specificity of the virus to human ACE2 (hACE2; receptor of SARS-CoV)",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(185, 213-218). The specificity of the virus to human ACE2 (hACE2; receptor of SARS-CoV)', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 601.588, 530.368, 612.496), True, False, 34, 841.92, 595.32)"
34,was  found  to  be  a  significant  hindrance  in  developing  animal  models  for  SARS-CoV.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('was  found  to  be  a  significant  hindrance  in  developing  animal  models  for  SARS-CoV.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 586.3480000000001, 526.42, 597.2560000000001), True, False, 34, 841.92, 595.32)"
34,"Consequently, a SARS-CoV transgenic mouse model was developed by inserting the hACE2",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Consequently, a SARS-CoV transgenic mouse model was developed by inserting the hACE2', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 571.198, 526.408, 582.106), True, False, 34, 841.92, 595.32)"
34,gene into the mouse genome (219). The inability of MERS-CoV to replicate in the respiratory,0,0,0,0,0,0,0,0,0,0,0,0,0,"('gene into the mouse genome (219). The inability of MERS-CoV to replicate in the respiratory', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 555.958, 526.3180000000001, 566.866), True, False, 34, 841.92, 595.32)"
34,"tracts  of  animals  (mice,  hamsters,  and  ferrets)  is  another  limiting  factor.  However,  with",0,0,0,0,0,0,0,0,0,0,0,0,0,"('tracts  of  animals  (mice,  hamsters,  and  ferrets)  is  another  limiting  factor.  However,  with', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 540.838, 526.3720000000001, 551.746), True, False, 34, 841.92, 595.32)"
34,"genetic  engineering,  288-330+/+  MERS-CoV  genetically  modified  mouse  model  was",0,0,0,0,0,0,0,0,0,0,0,0,0,"('genetic  engineering,  288-330+/+  MERS-CoV  genetically  modified  mouse  model  was', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 525.5980000000001, 526.42, 536.5060000000001), True, False, 34, 841.92, 595.32)"
34,developed and now is in use for the evaluation of novel drugs and vaccines against MERS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('developed and now is in use for the evaluation of novel drugs and vaccines against MERS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 510.47800000000007, 523.456, 521.3860000000001), True, False, 34, 841.92, 595.32)"
34,"CoV (220). In the past, the small animals (mice or hamsters) have been targeted for closer to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV (220). In the past, the small animals (mice or hamsters) have been targeted for closer to', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 495.238, 526.396, 506.14599999999996), True, False, 34, 841.92, 595.32)"
34,"humanized structure, such as mice altered DPP4 with hDPP4human, hDPP4-transduced mice,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('humanized structure, such as mice altered DPP4 with hDPP4human, hDPP4-transduced mice,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 480.118, 526.396, 491.02599999999995), True, False, 34, 841.92, 595.32)"
34,and  hDPP4-Tg  mice  (transgenic  for  expressing  hDPP4)  for  MERS-CoV  infection  (221).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  hDPP4-Tg  mice  (transgenic  for  expressing  hDPP4)  for  MERS-CoV  infection  (221).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 464.87800000000004, 526.3960000000001, 475.786), True, False, 34, 841.92, 595.32)"
34,"CRISPR-Cas9 gene-editing tool has been used for inserting the genomic alterations in mouse,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CRISPR-Cas9 gene-editing tool has been used for inserting the genomic alterations in mouse,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 449.75800000000004, 526.42, 460.666), True, False, 34, 841.92, 595.32)"
34,making them susceptible to MERS-CoV infection (222). Efforts are on the way to recognize,0,0,0,0,0,0,0,0,0,0,0,0,0,"('making them susceptible to MERS-CoV infection (222). Efforts are on the way to recognize', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 434.51800000000003, 526.246, 445.426), True, False, 34, 841.92, 595.32)"
34,"suitable  animal  models  for  SARS-CoV2  /COVID-19,  identify  the  receptor  affinity  of  this",0,0,0,0,0,0,0,0,0,0,0,0,0,"('suitable  animal  models  for  SARS-CoV2  /COVID-19,  identify  the  receptor  affinity  of  this', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 419.398, 526.396, 430.306), True, False, 34, 841.92, 595.32)"
34,"virus,  studying  pathology  in  experimental  animal  models,  exploring  virus-specific  immune",0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus,  studying  pathology  in  experimental  animal  models,  exploring  virus-specific  immune', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 404.158, 526.396, 415.066), True, False, 34, 841.92, 595.32)"
34,"responses and protection studies, which together would give a pace to efforts being made for",0,0,0,0,0,0,0,0,0,0,0,0,0,"('responses and protection studies, which together would give a pace to efforts being made for', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 389.01800000000003, 526.318, 399.926), True, False, 34, 841.92, 595.32)"
34,developing  effective  vaccines  and  drugs  against  this  emerging  virus.  Cell  lines  such  as,0,0,0,0,0,0,0,0,0,0,0,0,0,"('developing  effective  vaccines  and  drugs  against  this  emerging  virus.  Cell  lines  such  as', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 373.778, 526.42, 384.686), True, False, 34, 841.92, 595.32)"
34,"monkey  epithelial  cell  lines  (LLC-MK2  and  Vero-B4),  goat  lung  cells,  alpaca  kidney  cells,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('monkey  epithelial  cell  lines  (LLC-MK2  and  Vero-B4),  goat  lung  cells,  alpaca  kidney  cells,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 358.658, 526.282, 369.566), True, False, 34, 841.92, 595.32)"
34,"dromedary  umbilical  cord  cells,  advanced  ex  vivo three-dimensional  (3D)  tracheobronchial",0,0,0,0,0,0,0,0,0,0,0,0,0,"('dromedary  umbilical  cord  cells,  advanced  ex  vivo three-dimensional  (3D)  tracheobronchial', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 343.418, 526.2940000000001, 354.33799999999997), False, False, 34, 841.92, 595.32)"
34,"tissue have been explored to study human CoVs (MERS-CoV)(223, 224). Vero and the Huh-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('tissue have been explored to study human CoVs (MERS-CoV)(223, 224). Vero and the Huh-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 328.298, 523.336, 339.20599999999996), True, False, 34, 841.92, 595.32)"
34,7 cells (human liver cancer cells) have been used for isolating the SARS-CoV-2 (194).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('7 cells (human liver cancer cells) have been used for isolating the SARS-CoV-2 (194).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 313.058, 490.9, 323.96599999999995), True, False, 34, 841.92, 595.32)"
34,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 291.938, 75.024, 302.84599999999995), True, False, 34, 841.92, 595.32)"
34,"Recently, in an animal model using rhesus monkeys, authors found that neither viral",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Recently, in an animal model using rhesus monkeys, authors found that neither viral', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 291.938, 526.2700000000001, 302.84599999999995), True, False, 34, 841.92, 595.32)"
34,loads in nasopharyngeal and anal swabs along the timeline nor viral replication in all primary,0,0,0,0,0,0,0,0,0,0,0,0,0,"('loads in nasopharyngeal and anal swabs along the timeline nor viral replication in all primary', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 276.69800000000004, 526.2940000000001, 287.606), True, False, 34, 841.92, 595.32)"
34,tissue  compartments  at  five  days  post-reinfection  was  found  in  re-exposed  monkeys  (279).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('tissue  compartments  at  five  days  post-reinfection  was  found  in  re-exposed  monkeys  (279).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 261.57800000000003, 526.354, 272.486), True, False, 34, 841.92, 595.32)"
34,"Combined with the follow-up virologic, radiological, and pathological findings, the monkeys",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Combined with the follow-up virologic, radiological, and pathological findings, the monkeys', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 246.338, 526.342, 257.246), True, False, 34, 841.92, 595.32)"
34,"with  re-exposure  showed  no  recurrence  of  COVID-19,  similarly  to  the  infected  monkey",0,0,0,0,0,0,0,0,0,0,0,0,0,"('with  re-exposure  showed  no  recurrence  of  COVID-19,  similarly  to  the  infected  monkey', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 231.218, 526.294, 242.126), True, False, 34, 841.92, 595.32)"
34,"without  rechallenge.  Taken  together,  their  results  indicated  that  the  primary  SARS-CoV-2",0,0,0,0,0,0,0,0,0,0,0,0,0,"('without  rechallenge.  Taken  together,  their  results  indicated  that  the  primary  SARS-CoV-2', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 215.97799999999998, 526.42, 226.886), True, False, 34, 841.92, 595.32)"
34,"infection could protect from subsequent exposures, which have the reference of prognosis of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('infection could protect from subsequent exposures, which have the reference of prognosis of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 200.82799999999997, 526.0919999999999, 211.736), True, False, 34, 841.92, 595.32)"
34,the disease and vital implications for vaccine design (279).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the disease and vital implications for vaccine design (279).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 185.588, 357.31, 196.496), True, False, 34, 841.92, 595.32)"
34,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 164.468, 75.024, 175.376), True, False, 34, 841.92, 595.32)"
34,"PREVENTION, CONTROL, AND MANAGEMENT",0,0,0,0,0,0,0,0,0,0,0,0,0,"('PREVENTION, CONTROL, AND MANAGEMENT', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 143.22799999999998, 347.47, 153.944), True, False, 34, 841.92, 595.32)"
34,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 128.10799999999998, 75.024, 139.016), True, False, 34, 841.92, 595.32)"
34,"In  contrast  to  China's  response  to  the  2002  SARS  outbreak,  they  have  shown",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""In  contrast  to  China's  response  to  the  2002  SARS  outbreak,  they  have  shown"", 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 128.10799999999998, 526.238, 139.016), True, False, 34, 841.92, 595.32)"
34,immense  political  openness  in  reporting  the  COVID-19  outbreak  promptly.  They  have  also,0,0,0,0,0,0,0,0,0,0,0,0,0,"('immense  political  openness  in  reporting  the  COVID-19  outbreak  promptly.  They  have  also', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 113.228, 526.3720000000001, 124.136), True, False, 34, 841.92, 595.32)"
34,performed rapid sequencing of COVID-19 at multiple levels and shared the findings globally,0,0,0,0,0,0,0,0,0,0,0,0,0,"('performed rapid sequencing of COVID-19 at multiple levels and shared the findings globally', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 98.348, 526.33, 109.256), True, False, 34, 841.92, 595.32)"
34,within  days  of  identifying  the  novel  virus  (225).  The  move  made  by  China  opened  a  new,0,0,0,0,0,0,0,0,0,0,0,0,0,"('within  days  of  identifying  the  novel  virus  (225).  The  move  made  by  China  opened  a  new', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 83.472, 526.3960000000001, 94.38), True, False, 34, 841.92, 595.32)"
34,chapter  in  global  health  security  and  diplomacy.  Even  though  complete  lockdown  was,0,0,0,0,0,0,0,0,0,0,0,0,0,"('chapter  in  global  health  security  and  diplomacy.  Even  though  complete  lockdown  was', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 68.592, 526.294, 79.5), True, False, 34, 841.92, 595.32)"
34,33,0,0,0,0,0,0,0,0,0,0,0,0,0,"('33', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 34, 841.92, 595.32)"
34,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 34, 841.92, 595.32)"
35,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 35, 841.92, 595.32)"
35,"declared  following  the  COVID-19  outbreak  in  Wuhan,  large-scale  movement  of  people  has",0,0,0,0,0,0,0,0,0,0,0,0,0,"('declared  following  the  COVID-19  outbreak  in  Wuhan,  large-scale  movement  of  people  has', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.306, 767.076), True, False, 35, 841.92, 595.32)"
35,resulted in a radiating spread of infections in the surrounding provinces as well as to several,0,0,0,0,0,0,0,0,0,0,0,0,0,"('resulted in a radiating spread of infections in the surrounding provinces as well as to several', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.268, 526.008, 752.176), True, False, 35, 841.92, 595.32)"
35,other  countries.  Large-scale  screening  programs  might  help  us  to  control  the  spread  of  this,0,0,0,0,0,0,0,0,0,0,0,0,0,"('other  countries.  Large-scale  screening  programs  might  help  us  to  control  the  spread  of  this', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 526.124, 737.296), True, False, 35, 841.92, 595.32)"
35,"virus. However, this is both challenging as well as time-consuming due to the present extent",0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus. However, this is both challenging as well as time-consuming due to the present extent', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.2940000000001, 722.416), True, False, 35, 841.92, 595.32)"
35,of infection (226). The current scenario warrants the need for implementing robust preventive,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of infection (226). The current scenario warrants the need for implementing robust preventive', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 696.628, 526.306, 707.5360000000001), True, False, 35, 841.92, 595.32)"
35,and  control  measures  due  to  the  potential  of  COVID-19  for  nosocomial  infections  (68).  A,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  control  measures  due  to  the  potential  of  COVID-19  for  nosocomial  infections  (68).  A', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 681.748, 526.42, 692.6560000000001), True, False, 35, 841.92, 595.32)"
35,follow-up of infected patients by telephone on day seven and day 14 are advised to avoid any,0,0,0,0,0,0,0,0,0,0,0,0,0,"('follow-up of infected patients by telephone on day seven and day 14 are advised to avoid any', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 666.748, 526.342, 677.6560000000001), True, False, 35, 841.92, 595.32)"
35,further  unintentional  spread  or  nosocomial  transmission  (317).  The  availability  of  public,0,0,0,0,0,0,0,0,0,0,0,0,0,"('further  unintentional  spread  or  nosocomial  transmission  (317).  The  availability  of  public', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 651.868, 526.318, 662.7760000000001), True, False, 35, 841.92, 595.32)"
35,datasets  provided  by  independent  analytical  teams  will  act  as  robust  evidence  that  would,0,0,0,0,0,0,0,0,0,0,0,0,0,"('datasets  provided  by  independent  analytical  teams  will  act  as  robust  evidence  that  would', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 636.988, 526.42, 647.8960000000001), True, False, 35, 841.92, 595.32)"
35,guide us in  designing interventions against the COVID-19 outbreak. The  newspaper reports,0,0,0,0,0,0,0,0,0,0,0,0,0,"('guide us in  designing interventions against the COVID-19 outbreak. The  newspaper reports', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 622.1080000000001, 526.3180000000001, 633.0160000000001), True, False, 35, 841.92, 595.32)"
35,and social media can be used to analyze and reconstruct the progression of an outbreak. They,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and social media can be used to analyze and reconstruct the progression of an outbreak. They', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 607.2280000000001, 526.42, 618.1360000000001), True, False, 35, 841.92, 595.32)"
35,can help us to obtain detailed patient-level data in the early stages of an outbreak (227). The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('can help us to obtain detailed patient-level data in the early stages of an outbreak (227). The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 592.3480000000001, 526.408, 603.2560000000001), True, False, 35, 841.92, 595.32)"
35,immediate  travel  restrictions  imposed  by  several  countries  might  have  contributed,0,0,0,0,0,0,0,0,0,0,0,0,0,"('immediate  travel  restrictions  imposed  by  several  countries  might  have  contributed', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 577.468, 526.152, 588.376), True, False, 35, 841.92, 595.32)"
35,"significantly  to  prevent  the  spread  of  SARS-CoV-2  globally  (89,  228).  Following  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('significantly  to  prevent  the  spread  of  SARS-CoV-2  globally  (89,  228).  Following  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 562.558, 526.42, 573.466), True, False, 35, 841.92, 595.32)"
35,"outbreak,  a  temporary  ban  was  imposed  on  the wildlife  trade,  keeping  in  mind  the  possible",0,0,0,0,0,0,0,0,0,0,0,0,0,"('outbreak,  a  temporary  ban  was  imposed  on  the wildlife  trade,  keeping  in  mind  the  possible', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 547.678, 526.318, 558.586), True, False, 35, 841.92, 595.32)"
35,role played by wild animal species in the origin of SARS-CoV-2/COVID-19 (147). Taking a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('role played by wild animal species in the origin of SARS-CoV-2/COVID-19 (147). Taking a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 532.798, 526.396, 543.706), True, False, 35, 841.92, 595.32)"
35,permanent and bold decision on the trade of wild animal species is necessary to prevent the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('permanent and bold decision on the trade of wild animal species is necessary to prevent the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 517.798, 526.0559999999998, 528.706), True, False, 35, 841.92, 595.32)"
35,possibility of the virus spread and initiation of an outbreak due to zoonotic spillover (1).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('possibility of the virus spread and initiation of an outbreak due to zoonotic spillover (1).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 502.918, 497.98, 513.826), True, False, 35, 841.92, 595.32)"
35,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 480.118, 75.024, 491.02599999999995), True, False, 35, 841.92, 595.32)"
35,Personal protective equipments (PPE) like face masks will help to prevent the spread,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Personal protective equipments (PPE) like face masks will help to prevent the spread', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 480.118, 526.214, 491.02599999999995), True, False, 35, 841.92, 595.32)"
35,of  respiratory  infections  like  COVID-19.  Face  masks  not  only  protect  from  infectious,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  respiratory  infections  like  COVID-19.  Face  masks  not  only  protect  from  infectious', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 465.238, 526.384, 476.14599999999996), True, False, 35, 841.92, 595.32)"
35,aerosols  but  also  prevent  the  transmission  of  disease  to  other  susceptible  individuals  while,0,0,0,0,0,0,0,0,0,0,0,0,0,"('aerosols  but  also  prevent  the  transmission  of  disease  to  other  susceptible  individuals  while', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 450.238, 526.1760000000002, 461.14599999999996), True, False, 35, 841.92, 595.32)"
35,traveling through public transport systems (318). Another critical practice that can reduce the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('traveling through public transport systems (318). Another critical practice that can reduce the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 435.358, 526.306, 446.26599999999996), True, False, 35, 841.92, 595.32)"
35,"transmission  of  respiratory  diseases  is  the  maintenance  of  hand  hygiene.  However,  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('transmission  of  respiratory  diseases  is  the  maintenance  of  hand  hygiene.  However,  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 420.478, 526.408, 431.38599999999997), True, False, 35, 841.92, 595.32)"
35,efficacy of this practice in reducing transmission of respiratory viruses like SARS-CoV-2 is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('efficacy of this practice in reducing transmission of respiratory viruses like SARS-CoV-2 is', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 405.598, 526.408, 416.506), True, False, 35, 841.92, 595.32)"
35,much  dependent  upon  the  size  of  droplets  produced.  Hand  hygiene  will  reduce  disease,0,0,0,0,0,0,0,0,0,0,0,0,0,"('much  dependent  upon  the  size  of  droplets  produced.  Hand  hygiene  will  reduce  disease', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 390.69800000000004, 526.258, 401.606), True, False, 35, 841.92, 595.32)"
35,transmission  only  if  the  virus  transmitted  through  the  formation  of  large  droplets  (319).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('transmission  only  if  the  virus  transmitted  through  the  formation  of  large  droplets  (319).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 375.81800000000004, 526.42, 386.726), True, False, 35, 841.92, 595.32)"
35,"Hence,  it  is  better  not  to  overemphasize  that  hand  hygiene  will  prevent  transmission  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Hence,  it  is  better  not  to  overemphasize  that  hand  hygiene  will  prevent  transmission  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 360.938, 526.112, 371.84599999999995), True, False, 35, 841.92, 595.32)"
35,SARS-CoV-2  since  it  may  produce  a  false  sense  of  safety  among  the  general  public  that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  since  it  may  produce  a  false  sense  of  safety  among  the  general  public  that', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 346.058, 526.2140000000002, 356.96599999999995), True, False, 35, 841.92, 595.32)"
35,further  contribute  to  the  transmission  of  COVID-19.  Even  though  airborne  spread  has  not,0,0,0,0,0,0,0,0,0,0,0,0,0,"('further  contribute  to  the  transmission  of  COVID-19.  Even  though  airborne  spread  has  not', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 331.178, 526.258, 342.08599999999996), True, False, 35, 841.92, 595.32)"
35,"been reported in SARS-CoV-2 infection, transmission can occur through droplets and fomites,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('been reported in SARS-CoV-2 infection, transmission can occur through droplets and fomites,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 316.298, 529.42, 327.20599999999996), True, False, 35, 841.92, 595.32)"
35,especially  when  there  is  close  unprotected  contact  between  the  infected  and  susceptible,0,0,0,0,0,0,0,0,0,0,0,0,0,"('especially  when  there  is  close  unprotected  contact  between  the  infected  and  susceptible', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 301.298, 526.25, 312.20599999999996), True, False, 35, 841.92, 595.32)"
35,"individuals. Hence, hand hygiene is equally important as the use of appropriate PPE like face",0,0,0,0,0,0,0,0,0,0,0,0,0,"('individuals. Hence, hand hygiene is equally important as the use of appropriate PPE like face', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 286.418, 526.372, 297.32599999999996), True, False, 35, 841.92, 595.32)"
35,masks to break the transmission cycle of the virus--both hand hygiene and face masking help,0,0,0,0,0,0,0,0,0,0,0,0,0,"('masks to break the transmission cycle of the virus--both hand hygiene and face masking help', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 271.538, 526.318, 282.44599999999997), True, False, 35, 841.92, 595.32)"
35,to reduce the risk of COVID-19 transmission (320).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('to reduce the risk of COVID-19 transmission (320).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 256.658, 323.71, 267.566), True, False, 35, 841.92, 595.32)"
35,Medical staffs come under the riskiest group of individuals that can get the COVID-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Medical staffs come under the riskiest group of individuals that can get the COVID-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 233.738, 523.336, 244.64600000000002), True, False, 35, 841.92, 595.32)"
35,19  infection.  This  is  because  they  are  exposed  directly  to  the  frontline  of  infected  patients.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('19  infection.  This  is  because  they  are  exposed  directly  to  the  frontline  of  infected  patients.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 218.85799999999998, 526.0439999999999, 229.766), True, False, 35, 841.92, 595.32)"
35,"Hence, proper training must be given to  all the hospital staff on methods of prevention and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Hence, proper training must be given to  all the hospital staff on methods of prevention and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 203.94799999999998, 526.068, 214.856), True, False, 35, 841.92, 595.32)"
35,protection so that they become competent enough to protect themselves and others from this,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protection so that they become competent enough to protect themselves and others from this', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 189.06799999999998, 526.1600000000002, 199.976), True, False, 35, 841.92, 595.32)"
35,"deadly  disease  (321).  As  a  preventive  measure,  healthcare  workers  caring  for  infected",0,0,0,0,0,0,0,0,0,0,0,0,0,"('deadly  disease  (321).  As  a  preventive  measure,  healthcare  workers  caring  for  infected', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 174.188, 526.2940000000001, 185.096), True, False, 35, 841.92, 595.32)"
35,patients  should  take  extreme  precautions  against  both  contact  and  airborne  transmission.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients  should  take  extreme  precautions  against  both  contact  and  airborne  transmission.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 159.308, 526.1399999999999, 170.216), True, False, 35, 841.92, 595.32)"
35,"They  should  use  PPE  such  as  face  masks  (N95  or  FFP3),  eye  protection  (goggles),  gowns,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('They  should  use  PPE  such  as  face  masks  (N95  or  FFP3),  eye  protection  (goggles),  gowns,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 144.428, 526.396, 155.336), True, False, 35, 841.92, 595.32)"
35,and gloves to nullify the risk of infection (304).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and gloves to nullify the risk of infection (304).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 129.54799999999997, 303.29, 140.456), True, False, 35, 841.92, 595.32)"
35,The human-to-human transmission reported in SARS-CoV-2 infection occurs mainly,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The human-to-human transmission reported in SARS-CoV-2 infection occurs mainly', 'TimesNewRomanPSMT', 10.908000000000001, (108.02, 106.628, 526.42, 117.536), True, False, 35, 841.92, 595.32)"
35,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 106.628, 75.024, 117.536), True, False, 35, 841.92, 595.32)"
35,"through droplet or direct contact. Due to this, the first-line healthcare workers should follow",0,0,0,0,0,0,0,0,0,0,0,0,0,"('through droplet or direct contact. Due to this, the first-line healthcare workers should follow', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 91.752, 526.2940000000001, 102.66), True, False, 35, 841.92, 595.32)"
35,stringent infection control and preventive measures such as the use of PPE to prevent the risk,0,0,0,0,0,0,0,0,0,0,0,0,0,"('stringent infection control and preventive measures such as the use of PPE to prevent the risk', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 76.872, 526.258, 87.78), True, False, 35, 841.92, 595.32)"
35,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 35, 841.92, 595.32)"
35,34,0,0,0,0,0,0,0,0,0,0,0,0,0,"('34', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 35, 841.92, 595.32)"
36,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 36, 841.92, 595.32)"
36,of infection (110). The mental health of the medical/health workers who are involved in the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of infection (110). The mental health of the medical/health workers who are involved in the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.1239999999999, 767.076), True, False, 36, 841.92, 595.32)"
36,"COVID-19  outbreak  is  of  great  importance  because  this  will  affect  their  attention,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19  outbreak  is  of  great  importance  because  this  will  affect  their  attention,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.268, 526.282, 752.176), True, False, 36, 841.92, 595.32)"
36,"concentration, and decision-making capacity. Hence, for control of the COVID-19 outbreak,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('concentration, and decision-making capacity. Hence, for control of the COVID-19 outbreak,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 526.384, 737.296), True, False, 36, 841.92, 595.32)"
36,rapid  steps  are  to  be  taken  to  protect  the  mental  health  of  medical  workers  (229)  since  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('rapid  steps  are  to  be  taken  to  protect  the  mental  health  of  medical  workers  (229)  since  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.432, 722.416), True, False, 36, 841.92, 595.32)"
36,living  mammals sold  in the wet  market  are suspected to  be the intermediate host of  SARS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('living  mammals sold  in the wet  market  are suspected to  be the intermediate host of  SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 696.628, 523.456, 707.5360000000001), True, False, 36, 841.92, 595.32)"
36,CoV-2.  There  is  a  need  for  strengthening  the  regulatory  mechanism  for  wild  animal  trade,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2.  There  is  a  need  for  strengthening  the  regulatory  mechanism  for  wild  animal  trade', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 681.748, 526.4200000000001, 692.6560000000001), True, False, 36, 841.92, 595.32)"
36,"(13). The total  number of  COVID-19  confirmed  cases  is  on  a continuous rise,  and the cure",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(13). The total  number of  COVID-19  confirmed  cases  is  on  a continuous rise,  and the cure', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 666.748, 526.36, 677.6560000000001), True, False, 36, 841.92, 595.32)"
36,"rate  is  relatively  low,  making  the  disease  control  very  difficult  to  achieve.  The  Chinese",0,0,0,0,0,0,0,0,0,0,0,0,0,"('rate  is  relatively  low,  making  the  disease  control  very  difficult  to  achieve.  The  Chinese', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 651.868, 526.1840000000001, 662.7760000000001), True, False, 36, 841.92, 595.32)"
36,government is making continuous efforts to contain the disease by taking emergency control,0,0,0,0,0,0,0,0,0,0,0,0,0,"('government is making continuous efforts to contain the disease by taking emergency control', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 636.988, 526.2260000000001, 647.8960000000001), True, False, 36, 841.92, 595.32)"
36,and prevention measures. They have already built a hospital for patients affected by this virus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and prevention measures. They have already built a hospital for patients affected by this virus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 622.1080000000001, 526.27, 633.0160000000001), True, False, 36, 841.92, 595.32)"
36,and  are  currently  building  several  more  for  accommodating  the  continuously  increasing,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  are  currently  building  several  more  for  accommodating  the  continuously  increasing', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 607.2280000000001, 526.08, 618.1360000000001), True, False, 36, 841.92, 595.32)"
36,infected  population  (230).  The  effective  control  of  SARS-CoV-2/COVID-19  requires  high-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infected  population  (230).  The  effective  control  of  SARS-CoV-2/COVID-19  requires  high-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 592.3480000000001, 523.336, 603.2560000000001), True, False, 36, 841.92, 595.32)"
36,"level  interventions  like  intensive  contact  tracing,  as  well  as  quarantine  of  suspected  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('level  interventions  like  intensive  contact  tracing,  as  well  as  quarantine  of  suspected  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 577.468, 526.33, 588.376), True, False, 36, 841.92, 595.32)"
36,"isolation of infected individuals. Implementation of rigorous control and preventive measures,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('isolation of infected individuals. Implementation of rigorous control and preventive measures,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 562.558, 529.42, 573.466), True, False, 36, 841.92, 595.32)"
36,"all  together,  might  control  the  reproduction  number  and  reduce  the  transmission  risk  (228).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('all  together,  might  control  the  reproduction  number  and  reduce  the  transmission  risk  (228).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 547.678, 526.42, 558.586), True, False, 36, 841.92, 595.32)"
36,"Considering  the  zoonotic  links  associated  with  SARS-CoV-2,  the  one  health  approach  may",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Considering  the  zoonotic  links  associated  with  SARS-CoV-2,  the  one  health  approach  may', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 532.798, 526.342, 543.706), True, False, 36, 841.92, 595.32)"
36,play  a  vital  role  in  the  prevention  and  control  measures  being  followed  to  restrain  this,0,0,0,0,0,0,0,0,0,0,0,0,0,"('play  a  vital  role  in  the  prevention  and  control  measures  being  followed  to  restrain  this', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 517.798, 526.124, 528.706), True, False, 36, 841.92, 595.32)"
36,pandemic virus (322-324). The substantial importation of COVID-19 pre-symptomatic cases,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pandemic virus (322-324). The substantial importation of COVID-19 pre-symptomatic cases', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 502.918, 526.33, 513.826), True, False, 36, 841.92, 595.32)"
36,"from  Wuhan  has  resulted  in  independent,  self-sustaining  outbreaks  across  the  major  cities",0,0,0,0,0,0,0,0,0,0,0,0,0,"('from  Wuhan  has  resulted  in  independent,  self-sustaining  outbreaks  across  the  major  cities', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 488.038, 526.2740000000001, 498.94599999999997), True, False, 36, 841.92, 595.32)"
36,both  within  the  country  and  across  the  globe.  The  majority  of  the  Chinese  cities  are  now,0,0,0,0,0,0,0,0,0,0,0,0,0,"('both  within  the  country  and  across  the  globe.  The  majority  of  the  Chinese  cities  are  now', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 473.158, 526.27, 484.066), True, False, 36, 841.92, 595.32)"
36,"facing  localized  outbreaks  of  COVID-19  (231).  Hence,  deploying  efficient  public  health",0,0,0,0,0,0,0,0,0,0,0,0,0,"('facing  localized  outbreaks  of  COVID-19  (231).  Hence,  deploying  efficient  public  health', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 458.278, 526.282, 469.186), True, False, 36, 841.92, 595.32)"
36,interventions might help to cut the spread of this virus globally.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('interventions might help to cut the spread of this virus globally.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 443.398, 380.11, 454.306), True, False, 36, 841.92, 595.32)"
36,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 420.478, 75.024, 431.38599999999997), True, False, 36, 841.92, 595.32)"
36,The  occurrence  of  COVID-19  infection  in  two  cruise  ships  gave  us  the  preliminary,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  occurrence  of  COVID-19  infection  in  two  cruise  ships  gave  us  the  preliminary', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 420.478, 526.318, 431.38599999999997), True, False, 36, 841.92, 595.32)"
36,idea regarding the transmission pattern of the disease. Cruise ships act as a close environment,0,0,0,0,0,0,0,0,0,0,0,0,0,"('idea regarding the transmission pattern of the disease. Cruise ships act as a close environment', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 405.358, 526.068, 416.26599999999996), True, False, 36, 841.92, 595.32)"
36,and  provide  an  ideal  setting  for  the  occurrence  of  respiratory  disease  outbreaks.  Such  an,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  provide  an  ideal  setting  for  the  occurrence  of  respiratory  disease  outbreaks.  Such  an', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 390.098, 526.02, 401.006), True, False, 36, 841.92, 595.32)"
36,environment  poses  a  significant  threat  to  travelers  since  people  from  different  countries  are,0,0,0,0,0,0,0,0,0,0,0,0,0,"('environment  poses  a  significant  threat  to  travelers  since  people  from  different  countries  are', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 374.978, 526.238, 385.88599999999997), True, False, 36, 841.92, 595.32)"
36,on board that favors the  introduction of  the pathogen (325). The two major cruise ship  that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('on board that favors the  introduction of  the pathogen (325). The two major cruise ship  that', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 359.738, 526.258, 370.64599999999996), True, False, 36, 841.92, 595.32)"
36,got  involved  in  the  COVID-19  outbreaks  were  the  Diamond  Princess  and  Grand  Princess.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('got  involved  in  the  COVID-19  outbreaks  were  the  Diamond  Princess  and  Grand  Princess.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 344.618, 526.42, 355.52599999999995), True, False, 36, 841.92, 595.32)"
36,The number of confirmed COVID-19 cases around the world are on the rise.  The success of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The number of confirmed COVID-19 cases around the world are on the rise.  The success of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 329.37800000000004, 526.202, 340.286), True, False, 36, 841.92, 595.32)"
36,preventive measures put forward by every country is mainly dependent upon their ability to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('preventive measures put forward by every country is mainly dependent upon their ability to', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 314.25800000000004, 526.306, 325.166), True, False, 36, 841.92, 595.32)"
36,anticipate the oncoming waves of patients. This will help to properly prepare the healthcare,0,0,0,0,0,0,0,0,0,0,0,0,0,"('anticipate the oncoming waves of patients. This will help to properly prepare the healthcare', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 299.01800000000003, 526.0919999999996, 309.926), True, False, 36, 841.92, 595.32)"
36,workers and increase the intensive care unit (ICU) capacity (326). Instead of entirely relying,0,0,0,0,0,0,0,0,0,0,0,0,0,"('workers and increase the intensive care unit (ICU) capacity (326). Instead of entirely relying', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 283.898, 526.3960000000001, 294.806), True, False, 36, 841.92, 595.32)"
36,"on  lockdown  protocols,  countries  should  focus  mainly  on  the  alternative  intervention",0,0,0,0,0,0,0,0,0,0,0,0,0,"('on  lockdown  protocols,  countries  should  focus  mainly  on  the  alternative  intervention', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 268.658, 526.166, 279.566), True, False, 36, 841.92, 595.32)"
36,"strategies such as large-scale testing, contract tracing, and localized quarantine of suspected",0,0,0,0,0,0,0,0,0,0,0,0,0,"('strategies such as large-scale testing, contract tracing, and localized quarantine of suspected', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 253.53799999999998, 526.2819999999999, 264.44599999999997), True, False, 36, 841.92, 595.32)"
36,cases  for  limiting  the  spread  of  this  pandemic  virus.  Such  intervention  strategies  will  be,0,0,0,0,0,0,0,0,0,0,0,0,0,"('cases  for  limiting  the  spread  of  this  pandemic  virus.  Such  intervention  strategies  will  be', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 238.29799999999997, 526.282, 249.206), True, False, 36, 841.92, 595.32)"
36,useful either at the beginning of the pandemic or after lockdown relaxation (327). Lockdown,0,0,0,0,0,0,0,0,0,0,0,0,0,"('useful either at the beginning of the pandemic or after lockdown relaxation (327). Lockdown', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 223.178, 526.384, 234.086), True, False, 36, 841.92, 595.32)"
36,should be imposed only to slow down the disease progression among the population so that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('should be imposed only to slow down the disease progression among the population so that', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 207.908, 526.1399999999999, 218.816), True, False, 36, 841.92, 595.32)"
36,the health-care system is not overloaded.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the health-care system is not overloaded.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 192.78799999999998, 271.01, 203.696), True, False, 36, 841.92, 595.32)"
36,The reproduction number (R0) of COVID-19 infection was earlier estimated to be in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The reproduction number (R0) of COVID-19 infection was earlier estimated to be in', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 171.44336, 526.396, 182.456), True, False, 36, 841.92, 595.32)"
36,"the range of 1.4-2.5 (70), and recently, it is estimated to be 2.24 to 3.58 (76). When compared",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the range of 1.4-2.5 (70), and recently, it is estimated to be 2.24 to 3.58 (76). When compared', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 156.428, 526.342, 167.336), True, False, 36, 841.92, 595.32)"
36,"to  their  coronavirus  predecessors,  COVID-19  has  anR0  value  that  is  greater  than  that  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('to  their  coronavirus  predecessors,  COVID-19  has  anR0  value  that  is  greater  than  that  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 141.08336, 526.2940000000001, 152.096), True, False, 36, 841.92, 595.32)"
36,"MERS (R0 <1) (108) but less than that of SARS (R0 value of2-5) (93). Still, to prevent further",0,0,0,0,0,0,0,0,0,0,0,0,0,"('MERS (R0 <1) (108) but less than that of SARS (R0 value of2-5) (93). Still, to prevent further', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 125.96336000000001, 526.366, 136.976), True, False, 36, 841.92, 595.32)"
36,"spread  of  disease  mass  gatherings,  functions  remain  canceled  in  the  affected  cities,  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('spread  of  disease  mass  gatherings,  functions  remain  canceled  in  the  affected  cities,  and', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 110.828, 526.408, 121.736), True, False, 36, 841.92, 595.32)"
36,"persons are also asked to work from home (232). Hence, it is a relief that the current outbreak",0,0,0,0,0,0,0,0,0,0,0,0,0,"('persons are also asked to work from home (232). Hence, it is a relief that the current outbreak', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 95.712, 526.202, 106.62), True, False, 36, 841.92, 595.32)"
36,of  COVID-19  infection  can  be  brought  under  control  with  the  adoption  of  strategic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  COVID-19  infection  can  be  brought  under  control  with  the  adoption  of  strategic', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 80.472, 526.202, 91.38), True, False, 36, 841.92, 595.32)"
36,preventive  and  control  measures  along  with  the  early  isolation  of  subsequent  cases  in  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('preventive  and  control  measures  along  with  the  early  isolation  of  subsequent  cases  in  the', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 65.352, 526.116, 76.26), True, False, 36, 841.92, 595.32)"
36,35,0,0,0,0,0,0,0,0,0,0,0,0,0,"('35', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 36, 841.92, 595.32)"
36,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 36, 841.92, 595.32)"
37,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 37, 841.92, 595.32)"
37,coming  days.  Studies  also  report  that  since  the  air  traffic  between  China  and  African,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coming  days.  Studies  also  report  that  since  the  air  traffic  between  China  and  African', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.2379999999999, 767.076), True, False, 37, 841.92, 595.32)"
37,"countries increased many folds in the past decade after the SARS outbreak, African countries",0,0,0,0,0,0,0,0,0,0,0,0,0,"('countries increased many folds in the past decade after the SARS outbreak, African countries', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.028, 526.2940000000001, 751.936), True, False, 37, 841.92, 595.32)"
37,need to be vigilant to prevent the spread of novel coronavirus in Africa (225). Due to fear of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('need to be vigilant to prevent the spread of novel coronavirus in Africa (225). Due to fear of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 725.788, 526.372, 736.696), True, False, 37, 841.92, 595.32)"
37,"virus spread, Wuhan city has been completely shut down (233). The immediate control over",0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus spread, Wuhan city has been completely shut down (233). The immediate control over', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 710.668, 526.408, 721.576), True, False, 37, 841.92, 595.32)"
37,"the ongoing COVID-19 outbreaks appears a mammoth task, especially for the third world and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the ongoing COVID-19 outbreaks appears a mammoth task, especially for the third world and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 695.428, 526.366, 706.336), True, False, 37, 841.92, 595.32)"
37,developing  countries  due  to  their  inability  to  allocate  quarantine  stations  that  could  screen,0,0,0,0,0,0,0,0,0,0,0,0,0,"('developing  countries  due  to  their  inability  to  allocate  quarantine  stations  that  could  screen', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 680.308, 526.408, 691.216), True, False, 37, 841.92, 595.32)"
37,infected  individuals'  movement  (234).  Such  underdeveloped  countries  should  divert  their,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""infected  individuals'  movement  (234).  Such  underdeveloped  countries  should  divert  their"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 665.068, 526.2140000000002, 675.976), True, False, 37, 841.92, 595.32)"
37,resources and energy on enforcing the primary level of preventive measures like controlling,0,0,0,0,0,0,0,0,0,0,0,0,0,"('resources and energy on enforcing the primary level of preventive measures like controlling', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 649.948, 526.2580000000002, 660.856), True, False, 37, 841.92, 595.32)"
37,"the entry of individuals from China or countries where the disease has flared-up, isolating the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the entry of individuals from China or countries where the disease has flared-up, isolating the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 634.708, 526.408, 645.616), True, False, 37, 841.92, 595.32)"
37,"infected  individuals,  and  quarantine  of  suspected  individuals.  Most  of  the  sub-Saharan",0,0,0,0,0,0,0,0,0,0,0,0,0,"('infected  individuals,  and  quarantine  of  suspected  individuals.  Most  of  the  sub-Saharan', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 619.588, 526.408, 630.496), True, False, 37, 841.92, 595.32)"
37,African countries have a fragile health system that gets crippled in the event of an outbreak.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('African countries have a fragile health system that gets crippled in the event of an outbreak.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 604.3480000000001, 526.1540000000001, 615.2560000000001), True, False, 37, 841.92, 595.32)"
37,Effective management of COVID-19 would be difficult for low-income countries due to their,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Effective management of COVID-19 would be difficult for low-income countries due to their', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 589.2280000000001, 526.2940000000001, 600.1360000000001), True, False, 37, 841.92, 595.32)"
37,inability to respond rapidly due to the lack of an efficient health care system (65). Controlling,0,0,0,0,0,0,0,0,0,0,0,0,0,"('inability to respond rapidly due to the lack of an efficient health care system (65). Controlling', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 573.988, 526.42, 584.8960000000001), True, False, 37, 841.92, 595.32)"
37,the  imported  cases  is  critical  in  preventing  the  spread  of  COVID-19  to  other  countries  that,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  imported  cases  is  critical  in  preventing  the  spread  of  COVID-19  to  other  countries  that', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 558.838, 526.342, 569.746), True, False, 37, 841.92, 595.32)"
37,have not reported the disease until now. The probability that an imported case of COVID-19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('have not reported the disease until now. The probability that an imported case of COVID-19', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 543.5980000000001, 526.42, 554.5060000000001), True, False, 37, 841.92, 595.32)"
37,is followed by sustained human-to-human transmission was estimated to be 0.41. This can be,0,0,0,0,0,0,0,0,0,0,0,0,0,"('is followed by sustained human-to-human transmission was estimated to be 0.41. This can be', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 528.4780000000001, 526.3299999999999, 539.3860000000001), True, False, 37, 841.92, 595.32)"
37,reduced  to  a  value  of  0.012  by  decreasing  the  meantime  from  the  onset  of  symptoms  to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('reduced  to  a  value  of  0.012  by  decreasing  the  meantime  from  the  onset  of  symptoms  to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 513.238, 526.3299999999999, 524.1460000000001), True, False, 37, 841.92, 595.32)"
37,hospitalization by half and can only  be made possible by using intense disease surveillance,0,0,0,0,0,0,0,0,0,0,0,0,0,"('hospitalization by half and can only  be made possible by using intense disease surveillance', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 498.118, 526.0319999999999, 509.02599999999995), True, False, 37, 841.92, 595.32)"
37,systems  (235).  The  silent  importations  of  infected  individuals  (before  the  manifestation  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('systems  (235).  The  silent  importations  of  infected  individuals  (before  the  manifestation  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 482.87800000000004, 526.2200000000001, 493.786), True, False, 37, 841.92, 595.32)"
37,clinical signs) also contributed significantly to the spread of disease across the major cities of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('clinical signs) also contributed significantly to the spread of disease across the major cities of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 467.75800000000004, 526.408, 478.666), True, False, 37, 841.92, 595.32)"
37,"the  world.  Even  though  the  travel  ban  was  hosted  in  Wuhan  (89),  infected  persons  who",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  world.  Even  though  the  travel  ban  was  hosted  in  Wuhan  (89),  infected  persons  who', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 452.51800000000003, 526.3960000000001, 463.426), True, False, 37, 841.92, 595.32)"
37,traveled out of the city just before the imposition of the ban might have remained undetected,0,0,0,0,0,0,0,0,0,0,0,0,0,"('traveled out of the city just before the imposition of the ban might have remained undetected', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 437.398, 526.318, 448.306), True, False, 37, 841.92, 595.32)"
37,and  resulted  in  local  outbreaks  (236).  Emerging  novel  diseases  like  COVID-19  are,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  resulted  in  local  outbreaks  (236).  Emerging  novel  diseases  like  COVID-19  are', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 422.158, 526.396, 433.066), True, False, 37, 841.92, 595.32)"
37,challenging to be contained within the country of origin since globalization has led to a world,0,0,0,0,0,0,0,0,0,0,0,0,0,"('challenging to be contained within the country of origin since globalization has led to a world', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 407.038, 526.124, 417.94599999999997), True, False, 37, 841.92, 595.32)"
37,"without borders. Hence, international collaboration plays a vital role in preventing the further",0,0,0,0,0,0,0,0,0,0,0,0,0,"('without borders. Hence, international collaboration plays a vital role in preventing the further', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 391.778, 526.1420000000002, 402.686), True, False, 37, 841.92, 595.32)"
37,spread of this virus across the globe (237).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('spread of this virus across the globe (237).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 376.658, 279.05, 387.566), True, False, 37, 841.92, 595.32)"
37,"We also predict the possibility of another outbreak, as predicted by Fan et al. (6). The",0,0,0,0,0,0,0,0,0,0,0,0,0,"('We also predict the possibility of another outbreak, as predicted by Fan et al. (6). The', 'TimesNewRomanPSMT', 10.907999999999959, (108.02, 355.418, 526.396, 366.32599999999996), True, False, 37, 841.92, 595.32)"
37,present  outbreak  caused  by SARS-CoV-2  (COVID-19)  was  indeed  expected.  Similar  to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('present  outbreak  caused  by SARS-CoV-2  (COVID-19)  was  indeed  expected.  Similar  to', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 340.298, 526.2700000000001, 351.20599999999996), True, False, 37, 841.92, 595.32)"
37,"previous  outbreaks,  the  current  outbreak  will  also  be  contained  shortly.  However,  the  real",0,0,0,0,0,0,0,0,0,0,0,0,0,"('previous  outbreaks,  the  current  outbreak  will  also  be  contained  shortly.  However,  the  real', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 325.058, 526.318, 335.96599999999995), True, False, 37, 841.92, 595.32)"
37,"question is, how are we planning to counter the next zoonotic CoV epidemic that is likely to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('question is, how are we planning to counter the next zoonotic CoV epidemic that is likely to', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 309.938, 526.1480000000001, 320.84599999999995), True, False, 37, 841.92, 595.32)"
37,occur within the next 5-10 years or perhaps within a lesser time? (Fig. 7).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('occur within the next 5-10 years or perhaps within a lesser time? (Fig. 7).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 294.69800000000004, 430.03, 305.606), False, False, 37, 841.92, 595.32)"
37,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 273.57800000000003, 75.024, 284.29400000000004), True, False, 37, 841.92, 595.32)"
37,CONCLUDING REMARKS,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CONCLUDING REMARKS', 'TimesNewRomanPS-BoldMT', 10.716000000000037, (72.024, 252.338, 222.77, 263.05400000000003), True, False, 37, 841.92, 595.32)"
37,"Several  years  after  the  global  SARS  epidemic,  the  current  SARS-CoV-2/COVID-19",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Several  years  after  the  global  SARS  epidemic,  the  current  SARS-CoV-2/COVID-19', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 231.218, 526.408, 242.126), True, False, 37, 841.92, 595.32)"
37,pandemic  has  served  as  a  reminder  of  how  novel  pathogens  can  rapidly  emerge  and  spread,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pandemic  has  served  as  a  reminder  of  how  novel  pathogens  can  rapidly  emerge  and  spread', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 215.34799999999998, 526.1599999999999, 226.256), True, False, 37, 841.92, 595.32)"
37,"through  the  human  population,  which  may  eventually  cause  severe  public  health  crises.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('through  the  human  population,  which  may  eventually  cause  severe  public  health  crises.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 199.38799999999998, 526.1639999999998, 210.296), True, False, 37, 841.92, 595.32)"
37,Further  research  should  be  conducted  to  establish  animal  models  for  SARS-CoV-2to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Further  research  should  be  conducted  to  establish  animal  models  for  SARS-CoV-2to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 183.54799999999997, 526.42, 194.456), True, False, 37, 841.92, 595.32)"
37,"investigate  replication,  transmission  dynamics,  and  pathogenesis  in  humans.  This  may  help",0,0,0,0,0,0,0,0,0,0,0,0,0,"('investigate  replication,  transmission  dynamics,  and  pathogenesis  in  humans.  This  may  help', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 167.708, 526.1, 178.616), True, False, 37, 841.92, 595.32)"
37,develop and evaluate potential therapeutic strategies against zoonotic CoV epidemics. Present,0,0,0,0,0,0,0,0,0,0,0,0,0,"('develop and evaluate potential therapeutic strategies against zoonotic CoV epidemics. Present', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 151.868, 526.152, 162.776), True, False, 37, 841.92, 595.32)"
37,"trends  suggest  the  occurrence  of  future  outbreaks  of  CoVs  due  to  changes  in  climate,  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('trends  suggest  the  occurrence  of  future  outbreaks  of  CoVs  due  to  changes  in  climate,  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 135.908, 526.408, 146.816), True, False, 37, 841.92, 595.32)"
37,"ecological  conditions  may  be  associated  with  human-animal  contact.  Live-animal  markets,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('ecological  conditions  may  be  associated  with  human-animal  contact.  Live-animal  markets,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 120.068, 526.42, 130.976), True, False, 37, 841.92, 595.32)"
37,"such as the Huanan South China Seafood Market, represent ideal conditions for inter-species",0,0,0,0,0,0,0,0,0,0,0,0,0,"('such as the Huanan South China Seafood Market, represent ideal conditions for inter-species', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 104.228, 526.396, 115.136), True, False, 37, 841.92, 595.32)"
37,"contact of wildlife with domestic birds, pigs, and mammals, which substantially increases the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('contact of wildlife with domestic birds, pigs, and mammals, which substantially increases the', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 88.392, 526.16, 99.3), True, False, 37, 841.92, 595.32)"
37,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 37, 841.92, 595.32)"
37,36,0,0,0,0,0,0,0,0,0,0,0,0,0,"('36', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 37, 841.92, 595.32)"
38,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 38, 841.92, 595.32)"
38,probability  of  inter-species  transmission  of  CoV infections  and  could  result  in  high  risks to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('probability  of  inter-species  transmission  of  CoV infections  and  could  result  in  high  risks to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.124, 767.076), True, False, 38, 841.92, 595.32)"
38,humans due to adaptive genetic recombination in these viruses (328-330).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('humans due to adaptive genetic recombination in these viruses (328-330).', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 740.308, 429.67, 751.216), True, False, 38, 841.92, 595.32)"
38,"The COVID-19 associated symptoms such as fever, cough, expectoration, headache,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('The COVID-19 associated symptoms such as fever, cough, expectoration, headache,', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 718.468, 526.42, 729.376), True, False, 38, 841.92, 595.32)"
38,and  myalgia  or  fatigue.  Individuals  with  asymptomatic  and  atypical  clinical  manifestations,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  myalgia  or  fatigue.  Individuals  with  asymptomatic  and  atypical  clinical  manifestations', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 702.508, 526.2140000000002, 713.416), True, False, 38, 841.92, 595.32)"
38,"were  also  identified  recently,  further  adding  to  the  complexity  of  disease  transmission",0,0,0,0,0,0,0,0,0,0,0,0,0,"('were  also  identified  recently,  further  adding  to  the  complexity  of  disease  transmission', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 686.668, 526.2620000000001, 697.576), True, False, 38, 841.92, 595.32)"
38,dynamics.  Atypical  clinical  manifestations  may  only  express  symptoms  such  as  fatigue,0,0,0,0,0,0,0,0,0,0,0,0,0,"('dynamics.  Atypical  clinical  manifestations  may  only  express  symptoms  such  as  fatigue', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 670.828, 526.384, 681.736), True, False, 38, 841.92, 595.32)"
38,"instead of the respiratory signs such as fever, cough, and sputum. In such cases, the clinician",0,0,0,0,0,0,0,0,0,0,0,0,0,"('instead of the respiratory signs such as fever, cough, and sputum. In such cases, the clinician', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 654.988, 526.42, 665.8960000000001), True, False, 38, 841.92, 595.32)"
38,must  be  vigilant  for  the  possible  occurrence  of  asymptomatic  and  atypical  clinical,0,0,0,0,0,0,0,0,0,0,0,0,0,"('must  be  vigilant  for  the  possible  occurrence  of  asymptomatic  and  atypical  clinical', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 639.028, 526.348, 649.936), True, False, 38, 841.92, 595.32)"
38,manifestations to avoid the possibility of missed diagnosis.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('manifestations to avoid the possibility of missed diagnosis.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 623.188, 358.39, 634.096), True, False, 38, 841.92, 595.32)"
38,The  present  outbreak  caused  by  SARS-CoV-2  was  indeed  expected.  Similar  to,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  present  outbreak  caused  by  SARS-CoV-2  was  indeed  expected.  Similar  to', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 601.3480000000001, 526.2460000000001, 612.2560000000001), True, False, 38, 841.92, 595.32)"
38,"previous  outbreaks,  the  current  outbreak  will  also  be  contained  shortly.  However,  the  real",0,0,0,0,0,0,0,0,0,0,0,0,0,"('previous  outbreaks,  the  current  outbreak  will  also  be  contained  shortly.  However,  the  real', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 585.508, 526.318, 596.416), True, False, 38, 841.92, 595.32)"
38,"question is, how are we planning to counter the next zoonotic CoV epidemic that is likely to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('question is, how are we planning to counter the next zoonotic CoV epidemic that is likely to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 569.518, 526.1480000000001, 580.426), True, False, 38, 841.92, 595.32)"
38,occur within the next 5-10 years or perhaps within a lesser time? Our knowledge of most of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('occur within the next 5-10 years or perhaps within a lesser time? Our knowledge of most of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 553.678, 526.354, 564.586), True, False, 38, 841.92, 595.32)"
38,"the  bat  CoVs  is  scarce  as  these  viruses  have  not  been  isolated  and  studied,  and  extensive",0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  bat  CoVs  is  scarce  as  these  viruses  have  not  been  isolated  and  studied,  and  extensive', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.838, 526.432, 548.746), True, False, 38, 841.92, 595.32)"
38,studies on such viruses  are typically only  conducted when they  are  associated with  specific,0,0,0,0,0,0,0,0,0,0,0,0,0,"('studies on such viruses  are typically only  conducted when they  are  associated with  specific', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 521.998, 526.0799999999998, 532.9060000000001), True, False, 38, 841.92, 595.32)"
38,disease  outbreaks.  The  next  step  following  the  control  of  the  COVID-19  outbreak  in  China,0,0,0,0,0,0,0,0,0,0,0,0,0,"('disease  outbreaks.  The  next  step  following  the  control  of  the  COVID-19  outbreak  in  China', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 506.038, 526.378, 516.946), True, False, 38, 841.92, 595.32)"
38,"should  be  focused  on  screening,  identification,  isolation,  and  characterization  of  CoVs",0,0,0,0,0,0,0,0,0,0,0,0,0,"('should  be  focused  on  screening,  identification,  isolation,  and  characterization  of  CoVs', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 490.19800000000004, 526.3299999999999, 501.106), True, False, 38, 841.92, 595.32)"
38,"present  in  wildlife  species  of  China,  particularly  in  bats.  Both  in  vitro  and  in  vivo  studies",0,0,0,0,0,0,0,0,0,0,0,0,0,"('present  in  wildlife  species  of  China,  particularly  in  bats.  Both  in  vitro  and  in  vivo  studies', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 474.358, 526.396, 485.27799999999996), False, False, 38, 841.92, 595.32)"
38,(using suitable animal models) should be conducted to evaluate the risk of future epidemics.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(using suitable animal models) should be conducted to evaluate the risk of future epidemics.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 458.51800000000003, 526.42, 469.426), True, False, 38, 841.92, 595.32)"
38,"Presently, licensed antiviral drugs or vaccines against SARS-CoV, MERS-CoV, and SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Presently, licensed antiviral drugs or vaccines against SARS-CoV, MERS-CoV, and SARS-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 442.558, 523.576, 453.46599999999995), True, False, 38, 841.92, 595.32)"
38,"CoV-2  are  lacking.  However,  advances  in  designing  antiviral  drugs  and  vaccines  against",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2  are  lacking.  However,  advances  in  designing  antiviral  drugs  and  vaccines  against', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 426.718, 526.1479999999999, 437.626), True, False, 38, 841.92, 595.32)"
38,several other emerging diseases will help develop suitable therapeutic agents against COVID-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('several other emerging diseases will help develop suitable therapeutic agents against COVID-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 410.87800000000004, 523.456, 421.786), True, False, 38, 841.92, 595.32)"
38,"19  in  a  short  time.  Until  then,  we  must  rely  exclusively  on  various  control  and  prevention",0,0,0,0,0,0,0,0,0,0,0,0,0,"('19  in  a  short  time.  Until  then,  we  must  rely  exclusively  on  various  control  and  prevention', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 395.038, 526.0319999999999, 405.94599999999997), True, False, 38, 841.92, 595.32)"
38,measures to prevent this new disease from becoming a pandemic.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('measures to prevent this new disease from becoming a pandemic.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 379.178, 389.59, 390.08599999999996), True, False, 38, 841.92, 595.32)"
38,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 357.218, 75.024, 367.934), True, False, 38, 841.92, 595.32)"
38,ACKNOWLEDGMENTS,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ACKNOWLEDGMENTS', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 336.098, 208.37, 346.814), True, False, 38, 841.92, 595.32)"
38,None.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('None.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 314.858, 104.06, 325.76599999999996), True, False, 38, 841.92, 595.32)"
38,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 293.738, 75.024, 304.64599999999996), True, False, 38, 841.92, 595.32)"
38,AUTHOR CONTRIBUTIONS,0,0,0,0,0,0,0,0,0,0,0,0,0,"('AUTHOR CONTRIBUTIONS', 'TimesNewRomanPS-BoldMT', 10.907999999999959, (72.024, 272.498, 235.73, 283.40599999999995), False, False, 38, 841.92, 595.32)"
38,"All the authors substantially contributed to the conception, design, analysis, and interpretation",0,0,0,0,0,0,0,0,0,0,0,0,0,"('All the authors substantially contributed to the conception, design, analysis, and interpretation', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 251.378, 526.354, 262.286), True, False, 38, 841.92, 595.32)"
38,"of  data,  checking  and  approving  the  final  version  of  the  manuscript,  and  agree  to  be",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  data,  checking  and  approving  the  final  version  of  the  manuscript,  and  agree  to  be', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 236.13799999999998, 526.25, 247.046), True, False, 38, 841.92, 595.32)"
38,accountable for its contents.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('accountable for its contents.', 'TimesNewRomanPSMT', 10.716000000000008, (72.024, 221.018, 212.69, 231.92600000000002), False, False, 38, 841.92, 595.32)"
38,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 199.748, 75.024, 210.464), True, False, 38, 841.92, 595.32)"
38,FUNDING,0,0,0,0,0,0,0,0,0,0,0,0,0,"('FUNDING', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 178.628, 131.06, 189.344), True, False, 38, 841.92, 595.32)"
38,"This  compilation  is  a  review  article  written,  analyzed,  and  designed  by  its  authors  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('This  compilation  is  a  review  article  written,  analyzed,  and  designed  by  its  authors  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 157.38799999999998, 526.396, 168.296), True, False, 38, 841.92, 595.32)"
38,required no substantial funding to be developed.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('required no substantial funding to be developed.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 142.268, 306.65, 153.17600000000002), True, False, 38, 841.92, 595.32)"
38,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 121.028, 75.024, 131.936), True, False, 38, 841.92, 595.32)"
38,DISCLOSURE STATEMENT,0,0,0,0,0,0,0,0,0,0,0,0,0,"('DISCLOSURE STATEMENT', 'TimesNewRomanPS-BoldMT', 10.715999999999994, (72.024, 99.908, 231.41, 110.624), True, False, 38, 841.92, 595.32)"
38,"All authors declare that there no existing commercial or financial relationships that could, in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('All authors declare that there no existing commercial or financial relationships that could, in', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 78.672, 526.318, 89.58), True, False, 38, 841.92, 595.32)"
38,"any way, lead to a potential conflicts of interest.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('any way, lead to a potential conflicts of interest.', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 63.55200000000001, 305.69, 74.46000000000001), True, False, 38, 841.92, 595.32)"
38,37,0,0,0,0,0,0,0,0,0,0,0,0,0,"('37', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 38, 841.92, 595.32)"
38,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 38, 841.92, 595.32)"
39,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 39, 841.92, 595.32)"
39,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 75.024, 767.076), True, False, 39, 841.92, 595.32)"
39,REFERENCES,0,0,0,0,0,0,0,0,0,0,0,0,0,"('REFERENCES', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 741.028, 158.66, 751.744), True, False, 39, 841.92, 595.32)"
39,"1.  Rodriguez-Morales  AJ,  Bonilla-Aldana  DK,  Balbin-Ramon  GJ,  Rabaan  AA,  Sah  R,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('1.  Rodriguez-Morales  AJ,  Bonilla-Aldana  DK,  Balbin-Ramon  GJ,  Rabaan  AA,  Sah  R,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 718.1080000000001, 526.282, 729.436), False, False, 39, 841.92, 595.32)"
39,"Paniz-Mondolfi  A,  Pagliano  P,  Esposito  S.  2020.  History  is  repeating  itself:  Probable",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Paniz-Mondolfi  A,  Pagliano  P,  Esposito  S.  2020.  History  is  repeating  itself:  Probable', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 703.2280000000001, 526.112, 714.1360000000001), True, False, 39, 841.92, 595.32)"
39,zoonotic  spillover  as  the  cause  of  the  2019  novel  Coronavirus  Epidemic.  Infez  Med,0,0,0,0,0,0,0,0,0,0,0,0,0,"('zoonotic  spillover  as  the  cause  of  the  2019  novel  Coronavirus  Epidemic.  Infez  Med', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 688.3480000000001, 526.0799999999998, 699.2560000000001), True, False, 39, 841.92, 595.32)"
39,28(1):3-5.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('28(1):3-5.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 673.3480000000001, 144.74, 684.2560000000001), True, False, 39, 841.92, 595.32)"
39,"2.  Gralinski  LE,  Menachery  VD.  2020.  Return  of  the  Coronavirus:  2019-nCoV.  Viruses",0,0,0,0,0,0,0,0,0,0,0,0,0,"('2.  Gralinski  LE,  Menachery  VD.  2020.  Return  of  the  Coronavirus:  2019-nCoV.  Viruses', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 658.468, 526.3960000000001, 669.7959999999999), False, False, 39, 841.92, 595.32)"
39,12(2):E135.  doi: 10.3390/v12020135.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('12(2):E135.  doi: 10.3390/v12020135.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 642.628, 284.09, 653.5360000000001), True, False, 39, 841.92, 595.32)"
39,"3.  Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('3.  Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 626.788, 529.212, 638.116), False, False, 39, 841.92, 595.32)"
39,"Zhan  F,  Ma  X,  Wang  D,  Xu  W,  Wu  G,  Gao  GF,  Tan  W,  China  Novel  Coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Zhan  F,  Ma  X,  Wang  D,  Xu  W,  Wu  G,  Gao  GF,  Tan  W,  China  Novel  Coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 611.908, 526.354, 622.816), True, False, 39, 841.92, 595.32)"
39,Investigating  and  Research  Team.  2020.  A  Novel  Coronavirus  from  Patients  with,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Investigating  and  Research  Team.  2020.  A  Novel  Coronavirus  from  Patients  with', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 597.028, 526.0679999999999, 607.936), True, False, 39, 841.92, 595.32)"
39,"Pneumonia  in  China,  2019.  N  Engl  J  Med  10.1056/NEJMoa2001017.  doi:",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Pneumonia  in  China,  2019.  N  Engl  J  Med  10.1056/NEJMoa2001017.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 582.148, 526.1880000000001, 593.056), True, False, 39, 841.92, 595.32)"
39,10.1056/NEJMoa2001017.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1056/NEJMoa2001017.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 567.238, 229.37, 578.1460000000001), True, False, 39, 841.92, 595.32)"
39,"4.  Wei X, Li X, Cui J. 2020. Evolutionary perspectives on novel Coronaviruses identified",0,0,0,0,0,0,0,0,0,0,0,0,0,"('4.  Wei X, Li X, Cui J. 2020. Evolutionary perspectives on novel Coronaviruses identified', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 552.238, 526.408, 563.566), False, False, 39, 841.92, 595.32)"
39,in pneumonia cases in China. National Science Review. doi: 10.1093/nsr/nwaa009.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in pneumonia cases in China. National Science Review. doi: 10.1093/nsr/nwaa009.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 537.3580000000001, 496.06, 548.2660000000001), True, False, 39, 841.92, 595.32)"
39,"5.  Munster  VJ,  Koopmans  M,  van  Doremalen  N,  van  Riel  D,  de  Wit  E.  2020.  A  novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('5.  Munster  VJ,  Koopmans  M,  van  Doremalen  N,  van  Riel  D,  de  Wit  E.  2020.  A  novel', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 522.4780000000001, 526.1400000000001, 533.806), False, False, 39, 841.92, 595.32)"
39,Coronavirus  emerging  in  China-key  questions  for  impact  assessment  N  Engl  J  Med,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus  emerging  in  China-key  questions  for  impact  assessment  N  Engl  J  Med', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 506.63800000000003, 526.25, 517.546), True, False, 39, 841.92, 595.32)"
39,10.1056/NEJMp2000929. doi:10.1056/NEJMp2000929,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1056/NEJMp2000929. doi:10.1056/NEJMp2000929', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 490.798, 367.51, 501.70599999999996), True, False, 39, 841.92, 595.32)"
39,"6.  Fan Y, Zhao K, Shi ZL, Zhou P. 2019. Bat Coronaviruses in China. Viruses 11(3):210.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('6.  Fan Y, Zhao K, Shi ZL, Zhou P. 2019. Bat Coronaviruses in China. Viruses 11(3):210.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 474.958, 526.0559999999999, 486.286), False, False, 39, 841.92, 595.32)"
39,doi:10.3390/v11030210.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:10.3390/v11030210.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 458.998, 214.37, 469.90599999999995), True, False, 39, 841.92, 595.32)"
39,7.  Lu H. 2020. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci,0,0,0,0,0,0,0,0,0,0,0,0,0,"('7.  Lu H. 2020. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 443.158, 526.372, 454.486), False, False, 39, 841.92, 595.32)"
39,Trends 10.5582/bst.2020.01020. doi: 10.5582/bst.2020.01020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Trends 10.5582/bst.2020.01020. doi: 10.5582/bst.2020.01020.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 427.31800000000004, 399.07, 438.226), True, False, 39, 841.92, 595.32)"
39,"8.  Sheahan TP, Sims AC, Leist SR, Schäfer A, Won J, Brown AJ, Montgomery SA, Hogg",0,0,0,0,0,0,0,0,0,0,0,0,0,"('8.  Sheahan TP, Sims AC, Leist SR, Schäfer A, Won J, Brown AJ, Montgomery SA, Hogg', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 411.478, 526.0200000000001, 422.806), False, False, 39, 841.92, 595.32)"
39,"A,  Babusis  D,  Clarke  MO,  Spahn  JE,  Bauer  L, Sellers  S,  Porter  D,  Feng  JY,  Cihlar  T,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('A,  Babusis  D,  Clarke  MO,  Spahn  JE,  Bauer  L, Sellers  S,  Porter  D,  Feng  JY,  Cihlar  T,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 396.478, 526.1659999999999, 407.38599999999997), True, False, 39, 841.92, 595.32)"
39,"Jordan R, Denison MR, Baric RS. 2020. Comparative therapeutic efficacy of remdesivir",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Jordan R, Denison MR, Baric RS. 2020. Comparative therapeutic efficacy of remdesivir', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 381.57800000000003, 526.1039999999998, 392.486), True, False, 39, 841.92, 595.32)"
39,"and  combination  lopinavir,  ritonavir,  and  interferon  beta  against  MERS-CoV.  Nat",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  combination  lopinavir,  ritonavir,  and  interferon  beta  against  MERS-CoV.  Nat', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 366.69800000000004, 526.372, 377.606), True, False, 39, 841.92, 595.32)"
39,Commun 11(1):222. doi: 10.1038/s41467-019-13940-6.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Commun 11(1):222. doi: 10.1038/s41467-019-13940-6.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 351.81800000000004, 367.99, 362.726), True, False, 39, 841.92, 595.32)"
39,"9.  Pillaiyar  T,  Meenakshisundaram  S,  Manickam  M.  2020.  Recent  discovery  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('9.  Pillaiyar  T,  Meenakshisundaram  S,  Manickam  M.  2020.  Recent  discovery  and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 336.938, 526.1519999999999, 348.26599999999996), False, False, 39, 841.92, 595.32)"
39,development  of  inhibitors  targeting  coronaviruses.  Drug  Discov  Today  S1359-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('development  of  inhibitors  targeting  coronaviruses.  Drug  Discov  Today  S1359-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 322.058, 523.576, 332.96599999999995), True, False, 39, 841.92, 595.32)"
39,6446(20)30041-6. doi: 10.1016/j.drudis.2020.01.015.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('6446(20)30041-6. doi: 10.1016/j.drudis.2020.01.015.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 307.178, 355.87, 318.08599999999996), True, False, 39, 841.92, 595.32)"
39,"10.  Su  S,  Wong  G,  Shi  W,  Liu  J,  Lai  ACK,  Zhou  J,  Liu  W,  Bi  Y,  Gao  GF.  2016.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.  Su  S,  Wong  G,  Shi  W,  Liu  J,  Lai  ACK,  Zhou  J,  Liu  W,  Bi  Y,  Gao  GF.  2016.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 292.298, 526.258, 303.626), False, False, 39, 841.92, 595.32)"
39,"Epidemiology,  genetic  recombination,  and  pathogenesis  of  Coronaviruses.  Trends",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Epidemiology,  genetic  recombination,  and  pathogenesis  of  Coronaviruses.  Trends', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 277.418, 526.1519999999999, 288.32599999999996), True, False, 39, 841.92, 595.32)"
39,Microbiol 24(6):490-502. doi: 10.1016/j.tim.2016.03.003.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Microbiol 24(6):490-502. doi: 10.1016/j.tim.2016.03.003.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 262.538, 378.19, 273.44599999999997), True, False, 39, 841.92, 595.32)"
39,"11.  Ng OW, Tan YJ. 2017. Understanding bat SARS-like coronaviruses for the preparation",0,0,0,0,0,0,0,0,0,0,0,0,0,"('11.  Ng OW, Tan YJ. 2017. Understanding bat SARS-like coronaviruses for the preparation', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 247.658, 526.306, 258.986), False, False, 39, 841.92, 595.32)"
39,of future corona virus outbreaks-Implications for coronavirus vaccine development. Hum,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of future corona virus outbreaks-Implications for coronavirus vaccine development. Hum', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 232.658, 526.2260000000001, 243.566), True, False, 39, 841.92, 595.32)"
39,VaccinImmunother 13(1):186-189. doi: 10.1080/21645515.2016.1228500.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('VaccinImmunother 13(1):186-189. doi: 10.1080/21645515.2016.1228500.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 217.778, 458.14, 228.686), True, False, 39, 841.92, 595.32)"
39,"12.  Bonilla-Aldana DK, Holguin-Rivera Y, Cortes-Bonilla I, Cardona-Trujillo MC, García-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('12.  Bonilla-Aldana DK, Holguin-Rivera Y, Cortes-Bonilla I, Cardona-Trujillo MC, García-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 202.868, 523.456, 214.196), False, False, 39, 841.92, 595.32)"
39,"Barco  A,  Bedoya-Arias  HA,  Rabaan  AA,  Sah  R,  Rodriguez-Morales  AJ.  2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Barco  A,  Bedoya-Arias  HA,  Rabaan  AA,  Sah  R,  Rodriguez-Morales  AJ.  2020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 187.028, 526.42, 197.936), True, False, 39, 841.92, 595.32)"
39,"Coronavirus infections reported by ProMED, February 2000-January 2020. Travel Med",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus infections reported by ProMED, February 2000-January 2020. Travel Med', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 171.188, 526.342, 182.096), True, False, 39, 841.92, 595.32)"
39,Infect Dis doi:10.1016/j.tmaid.2020.101575:101575.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infect Dis doi:10.1016/j.tmaid.2020.101575:101575.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 155.34799999999998, 350.11, 166.256), True, False, 39, 841.92, 595.32)"
39,"13.  Zhang  L,  Shen  FM,  Chen  F,  Lin  Z.  2020.  Origin  and  evolution  of  the  2019  novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('13.  Zhang  L,  Shen  FM,  Chen  F,  Lin  Z.  2020.  Origin  and  evolution  of  the  2019  novel', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 139.38799999999998, 526.238, 150.71599999999998), False, False, 39, 841.92, 595.32)"
39,"coronavirus  [published  online  ahead  of  print,  2020  Feb  3].  Clin  Infect  Dis  ciaa112.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus  [published  online  ahead  of  print,  2020  Feb  3].  Clin  Infect  Dis  ciaa112.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 124.508, 526.1519999999998, 135.416), True, False, 39, 841.92, 595.32)"
39,doi:10.1093/cid/ciaa112.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:10.1093/cid/ciaa112.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 109.628, 215.69, 120.536), True, False, 39, 841.92, 595.32)"
39,"14.  Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao",0,0,0,0,0,0,0,0,0,0,0,0,0,"('14.  Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 94.752, 526.318, 106.08), False, False, 39, 841.92, 595.32)"
39,"HN,  Sheng  JF,  Cai  HL,  Qiu  YQ,  Li  LJ.  2020.  Clinical  findings  in  a  group  of  patients",0,0,0,0,0,0,0,0,0,0,0,0,0,"('HN,  Sheng  JF,  Cai  HL,  Qiu  YQ,  Li  LJ.  2020.  Clinical  findings  in  a  group  of  patients', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 79.872, 526.2220000000001, 90.78), True, False, 39, 841.92, 595.32)"
39,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 39, 841.92, 595.32)"
39,38,0,0,0,0,0,0,0,0,0,0,0,0,0,"('38', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 39, 841.92, 595.32)"
40,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 40, 841.92, 595.32)"
40,"infected  with  the  2019  novel  coronavirus  (SARS-Cov-2)  outside  of  Wuhan,  China:",0,0,0,0,0,0,0,0,0,0,0,0,0,"('infected  with  the  2019  novel  coronavirus  (SARS-Cov-2)  outside  of  Wuhan,  China:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 756.168, 526.306, 767.076), True, False, 40, 841.92, 595.32)"
40,retrospective case series. BMJ 368:m606. doi: 10.1136/bmj.m606.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('retrospective case series. BMJ 368:m606. doi: 10.1136/bmj.m606.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 418.39, 752.176), True, False, 40, 841.92, 595.32)"
40,15.  Chen  J.  2020.  Pathogenicity  and  transmissibility  of  2019-nCoV-A  quick  overview  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('15.  Chen  J.  2020.  Pathogenicity  and  transmissibility  of  2019-nCoV-A  quick  overview  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 526.342, 737.716), False, False, 40, 841.92, 595.32)"
40,comparison  with  other  emerging  viruses.  Microbes  Infect  S1286-4579(20)30026-5.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('comparison  with  other  emerging  viruses.  Microbes  Infect  S1286-4579(20)30026-5.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 711.508, 526.42, 722.416), True, False, 40, 841.92, 595.32)"
40,doi:10.1016/j.micinf.2020.01.004.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:10.1016/j.micinf.2020.01.004.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 696.628, 261.05, 707.5360000000001), True, False, 40, 841.92, 595.32)"
40,"16.  Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('16.  Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 681.748, 526.384, 693.076), False, False, 40, 841.92, 595.32)"
40,"Sheng  J,  Quan  L,  Xia  Z,  Tan  W,  Cheng  G,  Jiang  T.  2020.  Genome  composition  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sheng  J,  Quan  L,  Xia  Z,  Tan  W,  Cheng  G,  Jiang  T.  2020.  Genome  composition  and', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 666.748, 526.306, 677.6560000000001), True, False, 40, 841.92, 595.32)"
40,divergence  of  the  novel  Coronavirus  (2019-nCoV)  originating  in  China.  Cell  Host,0,0,0,0,0,0,0,0,0,0,0,0,0,"('divergence  of  the  novel  Coronavirus  (2019-nCoV)  originating  in  China.  Cell  Host', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 651.868, 526.27, 662.7760000000001), True, False, 40, 841.92, 595.32)"
40,Microbe S1931-3128(20)30072-X. doi: 10.1016/j.chom.2020.02.001.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Microbe S1931-3128(20)30072-X. doi: 10.1016/j.chom.2020.02.001.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 636.988, 430.39, 647.8960000000001), True, False, 40, 841.92, 595.32)"
40,"17.  Lu  R, Zhao  X, Li  J, Niu  P, Yang  B, Wu  H, Wang  W, Song  H, Huang  B, Zhu  N, Bi",0,0,0,0,0,0,0,0,0,0,0,0,0,"('17.  Lu  R, Zhao  X, Li  J, Niu  P, Yang  B, Wu  H, Wang  W, Song  H, Huang  B, Zhu  N, Bi', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 622.1080000000001, 526.408, 633.436), False, False, 40, 841.92, 595.32)"
40,"Y, Ma  X, Zhan  F, Wang  L, Hu  T, Zhou  H, Hu  Z, Zhou  W, Zhao  L, Chen  J, Meng",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Y, Ma  X, Zhan  F, Wang  L, Hu  T, Zhou  H, Hu  Z, Zhou  W, Zhao  L, Chen  J, Meng', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 606.268, 526.42, 617.176), True, False, 40, 841.92, 595.32)"
40,"Y, Wang  J, Lin  Y, Yuan  J, Xie  Z, Ma  J, Liu  WJ, Wang  D, Xu  W, Holmes  EC, Gao",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Y, Wang  J, Lin  Y, Yuan  J, Xie  Z, Ma  J, Liu  WJ, Wang  D, Xu  W, Holmes  EC, Gao', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 590.428, 526.42, 601.336), True, False, 40, 841.92, 595.32)"
40,"GF, Wu  G, Chen W, Shi W, Tan W.  2020. Genomic characterization and epidemiology",0,0,0,0,0,0,0,0,0,0,0,0,0,"('GF, Wu  G, Chen W, Shi W, Tan W.  2020. Genomic characterization and epidemiology', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 574.468, 526.318, 585.376), True, False, 40, 841.92, 595.32)"
40,of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet pii:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet pii:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 558.5980000000001, 529.768, 569.5060000000001), True, False, 40, 841.92, 595.32)"
40,S0140-6736(20)30251-8. doi: 10.1016/S0140-6736(20)30251-8.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('S0140-6736(20)30251-8. doi: 10.1016/S0140-6736(20)30251-8.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 542.758, 406.75, 553.666), True, False, 40, 841.92, 595.32)"
40,"18.  Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li",0,0,0,0,0,0,0,0,0,0,0,0,0,"('18.  Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 526.918, 526.044, 538.246), False, False, 40, 841.92, 595.32)"
40,"CH, Li GC, Liu HG. 2020. Clinical characteristics of novel coronavirus cases in tertiary",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CH, Li GC, Liu HG. 2020. Clinical characteristics of novel coronavirus cases in tertiary', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 512.038, 526.128, 522.946), True, False, 40, 841.92, 595.32)"
40,hospitals in Hubei Province. Chin Med J (Engl) 10.1097/CM9.0000000000000744. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('hospitals in Hubei Province. Chin Med J (Engl) 10.1097/CM9.0000000000000744. doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 497.158, 526.176, 508.066), True, False, 40, 841.92, 595.32)"
40,10.1097/CM9.0000000000000744.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1097/CM9.0000000000000744.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 482.158, 265.37, 493.066), True, False, 40, 841.92, 595.32)"
40,19.  Cyranoski  D.  2020.  This  scientist  hopes  to  test coronavirus drugs  on animals in  locked-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('19.  Cyranoski  D.  2020.  This  scientist  hopes  to  test coronavirus drugs  on animals in  locked-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 467.278, 523.576, 478.606), False, False, 40, 841.92, 595.32)"
40,down Wuhan. Nature. 577(7792):607. doi: 10.1038/d41586-020-00190-6.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('down Wuhan. Nature. 577(7792):607. doi: 10.1038/d41586-020-00190-6.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 451.438, 451.78, 462.34599999999995), True, False, 40, 841.92, 595.32)"
40,"20.  Dhama K, Pawaiya RVS,  Chakraborty S, Tiwari R, Saminathan M, Verma AK. 2014a.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('20.  Dhama K, Pawaiya RVS,  Chakraborty S, Tiwari R, Saminathan M, Verma AK. 2014a.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 435.598, 526.1159999999999, 446.926), False, False, 40, 841.92, 595.32)"
40,Coronavirus  infection  in  equines:  A  review.  Asian  J  Anim  Vet  Adv.  9(3):  164-176.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus  infection  in  equines:  A  review.  Asian  J  Anim  Vet  Adv.  9(3):  164-176.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 420.718, 526.42, 431.626), True, False, 40, 841.92, 595.32)"
40,DOI: 10.3923/ajava.2014.164.176,0,0,0,0,0,0,0,0,0,0,0,0,0,"('DOI: 10.3923/ajava.2014.164.176', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 405.838, 260.69, 416.746), True, False, 40, 841.92, 595.32)"
40,"21.  Zaher NH, Mostafa MI, Altaher AY. 2020. Design, synthesis and molecular docking of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('21.  Zaher NH, Mostafa MI, Altaher AY. 2020. Design, synthesis and molecular docking of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 390.938, 526.0679999999998, 402.26599999999996), False, False, 40, 841.92, 595.32)"
40,novel  triazole  derivatives  as  potential  CoV  helicase  inhibitors.  Acta  Pharm  70(2):145-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('novel  triazole  derivatives  as  potential  CoV  helicase  inhibitors.  Acta  Pharm  70(2):145-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 375.938, 523.336, 386.84599999999995), True, False, 40, 841.92, 595.32)"
40,159. doi: 10.2478/acph-2020-0024.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('159. doi: 10.2478/acph-2020-0024.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 361.058, 268.97, 371.96599999999995), True, False, 40, 841.92, 595.32)"
40,"22.  Bonilla-Aldana  DK,  Villamil-Gómez  WE,  Rabaan  AA,  Rodriguez-Morales  AJ.  2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('22.  Bonilla-Aldana  DK,  Villamil-Gómez  WE,  Rabaan  AA,  Rodriguez-Morales  AJ.  2020.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 346.178, 526.342, 357.506), False, False, 40, 841.92, 595.32)"
40,"Una  nueva  zoonosis  viral  de  preocupación  global:  COVID-19,  enfermedad  por",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Una  nueva  zoonosis  viral  de  preocupación  global:  COVID-19,  enfermedad  por', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 330.338, 526.3299999999999, 341.246), True, False, 40, 841.92, 595.32)"
40,coronavirus 2019. Iatreia 33(2).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus 2019. Iatreia 33(2).', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 314.498, 248.69, 325.40599999999995), True, False, 40, 841.92, 595.32)"
40,"23.  Weiss SR, Leibowitz JL. 2011. Coronavirus pathogenesis. Adv Virus Res 81:85-164. doi:",0,0,0,0,0,0,0,0,0,0,0,0,0,"('23.  Weiss SR, Leibowitz JL. 2011. Coronavirus pathogenesis. Adv Virus Res 81:85-164. doi:', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 298.658, 529.768, 309.986), False, False, 40, 841.92, 595.32)"
40,10.1016/B978-0-12-385885-6.00009-2.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/B978-0-12-385885-6.00009-2.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 282.69800000000004, 289.73, 293.606), True, False, 40, 841.92, 595.32)"
40,"24.  Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('24.  Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 266.858, 526.0199999999999, 278.186), False, False, 40, 841.92, 595.32)"
40,2020.  Coronavirus  infections  and  immune  responses.  J  Med  Virol  10.1002/jmv.25685.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020.  Coronavirus  infections  and  immune  responses.  J  Med  Virol  10.1002/jmv.25685.', 'TimesNewRomanPSMT', 10.907999999999987, (93.384, 251.018, 526.1600000000001, 261.926), True, False, 40, 841.92, 595.32)"
40,doi: 10.1002/jmv.25685.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi: 10.1002/jmv.25685.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 235.178, 218.09, 246.086), True, False, 40, 841.92, 595.32)"
40,25.  WHO.  2020.  World  Health  Organization.  Coronavirus  disease  2019  (COVID-19),0,0,0,0,0,0,0,0,0,0,0,0,0,"('25.  WHO.  2020.  World  Health  Organization.  Coronavirus  disease  2019  (COVID-19)', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 219.218, 526.456, 230.546), False, False, 40, 841.92, 595.32)"
40,"situation  report,  Situation  report  -  33  (22ndFebruary  2020).  Available",0,0,0,0,0,0,0,0,0,0,0,0,0,"('situation  report,  Situation  report  -  33  (22ndFebruary  2020).  Available', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 203.34799999999998, 526.33, 216.07172), True, False, 40, 841.92, 595.32)"
40,online:  https://www.who.int/docs/default-source/coronaviruse/situation-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('online:  https://www.who.int/docs/default-source/coronaviruse/situation-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 187.50799999999998, 442.786, 198.416), True, False, 40, 841.92, 595.32)"
40,reports/20200222-sitrep-33-covid-19.pdf (accessed on 25 February 2020).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('reports/20200222-sitrep-33-covid-19.pdf (accessed on 25 February 2020).', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 171.66799999999998, 455.62, 182.576), True, False, 40, 841.92, 595.32)"
40,"26.  Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, Haagmans",0,0,0,0,0,0,0,0,0,0,0,0,0,"('26.  Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, Haagmans', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 155.708, 526.02, 167.036), False, False, 40, 841.92, 595.32)"
40,"BL,  Lauber  C,  Leontovich  AM,  Neuman  BW,  Penzar  D.  Severe  acute  respiratory",0,0,0,0,0,0,0,0,0,0,0,0,0,"('BL,  Lauber  C,  Leontovich  AM,  Neuman  BW,  Penzar  D.  Severe  acute  respiratory', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 140.82799999999997, 526.282, 151.736), True, False, 40, 841.92, 595.32)"
40,syndrome-related  coronavirus:  The  species  and  its  viruses-a  statement  of  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('syndrome-related  coronavirus:  The  species  and  its  viruses-a  statement  of  the', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 125.948, 526.354, 136.856), True, False, 40, 841.92, 595.32)"
40,Coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 111.068, 155.652, 121.976), True, False, 40, 841.92, 595.32)"
40,doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:', 'TimesNewRomanPSMT', 10.908000000000001, (504.8880000000001, 111.068, 526.248, 121.976), True, False, 40, 841.92, 595.32)"
40,10.1101/2020.02.07.937862,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1101/2020.02.07.937862', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 96.19200000000001, 231.77, 107.10000000000001), True, False, 40, 841.92, 595.32)"
40,Study  Group.bioRxiv2020;,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Study  Group.bioRxiv2020;', 'TimesNewRomanPSMT', 10.908000000000001, (184.68, 111.068, 347.47200000000004, 121.976), True, False, 40, 841.92, 595.32)"
40,2020.02.07.937862;,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020.02.07.937862;', 'TimesNewRomanPSMT', 10.908000000000001, (376.50000000000006, 111.068, 475.83600000000007, 121.976), True, False, 40, 841.92, 595.32)"
40,"27.  Chen  Y,  Liu  Q,  Guo  D.  2020.  Emerging  coronaviruses:  genome  structure,  replication,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('27.  Chen  Y,  Liu  Q,  Guo  D.  2020.  Emerging  coronaviruses:  genome  structure,  replication,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 81.312, 526.306, 92.64), False, False, 40, 841.92, 595.32)"
40,and pathogenesis J Med Virol 10.1002/jmv.25681. doi:10.1002/jmv.25681.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and pathogenesis J Med Virol 10.1002/jmv.25681. doi:10.1002/jmv.25681.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 65.472, 461.5, 76.38), True, False, 40, 841.92, 595.32)"
40,39,0,0,0,0,0,0,0,0,0,0,0,0,0,"('39', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 40, 841.92, 595.32)"
40,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 40, 841.92, 595.32)"
41,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 41, 841.92, 595.32)"
41,"28.  Lai MMC, Holmes KV. 2001. Coronaviridae: the viruses and their replication Fields, BN",0,0,0,0,0,0,0,0,0,0,0,0,0,"('28.  Lai MMC, Holmes KV. 2001. Coronaviridae: the viruses and their replication Fields, BN', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.152, 767.496), False, False, 41, 841.92, 595.32)"
41,"Knipe, DM Howley, PM eds. Fields virology Lippincott-Raven Philadephia 1163: 1185.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Knipe, DM Howley, PM eds. Fields virology Lippincott-Raven Philadephia 1163: 1185.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 524.26, 752.176), True, False, 41, 841.92, 595.32)"
41,"29.  Woo  PC,  Lau  SK,  Lam  CS,  Lau  CC,  Tsang  AK,  Lau  JH,  Bai  R,  Teng  JL,  Tsang  CC,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('29.  Woo  PC,  Lau  SK,  Lam  CS,  Lau  CC,  Tsang  AK,  Lau  JH,  Bai  R,  Teng  JL,  Tsang  CC,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 525.9479999999999, 737.716), False, False, 41, 841.92, 595.32)"
41,"Wang M, Zheng BJ, Chan KH, Yuen KY. 2012. Discovery of seven novel  mammalian",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Wang M, Zheng BJ, Chan KH, Yuen KY. 2012. Discovery of seven novel  mammalian', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 710.548, 526.1879999999998, 721.456), True, False, 41, 841.92, 595.32)"
41,and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 694.588, 526.14, 705.496), True, False, 41, 841.92, 595.32)"
41,gene  source  of  alphacoronavirus  and  betacoronavirus  and  avian  coronaviruses  as  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('gene  source  of  alphacoronavirus  and  betacoronavirus  and  avian  coronaviruses  as  the', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 678.748, 526.232, 689.6560000000001), True, False, 41, 841.92, 595.32)"
41,gene  source  of  gammacoronavirus  and  deltacoronavirus.  J  Virol  86(7):3995-4008.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('gene  source  of  gammacoronavirus  and  deltacoronavirus.  J  Virol  86(7):3995-4008.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 662.908, 526.408, 673.816), True, False, 41, 841.92, 595.32)"
41,10.1128/JVI.06540-11.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1128/JVI.06540-11.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 647.068, 211.13, 657.976), True, False, 41, 841.92, 595.32)"
41,"30.  Fehr  AR,  Perlman  S.  2015.  Coronaviruses:  an  overview  of  their  replication  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('30.  Fehr  AR,  Perlman  S.  2015.  Coronaviruses:  an  overview  of  their  replication  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 631.1080000000001, 526.0799999999998, 642.436), False, False, 41, 841.92, 595.32)"
41,pathogenesis. Methods Mol Biol 1282:1-23. doi: 10.1007/978-1-4939-2438-7_1.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pathogenesis. Methods Mol Biol 1282:1-23. doi: 10.1007/978-1-4939-2438-7_1.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 615.268, 487.54, 626.176), True, False, 41, 841.92, 595.32)"
41,"31.  Chan  JF,  Kok  KH,  Zhu  Z,  Chu  H,  To  KK,  Yuan  S,  Yuen  KY.  2020.  Genomic",0,0,0,0,0,0,0,0,0,0,0,0,0,"('31.  Chan  JF,  Kok  KH,  Zhu  Z,  Chu  H,  To  KK,  Yuan  S,  Yuen  KY.  2020.  Genomic', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 599.428, 526.396, 610.756), False, False, 41, 841.92, 595.32)"
41,characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient,0,0,0,0,0,0,0,0,0,0,0,0,0,"('characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 583.588, 526.2500000000001, 594.496), True, False, 41, 841.92, 595.32)"
41,with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9(1):221-236. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9(1):221-236. doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 567.5980000000001, 526.408, 578.5060000000001), True, False, 41, 841.92, 595.32)"
41,10.1080/22221751.2020.1719902.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1080/22221751.2020.1719902.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 551.758, 264.77, 562.666), True, False, 41, 841.92, 595.32)"
41,"32.  Brian  DA,  Baric  RS.  (2005).  Coronavirus  Genome  Structure  and  Replication,  p  1-30",0,0,0,0,0,0,0,0,0,0,0,0,0,"('32.  Brian  DA,  Baric  RS.  (2005).  Coronavirus  Genome  Structure  and  Replication,  p  1-30', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 535.918, 526.4200000000001, 547.246), False, False, 41, 841.92, 595.32)"
41,"In:Enjuanes L. (eds), Coronavirus Replication and Reverse Genetics. Current  Topics in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('In:Enjuanes L. (eds), Coronavirus Replication and Reverse Genetics. Current  Topics in', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 520.078, 526.408, 530.9979999999999), False, False, 41, 841.92, 595.32)"
41,"Microbiology  and  Immunology,  vol  287.  Springer,  Berlin,  Heidelberg.  doi:  10.1007/3-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Microbiology  and  Immunology,  vol  287.  Springer,  Berlin,  Heidelberg.  doi:  10.1007/3-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 504.118, 523.576, 515.026), True, False, 41, 841.92, 595.32)"
41,540-26765-4_1,0,0,0,0,0,0,0,0,0,0,0,0,0,"('540-26765-4_1', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 488.278, 170.42, 499.186), True, False, 41, 841.92, 595.32)"
41,"33.  Nakagawa K, LokugamageKG,Makino S. 2016. Viral and cellular mRNA translation in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('33.  Nakagawa K, LokugamageKG,Makino S. 2016. Viral and cellular mRNA translation in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 472.438, 526.2260000000001, 483.76599999999996), False, False, 41, 841.92, 595.32)"
41,coronavirus-infected cells. Adv Virus Res 96:165-192. doi: 10.1016/bs.aivir.2016.08.001,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus-infected cells. Adv Virus Res 96:165-192. doi: 10.1016/bs.aivir.2016.08.001', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 456.598, 528.1, 467.506), True, False, 41, 841.92, 595.32)"
41,"34.  Snijder  EJ,  Van  Der  Meer  Y,  Zevenhoven-Dobbe  J,  Onderwater  JJ,  van  derMeulen  J,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('34.  Snijder  EJ,  Van  Der  Meer  Y,  Zevenhoven-Dobbe  J,  Onderwater  JJ,  van  derMeulen  J,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 440.75800000000004, 526.226, 452.086), False, False, 41, 841.92, 595.32)"
41,"Koerten  HK,  Mommaas  AM.  2006.  Ultrastructure  and  origin  of  membrane  vesicles",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Koerten  HK,  Mommaas  AM.  2006.  Ultrastructure  and  origin  of  membrane  vesicles', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 424.798, 526.2860000000001, 435.70599999999996), True, False, 41, 841.92, 595.32)"
41,associated with the severe acute respiratory syndrome coronavirus replication complex. J,0,0,0,0,0,0,0,0,0,0,0,0,0,"('associated with the severe acute respiratory syndrome coronavirus replication complex. J', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 408.958, 526.128, 419.866), True, False, 41, 841.92, 595.32)"
41,Virol 80:5927-5940. doi: 10.1128/JVI.02501-05,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Virol 80:5927-5940. doi: 10.1128/JVI.02501-05', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 393.098, 328.51, 404.006), True, False, 41, 841.92, 595.32)"
41,"35.  Hussain S, Chen Y, Yang Y, Xu J, Peng Y, Wu Y, Li Z, Zhu Y, Tien P, Guo D. 2005.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('35.  Hussain S, Chen Y, Yang Y, Xu J, Peng Y, Wu Y, Li Z, Zhu Y, Tien P, Guo D. 2005.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 377.25800000000004, 526.4200000000001, 388.586), False, False, 41, 841.92, 595.32)"
41,Identification  of  novel  subgenomic  RNAs  and  noncanonical  transcription  initiation,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Identification  of  novel  subgenomic  RNAs  and  noncanonical  transcription  initiation', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 361.298, 526.1399999999999, 372.20599999999996), True, False, 41, 841.92, 595.32)"
41,signals  of  severe  acute  respiratory  syndrome  coronavirus. J  Virol 79:5288-5295.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('signals  of  severe  acute  respiratory  syndrome  coronavirus. J  Virol 79:5288-5295.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 345.458, 526.408, 356.366), True, False, 41, 841.92, 595.32)"
41,10.1128/JVI.79.9.5288-5295.2005,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1128/JVI.79.9.5288-5295.2005', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 329.618, 262.13, 340.52599999999995), True, False, 41, 841.92, 595.32)"
41,"36.  Malik  YS,  Sircar  S,  Bhat  S,  Sharun  K,  Dhama  K,  Dadar  M,  Tiwari  R,  Chaicumpa  W.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('36.  Malik  YS,  Sircar  S,  Bhat  S,  Sharun  K,  Dhama  K,  Dadar  M,  Tiwari  R,  Chaicumpa  W.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 313.778, 526.306, 325.106), False, False, 41, 841.92, 595.32)"
41,"2020.  Emerging  novel  Coronavirus  (2019-nCoV)  -  Current  scenario,  evolutionary",0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020.  Emerging  novel  Coronavirus  (2019-nCoV)  -  Current  scenario,  evolutionary', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 297.81800000000004, 526.294, 308.726), True, False, 41, 841.92, 595.32)"
41,perspective  based  on  genome  analysis  and  recent  developments. Vet  Q  1-12.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('perspective  based  on  genome  analysis  and  recent  developments. Vet  Q  1-12.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 281.978, 526.408, 292.88599999999997), True, False, 41, 841.92, 595.32)"
41,10.1080/01652176.2020.1727993.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1080/01652176.2020.1727993.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 266.13800000000003, 264.77, 277.046), True, False, 41, 841.92, 595.32)"
41,"37.  Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, Jiang YZ, Xiong Y, Li YJ, Li H,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('37.  Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, Jiang YZ, Xiong Y, Li YJ, Li H,', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 250.29799999999997, 526.2579999999999, 261.626), False, False, 41, 841.92, 595.32)"
41,"Fan GH, Gu XY, Xiao Y, Gao H, Xu JY, Yang F, Wang XM, Wu C, Chen L, Liu YW,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Fan GH, Gu XY, Xiao Y, Gao H, Xu JY, Yang F, Wang XM, Wu C, Chen L, Liu YW,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 235.41799999999998, 526.02, 246.326), True, False, 41, 841.92, 595.32)"
41,"Liu B, Yang J, Wang XR, Dong J, Li L, Huang CL, Zhao JP, Hu Y, Cheng ZS, Liu LL,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Liu B, Yang J, Wang XR, Dong J, Li L, Huang CL, Zhao JP, Hu Y, Cheng ZS, Liu LL,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 220.41799999999998, 526.0200000000001, 231.326), True, False, 41, 841.92, 595.32)"
41,"Qian  ZH,  Qin  C,  Jin  Q,  Cao  B,  Wang  JW.  2020.  Identification  of  a  novel  coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Qian  ZH,  Qin  C,  Jin  Q,  Cao  B,  Wang  JW.  2020.  Identification  of  a  novel  coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 205.50799999999998, 526.33, 216.416), True, False, 41, 841.92, 595.32)"
41,causing  severe  pneumonia  in  human:  a  descriptive  study. Chin  Med  J  (Engl),0,0,0,0,0,0,0,0,0,0,0,0,0,"('causing  severe  pneumonia  in  human:  a  descriptive  study. Chin  Med  J  (Engl)', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 190.628, 526.42, 201.536), True, False, 41, 841.92, 595.32)"
41,10.1097/CM9.0000000000000722. doi: 10.1097/CM9.0000000000000722.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1097/CM9.0000000000000722. doi: 10.1097/CM9.0000000000000722.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 175.748, 462.1, 186.656), True, False, 41, 841.92, 595.32)"
41,"38.  Hu B, Ge X, Wang LF, Shi Z. 2015. Bat origin of human coronaviruses. Virol J 12:221.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('38.  Hu B, Ge X, Wang LF, Shi Z. 2015. Bat origin of human coronaviruses. Virol J 12:221.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 160.868, 526.396, 172.196), False, False, 41, 841.92, 595.32)"
41,doi:10.1186/s12985-015-0422-1.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:10.1186/s12985-015-0422-1.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 145.028, 255.05, 155.936), True, False, 41, 841.92, 595.32)"
41,"39.  Li  B,  Si  HR,  Zhu  Y,  Yang  XL,  Anderson  DE,  Shi  ZL,  Wang  LF,  Zhou  P.  2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('39.  Li  B,  Si  HR,  Zhu  Y,  Yang  XL,  Anderson  DE,  Shi  ZL,  Wang  LF,  Zhou  P.  2020.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 129.188, 526.42, 140.516), False, False, 41, 841.92, 595.32)"
41,Discovery  of  bat  coronaviruses  through  surveillance  and  probe  capture-based  next-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Discovery  of  bat  coronaviruses  through  surveillance  and  probe  capture-based  next-', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 113.228, 523.456, 124.136), True, False, 41, 841.92, 595.32)"
41,generation sequencing. mSphere. 5(1):e00807-19. doi: 10.1128/mSphere.00807-19.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('generation sequencing. mSphere. 5(1):e00807-19. doi: 10.1128/mSphere.00807-19.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 97.392, 501.1, 108.3), True, False, 41, 841.92, 595.32)"
41,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 41, 841.92, 595.32)"
41,40,0,0,0,0,0,0,0,0,0,0,0,0,0,"('40', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 41, 841.92, 595.32)"
42,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 42, 841.92, 595.32)"
42,"40.  Wang  LF,  Eaton  BT.  2007.  Bats,  civets  and  the  emergence  of  SARS.  In  Wildlife  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('40.  Wang  LF,  Eaton  BT.  2007.  Bats,  civets  and  the  emergence  of  SARS.  In  Wildlife  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.02, 767.496), False, False, 42, 841.92, 595.32)"
42,"emerging  zoonotic  diseases:  the  biology,  circumstances  and  consequences  of  cross-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('emerging  zoonotic  diseases:  the  biology,  circumstances  and  consequences  of  cross-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 740.308, 523.456, 751.216), True, False, 42, 841.92, 595.32)"
42,"species transmission. Springer, Berlin, Heidelberg. Pp:325-344.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('species transmission. Springer, Berlin, Heidelberg. Pp:325-344.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 724.468, 402.43, 735.376), True, False, 42, 841.92, 595.32)"
42,41.  Hemida MG. 2019. Middle East Respiratory Syndrome Coronavirus and the One Health,0,0,0,0,0,0,0,0,0,0,0,0,0,"('41.  Hemida MG. 2019. Middle East Respiratory Syndrome Coronavirus and the One Health', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 708.508, 526.1780000000001, 719.836), False, False, 42, 841.92, 595.32)"
42,concept. Peer J7:e7556. doi: 10.7717/peerj.7556.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('concept. Peer J7:e7556. doi: 10.7717/peerj.7556.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 692.668, 334.39, 703.576), True, False, 42, 841.92, 595.32)"
42,42.  Masters PS. 2006. The molecular biology of coronaviruses. Adv Virus Res 66: 193-292.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('42.  Masters PS. 2006. The molecular biology of coronaviruses. Adv Virus Res 66: 193-292.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 676.828, 526.4200000000001, 688.156), False, False, 42, 841.92, 595.32)"
42,doi: 10.1016/S0065-3527(06)66005-3,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi: 10.1016/S0065-3527(06)66005-3', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 660.988, 279.05, 671.8960000000001), True, False, 42, 841.92, 595.32)"
42,"43.  Belouzard  S,  Millet  JK,  Licitra  BN,  Whittaker  GR.  2012.  Mechanisms  of  coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('43.  Belouzard  S,  Millet  JK,  Licitra  BN,  Whittaker  GR.  2012.  Mechanisms  of  coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 645.028, 526.2500000000002, 656.356), False, False, 42, 841.92, 595.32)"
42,cell  entry  mediated  by  the  viral  spike  protein.  Viruses  4(6):1011-1033.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('cell  entry  mediated  by  the  viral  spike  protein.  Viruses  4(6):1011-1033.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 629.188, 526.408, 640.096), True, False, 42, 841.92, 595.32)"
42,10.3390/v4061011.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.3390/v4061011.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 613.3480000000001, 192.77, 624.2560000000001), True, False, 42, 841.92, 595.32)"
42,"44.  Beniac  DR,  Andonov  A,  Grudeski  E,  Booth  TF.  2006.  Architecture  of  the  SARS",0,0,0,0,0,0,0,0,0,0,0,0,0,"('44.  Beniac  DR,  Andonov  A,  Grudeski  E,  Booth  TF.  2006.  Architecture  of  the  SARS', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 597.508, 526.0799999999999, 608.836), False, False, 42, 841.92, 595.32)"
42,coronavirus prefusion spike. Nat Struct Mol Bio 13:751-752. doi: 10.1038/nsmb1123,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus prefusion spike. Nat Struct Mol Bio 13:751-752. doi: 10.1038/nsmb1123', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 581.548, 506.62, 592.456), True, False, 42, 841.92, 595.32)"
42,"45.  Li F. 2016. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev",0,0,0,0,0,0,0,0,0,0,0,0,0,"('45.  Li F. 2016. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 565.678, 526.1040000000002, 577.006), False, False, 42, 841.92, 595.32)"
42,Virol 3(1):237-261. doi: 10.1146/annurev-virology-110615-042301.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Virol 3(1):237-261. doi: 10.1146/annurev-virology-110615-042301.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 549.838, 427.39, 560.746), True, False, 42, 841.92, 595.32)"
42,"46.  Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, Mazet JK, Hu B, Zhang W,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('46.  Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, Mazet JK, Hu B, Zhang W,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 533.998, 526.282, 545.326), False, False, 42, 841.92, 595.32)"
42,"Peng C, Zhang YJ, Luo CM, Tan B, Wang N, Zhu Y, Crameri G, Zhang SY, Wang LF,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Peng C, Zhang YJ, Luo CM, Tan B, Wang N, Zhu Y, Crameri G, Zhang SY, Wang LF,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 519.118, 526.0679999999999, 530.0260000000001), True, False, 42, 841.92, 595.32)"
42,"Daszak  P,  Shi  ZL.  2013.  Isolation  and  characterization  of  a  bat  SARS-like  coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Daszak  P,  Shi  ZL.  2013.  Isolation  and  characterization  of  a  bat  SARS-like  coronavirus', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 504.118, 526.396, 515.026), True, False, 42, 841.92, 595.32)"
42,that uses the ACE2 receptor. Nature 503(7477):535-538. doi: 10.1038/nature12711.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('that uses the ACE2 receptor. Nature 503(7477):535-538. doi: 10.1038/nature12711.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 489.238, 502.06, 500.14599999999996), True, False, 42, 841.92, 595.32)"
42,"47.  Li X, Song Y, Wong G, Cui J. 2020. Bat origin of a new human coronavirus: there and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('47.  Li X, Song Y, Wong G, Cui J. 2020. Bat origin of a new human coronavirus: there and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 474.358, 526.214, 485.686), False, False, 42, 841.92, 595.32)"
42,back  again.  Sci  China  Life  Sci  10.1007/s11427-020-1645-7.  doi:  10.1007/s11427-020-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('back  again.  Sci  China  Life  Sci  10.1007/s11427-020-1645-7.  doi:  10.1007/s11427-020-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 459.478, 523.456, 470.38599999999997), True, False, 42, 841.92, 595.32)"
42,1645-7.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('1645-7.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 444.598, 136.34, 455.506), True, False, 42, 841.92, 595.32)"
42,"48.  Neuman BW, Kiss G, Kunding AH, Bhella D, Baksh MF, Connelly S, Droese B, Klaus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('48.  Neuman BW, Kiss G, Kunding AH, Bhella D, Baksh MF, Connelly S, Droese B, Klaus', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 429.718, 526.0800000000002, 441.046), False, False, 42, 841.92, 595.32)"
42,"JP, Makino S, Sawicki SG, Siddell SG, Stamou DG, Wilson IA, Kuhn P, Buchmeier MJ.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('JP, Makino S, Sawicki SG, Siddell SG, Stamou DG, Wilson IA, Kuhn P, Buchmeier MJ.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 414.838, 526.056, 425.746), True, False, 42, 841.92, 595.32)"
42,2011.  A  structural  analysis  of  M  protein  in  coronavirus  assembly  and  morphology.  J,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2011.  A  structural  analysis  of  M  protein  in  coronavirus  assembly  and  morphology.  J', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 399.958, 526.1880000000001, 410.866), True, False, 42, 841.92, 595.32)"
42,Struct Biol 174(1):11-22. doi: 10.1016/j.jsb.2010.11.021.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Struct Biol 174(1):11-22. doi: 10.1016/j.jsb.2010.11.021.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 385.058, 374.47, 395.96599999999995), True, False, 42, 841.92, 595.32)"
42,"49.  Nal B, Chan C, Kien F, Siu L, Tse J, Chu K, Kam J, Staropoli I, Crescenzo-Chaigne B,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('49.  Nal B, Chan C, Kien F, Siu L, Tse J, Chu K, Kam J, Staropoli I, Crescenzo-Chaigne B,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 370.178, 526.384, 381.506), False, False, 42, 841.92, 595.32)"
42,"Escriou N, van der Werf S. 2005. Differential maturation and subcellular localization of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Escriou N, van der Werf S. 2005. Differential maturation and subcellular localization of', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 355.298, 525.9960000000001, 366.20599999999996), True, False, 42, 841.92, 595.32)"
42,"severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol",0,0,0,0,0,0,0,0,0,0,0,0,0,"('severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 340.298, 526.2379999999999, 351.20599999999996), True, False, 42, 841.92, 595.32)"
42,86:1423-1434. doi: 10.1099/vir.0.80671-0,0,0,0,0,0,0,0,0,0,0,0,0,0,"('86:1423-1434. doi: 10.1099/vir.0.80671-0', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 325.418, 302.09, 336.32599999999996), True, False, 42, 841.92, 595.32)"
42,"50.  Arndt  AL,  Larson  BJ,  Hogue  BG.  2010.  A  conserveddomain  in  the  coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('50.  Arndt  AL,  Larson  BJ,  Hogue  BG.  2010.  A  conserveddomain  in  the  coronavirus', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 310.538, 526.1759999999998, 321.866), False, False, 42, 841.92, 595.32)"
42,membraneproteintailisimportantfor  virus  assembly.  J  Virol  84(21):11418-11428.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('membraneproteintailisimportantfor  virus  assembly.  J  Virol  84(21):11418-11428.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 294.69800000000004, 526.408, 305.606), True, False, 42, 841.92, 595.32)"
42,10.1128/JVI.01131-10.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1128/JVI.01131-10.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 278.858, 211.13, 289.76599999999996), True, False, 42, 841.92, 595.32)"
42,"51.  Schoeman  D,  Fielding  BC.  2019.  Coronavirus  envelope  protein:  current  knowledge.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('51.  Schoeman  D,  Fielding  BC.  2019.  Coronavirus  envelope  protein:  current  knowledge.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 263.01800000000003, 526.1519999999998, 274.346), False, False, 42, 841.92, 595.32)"
42,Virol J 16(1):69. doi: 10.1186/s12985-019-1182-0.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Virol J 16(1):69. doi: 10.1186/s12985-019-1182-0.', 'TimesNewRomanPSMT', 10.907999999999987, (93.384, 248.018, 344.47, 258.926), True, False, 42, 841.92, 595.32)"
42,"52.  Nieto-Torres JL, DeDiego ML, Verdia-Baguena  C, Jimenez-Guardeno JM, Regla-Nava",0,0,0,0,0,0,0,0,0,0,0,0,0,"('52.  Nieto-Torres JL, DeDiego ML, Verdia-Baguena  C, Jimenez-Guardeno JM, Regla-Nava', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 233.13799999999998, 526.408, 244.46599999999998), False, False, 42, 841.92, 595.32)"
42,"JA,  Fernandez-Delgado  R,  Castano-Rodriguez  C,  Alcaraz  A,  Torres  J,  Aguilella  VM,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('JA,  Fernandez-Delgado  R,  Castano-Rodriguez  C,  Alcaraz  A,  Torres  J,  Aguilella  VM,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 218.25799999999998, 526.25, 229.166), True, False, 42, 841.92, 595.32)"
42,Enjuanes  L.  2014.  Severe  acute  respiratory  syndrome  coronavirus  envelope  protein  ion,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Enjuanes  L.  2014.  Severe  acute  respiratory  syndrome  coronavirus  envelope  protein  ion', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 203.34799999999998, 526.1039999999998, 214.256), True, False, 42, 841.92, 595.32)"
42,channel  activity promotes virus fitness  and pathogenesis. PLoSPathog10:e1004077 doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('channel  activity promotes virus fitness  and pathogenesis. PLoSPathog10:e1004077 doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 188.468, 526.1280000000002, 199.376), True, False, 42, 841.92, 595.32)"
42,10.1371/journal.ppat.1004077,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1371/journal.ppat.1004077', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 173.588, 241.37, 184.496), True, False, 42, 841.92, 595.32)"
42,"53.  Pervushin K, Tan E, Parthasarathy K, Lin X, Jiang FL, Yu D, Vararattanavech A, Soong",0,0,0,0,0,0,0,0,0,0,0,0,0,"('53.  Pervushin K, Tan E, Parthasarathy K, Lin X, Jiang FL, Yu D, Vararattanavech A, Soong', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 158.708, 526.0999999999999, 170.036), False, False, 42, 841.92, 595.32)"
42,"TW, Liu DX, Torres J. 2009. Structure and inhibition of the SARS coronavirus envelope",0,0,0,0,0,0,0,0,0,0,0,0,0,"('TW, Liu DX, Torres J. 2009. Structure and inhibition of the SARS coronavirus envelope', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 142.868, 526.0680000000001, 153.776), True, False, 42, 841.92, 595.32)"
42,protein ion channel. PLoSPathog 5(7):e1000511. doi: 10.1371/journal.ppat.1000511.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein ion channel. PLoSPathog 5(7):e1000511. doi: 10.1371/journal.ppat.1000511.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 126.908, 507.46, 137.816), True, False, 42, 841.92, 595.32)"
42,"54.  DeDiego  ML,  Alvarez  E,  Almazán  F,  Rejas  MT,  Lamirande  E,  Roberts  A,  Shieh  WJ,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('54.  DeDiego  ML,  Alvarez  E,  Almazán  F,  Rejas  MT,  Lamirande  E,  Roberts  A,  Shieh  WJ,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 111.068, 526.088, 122.396), False, False, 42, 841.92, 595.32)"
42,"Zaki  SR,  Subbarao  K,  Enjuanes  L.  2007.  A  severe  acute  respiratory  syndrome  corona",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Zaki  SR,  Subbarao  K,  Enjuanes  L.  2007.  A  severe  acute  respiratory  syndrome  corona', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 96.19200000000001, 526.1519999999998, 107.10000000000001), True, False, 42, 841.92, 595.32)"
42,virus that lacks the E gene is attenuated in vitro and in vivo. J Virol 81(4):1701-1713. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus that lacks the E gene is attenuated in vitro and in vivo. J Virol 81(4):1701-1713. doi:', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 81.312, 529.768, 92.22), True, False, 42, 841.92, 595.32)"
42,10.1128/JVI.01467-06.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1128/JVI.01467-06.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 66.432, 211.13, 77.34), True, False, 42, 841.92, 595.32)"
42,41,0,0,0,0,0,0,0,0,0,0,0,0,0,"('41', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 42, 841.92, 595.32)"
42,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 42, 841.92, 595.32)"
43,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 43, 841.92, 595.32)"
43,"55.  Chang CK, Sue SC, Yu TH, Hsieh CM, Tsai CK, Chiang YC, Lee SJ, Hsiao HH, Wu WJ,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('55.  Chang CK, Sue SC, Yu TH, Hsieh CM, Tsai CK, Chiang YC, Lee SJ, Hsiao HH, Wu WJ,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 529.2119999999999, 767.496), False, False, 43, 841.92, 595.32)"
43,"Chang  WL,  Lin  CH.  2006.  Modular  organization  of  SARS  coronavirus  nucleocapsid",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chang  WL,  Lin  CH.  2006.  Modular  organization  of  SARS  coronavirus  nucleocapsid', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.0559999999999, 752.176), True, False, 43, 841.92, 595.32)"
43,protein. J Biomed Sci 13:59-72. doi: 10.1007/s11373-005-9035-9,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein. J Biomed Sci 13:59-72. doi: 10.1007/s11373-005-9035-9', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 411.43, 737.296), True, False, 43, 841.92, 595.32)"
43,"56.  Sheikh  A,  Al-Taher  A,  Al-Nazawi  M,  Al-Mubarak  AI,  Kandeel  M.  2020.  Analysis  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('56.  Sheikh  A,  Al-Taher  A,  Al-Nazawi  M,  Al-Mubarak  AI,  Kandeel  M.  2020.  Analysis  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.214, 722.836), False, False, 43, 841.92, 595.32)"
43,preferred  codon  usage  in  the  coronavirus  N  genes  and  their  implications  for  genome,0,0,0,0,0,0,0,0,0,0,0,0,0,"('preferred  codon  usage  in  the  coronavirus  N  genes  and  their  implications  for  genome', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 696.628, 526.0920000000001, 707.5360000000001), True, False, 43, 841.92, 595.32)"
43,evolution  and  vaccine  design. J  Virol  Methods  277:113806.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('evolution  and  vaccine  design. J  Virol  Methods  277:113806.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 681.748, 535.3779999999999, 692.6560000000001), True, False, 43, 841.92, 595.32)"
43,10.1016/j.jviromet.2019.113806,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/j.jviromet.2019.113806', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 666.748, 251.69, 677.6560000000001), True, False, 43, 841.92, 595.32)"
43,"57.  McBride  R,  van  Zyl  M,  Fielding  BC.  2014.  The  coronavirus  nucleocapsid  is  a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('57.  McBride  R,  van  Zyl  M,  Fielding  BC.  2014.  The  coronavirus  nucleocapsid  is  a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 651.868, 526.178, 663.196), False, False, 43, 841.92, 595.32)"
43,multifunctional protein. Viruses 6(8):2991-3018. doi: 10.3390/v6082991.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('multifunctional protein. Viruses 6(8):2991-3018. doi: 10.3390/v6082991.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 636.028, 452.38, 646.936), True, False, 43, 841.92, 595.32)"
43,"58.  Fan  H,  Ooi  A,  Tan  YW,  Wang  S,  Fang  S,  Liu  DX,  Lescar  J.  2005.  The  nucleocapsid",0,0,0,0,0,0,0,0,0,0,0,0,0,"('58.  Fan  H,  Ooi  A,  Tan  YW,  Wang  S,  Fang  S,  Liu  DX,  Lescar  J.  2005.  The  nucleocapsid', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 620.188, 526.1159999999998, 631.516), False, False, 43, 841.92, 595.32)"
43,protein  of  coronavirus  infectious  bronchitis  virus:  crystal  structure  of  its  N-terminal,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein  of  coronavirus  infectious  bronchitis  virus:  crystal  structure  of  its  N-terminal', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 604.3480000000001, 526.384, 615.2560000000001), True, False, 43, 841.92, 595.32)"
43,domain  and  multimerization  properties.  Structure  13(12):1859-1868.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('domain  and  multimerization  properties.  Structure  13(12):1859-1868.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 588.388, 526.396, 599.296), True, False, 43, 841.92, 595.32)"
43,10.1016/j.str.2005.08.021.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/j.str.2005.08.021.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 572.548, 226.13, 583.456), True, False, 43, 841.92, 595.32)"
43,"59.  Hurst KR, Koetzner CA, Masters PS. 2009. Identification of in vivo-interacting domains",0,0,0,0,0,0,0,0,0,0,0,0,0,"('59.  Hurst KR, Koetzner CA, Masters PS. 2009. Identification of in vivo-interacting domains', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 556.678, 526.33, 568.006), False, False, 43, 841.92, 595.32)"
43,of  the  murine  coronavirus  nucleocapsid  protein.  J  Virol  83(14):7221-7234.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  the  murine  coronavirus  nucleocapsid  protein.  J  Virol  83(14):7221-7234.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 541.798, 526.396, 552.706), True, False, 43, 841.92, 595.32)"
43,10.1128/JVI.00440-09.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1128/JVI.00440-09.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 526.918, 211.13, 537.826), True, False, 43, 841.92, 595.32)"
43,"60.  Stohlman  SA,  Baric  RS,  Nelson  GN,  Soe  LH,  Welter  LM,  Deans  RJ.  1988.  Specific",0,0,0,0,0,0,0,0,0,0,0,0,0,"('60.  Stohlman  SA,  Baric  RS,  Nelson  GN,  Soe  LH,  Welter  LM,  Deans  RJ.  1988.  Specific', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 512.038, 526.0799999999999, 523.366), False, False, 43, 841.92, 595.32)"
43,interaction  between  coronavirus  leader  RNA  and  nucleocapsid  protein.  J  Virol,0,0,0,0,0,0,0,0,0,0,0,0,0,"('interaction  between  coronavirus  leader  RNA  and  nucleocapsid  protein.  J  Virol', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 497.158, 526.1759999999999, 508.066), True, False, 43, 841.92, 595.32)"
43,62(11):4288-4295.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('62(11):4288-4295.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 482.158, 189.74, 493.066), True, False, 43, 841.92, 595.32)"
43,"61.  You J, Dove BK, Enjuanes L, DeDiego ML, Alvarez E, Howell G, Heinen P, Zambon M,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('61.  You J, Dove BK, Enjuanes L, DeDiego ML, Alvarez E, Howell G, Heinen P, Zambon M,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 467.278, 529.088, 478.606), False, False, 43, 841.92, 595.32)"
43,Hiscox  JA.  2005.  Subcellular  localization  of  the  severe  acute  respiratory  syndrome,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Hiscox  JA.  2005.  Subcellular  localization  of  the  severe  acute  respiratory  syndrome', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 451.438, 526.1399999999999, 462.34599999999995), True, False, 43, 841.92, 595.32)"
43,coronavirus  nucleocapsid  protein.  J  Gen  Virol  86(Pt  12):3303-3310.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus  nucleocapsid  protein.  J  Gen  Virol  86(Pt  12):3303-3310.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 435.598, 526.408, 446.506), True, False, 43, 841.92, 595.32)"
43,10.1099/vir.0.81076-0.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1099/vir.0.81076-0.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 419.75800000000004, 210.05, 430.666), True, False, 43, 841.92, 595.32)"
43,"62.  Cui L, Wang H, Ji Y, Yang J, Xu S, Huang X, Wang Z, Qin L, Tien P, Zhou X, Guo D,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('62.  Cui L, Wang H, Ji Y, Yang J, Xu S, Huang X, Wang Z, Qin L, Tien P, Zhou X, Guo D,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 403.798, 526.1, 415.126), False, False, 43, 841.92, 595.32)"
43,ChenY. 2015. The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ChenY. 2015. The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor of', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 387.938, 526.14, 398.84599999999995), True, False, 43, 841.92, 595.32)"
43,RNA Silencing in Mammalian Cells. J Virol 89(17):9029-43. doi: 10.1128/JVI.01331-15.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('RNA Silencing in Mammalian Cells. J Virol 89(17):9029-43. doi: 10.1128/JVI.01331-15.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 372.098, 532.54, 383.006), True, False, 43, 841.92, 595.32)"
43,"63.  Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Shi ZL. 2020. Discovery of a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('63.  Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Shi ZL. 2020. Discovery of a', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 356.25800000000004, 526.336, 367.586), False, False, 43, 841.92, 595.32)"
43,novel  coronavirus  associated  with  the  recent  pneumonia  outbreak  in  humans  and  its,0,0,0,0,0,0,0,0,0,0,0,0,0,"('novel  coronavirus  associated  with  the  recent  pneumonia  outbreak  in  humans  and  its', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 340.298, 526.1879999999999, 351.20599999999996), True, False, 43, 841.92, 595.32)"
43,potential bat origin. bioRxiv 2020.2001.2022.914952. doi:10.1101/2020.01.22.914952.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('potential bat origin. bioRxiv 2020.2001.2022.914952. doi:10.1101/2020.01.22.914952.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 324.458, 515.38, 335.366), True, False, 43, 841.92, 595.32)"
43,"64.  Bastola  A,  Sah  R,  Rodriguez-Morales  AJ,  Lal  BK,  Jha  R,  Ojha  HC,  Shrestha  B,  Chu",0,0,0,0,0,0,0,0,0,0,0,0,0,"('64.  Bastola  A,  Sah  R,  Rodriguez-Morales  AJ,  Lal  BK,  Jha  R,  Ojha  HC,  Shrestha  B,  Chu', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 308.618, 526.154, 319.94599999999997), False, False, 43, 841.92, 595.32)"
43,"DKW,  Poon  LLM,  Costello  A,  Morita  K,  Pandey  BD.  2020.  The  first  2019  novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('DKW,  Poon  LLM,  Costello  A,  Morita  K,  Pandey  BD.  2020.  The  first  2019  novel', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 293.738, 526.032, 304.64599999999996), True, False, 43, 841.92, 595.32)"
43,coronavirus  case  in  Nepal.  Lancet  Infect  Dis  20(3):279-80  doi:10.1016/S1473-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus  case  in  Nepal.  Lancet  Infect  Dis  20(3):279-80  doi:10.1016/S1473-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 278.858, 523.576, 289.76599999999996), True, False, 43, 841.92, 595.32)"
43,3099(20)30067-0,0,0,0,0,0,0,0,0,0,0,0,0,0,"('3099(20)30067-0', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 263.978, 180.38, 274.88599999999997), True, False, 43, 841.92, 595.32)"
43,"65.  Velavan  TP,  Meyer  CG.  2020.  The  Covid-19  epidemic.  Trop  Med  Int  Health",0,0,0,0,0,0,0,0,0,0,0,0,0,"('65.  Velavan  TP,  Meyer  CG.  2020.  The  Covid-19  epidemic.  Trop  Med  Int  Health', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 249.09799999999998, 526.294, 260.426), False, False, 43, 841.92, 595.32)"
43,12:10.1111/tmi.13383. doi: 10.1111/tmi.13383.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('12:10.1111/tmi.13383. doi: 10.1111/tmi.13383.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 234.09799999999998, 328.15, 245.006), True, False, 43, 841.92, 595.32)"
43,"66.  Ayittey FK, Ayittey MK, Chiwero NB, Kamasah JS, Dzuvor C. 2020. Economic Impacts",0,0,0,0,0,0,0,0,0,0,0,0,0,"('66.  Ayittey FK, Ayittey MK, Chiwero NB, Kamasah JS, Dzuvor C. 2020. Economic Impacts', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 219.218, 526.1519999999999, 230.546), False, False, 43, 841.92, 595.32)"
43,of  Wuhan  2019-nCoV  on  China  and  the  World.  J  Med  Virol  10.1002/jmv.25706.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  Wuhan  2019-nCoV  on  China  and  the  World.  J  Med  Virol  10.1002/jmv.25706.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 204.308, 526.366, 215.216), True, False, 43, 841.92, 595.32)"
43,10.1002/jmv.25706.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1002/jmv.25706.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 189.428, 196.37, 200.336), True, False, 43, 841.92, 595.32)"
43,"67.  Qiu H, Tong Z, Ma P, Hu M, Peng Z, Wu W, Du B; China Critical Care Clinical Trials",0,0,0,0,0,0,0,0,0,0,0,0,0,"('67.  Qiu H, Tong Z, Ma P, Hu M, Peng Z, Wu W, Du B; China Critical Care Clinical Trials', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 174.54799999999997, 525.984, 185.87599999999998), False, False, 43, 841.92, 595.32)"
43,Group (CCCCTG). 2020. Intensive care during the coronavirus epidemic. Intensive Care,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Group (CCCCTG). 2020. Intensive care during the coronavirus epidemic. Intensive Care', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 159.66799999999998, 526.2260000000001, 170.576), True, False, 43, 841.92, 595.32)"
43,Med. 10.1007/s00134-020-05966-y. doi: 10.1007/s00134-020-05966-y.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Med. 10.1007/s00134-020-05966-y. doi: 10.1007/s00134-020-05966-y.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 144.78799999999998, 441.07, 155.696), True, False, 43, 841.92, 595.32)"
43,"68.  Cheng VCC, Wong SC, To KKW, Ho PL, Yuen KY. 2020. Preparedness and proactive",0,0,0,0,0,0,0,0,0,0,0,0,0,"('68.  Cheng VCC, Wong SC, To KKW, Ho PL, Yuen KY. 2020. Preparedness and proactive', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 129.908, 526.0559999999998, 141.236), False, False, 43, 841.92, 595.32)"
43,infection control measures against the emerging Wuhan coronavirus pneumonia in China,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infection control measures against the emerging Wuhan coronavirus pneumonia in China', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 115.028, 526.1400000000001, 125.936), True, False, 43, 841.92, 595.32)"
43,J Hosp Infect S0195-6701(20)30034-7. doi:10.1016/j.jhin.2020.01.010,0,0,0,0,0,0,0,0,0,0,0,0,0,"('J Hosp Infect S0195-6701(20)30034-7. doi:10.1016/j.jhin.2020.01.010', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 100.148, 440.11, 111.056), True, False, 43, 841.92, 595.32)"
43,"69.  Liu  SL,  Saif  L.  2020.  Emerging  viruses  without  borders:  The  Wuhan  Coronavirus.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('69.  Liu  SL,  Saif  L.  2020.  Emerging  viruses  without  borders:  The  Wuhan  Coronavirus.', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 85.272, 526.184, 96.60000000000001), False, False, 43, 841.92, 595.32)"
43,Viruses 12(2):E130. doi: 10.3390/v12020130.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Viruses 12(2):E130. doi: 10.3390/v12020130.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 69.312, 320.83, 80.22), True, False, 43, 841.92, 595.32)"
43,42,0,0,0,0,0,0,0,0,0,0,0,0,0,"('42', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 43, 841.92, 595.32)"
43,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 43, 841.92, 595.32)"
44,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 44, 841.92, 595.32)"
44,70.  Mahase  E.  2020.  China  coronavirus:  what  do  we  know  so  far?,0,0,0,0,0,0,0,0,0,0,0,0,0,"('70.  Mahase  E.  2020.  China  coronavirus:  what  do  we  know  so  far?', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.2619999999998, 767.496), False, False, 44, 841.92, 595.32)"
44,BMJ.  368. doi:  10.1136/bmj.m308,0,0,0,0,0,0,0,0,0,0,0,0,0,"('BMJ.  368. doi:  10.1136/bmj.m308', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 740.308, 268.73, 751.216), True, False, 44, 841.92, 595.32)"
44,"71.  Hui  DS,  I  Azhar  E,  Madani  TA,  Ntoumi  F,  Kock  R,  Dar  O,  Ippolito  G,  Mchugh  TD,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('71.  Hui  DS,  I  Azhar  E,  Madani  TA,  Ntoumi  F,  Kock  R,  Dar  O,  Ippolito  G,  Mchugh  TD,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 724.468, 526.0799999999999, 735.7959999999999), False, False, 44, 841.92, 595.32)"
44,"Memish  ZA,  Drosten  C,  Zumla  A,  Petersen  E.  2020.  The  continuing  2019-nCoV",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Memish  ZA,  Drosten  C,  Zumla  A,  Petersen  E.  2020.  The  continuing  2019-nCoV', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 709.468, 526.432, 720.376), True, False, 44, 841.92, 595.32)"
44,epidemic  threat  of  novel  coronaviruses  to  global  health  -  The  latest  2019  novel,0,0,0,0,0,0,0,0,0,0,0,0,0,"('epidemic  threat  of  novel  coronaviruses  to  global  health  -  The  latest  2019  novel', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 694.588, 526.318, 705.496), True, False, 44, 841.92, 595.32)"
44,"coronavirus  outbreak  in  Wuhan,  China.  Int  J  Infect  Dis  91:264-266.  doi:",0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus  outbreak  in  Wuhan,  China.  Int  J  Infect  Dis  91:264-266.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 679.708, 526.396, 690.616), True, False, 44, 841.92, 595.32)"
44,10.1016/j.ijid.2020.01.009.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/j.ijid.2020.01.009.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 664.828, 230.09, 675.736), True, False, 44, 841.92, 595.32)"
44,"72.  Lu  H,  Stratton  CW,  Tang  YW.  2020.  Outbreak  of  pneumonia  of  unknown  etiology  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('72.  Lu  H,  Stratton  CW,  Tang  YW.  2020.  Outbreak  of  pneumonia  of  unknown  etiology  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 649.948, 526.2620000000001, 661.276), False, False, 44, 841.92, 595.32)"
44,Wuhan  China:  the  mystery  and  the  miracle  J  Med  Virol  10.1002/jmv.25678.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Wuhan  China:  the  mystery  and  the  miracle  J  Med  Virol  10.1002/jmv.25678.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 634.1080000000001, 526.1880000000002, 645.0160000000001), True, False, 44, 841.92, 595.32)"
44,doi:10.1002/jmv.25678.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:10.1002/jmv.25678.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 618.268, 215.09, 629.176), True, False, 44, 841.92, 595.32)"
44,"73.  Nishiura  H,  Kobayashi  T,  Yang  Y,  Hayashi  K,  Miyama  T,  Kinoshita  R,  Linton  NM,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('73.  Nishiura  H,  Kobayashi  T,  Yang  Y,  Hayashi  K,  Miyama  T,  Kinoshita  R,  Linton  NM,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 602.308, 526.1120000000001, 613.636), False, False, 44, 841.92, 595.32)"
44,"Jung SM, Yuan B, Suzuki A, Akhmetzhanov AR. 2020. The Rate of Underascertainment",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Jung SM, Yuan B, Suzuki A, Akhmetzhanov AR. 2020. The Rate of Underascertainment', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 587.428, 526.2700000000001, 598.336), True, False, 44, 841.92, 595.32)"
44,of Novel Corona virus (2019-nCoV) Infection: estimation using japanesepassengers data,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of Novel Corona virus (2019-nCoV) Infection: estimation using japanesepassengers data', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 572.548, 526.2020000000001, 583.456), True, False, 44, 841.92, 595.32)"
44,on evacuation flights. J Clin Med 9(2):E419. doi: 10.3390/jcm9020419.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('on evacuation flights. J Clin Med 9(2):E419. doi: 10.3390/jcm9020419.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 557.638, 441.07, 568.546), True, False, 44, 841.92, 595.32)"
44,"74.  Nishiura  H,  Linton  NM,  Akhmetzhanov  AR.  2020.  Initial  cluster  of  novel  Coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('74.  Nishiura  H,  Linton  NM,  Akhmetzhanov  AR.  2020.  Initial  cluster  of  novel  Coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 542.758, 526.282, 554.086), False, False, 44, 841.92, 595.32)"
44,"(2019-nCoV) infections in Wuhan, China is consistent with substantial human-to-human",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(2019-nCoV) infections in Wuhan, China is consistent with substantial human-to-human', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 527.878, 526.42, 538.7860000000001), True, False, 44, 841.92, 595.32)"
44,transmission. J Clin Med 9(2):E488. doi: 10.3390/jcm9020488.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('transmission. J Clin Med 9(2):E488. doi: 10.3390/jcm9020488.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 512.998, 404.11, 523.9060000000001), True, False, 44, 841.92, 595.32)"
44,75.  Parry  J.  2020.  China  coronavirus:  cases  surge  as  official  admits  human  to  human,0,0,0,0,0,0,0,0,0,0,0,0,0,"('75.  Parry  J.  2020.  China  coronavirus:  cases  surge  as  official  admits  human  to  human', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 498.118, 526.0920000000001, 509.44599999999997), False, False, 44, 841.92, 595.32)"
44,transmission. BMJ 368:m236. Published 2020 Jan 20. doi:10.1136/bmj.m236.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('transmission. BMJ 368:m236. Published 2020 Jan 20. doi:10.1136/bmj.m236.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 482.158, 471.58, 493.066), True, False, 44, 841.92, 595.32)"
44,"76.  Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, Lou Y, Gao D, Yang L, He D, Wang",0,0,0,0,0,0,0,0,0,0,0,0,0,"('76.  Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, Lou Y, Gao D, Yang L, He D, Wang', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 466.31800000000004, 526.4200000000001, 477.646), False, False, 44, 841.92, 595.32)"
44,MH. 2020. Preliminary estimation of the basic reproduction number of novel coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('MH. 2020. Preliminary estimation of the basic reproduction number of novel coronavirus', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 450.478, 526.212, 461.38599999999997), True, False, 44, 841.92, 595.32)"
44,"(2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 434.63800000000003, 526.33, 445.546), True, False, 44, 841.92, 595.32)"
44,the outbreak. Int J Infect Dis 92:214-217. doi: 10.1016/j.ijid.2020.01.050.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the outbreak. Int J Infect Dis 92:214-217. doi: 10.1016/j.ijid.2020.01.050.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 418.678, 453.46, 429.58599999999996), True, False, 44, 841.92, 595.32)"
44,"77.  Liu  Y,  Gayle  AA,  Wilder-Smith  A,  Rocklöv  J.  2020.  The  reproductive  number  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('77.  Liu  Y,  Gayle  AA,  Wilder-Smith  A,  Rocklöv  J.  2020.  The  reproductive  number  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 402.838, 526.3420000000001, 414.166), False, False, 44, 841.92, 595.32)"
44,"COVID-19  is  higher  compared  to  SARS  coronavirus  [published  online  ahead  of  print,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19  is  higher  compared  to  SARS  coronavirus  [published  online  ahead  of  print,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 387.938, 526.1479999999999, 398.84599999999995), True, False, 44, 841.92, 595.32)"
44,2020 Feb 13]. J Travel Med taaa021. doi:10.1093/jtm/taaa021.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020 Feb 13]. J Travel Med taaa021. doi:10.1093/jtm/taaa021.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 373.058, 397.39, 383.96599999999995), True, False, 44, 841.92, 595.32)"
44,"78.  Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('78.  Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 358.178, 529.226, 369.506), False, False, 44, 841.92, 595.32)"
44,"Guan YJ, Butt KM, Wong KL, Chan KW, Lim W, Shortridge KF, Yuen KY, Peiris JS,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Guan YJ, Butt KM, Wong KL, Chan KW, Lim W, Shortridge KF, Yuen KY, Peiris JS,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 343.298, 525.984, 354.20599999999996), True, False, 44, 841.92, 595.32)"
44,Poon LL. 2003. Isolation and characterization of viruses related to the SARS coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Poon LL. 2003. Isolation and characterization of viruses related to the SARS coronavirus', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 328.418, 526.0920000000001, 339.32599999999996), True, False, 44, 841.92, 595.32)"
44,from  animals,0,0,0,0,0,0,0,0,0,0,0,0,0,"('from  animals', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 313.538, 176.12400000000002, 324.44599999999997), True, False, 44, 841.92, 595.32)"
44,in  southern  China.  Science  302(5643):276-278.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  southern  China.  Science  302(5643):276-278.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (192.348, 313.538, 526.396, 324.44599999999997), True, False, 44, 841.92, 595.32)"
44,10.1126/science.1087139.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1126/science.1087139.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 298.658, 225.05, 309.566), True, False, 44, 841.92, 595.32)"
44,"79.  Monchatre-Leroy E, Boue F, Boucher JM, Renault C, Moutou F, Ar Gouilh M, Umhang",0,0,0,0,0,0,0,0,0,0,0,0,0,"('79.  Monchatre-Leroy E, Boue F, Boucher JM, Renault C, Moutou F, Ar Gouilh M, Umhang', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 283.658, 526.0520000000001, 294.986), False, False, 44, 841.92, 595.32)"
44,"G. 2017. Identification of Alpha and Beta Coronavirus in wildlife species in France: bats,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('G. 2017. Identification of Alpha and Beta Coronavirus in wildlife species in France: bats,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 267.81800000000004, 526.14, 278.726), True, False, 44, 841.92, 595.32)"
44,"rodents, rabbits, and hedgehogs. Viruses 9(12):364. doi: 10.3390/v9120364.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('rodents, rabbits, and hedgehogs. Viruses 9(12):364. doi: 10.3390/v9120364.', 'TimesNewRomanPSMT', 10.907999999999987, (93.384, 251.97799999999998, 464.98, 262.88599999999997), True, False, 44, 841.92, 595.32)"
44,"80.  Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, Zheng Y, Xu B, Xie Z, Lin L, Shang",0,0,0,0,0,0,0,0,0,0,0,0,0,"('80.  Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, Zheng Y, Xu B, Xie Z, Lin L, Shang', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 236.13799999999998, 526.056, 247.46599999999998), False, False, 44, 841.92, 595.32)"
44,"Y, Lu X, Shu S, Bai Y, Deng J, Lu M, Ye L, Wang X, Wang Y, Gao L. 2020. Diagnosis,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Y, Lu X, Shu S, Bai Y, Deng J, Lu M, Ye L, Wang X, Wang Y, Gao L. 2020. Diagnosis,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 221.25799999999998, 525.996, 232.166), True, False, 44, 841.92, 595.32)"
44,"treatment,  and  prevention  of  2019  novel  coronavirus  infection  in  children:  experts'",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""treatment,  and  prevention  of  2019  novel  coronavirus  infection  in  children:  experts'"", 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 206.34799999999998, 526.1759999999999, 217.256), True, False, 44, 841.92, 595.32)"
44,consensus  statement.  World  J  Pediatr  10.1007/s12519-020-00343-7.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('consensus  statement.  World  J  Pediatr  10.1007/s12519-020-00343-7.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 191.34799999999998, 526.408, 202.256), True, False, 44, 841.92, 595.32)"
44,10.1007/s12519-020-00343-7.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1007/s12519-020-00343-7.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 176.468, 245.33, 187.376), True, False, 44, 841.92, 595.32)"
44,"81.  Lin  L,  Li  TS.  2020.  Interpretation  of  'Guidelines  for  the  Diagnosis  and  Treatment  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""81.  Lin  L,  Li  TS.  2020.  Interpretation  of  'Guidelines  for  the  Diagnosis  and  Treatment  of"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 161.588, 526.104, 172.916), False, False, 44, 841.92, 595.32)"
44,Novel  Coronavirus  (2019-nCoV)  Infection  by  the  National  Health  Commission  (Trial,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Novel  Coronavirus  (2019-nCoV)  Infection  by  the  National  Health  Commission  (Trial', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 146.708, 526.396, 157.616), True, False, 44, 841.92, 595.32)"
44,Version  5)'.  Zhonghua  Yi  XueZaZhi  100(0):E001.  doi:  10.3760/cma.j.issn.0376-,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""Version  5)'.  Zhonghua  Yi  XueZaZhi  100(0):E001.  doi:  10.3760/cma.j.issn.0376-"", 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 131.82799999999997, 523.456, 142.736), True, False, 44, 841.92, 595.32)"
44,2491.2020.0001.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2491.2020.0001.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 116.94800000000001, 180.38, 127.85600000000001), True, False, 44, 841.92, 595.32)"
44,"82.  Zou L, Ruan F, Huang  M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('82.  Zou L, Ruan F, Huang  M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 102.068, 526.0919999999998, 113.396), False, False, 44, 841.92, 595.32)"
44,"Guo Q, Song T, He J, Yen HL, Peiris M, Wu J. 2020. SARS-CoV-2 Viral Load in Upper",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Guo Q, Song T, He J, Yen HL, Peiris M, Wu J. 2020. SARS-CoV-2 Viral Load in Upper', 'TimesNewRomanPSMT', 10.908000000000001, (93.624, 87.19200000000001, 526.42, 98.10000000000001), True, False, 44, 841.92, 595.32)"
44,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 44, 841.92, 595.32)"
44,43,0,0,0,0,0,0,0,0,0,0,0,0,0,"('43', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 44, 841.92, 595.32)"
45,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 45, 841.92, 595.32)"
45,Respiratory Specimens of Infected Patients. N Engl J Med 10.1056/NEJMc2001737. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Respiratory Specimens of Infected Patients. N Engl J Med 10.1056/NEJMc2001737. doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.624, 756.168, 526.128, 767.076), True, False, 45, 841.92, 595.32)"
45,10.1056/NEJMc2001737.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1056/NEJMc2001737.', 'TimesNewRomanPSMT', 10.908000000000015, (93.624, 741.268, 223.61, 752.176), True, False, 45, 841.92, 595.32)"
45,"83.  Hao W, Li M, Huang X. 2020. First Atypical case of 2019 novel coronavirus in Yan'an,",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""83.  Hao W, Li M, Huang X. 2020. First Atypical case of 2019 novel coronavirus in Yan'an,"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 526.164, 737.716), False, False, 45, 841.92, 595.32)"
45,China. Clin Microbiol Infect. S1198-743X(20)30091-4. doi: 10.1016/j.cmi.2020.02.011.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('China. Clin Microbiol Infect. S1198-743X(20)30091-4. doi: 10.1016/j.cmi.2020.02.011.', 'TimesNewRomanPSMT', 10.908000000000015, (93.624, 711.508, 521.62, 722.416), True, False, 45, 841.92, 595.32)"
45,"84.  Zhou  T,  Liu  Q,  Yang  Z,  Liao  J,  Yang  K,  Bai  W,  Lu  X,  Zhang  W.  2020.  Preliminary",0,0,0,0,0,0,0,0,0,0,0,0,0,"('84.  Zhou  T,  Liu  Q,  Yang  Z,  Liao  J,  Yang  K,  Bai  W,  Lu  X,  Zhang  W.  2020.  Preliminary', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 696.628, 526.372, 707.956), False, False, 45, 841.92, 595.32)"
45,prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 681.748, 529.432, 692.6560000000001), True, False, 45, 841.92, 595.32)"
45,J Evid Based Med 10.1111/jebm.12376. doi: 10.1111/jebm.12376.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('J Evid Based Med 10.1111/jebm.12376. doi: 10.1111/jebm.12376.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 666.748, 419.47, 677.6560000000001), True, False, 45, 841.92, 595.32)"
45,"85.  Wang  L,  Su  S,  Bi  Y,  Wong  G,  Gao  GF.  2018a.  Bat-origin  Coronaviruses  expand  their",0,0,0,0,0,0,0,0,0,0,0,0,0,"('85.  Wang  L,  Su  S,  Bi  Y,  Wong  G,  Gao  GF.  2018a.  Bat-origin  Coronaviruses  expand  their', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 651.868, 526.33, 663.196), False, False, 45, 841.92, 595.32)"
45,host range to pigs. Trends Microbiol 26(6):466-470. doi: 10.1016/j.tim.2018.03.001.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('host range to pigs. Trends Microbiol 26(6):466-470. doi: 10.1016/j.tim.2018.03.001.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 636.028, 505.54, 646.936), True, False, 45, 841.92, 595.32)"
45,"86.  Benvenuto  D,  Giovanetti  M,  Salemi  M,  Prosperi  M,  De  Flora  C,  Junior  Alcantara  LC,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('86.  Benvenuto  D,  Giovanetti  M,  Salemi  M,  Prosperi  M,  De  Flora  C,  Junior  Alcantara  LC,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 620.188, 526.0799999999998, 631.516), False, False, 45, 841.92, 595.32)"
45,"Angeletti  S,  Ciccozzi  M.  2020.  The  global  spread  of  2019-nCoV:  a  molecular",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Angeletti  S,  Ciccozzi  M.  2020.  The  global  spread  of  2019-nCoV:  a  molecular', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 604.3480000000001, 526.33, 615.2560000000001), True, False, 45, 841.92, 595.32)"
45,evolutionary analysis. Pathog Glob Health 1-4. doi: 10.1080/20477724.2020.1725339.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('evolutionary analysis. Pathog Glob Health 1-4. doi: 10.1080/20477724.2020.1725339.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 588.388, 515.14, 599.296), True, False, 45, 841.92, 595.32)"
45,"87.  Wan  Y,  Shang  J,  Graham  R,  Baric  RS,  Li  F.  2020.  Receptor  recognition  by  novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('87.  Wan  Y,  Shang  J,  Graham  R,  Baric  RS,  Li  F.  2020.  Receptor  recognition  by  novel', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 572.548, 526.088, 583.876), False, False, 45, 841.92, 595.32)"
45,coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 556.678, 526.318, 567.586), True, False, 45, 841.92, 595.32)"
45,J Virol JVI.00127-20. doi: 10.1128/JVI.00127-20.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('J Virol JVI.00127-20. doi: 10.1128/JVI.00127-20.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 540.838, 341.11, 551.746), True, False, 45, 841.92, 595.32)"
45,"88.  Biscayart C, Angeleri P, Lloveras S, Chaves TDSS, Schlagenhauf P, Rodríguez-Morales",0,0,0,0,0,0,0,0,0,0,0,0,0,"('88.  Biscayart C, Angeleri P, Lloveras S, Chaves TDSS, Schlagenhauf P, Rodríguez-Morales', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 524.878, 526.408, 536.206), False, False, 45, 841.92, 595.32)"
45,AJ.  2020.  The  next  big  threat  to  global  health?  2019 novel coronavirus (2019-nCoV):,0,0,0,0,0,0,0,0,0,0,0,0,0,"('AJ.  2020.  The  next  big  threat  to  global  health?  2019 novel coronavirus (2019-nCoV):', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 509.038, 526.384, 519.946), True, False, 45, 841.92, 595.32)"
45,"What  advice  can  we  give  to  travellers?  -  Interim  recommendations  January  2020,  from",0,0,0,0,0,0,0,0,0,0,0,0,0,"('What  advice  can  we  give  to  travellers?  -  Interim  recommendations  January  2020,  from', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 493.19800000000004, 526.2740000000001, 504.106), True, False, 45, 841.92, 595.32)"
45,the  Latin-American  society  for  Travel  Medicine  (SLAMVI).  Travel  Med  Infect,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  Latin-American  society  for  Travel  Medicine  (SLAMVI).  Travel  Med  Infect', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 477.358, 526.36, 488.26599999999996), True, False, 45, 841.92, 595.32)"
45,Dis 33:101567. doi: 10.1016/j.tmaid.2020.101567.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Dis 33:101567. doi: 10.1016/j.tmaid.2020.101567.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 461.398, 340.03, 472.306), True, False, 45, 841.92, 595.32)"
45,"89.  Rodriguez-Morales  AJ,  MacGregor  K,  Kanagarajah  S,  Patel  D,  Schlagenhauf  P.  2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('89.  Rodriguez-Morales  AJ,  MacGregor  K,  Kanagarajah  S,  Patel  D,  Schlagenhauf  P.  2020.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 445.558, 526.42, 456.88599999999997), False, False, 45, 841.92, 595.32)"
45,Going  global  -  Travel  and  the  2019  novel  coronavirus.  Travel  Med  Infect  Dis,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Going  global  -  Travel  and  the  2019  novel  coronavirus.  Travel  Med  Infect  Dis', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 430.678, 526.196, 441.58599999999996), True, False, 45, 841.92, 595.32)"
45,33:101578.doi: 10.1016/j.tmaid.2020.101578,0,0,0,0,0,0,0,0,0,0,0,0,0,"('33:101578.doi: 10.1016/j.tmaid.2020.101578', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 415.798, 314.45, 426.70599999999996), True, False, 45, 841.92, 595.32)"
45,"90.  Peiris JS, Guan Y, Yuen KY. 2004. Severe acute respiratory syndrome. Nat Med 10(12",0,0,0,0,0,0,0,0,0,0,0,0,0,"('90.  Peiris JS, Guan Y, Yuen KY. 2004. Severe acute respiratory syndrome. Nat Med 10(12', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 400.918, 526.1279999999998, 412.246), False, False, 45, 841.92, 595.32)"
45,Suppl): S88-97. doi: 10.1038/nm1143.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Suppl): S88-97. doi: 10.1038/nm1143.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 385.058, 284.81, 395.96599999999995), True, False, 45, 841.92, 595.32)"
45,"91.  Hui  DS,  Azhar  EI,  Kim  YJ,  Memish  ZA,  Oh  MD,  Zumla  A.  2018.  Middle  East",0,0,0,0,0,0,0,0,0,0,0,0,0,"('91.  Hui  DS,  Azhar  EI,  Kim  YJ,  Memish  ZA,  Oh  MD,  Zumla  A.  2018.  Middle  East', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 369.098, 526.128, 380.426), False, False, 45, 841.92, 595.32)"
45,"respiratory  syndrome  coronavirus:  risk  factors  and  determinants  of  primary,  household,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory  syndrome  coronavirus:  risk  factors  and  determinants  of  primary,  household,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 353.25800000000004, 526.3299999999999, 364.166), True, False, 45, 841.92, 595.32)"
45,and  nosocomial  transmission.  Lancet  Infect  Dis  18(8):e217-e227.  doi:  10.1016/S1473-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  nosocomial  transmission.  Lancet  Infect  Dis  18(8):e217-e227.  doi:  10.1016/S1473-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 337.418, 523.576, 348.32599999999996), True, False, 45, 841.92, 595.32)"
45,3099(18)30127-0.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('3099(18)30127-0.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 321.57800000000003, 186.38, 332.486), True, False, 45, 841.92, 595.32)"
45,"92.  Kritas  SK,  Ronconi  G,  Caraffa  A,  Gallenga  CE,  Ross  R,  Conti  P.  2020.  Mast  cells",0,0,0,0,0,0,0,0,0,0,0,0,0,"('92.  Kritas  SK,  Ronconi  G,  Caraffa  A,  Gallenga  CE,  Ross  R,  Conti  P.  2020.  Mast  cells', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 305.738, 525.996, 317.066), False, False, 45, 841.92, 595.32)"
45,contribute  to  coronavirus-induced  inflammation:  new  anti-inflammatory  strategy.  J,0,0,0,0,0,0,0,0,0,0,0,0,0,"('contribute  to  coronavirus-induced  inflammation:  new  anti-inflammatory  strategy.  J', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 290.738, 526.318, 301.64599999999996), True, False, 45, 841.92, 595.32)"
45,BiolRegulHomeost  Agents  34(1):10.23812/20-Editorial-Kritas.  doi:  10.23812/20-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('BiolRegulHomeost  Agents  34(1):10.23812/20-Editorial-Kritas.  doi:  10.23812/20-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 275.858, 523.456, 286.76599999999996), True, False, 45, 841.92, 595.32)"
45,Editorial-Kritas.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Editorial-Kritas.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 260.978, 177.74, 271.88599999999997), True, False, 45, 841.92, 595.32)"
45,93.  WHO.  2003.  World  Health  Organization.  Consensus  document  on  the  epidemiology  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('93.  WHO.  2003.  World  Health  Organization.  Consensus  document  on  the  epidemiology  of', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 246.09799999999998, 526.1519999999999, 257.426), False, False, 45, 841.92, 595.32)"
45,online:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('online:', 'TimesNewRomanPSMT', 10.908000000000015, (490.13800000000003, 230.25799999999998, 526.366, 241.166), True, False, 45, 841.92, 595.32)"
45,severe,0,0,0,0,0,0,0,0,0,0,0,0,0,"('severe', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 230.25799999999998, 126.864, 241.166), True, False, 45, 841.92, 595.32)"
45,https://www.who.int/csr/sars/en/WHOconsensus.pdf (accessed on 29 January 2020).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://www.who.int/csr/sars/en/WHOconsensus.pdf (accessed on 29 January 2020).', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 214.38799999999998, 502.18, 225.296), True, False, 45, 841.92, 595.32)"
45,(SARS).  Available,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(SARS).  Available', 'TimesNewRomanPSMT', 10.908000000000015, (351.1800000000001, 230.25799999999998, 467.494, 241.166), True, False, 45, 841.92, 595.32)"
45,respiratory,0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory', 'TimesNewRomanPSMT', 10.908000000000015, (200.508, 230.25799999999998, 255.46800000000007, 241.166), True, False, 45, 841.92, 595.32)"
45,syndrome,0,0,0,0,0,0,0,0,0,0,0,0,0,"('syndrome', 'TimesNewRomanPSMT', 10.908000000000015, (278.1240000000001, 230.25799999999998, 328.5120000000001, 241.166), True, False, 45, 841.92, 595.32)"
45,acute,0,0,0,0,0,0,0,0,0,0,0,0,0,"('acute', 'TimesNewRomanPSMT', 10.908000000000015, (149.532, 230.25799999999998, 177.864, 241.166), True, False, 45, 841.92, 595.32)"
45,"94.  Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Abu-Raddad LJ, Ho",0,0,0,0,0,0,0,0,0,0,0,0,0,"('94.  Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Abu-Raddad LJ, Ho', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 198.428, 526.384, 209.756), False, False, 45, 841.92, 595.32)"
45,"LM, Thach TQ, Chau P, Chan KP, Lam TH, Tse LY, Tsang T, Liu SH, Kong JH, Lau",0,0,0,0,0,0,0,0,0,0,0,0,0,"('LM, Thach TQ, Chau P, Chan KP, Lam TH, Tse LY, Tsang T, Liu SH, Kong JH, Lau', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 183.54799999999997, 526.0319999999998, 194.456), True, False, 45, 841.92, 595.32)"
45,"EM,  Ferguson  NM,  Anderson  RM.  2003.  Epidemiological  determinants  of  spread  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('EM,  Ferguson  NM,  Anderson  RM.  2003.  Epidemiological  determinants  of  spread  of', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 168.66799999999998, 526.1719999999998, 179.576), True, False, 45, 841.92, 595.32)"
45,causal  agent  of  severe  acute  respiratory  syndrome  in  Hong  Kong.  Lancet,0,0,0,0,0,0,0,0,0,0,0,0,0,"('causal  agent  of  severe  acute  respiratory  syndrome  in  Hong  Kong.  Lancet', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 153.78799999999998, 526.152, 164.696), True, False, 45, 841.92, 595.32)"
45,361(9371):1761-1766. doi: 10.1016/S0140-6736(03)13410-1.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('361(9371):1761-1766. doi: 10.1016/S0140-6736(03)13410-1.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 138.908, 396.55, 149.816), True, False, 45, 841.92, 595.32)"
45,"95.  Millan-Oñate  J,  Rodríguez-Morales  AJ,  Camacho-Moreno  G,  Mendoza-Ramírez  H,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('95.  Millan-Oñate  J,  Rodríguez-Morales  AJ,  Camacho-Moreno  G,  Mendoza-Ramírez  H,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 124.028, 526.372, 135.356), False, False, 45, 841.92, 595.32)"
45,"Rodríguez-Sabogal  IA,  Álvarez-Moreno  C.  2020.  A  new  emerging  zoonotic  virus  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Rodríguez-Sabogal  IA,  Álvarez-Moreno  C.  2020.  A  new  emerging  zoonotic  virus  of', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 108.188, 526.1780000000001, 119.096), True, False, 45, 841.92, 595.32)"
45,concern:  the  2019  novel  Coronavirus  (COVID-19).  Infectio  24(3).  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('concern:  the  2019  novel  Coronavirus  (COVID-19).  Infectio  24(3).  doi:', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 92.232, 526.318, 103.14), True, False, 45, 841.92, 595.32)"
45,10.22354/in.v24i3.848.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.22354/in.v24i3.848.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 76.392, 208.37, 87.3), True, False, 45, 841.92, 595.32)"
45,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 45, 841.92, 595.32)"
45,44,0,0,0,0,0,0,0,0,0,0,0,0,0,"('44', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 45, 841.92, 595.32)"
46,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 46, 841.92, 595.32)"
46,"96.  Wilder-Smith  A,  Freedman  DO.  2020.  Isolation,  quarantine,  social  distancing  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('96.  Wilder-Smith  A,  Freedman  DO.  2020.  Isolation,  quarantine,  social  distancing  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.342, 767.496), False, False, 46, 841.92, 595.32)"
46,community  containment:  pivotal  role  for  old-style  public  health  measures  in  the  novel,0,0,0,0,0,0,0,0,0,0,0,0,0,"('community  containment:  pivotal  role  for  old-style  public  health  measures  in  the  novel', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.258, 752.176), True, False, 46, 841.92, 595.32)"
46,coronavirus (2019-nCoV) outbreak. J Travel Med taaa020. doi: 10.1093/jtm/taaa020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus (2019-nCoV) outbreak. J Travel Med taaa020. doi: 10.1093/jtm/taaa020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 508.78, 737.296), True, False, 46, 841.92, 595.32)"
46,97.  WHO. 2019. World Health Organization. Middle East respiratory syndrome coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('97.  WHO. 2019. World Health Organization. Middle East respiratory syndrome coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.3720000000001, 722.836), False, False, 46, 841.92, 595.32)"
46,(MERS-CoV).  Available,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(MERS-CoV).  Available', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 695.548, 241.208, 706.456), True, False, 46, 841.92, 595.32)"
46,https://www.who.int/en/news-room/fact-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://www.who.int/en/news-room/fact-', 'TimesNewRomanPSMT', 10.908000000000015, (327.42800000000005, 695.548, 523.336, 706.456), True, False, 46, 841.92, 595.32)"
46,sheets/detail/middle-east-respiratory-syndromecoronavirus-(mers-cov)  (accessed  on  29,0,0,0,0,0,0,0,0,0,0,0,0,0,"('sheets/detail/middle-east-respiratory-syndromecoronavirus-(mers-cov)  (accessed  on  29', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 679.708, 526.342, 690.616), True, False, 46, 841.92, 595.32)"
46,January 2020).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('January 2020).', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 663.868, 167.66, 674.7760000000001), True, False, 46, 841.92, 595.32)"
46,online:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('online:', 'TimesNewRomanPSMT', 10.908000000000015, (266.132, 695.548, 302.456, 706.456), True, False, 46, 841.92, 595.32)"
46,"98.  Jiang  X,  Rayner  S,  Luo  MH.  2020.  Does  SARS-CoV-2  has  a  longer  incubation  period",0,0,0,0,0,0,0,0,0,0,0,0,0,"('98.  Jiang  X,  Rayner  S,  Luo  MH.  2020.  Does  SARS-CoV-2  has  a  longer  incubation  period', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 648.028, 526.366, 659.356), False, False, 46, 841.92, 595.32)"
46,than SARS and MERS? J Med Virol 10.1002/jmv.25708. doi: 10.1002/jmv.25708.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('than SARS and MERS? J Med Virol 10.1002/jmv.25708. doi: 10.1002/jmv.25708.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 633.148, 494.14, 644.056), True, False, 46, 841.92, 595.32)"
46,"99.  Coutard  B,  Valle  C,  de  Lamballerie  X,  Canard  B,  Seidah  NG,  Decroly  E.  2020.  The",0,0,0,0,0,0,0,0,0,0,0,0,0,"('99.  Coutard  B,  Valle  C,  de  Lamballerie  X,  Canard  B,  Seidah  NG,  Decroly  E.  2020.  The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 618.268, 526.0559999999999, 629.596), False, False, 46, 841.92, 595.32)"
46,spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site,0,0,0,0,0,0,0,0,0,0,0,0,0,"('spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 603.268, 526.408, 614.176), True, False, 46, 841.92, 595.32)"
46,absent,0,0,0,0,0,0,0,0,0,0,0,0,0,"('absent', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 588.388, 126.96000000000001, 599.296), True, False, 46, 841.92, 595.32)"
46,the  same  clade.  Antiviral  Res  176:104742.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  same  clade.  Antiviral  Res  176:104742.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (225.66000000000003, 588.388, 526.1160000000001, 599.296), True, False, 46, 841.92, 595.32)"
46,10.1016/j.antiviral.2020.104742.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/j.antiviral.2020.104742.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 573.508, 257.09000000000003, 584.416), True, False, 46, 841.92, 595.32)"
46,in  CoV  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  CoV  of', 'TimesNewRomanPSMT', 10.908000000000015, (138.852, 588.388, 213.792, 599.296), True, False, 46, 841.92, 595.32)"
46,"100. Angeletti  S,  Benvenuto  D,  Bianchi  M,  Giovanetti  M,  Pascarella  S,  Ciccozzi  M.  2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('100. Angeletti  S,  Benvenuto  D,  Bianchi  M,  Giovanetti  M,  Pascarella  S,  Ciccozzi  M.  2020.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 558.5980000000001, 526.092, 569.926), False, False, 46, 841.92, 595.32)"
46,COVID-2019:  the  role  of  the  nsp2  and  nsp3  in  its  pathogenesis.  J  Med  Virol.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-2019:  the  role  of  the  nsp2  and  nsp3  in  its  pathogenesis.  J  Med  Virol.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 543.718, 526.42, 554.626), True, False, 46, 841.92, 595.32)"
46,10.1002/jmv.25719. doi: 10.1002/jmv.25719.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1002/jmv.25719. doi: 10.1002/jmv.25719.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 528.838, 315.05, 539.746), True, False, 46, 841.92, 595.32)"
46,101. Mahase  E.  2020.  Coronavirus  covid-19  has  killed  more  people  than  SARS  and  MERS,0,0,0,0,0,0,0,0,0,0,0,0,0,"('101. Mahase  E.  2020.  Coronavirus  covid-19  has  killed  more  people  than  SARS  and  MERS', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 513.958, 526.2379999999999, 525.286), False, False, 46, 841.92, 595.32)"
46,"combined, despite lower case fatality rate. BMJ. 368:m641. doi: 10.1136/bmj.m641.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('combined, despite lower case fatality rate. BMJ. 368:m641. doi: 10.1136/bmj.m641.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 499.07800000000003, 501.7, 509.986), True, False, 46, 841.92, 595.32)"
46,"102. Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, Zhu H, Zhao W, Han Y, Qin C. 2019. From",0,0,0,0,0,0,0,0,0,0,0,0,0,"('102. Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, Zhu H, Zhao W, Han Y, Qin C. 2019. From', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 482.158, 526.2119999999999, 493.486), False, False, 46, 841.92, 595.32)"
46,"SARS  to  MERS,  Thrusting  Coronaviruses  into  the  spotlight.  Viruses  11(1):59.  doi:",0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS  to  MERS,  Thrusting  Coronaviruses  into  the  spotlight.  Viruses  11(1):59.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 466.31800000000004, 526.1160000000001, 477.226), True, False, 46, 841.92, 595.32)"
46,10.3390/v11010059.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.3390/v11010059.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 450.478, 198.77, 461.38599999999997), True, False, 46, 841.92, 595.32)"
46,"103. Perlman  S.  2020.  Another  decade,  another  coronavirus  N  Engl  J  Med",0,0,0,0,0,0,0,0,0,0,0,0,0,"('103. Perlman  S.  2020.  Another  decade,  another  coronavirus  N  Engl  J  Med', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 434.51800000000003, 529.164, 445.846), False, False, 46, 841.92, 595.32)"
46,10.1056/NEJMe2001126. doi:10.1056/NEJMe2001126.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1056/NEJMe2001126. doi:10.1056/NEJMe2001126.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 418.678, 369.07, 429.58599999999996), True, False, 46, 841.92, 595.32)"
46,"104. Graham  RL,  Donaldson  EF,  Baric  RS.  2013.  A  decade  after  SARS:  strategies  for",0,0,0,0,0,0,0,0,0,0,0,0,0,"('104. Graham  RL,  Donaldson  EF,  Baric  RS.  2013.  A  decade  after  SARS:  strategies  for', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 402.838, 526.0799999999999, 414.166), False, False, 46, 841.92, 595.32)"
46,controlling  emerging  coronaviruses.  Nat  Rev  Microbiol  11(12):836-848.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('controlling  emerging  coronaviruses.  Nat  Rev  Microbiol  11(12):836-848.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 386.978, 526.408, 397.88599999999997), True, False, 46, 841.92, 595.32)"
46,10.1038/nrmicro3143.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1038/nrmicro3143.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 371.01800000000003, 206.69, 381.926), True, False, 46, 841.92, 595.32)"
46,"105. Menachery  VD,  Yount  BL  Jr,  Debbink  K,  Agnihothram  S,  Gralinski  LE,  Plante  JA,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('105. Menachery  VD,  Yount  BL  Jr,  Debbink  K,  Agnihothram  S,  Gralinski  LE,  Plante  JA,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 355.178, 526.27, 366.506), False, False, 46, 841.92, 595.32)"
46,"Graham  RL, Scobey T,  Ge XY, Donaldson EF,  Randell SH, Lanzavecchia A, Marasco",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Graham  RL, Scobey T,  Ge XY, Donaldson EF,  Randell SH, Lanzavecchia A, Marasco', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 339.338, 526.0199999999996, 350.246), True, False, 46, 841.92, 595.32)"
46,"WA,  Shi  ZL,  Baric  RS.  2015.  A  SARS-like  cluster  of  circulating  bat  coronaviruses",0,0,0,0,0,0,0,0,0,0,0,0,0,"('WA,  Shi  ZL,  Baric  RS.  2015.  A  SARS-like  cluster  of  circulating  bat  coronaviruses', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 323.498, 526.2860000000001, 334.40599999999995), True, False, 46, 841.92, 595.32)"
46,shows  potential  for  human  emergence.  Nat  Med  21(12):1508-1513.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('shows  potential  for  human  emergence.  Nat  Med  21(12):1508-1513.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 307.538, 526.408, 318.44599999999997), True, False, 46, 841.92, 595.32)"
46,10.1038/nm.3985.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1038/nm.3985.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 291.69800000000004, 187.1, 302.606), True, False, 46, 841.92, 595.32)"
46,"106. Cui  J,  Li  F,  Shi  ZL.  2019.  Origin  and  evolution  of  pathogenic  coronaviruses.  Nat  Rev",0,0,0,0,0,0,0,0,0,0,0,0,0,"('106. Cui  J,  Li  F,  Shi  ZL.  2019.  Origin  and  evolution  of  pathogenic  coronaviruses.  Nat  Rev', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 275.858, 526.0319999999998, 287.186), False, False, 46, 841.92, 595.32)"
46,Microbiol 17(3):181-192. doi: 10.1038/s41579-018-0118-9.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Microbiol 17(3):181-192. doi: 10.1038/s41579-018-0118-9.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 260.01800000000003, 387.55, 270.926), True, False, 46, 841.92, 595.32)"
46,"107. Lau  SKP, Luk  HKH, Wong  ACP, Fan  RYY, Lam  CSF, Li  KSM, Ahmed  SS, Chow",0,0,0,0,0,0,0,0,0,0,0,0,0,"('107. Lau  SKP, Luk  HKH, Wong  ACP, Fan  RYY, Lam  CSF, Li  KSM, Ahmed  SS, Chow', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 244.058, 526.408, 255.386), False, False, 46, 841.92, 595.32)"
46,"FWN, Cai  JP, Zhu  X, Chan  JFW, Lau  TCK, Cao  K, Li  M, Woo  PCY, Yuen  KY.  2019.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('FWN, Cai  JP, Zhu  X, Chan  JFW, Lau  TCK, Cao  K, Li  M, Woo  PCY, Yuen  KY.  2019.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 228.218, 526.372, 239.126), True, False, 46, 841.92, 595.32)"
46,Identification  of  a  Novel  Betacoronavirus  (Merbecovirus)  in  Amur  Hedgehogs  from,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Identification  of  a  Novel  Betacoronavirus  (Merbecovirus)  in  Amur  Hedgehogs  from', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 212.34799999999998, 526.1279999999999, 223.256), True, False, 46, 841.92, 595.32)"
46,China. Viruses 11(11): pii: E980. doi: 10.3390/v11110980.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('China. Viruses 11(11): pii: E980. doi: 10.3390/v11110980.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 196.50799999999998, 380.47, 207.416), True, False, 46, 841.92, 595.32)"
46,108. WHO. 2018. World Health Organization. WHO MERS global summary and assessment,0,0,0,0,0,0,0,0,0,0,0,0,0,"('108. WHO. 2018. World Health Organization. WHO MERS global summary and assessment', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 180.66799999999998, 526.366, 191.99599999999998), False, False, 46, 841.92, 595.32)"
46,online:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('online:', 'TimesNewRomanPSMT', 10.908000000000015, (489.996, 164.708, 526.2239999999999, 175.616), True, False, 46, 841.92, 595.32)"
46,of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 164.708, 106.38, 175.616), True, False, 46, 841.92, 595.32)"
46,https://www.who.int/csr/disease/coronavirus_infections/risk-assessment-august-2018.pdf,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://www.who.int/csr/disease/coronavirus_infections/risk-assessment-august-2018.pdf', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 148.868, 524.74, 159.776), True, False, 46, 841.92, 595.32)"
46,(accessed on 29 January 2020).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(accessed on 29 January 2020).', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 133.028, 246.65, 143.936), True, False, 46, 841.92, 595.32)"
46,Available,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Available', 'TimesNewRomanPSMT', 10.908000000000015, (389.112, 164.708, 438.768, 175.616), True, False, 46, 841.92, 595.32)"
46,2018.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2018.', 'TimesNewRomanPSMT', 10.908000000000015, (307.884, 164.708, 337.884, 175.616), True, False, 46, 841.92, 595.32)"
46,risk.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('risk.', 'TimesNewRomanPSMT', 10.908000000000015, (157.572, 164.708, 181.68, 175.616), True, False, 46, 841.92, 595.32)"
46,Aug,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Aug', 'TimesNewRomanPSMT', 10.908000000000015, (232.90800000000002, 164.708, 256.656, 175.616), True, False, 46, 841.92, 595.32)"
46,"109. Vergara-Alert  J,  van  den  Brand  JM,  Widagdo  W,  Muñoz  M  5th,  Raj  S,  Schipper  D,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('109. Vergara-Alert  J,  van  den  Brand  JM,  Widagdo  W,  Muñoz  M  5th,  Raj  S,  Schipper  D,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 117.188, 526.1240000000001, 128.516), False, False, 46, 841.92, 595.32)"
46,"Solanes D, Cordón I, Bensaid A, Haagmans BL, Segalés J. 2017. Livestock susceptibility",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Solanes D, Cordón I, Bensaid A, Haagmans BL, Segalés J. 2017. Livestock susceptibility', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 101.228, 526.208, 112.136), True, False, 46, 841.92, 595.32)"
46,to  infection  with  middle  east  respiratory  syndrome  Coronavirus.  Emerg  Infect  Dis,0,0,0,0,0,0,0,0,0,0,0,0,0,"('to  infection  with  middle  east  respiratory  syndrome  Coronavirus.  Emerg  Infect  Dis', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 85.392, 526.104, 96.3), True, False, 46, 841.92, 595.32)"
46,23(2):232-240. doi: 10.3201/eid2302.161239.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('23(2):232-240. doi: 10.3201/eid2302.161239.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 69.552, 319.39, 80.46000000000001), True, False, 46, 841.92, 595.32)"
46,45,0,0,0,0,0,0,0,0,0,0,0,0,0,"('45', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 46, 841.92, 595.32)"
46,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 46, 841.92, 595.32)"
47,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 47, 841.92, 595.32)"
47,"110. Wu  YC,  Chen  CS,  Chan  YJ.  2020.  Overview  of  the  2019  novel  Coronavirus  (2019-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('110. Wu  YC,  Chen  CS,  Chan  YJ.  2020.  Overview  of  the  2019  novel  Coronavirus  (2019-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 523.336, 767.496), False, False, 47, 841.92, 595.32)"
47,nCoV):  The  pathogen  of  Severe  Specific  Contagious  Pneumonia  (SSCP).  J  Chin  Med,0,0,0,0,0,0,0,0,0,0,0,0,0,"('nCoV):  The  pathogen  of  Severe  Specific  Contagious  Pneumonia  (SSCP).  J  Chin  Med', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.0440000000002, 752.176), True, False, 47, 841.92, 595.32)"
47,Assoc 10.1097/JCMA.0000000000000270. doi: 10.1097/JCMA.0000000000000270.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Assoc 10.1097/JCMA.0000000000000270. doi: 10.1097/JCMA.0000000000000270.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 506.26, 737.296), True, False, 47, 841.92, 595.32)"
47,111. Tian  HY.  2020.  2019-nCoV:  new  challenges  from  coronavirus.  Zhonghua  Yu  Fang  Yi,0,0,0,0,0,0,0,0,0,0,0,0,0,"('111. Tian  HY.  2020.  2019-nCoV:  new  challenges  from  coronavirus.  Zhonghua  Yu  Fang  Yi', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.4200000000001, 722.836), False, False, 47, 841.92, 595.32)"
47,XueZaZhi 54(00): E001-E001. doi: 10.3760/cma.j.issn.0253-9624.2020.0001.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('XueZaZhi 54(00): E001-E001. doi: 10.3760/cma.j.issn.0253-9624.2020.0001.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 696.628, 471.82, 707.5360000000001), True, False, 47, 841.92, 595.32)"
47,"112. Chan  JF, Yuan  S, Kok  KH, To  KK, Chu  H, Yang  J, Xing  F, Liu  J, Yip  CC, Poon",0,0,0,0,0,0,0,0,0,0,0,0,0,"('112. Chan  JF, Yuan  S, Kok  KH, To  KK, Chu  H, Yang  J, Xing  F, Liu  J, Yip  CC, Poon', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 681.748, 526.408, 693.076), False, False, 47, 841.92, 595.32)"
47,"RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen",0,0,0,0,0,0,0,0,0,0,0,0,0,"('RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 665.788, 526.408, 676.696), True, False, 47, 841.92, 595.32)"
47,"H, Hui  CK, Yuen  KY.  2020.  A familial cluster of pneumonia associated with",0,0,0,0,0,0,0,0,0,0,0,0,0,"('H, Hui  CK, Yuen  KY.  2020.  A familial cluster of pneumonia associated with', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 649.948, 526.408, 660.856), True, False, 47, 841.92, 595.32)"
47,the 2019 novel coronavirus indicating person-to-person transmission:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the 2019 novel coronavirus indicating person-to-person transmission:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 634.1080000000001, 429.74199999999996, 645.0160000000001), True, False, 47, 841.92, 595.32)"
47,a study of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('a study of', 'TimesNewRomanPSMT', 10.908000000000015, (476.19399999999996, 634.1080000000001, 526.4200000000001, 645.0160000000001), True, False, 47, 841.92, 595.32)"
47,a family cluster.  Lancet pii:  S0140-6736(20)30154-9.  doi:  10.1016/S0140-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('a family cluster.  Lancet pii:  S0140-6736(20)30154-9.  doi:  10.1016/S0140-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 618.268, 523.576, 629.176), True, False, 47, 841.92, 595.32)"
47,6736(20)30154-9.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('6736(20)30154-9.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 602.308, 183.38, 613.216), True, False, 47, 841.92, 595.32)"
47,"113. Backer  JA,  Klinkenberg  D,  Wallinga  J.  2020.  Incubation  period  of  2019  novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('113. Backer  JA,  Klinkenberg  D,  Wallinga  J.  2020.  Incubation  period  of  2019  novel', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 586.468, 526.306, 597.7959999999999), False, False, 47, 841.92, 595.32)"
47,"coronavirus  (2019-nCoV)  infections  among  travellers  from  Wuhan,  China,  20-28",0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus  (2019-nCoV)  infections  among  travellers  from  Wuhan,  China,  20-28', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 571.558, 526.4200000000001, 582.466), True, False, 47, 841.92, 595.32)"
47,January  2020.  Euro  Surveill  25(5):10.2807/1560-7917.ES.2020.25.5.2000062.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('January  2020.  Euro  Surveill  25(5):10.2807/1560-7917.ES.2020.25.5.2000062.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 556.678, 526.366, 567.586), True, False, 47, 841.92, 595.32)"
47,10.2807/1560-7917.ES.2020.25.5.2000062.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.2807/1560-7917.ES.2020.25.5.2000062.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 541.798, 309.77, 552.706), True, False, 47, 841.92, 595.32)"
47,"114. Li  Q, Guan  X, Wu  P, Wang  X, Zhou  L, Tong  Y, Ren  R, Leung  KSM, Lau  EHY, Wong",0,0,0,0,0,0,0,0,0,0,0,0,0,"('114. Li  Q, Guan  X, Wu  P, Wang  X, Zhou  L, Tong  Y, Ren  R, Leung  KSM, Lau  EHY, Wong', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 526.918, 526.42, 538.246), False, False, 47, 841.92, 595.32)"
47,"JY, Xing  X, Xiang  N, Wu  Y, Li  C, Chen  Q, Li  D, Liu  T, Zhao  J, Li  M, Tu  W, Chen",0,0,0,0,0,0,0,0,0,0,0,0,0,"('JY, Xing  X, Xiang  N, Wu  Y, Li  C, Chen  Q, Li  D, Liu  T, Zhao  J, Li  M, Tu  W, Chen', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 510.95799999999997, 526.408, 521.866), True, False, 47, 841.92, 595.32)"
47,"C, Jin  L, Yang  R, Wang  Q, Zhou  S, Wang  R, Liu  H, Luo  Y, Liu  Y, Shao  G, Li  H, Tao",0,0,0,0,0,0,0,0,0,0,0,0,0,"('C, Jin  L, Yang  R, Wang  Q, Zhou  S, Wang  R, Liu  H, Luo  Y, Liu  Y, Shao  G, Li  H, Tao', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 495.118, 526.42, 506.02599999999995), True, False, 47, 841.92, 595.32)"
47,"Z, Yang  Y, Deng  Z, Liu  B, Ma  Z, Zhang  Y, Shi  G, Lam  TTY, Wu  JTK, Gao",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Z, Yang  Y, Deng  Z, Liu  B, Ma  Z, Zhang  Y, Shi  G, Lam  TTY, Wu  JTK, Gao', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 479.278, 526.408, 490.186), True, False, 47, 841.92, 595.32)"
47,"GF, Cowling  BJ, Yang  B, Leung  GM, Feng  Z.  2020.  Early  transmission  dynamics  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('GF, Cowling  BJ, Yang  B, Leung  GM, Feng  Z.  2020.  Early  transmission  dynamics  in', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 463.438, 526.306, 474.34599999999995), True, False, 47, 841.92, 595.32)"
47,"Wuhan,  China,  of novel Coronavirus-infected  pneumonia.  N  Engl  J  Med  doi:",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Wuhan,  China,  of novel Coronavirus-infected  pneumonia.  N  Engl  J  Med  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 447.598, 526.2620000000001, 458.506), True, False, 47, 841.92, 595.32)"
47,10.1056/NEJMoa2001316.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1056/NEJMoa2001316.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 431.63800000000003, 226.37, 442.546), True, False, 47, 841.92, 595.32)"
47,"115. Assiri  A,  Al-Tawfiq  JA,  Al-Rabeeah  AA,  Al-Rabiah  FA,  Al-Hajjar  S,  Al-Barrak  A,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('115. Assiri  A,  Al-Tawfiq  JA,  Al-Rabeeah  AA,  Al-Rabiah  FA,  Al-Hajjar  S,  Al-Barrak  A,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 415.798, 526.384, 427.126), False, False, 47, 841.92, 595.32)"
47,"Flemban  H,  Al-Nassir  WN,  Balkhy  HH,  Al-Hakeem  RF,  Makhdoom  HQ,  Zumla  AI,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Flemban  H,  Al-Nassir  WN,  Balkhy  HH,  Al-Hakeem  RF,  Makhdoom  HQ,  Zumla  AI,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 400.918, 526.258, 411.82599999999996), True, False, 47, 841.92, 595.32)"
47,"Memish  ZA.  2013.  Epidemiological,  demographic,  and  clinical  characteristics  of  47",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Memish  ZA.  2013.  Epidemiological,  demographic,  and  clinical  characteristics  of  47', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 386.01800000000003, 526.0919999999999, 396.926), True, False, 47, 841.92, 595.32)"
47,cases  of  Middle  East  respiratory  syndrome  coronavirus  disease  from  Saudi  Arabia:  a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('cases  of  Middle  East  respiratory  syndrome  coronavirus  disease  from  Saudi  Arabia:  a', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 371.13800000000003, 526.408, 382.046), True, False, 47, 841.92, 595.32)"
47,descriptive study. Lancet Infect Dis 13(9):752-761. doi: 10.1016/S1473-3099(13)70204-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('descriptive study. Lancet Infect Dis 13(9):752-761. doi: 10.1016/S1473-3099(13)70204-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 356.25800000000004, 523.336, 367.166), True, False, 47, 841.92, 595.32)"
47,4.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('4.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 341.37800000000004, 108.38, 352.286), True, False, 47, 841.92, 595.32)"
47,"116. Huang  C, Wang  Y, Li  X, Ren  L, Zhao  J, Hu  Y, Zhang  L, Fan  G, Xu  J, Gu  X, Cheng",0,0,0,0,0,0,0,0,0,0,0,0,0,"('116. Huang  C, Wang  Y, Li  X, Ren  L, Zhao  J, Hu  Y, Zhang  L, Fan  G, Xu  J, Gu  X, Cheng', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 326.37800000000004, 526.408, 337.706), False, False, 47, 841.92, 595.32)"
47,"Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 310.538, 526.42, 321.44599999999997), True, False, 47, 841.92, 595.32)"
47,"J, Wang  G, Jiang  R, Gao  Z, Jin  Q, Wang  J, Cao  B.  2020.  Clinical  features  of  patients",0,0,0,0,0,0,0,0,0,0,0,0,0,"('J, Wang  G, Jiang  R, Gao  Z, Jin  Q, Wang  J, Cao  B.  2020.  Clinical  features  of  patients', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 294.69800000000004, 526.19, 305.606), True, False, 47, 841.92, 595.32)"
47,"infected  with  2019 novel coronavirus in  Wuhan,  China.  Lancetpii:  S0140-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('infected  with  2019 novel coronavirus in  Wuhan,  China.  Lancetpii:  S0140-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 278.858, 523.576, 289.76599999999996), True, False, 47, 841.92, 595.32)"
47,6736(20)30183-5. doi: 10.1016/S0140-6736(20)30183-5.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('6736(20)30183-5. doi: 10.1016/S0140-6736(20)30183-5.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 263.01800000000003, 372.07, 273.926), True, False, 47, 841.92, 595.32)"
47,"117. Bonilla-Aldana DK, Quintero-Rada K, Montoya-Posada JP, Ramirez S, Paniz-Mondolfi",0,0,0,0,0,0,0,0,0,0,0,0,0,"('117. Bonilla-Aldana DK, Quintero-Rada K, Montoya-Posada JP, Ramirez S, Paniz-Mondolfi', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 247.058, 526.42, 258.386), False, False, 47, 841.92, 595.32)"
47,"A,  Rabaan  A,  Sah  R,  Rodriguez-Morales  AJ.  2020.  SARS-CoV,  MERS-CoV  and  now",0,0,0,0,0,0,0,0,0,0,0,0,0,"('A,  Rabaan  A,  Sah  R,  Rodriguez-Morales  AJ.  2020.  SARS-CoV,  MERS-CoV  and  now', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 231.218, 526.408, 242.126), True, False, 47, 841.92, 595.32)"
47,the  2019-novel  CoV:  Have  we  investigated  enough  about  coronaviruses?  -  A,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  2019-novel  CoV:  Have  we  investigated  enough  about  coronaviruses?  -  A', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 215.34799999999998, 526.42, 226.256), True, False, 47, 841.92, 595.32)"
47,bibliometric analysis. Travel Med Infect Dis doi:10.1016/j.tmaid.2020.101566:101566.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('bibliometric analysis. Travel Med Infect Dis doi:10.1016/j.tmaid.2020.101566:101566.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 199.50799999999998, 515.74, 210.416), True, False, 47, 841.92, 595.32)"
47,"118. Zhou  L,  Liu  HG.  2020.  Early  detection  and  disease  assessment  of  patients  with  novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('118. Zhou  L,  Liu  HG.  2020.  Early  detection  and  disease  assessment  of  patients  with  novel', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 183.54799999999997, 526.0680000000001, 194.87599999999998), False, False, 47, 841.92, 595.32)"
47,coronavirus  pneumonia.  ZhonghuaJie  He  He  Hu  Xi  ZaZhi  43(0):E003.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus  pneumonia.  ZhonghuaJie  He  He  Hu  Xi  ZaZhi  43(0):E003.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 168.66799999999998, 526.1999999999999, 179.576), True, False, 47, 841.92, 595.32)"
47,10.3760/cma.j.issn.1001-0939.2020.0003.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.3760/cma.j.issn.1001-0939.2020.0003.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 153.78799999999998, 298.73, 164.696), True, False, 47, 841.92, 595.32)"
47,"119. Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu S, Zhao P, Liu H, Zhu L,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('119. Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu S, Zhao P, Liu H, Zhu L,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 138.908, 526.166, 150.236), False, False, 47, 841.92, 595.32)"
47,"Tai  Y,  Bai  C,Gao  T,  Song  J,  Xia  P,  Dong  J,  Zhao  J,  Wang,  F.-S.  2020.  Pathological",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Tai  Y,  Bai  C,Gao  T,  Song  J,  Xia  P,  Dong  J,  Zhao  J,  Wang,  F.-S.  2020.  Pathological', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 123.068, 526.384, 133.976), True, False, 47, 841.92, 595.32)"
47,findings  of COVID-19 associated with  acute respiratory distress  syndrome. The Lancet,0,0,0,0,0,0,0,0,0,0,0,0,0,"('findings  of COVID-19 associated with  acute respiratory distress  syndrome. The Lancet', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 107.228, 526.178, 118.136), True, False, 47, 841.92, 595.32)"
47,Respiratory Medicine. doi:10.1016/S2213-2600(20)30076-X,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Respiratory Medicine. doi:10.1016/S2213-2600(20)30076-X', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 91.272, 389.11, 102.18), True, False, 47, 841.92, 595.32)"
47,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 47, 841.92, 595.32)"
47,46,0,0,0,0,0,0,0,0,0,0,0,0,0,"('46', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 47, 841.92, 595.32)"
48,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 48, 841.92, 595.32)"
48,"120. Schwartz DA, Graham AL. 2020. Potential maternal and infant outcomes from (Wuhan)",0,0,0,0,0,0,0,0,0,0,0,0,0,"('120. Schwartz DA, Graham AL. 2020. Potential maternal and infant outcomes from (Wuhan)', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.152, 767.496), False, False, 48, 841.92, 595.32)"
48,"Coronavirus  2019-nCoV  infecting  pregnant  women:  lessons  from  SARS,  MERS,  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus  2019-nCoV  infecting  pregnant  women:  lessons  from  SARS,  MERS,  and', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.1240000000001, 752.176), True, False, 48, 841.92, 595.32)"
48,other human Coronavirus infections. Viruses 12(2):E194. doi: 10.3390/v12020194.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('other human Coronavirus infections. Viruses 12(2):E194. doi: 10.3390/v12020194.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 496.78, 737.296), True, False, 48, 841.92, 595.32)"
48,"121. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, Zhang",0,0,0,0,0,0,0,0,0,0,0,0,0,"('121. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, Zhang', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.0440000000001, 722.836), False, False, 48, 841.92, 595.32)"
48,"Z, Wang L, Peng L, Chen L, Qin Y, Zhao D, Tan S, Yin L, Xu J, Zhou C, Jiang C, Liu L.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Z, Wang L, Peng L, Chen L, Qin Y, Zhao D, Tan S, Yin L, Xu J, Zhou C, Jiang C, Liu L.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 695.548, 526.26, 706.456), True, False, 48, 841.92, 595.32)"
48,2020. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 679.708, 526.36, 690.616), True, False, 48, 841.92, 595.32)"
48,loads  and  lung  injury.  Sci  China  Life  Sci  10.1007/s11427-020-1643-8.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('loads  and  lung  injury.  Sci  China  Life  Sci  10.1007/s11427-020-1643-8.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 663.868, 526.408, 674.7760000000001), True, False, 48, 841.92, 595.32)"
48,10.1007/s11427-020-1643-8.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1007/s11427-020-1643-8.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 648.028, 239.33, 658.936), True, False, 48, 841.92, 595.32)"
48,"122. Qiu  HB,  Li  XY,  Du  B,  Kang  HYJ,  Wang  YS,  Wang  F,  Sun  B,  Tong  ZH.  2020.  [The",0,0,0,0,0,0,0,0,0,0,0,0,0,"('122. Qiu  HB,  Li  XY,  Du  B,  Kang  HYJ,  Wang  YS,  Wang  F,  Sun  B,  Tong  ZH.  2020.  [The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 624.148, 526.396, 635.476), False, False, 48, 841.92, 595.32)"
48,keypoints in treatment of the critical novel coronavirus pneumonia patient]. ZhonghuaJie,0,0,0,0,0,0,0,0,0,0,0,0,0,"('keypoints in treatment of the critical novel coronavirus pneumonia patient]. ZhonghuaJie', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 609.268, 526.152, 620.176), True, False, 48, 841.92, 595.32)"
48,He  He  Hu  Xi  Za  Zhi.  43(0):E022.  Chinese.  doi:  10.3760/cma.j.cn112147-20200222-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('He  He  Hu  Xi  Za  Zhi.  43(0):E022.  Chinese.  doi:  10.3760/cma.j.cn112147-20200222-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 594.388, 523.456, 605.296), True, False, 48, 841.92, 595.32)"
48,00151.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('00151.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 579.508, 132.38, 590.416), True, False, 48, 841.92, 595.32)"
48,"123. Guan GW, Gao L, Wang JW, Wen XJ, Mao TH, Peng SW, Zhang T, Chen XM, Lu FM.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('123. Guan GW, Gao L, Wang JW, Wen XJ, Mao TH, Peng SW, Zhang T, Chen XM, Lu FM.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 564.4780000000001, 526.42, 575.806), False, False, 48, 841.92, 595.32)"
48,2020.  [Exploring  the  mechanism  of  liver  enzyme  abnormalities  in  patients  with  novel,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020.  [Exploring  the  mechanism  of  liver  enzyme  abnormalities  in  patients  with  novel', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 549.5980000000001, 526.1400000000001, 560.5060000000001), True, False, 48, 841.92, 595.32)"
48,coronavirus-infected  pneumonia].  Zhonghua  Gan  Zang  Bing  Za  Zhi.  28(2):E002.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus-infected  pneumonia].  Zhonghua  Gan  Zang  Bing  Za  Zhi.  28(2):E002.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 534.718, 526.124, 545.626), True, False, 48, 841.92, 595.32)"
48,Chinese. doi: 10.3760/cma.j.issn.1007-3418.2020.02.002.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chinese. doi: 10.3760/cma.j.issn.1007-3418.2020.02.002.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 519.838, 374.11, 530.746), True, False, 48, 841.92, 595.32)"
48,"124. MacLachlan NJ, Dubovi EJ. 2017. In Fenner's Veterinary Virology (Fifth Edition) (eds",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""124. MacLachlan NJ, Dubovi EJ. 2017. In Fenner's Veterinary Virology (Fifth Edition) (eds"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 502.918, 526.2740000000001, 514.246), False, False, 48, 841.92, 595.32)"
48,N. James MacLachlan & Edward J. Dubovi) Academic Press. 393-413.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('N. James MacLachlan & Edward J. Dubovi) Academic Press. 393-413.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 487.07800000000003, 441.67, 497.986), True, False, 48, 841.92, 595.32)"
48,"125. ArGouilh M, Puechmaille SJ, Diancourt L, Vandenbogaert M, Serra-Cobo J, Lopez Roïg",0,0,0,0,0,0,0,0,0,0,0,0,0,"('125. ArGouilh M, Puechmaille SJ, Diancourt L, Vandenbogaert M, Serra-Cobo J, Lopez Roïg', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 471.238, 526.33, 482.566), False, False, 48, 841.92, 595.32)"
48,"M,  Brown  P,  Moutou  F,  Caro  V,  Vabret  A,  Manuguerra  JC,  EPICOREM  consortium.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('M,  Brown  P,  Moutou  F,  Caro  V,  Vabret  A,  Manuguerra  JC,  EPICOREM  consortium.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 455.398, 526.384, 466.306), True, False, 48, 841.92, 595.32)"
48,2018. SARS-CoV related Betacoronavirus and diverse Alphacoronavirus members found,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2018. SARS-CoV related Betacoronavirus and diverse Alphacoronavirus members found', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 439.438, 526.16, 450.34599999999995), True, False, 48, 841.92, 595.32)"
48,in western old-world. Virology 517:88-97. doi: 10.1016/j.virol.2018.01.014.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in western old-world. Virology 517:88-97. doi: 10.1016/j.virol.2018.01.014.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 423.598, 466.3, 434.506), True, False, 48, 841.92, 595.32)"
48,"126. Suzuki T, Otake Y, Uchimoto S, Hasebe A, Goto Y. 2020. Genomic characterization and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('126. Suzuki T, Otake Y, Uchimoto S, Hasebe A, Goto Y. 2020. Genomic characterization and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 407.75800000000004, 526.42, 419.086), False, False, 48, 841.92, 595.32)"
48,phylogenetic  classification  of  bovine  Coronaviruses  through  whole  genome  sequence,0,0,0,0,0,0,0,0,0,0,0,0,0,"('phylogenetic  classification  of  bovine  Coronaviruses  through  whole  genome  sequence', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 392.858, 526.1639999999999, 403.76599999999996), True, False, 48, 841.92, 595.32)"
48,analysis. Viruses 12(2):E183. doi: 10.3390/v12020183.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('analysis. Viruses 12(2):E183. doi: 10.3390/v12020183.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 377.978, 365.35, 388.88599999999997), True, False, 48, 841.92, 595.32)"
48,"127. Zhang  XM,  Herbst  W,  Kousoulas  KG,  Storz  J.  1994.  Biological  and  genetic",0,0,0,0,0,0,0,0,0,0,0,0,0,"('127. Zhang  XM,  Herbst  W,  Kousoulas  KG,  Storz  J.  1994.  Biological  and  genetic', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 363.098, 526.1279999999999, 374.426), False, False, 48, 841.92, 595.32)"
48,characterization  of  a  hemagglutinating  coronavirus  isolated  from  a  diarrhoeic  child.  J,0,0,0,0,0,0,0,0,0,0,0,0,0,"('characterization  of  a  hemagglutinating  coronavirus  isolated  from  a  diarrhoeic  child.  J', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 348.218, 526.282, 359.126), True, False, 48, 841.92, 595.32)"
48,Med Virol 44(2):152-161. doi: 10.1002/jmv.1890440207.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Med Virol 44(2):152-161. doi: 10.1002/jmv.1890440207.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 333.338, 376.75, 344.246), True, False, 48, 841.92, 595.32)"
48,"128. Tekes  G,  Thiel  HJ.  2016.  Feline  coronaviruses:  pathogenesis  of  feline  infectious",0,0,0,0,0,0,0,0,0,0,0,0,0,"('128. Tekes  G,  Thiel  HJ.  2016.  Feline  coronaviruses:  pathogenesis  of  feline  infectious', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 318.338, 526.116, 329.666), False, False, 48, 841.92, 595.32)"
48,peritonitis. In Advances in virus research 96:193-218. Academic Press.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('peritonitis. In Advances in virus research 96:193-218. Academic Press.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 303.458, 438.07, 314.366), True, False, 48, 841.92, 595.32)"
48,"129. Licitra BN, Duhamel GE, Whittaker GR. 2014. Canine enteric coronaviruses: emerging",0,0,0,0,0,0,0,0,0,0,0,0,0,"('129. Licitra BN, Duhamel GE, Whittaker GR. 2014. Canine enteric coronaviruses: emerging', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 288.57800000000003, 526.1119999999999, 299.906), False, False, 48, 841.92, 595.32)"
48,viral pathogens with distinct recombinant spike proteins. Viruses 6(8):3363-3376.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('viral pathogens with distinct recombinant spike proteins. Viruses 6(8):3363-3376.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 273.69800000000004, 489.7, 284.606), True, False, 48, 841.92, 595.32)"
48,"130. Erles K, Brownlie J. 2008. Canine respiratory coronavirus: an emerging pathogen in the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('130. Erles K, Brownlie J. 2008. Canine respiratory coronavirus: an emerging pathogen in the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 258.81800000000004, 526.0680000000001, 270.146), False, False, 48, 841.92, 595.32)"
48,canine  infectious  respiratory  disease  complex.  Vet  Clin  North  Am  Small  AnimPract,0,0,0,0,0,0,0,0,0,0,0,0,0,"('canine  infectious  respiratory  disease  complex.  Vet  Clin  North  Am  Small  AnimPract', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 243.938, 526.124, 254.846), True, False, 48, 841.92, 595.32)"
48,"38(4):815-825, viii. doi: 10.1016/j.cvsm.2008.02.008.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('38(4):815-825, viii. doi: 10.1016/j.cvsm.2008.02.008.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 229.058, 358.51, 239.966), True, False, 48, 841.92, 595.32)"
48,"131. Dhama K, Singh SD, Barathidasan R, Desingu PA, Chakraborty S, Tiwari R, Kumar MA.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('131. Dhama K, Singh SD, Barathidasan R, Desingu PA, Chakraborty S, Tiwari R, Kumar MA.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 214.148, 529.0679999999999, 225.476), False, False, 48, 841.92, 595.32)"
48,2014b.  Emergence  of  avian  infectious  bronchitis  virus  and  its  variants  need  better,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2014b.  Emergence  of  avian  infectious  bronchitis  virus  and  its  variants  need  better', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 198.308, 526.342, 209.216), True, False, 48, 841.92, 595.32)"
48,"diagnosis,  prevention  and  control  strategies:  a  global  perspective.  Pak  J  Biol  Sci",0,0,0,0,0,0,0,0,0,0,0,0,0,"('diagnosis,  prevention  and  control  strategies:  a  global  perspective.  Pak  J  Biol  Sci', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 182.34799999999998, 526.1519999999999, 193.256), True, False, 48, 841.92, 595.32)"
48,17(6):751-767. doi: 10.3923/pjbs.2014.751.767.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('17(6):751-767. doi: 10.3923/pjbs.2014.751.767.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 166.50799999999998, 330.79, 177.416), True, False, 48, 841.92, 595.32)"
48,"132. Bande F, Arshad SS, Omar AR, Bejo MH, Abubakar MS, Abba Y. 2016. Pathogenesis",0,0,0,0,0,0,0,0,0,0,0,0,0,"('132. Bande F, Arshad SS, Omar AR, Bejo MH, Abubakar MS, Abba Y. 2016. Pathogenesis', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 150.66799999999998, 526.0559999999998, 161.99599999999998), False, False, 48, 841.92, 595.32)"
48,and diagnostic approaches of avian infectious bronchitis. Adv Virol 2016:4621659. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and diagnostic approaches of avian infectious bronchitis. Adv Virol 2016:4621659. doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 135.78799999999998, 526.1840000000001, 146.696), True, False, 48, 841.92, 595.32)"
48,10.1155/2016/4621659.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1155/2016/4621659.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 120.908, 214.13, 131.816), True, False, 48, 841.92, 595.32)"
48,"133. Wege H, Siddell S, terMeulen V. 1982. The biology and pathogenesis of coronaviruses.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('133. Wege H, Siddell S, terMeulen V. 1982. The biology and pathogenesis of coronaviruses.', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 106.028, 526.1279999999999, 117.35600000000001), False, False, 48, 841.92, 595.32)"
48,Curr Top Microbiol Immunol 99:165-200. doi: 10.1007/978-3-642-68528-6_5.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Curr Top Microbiol Immunol 99:165-200. doi: 10.1007/978-3-642-68528-6_5.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 90.072, 479.14, 100.98), True, False, 48, 841.92, 595.32)"
48,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 48, 841.92, 595.32)"
48,47,0,0,0,0,0,0,0,0,0,0,0,0,0,"('47', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 48, 841.92, 595.32)"
49,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 49, 841.92, 595.32)"
49,"134. Zhou P, Fan H, Lan T, Yang XL, Shi WF, Zhang W, Zhu Y, Zhang YW, Xie QM, Mani",0,0,0,0,0,0,0,0,0,0,0,0,0,"('134. Zhou P, Fan H, Lan T, Yang XL, Shi WF, Zhang W, Zhu Y, Zhang YW, Xie QM, Mani', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.1039999999999, 767.496), False, False, 49, 841.92, 595.32)"
49,"S, Zheng XS, Li B, Li JM, Guo H, Pei GQ, An XP, Chen JW, Zhou L, Mai KJ, Wu ZX,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('S, Zheng XS, Li B, Li JM, Guo H, Pei GQ, An XP, Chen JW, Zhou L, Mai KJ, Wu ZX,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 740.308, 526.044, 751.216), True, False, 49, 841.92, 595.32)"
49,"Li D, Anderson DE, Zhang LB, Li SY, Mi ZQ, He TT, Cong F, Guo PJ, Huang R, Luo Y,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Li D, Anderson DE, Zhang LB, Li SY, Mi ZQ, He TT, Cong F, Guo PJ, Huang R, Luo Y,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 724.468, 529.212, 735.376), True, False, 49, 841.92, 595.32)"
49,"Liu XL, Chen J, Huang Y, Sun Q, Zhang XL, Wang YY, Xing SZ, Chen YS, Sun Y, Li J,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Liu XL, Chen J, Huang Y, Sun Q, Zhang XL, Wang YY, Xing SZ, Chen YS, Sun Y, Li J,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 708.508, 529.136, 719.416), True, False, 49, 841.92, 595.32)"
49,"Daszak  P,  Wang  LF,  Shi  ZL,  Tong  YG,  Ma  JY.  2018a.  Fatal  swine  acute  diarrhoea",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Daszak  P,  Wang  LF,  Shi  ZL,  Tong  YG,  Ma  JY.  2018a.  Fatal  swine  acute  diarrhoea', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 692.668, 526.0439999999996, 703.576), True, False, 49, 841.92, 595.32)"
49,syndrome caused by an HKU2-related coronavirus of bat origin. Nature 556(7700):255-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('syndrome caused by an HKU2-related coronavirus of bat origin. Nature 556(7700):255-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 676.828, 523.456, 687.736), True, False, 49, 841.92, 595.32)"
49,258. doi: 10.1038/s41586-018-0010-9.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('258. doi: 10.1038/s41586-018-0010-9.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 660.988, 285.05, 671.8960000000001), True, False, 49, 841.92, 595.32)"
49,"135. Lau SK, Woo PC, Li KS, Huang Y, Wang M, Lam CS, Xu H, Guo R, Chan KH, Zheng",0,0,0,0,0,0,0,0,0,0,0,0,0,"('135. Lau SK, Woo PC, Li KS, Huang Y, Wang M, Lam CS, Xu H, Guo R, Chan KH, Zheng', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 645.028, 526.008, 656.356), False, False, 49, 841.92, 595.32)"
49,"BJ, Yuen KY. 2007. Complete genome sequence of bat coronavirus HKU2 from Chinese",0,0,0,0,0,0,0,0,0,0,0,0,0,"('BJ, Yuen KY. 2007. Complete genome sequence of bat coronavirus HKU2 from Chinese', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 630.148, 526.1159999999999, 641.056), True, False, 49, 841.92, 595.32)"
49,horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage,0,0,0,0,0,0,0,0,0,0,0,0,0,"('horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 615.268, 526.08, 626.176), True, False, 49, 841.92, 595.32)"
49,from the rest of the genome. Virology 367(2):428-439. doi: 10.1016/j.virol.2007.06.009.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('from the rest of the genome. Virology 367(2):428-439. doi: 10.1016/j.virol.2007.06.009.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 600.388, 525.1, 611.296), True, False, 49, 841.92, 595.32)"
49,136. Brown IH. 2001. The pig as an intermediate host for influenza A viruses between birds,0,0,0,0,0,0,0,0,0,0,0,0,0,"('136. Brown IH. 2001. The pig as an intermediate host for influenza A viruses between birds', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 585.508, 526.0919999999999, 596.836), False, False, 49, 841.92, 595.32)"
49,and humans. Int Congr Ser 1219: 173-178.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and humans. Int Congr Ser 1219: 173-178.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 569.638, 303.77, 580.546), True, False, 49, 841.92, 595.32)"
49,"137. Chen W, Yan M, Yang L, Ding B, He B, Wang Y, Liu X, Liu C, Zhu H, You B, Huang",0,0,0,0,0,0,0,0,0,0,0,0,0,"('137. Chen W, Yan M, Yang L, Ding B, He B, Wang Y, Liu X, Liu C, Zhu H, You B, Huang', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 553.678, 526.2579999999999, 565.006), False, False, 49, 841.92, 595.32)"
49,"S, Zhang J, Mu F, Xiang Z, Feng X, Wen J, Fang J, Yu J, Yang H. 2005. Wang J. SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('S, Zhang J, Mu F, Xiang Z, Feng X, Wen J, Fang J, Yu J, Yang H. 2005. Wang J. SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 537.838, 523.576, 548.746), True, False, 49, 841.92, 595.32)"
49,associated coronavirus transmitted from human to pig. Emerg Infect Dis 11(3):446-448.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('associated coronavirus transmitted from human to pig. Emerg Infect Dis 11(3):446-448.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 521.998, 526.4200000000001, 532.9060000000001), True, False, 49, 841.92, 595.32)"
49,doi: 10.3201/eid1103.040824.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi: 10.3201/eid1103.040824.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 506.158, 244.13, 517.066), True, False, 49, 841.92, 595.32)"
49,"138. Mihindukulasuriya  KA,  Wu  G,  St  Leger  J,  Nordhausen  RW,  Wang  D.  2008.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('138. Mihindukulasuriya  KA,  Wu  G,  St  Leger  J,  Nordhausen  RW,  Wang  D.  2008.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 490.31800000000004, 526.2139999999999, 501.646), False, False, 49, 841.92, 595.32)"
49,Identification of a novel coronavirus from a beluga whale by using a panviral microarray.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Identification of a novel coronavirus from a beluga whale by using a panviral microarray.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 474.358, 526.1999999999999, 485.26599999999996), True, False, 49, 841.92, 595.32)"
49,J Virol 82(10):5084-5088. doi: 10.1128/JVI.02722-07.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('J Virol 82(10):5084-5088. doi: 10.1128/JVI.02722-07.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 458.51800000000003, 362.11, 469.426), True, False, 49, 841.92, 595.32)"
49,"139. Wassenaar TM, Zou Y. 2020. 2019_nCoV: Rapid classification of betacoronaviruses and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('139. Wassenaar TM, Zou Y. 2020. 2019_nCoV: Rapid classification of betacoronaviruses and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 442.678, 526.3420000000001, 454.006), False, False, 49, 841.92, 595.32)"
49,identification  of  traditional  Chinese  medicine  as  potential  origin  of  zoonotic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('identification  of  traditional  Chinese  medicine  as  potential  origin  of  zoonotic', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 427.798, 526.14, 438.70599999999996), True, False, 49, 841.92, 595.32)"
49,"coronaviruses  [published  online  ahead  of  print,  2020  Feb  14].  Lett  ApplMicrobiol",0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronaviruses  [published  online  ahead  of  print,  2020  Feb  14].  Lett  ApplMicrobiol', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 412.918, 526.1640000000001, 423.82599999999996), True, False, 49, 841.92, 595.32)"
49,10.1111/lam.13285. doi:10.1111/lam.13285.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1111/lam.13285. doi:10.1111/lam.13285.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 398.038, 310.73, 408.94599999999997), True, False, 49, 841.92, 595.32)"
49,140. Phan  T.  2020.  Novel coronavirus:  From  discovery  to  clinical  diagnostics.  Infect  Genet,0,0,0,0,0,0,0,0,0,0,0,0,0,"('140. Phan  T.  2020.  Novel coronavirus:  From  discovery  to  clinical  diagnostics.  Infect  Genet', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 383.01800000000003, 526.202, 394.346), False, False, 49, 841.92, 595.32)"
49,Evol 104211. doi: 10.1016/j.meegid.2020.104211.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Evol 104211. doi: 10.1016/j.meegid.2020.104211.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 367.178, 341.83, 378.08599999999996), True, False, 49, 841.92, 595.32)"
49,"141. Li HY, Zhu GJ, Zhang YZ, Zhang LB, Hagan EA, Martinez S, Chmura AA, Francisco L,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('141. Li HY, Zhu GJ, Zhang YZ, Zhang LB, Hagan EA, Martinez S, Chmura AA, Francisco L,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 351.338, 526.2119999999998, 362.666), False, False, 49, 841.92, 595.32)"
49,"Tai  H,  Miller  M,  Daszak  P.  2020.  A  qualitative  study  of  zoonotic  risk  factors  among",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Tai  H,  Miller  M,  Daszak  P.  2020.  A  qualitative  study  of  zoonotic  risk  factors  among', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 336.458, 526.306, 347.366), True, False, 49, 841.92, 595.32)"
49,rural  communities,0,0,0,0,0,0,0,0,0,0,0,0,0,"('rural  communities', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 321.57800000000003, 198.36, 332.486), True, False, 49, 841.92, 595.32)"
49,Int  Health  12(2):77-85.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Int  Health  12(2):77-85.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (346.9560000000001, 321.57800000000003, 526.408, 332.486), True, False, 49, 841.92, 595.32)"
49,10.1093/inthealth/ihaa001.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1093/inthealth/ihaa001.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 306.69800000000004, 228.05, 317.606), True, False, 49, 841.92, 595.32)"
49,in  southern  China.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  southern  China.', 'TimesNewRomanPSMT', 10.907999999999959, (212.73600000000002, 321.57800000000003, 332.56800000000004, 332.486), True, False, 49, 841.92, 595.32)"
49,"142. Bonilla-Aldana  DK,  Suarez  JA,  Franco-Paredes  C,  Vilcarromero  S,  Mattar  S,  Gomez-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('142. Bonilla-Aldana  DK,  Suarez  JA,  Franco-Paredes  C,  Vilcarromero  S,  Mattar  S,  Gomez-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 291.81800000000004, 523.336, 303.146), False, False, 49, 841.92, 595.32)"
49,"Marin JE, Villamil-Gomez WE, Ruiz-Saenz J, Cardona-Ospina JA, Idarraga-Bedoya SE,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Marin JE, Villamil-Gomez WE, Ruiz-Saenz J, Cardona-Ospina JA, Idarraga-Bedoya SE,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 275.858, 526.3960000000001, 286.76599999999996), True, False, 49, 841.92, 595.32)"
49,"Garcia-Bustos  JJ,  Jimenez-Posada  EV,  Rodriguez-Morales  AJ.  2019.  Brazil  burning!",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Garcia-Bustos  JJ,  Jimenez-Posada  EV,  Rodriguez-Morales  AJ.  2019.  Brazil  burning!', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 260.01800000000003, 526.282, 270.926), True, False, 49, 841.92, 595.32)"
49,What  is  the  potential  impact  of  the  Amazon  wildfires  on  vector-borne  and  zoonotic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('What  is  the  potential  impact  of  the  Amazon  wildfires  on  vector-borne  and  zoonotic', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 244.178, 526.318, 255.086), True, False, 49, 841.92, 595.32)"
49,emerging  diseases?  -  A  statement  from  an  international  experts  meeting.  Travel  Med,0,0,0,0,0,0,0,0,0,0,0,0,0,"('emerging  diseases?  -  A  statement  from  an  international  experts  meeting.  Travel  Med', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 228.338, 526.342, 239.246), True, False, 49, 841.92, 595.32)"
49,Infect Dis 31:101474.doi: 10.1016/j.tmaid.2019.101474,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infect Dis 31:101474.doi: 10.1016/j.tmaid.2019.101474', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 212.34799999999998, 365.11, 223.256), True, False, 49, 841.92, 595.32)"
49,"143. Ji W, Wang W, Zhao X, Zai J, Li X. 2020. Homologous recombination within the spike",0,0,0,0,0,0,0,0,0,0,0,0,0,"('143. Ji W, Wang W, Zhao X, Zai J, Li X. 2020. Homologous recombination within the spike', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 196.50799999999998, 526.116, 207.83599999999998), False, False, 49, 841.92, 595.32)"
49,glycoprotein  of  the  newly  identified  coronavirus  may  boost  cross-species  transmission,0,0,0,0,0,0,0,0,0,0,0,0,0,"('glycoprotein  of  the  newly  identified  coronavirus  may  boost  cross-species  transmission', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 181.628, 526.342, 192.536), True, False, 49, 841.92, 595.32)"
49,from snake to human. J Med Virol 10.1002/jmv.25682. doi: 10.1002/jmv.25682.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('from snake to human. J Med Virol 10.1002/jmv.25682. doi: 10.1002/jmv.25682.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 166.748, 486.82, 177.656), True, False, 49, 841.92, 595.32)"
49,"144. Liu  P,  Chen  W,  Chen  JP.  2019.  Viral  metagenomics  revealed  Sendai  Virus  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('144. Liu  P,  Chen  W,  Chen  JP.  2019.  Viral  metagenomics  revealed  Sendai  Virus  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 151.868, 526.1039999999998, 163.196), False, False, 49, 841.92, 595.32)"
49,Coronavirus  infection  of  Malayan  Pangolins  (Manisjavanica).  Viruses  11(11):979.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus  infection  of  Malayan  Pangolins  (Manisjavanica).  Viruses  11(11):979.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 136.028, 526.1639999999999, 146.936), True, False, 49, 841.92, 595.32)"
49,10.3390/v11110979.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.3390/v11110979.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 120.068, 198.77, 130.976), True, False, 49, 841.92, 595.32)"
49,"145. Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou JJ, Li N, Guo Y, Li X, Shen X, Zhang Z,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('145. Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou JJ, Li N, Guo Y, Li X, Shen X, Zhang Z,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 104.228, 526.42, 115.556), False, False, 49, 841.92, 595.32)"
49,"Shu F, Huang W, Li Y, Zhang Z, Chen R-A, Wu Y-J, Peng S-M, Huang M, Xie W-J, Cai",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Shu F, Huang W, Li Y, Zhang Z, Chen R-A, Wu Y-J, Peng S-M, Huang M, Xie W-J, Cai', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 88.392, 526.408, 99.3), True, False, 49, 841.92, 595.32)"
49,"Q-H, Hou F-H, Liu Y, Chen W, Xiao L, Shen, Y. 2020. Isolation and Characterization of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Q-H, Hou F-H, Liu Y, Chen W, Xiao L, Shen, Y. 2020. Isolation and Characterization of', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 72.552, 526.3180000000001, 83.46000000000001), True, False, 49, 841.92, 595.32)"
49,48,0,0,0,0,0,0,0,0,0,0,0,0,0,"('48', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 49, 841.92, 595.32)"
49,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 49, 841.92, 595.32)"
50,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 50, 841.92, 595.32)"
50,2019-nCoV-like Coronavirus from Malayan Pangolins. bioRxiv 2020.2002.2017.951335.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2019-nCoV-like Coronavirus from Malayan Pangolins. bioRxiv 2020.2002.2017.951335.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 756.168, 529.42, 767.076), True, False, 50, 841.92, 595.32)"
50,doi:10.1101/2020.02.17.951335.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:10.1101/2020.02.17.951335.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 740.308, 253.37, 751.216), True, False, 50, 841.92, 595.32)"
50,"146. Daszak  P,  Olival  KJ,  Li  H.  2020.  A  strategy  to  prevent  future  epidemics  similar  to  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('146. Daszak  P,  Olival  KJ,  Li  H.  2020.  A  strategy  to  prevent  future  epidemics  similar  to  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 724.468, 526.2260000000001, 735.7959999999999), False, False, 50, 841.92, 595.32)"
50,2019-nCoV  outbreak.  Biosafety  and  Health  10.1016/j.bsheal.2020.01.003.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2019-nCoV  outbreak.  Biosafety  and  Health  10.1016/j.bsheal.2020.01.003.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 709.468, 526.2080000000001, 720.376), True, False, 50, 841.92, 595.32)"
50,10.1016/j.bsheal.2020.01.003.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/j.bsheal.2020.01.003.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 694.588, 241.73, 705.496), True, False, 50, 841.92, 595.32)"
50,"147. Wang N, Li SY, Yang XL, Huang HM, Zhang YJ, Guo H, Luo CM, Miller M, Zhu G,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('147. Wang N, Li SY, Yang XL, Huang HM, Zhang YJ, Guo H, Luo CM, Miller M, Zhu G,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 679.708, 526.1159999999999, 691.036), False, False, 50, 841.92, 595.32)"
50,"Chmura  AA,  Hagan  E,  Zhou  JH,  Zhang  YZ,  Wang  LF,  Daszak  P,  Shi  ZL.  2018b.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chmura  AA,  Hagan  E,  Zhou  JH,  Zhang  YZ,  Wang  LF,  Daszak  P,  Shi  ZL.  2018b.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 664.828, 526.124, 675.736), True, False, 50, 841.92, 595.32)"
50,"Serological evidence of bat SARS-related Coronavirus infection in humans, China. Virol",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Serological evidence of bat SARS-related Coronavirus infection in humans, China. Virol', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 649.948, 526.2380000000002, 660.856), True, False, 50, 841.92, 595.32)"
50,Sin 33(1):104-107. doi: 10.1007/s12250-018-0012-7.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sin 33(1):104-107. doi: 10.1007/s12250-018-0012-7.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 635.068, 352.39, 645.976), True, False, 50, 841.92, 595.32)"
50,148. Gao  ZC.  2020.  Efficient  management  of  novel  coronavirus  pneumonia  by  efficient,0,0,0,0,0,0,0,0,0,0,0,0,0,"('148. Gao  ZC.  2020.  Efficient  management  of  novel  coronavirus  pneumonia  by  efficient', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 620.188, 526.318, 631.516), False, False, 50, 841.92, 595.32)"
50,prevention  and  control  in  scientific  manner.  ZhonghuaJie  He  He  Hu  Xi  ZaZhi  43(00):,0,0,0,0,0,0,0,0,0,0,0,0,0,"('prevention  and  control  in  scientific  manner.  ZhonghuaJie  He  He  Hu  Xi  ZaZhi  43(00):', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 605.308, 526.1279999999999, 616.216), True, False, 50, 841.92, 595.32)"
50,E001-E001. doi: 10.3760/cma.j.issn.1001-0939.2020.0001.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('E001-E001. doi: 10.3760/cma.j.issn.1001-0939.2020.0001.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 590.428, 381.07, 601.336), True, False, 50, 841.92, 595.32)"
50,"149. Xiao SY, Wu Y, Liu H. 2020. Evolving status of the 2019 novel coronavirus Infection:",0,0,0,0,0,0,0,0,0,0,0,0,0,"('149. Xiao SY, Wu Y, Liu H. 2020. Evolving status of the 2019 novel coronavirus Infection:', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 575.548, 526.2020000000001, 586.876), False, False, 50, 841.92, 595.32)"
50,proposal of conventional serologic assays for disease diagnosis and infection monitoring,0,0,0,0,0,0,0,0,0,0,0,0,0,"('proposal of conventional serologic assays for disease diagnosis and infection monitoring', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 559.558, 526.1480000000001, 570.466), True, False, 50, 841.92, 595.32)"
50,[Commentary/Review]. J Med Virol 10.1002/jmv.25702. doi: 10.1002/jmv.25702.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('[Commentary/Review]. J Med Virol 10.1002/jmv.25702. doi: 10.1002/jmv.25702.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 543.718, 495.82, 554.626), True, False, 50, 841.92, 595.32)"
50,"150. Yu  F,  Du  L,  Ojcius  DM,  Pan  C,  Jiang  S.  2020.  Measures  for  diagnosing  and  treating",0,0,0,0,0,0,0,0,0,0,0,0,0,"('150. Yu  F,  Du  L,  Ojcius  DM,  Pan  C,  Jiang  S.  2020.  Measures  for  diagnosing  and  treating', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 527.878, 526.1039999999999, 539.206), False, False, 50, 841.92, 595.32)"
50,infections  by  a  novel  coronavirus  responsible  for  a  pneumonia  outbreak  originating  in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infections  by  a  novel  coronavirus  responsible  for  a  pneumonia  outbreak  originating  in', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 512.038, 526.1120000000001, 522.946), True, False, 50, 841.92, 595.32)"
50,"Wuhan,  China.  Microbes",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Wuhan,  China.  Microbes', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 496.07800000000003, 269.72400000000005, 506.986), True, False, 50, 841.92, 595.32)"
50,doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:', 'TimesNewRomanPSMT', 10.907999999999959, (504.808, 496.07800000000003, 526.408, 506.986), True, False, 50, 841.92, 595.32)"
50,10.1016/j.micinf.2020.01.003.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/j.micinf.2020.01.003.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 480.238, 242.45, 491.14599999999996), True, False, 50, 841.92, 595.32)"
50,S1286-4579(20)30025-3.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('S1286-4579(20)30025-3.', 'TimesNewRomanPSMT', 10.907999999999959, (353.5680000000001, 496.07800000000003, 478.42, 506.986), True, False, 50, 841.92, 595.32)"
50,Infect,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infect', 'TimesNewRomanPSMT', 10.907999999999959, (296.2440000000001, 496.07800000000003, 327.1560000000001, 506.986), True, False, 50, 841.92, 595.32)"
50,"151. Pan  Y,  Zhang  D,  Yang  P,  Poon  LLM,  Wang  Q.  2020.  Viral  load  of  SARS-CoV-2  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('151. Pan  Y,  Zhang  D,  Yang  P,  Poon  LLM,  Wang  Q.  2020.  Viral  load  of  SARS-CoV-2  in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 464.398, 526.384, 475.726), False, False, 50, 841.92, 595.32)"
50,clinical samples. The Lancet Infectious Diseases. doi:10.1016/S1473-3099(20)30113-4,0,0,0,0,0,0,0,0,0,0,0,0,0,"('clinical samples. The Lancet Infectious Diseases. doi:10.1016/S1473-3099(20)30113-4', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 448.558, 515.26, 459.46599999999995), True, False, 50, 841.92, 595.32)"
50,"152. To KK, Tsang OT, Chik-Yan Yip C, Chan KH, Wu TC, Chan JMC, Leung WS, Chik TS,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('152. To KK, Tsang OT, Chik-Yan Yip C, Chan KH, Wu TC, Chan JMC, Leung WS, Chik TS,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 432.598, 529.1540000000001, 443.926), False, False, 50, 841.92, 595.32)"
50,"Choi CY, Kandamby DH, Lung DC, Tam AR, Poon RW, Fung AY, Hung IF, Cheng VC,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Choi CY, Kandamby DH, Lung DC, Tam AR, Poon RW, Fung AY, Hung IF, Cheng VC,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 417.718, 529.068, 428.626), True, False, 50, 841.92, 595.32)"
50,"Chan JF, Yuen KY. 2020. Consistent detection of 2019 novel coronavirus in saliva. Clin",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chan JF, Yuen KY. 2020. Consistent detection of 2019 novel coronavirus in saliva. Clin', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 402.838, 526.2260000000001, 413.746), True, False, 50, 841.92, 595.32)"
50,Infect Dis ciaa149. doi: 10.1093/cid/ciaa149.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infect Dis ciaa149. doi: 10.1093/cid/ciaa149.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 387.938, 315.77, 398.84599999999995), True, False, 50, 841.92, 595.32)"
50,"153. Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY, Xiao GF, Yan B, Shi ZL,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('153. Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY, Xiao GF, Yan B, Shi ZL,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 373.058, 529.2359999999999, 384.38599999999997), False, False, 50, 841.92, 595.32)"
50,Zhou P.  2020. Molecular and serological  investigation of 2019-nCoV infected patients:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Zhou P.  2020. Molecular and serological  investigation of 2019-nCoV infected patients:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 358.178, 526.42, 369.08599999999996), True, False, 50, 841.92, 595.32)"
50,implication  of  multiple  shedding  routes.  Emerg  Microbes  Infect  9(1):386-389.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('implication  of  multiple  shedding  routes.  Emerg  Microbes  Infect  9(1):386-389.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 343.298, 526.3960000000001, 354.20599999999996), True, False, 50, 841.92, 595.32)"
50,10.1080/22221751.2020.1729071.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1080/22221751.2020.1729071.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 328.418, 264.77, 339.32599999999996), True, False, 50, 841.92, 595.32)"
50,"154. Xie  X,  Zhong  Z,  Zhao  W,  Zheng  C,  Wang  F,  Liu  J.  2020.  Chest  CT  for  typical  2019-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('154. Xie  X,  Zhong  Z,  Zhao  W,  Zheng  C,  Wang  F,  Liu  J.  2020.  Chest  CT  for  typical  2019-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 313.538, 523.456, 324.866), False, False, 50, 841.92, 595.32)"
50,nCoV  pneumonia:  relationship  to  negative  RT-PCR  testing.  Radiology  200343.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('nCoV  pneumonia:  relationship  to  negative  RT-PCR  testing.  Radiology  200343.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 298.658, 526.342, 309.566), True, False, 50, 841.92, 595.32)"
50,10.1148/radiol.2020200343.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1148/radiol.2020200343.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 283.658, 232.73, 294.566), True, False, 50, 841.92, 595.32)"
50,155. Binnicker  MJ.  2020.  Emergence  of  a  Novel  Coronavirus  Disease  (COVID-19)  and  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('155. Binnicker  MJ.  2020.  Emergence  of  a  Novel  Coronavirus  Disease  (COVID-19)  and  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 268.778, 526.384, 280.106), False, False, 50, 841.92, 595.32)"
50,"Importance  of  Diagnostic  Testing:  Why  Partnership  between  Clinical  Laboratories,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Importance  of  Diagnostic  Testing:  Why  Partnership  between  Clinical  Laboratories,', 'TimesNewRomanPSMT', 10.907999999999987, (93.384, 253.898, 526.1519999999999, 264.806), True, False, 50, 841.92, 595.32)"
50,"Public  Health  Agencies,  and  Industry  Is  Essential  to  Control  the  Outbreak.  Clin  Chem.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Public  Health  Agencies,  and  Industry  Is  Essential  to  Control  the  Outbreak.  Clin  Chem.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 239.018, 526.258, 249.92600000000002), True, False, 50, 841.92, 595.32)"
50,hvaa071. doi: 10.1093/clinchem/hvaa071.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('hvaa071. doi: 10.1093/clinchem/hvaa071.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 224.13799999999998, 301.01, 235.046), True, False, 50, 841.92, 595.32)"
50,"156. Chu  DKW,  Pan  Y,  Cheng  SMS,  Hui  KPY,  Krishnan  P,  Liu  Y,  Ng  DYM,  Wan  CKC,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('156. Chu  DKW,  Pan  Y,  Cheng  SMS,  Hui  KPY,  Krishnan  P,  Liu  Y,  Ng  DYM,  Wan  CKC,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 209.22799999999998, 525.9959999999999, 220.55599999999998), False, False, 50, 841.92, 595.32)"
50,"Yang  P,  Wang  Q,  Peiris  M,  Poon  LLM.  2020.  Molecular  Diagnosis  of  a  Novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Yang  P,  Wang  Q,  Peiris  M,  Poon  LLM.  2020.  Molecular  Diagnosis  of  a  Novel', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 194.34799999999998, 526.0439999999998, 205.256), True, False, 50, 841.92, 595.32)"
50,Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem hvaa029. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem hvaa029. doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 179.468, 526.136, 190.376), True, False, 50, 841.92, 595.32)"
50,10.1093/clinchem/hvaa029.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1093/clinchem/hvaa029.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 164.588, 229.73, 175.496), True, False, 50, 841.92, 595.32)"
50,"157. Cohen J, Kupferschmidt K. 2020. Labs scramble to produce new coronavirus diagnostics.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('157. Cohen J, Kupferschmidt K. 2020. Labs scramble to produce new coronavirus diagnostics.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 149.708, 529.1519999999999, 161.036), False, False, 50, 841.92, 595.32)"
50,Science. 367(6479):727. doi: 10.1126/science.367.6479.727.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Science. 367(6479):727. doi: 10.1126/science.367.6479.727.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 134.82799999999997, 388.39, 145.736), True, False, 50, 841.92, 595.32)"
50,"158. Zhang  J,  Zhou  L,  Yang  Y,  Peng  W,  Wang  W,  Chen  X.  2020.  Therapeutic  and  triage",0,0,0,0,0,0,0,0,0,0,0,0,0,"('158. Zhang  J,  Zhou  L,  Yang  Y,  Peng  W,  Wang  W,  Chen  X.  2020.  Therapeutic  and  triage', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 119.828, 526.342, 131.156), False, False, 50, 841.92, 595.32)"
50,strategies for 2019 novel coronavirus disease in fever clinics. Lancet Respir Med S2213-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('strategies for 2019 novel coronavirus disease in fever clinics. Lancet Respir Med S2213-', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 104.94800000000001, 523.576, 115.85600000000001), True, False, 50, 841.92, 595.32)"
50,2600(20)30071-0. doi: 10.1016/S2213-2600(20)30071-0.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2600(20)30071-0. doi: 10.1016/S2213-2600(20)30071-0.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 90.072, 375.07, 100.98), True, False, 50, 841.92, 595.32)"
50,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 50, 841.92, 595.32)"
50,49,0,0,0,0,0,0,0,0,0,0,0,0,0,"('49', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 50, 841.92, 595.32)"
51,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 51, 841.92, 595.32)"
51,"159. Shi  H, Han X, Jiang N,  Cao Y,  Alwalid O, Gu J, Fan  Y, Zheng C. 2020. Radiological",0,0,0,0,0,0,0,0,0,0,0,0,0,"('159. Shi  H, Han X, Jiang N,  Cao Y,  Alwalid O, Gu J, Fan  Y, Zheng C. 2020. Radiological', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.2460000000001, 767.496), False, False, 51, 841.92, 595.32)"
51,"findings  from  81  patients  with  COVID-19  pneumonia  in  Wuhan,  China:  a  descriptive",0,0,0,0,0,0,0,0,0,0,0,0,0,"('findings  from  81  patients  with  COVID-19  pneumonia  in  Wuhan,  China:  a  descriptive', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.2500000000001, 752.176), True, False, 51, 841.92, 595.32)"
51,study. The Lancet Infectious Diseases. doi:10.1016/S1473-3099(20)30086-4.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('study. The Lancet Infectious Diseases. doi:10.1016/S1473-3099(20)30086-4.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 470.38, 737.296), True, False, 51, 841.92, 595.32)"
51,160. Kim  H.  2020.  Outbreak  of  novel  coronavirus  (COVID-19):  What  is  the  role  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('160. Kim  H.  2020.  Outbreak  of  novel  coronavirus  (COVID-19):  What  is  the  role  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.396, 722.836), False, False, 51, 841.92, 595.32)"
51,radiologists?  Eur  Radiol.  10.1007/s00330-020-06748-2.  doi:  10.1007/s00330-020-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('radiologists?  Eur  Radiol.  10.1007/s00330-020-06748-2.  doi:  10.1007/s00330-020-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 696.628, 523.576, 707.5360000000001), True, False, 51, 841.92, 595.32)"
51,06748-2.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('06748-2.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 681.748, 139.34, 692.6560000000001), True, False, 51, 841.92, 595.32)"
51,"161. Munjal A, Khandia R, Dhama K, Sachan S, Karthik K, Tiwari R, Malik YS, Kumar D,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('161. Munjal A, Khandia R, Dhama K, Sachan S, Karthik K, Tiwari R, Malik YS, Kumar D,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 666.748, 526.0079999999998, 678.076), False, False, 51, 841.92, 595.32)"
51,"Singh  RK,  Iqbal  HMN,  Joshi  SK.  2017.  Advances  in  developing  therapies  to  combat",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Singh  RK,  Iqbal  HMN,  Joshi  SK.  2017.  Advances  in  developing  therapies  to  combat', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 650.908, 526.42, 661.816), True, False, 51, 841.92, 595.32)"
51,Zika  virus:  current  knowledge  and  future  perspectives. Front  Microbiol  8:1469.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Zika  virus:  current  knowledge  and  future  perspectives. Front  Microbiol  8:1469.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 635.068, 526.408, 645.976), True, False, 51, 841.92, 595.32)"
51,10.3389/fmicb.2017.01469.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.3389/fmicb.2017.01469.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 619.2280000000001, 232.73, 630.1360000000001), True, False, 51, 841.92, 595.32)"
51,"162. Dhama  K,  Karthik  K,  Khandia  R,  Chakraborty  S,  Munjal  A,  Latheef  SK,  Kumar  D,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('162. Dhama  K,  Karthik  K,  Khandia  R,  Chakraborty  S,  Munjal  A,  Latheef  SK,  Kumar  D,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 603.268, 526.056, 614.596), False, False, 51, 841.92, 595.32)"
51,"Ramakrishnan  MA,  Malik  YS,  Singh  R,  Malik  SVS,  Singh  RK,  Chaicumpa  W.  2018.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Ramakrishnan  MA,  Malik  YS,  Singh  R,  Malik  SVS,  Singh  RK,  Chaicumpa  W.  2018.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 587.428, 526.3960000000001, 598.336), True, False, 51, 841.92, 595.32)"
51,"Advances  in  designing  and  developing  vaccines,  drugs,  and  therapies  to  counter  Ebola",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Advances  in  designing  and  developing  vaccines,  drugs,  and  therapies  to  counter  Ebola', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 571.558, 526.1039999999998, 582.466), True, False, 51, 841.92, 595.32)"
51,virus. Front Immunol 9:1803. doi: 10.3389/fimmu.2018.01803.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus. Front Immunol 9:1803. doi: 10.3389/fimmu.2018.01803.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 555.718, 403.75, 566.626), True, False, 51, 841.92, 595.32)"
51,"163. Singh RK, Dhama K, Chakraborty S, Tiwari R, Natesan S, Khandia R, Munjal A, Vora",0,0,0,0,0,0,0,0,0,0,0,0,0,"('163. Singh RK, Dhama K, Chakraborty S, Tiwari R, Natesan S, Khandia R, Munjal A, Vora', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 539.878, 526.0919999999998, 551.206), False, False, 51, 841.92, 595.32)"
51,"KS, Latheef SK, Karthik K, Singh Malik Y, Singh R, Chaicumpa W, Mourya DT. 2019.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('KS, Latheef SK, Karthik K, Singh Malik Y, Singh R, Chaicumpa W, Mourya DT. 2019.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 523.918, 526.136, 534.826), True, False, 51, 841.92, 595.32)"
51,"Nipah  virus:  epidemiology,  pathology,  immunobiology  and  advances  in  diagnosis,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Nipah  virus:  epidemiology,  pathology,  immunobiology  and  advances  in  diagnosis,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 508.07800000000003, 526.1759999999999, 518.986), True, False, 51, 841.92, 595.32)"
51,vaccine designing and control strategies-a comprehensive review. Vet Q 39(1):26-55. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('vaccine designing and control strategies-a comprehensive review. Vet Q 39(1):26-55. doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 492.238, 529.756, 503.14599999999996), True, False, 51, 841.92, 595.32)"
51,10.1080/01652176.2019.1580827.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1080/01652176.2019.1580827.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 476.398, 264.77, 487.306), True, False, 51, 841.92, 595.32)"
51,"164. Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ. 2004. A",0,0,0,0,0,0,0,0,0,0,0,0,0,"('164. Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ. 2004. A', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 460.438, 526.032, 471.76599999999996), False, False, 51, 841.92, 595.32)"
51,DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 444.598, 526.1640000000001, 455.506), True, False, 51, 841.92, 595.32)"
51,Nature 428(6982):561-564. doi: 10.1038/nature02463.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Nature 428(6982):561-564. doi: 10.1038/nature02463.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 428.75800000000004, 358.39, 439.666), True, False, 51, 841.92, 595.32)"
51,"165. Chu  CM,  Cheng  VC,  Hung  IF,  Wong  MM,  Chan  KH,  Chan  KS,  Kao  RY,  Poon  LL,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('165. Chu  CM,  Cheng  VC,  Hung  IF,  Wong  MM,  Chan  KH,  Chan  KS,  Kao  RY,  Poon  LL,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 412.918, 526.202, 424.246), False, False, 51, 841.92, 595.32)"
51,"Wong CL, Guan Y, Peiris JS, Yuen KY, HKU/UCH SARS Study Group. 2004. Role of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Wong CL, Guan Y, Peiris JS, Yuen KY, HKU/UCH SARS Study Group. 2004. Role of', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 398.038, 526.0440000000001, 408.94599999999997), True, False, 51, 841.92, 595.32)"
51,lopinavir/ritonavir  in  the  treatment  of  SARS:  initial  virological  and  clinical  findings.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('lopinavir/ritonavir  in  the  treatment  of  SARS:  initial  virological  and  clinical  findings.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 383.01800000000003, 526.1039999999999, 393.926), True, False, 51, 841.92, 595.32)"
51,Thorax 59(3):252-256. doi: 10.1136/thorax.2003.012658.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Thorax 59(3):252-256. doi: 10.1136/thorax.2003.012658.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 368.13800000000003, 376.15, 379.046), True, False, 51, 841.92, 595.32)"
51,"166. Kumar V, Jung Y-S, Liang P-H. 2013. Anti-SARS coronavirus  agents: a  patent review",0,0,0,0,0,0,0,0,0,0,0,0,0,"('166. Kumar V, Jung Y-S, Liang P-H. 2013. Anti-SARS coronavirus  agents: a  patent review', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 353.25800000000004, 526.2620000000001, 364.586), False, False, 51, 841.92, 595.32)"
51,(2008-present).  Expert  Opin  Therapeutic  Patents  23(10):1337-1348.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(2008-present).  Expert  Opin  Therapeutic  Patents  23(10):1337-1348.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 338.37800000000004, 526.408, 349.286), True, False, 51, 841.92, 595.32)"
51,10.1517/13543776.2013.823159.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1517/13543776.2013.823159.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 323.498, 258.77, 334.40599999999995), True, False, 51, 841.92, 595.32)"
51,"167. Li E, Yan F, Huang P, Chi H, Xu S, Li G, Liu C, Feng N, Wang H, Zhao Y, Yang S, Xia",0,0,0,0,0,0,0,0,0,0,0,0,0,"('167. Li E, Yan F, Huang P, Chi H, Xu S, Li G, Liu C, Feng N, Wang H, Zhao Y, Yang S, Xia', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 308.618, 526.318, 319.94599999999997), False, False, 51, 841.92, 595.32)"
51,X.  2020.  Characterization  of  the  immune  response  of  MERS-CoV  vaccine  candidates,0,0,0,0,0,0,0,0,0,0,0,0,0,"('X.  2020.  Characterization  of  the  immune  response  of  MERS-CoV  vaccine  candidates', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 293.738, 526.33, 304.64599999999996), True, False, 51, 841.92, 595.32)"
51,derived from two different vectors in mice. Viruses 12(1):E125. doi: 10.3390/v12010125.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('derived from two different vectors in mice. Viruses 12(1):E125. doi: 10.3390/v12010125.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 278.858, 532.42, 289.76599999999996), True, False, 51, 841.92, 595.32)"
51,"168. Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. 2009. The spike protein of SARS-CoV-a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('168. Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. 2009. The spike protein of SARS-CoV-a', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 263.978, 526.42, 275.306), False, False, 51, 841.92, 595.32)"
51,target  for  vaccine  and  therapeutic  development.  Nat  Rev  Microbiol  7(3):226-236.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('target  for  vaccine  and  therapeutic  development.  Nat  Rev  Microbiol  7(3):226-236.  doi:', 'TimesNewRomanPSMT', 10.907999999999987, (93.384, 249.09799999999998, 526.408, 260.006), True, False, 51, 841.92, 595.32)"
51,10.1038/nrmicro2090.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1038/nrmicro2090.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 234.09799999999998, 203.69, 245.006), True, False, 51, 841.92, 595.32)"
51,"169. Wirblich C, Coleman CM, Kurup D, Abraham TS, Bernbaum JG, Jahrling PB, Hensley",0,0,0,0,0,0,0,0,0,0,0,0,0,"('169. Wirblich C, Coleman CM, Kurup D, Abraham TS, Bernbaum JG, Jahrling PB, Hensley', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 219.218, 526.1399999999998, 230.546), False, False, 51, 841.92, 595.32)"
51,"LE, Johnson RF, Frieman MB, Schnell MJ. 2017. One-health: a safe, efficient, dual-use",0,0,0,0,0,0,0,0,0,0,0,0,0,"('LE, Johnson RF, Frieman MB, Schnell MJ. 2017. One-health: a safe, efficient, dual-use', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 204.308, 526.42, 215.216), True, False, 51, 841.92, 595.32)"
51,vaccine for humans and animals against Middle East Respiratory syndrome Coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('vaccine for humans and animals against Middle East Respiratory syndrome Coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 189.428, 526.1640000000001, 200.336), True, False, 51, 841.92, 595.32)"
51,and Rabies virus. J Virol 91(2):e02040-16. doi: 10.1128/JVI.02040-16.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and Rabies virus. J Virol 91(2):e02040-16. doi: 10.1128/JVI.02040-16.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 174.54799999999997, 441.55, 185.456), True, False, 51, 841.92, 595.32)"
51,"170. Buchholz  UJ,  Bukreyev  A,  Yang  L,  Lamirande  EW,  Murphy  BR,  Subbarao  K,  Collins",0,0,0,0,0,0,0,0,0,0,0,0,0,"('170. Buchholz  UJ,  Bukreyev  A,  Yang  L,  Lamirande  EW,  Murphy  BR,  Subbarao  K,  Collins', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 159.66799999999998, 526.1039999999999, 170.99599999999998), False, False, 51, 841.92, 595.32)"
51,PL.  2004.  Contributions of  the  structural  proteins  of  severe  acute  respiratory  syndrome,0,0,0,0,0,0,0,0,0,0,0,0,0,"('PL.  2004.  Contributions of  the  structural  proteins  of  severe  acute  respiratory  syndrome', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 143.82799999999997, 526.184, 154.736), True, False, 51, 841.92, 595.32)"
51,coronavirus to protective immunity. Proc Natl Acad Sci U S A 101(26):9804-9809. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus to protective immunity. Proc Natl Acad Sci U S A 101(26):9804-9809. doi:', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 127.98800000000001, 526.408, 138.89600000000002), True, False, 51, 841.92, 595.32)"
51,10.1073/pnas.0403492101.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1073/pnas.0403492101.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 112.028, 232.73, 122.936), True, False, 51, 841.92, 595.32)"
51,"171. Chen  R,  Fu  J,  Hu  J,  Li  C,  Zhao  Y,  Qu  H,  Wen  X,  Cao  S,  Wen  Y,  Wu  R.  2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('171. Chen  R,  Fu  J,  Hu  J,  Li  C,  Zhao  Y,  Qu  H,  Wen  X,  Cao  S,  Wen  Y,  Wu  R.  2020.', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 96.19200000000001, 526.42, 107.52000000000001), False, False, 51, 841.92, 595.32)"
51,Identification  of  the  immunodominant  neutralizing  regions  in  the  spike  glycoprotein  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Identification  of  the  immunodominant  neutralizing  regions  in  the  spike  glycoprotein  of', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 81.312, 526.14, 92.22), True, False, 51, 841.92, 595.32)"
51,porcine deltacoronavirus. Virus Res 276:197834. doi: 10.1016/j.virusres.2019.197834.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('porcine deltacoronavirus. Virus Res 276:197834. doi: 10.1016/j.virusres.2019.197834.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 66.432, 515.74, 77.34), True, False, 51, 841.92, 595.32)"
51,50,0,0,0,0,0,0,0,0,0,0,0,0,0,"('50', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 51, 841.92, 595.32)"
51,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 51, 841.92, 595.32)"
52,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 52, 841.92, 595.32)"
52,"172. Liu  WJ,  Zhao  M,  Liu  K,  Xu  K,  Wong  G,  Tan  W,  Gao  GF.  2017.  T-cell  immunity  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('172. Liu  WJ,  Zhao  M,  Liu  K,  Xu  K,  Wong  G,  Tan  W,  Gao  GF.  2017.  T-cell  immunity  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.306, 767.496), False, False, 52, 841.92, 595.32)"
52,SARS-CoV:  Implications  for  vaccine  development  against  MERS-CoV.  Antiviral  Res.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV:  Implications  for  vaccine  development  against  MERS-CoV.  Antiviral  Res.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.318, 752.176), True, False, 52, 841.92, 595.32)"
52,137:82-92. doi: 10.1016/j.antiviral.2016.11.006.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('137:82-92. doi: 10.1016/j.antiviral.2016.11.006.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 331.03, 737.296), True, False, 52, 841.92, 595.32)"
52,"173. Jiang  S,  Du  L,  Shi  Z.    2020.  An  emerging  coronavirus  causing  pneumonia  outbreak  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('173. Jiang  S,  Du  L,  Shi  Z.    2020.  An  emerging  coronavirus  causing  pneumonia  outbreak  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.2139999999999, 722.836), False, False, 52, 841.92, 595.32)"
52,"Wuhan,  China:  calling  for  developing  therapeutic  and  prophylactic  strategies.  Emerg",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Wuhan,  China:  calling  for  developing  therapeutic  and  prophylactic  strategies.  Emerg', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 695.548, 526.318, 706.456), True, False, 52, 841.92, 595.32)"
52,Microbe Infect 9(1):275-277. doi: 10.1080/22221751.2020.1723441.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Microbe Infect 9(1):275-277. doi: 10.1080/22221751.2020.1723441.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 679.708, 430.39, 690.616), True, False, 52, 841.92, 595.32)"
52,"174. Veljkovic  V,  Vergara-Alert  J,  Segalés  J,  Paessler  S.  2020.  Use  of  the  informational",0,0,0,0,0,0,0,0,0,0,0,0,0,"('174. Veljkovic  V,  Vergara-Alert  J,  Segalés  J,  Paessler  S.  2020.  Use  of  the  informational', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 663.868, 526.2020000000001, 675.196), False, False, 52, 841.92, 595.32)"
52,spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 648.988, 529.756, 659.8960000000001), True, False, 52, 841.92, 595.32)"
52,"prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 634.1080000000001, 526.104, 645.0160000000001), True, False, 52, 841.92, 595.32)"
52,F1000Research 9(52): 52. doi: 10.12688/f1000research.22149.1.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('F1000Research 9(52): 52. doi: 10.12688/f1000research.22149.1.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 619.2280000000001, 407.47, 630.1360000000001), True, False, 52, 841.92, 595.32)"
52,"175. Jiang S, He Y, Liu S. 2005. SARS vaccine development. Emerg Infect Dis 11(7):1016-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('175. Jiang S, He Y, Liu S. 2005. SARS vaccine development. Emerg Infect Dis 11(7):1016-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 604.3480000000001, 523.456, 615.676), False, False, 52, 841.92, 595.32)"
52,1020. doi: 10.3201/1107.050219.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('1020. doi: 10.3201/1107.050219.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 588.388, 256.37, 599.296), True, False, 52, 841.92, 595.32)"
52,"176. Baruah  V,  Bose  S.  2020.  Immunoinformatics-aided  identification  of  T  cell  and  B  cell",0,0,0,0,0,0,0,0,0,0,0,0,0,"('176. Baruah  V,  Bose  S.  2020.  Immunoinformatics-aided  identification  of  T  cell  and  B  cell', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 572.548, 526.2220000000001, 583.876), False, False, 52, 841.92, 595.32)"
52,epitopes in the surface glycoprotein of 2019-nCoV. J Med Virol 10.1002/jmv.25698. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('epitopes in the surface glycoprotein of 2019-nCoV. J Med Virol 10.1002/jmv.25698. doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 557.638, 526.3100000000001, 568.546), True, False, 52, 841.92, 595.32)"
52,10.1002/jmv.25698.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1002/jmv.25698.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 542.758, 196.37, 553.666), True, False, 52, 841.92, 595.32)"
52,"177. Kim  MH,  Kim  HJ,  Chang  J.  2019.  Superior  immune  responses  induced  by  intranasal",0,0,0,0,0,0,0,0,0,0,0,0,0,"('177. Kim  MH,  Kim  HJ,  Chang  J.  2019.  Superior  immune  responses  induced  by  intranasal', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 527.878, 526.2620000000001, 539.206), False, False, 52, 841.92, 595.32)"
52,immunization  with  recombinant  adenovirus-based  vaccine  expressing  full-length  spike,0,0,0,0,0,0,0,0,0,0,0,0,0,"('immunization  with  recombinant  adenovirus-based  vaccine  expressing  full-length  spike', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 512.998, 526.408, 523.9060000000001), True, False, 52, 841.92, 595.32)"
52,protein of Middle East respiratory syndrome coronavirus. PLoS One 14(7):e0220196. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein of Middle East respiratory syndrome coronavirus. PLoS One 14(7):e0220196. doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 498.118, 529.6080000000001, 509.02599999999995), True, False, 52, 841.92, 595.32)"
52,10.1371/journal.pone.0220196.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1371/journal.pone.0220196.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 483.238, 250.01, 494.14599999999996), True, False, 52, 841.92, 595.32)"
52,"178. Shi  J,  Zhang  J,  Li  S,  Sun  J,  Teng  Y,  Wu  M,  Li  J,  Li  Y,  Hu  N,  Wang  H,  Hu  Y.  2015.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('178. Shi  J,  Zhang  J,  Li  S,  Sun  J,  Teng  Y,  Wu  M,  Li  J,  Li  Y,  Hu  N,  Wang  H,  Hu  Y.  2015.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 468.238, 526.0279999999998, 479.566), False, False, 52, 841.92, 595.32)"
52,Epitope-based  vaccine  target  screening  against  highly  pathogenic  MERS-CoV:  an  in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Epitope-based  vaccine  target  screening  against  highly  pathogenic  MERS-CoV:  an  in', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 453.358, 526.36, 464.26599999999996), True, False, 52, 841.92, 595.32)"
52,silico approach applied to emerging infectious diseases. PLoS One 10(12):e0144475. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('silico approach applied to emerging infectious diseases. PLoS One 10(12):e0144475. doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 438.478, 529.44, 449.38599999999997), True, False, 52, 841.92, 595.32)"
52,10.1371/journal.pone.0144475.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1371/journal.pone.0144475.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 423.598, 250.01, 434.506), True, False, 52, 841.92, 595.32)"
52,"179. Xie  Q,  He  X,  Yang  F,  Liu  X,  Li  Y,  Liu  Y,  Yang  Z,  Yu  J,  Zhang  B,  Zhao  W.  2018.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('179. Xie  Q,  He  X,  Yang  F,  Liu  X,  Li  Y,  Liu  Y,  Yang  Z,  Yu  J,  Zhang  B,  Zhao  W.  2018.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 408.718, 526.0079999999999, 420.046), False, False, 52, 841.92, 595.32)"
52,Analysis  of  the  genome  sequence  and  prediction  of  B-cell  epitopes  of  the  envelope,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Analysis  of  the  genome  sequence  and  prediction  of  B-cell  epitopes  of  the  envelope', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 392.858, 526.294, 403.76599999999996), True, False, 52, 841.92, 595.32)"
52,protein  of  Middle  East  Respiratory  Syndrome-Coronavirus.  IEEE/ACM  Trans,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein  of  Middle  East  Respiratory  Syndrome-Coronavirus.  IEEE/ACM  Trans', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 377.01800000000003, 526.3299999999999, 387.926), True, False, 52, 841.92, 595.32)"
52,ComputBiolBioinform 15(4):1344-1350. doi: 10.1109/TCBB.2017.2702588.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ComputBiolBioinform 15(4):1344-1350. doi: 10.1109/TCBB.2017.2702588.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 361.058, 469.42, 371.96599999999995), True, False, 52, 841.92, 595.32)"
52,180. NIAID  2020.  Developing  Therapeutics  and  Vaccines  for  Coronaviruses.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('180. NIAID  2020.  Developing  Therapeutics  and  Vaccines  for  Coronaviruses.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 345.218, 526.1279999999998, 356.546), False, False, 52, 841.92, 595.32)"
52,https://www.niaid.nih.gov/diseases-conditions/coronaviruses-therapeutics-vaccines,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://www.niaid.nih.gov/diseases-conditions/coronaviruses-therapeutics-vaccines', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 329.37800000000004, 495.83200000000005, 340.286), True, False, 52, 841.92, 595.32)"
52,"(Accessed on February 15, 2020).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(Accessed on February 15, 2020).', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 313.538, 259.01, 324.44599999999997), True, False, 52, 841.92, 595.32)"
52,181. CEPI  2020.  CEPI  to  fund  three  programmes  to  develop  vaccines  against  the  novel,0,0,0,0,0,0,0,0,0,0,0,0,0,"('181. CEPI  2020.  CEPI  to  fund  three  programmes  to  develop  vaccines  against  the  novel', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 297.57800000000003, 526.0799999999998, 308.906), False, False, 52, 841.92, 595.32)"
52,"coronavirus,  nCoV-2019.  https://cepi.net/news_cepi/cepi-to-fund-three-programmes-to-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus,  nCoV-2019.  https://cepi.net/news_cepi/cepi-to-fund-three-programmes-to-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 281.738, 523.336, 292.64599999999996), True, False, 52, 841.92, 595.32)"
52,"develop-vaccines-against-the-novel-coronavirus-ncov-2019/  (Accessed  on  February  15,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('develop-vaccines-against-the-novel-coronavirus-ncov-2019/  (Accessed  on  February  15,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 265.898, 526.306, 276.806), True, False, 52, 841.92, 595.32)"
52,2020).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020).', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 250.058, 127.34, 260.966), True, False, 52, 841.92, 595.32)"
52,182. Moderna  2020.  Moderna  Announces  Funding  Award  from  CEPI  to  Accelerate,0,0,0,0,0,0,0,0,0,0,0,0,0,"('182. Moderna  2020.  Moderna  Announces  Funding  Award  from  CEPI  to  Accelerate', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 234.09799999999998, 526.1759999999997, 245.426), False, False, 52, 841.92, 595.32)"
52,Development  of  Messenger  RNA  (mRNA)  Vaccine  Against  Novel  Coronavirus.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Development  of  Messenger  RNA  (mRNA)  Vaccine  Against  Novel  Coronavirus.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 218.25799999999998, 526.1639999999999, 229.166), True, False, 52, 841.92, 595.32)"
52,https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 202.38799999999998, 522.616, 213.296), True, False, 52, 841.92, 595.32)"
52,"funding-award-cepi-accelerate-development (Accessed on February 15, 2020).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('funding-award-cepi-accelerate-development (Accessed on February 15, 2020).', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 186.54799999999997, 474.58, 197.456), True, False, 52, 841.92, 595.32)"
52,"183. Adedeji AO, Severson W, Jonsson C, Singh  K, Weiss SR, Sarafianos SG. 2013. Novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('183. Adedeji AO, Severson W, Jonsson C, Singh  K, Weiss SR, Sarafianos SG. 2013. Novel', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 170.708, 526.0679999999999, 182.036), False, False, 52, 841.92, 595.32)"
52,inhibitors  of  severe  acute  respiratory  syndrome  coronavirus  entry  that  act  by  three,0,0,0,0,0,0,0,0,0,0,0,0,0,"('inhibitors  of  severe  acute  respiratory  syndrome  coronavirus  entry  that  act  by  three', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 154.748, 526.2080000000001, 165.656), True, False, 52, 841.92, 595.32)"
52,distinct mechanisms. J Virol 87(14):8017-8028. doi: 10.1128/JVI.00998-13.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('distinct mechanisms. J Virol 87(14):8017-8028. doi: 10.1128/JVI.00998-13.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 138.908, 465.82, 149.816), True, False, 52, 841.92, 595.32)"
52,"184. Falzarano D, de Wit E, Rasmussen AL, Feldmann F, Okumura A, Scott DP, Brining D,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('184. Falzarano D, de Wit E, Rasmussen AL, Feldmann F, Okumura A, Scott DP, Brining D,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 123.068, 526.0440000000001, 134.396), False, False, 52, 841.92, 595.32)"
52,"Bushmaker T, Martellaro C, Baseler L, Benecke AG, Katze MG, Munster VJ, Feldmann",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Bushmaker T, Martellaro C, Baseler L, Benecke AG, Katze MG, Munster VJ, Feldmann', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 108.188, 526.1540000000001, 119.096), True, False, 52, 841.92, 595.32)"
52,H. 2013. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('H. 2013. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 93.312, 523.456, 104.22), True, False, 52, 841.92, 595.32)"
52,infected rhesus macaques. Nat Med 19(10):1313-1317. doi: 10.1038/nm.3362.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infected rhesus macaques. Nat Med 19(10):1313-1317. doi: 10.1038/nm.3362.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 78.432, 476.02, 89.34), True, False, 52, 841.92, 595.32)"
52,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 52, 841.92, 595.32)"
52,51,0,0,0,0,0,0,0,0,0,0,0,0,0,"('51', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 52, 841.92, 595.32)"
53,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 53, 841.92, 595.32)"
53,"185. Lu  L,  Liu  Q,  Du  L,  Jiang  S.  2013.  Middle  East  respiratory  syndrome  coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('185. Lu  L,  Liu  Q,  Du  L,  Jiang  S.  2013.  Middle  East  respiratory  syndrome  coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.3299999999999, 767.496), False, False, 53, 841.92, 595.32)"
53,(MERS-CoV):  challenges  in  identifying  its  source  and  controlling  its  spread.  Microbes,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(MERS-CoV):  challenges  in  identifying  its  source  and  controlling  its  spread.  Microbes', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 740.308, 526.136, 751.216), True, False, 53, 841.92, 595.32)"
53,Infect 15(8-9):625-629. doi:10.1016/j.micinf.2013.06.003.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infect 15(8-9):625-629. doi:10.1016/j.micinf.2013.06.003.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 724.468, 379.39, 735.376), True, False, 53, 841.92, 595.32)"
53,"186. Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W. COVID-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('186. Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W. COVID-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 708.508, 523.456, 719.836), False, False, 53, 841.92, 595.32)"
53,"19,  an  emerging  coronavirus  infection:  advances  and  prospects  in  designing  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('19,  an  emerging  coronavirus  infection:  advances  and  prospects  in  designing  and', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 692.668, 526.1360000000001, 703.576), True, False, 53, 841.92, 595.32)"
53,"developing  vaccines,  immunotherapeutics,  and  therapeutics.  Hum  Vaccin  Immunother.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('developing  vaccines,  immunotherapeutics,  and  therapeutics.  Hum  Vaccin  Immunother.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 676.828, 526.128, 687.736), True, False, 53, 841.92, 595.32)"
53,2020:1-7. doi: 10.1080/21645515.2020.1735227.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020:1-7. doi: 10.1080/21645515.2020.1735227.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 660.988, 335.83, 671.8960000000001), True, False, 53, 841.92, 595.32)"
53,"187. Li  H,  Wang  YM,  Xu  JY,  Cao  B.  2020.  Potential  antiviral  therapeutics  for  2019  novel",0,0,0,0,0,0,0,0,0,0,0,0,0,"('187. Li  H,  Wang  YM,  Xu  JY,  Cao  B.  2020.  Potential  antiviral  therapeutics  for  2019  novel', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 645.028, 526.33, 656.356), False, False, 53, 841.92, 595.32)"
53,Coronavirus.  ZhonghuaJie  He  He  Hu  Xi  ZaZhi  43(00):  E002-E002.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus.  ZhonghuaJie  He  He  Hu  Xi  ZaZhi  43(00):  E002-E002.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 630.148, 526.408, 641.056), True, False, 53, 841.92, 595.32)"
53,10.3760/cma.j.issn.1001-0939.2020.0002.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.3760/cma.j.issn.1001-0939.2020.0002.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 615.268, 301.73, 626.176), True, False, 53, 841.92, 595.32)"
53,"188. Wang C, Horby PW, Hayden FG, Gao GF. 2020. A novel coronavirus outbreak of global",0,0,0,0,0,0,0,0,0,0,0,0,0,"('188. Wang C, Horby PW, Hayden FG, Gao GF. 2020. A novel coronavirus outbreak of global', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 600.388, 526.2700000000001, 611.716), False, False, 53, 841.92, 595.32)"
53,health concern. Lancet 395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('health concern. Lancet 395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 585.508, 502.3, 596.416), True, False, 53, 841.92, 595.32)"
53,"189. Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. 2016. Coronaviruses - drug discovery",0,0,0,0,0,0,0,0,0,0,0,0,0,"('189. Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. 2016. Coronaviruses - drug discovery', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 570.5980000000001, 526.444, 581.926), False, False, 53, 841.92, 595.32)"
53,and therapeutic options. Nat Rev Drug Discov 15(5):327-347. doi:10.1038/nrd.2015.37.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and therapeutic options. Nat Rev Drug Discov 15(5):327-347. doi:10.1038/nrd.2015.37.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 555.718, 521.02, 566.626), True, False, 53, 841.92, 595.32)"
53,"190. Chan JF, Yao Y, Yeung ML, Deng W, Bao L, Jia L, Li F, Xiao C, Gao H, Yu P, Cai JP,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('190. Chan JF, Yao Y, Yeung ML, Deng W, Bao L, Jia L, Li F, Xiao C, Gao H, Yu P, Cai JP,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 540.838, 526.1980000000001, 552.1659999999999), False, False, 53, 841.92, 595.32)"
53,"Chu H, Zhou J, Chen H, Qin C, Yuen KY. 2015. Treatment  with  lopinavir/ritonavir or",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chu H, Zhou J, Chen H, Qin C, Yuen KY. 2015. Treatment  with  lopinavir/ritonavir or', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 525.958, 526.1039999999999, 536.866), True, False, 53, 841.92, 595.32)"
53,interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model,0,0,0,0,0,0,0,0,0,0,0,0,0,"('interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 510.95799999999997, 526.2860000000001, 521.866), True, False, 53, 841.92, 595.32)"
53,of common Marmoset. J Infect Dis 212(12):1904-1913. doi: 10.1093/infdis/jiv392.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of common Marmoset. J Infect Dis 212(12):1904-1913. doi: 10.1093/infdis/jiv392.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 496.07800000000003, 498.1, 506.986), True, False, 53, 841.92, 595.32)"
53,"191. Arabi  YM, Alothman A, Balkhy  HH, Al-Dawood A, AlJohani  S, Al Harbi S, Kojan S,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('191. Arabi  YM, Alothman A, Balkhy  HH, Al-Dawood A, AlJohani  S, Al Harbi S, Kojan S,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 481.19800000000004, 526.25, 492.526), False, False, 53, 841.92, 595.32)"
53,"Al  Jeraisy  M,  Deeb  AM,  Assiri  AM,  Al-Hameed  F,  AlSaedi  A,  Mandourah  Y,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Al  Jeraisy  M,  Deeb  AM,  Assiri  AM,  Al-Hameed  F,  AlSaedi  A,  Mandourah  Y,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 465.358, 526.294, 476.26599999999996), True, False, 53, 841.92, 595.32)"
53,"Almekhlafi  GA,  Sherbeeni  NM,  Elzein  FE,  Memon  J,  Taha  Y,  Almotairi  A,  Maghrabi",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Almekhlafi  GA,  Sherbeeni  NM,  Elzein  FE,  Memon  J,  Taha  Y,  Almotairi  A,  Maghrabi', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 449.51800000000003, 526.396, 460.426), True, False, 53, 841.92, 595.32)"
53,"KA, Qushmaq I, Al Bshabshe A, Kharaba A, Shalhoub S, Jose J, Fowler RA, Hayden FG,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('KA, Qushmaq I, Al Bshabshe A, Kharaba A, Shalhoub S, Jose J, Fowler RA, Hayden FG,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 433.678, 529.236, 444.58599999999996), True, False, 53, 841.92, 595.32)"
53,"Hussein  MA,  MIRACLE  trial  group.  2018.  Treatment  of  Middle  East  Respiratory",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Hussein  MA,  MIRACLE  trial  group.  2018.  Treatment  of  Middle  East  Respiratory', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 417.718, 526.1640000000001, 428.626), True, False, 53, 841.92, 595.32)"
53,Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial):,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial):', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 401.87800000000004, 529.726, 412.786), True, False, 53, 841.92, 595.32)"
53,study  protocol  for  a  randomized  controlled  trial.  Trials  19(1):81.  doi:  10.1186/s13063-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('study  protocol  for  a  randomized  controlled  trial.  Trials  19(1):81.  doi:  10.1186/s13063-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 386.01800000000003, 523.576, 396.926), True, False, 53, 841.92, 595.32)"
53,017-2427-0.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('017-2427-0.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 370.178, 158.42, 381.08599999999996), True, False, 53, 841.92, 595.32)"
53,192. WHO.  2020.  Clinical  management  of  severe  acute  respiratory  infection  when  novel,0,0,0,0,0,0,0,0,0,0,0,0,0,"('192. WHO.  2020.  Clinical  management  of  severe  acute  respiratory  infection  when  novel', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 354.218, 526.148, 365.546), False, False, 53, 841.92, 595.32)"
53,on,0,0,0,0,0,0,0,0,0,0,0,0,0,"('on', 'TimesNewRomanPSMT', 10.907999999999959, (511.22399999999993, 339.338, 526.2239999999999, 350.246), True, False, 53, 841.92, 595.32)"
53,coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 339.338, 152.904, 350.246), True, False, 53, 841.92, 595.32)"
53,https://www.who.int/publications-detail/clinical-management-of-severe-acute-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://www.who.int/publications-detail/clinical-management-of-severe-acute-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 324.458, 470.656, 335.366), True, False, 53, 841.92, 595.32)"
53,respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected  (Accessed,0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected  (Accessed', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 309.57800000000003, 526.342, 320.486), True, False, 53, 841.92, 595.32)"
53,"on February 7, 2020).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('on February 7, 2020).', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 294.69800000000004, 200.69, 305.606), True, False, 53, 841.92, 595.32)"
53,suspected.  Available,0,0,0,0,0,0,0,0,0,0,0,0,0,"('suspected.  Available', 'TimesNewRomanPSMT', 10.907999999999959, (355.75200000000007, 339.338, 484.61999999999995, 350.246), True, False, 53, 841.92, 595.32)"
53,infection,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infection', 'TimesNewRomanPSMT', 10.907999999999959, (245.868, 339.338, 291.4560000000001, 350.246), True, False, 53, 841.92, 595.32)"
53,(nCoV),0,0,0,0,0,0,0,0,0,0,0,0,0,"('(nCoV)', 'TimesNewRomanPSMT', 10.907999999999959, (179.53199999999998, 339.338, 219.276, 350.246), True, False, 53, 841.92, 595.32)"
53,is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('is', 'TimesNewRomanPSMT', 10.907999999999959, (318.08400000000006, 339.338, 329.0880000000001, 350.246), True, False, 53, 841.92, 595.32)"
53,"193. Wang Z, Chen X, Lu Y, Chen F, Zhang W. 2020. Clinical characteristics and therapeutic",0,0,0,0,0,0,0,0,0,0,0,0,0,"('193. Wang Z, Chen X, Lu Y, Chen F, Zhang W. 2020. Clinical characteristics and therapeutic', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 279.81800000000004, 526.282, 291.146), False, False, 53, 841.92, 595.32)"
53,procedure  for  four  cases  with  2019  novel  coronavirus  pneumonia  receiving  combined,0,0,0,0,0,0,0,0,0,0,0,0,0,"('procedure  for  four  cases  with  2019  novel  coronavirus  pneumonia  receiving  combined', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 264.938, 526.172, 275.84599999999995), True, False, 53, 841.92, 595.32)"
53,Chinese  and  Western  medicine  treatment.  Biosci  Trends  10.5582/bst.2020.01030.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chinese  and  Western  medicine  treatment.  Biosci  Trends  10.5582/bst.2020.01030.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 250.058, 526.2120000000001, 260.966), True, False, 53, 841.92, 595.32)"
53,doi:10.5582/bst.2020.01030.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:10.5582/bst.2020.01030.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 235.178, 234.41, 246.086), True, False, 53, 841.92, 595.32)"
53,"194. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. 2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('194. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. 2020.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 220.29799999999997, 526.42, 231.62599999999998), False, False, 53, 841.92, 595.32)"
53,Remdesivir  and  chloroquine  effectively  inhibit  the  recently  emerged  novel  coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Remdesivir  and  chloroquine  effectively  inhibit  the  recently  emerged  novel  coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 205.268, 526.1279999999998, 216.17600000000002), True, False, 53, 841.92, 595.32)"
53,(2019-nCoV)  in  vitro.  Cell  Res  10.1038/s41422-020-0282-0.  doi:  10.1038/s41422-020-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(2019-nCoV)  in  vitro.  Cell  Res  10.1038/s41422-020-0282-0.  doi:  10.1038/s41422-020-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 190.38799999999998, 523.456, 201.296), True, False, 53, 841.92, 595.32)"
53,0282-0.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('0282-0.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 175.50799999999998, 133.34, 186.416), True, False, 53, 841.92, 595.32)"
53,"195. Sheahan  TP,  Sims  AC, Graham  RL,  Menachery  VD,  Gralinski  LE,  Case  JB,  Leist  SR,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('195. Sheahan  TP,  Sims  AC, Graham  RL,  Menachery  VD,  Gralinski  LE,  Case  JB,  Leist  SR,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 160.628, 526.02, 171.956), False, False, 53, 841.92, 595.32)"
53,"Pyrc K, Feng JY, Trantcheva I, Bannister R, Park Y, Babusis D, Clarke MO, Mackman",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Pyrc K, Feng JY, Trantcheva I, Bannister R, Park Y, Babusis D, Clarke MO, Mackman', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 145.748, 526.04, 156.656), True, False, 53, 841.92, 595.32)"
53,"RL, Spahn JE, Palmiotti CA, Siegel D, Ray AS, Cihlar T, Jordan R, Denison MR, Baric",0,0,0,0,0,0,0,0,0,0,0,0,0,"('RL, Spahn JE, Palmiotti CA, Siegel D, Ray AS, Cihlar T, Jordan R, Denison MR, Baric', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 130.868, 525.972, 141.776), True, False, 53, 841.92, 595.32)"
53,RS.  2017.  Broad-spectrum  antiviral  GS-5734  inhibits  both  epidemic  and  zoonotic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('RS.  2017.  Broad-spectrum  antiviral  GS-5734  inhibits  both  epidemic  and  zoonotic', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 115.988, 526.274, 126.896), True, False, 53, 841.92, 595.32)"
53,coronaviruses. Sci Transl Med 9(396):eaal3653. doi: 10.1126/scitranslmed.aal3653.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronaviruses. Sci Transl Med 9(396):eaal3653. doi: 10.1126/scitranslmed.aal3653.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 101.108, 502.54, 112.016), True, False, 53, 841.92, 595.32)"
53,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 53, 841.92, 595.32)"
53,52,0,0,0,0,0,0,0,0,0,0,0,0,0,"('52', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 53, 841.92, 595.32)"
54,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 54, 841.92, 595.32)"
54,"196. Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('196. Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.02, 767.496), False, False, 54, 841.92, 595.32)"
54,Nichol  ST.  2005.  Chloroquine  is  a  potent  inhibitor  of  SARS  coronavirus  infection  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Nichol  ST.  2005.  Chloroquine  is  a  potent  inhibitor  of  SARS  coronavirus  infection  and', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.092, 752.176), True, False, 54, 841.92, 595.32)"
54,spread. Virol J 2:69. doi: 10.1186/1743-422X-2-69.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('spread. Virol J 2:69. doi: 10.1186/1743-422X-2-69.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 347.71, 737.296), True, False, 54, 841.92, 595.32)"
54,"197. Gao J, Tian Z, Yang X. 2020. Breakthrough: Chloroquine phosphate has shown apparent",0,0,0,0,0,0,0,0,0,0,0,0,0,"('197. Gao J, Tian Z, Yang X. 2020. Breakthrough: Chloroquine phosphate has shown apparent', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 703.468, 526.2379999999999, 714.7959999999999), False, False, 54, 841.92, 595.32)"
54,efficacy  in  treatment  of  COVID-19  associated  pneumonia  in  clinical  studies.  Biosci,0,0,0,0,0,0,0,0,0,0,0,0,0,"('efficacy  in  treatment  of  COVID-19  associated  pneumonia  in  clinical  studies.  Biosci', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 688.588, 526.2500000000001, 699.496), True, False, 54, 841.92, 595.32)"
54,Trends. 10.5582/bst.2020.01047. doi: 10.5582/bst.2020.01047.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Trends. 10.5582/bst.2020.01047. doi: 10.5582/bst.2020.01047.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 673.708, 399.07, 684.616), True, False, 54, 841.92, 595.32)"
54,"198. Widjaja I, Wang C, van Haperen R, Gutiérrez-Álvarez J, van Dieren B, Okba NMA, Raj",0,0,0,0,0,0,0,0,0,0,0,0,0,"('198. Widjaja I, Wang C, van Haperen R, Gutiérrez-Álvarez J, van Dieren B, Okba NMA, Raj', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 658.828, 526.27, 670.156), False, False, 54, 841.92, 595.32)"
54,"VS,  Li  W,  Fernandez-Delgado  R,  Grosveld  F,  van  Kuppeveld  FJM,  Haagmans  BL,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('VS,  Li  W,  Fernandez-Delgado  R,  Grosveld  F,  van  Kuppeveld  FJM,  Haagmans  BL,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 643.948, 526.25, 654.856), True, False, 54, 841.92, 595.32)"
54,"Enjuanes L, Drabek D, Bosch BJ. 2019. Towards a solution to MERS: protective human",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Enjuanes L, Drabek D, Bosch BJ. 2019. Towards a solution to MERS: protective human', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 629.068, 526.0680000000001, 639.976), True, False, 54, 841.92, 595.32)"
54,monoclonal  antibodies  targeting  different  domains  and  functions  of  the  MERS-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('monoclonal  antibodies  targeting  different  domains  and  functions  of  the  MERS-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 614.068, 523.456, 624.976), True, False, 54, 841.92, 595.32)"
54,coronavirus  spike  glycoprotein.  Emerg  Microbes  Infect  8(1):516-530.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus  spike  glycoprotein.  Emerg  Microbes  Infect  8(1):516-530.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 599.188, 526.408, 610.096), True, False, 54, 841.92, 595.32)"
54,10.1080/22221751.2019.1597644.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1080/22221751.2019.1597644.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 584.308, 264.77, 595.216), True, False, 54, 841.92, 595.32)"
54,"199. Goo J, Jeong Y, Park Y-S, Yang E, Jung D-I, Rho S, Park U, Sung H, Park P-G, Choi JA.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('199. Goo J, Jeong Y, Park Y-S, Yang E, Jung D-I, Rho S, Park U, Sung H, Park P-G, Choi JA.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 569.398, 529.384, 580.726), False, False, 54, 841.92, 595.32)"
54,2020. Characterization of novel monoclonal antibodies against MERS-coronavirus spike,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020. Characterization of novel monoclonal antibodies against MERS-coronavirus spike', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 554.518, 526.39, 565.426), True, False, 54, 841.92, 595.32)"
54,protein. Virus Res 278:197863. doi: 10.1016/j.virusres.2020.197863.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein. Virus Res 278:197863. doi: 10.1016/j.virusres.2020.197863.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 539.638, 430.75, 550.546), True, False, 54, 841.92, 595.32)"
54,"200. Zeng LP, Ge XY, Peng C, Tai W, Jiang S, Du L, Shi ZL. 2017. Cross-neutralization of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('200. Zeng LP, Ge XY, Peng C, Tai W, Jiang S, Du L, Shi ZL. 2017. Cross-neutralization of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 524.758, 526.42, 536.086), False, False, 54, 841.92, 595.32)"
54,SARS  coronavirus-specific  antibodies  against  bat  SARS-like  coronaviruses.  Sci  China,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS  coronavirus-specific  antibodies  against  bat  SARS-like  coronaviruses.  Sci  China', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 509.87800000000004, 526.444, 520.7860000000001), True, False, 54, 841.92, 595.32)"
54,Life Sci 60(12):1399-1402. doi: 10.1007/s11427-017-9189-3.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Life Sci 60(12):1399-1402. doi: 10.1007/s11427-017-9189-3.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 494.998, 395.83, 505.90599999999995), True, False, 54, 841.92, 595.32)"
54,201. Cohen  J.  2020.  New  coronavirus  threat  galvanizes  scientists.  Science.  367(6477):492-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('201. Cohen  J.  2020.  New  coronavirus  threat  galvanizes  scientists.  Science.  367(6477):492-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 480.118, 523.456, 491.44599999999997), False, False, 54, 841.92, 595.32)"
54,493. doi: 10.1126/science.367.6477.492.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('493. doi: 10.1126/science.367.6477.492.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 465.238, 291.65, 476.14599999999996), True, False, 54, 841.92, 595.32)"
54,"202. Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, Lu L, Jiang S, Yang Z, Wu Y, Ying T. 2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('202. Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, Lu L, Jiang S, Yang Z, Wu Y, Ying T. 2020.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 450.238, 526.342, 461.566), False, False, 54, 841.92, 595.32)"
54,Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 435.358, 526.408, 446.26599999999996), True, False, 54, 841.92, 595.32)"
54,human  monoclonal  antibody.  Emerg  Microbes  Infect  9(1):382-385.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('human  monoclonal  antibody.  Emerg  Microbes  Infect  9(1):382-385.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 420.478, 526.408, 431.38599999999997), True, False, 54, 841.92, 595.32)"
54,10.1080/22221751.2020.1729069.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1080/22221751.2020.1729069.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 405.598, 264.77, 416.506), True, False, 54, 841.92, 595.32)"
54,"203. Kilianski  A,  Baker  SC.  2014.  Cell-based  antiviral  screening  against  coronaviruses:",0,0,0,0,0,0,0,0,0,0,0,0,0,"('203. Kilianski  A,  Baker  SC.  2014.  Cell-based  antiviral  screening  against  coronaviruses:', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 390.69800000000004, 526.2940000000001, 402.026), False, False, 54, 841.92, 595.32)"
54,developing virus-specific and broad-spectrum inhibitors. Antiviral Res 101:105-112. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('developing virus-specific and broad-spectrum inhibitors. Antiviral Res 101:105-112. doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 375.81800000000004, 526.396, 386.726), True, False, 54, 841.92, 595.32)"
54,10.1016/j.antiviral.2013.11.004.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/j.antiviral.2013.11.004.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 360.938, 254.09, 371.84599999999995), True, False, 54, 841.92, 595.32)"
54,"204. Zhao  J,  Perera  RA,  Kayali  G,  Meyerholz  D,  Perlman  S,  Peiris  M.  2015.  Passive",0,0,0,0,0,0,0,0,0,0,0,0,0,"('204. Zhao  J,  Perera  RA,  Kayali  G,  Meyerholz  D,  Perlman  S,  Peiris  M.  2015.  Passive', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 346.058, 525.9960000000002, 357.38599999999997), False, False, 54, 841.92, 595.32)"
54,immunotherapy  with  dromedary  immune  serum  in  an  experimental  animal  model  for,0,0,0,0,0,0,0,0,0,0,0,0,0,"('immunotherapy  with  dromedary  immune  serum  in  an  experimental  animal  model  for', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 331.178, 526.2020000000001, 342.08599999999996), True, False, 54, 841.92, 595.32)"
54,Middle  East  respiratory  syndrome  coronavirus  infection.  J  Virol  89(11):6117-6120.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Middle  East  respiratory  syndrome  coronavirus  infection.  J  Virol  89(11):6117-6120.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 316.298, 526.4200000000001, 327.20599999999996), True, False, 54, 841.92, 595.32)"
54,doi:10.1128/JVI.00446-15,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:10.1128/JVI.00446-15', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 301.298, 223.73, 312.20599999999996), True, False, 54, 841.92, 595.32)"
54,"205. Zhang  L,  Liu  Y.  2020.  Potential  interventions  for  novel  Coronavirus  in  China:  A",0,0,0,0,0,0,0,0,0,0,0,0,0,"('205. Zhang  L,  Liu  Y.  2020.  Potential  interventions  for  novel  Coronavirus  in  China:  A', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 286.418, 526.1040000000002, 297.746), False, False, 54, 841.92, 595.32)"
54,systemic review. J Med Virol 10.1002/jmv.25707. doi: 10.1002/jmv.25707.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('systemic review. J Med Virol 10.1002/jmv.25707. doi: 10.1002/jmv.25707.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 271.538, 462.82, 282.44599999999997), True, False, 54, 841.92, 595.32)"
54,"206. Seesuay  W,  Jittavisutthikul  S,  Sae-Lim  N,  Sookrung  N,  Sakolvaree  Y,  Chaicumpa  W.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('206. Seesuay  W,  Jittavisutthikul  S,  Sae-Lim  N,  Sookrung  N,  Sakolvaree  Y,  Chaicumpa  W.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 256.658, 526.238, 267.986), False, False, 54, 841.92, 595.32)"
54,2018. Human transbodies that interfere with the functions of Ebola virus VP35 protein in,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2018. Human transbodies that interfere with the functions of Ebola virus VP35 protein in', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 241.778, 526.0560000000002, 252.686), True, False, 54, 841.92, 595.32)"
54,genome  replication  and  transcription  and  innate  immune  antagonism.  Emerg  Microbes,0,0,0,0,0,0,0,0,0,0,0,0,0,"('genome  replication  and  transcription  and  innate  immune  antagonism.  Emerg  Microbes', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 226.898, 526.25, 237.806), True, False, 54, 841.92, 595.32)"
54,Infect 7(1):41. doi:10.1038/s41426-018-0031-3.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infect 7(1):41. doi:10.1038/s41426-018-0031-3.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 211.988, 327.43, 222.89600000000002), True, False, 54, 841.92, 595.32)"
54,"207. Sun ML, Yang JM, Sun YP, Su GH. 2020. Inhibitors of RAS might be a good choice for",0,0,0,0,0,0,0,0,0,0,0,0,0,"('207. Sun ML, Yang JM, Sun YP, Su GH. 2020. Inhibitors of RAS might be a good choice for', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 197.10799999999998, 526.214, 208.43599999999998), False, False, 54, 841.92, 595.32)"
54,the therapy of COVID-19 pneumonia]. ZhonghuaJie He He Hu Xi ZaZhi 43(00): E014-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the therapy of COVID-19 pneumonia]. ZhonghuaJie He He Hu Xi ZaZhi 43(00): E014-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 182.22799999999998, 523.456, 193.136), True, False, 54, 841.92, 595.32)"
54,E014. doi: 10.3760/cma.j.issn.1001-0939.2020.0014.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('E014. doi: 10.3760/cma.j.issn.1001-0939.2020.0014.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 167.34799999999998, 354.79, 178.256), True, False, 54, 841.92, 595.32)"
54,"208. de  Wilde  AH,  Jochmans  D,  Posthuma  CC,  Zevenhoven-Dobbe  JC,  van  Nieuwkoop  S,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('208. de  Wilde  AH,  Jochmans  D,  Posthuma  CC,  Zevenhoven-Dobbe  JC,  van  Nieuwkoop  S,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 152.468, 526.318, 163.796), False, False, 54, 841.92, 595.32)"
54,"Bestebroer TM, van den Hoogen BG, Neyts J, Snijder EJ. 2014. Screening of an FDA-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Bestebroer TM, van den Hoogen BG, Neyts J, Snijder EJ. 2014. Screening of an FDA-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 137.468, 523.336, 148.376), True, False, 54, 841.92, 595.32)"
54,approved  compound  library  identifies  four  small-molecule  inhibitors  of  Middle  East,0,0,0,0,0,0,0,0,0,0,0,0,0,"('approved  compound  library  identifies  four  small-molecule  inhibitors  of  Middle  East', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 122.58800000000001, 526.294, 133.496), True, False, 54, 841.92, 595.32)"
54,respiratory  syndrome  coronavirus  replication  in  cell  culture.  Antimicrob  Agents,0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory  syndrome  coronavirus  replication  in  cell  culture.  Antimicrob  Agents', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 107.708, 526.1039999999999, 118.616), True, False, 54, 841.92, 595.32)"
54,Chemother 58(8):4875-4884. doi: 10.1128/AAC.03011-14.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chemother 58(8):4875-4884. doi: 10.1128/AAC.03011-14.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 92.83200000000001, 384.43, 103.74000000000001), True, False, 54, 841.92, 595.32)"
54,"209. Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, Trilling M, Lu M, Dittmer U, Yang D.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('209. Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, Trilling M, Lu M, Dittmer U, Yang D.', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 77.952, 526.444, 89.28), False, False, 54, 841.92, 595.32)"
54,2020.  Overlapping  and  discrete  aspects  of  the  pathology  and  pathogenesis  of  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020.  Overlapping  and  discrete  aspects  of  the  pathology  and  pathogenesis  of  the', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 63.072, 526.112, 73.98), True, False, 54, 841.92, 595.32)"
54,53,0,0,0,0,0,0,0,0,0,0,0,0,0,"('53', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 54, 841.92, 595.32)"
54,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 54, 841.92, 595.32)"
55,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 55, 841.92, 595.32)"
55,"emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J",0,0,0,0,0,0,0,0,0,0,0,0,0,"('emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 756.168, 526.384, 767.076), True, False, 55, 841.92, 595.32)"
55,Med Virol 10.1002/jmv.25709. doi: 10.1002/jmv.25709.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Med Virol 10.1002/jmv.25709. doi: 10.1002/jmv.25709.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 371.47, 752.176), True, False, 55, 841.92, 595.32)"
55,"210. Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, Ying T, Liu S, Shi Z, Jiang S, Lu L. 2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('210. Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, Ying T, Liu S, Shi Z, Jiang S, Lu L. 2020.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 526.202, 737.716), False, False, 55, 841.92, 595.32)"
55,Fusion  mechanism  of  2019-nCoV  and  fusion  inhibitors  targeting  HR1  domain  in  spike,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Fusion  mechanism  of  2019-nCoV  and  fusion  inhibitors  targeting  HR1  domain  in  spike', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 710.548, 526.226, 721.456), True, False, 55, 841.92, 595.32)"
55,protein. Cell Mol Immunol 10.1038/s41423-020-0374-2. doi: 10.1038/s41423-020-0374-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('protein. Cell Mol Immunol 10.1038/s41423-020-0374-2. doi: 10.1038/s41423-020-0374-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 694.588, 523.336, 705.496), True, False, 55, 841.92, 595.32)"
55,2.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 678.748, 108.38, 689.6560000000001), True, False, 55, 841.92, 595.32)"
55,"211. Gretebeck LM, Subbarao K. 2015. Animal models for SARS and MERS coronaviruses.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('211. Gretebeck LM, Subbarao K. 2015. Animal models for SARS and MERS coronaviruses.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 662.908, 526.27, 674.236), False, False, 55, 841.92, 595.32)"
55,CurrOpinVirol. 13:123-9. doi: 10.1016/j.coviro.2015.06.009.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CurrOpinVirol. 13:123-9. doi: 10.1016/j.coviro.2015.06.009.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 648.028, 390.19, 658.936), True, False, 55, 841.92, 595.32)"
55,"212. Yong CY, Ong HK, Yeap SK, Ho KL, Tan WS. 2019. Recent  advances in  the vaccine",0,0,0,0,0,0,0,0,0,0,0,0,0,"('212. Yong CY, Ong HK, Yeap SK, Ho KL, Tan WS. 2019. Recent  advances in  the vaccine', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 633.148, 526.0919999999996, 644.476), False, False, 55, 841.92, 595.32)"
55,development  against  Middle  East  respiratory  syndrome-coronavirus.  Front  Microbiol.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('development  against  Middle  East  respiratory  syndrome-coronavirus.  Front  Microbiol.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 617.188, 526.42, 628.096), True, False, 55, 841.92, 595.32)"
55,10:1781. doi: 10.3389/fmicb.2019.01781.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10:1781. doi: 10.3389/fmicb.2019.01781.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 601.3480000000001, 299.69, 612.2560000000001), True, False, 55, 841.92, 595.32)"
55,"213. Martina  BE,  Haagmans  BL,  Kuiken  T,  Fouchier  RA,  Rimmelzwaan  GF,  Van",0,0,0,0,0,0,0,0,0,0,0,0,0,"('213. Martina  BE,  Haagmans  BL,  Kuiken  T,  Fouchier  RA,  Rimmelzwaan  GF,  Van', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 585.508, 526.0919999999999, 596.836), False, False, 55, 841.92, 595.32)"
55,"Amerongen G, Peiris JS, Lim W, Osterhaus AD. 2003. Virology: SARS virus infection",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Amerongen G, Peiris JS, Lim W, Osterhaus AD. 2003. Virology: SARS virus infection', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 569.638, 526.14, 580.546), True, False, 55, 841.92, 595.32)"
55,of cats and ferrets. Nature 425(6961):915. doi: 10.1038/425915a.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of cats and ferrets. Nature 425(6961):915. doi: 10.1038/425915a.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 553.678, 412.27, 564.586), True, False, 55, 841.92, 595.32)"
55,"214. Lamirande EW, DeDiego ML, Roberts A, Jackson JP, Alvarez E, Sheahan T, Shieh WJ,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('214. Lamirande EW, DeDiego ML, Roberts A, Jackson JP, Alvarez E, Sheahan T, Shieh WJ,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 537.838, 526.2339999999999, 549.1659999999999), False, False, 55, 841.92, 595.32)"
55,"Zaki  SR,  Baric  R,  Enjuanes  L,  Subbarao  K.  2008.  A  live  attenuated  severe  acute",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Zaki  SR,  Baric  R,  Enjuanes  L,  Subbarao  K.  2008.  A  live  attenuated  severe  acute', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 522.958, 526.0559999999998, 533.866), True, False, 55, 841.92, 595.32)"
55,respiratory  syndrome  coronavirus  is  immunogenic  and  efficacious  in  golden  Syrian,0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory  syndrome  coronavirus  is  immunogenic  and  efficacious  in  golden  Syrian', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 508.07800000000003, 526.188, 518.986), True, False, 55, 841.92, 595.32)"
55,hamsters. J Virol. 82(15):7721-4. doi: 10.1128/JVI.00304-08.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('hamsters. J Virol. 82(15):7721-4. doi: 10.1128/JVI.00304-08.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 493.19800000000004, 395.83, 504.106), True, False, 55, 841.92, 595.32)"
55,"215. Roberts  A,  Lamirande  EW,  Vogel  L,  Jackson  JP,  Paddock  CD,  Guarner  J,  Zaki  SR,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('215. Roberts  A,  Lamirande  EW,  Vogel  L,  Jackson  JP,  Paddock  CD,  Guarner  J,  Zaki  SR,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 478.31800000000004, 526.032, 489.646), False, False, 55, 841.92, 595.32)"
55,"Sheahan  T,  Baric  R,  Subbarao  K.  2008.  Animal  models  and  vaccines  for  SARS-CoV",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sheahan  T,  Baric  R,  Subbarao  K.  2008.  Animal  models  and  vaccines  for  SARS-CoV', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 463.438, 526.432, 474.34599999999995), True, False, 55, 841.92, 595.32)"
55,infection. Virus Res. 133(1):20-32. doi: 10.1016/j.virusres.2007.03.025.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infection. Virus Res. 133(1):20-32. doi: 10.1016/j.virusres.2007.03.025.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 448.558, 445.54, 459.46599999999995), True, False, 55, 841.92, 595.32)"
55,"216. Falzarano D, de Wit E, Feldmann F, Rasmussen AL, Okumura A, Peng X, Thomas MJ,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('216. Falzarano D, de Wit E, Feldmann F, Rasmussen AL, Okumura A, Peng X, Thomas MJ,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 433.678, 526.142, 445.006), False, False, 55, 841.92, 595.32)"
55,"van Doremalen N, Haddock E, Nagy L, LaCasse R, Liu T, Zhu J, McLellan JS, Scott DP,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('van Doremalen N, Haddock E, Nagy L, LaCasse R, Liu T, Zhu J, McLellan JS, Scott DP,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 418.678, 526.2, 429.58599999999996), True, False, 55, 841.92, 595.32)"
55,"Katze  MG,  Feldmann  H,  Munster  VJ.  2014.  Infection  with  MERS-CoV  causes  lethal",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Katze  MG,  Feldmann  H,  Munster  VJ.  2014.  Infection  with  MERS-CoV  causes  lethal', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 403.798, 526.306, 414.70599999999996), True, False, 55, 841.92, 595.32)"
55,pneumonia  in  the  common  marmoset.  PLoSPathog.  10(8):e1004250.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pneumonia  in  the  common  marmoset.  PLoSPathog.  10(8):e1004250.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 388.898, 526.33, 399.806), True, False, 55, 841.92, 595.32)"
55,10.1371/journal.ppat.1004250.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1371/journal.ppat.1004250.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 374.01800000000003, 247.37, 384.926), True, False, 55, 841.92, 595.32)"
55,"217. Du L, Tai  W, Zhou  Y, Jiang S. 2016. Vaccines  for the prevention against the threat  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('217. Du L, Tai  W, Zhou  Y, Jiang S. 2016. Vaccines  for the prevention against the threat  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 359.13800000000003, 526.0799999999998, 370.466), False, False, 55, 841.92, 595.32)"
55,15(9):1123-34.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('15(9):1123-34.', 'TimesNewRomanPSMT', 10.907999999999959, (449.048, 344.25800000000004, 526.4200000000001, 355.166), True, False, 55, 841.92, 595.32)"
55,Vaccines.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Vaccines.', 'TimesNewRomanPSMT', 10.907999999999959, (338.06, 344.25800000000004, 388.076, 355.166), True, False, 55, 841.92, 595.32)"
55,MERS-CoV. Expert,0,0,0,0,0,0,0,0,0,0,0,0,0,"('MERS-CoV. Expert', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 344.25800000000004, 193.712, 355.166), True, False, 55, 841.92, 595.32)"
55,Rev,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Rev', 'TimesNewRomanPSMT', 10.907999999999959, (254.672, 344.25800000000004, 277.088, 355.166), True, False, 55, 841.92, 595.32)"
55,doi:10.1586/14760584.2016.1167603,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:10.1586/14760584.2016.1167603', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 329.37800000000004, 277.37, 340.286), True, False, 55, 841.92, 595.32)"
55,"218. Enjuanes L, Zuñiga S, Castaño-Rodriguez C, Gutierrez-Alvarez J, Canton J, Sola I. 2016.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('218. Enjuanes L, Zuñiga S, Castaño-Rodriguez C, Gutierrez-Alvarez J, Canton J, Sola I. 2016.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 314.498, 529.282, 325.82599999999996), False, False, 55, 841.92, 595.32)"
55,Molecular  basis  of  coronavirus  virulence  and  vaccine  development. Adv  Virus  Res.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Molecular  basis  of  coronavirus  virulence  and  vaccine  development. Adv  Virus  Res.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 299.618, 526.36, 310.52599999999995), True, False, 55, 841.92, 595.32)"
55,96:245-86. doi:10.1016/bs.aivir.2016.08.003,0,0,0,0,0,0,0,0,0,0,0,0,0,"('96:245-86. doi:10.1016/bs.aivir.2016.08.003', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 284.738, 313.37, 295.64599999999996), True, False, 55, 841.92, 595.32)"
55,"219. Yang XH, Deng W, Tong Z, Liu YX, Zhang LF, Zhu H, Gao H, Huang L, Liu YL, Ma",0,0,0,0,0,0,0,0,0,0,0,0,0,"('219. Yang XH, Deng W, Tong Z, Liu YX, Zhang LF, Zhu H, Gao H, Huang L, Liu YL, Ma', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 269.858, 526.136, 281.186), False, False, 55, 841.92, 595.32)"
55,"CM, Xu YF, Ding MX, Deng HK, Qin C. 2007. Mice transgenic for human angiotensin-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('CM, Xu YF, Ding MX, Deng HK, Qin C. 2007. Mice transgenic for human angiotensin-', 'TimesNewRomanPSMT', 10.907999999999987, (93.384, 253.898, 523.456, 264.806), True, False, 55, 841.92, 595.32)"
55,converting  enzyme  2  provide  a  model  for  SARS  coronavirus  infection.  Comp  Med,0,0,0,0,0,0,0,0,0,0,0,0,0,"('converting  enzyme  2  provide  a  model  for  SARS  coronavirus  infection.  Comp  Med', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 238.058, 526.14, 248.966), True, False, 55, 841.92, 595.32)"
55,57(5):450-459.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('57(5):450-459.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 222.218, 171.74, 233.126), True, False, 55, 841.92, 595.32)"
55,"220. Leist  SR,  Cockrell  AS.  2020.  Genetically  engineering  a  susceptible  mouse  model  for",0,0,0,0,0,0,0,0,0,0,0,0,0,"('220. Leist  SR,  Cockrell  AS.  2020.  Genetically  engineering  a  susceptible  mouse  model  for', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 206.34799999999998, 526.1360000000001, 217.676), False, False, 55, 841.92, 595.32)"
55,MERS-CoV-induced acute respiratory distress syndrome. Methods Mol Biol. 2099:137-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('MERS-CoV-induced acute respiratory distress syndrome. Methods Mol Biol. 2099:137-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 191.34799999999998, 523.576, 202.256), True, False, 55, 841.92, 595.32)"
55,159. doi: 10.1007/978-1-0716-0211-9_12.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('159. doi: 10.1007/978-1-0716-0211-9_12.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 176.468, 302.45, 187.376), True, False, 55, 841.92, 595.32)"
55,"221. Zhou  Y,  Jiang  S,  Du  L.  2018b.  Prospects  for  a  MERS-CoV  spike  vaccine. Expert  Rev",0,0,0,0,0,0,0,0,0,0,0,0,0,"('221. Zhou  Y,  Jiang  S,  Du  L.  2018b.  Prospects  for  a  MERS-CoV  spike  vaccine. Expert  Rev', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 161.588, 526.396, 172.916), False, False, 55, 841.92, 595.32)"
55,Vaccines. 17(8):677-86. doi:10.1080/14760584.2018.1506702,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Vaccines. 17(8):677-86. doi:10.1080/14760584.2018.1506702', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 145.748, 398.71, 156.656), True, False, 55, 841.92, 595.32)"
55,"222. Cockrell AS,  Yount BL, Scobey T, Jensen K, Douglas M, Beall A, Tang XC, Marasco",0,0,0,0,0,0,0,0,0,0,0,0,0,"('222. Cockrell AS,  Yount BL, Scobey T, Jensen K, Douglas M, Beall A, Tang XC, Marasco', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 129.908, 526.1039999999998, 141.236), False, False, 55, 841.92, 595.32)"
55,"WA, Heise MT, Baric RS. 2016. A mouse model for MERS coronavirus-induced acute",0,0,0,0,0,0,0,0,0,0,0,0,0,"('WA, Heise MT, Baric RS. 2016. A mouse model for MERS coronavirus-induced acute', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 115.028, 526.408, 125.936), True, False, 55, 841.92, 595.32)"
55,respiratory,0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 100.148, 148.236, 111.056), True, False, 55, 841.92, 595.32)"
55,doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:', 'TimesNewRomanPSMT', 10.908000000000001, (504.83000000000004, 100.148, 526.3100000000001, 111.056), True, False, 55, 841.92, 595.32)"
55,10.1038/nmicrobiol.2016.226.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1038/nmicrobiol.2016.226.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 85.272, 245.45, 96.18), True, False, 55, 841.92, 595.32)"
55,syndrome.  Nat  Microbiol.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('syndrome.  Nat  Microbiol.', 'TimesNewRomanPSMT', 10.908000000000001, (235.536, 100.148, 411.374, 111.056), True, False, 55, 841.92, 595.32)"
55,2:16226.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2:16226.', 'TimesNewRomanPSMT', 10.908000000000001, (435.482, 100.148, 480.72200000000004, 111.056), True, False, 55, 841.92, 595.32)"
55,distress,0,0,0,0,0,0,0,0,0,0,0,0,0,"('distress', 'TimesNewRomanPSMT', 10.908000000000001, (172.332, 100.148, 211.42800000000003, 111.056), True, False, 55, 841.92, 595.32)"
55,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 55, 841.92, 595.32)"
55,54,0,0,0,0,0,0,0,0,0,0,0,0,0,"('54', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 55, 841.92, 595.32)"
56,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 56, 841.92, 595.32)"
56,"223. Eckerle I, Corman VM, Müller MA, Lenk M, Ulrich RG, Drosten C. 2014. Replicative",0,0,0,0,0,0,0,0,0,0,0,0,0,"('223. Eckerle I, Corman VM, Müller MA, Lenk M, Ulrich RG, Drosten C. 2014. Replicative', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.1039999999999, 767.496), False, False, 56, 841.92, 595.32)"
56,capacity of MERS coronavirus in livestock cell lines. Emerg Infect Dis. 20(2):276-9. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('capacity of MERS coronavirus in livestock cell lines. Emerg Infect Dis. 20(2):276-9. doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.408, 752.176), True, False, 56, 841.92, 595.32)"
56,10.3201/eid2002.131182.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.3201/eid2002.131182.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 222.41, 737.296), True, False, 56, 841.92, 595.32)"
56,"224. Milewska A, Nowak P, Owczarek K, Szczepanski A, Zarebski M, Hoang A, Berniak K,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('224. Milewska A, Nowak P, Owczarek K, Szczepanski A, Zarebski M, Hoang A, Berniak K,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.068, 722.836), False, False, 56, 841.92, 595.32)"
56,"Wojarski  J,  Zeglen  S,  Baster  Z,  Rajfur  Z,  Pyrc  K.  2018.  Entry  of  human  coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Wojarski  J,  Zeglen  S,  Baster  Z,  Rajfur  Z,  Pyrc  K.  2018.  Entry  of  human  coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 695.548, 526.1279999999999, 706.456), True, False, 56, 841.92, 595.32)"
56,NL63 into the cell. J Virol. 92(3):e01933-17. doi: 10.1128/JVI.01933-17.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('NL63 into the cell. J Virol. 92(3):e01933-17. doi: 10.1128/JVI.01933-17.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 679.708, 452.14, 690.616), True, False, 56, 841.92, 595.32)"
56,225. Nkengasong J. 2020. China's response to a novel coronavirus stands in stark contrast to,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""225. Nkengasong J. 2020. China's response to a novel coronavirus stands in stark contrast to"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 663.868, 526.1479999999999, 675.196), False, False, 56, 841.92, 595.32)"
56,the  2002  SARS  outbreak  response.  Nat  Med  10.1038/s41591-020-0771-1.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  2002  SARS  outbreak  response.  Nat  Med  10.1038/s41591-020-0771-1.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 648.028, 526.408, 658.936), True, False, 56, 841.92, 595.32)"
56,10.1038/s41591-020-0771-1.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1038/s41591-020-0771-1.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 632.188, 239.33, 643.096), True, False, 56, 841.92, 595.32)"
56,"226. Khan S, Ali A, Siddique R, Nabi G. 2020. Novel coronavirus is putting the whole world",0,0,0,0,0,0,0,0,0,0,0,0,0,"('226. Khan S, Ali A, Siddique R, Nabi G. 2020. Novel coronavirus is putting the whole world', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 616.2280000000001, 526.408, 627.556), False, False, 56, 841.92, 595.32)"
56,on alert. J Hosp Infect S0195-6701(20)30043-8. doi: 10.1016/j.jhin.2020.01.019.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('on alert. J Hosp Infect S0195-6701(20)30043-8. doi: 10.1016/j.jhin.2020.01.019.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 600.388, 485.5, 611.296), True, False, 56, 841.92, 595.32)"
56,"227. Sun  K,  Chen  J,  Viboud  C.  2020.  Early  epidemiological  analysis  of  the  coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('227. Sun  K,  Chen  J,  Viboud  C.  2020.  Early  epidemiological  analysis  of  the  coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 584.548, 526.2260000000001, 595.876), False, False, 56, 841.92, 595.32)"
56,disease  2019  outbreak  based  on  crowdsourced  data:  a  population-level  observational,0,0,0,0,0,0,0,0,0,0,0,0,0,"('disease  2019  outbreak  based  on  crowdsourced  data:  a  population-level  observational', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 569.638, 526.33, 580.546), True, False, 56, 841.92, 595.32)"
56,study. The Lancet Digital Health. doi: 10.1016/S2589-7500(20)30026-1,0,0,0,0,0,0,0,0,0,0,0,0,0,"('study. The Lancet Digital Health. doi: 10.1016/S2589-7500(20)30026-1', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 554.758, 442.75, 565.666), True, False, 56, 841.92, 595.32)"
56,"228. Tang  B,  Wang  X,  Li  Q,  Bragazzi  NL,  Tang  S,  Xiao  Y,  Wu  J.  2020.  Estimation  of  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('228. Tang  B,  Wang  X,  Li  Q,  Bragazzi  NL,  Tang  S,  Xiao  Y,  Wu  J.  2020.  Estimation  of  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 539.878, 526.0199999999999, 551.206), False, False, 56, 841.92, 595.32)"
56,transmission risk of the 2019-nCoV and its implication for public health interventions. J,0,0,0,0,0,0,0,0,0,0,0,0,0,"('transmission risk of the 2019-nCoV and its implication for public health interventions. J', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 524.878, 526.1780000000001, 535.7860000000001), True, False, 56, 841.92, 595.32)"
56,Clin Med 9(2):E462. doi: 10.3390/jcm9020462.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Clin Med 9(2):E462. doi: 10.3390/jcm9020462.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 509.99800000000005, 326.83, 520.9060000000001), True, False, 56, 841.92, 595.32)"
56,"229. Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, Wang Y, Hu J, Lai J, Ma X, Chen J,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('229. Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, Wang Y, Hu J, Lai J, Ma X, Chen J,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 495.118, 525.9720000000001, 506.44599999999997), False, False, 56, 841.92, 595.32)"
56,"Guan L, Wang G, Ma H, Liu Z. 2020. The mental health of medical workers in Wuhan,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Guan L, Wang G, Ma H, Liu Z. 2020. The mental health of medical workers in Wuhan,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 479.278, 526.092, 490.186), True, False, 56, 841.92, 595.32)"
56,China  dealing  with  the  2019  novel  coronavirus.  Lancet  Psychiatry  S2215-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('China  dealing  with  the  2019  novel  coronavirus.  Lancet  Psychiatry  S2215-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 463.438, 523.456, 474.34599999999995), True, False, 56, 841.92, 595.32)"
56,0366(20)30047-X. doi: 10.1016/S2215-0366(20)30047-X.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('0366(20)30047-X. doi: 10.1016/S2215-0366(20)30047-X.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 447.598, 377.47, 458.506), True, False, 56, 841.92, 595.32)"
56,"230. Guan W, Xian J. 2020. The progress of 2019 Novel Coronavirus (2019-nCoV) event in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('230. Guan W, Xian J. 2020. The progress of 2019 Novel Coronavirus (2019-nCoV) event in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 431.63800000000003, 526.384, 442.966), False, False, 56, 841.92, 595.32)"
56,China. J Med Virol 10.1002/jmv.25705. doi: 10.1002/jmv.25705.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('China. J Med Virol 10.1002/jmv.25705. doi: 10.1002/jmv.25705.', 'TimesNewRomanPSMT', 10.907999999999959, (93.624, 416.75800000000004, 410.95, 427.666), True, False, 56, 841.92, 595.32)"
56,"231. Wu JT, Leung K, Leung GM. 2020. Nowcasting and forecasting the potential domestic",0,0,0,0,0,0,0,0,0,0,0,0,0,"('231. Wu JT, Leung K, Leung GM. 2020. Nowcasting and forecasting the potential domestic', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 401.87800000000004, 526.2940000000001, 413.206), False, False, 56, 841.92, 595.32)"
56,"and  international  spread  of  the  2019-nCoV  outbreak  originating  in  Wuhan,  China:  a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  international  spread  of  the  2019-nCoV  outbreak  originating  in  Wuhan,  China:  a', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 386.978, 526.2620000000001, 397.88599999999997), True, False, 56, 841.92, 595.32)"
56,modelling study. Lancet S0140-6736(20)30260-9. doi: 10.1016/S0140-6736(20)30260-9.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('modelling study. Lancet S0140-6736(20)30260-9. doi: 10.1016/S0140-6736(20)30260-9.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 372.098, 526.06, 383.006), True, False, 56, 841.92, 595.32)"
56,"232. Kickbusch  I,  Leung  G.  2020.  Response  to  the  emerging novel coronavirus outbreak.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('232. Kickbusch  I,  Leung  G.  2020.  Response  to  the  emerging novel coronavirus outbreak.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 357.218, 526.4200000000001, 368.546), False, False, 56, 841.92, 595.32)"
56,BMJ 368:m406. doi: 10.1136/bmj.m406.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('BMJ 368:m406. doi: 10.1136/bmj.m406.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 341.37800000000004, 293.45, 352.286), True, False, 56, 841.92, 595.32)"
56,"233. Bogoch  II, Watts  A, Thomas-Bachli  A, Huber  C, Kraemer  MUG, Khan  K.  2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('233. Bogoch  II, Watts  A, Thomas-Bachli  A, Huber  C, Kraemer  MUG, Khan  K.  2020.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 325.418, 526.384, 336.746), False, False, 56, 841.92, 595.32)"
56,Potential for global spread of a novel coronavirus from China. J Travel Med pii: taaa011.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Potential for global spread of a novel coronavirus from China. J Travel Med pii: taaa011.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 309.57800000000003, 526.396, 320.486), True, False, 56, 841.92, 595.32)"
56,doi: 10.1093/jtm/taaa011.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi: 10.1093/jtm/taaa011.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 293.738, 220.01, 304.64599999999996), True, False, 56, 841.92, 595.32)"
56,"234. Khan S, Siddique R, Ali A, Xue M, Nabi G. 2020. Novel coronavirus, poor quarantine,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('234. Khan S, Siddique R, Ali A, Xue M, Nabi G. 2020. Novel coronavirus, poor quarantine,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 277.898, 526.306, 289.226), False, False, 56, 841.92, 595.32)"
56,and  the  risk  of  pandemic.  J  Hosp  Infect  S0195-6701(20)30048-7.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  the  risk  of  pandemic.  J  Hosp  Infect  S0195-6701(20)30048-7.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 263.01800000000003, 526.396, 273.926), True, False, 56, 841.92, 595.32)"
56,10.1016/j.jhin.2020.02.002.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/j.jhin.2020.02.002.', 'TimesNewRomanPSMT', 10.907999999999987, (93.384, 248.018, 232.73, 258.926), True, False, 56, 841.92, 595.32)"
56,"235. Thompson  RN.  2020.  Novel  Coronavirus  outbreak  in  Wuhan,  China,  2020:  intense",0,0,0,0,0,0,0,0,0,0,0,0,0,"('235. Thompson  RN.  2020.  Novel  Coronavirus  outbreak  in  Wuhan,  China,  2020:  intense', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 233.13799999999998, 526.152, 244.46599999999998), False, False, 56, 841.92, 595.32)"
56,surveillance is  vital  for  preventing sustained transmission in  new locations. J Clin Med,0,0,0,0,0,0,0,0,0,0,0,0,0,"('surveillance is  vital  for  preventing sustained transmission in  new locations. J Clin Med', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 218.25799999999998, 526.056, 229.166), True, False, 56, 841.92, 595.32)"
56,9(2):E498. doi: 10.3390/jcm9020498.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('9(2):E498. doi: 10.3390/jcm9020498.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 203.34799999999998, 281.09, 214.256), True, False, 56, 841.92, 595.32)"
56,"236. Du Z, Wang L, Cauchemez S, Xu X, Wang X, Cowling BJ, Meyers LA. 2020. Risk for",0,0,0,0,0,0,0,0,0,0,0,0,0,"('236. Du Z, Wang L, Cauchemez S, Xu X, Wang X, Cowling BJ, Meyers LA. 2020. Risk for', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 188.468, 526.33, 199.796), False, False, 56, 841.92, 595.32)"
56,Transportation of 2019 Novel Coronavirus Disease from Wuhan to Other Cities in China.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Transportation of 2019 Novel Coronavirus Disease from Wuhan to Other Cities in China.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 173.588, 529.1160000000001, 184.496), True, False, 56, 841.92, 595.32)"
56,Emerg Infect Dis 26(5):10.3201/eid2605.200146. doi: 10.3201/eid2605.200146.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Emerg Infect Dis 26(5):10.3201/eid2605.200146. doi: 10.3201/eid2605.200146.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 158.708, 485.14, 169.616), True, False, 56, 841.92, 595.32)"
56,"237. Wood  C.  2020.  Infections  without  borders:  a  new  coronavirus  in  Wuhan,  China.  Br  J",0,0,0,0,0,0,0,0,0,0,0,0,0,"('237. Wood  C.  2020.  Infections  without  borders:  a  new  coronavirus  in  Wuhan,  China.  Br  J', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 143.82799999999997, 526.348, 155.15599999999998), False, False, 56, 841.92, 595.32)"
56,Nurs 29(3):166-167. doi: 10.12968/bjon.2020.29.3.166.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Nurs 29(3):166-167. doi: 10.12968/bjon.2020.29.3.166.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 128.94799999999998, 364.51, 139.856), True, False, 56, 841.92, 595.32)"
56,"238. Dong  E,  Du  H,  Gardner  L.  An  interactive  web-based  dashboard  to  track  COVID-19  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('238. Dong  E,  Du  H,  Gardner  L.  An  interactive  web-based  dashboard  to  track  COVID-19  in', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 114.068, 526.384, 125.396), False, False, 56, 841.92, 595.32)"
56,real time. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30120-1.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('real time. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30120-1.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 99.068, 446.74, 109.976), True, False, 56, 841.92, 595.32)"
56,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 56, 841.92, 595.32)"
56,55,0,0,0,0,0,0,0,0,0,0,0,0,0,"('55', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 56, 841.92, 595.32)"
57,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 57, 841.92, 595.32)"
57,"239. Sawano  T,  Ozaki  A,  Rodriguez-Morales  AJ,  Tanimoto  T,  Sah  R.  Limiting  spread  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('239. Sawano  T,  Ozaki  A,  Rodriguez-Morales  AJ,  Tanimoto  T,  Sah  R.  Limiting  spread  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.214, 767.496), False, False, 57, 841.92, 595.32)"
57,COVID-19  from  cruise  ships  -  lessons  to  be  learnt  from  Japan.  QJM.  2020  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19  from  cruise  ships  -  lessons  to  be  learnt  from  Japan.  QJM.  2020  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.2260000000001, 752.176), True, False, 57, 841.92, 595.32)"
57,10.1093/qjmed/hcaa092,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1093/qjmed/hcaa092', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 212.09, 737.296), True, False, 57, 841.92, 595.32)"
57,"240. Chen  H,  Guo  J,  Wang  C,  Luo  F,  Yu  X,  Zhang  W,  et  al.  Clinical  characteristics  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('240. Chen  H,  Guo  J,  Wang  C,  Luo  F,  Yu  X,  Zhang  W,  et  al.  Clinical  characteristics  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.0679999999999, 722.836), False, False, 57, 841.92, 595.32)"
57,intrauterine  vertical  transmission  potential  of  COVID-19  infection  in  nine  pregnant,0,0,0,0,0,0,0,0,0,0,0,0,0,"('intrauterine  vertical  transmission  potential  of  COVID-19  infection  in  nine  pregnant', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 696.628, 526.294, 707.5360000000001), True, False, 57, 841.92, 595.32)"
57,women: a retrospective review of medical records. Lancet. 2020;395(10226):809-15.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('women: a retrospective review of medical records. Lancet. 2020;395(10226):809-15.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 681.748, 504.58, 692.6560000000001), True, False, 57, 841.92, 595.32)"
57,"241. Wang X, Zhou Z, Zhang J, Zhu F, Tang Y, Shen X. A case of 2019 Novel Coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('241. Wang X, Zhou Z, Zhang J, Zhu F, Tang Y, Shen X. A case of 2019 Novel Coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 666.748, 526.092, 678.076), False, False, 57, 841.92, 595.32)"
57,in a pregnant woman with preterm delivery. Clin Infect Dis. 2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in a pregnant woman with preterm delivery. Clin Infect Dis. 2020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 651.868, 414.67, 662.7760000000001), True, False, 57, 841.92, 595.32)"
57,"242. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('242. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 636.988, 526.0679999999999, 648.316), False, False, 57, 841.92, 595.32)"
57,"neonatal  outcomes  of  pregnant  patients  with  COVID-19  in  Wuhan,  China:  a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('neonatal  outcomes  of  pregnant  patients  with  COVID-19  in  Wuhan,  China:  a', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 622.1080000000001, 526.318, 633.0160000000001), True, False, 57, 841.92, 595.32)"
57,"retrospective, single-centre, descriptive study. The Lancet Infectious Diseases. 2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('retrospective, single-centre, descriptive study. The Lancet Infectious Diseases. 2020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 607.2280000000001, 503.38, 618.1360000000001), True, False, 57, 841.92, 595.32)"
57,"243. Zambrano  LI,  Fuentes-Barahona  IC,  Bejarano-Torres  DA,  Bustillo  C,  Gonzales  G,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('243. Zambrano  LI,  Fuentes-Barahona  IC,  Bejarano-Torres  DA,  Bustillo  C,  Gonzales  G,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 592.3480000000001, 526.258, 603.676), False, False, 57, 841.92, 595.32)"
57,"Vallecillo-Chinchilla  G,  et  al.  A  pregnant  woman  with  COVID-19  in  Central  America.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Vallecillo-Chinchilla  G,  et  al.  A  pregnant  woman  with  COVID-19  in  Central  America.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 577.468, 526.318, 588.376), True, False, 57, 841.92, 595.32)"
57,Travel Medicine and Infectious Disease. 2020:101639.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Travel Medicine and Infectious Disease. 2020:101639.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 562.558, 360.07, 573.466), True, False, 57, 841.92, 595.32)"
57,"244. Rodriguez-Morales  AJ,  Cardona-Ospina  JA,  Gutiérrez-Ocampo  E,  Villamizar-Peña  R,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('244. Rodriguez-Morales  AJ,  Cardona-Ospina  JA,  Gutiérrez-Ocampo  E,  Villamizar-Peña  R,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 547.678, 526.372, 559.006), False, False, 57, 841.92, 595.32)"
57,"Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 532.798, 526.19, 543.706), True, False, 57, 841.92, 595.32)"
57,of  COVID-19:  A  systematic  review  and  meta-analysis.  Travel  Medicine  and  Infectious,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of  COVID-19:  A  systematic  review  and  meta-analysis.  Travel  Medicine  and  Infectious', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 517.798, 526.258, 528.706), True, False, 57, 841.92, 595.32)"
57,Disease. 2020:101623.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Disease. 2020:101623.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 502.918, 206.09, 513.826), True, False, 57, 841.92, 595.32)"
57,"245. Xie C, Jiang L, Huang G, Pu H, Gong B, Lin H, Ma S, Chen X, Long B, Si G, Yu H,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('245. Xie C, Jiang L, Huang G, Pu H, Gong B, Lin H, Ma S, Chen X, Long B, Si G, Yu H,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 488.038, 526.0159999999998, 499.366), False, False, 57, 841.92, 595.32)"
57,"Jiang L, Yang X, Shi Y, Yang Z. Comparison of different samples for 2019 novel coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Jiang L, Yang X, Shi Y, Yang Z. Comparison of different samples for 2019 novel coronavirus', 'BCDEEE+Calibri', 11.039999999999964, (93.384, 472.99, 525.69992, 484.066), False, False, 57, 841.92, 595.32)"
57,detection  by  nucleic  acid  amplification  tests.  Int  J  Infect  Dis.  93:  264-267.  pii:  S1201-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('detection  by  nucleic  acid  amplification  tests.  Int  J  Infect  Dis.  93:  264-267.  pii:  S1201-', 'BCDEEE+Calibri', 10.907999999999959, (93.384, 457.75, 523.576, 468.82599999999996), False, False, 57, 841.92, 595.32)"
57,9712(20)30108-9. doi: 10.1016/j.ijid.2020.02.050.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('9712(20)30108-9. doi: 10.1016/j.ijid.2020.02.050.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 442.678, 338.83, 453.58599999999996), True, False, 57, 841.92, 595.32)"
57,"246. Wang  W,  Xu  Y,  Gao  R,  Lu  R,  Han  K,  Wu  G,  Tan  W.  Detection  of  SARS-CoV-2  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('246. Wang  W,  Xu  Y,  Gao  R,  Lu  R,  Han  K,  Wu  G,  Tan  W.  Detection  of  SARS-CoV-2  in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 427.798, 526.408, 439.126), False, False, 57, 841.92, 595.32)"
57,Different  Types  of  Clinical  Specimens.  JAMA.  2020  Mar  11.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Different  Types  of  Clinical  Specimens.  JAMA.  2020  Mar  11.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 412.918, 526.1520000000002, 423.82599999999996), True, False, 57, 841.92, 595.32)"
57,10.1001/jama.2020.3786,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1001/jama.2020.3786', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 398.038, 216.05, 408.94599999999997), True, False, 57, 841.92, 595.32)"
57,"247. Kam  K-Q,  Yung  CF,  Cui  L,  Lin  Tzer  Pin  R,  Mak  TM,  Maiwald  M,  Li  J,  Chong  CY,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('247. Kam  K-Q,  Yung  CF,  Cui  L,  Lin  Tzer  Pin  R,  Mak  TM,  Maiwald  M,  Li  J,  Chong  CY,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 383.13800000000003, 526.294, 394.466), False, False, 57, 841.92, 595.32)"
57,"Nadua K, Tan NWH, Thoon KC. A well infant with coronavirus disease 2019 (COVID-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Nadua K, Tan NWH, Thoon KC. A well infant with coronavirus disease 2019 (COVID-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 368.25800000000004, 523.456, 379.166), True, False, 57, 841.92, 595.32)"
57,"19) with high viral load. Clin Infect Dis. 2020, doi 10.1093/cid/ciaa201/5766416.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('19) with high viral load. Clin Infect Dis. 2020, doi 10.1093/cid/ciaa201/5766416.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 353.25800000000004, 487.42, 364.166), True, False, 57, 841.92, 595.32)"
57,"248. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 Viral Load in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('248. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 Viral Load in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 338.37800000000004, 526.372, 349.706), False, False, 57, 841.92, 595.32)"
57,Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 323.498, 442.75, 334.40599999999995), True, False, 57, 841.92, 595.32)"
57,"249. Woelfel  R,  Corman  VM,  Guggemos  W,  Seilmaier  M,  Zange  S,  Mueller  MA,  et  al.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('249. Woelfel  R,  Corman  VM,  Guggemos  W,  Seilmaier  M,  Zange  S,  Mueller  MA,  et  al.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 308.618, 526.0799999999998, 319.94599999999997), False, False, 57, 841.92, 595.32)"
57,Clinical  presentation  and  virological  assessment  of  hospitalized  cases  of  coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Clinical  presentation  and  virological  assessment  of  hospitalized  cases  of  coronavirus', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 293.738, 526.408, 304.64599999999996), True, False, 57, 841.92, 595.32)"
57,disease  2019,0,0,0,0,0,0,0,0,0,0,0,0,0,"('disease  2019', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 278.858, 174.012, 289.76599999999996), True, False, 57, 841.92, 595.32)"
57,in  a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  a', 'TimesNewRomanPSMT', 10.907999999999959, (190.07999999999998, 278.858, 226.788, 289.76599999999996), True, False, 57, 841.92, 595.32)"
57,transmission  cluster.  medRxiv.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('transmission  cluster.  medRxiv.', 'TimesNewRomanPSMT', 10.907999999999959, (342.61400000000003, 278.858, 526.2740000000001, 289.76599999999996), True, False, 57, 841.92, 595.32)"
57,2020:2020.03.05.20030502.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020:2020.03.05.20030502.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 263.978, 231.77, 274.88599999999997), True, False, 57, 841.92, 595.32)"
57,travel-associated,0,0,0,0,0,0,0,0,0,0,0,0,0,"('travel-associated', 'TimesNewRomanPSMT', 10.907999999999959, (242.856, 278.858, 326.546, 289.76599999999996), True, False, 57, 841.92, 595.32)"
57,"250. Pan  Y,  Zhang  D,  Yang  P,  Poon  LLM,  Wang  Q.  Viral  load  of  SARS-CoV-2  in  clinical",0,0,0,0,0,0,0,0,0,0,0,0,0,"('250. Pan  Y,  Zhang  D,  Yang  P,  Poon  LLM,  Wang  Q.  Viral  load  of  SARS-CoV-2  in  clinical', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 249.09799999999998, 526.384, 260.426), False, False, 57, 841.92, 595.32)"
57,samples. Lancet Infect Dis. 2020;20(4):411-2.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('samples. Lancet Infect Dis. 2020;20(4):411-2.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 234.218, 318.07, 245.126), True, False, 57, 841.92, 595.32)"
57,"251. He  Y,  Wang  Z,  Li  F,  Shi  Y.  Public  health  might  be  endangered  by  possible  prolonged",0,0,0,0,0,0,0,0,0,0,0,0,0,"('251. He  Y,  Wang  Z,  Li  F,  Shi  Y.  Public  health  might  be  endangered  by  possible  prolonged', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 219.338, 526.2139999999999, 230.666), False, False, 57, 841.92, 595.32)"
57,discharge of SARS-CoV-2 in stool. J Infect. 2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('discharge of SARS-CoV-2 in stool. J Infect. 2020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 204.428, 338.35, 215.336), True, False, 57, 841.92, 595.32)"
57,"252. Ianiro  G,  Mullish  BH,  Kelly  CR,  Sokol  H,  Kassam  Z,  Ng  S,  et  al.  Screening  of  faecal",0,0,0,0,0,0,0,0,0,0,0,0,0,"('252. Ianiro  G,  Mullish  BH,  Kelly  CR,  Sokol  H,  Kassam  Z,  Ng  S,  et  al.  Screening  of  faecal', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 189.428, 525.9599999999997, 200.756), False, False, 57, 841.92, 595.32)"
57,microbiota  transplant  donors  during  the  COVID-19  outbreak:  suggestions  for  urgent,0,0,0,0,0,0,0,0,0,0,0,0,0,"('microbiota  transplant  donors  during  the  COVID-19  outbreak:  suggestions  for  urgent', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 174.54799999999997, 526.294, 185.456), True, False, 57, 841.92, 595.32)"
57,updates from an international expert panel. Lancet Gastroenterol Hepatol. 2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('updates from an international expert panel. Lancet Gastroenterol Hepatol. 2020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 159.66799999999998, 480.46, 170.576), True, False, 57, 841.92, 595.32)"
57,"253. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection",0,0,0,0,0,0,0,0,0,0,0,0,0,"('253. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 144.78799999999998, 526.1039999999998, 156.11599999999999), False, False, 57, 841.92, 595.32)"
57,of SARS-CoV-2. Gastroenterology. 2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of SARS-CoV-2. Gastroenterology. 2020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 129.908, 298.49, 140.816), True, False, 57, 841.92, 595.32)"
57,"254. Yeo  C,  Kaushal  S,  Yeo  D.  Enteric  involvement  of  coronaviruses:  is  faecal-oral",0,0,0,0,0,0,0,0,0,0,0,0,0,"('254. Yeo  C,  Kaushal  S,  Yeo  D.  Enteric  involvement  of  coronaviruses:  is  faecal-oral', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 115.028, 526.408, 126.35600000000001), False, False, 57, 841.92, 595.32)"
57,transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020;5(4):335-7.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020;5(4):335-7.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 100.148, 520.18, 111.056), True, False, 57, 841.92, 595.32)"
57,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 57, 841.92, 595.32)"
57,56,0,0,0,0,0,0,0,0,0,0,0,0,0,"('56', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 57, 841.92, 595.32)"
58,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 58, 841.92, 595.32)"
58,"255. Kim  JY,  Ko  JH,  Kim  Y,  Kim  YJ,  Kim  JM,  Chung  YS,  et  al.  Viral  Load  Kinetics  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('255. Kim  JY,  Ko  JH,  Kim  Y,  Kim  YJ,  Kim  JM,  Chung  YS,  et  al.  Viral  Load  Kinetics  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.152, 767.496), False, False, 58, 841.92, 595.32)"
58,SARS-CoV-2  Infection  in  First  Two  Patients  in  Korea.  J  Korean  Med  Sci.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  Infection  in  First  Two  Patients  in  Korea.  J  Korean  Med  Sci.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.25, 752.176), True, False, 58, 841.92, 595.32)"
58,2020;35(7):e86.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020;35(7):e86.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 173.42, 737.296), True, False, 58, 841.92, 595.32)"
58,"256. Hoffmann  M,  Kleine-Weber  H,  Schroeder  S,  Kruger  N,  Herrler  T,  Erichsen  S,  et  al.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('256. Hoffmann  M,  Kleine-Weber  H,  Schroeder  S,  Kruger  N,  Herrler  T,  Erichsen  S,  et  al.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.1540000000001, 722.836), False, False, 58, 841.92, 595.32)"
58,SARS-CoV-2  Cell  Entry  Depends  on  ACE2  and  TMPRSS2  and  Is  Blocked  by  a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  Cell  Entry  Depends  on  ACE2  and  TMPRSS2  and  Is  Blocked  by  a', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 696.628, 526.1239999999999, 707.5360000000001), True, False, 58, 841.92, 595.32)"
58,Clinically Proven Protease Inhibitor. Cell. 2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Clinically Proven Protease Inhibitor. Cell. 2020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 681.748, 328.39, 692.6560000000001), True, False, 58, 841.92, 595.32)"
58,"257. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('257. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 666.748, 526.04, 678.076), False, False, 58, 841.92, 595.32)"
58,and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 651.868, 432.67, 662.7760000000001), True, False, 58, 841.92, 595.32)"
58,"258. Su YC, Anderson DE, Young BE, Zhu F, Linster M, Kalimuddin S, et al. Discovery of a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('258. Su YC, Anderson DE, Young BE, Zhu F, Linster M, Kalimuddin S, et al. Discovery of a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 636.988, 526.02, 648.316), False, False, 58, 841.92, 595.32)"
58,the  early  evolution  of  SARS-CoV-2.  bioRxiv.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  early  evolution  of  SARS-CoV-2.  bioRxiv.', 'TimesNewRomanPSMT', 10.908000000000015, (240.95600000000002, 622.1080000000001, 526.396, 633.0160000000001), True, False, 58, 841.92, 595.32)"
58,382-nt  deletion  during,0,0,0,0,0,0,0,0,0,0,0,0,0,"('382-nt  deletion  during', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 622.1080000000001, 228.488, 633.0160000000001), True, False, 58, 841.92, 595.32)"
58,2020:2020.03.11.987222.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020:2020.03.11.987222.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 607.2280000000001, 219.77, 618.1360000000001), True, False, 58, 841.92, 595.32)"
58,"259. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('259. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 592.3480000000001, 526.212, 603.676), False, False, 58, 841.92, 595.32)"
58,et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N,0,0,0,0,0,0,0,0,0,0,0,0,0,"('et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 577.468, 526.432, 588.376), True, False, 58, 841.92, 595.32)"
58,Engl J Med. 2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Engl J Med. 2020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 562.558, 184.7, 573.466), True, False, 58, 841.92, 595.32)"
58,"260. Loeffelholz  MJ,  Tang  YW.  Laboratory  Diagnosis  of  Emerging  Human  Coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('260. Loeffelholz  MJ,  Tang  YW.  Laboratory  Diagnosis  of  Emerging  Human  Coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 547.678, 526.1759999999999, 559.006), False, False, 58, 841.92, 595.32)"
58,Infections - The State of the Art. Emerg Microbes Infect. 2020:1-26.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infections - The State of the Art. Emerg Microbes Infect. 2020:1-26.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 532.798, 425.35, 543.706), True, False, 58, 841.92, 595.32)"
58,261. US Food and Drug Administration (FDA). Coronavirus Disease (COVID-19) Emergency,0,0,0,0,0,0,0,0,0,0,0,0,0,"('261. US Food and Drug Administration (FDA). Coronavirus Disease (COVID-19) Emergency', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 517.798, 526.384, 529.126), False, False, 58, 841.92, 595.32)"
58,Use  Authorization  (EUA)  Information  -  In  Vitro  Diagnostic  EUAs.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Use  Authorization  (EUA)  Information  -  In  Vitro  Diagnostic  EUAs.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 502.918, 526.354, 513.826), True, False, 58, 841.92, 595.32)"
58,https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 488.038, 521.2959999999999, 498.94599999999997), True, False, 58, 841.92, 595.32)"
58,use-authorizations#covid19ivd.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('use-authorizations#covid19ivd.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 473.158, 250.37, 484.066), True, False, 58, 841.92, 595.32)"
58,"262. Wang C, Liu Z, Chen Z, Huang X, Xu M, He T, Zhang Z. The establishment of reference",0,0,0,0,0,0,0,0,0,0,0,0,0,"('262. Wang C, Liu Z, Chen Z, Huang X, Xu M, He T, Zhang Z. The establishment of reference', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 458.278, 526.2239999999997, 469.606), False, False, 58, 841.92, 595.32)"
58,sequence  for  SARS-CoV-2  and  variation  analysis.  J  Med  Virol.  2020  Mar  13.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('sequence  for  SARS-CoV-2  and  variation  analysis.  J  Med  Virol.  2020  Mar  13.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 443.398, 526.1540000000001, 454.306), True, False, 58, 841.92, 595.32)"
58,10.1002/jmv.25762.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1002/jmv.25762.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 428.51800000000003, 193.37, 439.426), True, False, 58, 841.92, 595.32)"
58,"263. Colson  P,  Rolain  JM,  Lagier  JC,  Brouqui  P,  Raoult  D.  Chloroquine  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('263. Colson  P,  Rolain  JM,  Lagier  JC,  Brouqui  P,  Raoult  D.  Chloroquine  and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 413.63800000000003, 526.306, 424.966), False, False, 58, 841.92, 595.32)"
58,hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 398.75800000000004, 526.33, 409.666), True, False, 58, 841.92, 595.32)"
58,2020:105932.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020:105932.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 383.858, 162.74, 394.76599999999996), True, False, 58, 841.92, 595.32)"
58,"264. Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('264. Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 368.978, 526.116, 380.306), False, False, 58, 841.92, 595.32)"
58,efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 353.978, 504.46, 364.88599999999997), True, False, 58, 841.92, 595.32)"
58,"265. Devaux  CA,  Rolain  JM,  Colson  P,  Raoult  D.  New  insights  on  the  antiviral  effects  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('265. Devaux  CA,  Rolain  JM,  Colson  P,  Raoult  D.  New  insights  on  the  antiviral  effects  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 339.098, 526.056, 350.426), False, False, 58, 841.92, 595.32)"
58,chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 324.218, 529.282, 335.126), True, False, 58, 841.92, 595.32)"
58,2020:105938.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020:105938.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 309.338, 162.74, 320.246), True, False, 58, 841.92, 595.32)"
58,"266. Gao  J,  Tian  Z,  Yang  X.  Breakthrough:  Chloroquine  phosphate  has  shown  apparent",0,0,0,0,0,0,0,0,0,0,0,0,0,"('266. Gao  J,  Tian  Z,  Yang  X.  Breakthrough:  Chloroquine  phosphate  has  shown  apparent', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 294.458, 526.184, 305.786), False, False, 58, 841.92, 595.32)"
58,efficacy  in  treatment  of  COVID-19  associated  pneumonia  in  clinical  studies.  Biosci,0,0,0,0,0,0,0,0,0,0,0,0,0,"('efficacy  in  treatment  of  COVID-19  associated  pneumonia  in  clinical  studies.  Biosci', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 279.57800000000003, 526.2500000000001, 290.486), True, False, 58, 841.92, 595.32)"
58,Trends. 2020;14(1):72-3.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Trends. 2020;14(1):72-3.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 264.69800000000004, 217.37, 275.606), True, False, 58, 841.92, 595.32)"
58,"267. Sahraei  Z,  Shabani  M,  Shokouhi  S,  Saffaei  A.  Aminoquinolines  Against  Coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('267. Sahraei  Z,  Shabani  M,  Shokouhi  S,  Saffaei  A.  Aminoquinolines  Against  Coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 249.81799999999998, 526.116, 261.146), False, False, 58, 841.92, 595.32)"
58,Disease  2019  (COVID-19):  Chloroquine  or  Hydroxychloroquine.  Int  J  Antimicrob,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Disease  2019  (COVID-19):  Chloroquine  or  Hydroxychloroquine.  Int  J  Antimicrob', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 234.938, 526.2500000000001, 245.846), True, False, 58, 841.92, 595.32)"
58,Agents. 2020:105945.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Agents. 2020:105945.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 220.058, 202.73, 230.966), True, False, 58, 841.92, 595.32)"
58,"268. Touret  F,  de  Lamballerie  X.  Of  chloroquine  and  COVID-19.  Antiviral  Res.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('268. Touret  F,  de  Lamballerie  X.  Of  chloroquine  and  COVID-19.  Antiviral  Res.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 205.028, 526.3299999999999, 216.356), False, False, 58, 841.92, 595.32)"
58,2020;177:104762.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020;177:104762.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 190.148, 184.1, 201.056), True, False, 58, 841.92, 595.32)"
58,"269. Wang  M,  Cao  R,  Zhang  L,  Yang  X,  Liu  J,  Xu  M,  et  al.  Remdesivir  and  chloroquine",0,0,0,0,0,0,0,0,0,0,0,0,0,"('269. Wang  M,  Cao  R,  Zhang  L,  Yang  X,  Liu  J,  Xu  M,  et  al.  Remdesivir  and  chloroquine', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 175.268, 526.456, 186.596), False, False, 58, 841.92, 595.32)"
58,effectively  inhibit  the  recently  emerged  novel  coronavirus  (2019-nCoV)  in  vitro.  Cell,0,0,0,0,0,0,0,0,0,0,0,0,0,"('effectively  inhibit  the  recently  emerged  novel  coronavirus  (2019-nCoV)  in  vitro.  Cell', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 160.38799999999998, 526.294, 171.296), True, False, 58, 841.92, 595.32)"
58,Res. 2020;30(3):269-71.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Res. 2020;30(3):269-71.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 145.50799999999998, 214.13, 156.416), True, False, 58, 841.92, 595.32)"
58,"270. Yao  X,  Ye  F,  Zhang  M,  Cui  C,  Huang  B,  Niu  P,  et  al.  In  Vitro  Antiviral  Activity  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('270. Yao  X,  Ye  F,  Zhang  M,  Cui  C,  Huang  B,  Niu  P,  et  al.  In  Vitro  Antiviral  Activity  and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 130.628, 526.0079999999998, 141.956), False, False, 58, 841.92, 595.32)"
58,Projection  of  Optimized  Dosing  Design  of  Hydroxychloroquine  for  the  Treatment  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Projection  of  Optimized  Dosing  Design  of  Hydroxychloroquine  for  the  Treatment  of', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 115.748, 526.318, 126.656), True, False, 58, 841.92, 595.32)"
58,Severe  Acute  Respiratory  Syndrome  Coronavirus  2  (SARS-CoV-2).  Clin  Infect  Dis.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Severe  Acute  Respiratory  Syndrome  Coronavirus  2  (SARS-CoV-2).  Clin  Infect  Dis.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 100.868, 526.306, 111.776), True, False, 58, 841.92, 595.32)"
58,2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 85.992, 123.38, 96.9), True, False, 58, 841.92, 595.32)"
58,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 58, 841.92, 595.32)"
58,57,0,0,0,0,0,0,0,0,0,0,0,0,0,"('57', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 58, 841.92, 595.32)"
59,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 59, 841.92, 595.32)"
59,"271. Zhou  D,  Dai  SM,  Tong  Q.  COVID-19:  a  recommendation  to  examine  the  effect  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('271. Zhou  D,  Dai  SM,  Tong  Q.  COVID-19:  a  recommendation  to  examine  the  effect  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.2500000000001, 767.496), False, False, 59, 841.92, 595.32)"
59,hydroxychloroquine  in  preventing  infection  and  progression.  J  Antimicrob  Chemother.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('hydroxychloroquine  in  preventing  infection  and  progression.  J  Antimicrob  Chemother.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.318, 752.176), True, False, 59, 841.92, 595.32)"
59,2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 123.38, 737.296), True, False, 59, 841.92, 595.32)"
59,"272. Srinivasa  A,  Tosounidou  S,  Gordon  C.  Increased  Incidence  of  Gastrointestinal  Side",0,0,0,0,0,0,0,0,0,0,0,0,0,"('272. Srinivasa  A,  Tosounidou  S,  Gordon  C.  Increased  Incidence  of  Gastrointestinal  Side', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.0679999999999, 722.836), False, False, 59, 841.92, 595.32)"
59,Effects  in  Patients  Taking  Hydroxychloroquine:  A  Brand-related  Issue?  J  Rheumatol.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Effects  in  Patients  Taking  Hydroxychloroquine:  A  Brand-related  Issue?  J  Rheumatol.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 696.628, 526.306, 707.5360000000001), True, False, 59, 841.92, 595.32)"
59,2017;44(3):398.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2017;44(3):398.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 681.748, 174.02, 692.6560000000001), True, False, 59, 841.92, 595.32)"
59,273. U.S. National Library of Medicine. Clinical Trials  Registry - Chloroquine | COVID-19.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('273. U.S. National Library of Medicine. Clinical Trials  Registry - Chloroquine | COVID-19.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 666.748, 526.408, 678.076), False, False, 59, 841.92, 595.32)"
59,https://www.clinicaltrials.gov/ct2/results?cond=COVID-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://www.clinicaltrials.gov/ct2/results?cond=COVID-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 651.868, 366.106, 662.7760000000001), True, False, 59, 841.92, 595.32)"
59,19&term=Chloroquine&cntry=&state=&city=&dist= 2020 [,0,0,0,0,0,0,0,0,0,0,0,0,0,"('19&term=Chloroquine&cntry=&state=&city=&dist= 2020 [', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 636.988, 386.83, 647.8960000000001), True, False, 59, 841.92, 595.32)"
59,"274. Multicenter  collaboration  group  of  Department  of  S,  Technology  of  Guangdong  P,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('274. Multicenter  collaboration  group  of  Department  of  S,  Technology  of  Guangdong  P,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 622.1080000000001, 526.1400000000001, 633.436), False, False, 59, 841.92, 595.32)"
59,Health  Commission  of  Guangdong  Province  for  chloroquine  in  the  treatment  of  novel,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Health  Commission  of  Guangdong  Province  for  chloroquine  in  the  treatment  of  novel', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 607.2280000000001, 526.2260000000001, 618.1360000000001), True, False, 59, 841.92, 595.32)"
59,coronavirus  p.  [Expert  consensus  on  chloroquine  phosphate  for  the  treatment  of  novel,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus  p.  [Expert  consensus  on  chloroquine  phosphate  for  the  treatment  of  novel', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 592.3480000000001, 526.1759999999999, 603.2560000000001), True, False, 59, 841.92, 595.32)"
59,coronavirus pneumonia]. ZhonghuaJie He He Hu Xi Za Zhi. 2020;43(3):185-8.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus pneumonia]. ZhonghuaJie He He Hu Xi Za Zhi. 2020;43(3):185-8.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 577.468, 477.1, 588.376), True, False, 59, 841.92, 595.32)"
59,"275. Gautret  P,  Lagier  J-C,  Parola  P,  Hoang  VT,  Meddeb  L,  Mailhe  M,  et  al.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('275. Gautret  P,  Lagier  J-C,  Parola  P,  Hoang  VT,  Meddeb  L,  Mailhe  M,  et  al.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 562.558, 526.3299999999999, 573.886), False, False, 59, 841.92, 595.32)"
59,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 547.678, 523.456, 558.586), True, False, 59, 841.92, 595.32)"
59,label  non-randomized  clinical  trial.  International  Journal  of  Antimicrobial  Agents.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('label  non-randomized  clinical  trial.  International  Journal  of  Antimicrobial  Agents.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 532.798, 526.1480000000001, 543.706), True, False, 59, 841.92, 595.32)"
59,2020:105949.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020:105949.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 517.798, 162.74, 528.706), True, False, 59, 841.92, 595.32)"
59,"276. Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M. In vitro inhibition of severe acute",0,0,0,0,0,0,0,0,0,0,0,0,0,"('276. Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M. In vitro inhibition of severe acute', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 502.918, 526.27, 514.246), False, False, 59, 841.92, 595.32)"
59,respiratory  syndrome  coronavirus  by  chloroquine.  BiochemBiophys  Res  Commun.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('respiratory  syndrome  coronavirus  by  chloroquine.  BiochemBiophys  Res  Commun.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 488.038, 526.1640000000002, 498.94599999999997), True, False, 59, 841.92, 595.32)"
59,2004;323(1):264-8.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2004;323(1):264-8.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 473.158, 190.1, 484.066), True, False, 59, 841.92, 595.32)"
59,"277. Vincent  MJ,  Bergeron  E,  Benjannet  S,  Erickson  BR,  Rollin  PE,  Ksiazek  TG,  et  al.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('277. Vincent  MJ,  Bergeron  E,  Benjannet  S,  Erickson  BR,  Rollin  PE,  Ksiazek  TG,  et  al.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 458.278, 526.0559999999999, 469.606), False, False, 59, 841.92, 595.32)"
59,Chloroquine  is  a  potent  inhibitor  of  SARS  coronavirus  infection  and  spread.  Virol  J.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chloroquine  is  a  potent  inhibitor  of  SARS  coronavirus  infection  and  spread.  Virol  J.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 443.398, 526.306, 454.306), True, False, 59, 841.92, 595.32)"
59,2005;2:69.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2005;2:69.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 428.51800000000003, 148.1, 439.426), True, False, 59, 841.92, 595.32)"
59,"278. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir-Ritonavir in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('278. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir-Ritonavir in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 413.63800000000003, 526.384, 424.966), False, False, 59, 841.92, 595.32)"
59,Adults Hospitalized with Severe Covid-19. New England Journal of Medicine. 2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Adults Hospitalized with Severe Covid-19. New England Journal of Medicine. 2020.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 398.75800000000004, 504.82, 409.666), True, False, 59, 841.92, 595.32)"
59,"279. Bao  L,  Deng  W,  Gao  H,  Xiao  C,  Liu  J,  Xue  J,  et  al.  Reinfection  could  not  occur  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('279. Bao  L,  Deng  W,  Gao  H,  Xiao  C,  Liu  J,  Xue  J,  et  al.  Reinfection  could  not  occur  in', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 383.858, 526.282, 395.186), False, False, 59, 841.92, 595.32)"
59,SARS-CoV-2 infected rhesus macaques. bioRxiv. 2020:2020.03.13.990226.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2 infected rhesus macaques. bioRxiv. 2020:2020.03.13.990226.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 368.978, 462.82, 379.88599999999997), True, False, 59, 841.92, 595.32)"
59,"280. Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus",0,0,0,0,0,0,0,0,0,0,0,0,0,"('280. Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 353.978, 526.0559999999998, 365.306), False, False, 59, 841.92, 595.32)"
59,as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007;20(4):660-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007;20(4):660-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 339.098, 523.456, 350.006), True, False, 59, 841.92, 595.32)"
59,94.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('94.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 324.218, 111.38, 335.126), True, False, 59, 841.92, 595.32)"
59,"281. Ison MG, Hirsch HH. Community-Acquired Respiratory Viruses in Transplant Patients:",0,0,0,0,0,0,0,0,0,0,0,0,0,"('281. Ison MG, Hirsch HH. Community-Acquired Respiratory Viruses in Transplant Patients:', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 309.338, 526.2620000000002, 320.666), False, False, 59, 841.92, 595.32)"
59,"Diversity, Impact, Unmet Clinical Needs. Clin Microbiol Rev. 2019 Sep 11;32(4).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Diversity, Impact, Unmet Clinical Needs. Clin Microbiol Rev. 2019 Sep 11;32(4).', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 294.458, 491.38, 305.366), True, False, 59, 841.92, 595.32)"
59,"282. Sanchez JL, Cooper MJ,  Myers CA, Cummings JF, Vest  KG,  Russell  KL, Sanchez JL,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('282. Sanchez JL, Cooper MJ,  Myers CA, Cummings JF, Vest  KG,  Russell  KL, Sanchez JL,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 279.57800000000003, 526.33, 290.906), False, False, 59, 841.92, 595.32)"
59,"Hiser  MJ,  Gaydos  CA.  Respiratory  Infections  in  the  U.S.  Military:  Recent  Experience",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Hiser  MJ,  Gaydos  CA.  Respiratory  Infections  in  the  U.S.  Military:  Recent  Experience', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 264.69800000000004, 526.116, 275.606), True, False, 59, 841.92, 595.32)"
59,and Control. Clin Microbiol Rev. 2015 Jul;28(3):743-800.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and Control. Clin Microbiol Rev. 2015 Jul;28(3):743-800.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 249.81799999999998, 376.15, 260.726), True, False, 59, 841.92, 595.32)"
59,"283. Chan  JF,  Lau  SK,  To  KK,  Cheng  VC,  Woo  PC,  Yuen  KY.  Middle  East  respiratory",0,0,0,0,0,0,0,0,0,0,0,0,0,"('283. Chan  JF,  Lau  SK,  To  KK,  Cheng  VC,  Woo  PC,  Yuen  KY.  Middle  East  respiratory', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 234.938, 526.0799999999998, 246.266), False, False, 59, 841.92, 595.32)"
59,syndrome  coronavirus:  another  zoonotic  betacoronavirus  causing  SARS-like  disease.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('syndrome  coronavirus:  another  zoonotic  betacoronavirus  causing  SARS-like  disease.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 220.058, 526.396, 230.966), True, False, 59, 841.92, 595.32)"
59,Clin Microbiol Rev. 2015 Apr;28(2):465-522.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Clin Microbiol Rev. 2015 Apr;28(2):465-522.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 205.028, 317.69, 215.936), True, False, 59, 841.92, 595.32)"
59,"284. Cheng  VC,  To  KK,  Tse  H,  Hung  IF,  Yuen  KY.  Two  years  after  pandemic  influenza",0,0,0,0,0,0,0,0,0,0,0,0,0,"('284. Cheng  VC,  To  KK,  Tse  H,  Hung  IF,  Yuen  KY.  Two  years  after  pandemic  influenza', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 190.148, 526.0559999999997, 201.476), False, False, 59, 841.92, 595.32)"
59,A/2009/H1N1: what have we learned? Clin Microbiol Rev. 2012 Apr;25(2):223-63.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('A/2009/H1N1: what have we learned? Clin Microbiol Rev. 2012 Apr;25(2):223-63.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 175.268, 499.42, 186.17600000000002), True, False, 59, 841.92, 595.32)"
59,"285. Gillim-Ross  L,  Subbarao  K.  Emerging  respiratory  viruses:  challenges  and  vaccine",0,0,0,0,0,0,0,0,0,0,0,0,0,"('285. Gillim-Ross  L,  Subbarao  K.  Emerging  respiratory  viruses:  challenges  and  vaccine', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 160.38799999999998, 526.1599999999999, 171.71599999999998), False, False, 59, 841.92, 595.32)"
59,strategies. Clin Microbiol Rev. 2006 Oct;19(4):614-36.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('strategies. Clin Microbiol Rev. 2006 Oct;19(4):614-36.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 145.50799999999998, 361.63, 156.416), True, False, 59, 841.92, 595.32)"
59,286. Norkin  LC.  Virus  receptors:  implications  for  pathogenesis  and  the  design  of  antiviral,0,0,0,0,0,0,0,0,0,0,0,0,0,"('286. Norkin  LC.  Virus  receptors:  implications  for  pathogenesis  and  the  design  of  antiviral', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 130.628, 526.1160000000001, 141.956), False, False, 59, 841.92, 595.32)"
59,agents. Clin Microbiol Rev. 1995 Apr;8(2):293-315.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('agents. Clin Microbiol Rev. 1995 Apr;8(2):293-315.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 115.748, 348.31, 126.656), True, False, 59, 841.92, 595.32)"
59,"287. Dhama K, Patel SK, Pathak M, Yatoo MI, Tiwari R, Malik YS, Singh R, Sah R, Rabaan",0,0,0,0,0,0,0,0,0,0,0,0,0,"('287. Dhama K, Patel SK, Pathak M, Yatoo MI, Tiwari R, Malik YS, Singh R, Sah R, Rabaan', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 100.868, 525.9720000000002, 112.196), False, False, 59, 841.92, 595.32)"
59,"AA, Bonilla-Aldana DK, Rodriguez-Morales AJ. An Update on SARS-COV-2/COVID-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('AA, Bonilla-Aldana DK, Rodriguez-Morales AJ. An Update on SARS-COV-2/COVID-', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 85.992, 523.456, 96.9), True, False, 59, 841.92, 595.32)"
59,"19 with Particular Reference on Its Clinical Pathology, Pathogenesis, Immunopathology",0,0,0,0,0,0,0,0,0,0,0,0,0,"('19 with Particular Reference on Its Clinical Pathology, Pathogenesis, Immunopathology', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 71.112, 526.408, 82.02), True, False, 59, 841.92, 595.32)"
59,58,0,0,0,0,0,0,0,0,0,0,0,0,0,"('58', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 59, 841.92, 595.32)"
59,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 59, 841.92, 595.32)"
60,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 60, 841.92, 595.32)"
60,"and  Mitigation  Strategies-  A  Review.  Preprints  2020,  2020030348  (doi:",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  Mitigation  Strategies-  A  Review.  Preprints  2020,  2020030348  (doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 756.168, 526.354, 767.076), True, False, 60, 841.92, 595.32)"
60,10.20944/preprints202003.0348.v1).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.20944/preprints202003.0348.v1).', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 272.33, 752.176), True, False, 60, 841.92, 595.32)"
60,"288. Kimberlin  DW,  Stagno  S.  Can  SARS-CoV-2  Infection  Be  Acquired  In  Utero?  More",0,0,0,0,0,0,0,0,0,0,0,0,0,"('288. Kimberlin  DW,  Stagno  S.  Can  SARS-CoV-2  Infection  Be  Acquired  In  Utero?  More', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 526.282, 737.716), False, False, 60, 841.92, 595.32)"
60,"Definitive  Evidence  Is  Needed.  JAMA.  Published  online  March  26,  2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Definitive  Evidence  Is  Needed.  JAMA.  Published  online  March  26,  2020.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 711.508, 526.366, 722.416), True, False, 60, 841.92, 595.32)"
60,doi:10.1001/jama.2020.4868.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:10.1001/jama.2020.4868.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 696.628, 237.77, 707.5360000000001), True, False, 60, 841.92, 595.32)"
60,289. Akarsh  HP.  Wuhan  Virus:  Chinese  Animal  Markets  Reopened  With  Almost  No,0,0,0,0,0,0,0,0,0,0,0,0,0,"('289. Akarsh  HP.  Wuhan  Virus:  Chinese  Animal  Markets  Reopened  With  Almost  No', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 681.748, 526.176, 693.076), False, False, 60, 841.92, 595.32)"
60,Precautions.  https://metrosaga.com/wuhan-virus-chinese-animal-markets-reopened-with-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Precautions.  https://metrosaga.com/wuhan-virus-chinese-animal-markets-reopened-with-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 666.748, 523.456, 677.6560000000001), True, False, 60, 841.92, 595.32)"
60,almost-no-precautions/.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('almost-no-precautions/.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 651.868, 210.05, 662.7760000000001), True, False, 60, 841.92, 595.32)"
60,290. Blakeman  BA.  China  must,0,0,0,0,0,0,0,0,0,0,0,0,0,"('290. Blakeman  BA.  China  must', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 636.988, 282.30000000000007, 648.316), False, False, 60, 841.92, 595.32)"
60,close  down,0,0,0,0,0,0,0,0,0,0,0,0,0,"('close  down', 'TimesNewRomanPSMT', 10.908000000000015, (301.12800000000004, 636.988, 377.3280000000001, 647.8960000000001), True, False, 60, 841.92, 595.32)"
60,'wet  markets'  now.,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""'wet  markets'  now."", 'TimesNewRomanPSMT', 10.908000000000015, (396.13200000000006, 636.988, 526.188, 647.8960000000001), True, False, 60, 841.92, 595.32)"
60,https://thehill.com/opinion/international/490528-china-must-close-down-wet-markets-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://thehill.com/opinion/international/490528-china-must-close-down-wet-markets-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 622.1080000000001, 508.33599999999996, 633.0160000000001), True, False, 60, 841.92, 595.32)"
60,now,0,0,0,0,0,0,0,0,0,0,0,0,0,"('now', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 607.2280000000001, 117.02, 618.1360000000001), True, False, 60, 841.92, 595.32)"
60,291. Knowles G. Will they ever learn? Chinese markets are still selling bats and slaughtering,0,0,0,0,0,0,0,0,0,0,0,0,0,"('291. Knowles G. Will they ever learn? Chinese markets are still selling bats and slaughtering', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 592.3480000000001, 526.1160000000001, 603.676), False, False, 60, 841.92, 595.32)"
60,rabbits  on  blood-soaked  floors  as  Beijing  celebrates  'victory'  over  the  coronavirus.,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""rabbits  on  blood-soaked  floors  as  Beijing  celebrates  'victory'  over  the  coronavirus."", 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 577.468, 526.2080000000001, 588.376), True, False, 60, 841.92, 595.32)"
60,https://www.dailymail.co.uk/news/article-8163761/Chinese-markets-selling-bats.html.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://www.dailymail.co.uk/news/article-8163761/Chinese-markets-selling-bats.html.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 562.558, 512.14, 573.466), True, False, 60, 841.92, 595.32)"
60,"292. Dhama  K,  Patel  SK,  Sharun  K,  Pathak  M,  Tiwari  R,  Yatoo  MI,  Malik  YS,  Sah  R,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('292. Dhama  K,  Patel  SK,  Sharun  K,  Pathak  M,  Tiwari  R,  Yatoo  MI,  Malik  YS,  Sah  R,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 547.678, 525.996, 559.006), False, False, 60, 841.92, 595.32)"
60,"Rabaan  AA,  Panwar  PK,  Singh  KP,  Michalak  I,  Chaicumpa  W,  Bonilla-Aldana  DK,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Rabaan  AA,  Panwar  PK,  Singh  KP,  Michalak  I,  Chaicumpa  W,  Bonilla-Aldana  DK,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 532.798, 526.3960000000001, 543.706), True, False, 60, 841.92, 595.32)"
60,"Rodriguez-Morales AJ. SARS-CoV-2: Jumping the Species Barrier, Lessons from SARS",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Rodriguez-Morales AJ. SARS-CoV-2: Jumping the Species Barrier, Lessons from SARS', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 517.798, 526.2260000000001, 528.706), True, False, 60, 841.92, 595.32)"
60,"and  MERS,  Its  Zoonotic  Spillover,  Transmission  to  Humans,  Preventive  and  Control",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  MERS,  Its  Zoonotic  Spillover,  Transmission  to  Humans,  Preventive  and  Control', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 502.918, 526.2020000000001, 513.826), True, False, 60, 841.92, 595.32)"
60,"Measures  and  Recent  Developments  to  Counter  This  Pandemic  Virus.  Preprints  2020,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Measures  and  Recent  Developments  to  Counter  This  Pandemic  Virus.  Preprints  2020,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 488.038, 526.42, 498.94599999999997), True, False, 60, 841.92, 595.32)"
60,2020040011 (doi: 10.20944/preprints202004.0011.v1).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020040011 (doi: 10.20944/preprints202004.0011.v1).', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 473.158, 361.03, 484.066), True, False, 60, 841.92, 595.32)"
60,"293. Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic Features and Clinical Course",0,0,0,0,0,0,0,0,0,0,0,0,0,"('293. Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic Features and Clinical Course', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 458.278, 526.33, 469.606), False, False, 60, 841.92, 595.32)"
60,"of Patients Infected With SARS-CoV-2 in Singapore. JAMA. Published online March 03,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of Patients Infected With SARS-CoV-2 in Singapore. JAMA. Published online March 03,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 443.398, 529.2020000000001, 454.306), True, False, 60, 841.92, 595.32)"
60,2020. doi:10.1001/jama.2020.3204.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020. doi:10.1001/jama.2020.3204.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 428.51800000000003, 267.77, 439.426), True, False, 60, 841.92, 595.32)"
60,"294. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K. Air, Surface",0,0,0,0,0,0,0,0,0,0,0,0,0,"('294. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K. Air, Surface', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 413.63800000000003, 525.996, 424.966), False, False, 60, 841.92, 595.32)"
60,"Environmental,  and  Personal  Protective  Equipment  Contamination  by  Severe  Acute",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Environmental,  and  Personal  Protective  Equipment  Contamination  by  Severe  Acute', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 398.75800000000004, 526.3180000000001, 409.666), True, False, 60, 841.92, 595.32)"
60,Respiratory  Syndrome  Coronavirus  2  (SARS-CoV-2)  From  a  Symptomatic  Patient.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Respiratory  Syndrome  Coronavirus  2  (SARS-CoV-2)  From  a  Symptomatic  Patient.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 383.858, 526.282, 394.76599999999996), True, False, 60, 841.92, 595.32)"
60,JAMA. 2020:e203227. doi: 10.1001/jama.2020.3227.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('JAMA. 2020:e203227. doi: 10.1001/jama.2020.3227.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 368.978, 354.19, 379.88599999999997), True, False, 60, 841.92, 595.32)"
60,"295. Zhang  T,  Cui  X,  Zhao  X,  Wang  J,  Zheng  J,  Zheng  G,  Guo  W,  Cai  C,  He  S,  Xu  Y.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('295. Zhang  T,  Cui  X,  Zhao  X,  Wang  J,  Zheng  J,  Zheng  G,  Guo  W,  Cai  C,  He  S,  Xu  Y.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 353.978, 526.02, 365.306), False, False, 60, 841.92, 595.32)"
60,Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 339.098, 526.166, 350.006), True, False, 60, 841.92, 595.32)"
60,of COVID-19 Pneumonia. J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25795.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of COVID-19 Pneumonia. J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25795.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 324.218, 477.1, 335.126), True, False, 60, 841.92, 595.32)"
60,"296. Yu F, Yan L, Wang N, Yang S, Wang L, Tang Y, Gao G, Wang S, Ma C, Xie R, Wang F,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('296. Yu F, Yan L, Wang N, Yang S, Wang L, Tang Y, Gao G, Wang S, Ma C, Xie R, Wang F,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 309.338, 529.1759999999999, 320.666), False, False, 60, 841.92, 595.32)"
60,"Tan  C,  Zhu  L,  Guo  Y,  Zhang  F.  Quantitative  Detection  and  Viral  Load  Analysis  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Tan  C,  Zhu  L,  Guo  Y,  Zhang  F.  Quantitative  Detection  and  Viral  Load  Analysis  of', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 294.458, 526.298, 305.366), True, False, 60, 841.92, 595.32)"
60,SARS-CoV-2  in  Infected  Patients.  Clin  Infect  Dis.  2020  Mar  28:ciaa345.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  in  Infected  Patients.  Clin  Infect  Dis.  2020  Mar  28:ciaa345.  doi:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 279.57800000000003, 526.16, 290.486), True, False, 60, 841.92, 595.32)"
60,10.1093/cid/ciaa345.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1093/cid/ciaa345.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 264.69800000000004, 197.09, 275.606), True, False, 60, 841.92, 595.32)"
60,"297. Huang Y, Cheng W, Zhao N, Qu H, Tian J. CT screening for early diagnosis of SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('297. Huang Y, Cheng W, Zhao N, Qu H, Tian J. CT screening for early diagnosis of SARS-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 249.81799999999998, 523.576, 261.146), False, False, 60, 841.92, 595.32)"
60,CoV-2  infection.  Lancet  Infect  Dis.  2020  Mar  26:S1473-3099(20)30241-3.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2  infection.  Lancet  Infect  Dis.  2020  Mar  26:S1473-3099(20)30241-3.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 234.938, 526.396, 245.846), True, False, 60, 841.92, 595.32)"
60,10.1016/S1473-3099(20)30241-3.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/S1473-3099(20)30241-3.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 220.058, 260.33, 230.966), True, False, 60, 841.92, 595.32)"
60,"298. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z, Mu Z,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('298. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z, Mu Z,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 205.028, 526.0200000000001, 216.356), False, False, 60, 841.92, 595.32)"
60,"Chen X, Chen J, Hu K, Jin Q, Wang J, Qian Z. Characterization of spike glycoprotein of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chen X, Chen J, Hu K, Jin Q, Wang J, Qian Z. Characterization of spike glycoprotein of', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 190.148, 526.0079999999999, 201.056), True, False, 60, 841.92, 595.32)"
60,SARS-CoV-2  on  virus  entry  and  its  immune  cross-reactivity  with  SARS-CoV.  Nat,0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2  on  virus  entry  and  its  immune  cross-reactivity  with  SARS-CoV.  Nat', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 175.268, 526.396, 186.17600000000002), True, False, 60, 841.92, 595.32)"
60,Commun. 2020 Mar 27;11(1):1620. doi: 10.1038/s41467-020-15562-9.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Commun. 2020 Mar 27;11(1):1620. doi: 10.1038/s41467-020-15562-9.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 160.38799999999998, 442.51, 171.296), True, False, 60, 841.92, 595.32)"
60,"299. Ahmed  SF,  Quadeer  AA,  McKay  MR.  Preliminary  Identification  of  Potential  Vaccine",0,0,0,0,0,0,0,0,0,0,0,0,0,"('299. Ahmed  SF,  Quadeer  AA,  McKay  MR.  Preliminary  Identification  of  Potential  Vaccine', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 145.50799999999998, 526.092, 156.83599999999998), False, False, 60, 841.92, 595.32)"
60,Targets  for  the  COVID-19  Coronavirus  (SARS-CoV-2)  Based  on  SARS-CoV,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Targets  for  the  COVID-19  Coronavirus  (SARS-CoV-2)  Based  on  SARS-CoV', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 130.628, 526.408, 141.536), True, False, 60, 841.92, 595.32)"
60,Immunological Studies. Viruses. 2020; 12(3):E254. doi: 10.3390/v12030254.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Immunological Studies. Viruses. 2020; 12(3):E254. doi: 10.3390/v12030254.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 115.748, 468.82, 126.656), True, False, 60, 841.92, 595.32)"
60,"300. Ramaiah  A,  Arumugaswami  V.  Insights  into  cross-species  evolution  of  novel  human",0,0,0,0,0,0,0,0,0,0,0,0,0,"('300. Ramaiah  A,  Arumugaswami  V.  Insights  into  cross-species  evolution  of  novel  human', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 100.868, 526.354, 112.196), False, False, 60, 841.92, 595.32)"
60,coronavirus  2019-nCoV  and  defining  immune  determinants  for  vaccine  development.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('coronavirus  2019-nCoV  and  defining  immune  determinants  for  vaccine  development.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 85.992, 526.124, 96.9), True, False, 60, 841.92, 595.32)"
60,BioRxiv. 2020. 2020.01.29.925867. doi: 10.1101/2020.01.29.925867.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('BioRxiv. 2020. 2020.01.29.925867. doi: 10.1101/2020.01.29.925867.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 71.112, 432.07, 82.02), True, False, 60, 841.92, 595.32)"
60,59,0,0,0,0,0,0,0,0,0,0,0,0,0,"('59', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 60, 841.92, 595.32)"
60,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 60, 841.92, 595.32)"
61,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 61, 841.92, 595.32)"
61,301. Cohen  J.  Vaccine  designers  take  first  shots  at  COVID-19.  Science.  2020  Apr,0,0,0,0,0,0,0,0,0,0,0,0,0,"('301. Cohen  J.  Vaccine  designers  take  first  shots  at  COVID-19.  Science.  2020  Apr', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.318, 767.496), False, False, 61, 841.92, 595.32)"
61,3;368(6486):14-16. doi: 10.1126/science.368.6486.14.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('3;368(6486):14-16. doi: 10.1126/science.368.6486.14.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 358.39, 752.176), True, False, 61, 841.92, 595.32)"
61,302. Precision,0,0,0,0,0,0,0,0,0,0,0,0,0,"('302. Precision', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 141.0, 737.716), False, False, 61, 841.92, 595.32)"
61,Vaccinations.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Vaccinations.', 'TimesNewRomanPSMT', 10.908000000000015, (209.172, 726.388, 277.77600000000007, 737.296), True, False, 61, 841.92, 595.32)"
61,Coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus', 'TimesNewRomanPSMT', 10.908000000000015, (345.96000000000004, 726.388, 408.228, 737.296), True, False, 61, 841.92, 595.32)"
61,Vaccines.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Vaccines.', 'TimesNewRomanPSMT', 10.908000000000015, (476.4, 726.388, 526.2959999999998, 737.296), True, False, 61, 841.92, 595.32)"
61,https://www.precisionvaccinations.com/vaccines/coronavirus-vaccines,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://www.precisionvaccinations.com/vaccines/coronavirus-vaccines', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 711.508, 436.27, 722.416), True, False, 61, 841.92, 595.32)"
61,303. WHO.  Draft  landscape  of  COVID-19  candidate  vaccines  -  20  March  2020.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('303. WHO.  Draft  landscape  of  COVID-19  candidate  vaccines  -  20  March  2020.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 696.628, 526.366, 707.956), False, False, 61, 841.92, 595.32)"
61,https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 681.748, 521.2959999999999, 692.6560000000001), True, False, 61, 841.92, 595.32)"
61,ncov.pdf?ua=1,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ncov.pdf?ua=1', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 666.748, 168.14, 677.6560000000001), True, False, 61, 841.92, 595.32)"
61,"304. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('304. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 651.868, 526.1039999999998, 663.196), False, False, 61, 841.92, 595.32)"
61,Treatment  Coronavirus  (COVID-19).  2020  Mar  20.  In:  StatPearls  [Internet].  Treasure,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Treatment  Coronavirus  (COVID-19).  2020  Mar  20.  In:  StatPearls  [Internet].  Treasure', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 636.988, 526.42, 647.8960000000001), True, False, 61, 841.92, 595.32)"
61,Island (FL): StatPearls Publishing; 2020 Jan.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Island (FL): StatPearls Publishing; 2020 Jan.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 622.1080000000001, 311.69, 633.0160000000001), True, False, 61, 841.92, 595.32)"
61,"305. Shetty  R,  Ghosh  A,  Honavar  SG,  Khamar  P,  Sethu  S.  Therapeutic  opportunities  to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('305. Shetty  R,  Ghosh  A,  Honavar  SG,  Khamar  P,  Sethu  S.  Therapeutic  opportunities  to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 607.2280000000001, 526.068, 618.556), False, False, 61, 841.92, 595.32)"
61,manage  COVID-19/SARS-CoV-2  infection:  Present  and  future.  Indian  J  Ophthalmol.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('manage  COVID-19/SARS-CoV-2  infection:  Present  and  future.  Indian  J  Ophthalmol.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 592.3480000000001, 526.238, 603.2560000000001), True, False, 61, 841.92, 595.32)"
61,2020 Mar 28. doi: 10.4103/ijo.IJO_639_20.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020 Mar 28. doi: 10.4103/ijo.IJO_639_20.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 577.468, 306.41, 588.376), True, False, 61, 841.92, 595.32)"
61,"306. Zhang  W,  Zhao  Y,  Zhang  F,  Wang  Q,  Li  T,  Liu  Z,  Wang  J,  Qin  Y,  Zhang  X,  Yan  X,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('306. Zhang  W,  Zhao  Y,  Zhang  F,  Wang  Q,  Li  T,  Liu  Z,  Wang  J,  Qin  Y,  Zhang  X,  Yan  X,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 562.558, 526.0559999999997, 573.886), False, False, 61, 841.92, 595.32)"
61,"Zeng  X,  Zhang  S.  The  use  of  anti-inflammatory  drugs  in  the  treatment  of  people  with",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Zeng  X,  Zhang  S.  The  use  of  anti-inflammatory  drugs  in  the  treatment  of  people  with', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 547.678, 526.2260000000001, 558.586), True, False, 61, 841.92, 595.32)"
61,severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists,0,0,0,0,0,0,0,0,0,0,0,0,0,"('severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 532.798, 526.238, 543.706), True, False, 61, 841.92, 595.32)"
61,from China. Clin Immunol. 2020 Mar 25:108393. doi: 10.1016/j.clim.2020.108393.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('from China. Clin Immunol. 2020 Mar 25:108393. doi: 10.1016/j.clim.2020.108393.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 517.798, 502.06, 528.706), True, False, 61, 841.92, 595.32)"
61,307. Little  P.  Non-steroidal  anti-inflammatory  drugs  and  covid-19.  BMJ.  2020  Mar,0,0,0,0,0,0,0,0,0,0,0,0,0,"('307. Little  P.  Non-steroidal  anti-inflammatory  drugs  and  covid-19.  BMJ.  2020  Mar', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 502.918, 526.366, 514.246), False, False, 61, 841.92, 595.32)"
61,27;368:m1185. doi: 10.1136/bmj.m1185.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('27;368:m1185. doi: 10.1136/bmj.m1185.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 488.038, 294.41, 498.94599999999997), True, False, 61, 841.92, 595.32)"
61,"308. Alhazzani  W,  Møller  MH,  Arabi  YM,  Loeb  M,  Gong  MN,  Fan  E,  Oczkowski  S,  Levy",0,0,0,0,0,0,0,0,0,0,0,0,0,"('308. Alhazzani  W,  Møller  MH,  Arabi  YM,  Loeb  M,  Gong  MN,  Fan  E,  Oczkowski  S,  Levy', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 473.158, 526.42, 484.486), False, False, 61, 841.92, 595.32)"
61,"MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 458.278, 529.2479999999999, 469.186), True, False, 61, 841.92, 595.32)"
61,"Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 443.398, 526.1540000000001, 454.306), True, False, 61, 841.92, 595.32)"
61,"McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio",0,0,0,0,0,0,0,0,0,0,0,0,0,"('McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 428.51800000000003, 526.104, 439.426), True, False, 61, 841.92, 595.32)"
61,"G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis",0,0,0,0,0,0,0,0,0,0,0,0,0,"('G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 413.63800000000003, 526.1120000000001, 424.546), True, False, 61, 841.92, 595.32)"
61,Campaign:  guidelines  on  the  management  of  critically  ill  adults  with  Coronavirus,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Campaign:  guidelines  on  the  management  of  critically  ill  adults  with  Coronavirus', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 398.75800000000004, 526.164, 409.666), True, False, 61, 841.92, 595.32)"
61,Disease 2019 (COVID-19). Intensive Care Med. 2020 Mar 28. doi: 10.1007/s00134-020-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Disease 2019 (COVID-19). Intensive Care Med. 2020 Mar 28. doi: 10.1007/s00134-020-', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 383.858, 523.576, 394.76599999999996), True, False, 61, 841.92, 595.32)"
61,06022-5.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('06022-5.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 368.978, 139.34, 379.88599999999997), True, False, 61, 841.92, 595.32)"
61,"309. Atluri S, Manchikanti L, Hirsch JA. Expanded Umbilical Cord Mesenchymal Stem Cells",0,0,0,0,0,0,0,0,0,0,0,0,0,"('309. Atluri S, Manchikanti L, Hirsch JA. Expanded Umbilical Cord Mesenchymal Stem Cells', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 353.978, 526.124, 365.306), False, False, 61, 841.92, 595.32)"
61,(UC-MSCs)  as  a  Therapeutic  Strategy  in  Managing  Critically  Ill  COVID-19  Patients:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(UC-MSCs)  as  a  Therapeutic  Strategy  in  Managing  Critically  Ill  COVID-19  Patients:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 339.098, 526.3720000000001, 350.006), True, False, 61, 841.92, 595.32)"
61,The  Case  for  Compassionate  Use.  Pain  Physician.  2020  Mar;23(2):E71-E83.  PMID:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  Case  for  Compassionate  Use.  Pain  Physician.  2020  Mar;23(2):E71-E83.  PMID:', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 324.218, 526.3960000000001, 335.126), True, False, 61, 841.92, 595.32)"
61,32214286.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('32214286.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 309.338, 147.38, 320.246), True, False, 61, 841.92, 595.32)"
61,"310. Elfiky AA. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('310. Elfiky AA. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 294.458, 523.576, 305.786), False, False, 61, 841.92, 595.32)"
61,CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 279.57800000000003, 526.0400000000001, 290.486), True, False, 61, 841.92, 595.32)"
61,2020 Mar 25:117592. doi: 10.1016/j.lfs.2020.117592.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020 Mar 25:117592. doi: 10.1016/j.lfs.2020.117592.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 264.69800000000004, 355.03, 275.606), True, False, 61, 841.92, 595.32)"
61,"311. Ekins  S,  Lane  TR,  Madrid  PB.  Tilorone:  a  Broad-Spectrum  Antiviral  Invented  in  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('311. Ekins  S,  Lane  TR,  Madrid  PB.  Tilorone:  a  Broad-Spectrum  Antiviral  Invented  in  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 249.81799999999998, 526.342, 261.146), False, False, 61, 841.92, 595.32)"
61,USA and Commercialized in Russia and beyond. Pharm Res. 2020 Mar 25;37(4):71. doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('USA and Commercialized in Russia and beyond. Pharm Res. 2020 Mar 25;37(4):71. doi:', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 234.938, 526.08, 245.846), True, False, 61, 841.92, 595.32)"
61,10.1007/s11095-020-02799-8.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1007/s11095-020-02799-8.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 220.058, 242.33, 230.966), True, False, 61, 841.92, 595.32)"
61,"312. Molina JM, Delaugerre C, Goff JL, Mela-Lima B, Ponscarme D, Goldwirt L, de Castro",0,0,0,0,0,0,0,0,0,0,0,0,0,"('312. Molina JM, Delaugerre C, Goff JL, Mela-Lima B, Ponscarme D, Goldwirt L, de Castro', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 205.028, 526.25, 216.356), False, False, 61, 841.92, 595.32)"
61,N. No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination,0,0,0,0,0,0,0,0,0,0,0,0,0,"('N. No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 190.148, 526.1660000000002, 201.056), True, False, 61, 841.92, 595.32)"
61,of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 175.268, 526.384, 186.17600000000002), True, False, 61, 841.92, 595.32)"
61,Med  Mal,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Med  Mal', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 160.38799999999998, 154.668, 171.296), True, False, 61, 841.92, 595.32)"
61,Infect.  2020  Mar  30:S0399-077X(20)30085-8.  French.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infect.  2020  Mar  30:S0399-077X(20)30085-8.  French.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (168.72, 160.38799999999998, 526.342, 171.296), True, False, 61, 841.92, 595.32)"
61,10.1016/j.medmal.2020.03.006.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/j.medmal.2020.03.006.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 145.50799999999998, 249.77, 156.416), True, False, 61, 841.92, 595.32)"
61,"313. Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020). The FDA-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('313. Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020). The FDA-', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 130.628, 523.456, 141.956), False, False, 61, 841.92, 595.32)"
61,approved  Drug  Ivermectin  inhibits  the  replication  of  SARS-CoV-2  in  vitro.  Antiviral,0,0,0,0,0,0,0,0,0,0,0,0,0,"('approved  Drug  Ivermectin  inhibits  the  replication  of  SARS-CoV-2  in  vitro.  Antiviral', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 115.748, 526.306, 126.656), True, False, 61, 841.92, 595.32)"
61,"Research, 104787. doi: 10.1016/j.antiviral.2020.104787.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Research, 104787. doi: 10.1016/j.antiviral.2020.104787.', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 100.868, 367.75, 111.776), True, False, 61, 841.92, 595.32)"
61,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 61, 841.92, 595.32)"
61,60,0,0,0,0,0,0,0,0,0,0,0,0,0,"('60', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 61, 841.92, 595.32)"
62,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 62, 841.92, 595.32)"
62,"314. Ong  J,  Cross  GB,  Dan  YY.  Prevention  of  nosocomial  SARS-CoV-2  transmission  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('314. Ong  J,  Cross  GB,  Dan  YY.  Prevention  of  nosocomial  SARS-CoV-2  transmission  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.342, 767.496), False, False, 62, 841.92, 595.32)"
62,endoscopy:  international  recommendations  and  the  need  for  a  gold  standard.  Gut.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('endoscopy:  international  recommendations  and  the  need  for  a  gold  standard.  Gut.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 526.1519999999998, 752.176), True, False, 62, 841.92, 595.32)"
62,2020:gutjnl-2020-321154. doi: 10.1136/gutjnl-2020-321154.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020:gutjnl-2020-321154. doi: 10.1136/gutjnl-2020-321154.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 726.388, 388.75, 737.296), True, False, 62, 841.92, 595.32)"
62,"315. Shen C, Wang Z, Zhao F, Yang Yang, Jinxiu Li,  Jing Yuan,  Fuxiang Wang,  Delin Li,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('315. Shen C, Wang Z, Zhao F, Yang Yang, Jinxiu Li,  Jing Yuan,  Fuxiang Wang,  Delin Li,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 525.984, 722.836), False, False, 62, 841.92, 595.32)"
62,"Minghui Yang, Li Xing, Jinli Wei, Haixia Xiao,  Yan Yang,  Jiuxin Qu,  Ling Qing,  Li",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Minghui Yang, Li Xing, Jinli Wei, Haixia Xiao,  Yan Yang,  Jiuxin Qu,  Ling Qing,  Li', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 696.628, 526.0520000000001, 707.5360000000001), True, False, 62, 841.92, 595.32)"
62,"Chen,  Zhixiang  Xu,    Ling  Peng,    Yanjie  Li,  Haixia  Zheng,  Feng  Chen,  Kun  Huang,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Chen,  Zhixiang  Xu,    Ling  Peng,    Yanjie  Li,  Haixia  Zheng,  Feng  Chen,  Kun  Huang,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 681.748, 526.092, 692.6560000000001), True, False, 62, 841.92, 595.32)"
62,"Yujing  Jiang,  Dongjing  Liu,    Zheng  Zhang,  Yingxia  Liu,    Lei  Liu.  Treatment  of  5",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Yujing  Jiang,  Dongjing  Liu,    Zheng  Zhang,  Yingxia  Liu,    Lei  Liu.  Treatment  of  5', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 666.748, 526.0559999999998, 677.6560000000001), True, False, 62, 841.92, 595.32)"
62,Critically  Ill  Patients  With  COVID-19  With  Convalescent  Plasma.  JAMA.  Published,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Critically  Ill  Patients  With  COVID-19  With  Convalescent  Plasma.  JAMA.  Published', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 651.868, 526.2260000000001, 662.7760000000001), True, False, 62, 841.92, 595.32)"
62,"online March 27, 2020. doi:10.1001/jama.2020.4783.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('online March 27, 2020. doi:10.1001/jama.2020.4783.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 636.988, 353.11, 647.8960000000001), True, False, 62, 841.92, 595.32)"
62,"316. Keith P, Day M, Perkins L, Moyer L, Hewitt K, Wells A. A novel treatment approach to",0,0,0,0,0,0,0,0,0,0,0,0,0,"('316. Keith P, Day M, Perkins L, Moyer L, Hewitt K, Wells A. A novel treatment approach to', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 622.1080000000001, 526.0559999999999, 633.436), False, False, 62, 841.92, 595.32)"
62,the  novel  coronavirus:  an  argument  for  the  use  of  therapeutic  plasma  exchange  for,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the  novel  coronavirus:  an  argument  for  the  use  of  therapeutic  plasma  exchange  for', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 607.2280000000001, 526.294, 618.1360000000001), True, False, 62, 841.92, 595.32)"
62,fulminant COVID-19. Crit Care. 2020 Apr 2;24(1):128. doi: 10.1186/s13054-020-2836-4.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('fulminant COVID-19. Crit Care. 2020 Apr 2;24(1):128. doi: 10.1186/s13054-020-2836-4.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 592.3480000000001, 529.54, 603.2560000000001), True, False, 62, 841.92, 595.32)"
62,"317. Repici A, Maselli R, Colombo M, Gabbiadini R, Spadaccini M, Anderloni A, Carrara S,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('317. Repici A, Maselli R, Colombo M, Gabbiadini R, Spadaccini M, Anderloni A, Carrara S,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 577.468, 526.0559999999999, 588.7959999999999), False, False, 62, 841.92, 595.32)"
62,"Fugazza  A,  Di  Leo  M,  Galtieri  PA,  Pellegatta  G,  Ferrara  EC,  Azzolini  E,  Lagioia  M.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Fugazza  A,  Di  Leo  M,  Galtieri  PA,  Pellegatta  G,  Ferrara  EC,  Azzolini  E,  Lagioia  M.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 562.558, 526.282, 573.466), True, False, 62, 841.92, 595.32)"
62,Coronavirus  (COVID-19)  outbreak:  what  the  department  of  endoscopy  should  know.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus  (COVID-19)  outbreak:  what  the  department  of  endoscopy  should  know.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 547.678, 526.238, 558.586), True, False, 62, 841.92, 595.32)"
62,Gastrointest Endosc. 2020. doi: 10.1016/j.gie.2020.03.019.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Gastrointest Endosc. 2020. doi: 10.1016/j.gie.2020.03.019.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 532.798, 379.75, 543.706), True, False, 62, 841.92, 595.32)"
62,"318. Liu X, Zhang S. COVID-19: Face Masks and Human-to-human Transmission. Influenza",0,0,0,0,0,0,0,0,0,0,0,0,0,"('318. Liu X, Zhang S. COVID-19: Face Masks and Human-to-human Transmission. Influenza', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 517.798, 526.33, 529.126), False, False, 62, 841.92, 595.32)"
62,Other Respir Viruses. 2020 Mar 29. doi: 10.1111/irv.12740.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Other Respir Viruses. 2020 Mar 29. doi: 10.1111/irv.12740.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 502.918, 385.03, 513.826), True, False, 62, 841.92, 595.32)"
62,319. Yang C. Does hand hygiene reduce SARS-CoV-2 transmission? Graefes Arch Clin Exp,0,0,0,0,0,0,0,0,0,0,0,0,0,"('319. Yang C. Does hand hygiene reduce SARS-CoV-2 transmission? Graefes Arch Clin Exp', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 488.038, 526.282, 499.366), False, False, 62, 841.92, 595.32)"
62,Ophthalmol. 2020 Mar 27. doi: 10.1007/s00417-020-04652-5.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Ophthalmol. 2020 Mar 27. doi: 10.1007/s00417-020-04652-5.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 473.158, 395.47, 484.066), True, False, 62, 841.92, 595.32)"
62,"320. Lai THT, Tang EWH, Fung KSC, Li KKW. Reply to 'Does hand hygiene reduce SARS-",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""320. Lai THT, Tang EWH, Fung KSC, Li KKW. Reply to 'Does hand hygiene reduce SARS-"", 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 458.278, 523.456, 469.606), False, False, 62, 841.92, 595.32)"
62,CoV-2  transmission?'.  Graefes  Arch  Clin  Exp  Ophthalmol.  2020  Mar  28.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""CoV-2  transmission?'.  Graefes  Arch  Clin  Exp  Ophthalmol.  2020  Mar  28.  doi:"", 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 443.398, 526.1239999999999, 454.306), True, False, 62, 841.92, 595.32)"
62,10.1007/s00417-020-04653-4.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1007/s00417-020-04653-4.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 428.51800000000003, 242.33, 439.426), True, False, 62, 841.92, 595.32)"
62,"321. Chu J, Yang N, Wei Y, Yue H, Zhang F, Zhao J, He L, Sheng G, Chen P, Li G, Wu S,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('321. Chu J, Yang N, Wei Y, Yue H, Zhang F, Zhao J, He L, Sheng G, Chen P, Li G, Wu S,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 413.63800000000003, 525.9720000000001, 424.966), False, False, 62, 841.92, 595.32)"
62,"Zhang B, Zhang S, Wang C, Miao X, Li J, Liu W, Zhang H. Clinical Characteristics of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Zhang B, Zhang S, Wang C, Miao X, Li J, Liu W, Zhang H. Clinical Characteristics of', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 398.75800000000004, 526.306, 409.666), True, False, 62, 841.92, 595.32)"
62,"54  medical  staff  with  COVID-19:  A  retrospective  study  in  a  single  center  in  Wuhan,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('54  medical  staff  with  COVID-19:  A  retrospective  study  in  a  single  center  in  Wuhan,', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 383.858, 526.19, 394.76599999999996), True, False, 62, 841.92, 595.32)"
62,China. J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25793.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('China. J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25793.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 368.978, 381.79, 379.88599999999997), True, False, 62, 841.92, 595.32)"
62,"322. Bonilla-Aldana  DK,  Dhama  K,  Rodriguez-Morales  AJ.  Revisiting  the  one  health",0,0,0,0,0,0,0,0,0,0,0,0,0,"('322. Bonilla-Aldana  DK,  Dhama  K,  Rodriguez-Morales  AJ.  Revisiting  the  one  health', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 353.978, 526.258, 365.306), False, False, 62, 841.92, 595.32)"
62,approach in the context of COVID-19: A look into the ecology of this emerging Disease.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('approach in the context of COVID-19: A look into the ecology of this emerging Disease.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 339.098, 526.2260000000001, 350.006), True, False, 62, 841.92, 595.32)"
62,Adv Anim Vet Sci. 2020;8(3): 234-237.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Adv Anim Vet Sci. 2020;8(3): 234-237.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 324.218, 288.77, 335.126), True, False, 62, 841.92, 595.32)"
62,"323. Malik YS, Sircar S, Bhat S, Vinodhkumar OR, Tiwari R, SahR, Rabaan AA, Rodriguez-",0,0,0,0,0,0,0,0,0,0,0,0,0,"('323. Malik YS, Sircar S, Bhat S, Vinodhkumar OR, Tiwari R, SahR, Rabaan AA, Rodriguez-', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 309.338, 523.336, 320.666), False, False, 62, 841.92, 595.32)"
62,"Morales AJ, Dhama K.  Emerging Coronavirus  Disease(COVID-19), a pandemic public",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Morales AJ, Dhama K.  Emerging Coronavirus  Disease(COVID-19), a pandemic public', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 294.458, 526.384, 305.366), True, False, 62, 841.92, 595.32)"
62,health  emergency  with  animal  linkages:  Current  status  update.  Indian  J  Anim  Sci.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('health  emergency  with  animal  linkages:  Current  status  update.  Indian  J  Anim  Sci.', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 279.57800000000003, 526.1400000000001, 290.486), True, False, 62, 841.92, 595.32)"
62,2020;80(3): (In Press).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020;80(3): (In Press).', 'TimesNewRomanPSMT', 10.907999999999959, (93.384, 264.69800000000004, 205.37, 275.606), True, False, 62, 841.92, 595.32)"
62,"324. Rodriguez-Morales  A,  Tiwari  R,  Sah  R  and  Dhama  K.  COVID-19,  an  Emerging",0,0,0,0,0,0,0,0,0,0,0,0,0,"('324. Rodriguez-Morales  A,  Tiwari  R,  Sah  R  and  Dhama  K.  COVID-19,  an  Emerging', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 249.81799999999998, 526.342, 261.146), False, False, 62, 841.92, 595.32)"
62,Coronavirus  Infection:  Current  Scenario  and  Recent  Developments  -  An  Overview.  J,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Coronavirus  Infection:  Current  Scenario  and  Recent  Developments  -  An  Overview.  J', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 234.938, 526.372, 245.846), True, False, 62, 841.92, 595.32)"
62,Pure Appl Microbio. 2020;14:6150.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Pure Appl Microbio. 2020;14:6150.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 220.058, 268.85, 230.966), True, False, 62, 841.92, 595.32)"
62,"325. Moriarty LF, Plucinski MM, Marston BJ, Kurbatova EV, Knust B, Murray EL, Pesik N,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('325. Moriarty LF, Plucinski MM, Marston BJ, Kurbatova EV, Knust B, Murray EL, Pesik N,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 205.028, 526.408, 216.356), False, False, 62, 841.92, 595.32)"
62,"Rose D, Fitter D, Kobayashi  M, Toda M, Canty PT, Scheuer T, Halsey  ES, Cohen NJ,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Rose D, Fitter D, Kobayashi  M, Toda M, Canty PT, Scheuer T, Halsey  ES, Cohen NJ,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 190.148, 526.0679999999999, 201.056), True, False, 62, 841.92, 595.32)"
62,"Stockman  L,  Wadford  DA,  Medley  AM,  Green  G,  Regan  JJ,  Tardivel  K,  White  S,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Stockman  L,  Wadford  DA,  Medley  AM,  Green  G,  Regan  JJ,  Tardivel  K,  White  S,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 175.268, 526.1279999999998, 186.17600000000002), True, False, 62, 841.92, 595.32)"
62,"Brown C, Morales C, Yen C, Wittry B, Freeland A, Naramore S, Novak RT, Daigle D,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Brown C, Morales C, Yen C, Wittry B, Freeland A, Naramore S, Novak RT, Daigle D,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 160.38799999999998, 526.0559999999998, 171.296), True, False, 62, 841.92, 595.32)"
62,"Weinberg  M,  Acosta  A,  Herzig  C,  Kapella  BK,  Jacobson  KR,  Lamba  K,  Ishizumi  A,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Weinberg  M,  Acosta  A,  Herzig  C,  Kapella  BK,  Jacobson  KR,  Lamba  K,  Ishizumi  A,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 145.50799999999998, 526.1120000000001, 156.416), True, False, 62, 841.92, 595.32)"
62,"Sarisky  J,  Svendsen  E,  Blocher  T,  Wu  C,  Charles  J,  Wagner  R,  Stewart  A,  Mead  PS,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sarisky  J,  Svendsen  E,  Blocher  T,  Wu  C,  Charles  J,  Wagner  R,  Stewart  A,  Mead  PS,', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 130.628, 526.0439999999999, 141.536), True, False, 62, 841.92, 595.32)"
62,"Kurylo E, Campbell S, Murray R, Weidle P, Cetron M, Friedman CR; CDC Cruise Ship",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Kurylo E, Campbell S, Murray R, Weidle P, Cetron M, Friedman CR; CDC Cruise Ship', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 115.748, 526.0440000000001, 126.656), True, False, 62, 841.92, 595.32)"
62,Response  Team;  California  Department  of  Public  Health  COVID-19  Team;  Solano,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Response  Team;  California  Department  of  Public  Health  COVID-19  Team;  Solano', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 100.868, 526.3539999999999, 111.776), True, False, 62, 841.92, 595.32)"
62,County  COVID-19 Team.  Public Health Responses to  COVID-19 Outbreaks on Cruise,0,0,0,0,0,0,0,0,0,0,0,0,0,"('County  COVID-19 Team.  Public Health Responses to  COVID-19 Outbreaks on Cruise', 'TimesNewRomanPSMT', 10.908000000000001, (93.384, 85.992, 526.306, 96.9), True, False, 62, 841.92, 595.32)"
62,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 62, 841.92, 595.32)"
62,61,0,0,0,0,0,0,0,0,0,0,0,0,0,"('61', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 62, 841.92, 595.32)"
63,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 63, 841.92, 595.32)"
63,"Ships - Worldwide, February-March 2020. MMWR Morb Mortal Wkly  Rep. 2020 Mar",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Ships - Worldwide, February-March 2020. MMWR Morb Mortal Wkly  Rep. 2020 Mar', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 756.168, 526.214, 767.076), True, False, 63, 841.92, 595.32)"
63,27;69(12):347-352. doi: 10.15585/mmwr.mm6912e3.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('27;69(12):347-352. doi: 10.15585/mmwr.mm6912e3.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 741.268, 357.43, 752.176), True, False, 63, 841.92, 595.32)"
63,"326. Hasan  Z,  Narasimhan  M.  Preparing  for  the  COVID-19  Pandemic:  Our  Experience  in",0,0,0,0,0,0,0,0,0,0,0,0,0,"('326. Hasan  Z,  Narasimhan  M.  Preparing  for  the  COVID-19  Pandemic:  Our  Experience  in', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 526.294, 737.716), False, False, 63, 841.92, 595.32)"
63,doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('doi:', 'TimesNewRomanPSMT', 10.908000000000015, (504.808, 711.508, 526.408, 722.416), True, False, 63, 841.92, 595.32)"
63,25:S0012-3692(20)30547-X.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('25:S0012-3692(20)30547-X.', 'TimesNewRomanPSMT', 10.908000000000015, (340.476, 711.508, 483.364, 722.416), True, False, 63, 841.92, 595.32)"
63,2020  Mar,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020  Mar', 'TimesNewRomanPSMT', 10.908000000000015, (247.512, 711.508, 319.00800000000004, 722.416), True, False, 63, 841.92, 595.32)"
63,New  York.  Chest.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('New  York.  Chest.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 711.508, 226.00800000000004, 722.416), True, False, 63, 841.92, 595.32)"
63,10.1016/j.chest.2020.03.027.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/j.chest.2020.03.027.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 696.628, 235.73, 707.5360000000001), True, False, 63, 841.92, 595.32)"
63,327. Colbourn  T.  COVID-19:  extending  or  relaxing  distancing  control  measures.  Lancet,0,0,0,0,0,0,0,0,0,0,0,0,0,"('327. Colbourn  T.  COVID-19:  extending  or  relaxing  distancing  control  measures.  Lancet', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 681.748, 526.238, 693.076), False, False, 63, 841.92, 595.32)"
63,Public  Health.  2020  Mar  25:S2468-2667(20)30072-4.  doi:  10.1016/S2468-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Public  Health.  2020  Mar  25:S2468-2667(20)30072-4.  doi:  10.1016/S2468-', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 666.748, 523.576, 677.6560000000001), True, False, 63, 841.92, 595.32)"
63,2667(20)30072-4.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2667(20)30072-4.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 651.868, 183.38, 662.7760000000001), True, False, 63, 841.92, 595.32)"
63,328. Zheng J. SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat. Int J Biol,0,0,0,0,0,0,0,0,0,0,0,0,0,"('328. Zheng J. SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat. Int J Biol', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 636.988, 526.166, 648.316), False, False, 63, 841.92, 595.32)"
63,Sci. 2020 Mar 15;16(10):1678-1685. doi: 10.7150/ijbs.45053.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sci. 2020 Mar 15;16(10):1678-1685. doi: 10.7150/ijbs.45053.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 622.1080000000001, 393.91, 633.0160000000001), True, False, 63, 841.92, 595.32)"
63,"329. Chatterjee P, Nagi N, Agarwal A, Das B, Banerjee S, Sarkar S, Gupta N, Gangakhedkar",0,0,0,0,0,0,0,0,0,0,0,0,0,"('329. Chatterjee P, Nagi N, Agarwal A, Das B, Banerjee S, Sarkar S, Gupta N, Gangakhedkar', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 607.2280000000001, 526.166, 618.556), False, False, 63, 841.92, 595.32)"
63,RR. The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current,0,0,0,0,0,0,0,0,0,0,0,0,0,"('RR. The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 592.3480000000001, 526.282, 603.2560000000001), True, False, 63, 841.92, 595.32)"
63,evidence. Indian J Med Res. 2020 Mar 30. doi: 10.4103/ijmr.IJMR_519_20.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('evidence. Indian J Med Res. 2020 Mar 30. doi: 10.4103/ijmr.IJMR_519_20.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 577.468, 462.7, 588.376), True, False, 63, 841.92, 595.32)"
63,"330. Xiao  DAT,  Gao  DC,  Zhang  DS.  Profile  of  Specific  Antibodies  to  SARS-CoV-2:  The",0,0,0,0,0,0,0,0,0,0,0,0,0,"('330. Xiao  DAT,  Gao  DC,  Zhang  DS.  Profile  of  Specific  Antibodies  to  SARS-CoV-2:  The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 562.558, 526.408, 573.886), False, False, 63, 841.92, 595.32)"
63,Infect.  2020  Mar  21:S0163-4453(20)30138-9.  doi:,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infect.  2020  Mar  21:S0163-4453(20)30138-9.  doi:', 'TimesNewRomanPSMT', 10.908000000000015, (214.416, 547.678, 526.408, 558.586), True, False, 63, 841.92, 595.32)"
63,J,0,0,0,0,0,0,0,0,0,0,0,0,0,"('J', 'TimesNewRomanPSMT', 10.908000000000015, (190.06799999999998, 547.678, 197.736, 558.586), True, False, 63, 841.92, 595.32)"
63,First  Report.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('First  Report.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 547.678, 173.53199999999998, 558.586), True, False, 63, 841.92, 595.32)"
63,10.1016/j.jinf.2020.03.012.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('10.1016/j.jinf.2020.03.012.', 'TimesNewRomanPSMT', 10.908000000000015, (93.384, 532.798, 257.81, 543.706), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (108.02, 517.798, 111.02, 528.706), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 494.998, 75.024, 505.714), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 472.07800000000003, 75.024, 482.79400000000004), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 449.158, 75.024, 459.874), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 426.238, 75.024, 436.954), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 403.438, 75.024, 414.154), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 380.498, 75.024, 391.214), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 357.57800000000003, 75.024, 368.29400000000004), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 334.658, 75.024, 345.374), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 311.858, 75.024, 322.574), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 288.938, 75.024, 299.654), True, False, 63, 841.92, 595.32)"
63,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 63, 841.92, 595.32)"
63,62,0,0,0,0,0,0,0,0,0,0,0,0,0,"('62', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 63, 841.92, 595.32)"
64,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 64, 841.92, 595.32)"
64,Author Biographies,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Author Biographies', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 756.168, 176.66, 766.884), True, False, 64, 841.92, 595.32)"
64,"Kuldeep  Dhama,  M.V.Sc.,  Ph.D.  (Gold  Medalist),  is  working  as  Principal",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Kuldeep  Dhama,  M.V.Sc.,  Ph.D.  (Gold  Medalist),  is  working  as  Principal', 'TimesNewRomanPSMT', 10.908000000000015, (144.02, 657.1, 526.33, 668.176), False, False, 64, 841.92, 595.32)"
64,"Scientist  in  Division  of  Pathology,  ICAR-Indian  Veterinary  Research  Institute,  Izatnagar,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Scientist  in  Division  of  Pathology,  ICAR-Indian  Veterinary  Research  Institute,  Izatnagar,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 643.468, 526.2140000000002, 654.376), True, False, 64, 841.92, 595.32)"
64,"Uttar  Pradesh,  India.  With  25  years  of  research  and  teaching  experience  in  the  areas  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Uttar  Pradesh,  India.  With  25  years  of  research  and  teaching  experience  in  the  areas  of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 629.668, 526.1959999999999, 640.576), True, False, 64, 841.92, 595.32)"
64,"microbiology,  immunology,  virology,  public  health,  medicine,  and  biomedicine,  as  an",0,0,0,0,0,0,0,0,0,0,0,0,0,"('microbiology,  immunology,  virology,  public  health,  medicine,  and  biomedicine,  as  an', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 615.868, 526.342, 626.7760000000001), True, False, 64, 841.92, 595.32)"
64,"eminent  researcher,  he  has  developed  several  diagnostics,  vaccines,  immunomodulatory",0,0,0,0,0,0,0,0,0,0,0,0,0,"('eminent  researcher,  he  has  developed  several  diagnostics,  vaccines,  immunomodulatory', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 602.068, 526.1400000000001, 612.976), True, False, 64, 841.92, 595.32)"
64,"modules and hypothesis to  counter infectious diseases of animals,  poultry and public health",0,0,0,0,0,0,0,0,0,0,0,0,0,"('modules and hypothesis to  counter infectious diseases of animals,  poultry and public health', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 588.268, 526.1279999999999, 599.176), True, False, 64, 841.92, 595.32)"
64,"concerns. He has to his credit 600 publications, 06 books, and 65 book chapters. Dr. Dhama",0,0,0,0,0,0,0,0,0,0,0,0,0,"('concerns. He has to his credit 600 publications, 06 books, and 65 book chapters. Dr. Dhama', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 574.468, 526.408, 585.376), True, False, 64, 841.92, 595.32)"
64,has  been  recognized  as  an  extremely  productive  researcher  in  the  'Nature'  journal,0,0,0,0,0,0,0,0,0,0,0,0,0,"(""has  been  recognized  as  an  extremely  productive  researcher  in  the  'Nature'  journal"", 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 560.638, 526.396, 571.558), False, False, 64, 841.92, 595.32)"
64,publication. He is honored with 50 Best Paper Awards and other recognitions. He is NAAS,0,0,0,0,0,0,0,0,0,0,0,0,0,"('publication. He is honored with 50 Best Paper Awards and other recognitions. He is NAAS', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 546.838, 526.42, 557.746), True, False, 64, 841.92, 595.32)"
64,"(National  Academy  of  Agricultural  Science,  India)  Associate,  worked  as  Nodal  Officer,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(National  Academy  of  Agricultural  Science,  India)  Associate,  worked  as  Nodal  Officer,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 533.038, 526.366, 543.946), True, False, 64, 841.92, 595.32)"
64,"WTO,  and  Member,  Wildlife  Health  Specialist  Group  (IUCN).  He  is  actively  serving  as",0,0,0,0,0,0,0,0,0,0,0,0,0,"('WTO,  and  Member,  Wildlife  Health  Specialist  Group  (IUCN).  He  is  actively  serving  as', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 519.238, 526.04, 530.1460000000001), True, False, 64, 841.92, 595.32)"
64,"Editor-in-Chief, Co-EIC, Editor and Member, Editorial board of nearly 20 scientific journals.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Editor-in-Chief, Co-EIC, Editor and Member, Editorial board of nearly 20 scientific journals.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 505.438, 526.408, 516.346), True, False, 64, 841.92, 595.32)"
64,His Google scholar h-index is 46; Scopus h-index is 31.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('His Google scholar h-index is 46; Scopus h-index is 31.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 491.63800000000003, 346.03, 502.546), True, False, 64, 841.92, 595.32)"
64,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 469.918, 75.024, 480.82599999999996), True, False, 64, 841.92, 595.32)"
64,"Sharun  Khan,  M.V.Sc.  Scholar,  in  the  Division  of  Veterinary",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sharun  Khan,  M.V.Sc.  Scholar,  in  the  Division  of  Veterinary', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 448.07800000000003, 526.408, 458.986), False, False, 64, 841.92, 595.32)"
64,"Surgery  and  Radiology,  ICAR-Indian  Veterinary  Research",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Surgery  and  Radiology,  ICAR-Indian  Veterinary  Research', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 434.278, 526.306, 445.186), True, False, 64, 841.92, 595.32)"
64,"Institute, Izatnagar, India, is working as a researcher in the Stem",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Institute, Izatnagar, India, is working as a researcher in the Stem', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 420.478, 526.27, 431.38599999999997), True, False, 64, 841.92, 595.32)"
64,Cell  Laboratory.  His  area  of  interest  is  regenerative  medicine,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Cell  Laboratory.  His  area  of  interest  is  regenerative  medicine', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 406.678, 526.166, 417.58599999999996), True, False, 64, 841.92, 595.32)"
64,with  a  focus  on  understanding  cell  biology  and  molecular,0,0,0,0,0,0,0,0,0,0,0,0,0,"('with  a  focus  on  understanding  cell  biology  and  molecular', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 392.858, 526.202, 403.76599999999996), True, False, 64, 841.92, 595.32)"
64,pathway involved in the maintenance and differentiation of stem,0,0,0,0,0,0,0,0,0,0,0,0,0,"('pathway involved in the maintenance and differentiation of stem', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 379.058, 526.2020000000002, 389.96599999999995), True, False, 64, 841.92, 595.32)"
64,cells originating from different tissues. He has particular interest,0,0,0,0,0,0,0,0,0,0,0,0,0,"('cells originating from different tissues. He has particular interest', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 365.25800000000004, 526.36, 376.166), True, False, 64, 841.92, 595.32)"
64,"and  knowledge  also  in  the  fields  of  veterinary  medicine,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  knowledge  also  in  the  fields  of  veterinary  medicine,', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 351.458, 526.2940000000001, 362.366), True, False, 64, 841.92, 595.32)"
64,"pharmacology,  infectious  diseases  of  animals,  wildlife  diseases,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('pharmacology,  infectious  diseases  of  animals,  wildlife  diseases,', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 337.658, 526.238, 348.566), True, False, 64, 841.92, 595.32)"
64,"diagnosis  and  therapy  of  animal  diseases,  nutrition,  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('diagnosis  and  therapy  of  animal  diseases,  nutrition,  and', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 323.858, 526.42, 334.76599999999996), True, False, 64, 841.92, 595.32)"
64,"biomedicine.  With  excellent  academic  records,  he  has  received",0,0,0,0,0,0,0,0,0,0,0,0,0,"('biomedicine.  With  excellent  academic  records,  he  has  received', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 310.058, 526.306, 320.96599999999995), True, False, 64, 841.92, 595.32)"
64,awards  and  recognitions  (fellowships  and  scholarships)  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('awards  and  recognitions  (fellowships  and  scholarships)  and', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 296.25800000000004, 526.2260000000001, 307.166), True, False, 64, 841.92, 595.32)"
64,"participated  in  national  and  international  workshops,  training",0,0,0,0,0,0,0,0,0,0,0,0,0,"('participated  in  national  and  international  workshops,  training', 'TimesNewRomanPSMT', 10.907999999999959, (208.61, 282.458, 526.2020000000001, 293.366), True, False, 64, 841.92, 595.32)"
64,programs and courses. He has a keen interest in learning excellent scientific writing skills and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('programs and courses. He has a keen interest in learning excellent scientific writing skills and', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 268.658, 526.318, 279.566), True, False, 64, 841.92, 595.32)"
64,has published 30 papers including in international journals of repute. He is highly enthusiastic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('has published 30 papers including in international journals of repute. He is highly enthusiastic', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 254.85799999999998, 526.2440000000001, 265.76599999999996), True, False, 64, 841.92, 595.32)"
64,about gaining knowledge of the advancements in the educational and scientific research areas.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('about gaining knowledge of the advancements in the educational and scientific research areas.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 241.058, 529.54, 251.966), True, False, 64, 841.92, 595.32)"
64,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 219.338, 75.024, 230.246), True, False, 64, 841.92, 595.32)"
64,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 64, 841.92, 595.32)"
64,"Ruchi  Tiwari,  is  currently  working  as  Assistant  Professor  in  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Ruchi  Tiwari,  is  currently  working  as  Assistant  Professor  in  the', 'TimesNewRomanPSMT', 10.908000000000015, (197.33, 197.468, 526.42, 208.376), False, False, 64, 841.92, 595.32)"
64,"Department  of  Veterinary  Microbiology,  College  of  Veterinary",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Department  of  Veterinary  Microbiology,  College  of  Veterinary', 'TimesNewRomanPSMT', 10.908000000000015, (197.33, 183.66799999999998, 526.19, 194.576), True, False, 64, 841.92, 595.32)"
64,"Sciences, DUVASU, Mathura, India. She is currently pursuing her",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sciences, DUVASU, Mathura, India. She is currently pursuing her', 'TimesNewRomanPSMT', 10.908000000000015, (197.33, 169.868, 526.2020000000001, 180.776), True, False, 64, 841.92, 595.32)"
64,Ph.D.  (Hons)  degree  from  DUVASU.  With  an  excellent  academic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Ph.D.  (Hons)  degree  from  DUVASU.  With  an  excellent  academic', 'TimesNewRomanPSMT', 10.908000000000015, (197.33, 156.06799999999998, 526.1899999999998, 166.976), True, False, 64, 841.92, 595.32)"
64,"record  and  10years  of  research  and  teaching  experience,  she  has",0,0,0,0,0,0,0,0,0,0,0,0,0,"('record  and  10years  of  research  and  teaching  experience,  she  has', 'TimesNewRomanPSMT', 10.908000000000015, (197.33, 142.268, 526.42, 153.17600000000002), True, False, 64, 841.92, 595.32)"
64,"expertise  in  the  field  of  diagnosis,  prevention,  and  control  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('expertise  in  the  field  of  diagnosis,  prevention,  and  control  of', 'TimesNewRomanPSMT', 10.908000000000015, (197.33, 128.468, 526.384, 139.376), True, False, 64, 841.92, 595.32)"
64,important  livestock/poultry  diseases  /pathogens  having  public,0,0,0,0,0,0,0,0,0,0,0,0,0,"('important  livestock/poultry  diseases  /pathogens  having  public', 'TimesNewRomanPSMT', 10.908000000000001, (197.33, 114.668, 526.354, 125.57600000000001), True, False, 64, 841.92, 595.32)"
64,health  significance  along  with  particular  reference  to  veterinary,0,0,0,0,0,0,0,0,0,0,0,0,0,"('health  significance  along  with  particular  reference  to  veterinary', 'TimesNewRomanPSMT', 10.908000000000001, (197.33, 100.868, 526.306, 111.776), True, False, 64, 841.92, 595.32)"
64,"microbiology,  immunology,  ethnoveterinary  medicine,  alternative",0,0,0,0,0,0,0,0,0,0,0,0,0,"('microbiology,  immunology,  ethnoveterinary  medicine,  alternative', 'TimesNewRomanPSMT', 10.908000000000001, (197.33, 87.072, 526.226, 97.98), True, False, 64, 841.92, 595.32)"
64,"and  complementary  therapies,  and  bacteriophage  therapy.  Dr.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and  complementary  therapies,  and  bacteriophage  therapy.  Dr.', 'TimesNewRomanPSMT', 10.908000000000001, (197.33, 73.272, 526.42, 84.18), True, False, 64, 841.92, 595.32)"
64,63,0,0,0,0,0,0,0,0,0,0,0,0,0,"('63', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 64, 841.92, 595.32)"
65,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 65, 841.92, 595.32)"
65,Ruchi  has  published  150  research  /review  articles  and  05  Book  chapters.  She  has  been,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Ruchi  has  published  150  research  /review  articles  and  05  Book  chapters.  She  has  been', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.282, 767.076), True, False, 65, 841.92, 595.32)"
65,"honored with the Young Scientist Award, Best Paper Awards (10), and Outstanding Women",0,0,0,0,0,0,0,0,0,0,0,0,0,"('honored with the Young Scientist Award, Best Paper Awards (10), and Outstanding Women', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 742.3480000000001, 526.366, 753.2560000000001), True, False, 65, 841.92, 595.32)"
65,"Faculty Award (2019). She is serving as Editor and Member, Editorial Board & Reviewer of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Faculty Award (2019). She is serving as Editor and Member, Editorial Board & Reviewer of', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 728.548, 526.1659999999999, 739.456), True, False, 65, 841.92, 595.32)"
65,15 International Journals. Her Google scholar h-index is 40; Scopus h-index is 26.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('15 International Journals. Her Google scholar h-index is 40; Scopus h-index is 26.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 714.748, 469.66, 725.6560000000001), True, False, 65, 841.92, 595.32)"
65,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (198.77, 692.908, 201.77, 703.624), True, False, 65, 841.92, 595.32)"
65,"Shubhankar  Sircar,  Ph.D.  scholar,  received  his  Master's  degree",0,0,0,0,0,0,0,0,0,0,0,0,0,"(""Shubhankar  Sircar,  Ph.D.  scholar,  received  his  Master's  degree"", 'TimesNewRomanPSMT', 10.908000000000015, (198.77, 671.188, 526.384, 682.096), False, False, 65, 841.92, 595.32)"
65,"from Integral University Lucknow, India in 2012, and is presently",0,0,0,0,0,0,0,0,0,0,0,0,0,"('from Integral University Lucknow, India in 2012, and is presently', 'TimesNewRomanPSMT', 10.908000000000015, (198.77, 657.388, 526.42, 668.296), True, False, 65, 841.92, 595.32)"
65,serving as Senior Research Fellow in  an  ICAR  -  National  Fellow,0,0,0,0,0,0,0,0,0,0,0,0,0,"('serving as Senior Research Fellow in  an  ICAR  -  National  Fellow', 'TimesNewRomanPSMT', 10.908000000000015, (198.77, 643.588, 526.372, 654.496), True, False, 65, 841.92, 595.32)"
65,Scheme in the Division of Biological Standardization at the ICAR-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Scheme in the Division of Biological Standardization at the ICAR-', 'TimesNewRomanPSMT', 10.908000000000015, (198.77, 629.788, 523.336, 640.696), True, False, 65, 841.92, 595.32)"
65,"Indian  Veterinary  Research  Institute  (IVRI),  Izatnagar,  India.  His",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Indian  Veterinary  Research  Institute  (IVRI),  Izatnagar,  India.  His', 'TimesNewRomanPSMT', 10.908000000000015, (198.77, 615.988, 526.166, 626.8960000000001), True, False, 65, 841.92, 595.32)"
65,area  of  interest  is  molecular  epidemiology  and  genotype,0,0,0,0,0,0,0,0,0,0,0,0,0,"('area  of  interest  is  molecular  epidemiology  and  genotype', 'TimesNewRomanPSMT', 10.908000000000015, (198.77, 602.188, 526.384, 613.096), True, False, 65, 841.92, 595.32)"
65,distribution  of  major  enteric  viruses  with  a  focus  on  developing,0,0,0,0,0,0,0,0,0,0,0,0,0,"('distribution  of  major  enteric  viruses  with  a  focus  on  developing', 'TimesNewRomanPSMT', 10.908000000000015, (198.77, 588.388, 526.33, 599.296), True, False, 65, 841.92, 595.32)"
65,different molecular as well as serological diagnostic testing assays.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('different molecular as well as serological diagnostic testing assays.', 'TimesNewRomanPSMT', 10.908000000000015, (198.77, 574.588, 526.1900000000002, 585.496), True, False, 65, 841.92, 595.32)"
65,"Apart  from  his  expertise  in  viral  diagnosis,  he  has  particular",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Apart  from  his  expertise  in  viral  diagnosis,  he  has  particular', 'TimesNewRomanPSMT', 10.908000000000015, (198.77, 560.758, 526.42, 571.666), True, False, 65, 841.92, 595.32)"
65,"interest and knowledge in the fields of infectious diseases of farms,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('interest and knowledge in the fields of infectious diseases of farms,', 'TimesNewRomanPSMT', 10.908000000000015, (198.77, 546.958, 526.42, 557.866), True, False, 65, 841.92, 595.32)"
65,"animals, and wildlife. With good academic records, he has received",0,0,0,0,0,0,0,0,0,0,0,0,0,"('animals, and wildlife. With good academic records, he has received', 'TimesNewRomanPSMT', 10.908000000000015, (198.77, 533.158, 526.2740000000001, 544.066), True, False, 65, 841.92, 595.32)"
65,a few awards and recognitions (Best poster and Young Scientist) and participated in several,0,0,0,0,0,0,0,0,0,0,0,0,0,"('a few awards and recognitions (Best poster and Young Scientist) and participated in several', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 519.3580000000001, 526.0559999999998, 530.2660000000001), True, False, 65, 841.92, 595.32)"
65,"national and international workshops, training programs, and conferences. He has published",0,0,0,0,0,0,0,0,0,0,0,0,0,"('national and international workshops, training programs, and conferences. He has published', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 505.558, 526.372, 516.466), True, False, 65, 841.92, 595.32)"
65,30  papers  in  journals  of  repute.  He  is  highly  enthusiastic  about  gaining  knowledge  of  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('30  papers  in  journals  of  repute.  He  is  highly  enthusiastic  about  gaining  knowledge  of  the', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 491.75800000000004, 526.444, 502.666), True, False, 65, 841.92, 595.32)"
65,advancements in the educational and scientific research areas.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('advancements in the educational and scientific research areas.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 477.958, 372.31, 488.866), True, False, 65, 841.92, 595.32)"
65,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 456.118, 75.024, 467.02599999999995), True, False, 65, 841.92, 595.32)"
65,"Sudipta  Bhat,  a  Ph.D.  scholar,  received  his  bachelors  (B.V.Sc)",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sudipta  Bhat,  a  Ph.D.  scholar,  received  his  bachelors  (B.V.Sc)', 'TimesNewRomanPSMT', 10.907999999999959, (193.25, 434.398, 526.33, 445.306), False, False, 65, 841.92, 595.32)"
65,"from  West  Bengal  University  of  Animal  and  Fishery  Sciences,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('from  West  Bengal  University  of  Animal  and  Fishery  Sciences,', 'TimesNewRomanPSMT', 10.907999999999959, (193.25, 420.598, 526.202, 431.506), True, False, 65, 841.92, 595.32)"
65,"Kolkata,  India,  and  Masters  (M.V.Sc.)  from  ICAR-Indian",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Kolkata,  India,  and  Masters  (M.V.Sc.)  from  ICAR-Indian', 'TimesNewRomanPSMT', 10.907999999999959, (193.25, 406.798, 526.408, 417.70599999999996), True, False, 65, 841.92, 595.32)"
65,"Veterinary Research Institute (IVRI), Bareilly, India. He is pursuing",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Veterinary Research Institute (IVRI), Bareilly, India. He is pursuing', 'TimesNewRomanPSMT', 10.907999999999959, (193.25, 392.978, 526.1660000000002, 403.88599999999997), True, False, 65, 841.92, 595.32)"
65,"a  Ph.D.  degree  in  Veterinary  Virology,  ICAR-IVRI,  from  2016",0,0,0,0,0,0,0,0,0,0,0,0,0,"('a  Ph.D.  degree  in  Veterinary  Virology,  ICAR-IVRI,  from  2016', 'TimesNewRomanPSMT', 10.907999999999959, (193.25, 379.178, 526.3960000000001, 390.08599999999996), True, False, 65, 841.92, 595.32)"
65,onwards.  He  has  worked  on  highly  pathogenic  H5N1  avian,0,0,0,0,0,0,0,0,0,0,0,0,0,"('onwards.  He  has  worked  on  highly  pathogenic  H5N1  avian', 'TimesNewRomanPSMT', 10.907999999999959, (193.25, 365.37800000000004, 526.262, 376.286), True, False, 65, 841.92, 595.32)"
65,influenza  virus  and  now  working  on  emerging  enteric  viruses  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('influenza  virus  and  now  working  on  emerging  enteric  viruses  of', 'TimesNewRomanPSMT', 10.907999999999959, (193.25, 351.57800000000003, 526.2259999999999, 362.486), True, False, 65, 841.92, 595.32)"
65,zoonotic  importance  from  different  animal  species.  He  has,0,0,0,0,0,0,0,0,0,0,0,0,0,"('zoonotic  importance  from  different  animal  species.  He  has', 'TimesNewRomanPSMT', 10.907999999999959, (193.25, 337.778, 526.178, 348.686), True, False, 65, 841.92, 595.32)"
65,published his research findings in international journals. His area of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('published his research findings in international journals. His area of', 'TimesNewRomanPSMT', 10.907999999999959, (193.25, 323.978, 526.384, 334.88599999999997), True, False, 65, 841.92, 595.32)"
65,interest  is  infectious  diseases  with  a  focus  on  understanding  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('interest  is  infectious  diseases  with  a  focus  on  understanding  the', 'TimesNewRomanPSMT', 10.907999999999959, (193.25, 310.178, 526.444, 321.08599999999996), True, False, 65, 841.92, 595.32)"
65,"antigenic and genetic diversity of viruses, causing disease of several",0,0,0,0,0,0,0,0,0,0,0,0,0,"('antigenic and genetic diversity of viruses, causing disease of several', 'TimesNewRomanPSMT', 10.907999999999959, (193.25, 296.37800000000004, 526.306, 307.286), True, False, 65, 841.92, 595.32)"
65,"livestock  species.  With  brilliant  academic  records,  he  has  also  been  awarded  several",0,0,0,0,0,0,0,0,0,0,0,0,0,"('livestock  species.  With  brilliant  academic  records,  he  has  also  been  awarded  several', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 282.57800000000003, 526.0319999999998, 293.486), True, False, 65, 841.92, 595.32)"
65,"fellowships and scholarships and participated in several national and international workshops,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('fellowships and scholarships and participated in several national and international workshops,', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 268.778, 526.2200000000001, 279.686), True, False, 65, 841.92, 595.32)"
65,training programs and courses.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('training programs and courses.', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 254.97799999999998, 223.13, 265.88599999999997), True, False, 65, 841.92, 595.32)"
65,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 233.13799999999998, 75.024, 243.85399999999998), True, False, 65, 841.92, 595.32)"
65,"Yashpal Singh Malik, M.V.Sc., Ph.D., serving as ICAR-National",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Yashpal Singh Malik, M.V.Sc., Ph.D., serving as ICAR-National', 'TimesNewRomanPSMT', 10.908000000000015, (201.05, 219.338, 526.384, 230.246), False, False, 65, 841.92, 595.32)"
65,"Fellow  and  Professor  is  an  expert  on  enteric  viral  infections,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Fellow  and  Professor  is  an  expert  on  enteric  viral  infections,', 'TimesNewRomanPSMT', 10.908000000000015, (201.05, 205.50799999999998, 526.202, 216.416), True, False, 65, 841.92, 595.32)"
65,"zoonosis, and emerging viral diseases of animals and humans. He",0,0,0,0,0,0,0,0,0,0,0,0,0,"('zoonosis, and emerging viral diseases of animals and humans. He', 'TimesNewRomanPSMT', 10.908000000000015, (201.05, 191.708, 526.318, 202.616), True, False, 65, 841.92, 595.32)"
65,"contributed  immensely  to  viral  disease  epidemiology,  virus-host",0,0,0,0,0,0,0,0,0,0,0,0,0,"('contributed  immensely  to  viral  disease  epidemiology,  virus-host', 'TimesNewRomanPSMT', 10.908000000000015, (201.05, 177.908, 526.408, 188.816), True, False, 65, 841.92, 595.32)"
65,"interactions,  microbial  biodiversity,  characterization,  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('interactions,  microbial  biodiversity,  characterization,  and', 'TimesNewRomanPSMT', 10.908000000000015, (201.05, 164.10799999999998, 526.214, 175.016), True, False, 65, 841.92, 595.32)"
65,diagnosis  of  pathogens.  He  did  Postdoc  from  the  University  of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('diagnosis  of  pathogens.  He  did  Postdoc  from  the  University  of', 'TimesNewRomanPSMT', 10.908000000000015, (201.05, 150.308, 526.444, 161.216), True, False, 65, 841.92, 595.32)"
65,"Minnesota,  USA.  He  acquired  advanced  training  in  molecular",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Minnesota,  USA.  He  acquired  advanced  training  in  molecular', 'TimesNewRomanPSMT', 10.908000000000015, (201.05, 136.50799999999998, 526.2940000000001, 147.416), True, False, 65, 841.92, 595.32)"
65,"virology  from  the  Division  of  Virology,  University  of  Ottawa,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('virology  from  the  Division  of  Virology,  University  of  Ottawa,', 'TimesNewRomanPSMT', 10.907999999999987, (201.05, 122.708, 526.3100000000001, 133.61599999999999), True, False, 65, 841.92, 595.32)"
65,"Canada,  and  Wuhan  Institute  of  Virology,  China.  He  has",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Canada,  and  Wuhan  Institute  of  Virology,  China.  He  has', 'TimesNewRomanPSMT', 10.908000000000001, (201.05, 108.908, 526.396, 119.816), True, False, 65, 841.92, 595.32)"
65,represented India in the scientific arena in more than 12 countries.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('represented India in the scientific arena in more than 12 countries.', 'TimesNewRomanPSMT', 10.908000000000001, (201.05, 95.112, 526.2700000000001, 106.02), True, False, 65, 841.92, 595.32)"
65,He  is  the  Secretary-General  of  Indian  Virological  Society  and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('He  is  the  Secretary-General  of  Indian  Virological  Society  and', 'TimesNewRomanPSMT', 10.908000000000001, (201.05, 81.312, 526.318, 92.22), True, False, 65, 841.92, 595.32)"
65,Secretary-E for the World Society for Virology (USA). He is a study group member of ICTV,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Secretary-E for the World Society for Virology (USA). He is a study group member of ICTV', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 67.512, 526.076, 78.42), True, False, 65, 841.92, 595.32)"
65,64,0,0,0,0,0,0,0,0,0,0,0,0,0,"('64', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 65, 841.92, 595.32)"
65,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 65, 841.92, 595.32)"
66,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 66, 841.92, 595.32)"
66,"on  Birnaviridae  and  Picobirnaviridae.  He  has  authored  five  books  of  reputed  publishers,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('on  Birnaviridae  and  Picobirnaviridae.  He  has  authored  five  books  of  reputed  publishers,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.42, 767.088), False, False, 66, 841.92, 595.32)"
66,"including  Elsevier  and  Springer  Nature,  and  has  published  225  scientific  research  articles,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('including  Elsevier  and  Springer  Nature,  and  has  published  225  scientific  research  articles,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 742.3480000000001, 526.306, 753.2560000000001), True, False, 66, 841.92, 595.32)"
66,"reviews in journals of high impact factor. His h-index is 28, and the RG score is 38.6.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('reviews in journals of high impact factor. His h-index is 28, and the RG score is 38.6.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 728.548, 488.62, 739.456), True, False, 66, 841.92, 595.32)"
66,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 708.748, 75.024, 719.464), True, False, 66, 841.92, 595.32)"
66,"Karam  Pal  Singh,  Ph.D.,  obtained  his  B.V.Sc.  &  A.H.  degree",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Karam  Pal  Singh,  Ph.D.,  obtained  his  B.V.Sc.  &  A.H.  degree', 'TimesNewRomanPSMT', 10.908000000000015, (205.61, 686.908, 528.506, 697.816), False, False, 66, 841.92, 595.32)"
66,"from CSA University of Agriculture & Technology, Kanpur, India,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('from CSA University of Agriculture & Technology, Kanpur, India,', 'TimesNewRomanPSMT', 10.908000000000015, (205.61, 673.1080000000001, 531.7, 684.0160000000001), True, False, 66, 841.92, 595.32)"
66,M.V.Sc. (1987) and Ph.D. (1990) degrees in Veterinary Pathology,0,0,0,0,0,0,0,0,0,0,0,0,0,"('M.V.Sc. (1987) and Ph.D. (1990) degrees in Veterinary Pathology', 'TimesNewRomanPSMT', 10.908000000000015, (205.61, 659.308, 528.4580000000001, 670.216), True, False, 66, 841.92, 595.32)"
66,"from  the  ICAR-Indian  Veterinary  Research  Institute  (IVRI),",0,0,0,0,0,0,0,0,0,0,0,0,0,"('from  the  ICAR-Indian  Veterinary  Research  Institute  (IVRI),', 'TimesNewRomanPSMT', 10.908000000000015, (205.61, 645.508, 528.4820000000001, 656.416), True, False, 66, 841.92, 595.32)"
66,"Izatnagar, India. He has worked as Scientist, Senior Scientist, and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Izatnagar, India. He has worked as Scientist, Senior Scientist, and', 'TimesNewRomanPSMT', 10.908000000000015, (205.61, 631.708, 528.5619999999999, 642.616), True, False, 66, 841.92, 595.32)"
66,"Principal Scientist before taking charge of Acting Head, Division",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Principal Scientist before taking charge of Acting Head, Division', 'TimesNewRomanPSMT', 10.908000000000015, (205.61, 617.908, 528.7, 628.816), True, False, 66, 841.92, 595.32)"
66,"of Pathology, on 1st January 2019. Visited the Institute of Animal",0,0,0,0,0,0,0,0,0,0,0,0,0,"('of Pathology, on 1st January 2019. Visited the Institute of Animal', 'TimesNewRomanPSMT', 10.908000000000015, (205.61, 604.1080000000001, 528.5300000000001, 616.83172), True, False, 66, 841.92, 595.32)"
66,"Health,  Pirbright,  the  U.K.  as  a  visiting  fellow  from  April  -",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Health,  Pirbright,  the  U.K.  as  a  visiting  fellow  from  April  -', 'TimesNewRomanPSMT', 10.908000000000015, (205.61, 590.308, 528.7, 601.216), True, False, 66, 841.92, 595.32)"
66,"December  1996.  He  visited  the  Institute  of  Animal  Health,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('December  1996.  He  visited  the  Institute  of  Animal  Health,', 'TimesNewRomanPSMT', 10.908000000000015, (205.61, 576.508, 528.5500000000001, 587.416), True, False, 66, 841.92, 595.32)"
66,"Pirbright,  the  U.K.  as  Post  Doctoral  Fellow  on  Wellcome  Trust",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Pirbright,  the  U.K.  as  Post  Doctoral  Fellow  on  Wellcome  Trust', 'TimesNewRomanPSMT', 10.908000000000015, (205.61, 562.678, 528.47, 573.586), True, False, 66, 841.92, 595.32)"
66,"Fellowship  from  September  2002  to  August  2004.  Further,  he",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Fellowship  from  September  2002  to  August  2004.  Further,  he', 'TimesNewRomanPSMT', 10.908000000000015, (205.61, 548.878, 528.688, 559.7860000000001), True, False, 66, 841.92, 595.32)"
66,"visited the Veterinary Research Centre, Muscat, Sultanate of Oman, as an Expert Pathologist",0,0,0,0,0,0,0,0,0,0,0,0,0,"('visited the Veterinary Research Centre, Muscat, Sultanate of Oman, as an Expert Pathologist', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 535.078, 528.634, 545.986), True, False, 66, 841.92, 595.32)"
66,from  June  2008  to  May  2009.  Dr.  Singh  is  a  veterinary  pathologist.  His  area  of  interest  is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('from  June  2008  to  May  2009.  Dr.  Singh  is  a  veterinary  pathologist.  His  area  of  interest  is', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 521.278, 528.36, 532.186), True, False, 66, 841.92, 595.32)"
66,infectious diseases with a focus on understanding the pathogenesis and molecular diagnosis of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('infectious diseases with a focus on understanding the pathogenesis and molecular diagnosis of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 507.598, 528.518, 518.506), True, False, 66, 841.92, 595.32)"
66,viral diseases with particular reference to rabies and bluetongue.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('viral diseases with particular reference to rabies and bluetongue.', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 493.798, 383.83, 504.70599999999996), True, False, 66, 841.92, 595.32)"
66,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 471.958, 75.024, 482.866), True, False, 66, 841.92, 595.32)"
66,"Wanpen  Chaicumpa,  D.V.M.  (Hons.),  Ph.D.  (Microbiology),  is",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Wanpen  Chaicumpa,  D.V.M.  (Hons.),  Ph.D.  (Microbiology),  is', 'TimesNewRomanPSMT', 10.907999999999959, (186.02, 450.118, 528.5420000000001, 461.02599999999995), False, False, 66, 841.92, 595.32)"
66,"Emeritus  Professor,  Research  Consultant  and  Head  of  the  Center  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Emeritus  Professor,  Research  Consultant  and  Head  of  the  Center  of', 'TimesNewRomanPSMT', 10.907999999999959, (186.02, 436.31800000000004, 528.488, 447.226), True, False, 66, 841.92, 595.32)"
66,Research  Excellence  on  Therapeutic  Proteins  and  Antibody,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Research  Excellence  on  Therapeutic  Proteins  and  Antibody', 'TimesNewRomanPSMT', 10.907999999999959, (186.02, 422.51800000000003, 528.464, 433.426), True, False, 66, 841.92, 595.32)"
66,"Engineering,  at  Department  of  Parasitology,  Faculty  of  Medicine",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Engineering,  at  Department  of  Parasitology,  Faculty  of  Medicine', 'TimesNewRomanPSMT', 10.907999999999959, (186.02, 408.718, 528.5300000000001, 419.626), True, False, 66, 841.92, 595.32)"
66,"Siriraj  Hospital,  Mahidol  University,  Bangkok,  and  consultant  of  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Siriraj  Hospital,  Mahidol  University,  Bangkok,  and  consultant  of  the', 'TimesNewRomanPSMT', 10.907999999999959, (186.02, 394.918, 528.566, 405.82599999999996), True, False, 66, 841.92, 595.32)"
66,"Faculty  of  Allied  Health  Sciences,  Thammasat  University,  Thailand.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Faculty  of  Allied  Health  Sciences,  Thammasat  University,  Thailand.', 'TimesNewRomanPSMT', 10.907999999999959, (186.02, 381.098, 528.4040000000001, 392.006), True, False, 66, 841.92, 595.32)"
66,Her  research  interests  are  intestinal  immunity  against  enteric,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Her  research  interests  are  intestinal  immunity  against  enteric', 'TimesNewRomanPSMT', 10.907999999999959, (186.02, 367.298, 528.4040000000001, 378.20599999999996), True, False, 66, 841.92, 595.32)"
66,"infections, vaccine development, immuno- and molecular diagnoses of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('infections, vaccine development, immuno- and molecular diagnoses of', 'TimesNewRomanPSMT', 10.907999999999959, (186.02, 353.498, 528.634, 364.40599999999995), True, False, 66, 841.92, 595.32)"
66,"tropical infections; allergy; immunotherapy, and antibody engineering.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('tropical infections; allergy; immunotherapy, and antibody engineering.', 'TimesNewRomanPSMT', 10.907999999999959, (186.02, 339.69800000000004, 531.6460000000001, 350.606), True, False, 66, 841.92, 595.32)"
66,She  is  an  executive  member  of  the  Thailand  Academy  of  Sciences.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('She  is  an  executive  member  of  the  Thailand  Academy  of  Sciences.', 'TimesNewRomanPSMT', 10.907999999999959, (186.02, 325.898, 528.506, 336.806), True, False, 66, 841.92, 595.32)"
66,She has served as Editor in Chief of Asian Pacific J Allergy & Immunology. She served as a,0,0,0,0,0,0,0,0,0,0,0,0,0,"('She has served as Editor in Chief of Asian Pacific J Allergy & Immunology. She served as a', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 312.098, 528.6999999999999, 323.006), True, False, 66, 841.92, 595.32)"
66,"consultant  to  the  WHO  Southeast  Asian  Regional  Office,  India.  She  published  over  250",0,0,0,0,0,0,0,0,0,0,0,0,0,"('consultant  to  the  WHO  Southeast  Asian  Regional  Office,  India.  She  published  over  250', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 298.298, 528.7, 309.20599999999996), True, False, 66, 841.92, 595.32)"
66,publications  and  owned  more  than  30  patents/patent  applications;  three  textbooks  (Animal,0,0,0,0,0,0,0,0,0,0,0,0,0,"('publications  and  owned  more  than  30  patents/patent  applications;  three  textbooks  (Animal', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 284.498, 528.4460000000001, 295.40599999999995), True, False, 66, 841.92, 595.32)"
66,"viruses,  Immunology  for  Diagnosis  of  Diseases,  and  Practical  Immunology  for  Students  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('viruses,  Immunology  for  Diagnosis  of  Diseases,  and  Practical  Immunology  for  Students  of', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 270.69800000000004, 528.408, 281.606), True, False, 66, 841.92, 595.32)"
66,Diploma of Tropical Medicines).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Diploma of Tropical Medicines).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 256.898, 233.69, 267.806), True, False, 66, 841.92, 595.32)"
66,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 243.09799999999998, 75.024, 254.006), True, False, 66, 841.92, 595.32)"
66,"D.  Katterine  Bonilla-Aldana,  D.V.M.,  M.Sc.,  graduated  from",0,0,0,0,0,0,0,0,0,0,0,0,0,"('D.  Katterine  Bonilla-Aldana,  D.V.M.,  M.Sc.,  graduated  from', 'TimesNewRomanPSMT', 10.908000000000015, (174.02, 229.29799999999997, 526.408, 240.206), False, False, 66, 841.92, 595.32)"
66,"Universidad  de  la  Amazonia,  School  of  Veterinary  Medicine  and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Universidad  de  la  Amazonia,  School  of  Veterinary  Medicine  and', 'TimesNewRomanPSMT', 10.908000000000015, (174.02, 215.468, 526.208, 226.376), True, False, 66, 841.92, 595.32)"
66,"Zootechnics, in  Florencia, Colombia, 2015. She completed a Master of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Zootechnics, in  Florencia, Colombia, 2015. She completed a Master of', 'TimesNewRomanPSMT', 10.908000000000015, (174.02, 201.66799999999998, 526.27, 212.576), True, False, 66, 841.92, 595.32)"
66,"Sciences  in  Microbiology,  Universidad  Metropolitana,  Barranquilla,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sciences  in  Microbiology,  Universidad  Metropolitana,  Barranquilla,', 'TimesNewRomanPSMT', 10.908000000000015, (174.02, 187.868, 526.318, 198.776), True, False, 66, 841.92, 595.32)"
66,"Colombia, in 2019. She served as Young Researcher, Public Health and",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Colombia, in 2019. She served as Young Researcher, Public Health and', 'TimesNewRomanPSMT', 10.908000000000015, (174.02, 174.06799999999998, 526.33, 184.976), True, False, 66, 841.92, 595.32)"
66,"Infection  Research  Group,  Faculty  of  Health  Sciences,  Universidad",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infection  Research  Group,  Faculty  of  Health  Sciences,  Universidad', 'TimesNewRomanPSMT', 10.908000000000015, (174.02, 160.268, 526.396, 171.17600000000002), True, False, 66, 841.92, 595.32)"
66,"Tecnológica de Pereira (UTP) in Pereira, Risaralda, Colombia. She is  a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Tecnológica de Pereira (UTP) in Pereira, Risaralda, Colombia. She is  a', 'TimesNewRomanPSMT', 10.908000000000015, (174.02, 146.468, 526.42, 157.376), True, False, 66, 841.92, 595.32)"
66,member of the Colombian Infectious Diseases Association (ACIN) and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('member of the Colombian Infectious Diseases Association (ACIN) and', 'TimesNewRomanPSMT', 10.908000000000015, (174.02, 132.66799999999998, 526.136, 143.576), True, False, 66, 841.92, 595.32)"
66,the International Society for Infectious Diseases. She is a member of the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('the International Society for Infectious Diseases. She is a member of the', 'TimesNewRomanPSMT', 10.907999999999987, (174.02, 118.868, 526.3960000000001, 129.77599999999998), True, False, 66, 841.92, 595.32)"
66,"Committee  on  Tropical  Medicine,  Zoonoses,  and  Travel  Medicine  of",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Committee  on  Tropical  Medicine,  Zoonoses,  and  Travel  Medicine  of', 'TimesNewRomanPSMT', 10.908000000000001, (174.02, 105.068, 526.33, 115.976), True, False, 66, 841.92, 595.32)"
66,"ACIN.  She  has  been  recognized  as  Junior  Researcher,  Ministry  of  Science  in  Colombia,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('ACIN.  She  has  been  recognized  as  Junior  Researcher,  Ministry  of  Science  in  Colombia,', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 91.272, 526.2700000000001, 102.18), True, False, 66, 841.92, 595.32)"
66,"MinCiencias.  She  is  a  Professor  of  Veterinary  Medicine  and  Zootechnics,  Fundación",0,0,0,0,0,0,0,0,0,0,0,0,0,"('MinCiencias.  She  is  a  Professor  of  Veterinary  Medicine  and  Zootechnics,  Fundación', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 77.472, 526.238, 88.38), True, False, 66, 841.92, 595.32)"
66,"Universitaria Autónoma de las Americas (FUAM), in Pereira, Risaralda, Colombia. She is a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Universitaria Autónoma de las Americas (FUAM), in Pereira, Risaralda, Colombia. She is a', 'TimesNewRomanPSMT', 10.908000000000001, (72.024, 63.672, 526.42, 74.58), True, False, 66, 841.92, 595.32)"
66,65,0,0,0,0,0,0,0,0,0,0,0,0,0,"('65', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 66, 841.92, 595.32)"
66,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 66, 841.92, 595.32)"
67,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 67, 841.92, 595.32)"
67,"Leader  Professor  of  the  Zoonoses  Research  Incubator  (SIZOO),  FUAM.  Her  main  research",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Leader  Professor  of  the  Zoonoses  Research  Incubator  (SIZOO),  FUAM.  Her  main  research', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.0919999999998, 767.076), True, False, 67, 841.92, 595.32)"
67,interest is the study of zoonotic tick-borne and vector-borne diseases.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('interest is the study of zoonotic tick-borne and vector-borne diseases.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 742.3480000000001, 407.71, 753.2560000000001), True, False, 67, 841.92, 595.32)"
67,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (202.61, 720.508, 205.61, 731.224), True, False, 67, 841.92, 595.32)"
67,"Alfonso  J.  Rodriguez-Morales,  M.D.,  M.Sc.,  D.T.M.&H.,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Alfonso  J.  Rodriguez-Morales,  M.D.,  M.Sc.,  D.T.M.&H.,', 'TimesNewRomanPS-BoldMT', 10.908000000000015, (202.61, 706.708, 526.354, 717.616), False, False, 67, 841.92, 595.32)"
67,"F.R.S.T.M.H.(Lon), F.F.T.M. R.C.P.S.(Glasg), F.A.C.E., Ph.D.(c),",0,0,0,0,0,0,0,0,0,0,0,0,0,"('F.R.S.T.M.H.(Lon), F.F.T.M. R.C.P.S.(Glasg), F.A.C.E., Ph.D.(c),', 'TimesNewRomanPSMT', 10.908000000000015, (202.61, 692.908, 529.2139999999999, 703.816), True, False, 67, 841.92, 595.32)"
67,"Hon.D.Sc.,  is  an  Expert  in  Tropical  and  Emerging  Diseases,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Hon.D.Sc.,  is  an  Expert  in  Tropical  and  Emerging  Diseases,', 'TimesNewRomanPSMT', 10.908000000000015, (202.61, 679.1080000000001, 526.2260000000001, 690.0160000000001), True, False, 67, 841.92, 595.32)"
67,particularly  in  Zoonotic  and  Vector-Borne  Diseases.  He  is,0,0,0,0,0,0,0,0,0,0,0,0,0,"('particularly  in  Zoonotic  and  Vector-Borne  Diseases.  He  is', 'TimesNewRomanPSMT', 10.908000000000015, (202.61, 665.308, 526.318, 676.216), True, False, 67, 841.92, 595.32)"
67,"President  of  the  Travel  Medicine  Committee,  Pan  American",0,0,0,0,0,0,0,0,0,0,0,0,0,"('President  of  the  Travel  Medicine  Committee,  Pan  American', 'TimesNewRomanPSMT', 10.908000000000015, (202.61, 651.508, 526.408, 662.416), True, False, 67, 841.92, 595.32)"
67,"Infectious  Diseases  Association  (API),  as  well  as  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Infectious  Diseases  Association  (API),  as  well  as  the', 'TimesNewRomanPSMT', 10.908000000000015, (202.61, 637.708, 526.2140000000002, 648.616), True, False, 67, 841.92, 595.32)"
67,"Vicepresident,  Colombian  Infectious  Diseases  Association",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Vicepresident,  Colombian  Infectious  Diseases  Association', 'TimesNewRomanPSMT', 10.908000000000015, (202.61, 623.908, 526.2500000000001, 634.816), True, False, 67, 841.92, 595.32)"
67,"(ACIN). He is a member of the Committee on Tropical Medicine,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('(ACIN). He is a member of the Committee on Tropical Medicine,', 'TimesNewRomanPSMT', 10.908000000000015, (202.61, 610.1080000000001, 526.226, 621.0160000000001), True, False, 67, 841.92, 595.32)"
67,"Zoonoses,  and  Travel  Medicine,  ACIN.  He  is  part  of  the",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Zoonoses,  and  Travel  Medicine,  ACIN.  He  is  part  of  the', 'TimesNewRomanPSMT', 10.908000000000015, (202.61, 596.308, 526.27, 607.216), True, False, 67, 841.92, 595.32)"
67,Executive  Board  of  the  Latin  American  Society  for  Travel  Medicine  (SLAMVI)  and  of  the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Executive  Board  of  the  Latin  American  Society  for  Travel  Medicine  (SLAMVI)  and  of  the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 582.508, 526.1479999999999, 593.416), True, False, 67, 841.92, 595.32)"
67,"Council  of  the  International  Society  for  Infectious  Diseases.  Since  2014,  he  has  been",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Council  of  the  International  Society  for  Infectious  Diseases.  Since  2014,  he  has  been', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 568.678, 526.384, 579.586), True, False, 67, 841.92, 595.32)"
67,"recognized  as  Senior  Researcher,  Ministry  of  Science  in  Colombia,  MinCiencias.  He  is  a",0,0,0,0,0,0,0,0,0,0,0,0,0,"('recognized  as  Senior  Researcher,  Ministry  of  Science  in  Colombia,  MinCiencias.  He  is  a', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 554.878, 526.42, 565.7860000000001), True, False, 67, 841.92, 595.32)"
67,Professor of the Faculty of Health Sciences of the Universidad Tecnológica de Pereira (UTP),0,0,0,0,0,0,0,0,0,0,0,0,0,"('Professor of the Faculty of Health Sciences of the Universidad Tecnológica de Pereira (UTP)', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 541.078, 526.04, 551.986), True, False, 67, 841.92, 595.32)"
67,"in  Pereira,  Risaralda,  Colombia.  He  is  Co-Director  of  the  Public  Health  and  Infection",0,0,0,0,0,0,0,0,0,0,0,0,0,"('in  Pereira,  Risaralda,  Colombia.  He  is  Co-Director  of  the  Public  Health  and  Infection', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 527.278, 526.19, 538.186), True, False, 67, 841.92, 595.32)"
67,"Research  Group,  UTP,  classified  A1  by  Colciencias.  His  Scopus  H  index  is  currently  30",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Research  Group,  UTP,  classified  A1  by  Colciencias.  His  Scopus  H  index  is  currently  30', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 513.5980000000001, 526.42, 524.5060000000001), True, False, 67, 841.92, 595.32)"
67,(Google-Scholar H index 45).,0,0,0,0,0,0,0,0,0,0,0,0,0,"('(Google-Scholar H index 45).', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 499.798, 218.33, 510.70599999999996), True, False, 67, 841.92, 595.32)"
67,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 477.958, 75.024, 488.866), True, False, 67, 841.92, 595.32)"
67,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 67, 841.92, 595.32)"
67,66,0,0,0,0,0,0,0,0,0,0,0,0,0,"('66', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 67, 841.92, 595.32)"
68,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 68, 841.92, 595.32)"
68,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (297.65, 756.168, 300.65, 767.076), True, False, 68, 841.92, 595.32)"
68,Table 1. FDA-approved In Vitro Emergency Authorization Use Diagnostics Available for,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Table 1. FDA-approved In Vitro Emergency Authorization Use Diagnostics Available for', 'TimesNewRomanPSMT', 10.908000000000015, (80.904, 734.308, 517.4979999999999, 745.216), False, False, 68, 841.92, 595.32)"
68,"SARS-CoV-2, as of March 30, 2020 (260, 261).",0,0,0,0,0,0,0,0,0,0,0,0,0,"('SARS-CoV-2, as of March 30, 2020 (260, 261).', 'TimesNewRomanPSMT', 10.908000000000015, (182.18, 720.508, 416.23, 731.416), True, False, 68, 841.92, 595.32)"
68,Developer,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Developer', 'TimesNewRomanPS-BoldMT', 8.03699999999992, (52.2, 697.0360000000001, 93.474, 705.073), True, False, 68, 841.92, 595.32)"
68,Centers for Disease Control and Prevention's (CDC),0,0,0,0,0,0,0,0,0,0,0,0,0,"(""Centers for Disease Control and Prevention's (CDC)"", 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 686.116, 245.42, 694.2969999999999), True, False, 68, 841.92, 595.32)"
68,"Wadsworth Center, New York State Department of Public",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Wadsworth Center, New York State Department of Public', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 675.796, 264.4290000000001, 683.977), True, False, 68, 841.92, 595.32)"
68,Health's (CDC),0,0,0,0,0,0,0,0,0,0,0,0,0,"(""Health's (CDC)"", 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 665.476, 112.55, 673.6569999999999), True, False, 68, 841.92, 595.32)"
68,"Roche Molecular Systems, Inc. (RMS)",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Roche Molecular Systems, Inc. (RMS)', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 655.1560000000001, 196.7, 663.337), True, False, 68, 841.92, 595.32)"
68,"Thermo Fisher Scientific, Inc.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Thermo Fisher Scientific, Inc.', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 644.716, 164.99, 652.8969999999999), True, False, 68, 841.92, 595.32)"
68,Laboratory Corporation of America (LabCorp),0,0,0,0,0,0,0,0,0,0,0,0,0,"('Laboratory Corporation of America (LabCorp)', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 634.3960000000001, 225.74, 642.577), True, False, 68, 841.92, 595.32)"
68,"Hologic, Inc.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Hologic, Inc.', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 624.076, 103.91, 632.257), True, False, 68, 841.92, 595.32)"
68,"Quest Diagnostics Infectious Disease, Inc.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Quest Diagnostics Infectious Disease, Inc.', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 613.7560000000001, 209.3, 621.937), True, False, 68, 841.92, 595.32)"
68,Quidel Corporation,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Quidel Corporation', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 603.316, 126.95, 611.497), True, False, 68, 841.92, 595.32)"
68,Abbott Molecular,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Abbott Molecular', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 592.9960000000001, 120.95, 601.177), True, False, 68, 841.92, 595.32)"
68,"GenMark Diagnostics, Inc.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('GenMark Diagnostics, Inc.', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 582.676, 154.19, 590.857), True, False, 68, 841.92, 595.32)"
68,DiaSorin Molecular LLC,0,0,0,0,0,0,0,0,0,0,0,0,0,"('DiaSorin Molecular LLC', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 572.326, 147.71, 580.507), True, False, 68, 841.92, 595.32)"
68,Cepheid,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Cepheid', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 561.8860000000001, 86.754, 570.067), True, False, 68, 841.92, 595.32)"
68,Primerdesign Ltd.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Primerdesign Ltd.', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 551.566, 121.67, 559.747), True, False, 68, 841.92, 595.32)"
68,Mesa Biotech Inc.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Mesa Biotech Inc.', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 541.2460000000001, 122.51, 549.427), True, False, 68, 841.92, 595.32)"
68,"BioFire Defense, LLC",0,0,0,0,0,0,0,0,0,0,0,0,0,"('BioFire Defense, LLC', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 530.926, 137.51, 539.107), True, False, 68, 841.92, 595.32)"
68,"PerkinElmer, Inc.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('PerkinElmer, Inc.', 'TimesNewRomanPSMT', 8.180999999999926, (52.2, 520.486, 120.47, 528.6669999999999), True, False, 68, 841.92, 595.32)"
68,"Avellino Lab USA, Inc.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Avellino Lab USA, Inc.', 'TimesNewRomanPSMT', 8.180999999999983, (52.2, 510.166, 142.91, 518.347), True, False, 68, 841.92, 595.32)"
68,BGI Genomics Co. Ltd,0,0,0,0,0,0,0,0,0,0,0,0,0,"('BGI Genomics Co. Ltd', 'TimesNewRomanPSMT', 8.18100000000004, (52.2, 499.846, 140.75, 508.02700000000004), True, False, 68, 841.92, 595.32)"
68,"Luminex Molecular Diagnostics, Inc.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Luminex Molecular Diagnostics, Inc.', 'TimesNewRomanPSMT', 8.18100000000004, (52.2, 489.526, 191.42, 497.70700000000005), True, False, 68, 841.92, 595.32)"
68,"Abbott Diagnostics Scarborough, Inc.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('Abbott Diagnostics Scarborough, Inc.', 'TimesNewRomanPSMT', 8.18100000000004, (52.2, 479.20599999999996, 192.98, 487.387), True, False, 68, 841.92, 595.32)"
68,QIAGEN GmbH,0,0,0,0,0,0,0,0,0,0,0,0,0,"('QIAGEN GmbH', 'TimesNewRomanPSMT', 8.18100000000004, (52.2, 468.76599999999996, 117.95, 476.947), True, False, 68, 841.92, 595.32)"
68,"NeuMoDx Molecular, Inc.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('NeuMoDx Molecular, Inc.', 'TimesNewRomanPSMT', 8.18100000000004, (52.2, 458.44599999999997, 152.75, 466.627), True, False, 68, 841.92, 595.32)"
68,Diagnostic Platform,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Diagnostic Platform', 'TimesNewRomanPS-BoldMT', 8.03699999999992, (275.45, 697.0360000000001, 355.0, 705.073), True, False, 68, 841.92, 595.32)"
68,CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC),0,0,0,0,0,0,0,0,0,0,0,0,0,"('CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC)', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 686.116, 508.03, 694.2969999999999), True, False, 68, 841.92, 595.32)"
68,New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR,0,0,0,0,0,0,0,0,0,0,0,0,0,"('New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 675.796, 527.227, 683.977), True, False, 68, 841.92, 595.32)"
68,Diagnostic Panel,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Diagnostic Panel', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 665.476, 341.2, 673.6569999999999), True, False, 68, 841.92, 595.32)"
68,cobas SARS-CoV-2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('cobas SARS-CoV-2', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 655.1560000000001, 352.72, 663.337), True, False, 68, 841.92, 595.32)"
68,TaqPath COVID-19 Combo Kit,0,0,0,0,0,0,0,0,0,0,0,0,0,"('TaqPath COVID-19 Combo Kit', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 644.716, 395.2, 652.8969999999999), True, False, 68, 841.92, 595.32)"
68,COVID-19 RT-PCR Test,0,0,0,0,0,0,0,0,0,0,0,0,0,"('COVID-19 RT-PCR Test', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 634.3960000000001, 371.92, 642.577), True, False, 68, 841.92, 595.32)"
68,Panther Fusion SARS-CoV-2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Panther Fusion SARS-CoV-2', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 624.076, 386.44, 632.257), True, False, 68, 841.92, 595.32)"
68,Quest SARS-CoV-2 rRT-PCR,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Quest SARS-CoV-2 rRT-PCR', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 613.7560000000001, 390.04, 621.937), True, False, 68, 841.92, 595.32)"
68,Lyra SARS-CoV-2 Assay,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Lyra SARS-CoV-2 Assay', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 603.316, 373.48, 611.497), True, False, 68, 841.92, 595.32)"
68,Abbott RealTime SARS-CoV-2 assay,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Abbott RealTime SARS-CoV-2 assay', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 592.9960000000001, 416.68, 601.177), True, False, 68, 841.92, 595.32)"
68,ePlex SARS-CoV-2 Test,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ePlex SARS-CoV-2 Test', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 582.676, 370.0, 590.857), True, False, 68, 841.92, 595.32)"
68,Simplexa COVID-19 Direct assay,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Simplexa COVID-19 Direct assay', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 572.326, 403.12, 580.507), True, False, 68, 841.92, 595.32)"
68,Xpert Xpress SARS-CoV-2 test,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Xpert Xpress SARS-CoV-2 test', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 561.8860000000001, 394.72, 570.067), True, False, 68, 841.92, 595.32)"
68,Primerdesign Ltd COVID-19 genesig Real-Time PCR assay,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Primerdesign Ltd COVID-19 genesig Real-Time PCR assay', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 551.566, 496.99, 559.747), True, False, 68, 841.92, 595.32)"
68,Accula SARS-Cov-2 Test,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Accula SARS-Cov-2 Test', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 541.2460000000001, 373.48, 549.427), True, False, 68, 841.92, 595.32)"
68,BioFire COVID-19 Test,0,0,0,0,0,0,0,0,0,0,0,0,0,"('BioFire COVID-19 Test', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 530.926, 367.96, 539.107), True, False, 68, 841.92, 595.32)"
68,PerkinElmer New Coronavirus Nucleic Acid Detection Kit,0,0,0,0,0,0,0,0,0,0,0,0,0,"('PerkinElmer New Coronavirus Nucleic Acid Detection Kit', 'TimesNewRomanPSMT', 8.180999999999926, (275.45, 520.486, 492.43, 528.6669999999999), True, False, 68, 841.92, 595.32)"
68,AvellinoCoV2 test,0,0,0,0,0,0,0,0,0,0,0,0,0,"('AvellinoCoV2 test', 'TimesNewRomanPSMT', 8.180999999999983, (275.45, 510.166, 347.68, 518.347), True, False, 68, 841.92, 595.32)"
68,Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV', 'TimesNewRomanPSMT', 8.18100000000004, (275.45, 499.846, 530.47, 508.02700000000004), True, False, 68, 841.92, 595.32)"
68,NxTAG CoV Extended Panel Assay,0,0,0,0,0,0,0,0,0,0,0,0,0,"('NxTAG CoV Extended Panel Assay', 'TimesNewRomanPSMT', 8.18100000000004, (275.45, 489.526, 411.52, 497.70700000000005), True, False, 68, 841.92, 595.32)"
68,ID NOW COVID-19,0,0,0,0,0,0,0,0,0,0,0,0,0,"('ID NOW COVID-19', 'TimesNewRomanPSMT', 8.18100000000004, (275.45, 479.20599999999996, 355.96, 487.387), True, False, 68, 841.92, 595.32)"
68,QIAstat-Dx Respiratory SARS-CoV-2 Panel,0,0,0,0,0,0,0,0,0,0,0,0,0,"('QIAstat-Dx Respiratory SARS-CoV-2 Panel', 'TimesNewRomanPSMT', 8.18100000000004, (275.45, 468.76599999999996, 441.16, 476.947), True, False, 68, 841.92, 595.32)"
68,NeuMoDx SARS-CoV-2 Assay,0,0,0,0,0,0,0,0,0,0,0,0,0,"('NeuMoDx SARS-CoV-2 Assay', 'TimesNewRomanPSMT', 8.18100000000004, (275.45, 458.44599999999997, 392.68, 466.627), True, False, 68, 841.92, 595.32)"
68,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 444.238, 75.024, 455.14599999999996), True, False, 68, 841.92, 595.32)"
68,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 422.398, 75.024, 433.306), True, False, 68, 841.92, 595.32)"
68,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 68, 841.92, 595.32)"
68,67,0,0,0,0,0,0,0,0,0,0,0,0,0,"('67', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 68, 841.92, 595.32)"
69,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 69, 841.92, 595.32)"
69,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (297.65, 756.168, 300.65, 766.884), True, False, 69, 841.92, 595.32)"
69,Table 2. Clinical specimens for detection of SARS CoV-2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Table 2. Clinical specimens for detection of SARS CoV-2', 'TimesNewRomanPSMT', 10.908000000000015, (157.22, 734.308, 441.19, 745.216), False, False, 69, 841.92, 595.32)"
69,Sample,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sample', 'TimesNewRomanPS-BoldMT', 9.858719999999948, (148.46, 708.71536, 186.01999999999998, 718.57408), True, False, 69, 841.92, 595.32)"
69,Recommendation*,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Recommendation*', 'TimesNewRomanPS-BoldMT', 9.858719999999948, (340.15, 708.71536, 430.87, 718.57408), True, False, 69, 841.92, 595.32)"
69,Bronchoalveolar lavage fluid,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Bronchoalveolar lavage fluid', 'TimesNewRomanPSMT', 10.035359999999969, (148.46, 690.95536, 282.28999999999996, 700.99072), True, False, 69, 841.92, 595.32)"
69,Sputum,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Sputum', 'TimesNewRomanPSMT', 10.035359999999969, (148.46, 673.79536, 188.17999999999998, 683.8307199999999), True, False, 69, 841.92, 595.32)"
69,Nasal swabs,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Nasal swabs', 'TimesNewRomanPSMT', 10.035359999999969, (148.46, 656.51536, 208.73, 666.55072), True, False, 69, 841.92, 595.32)"
69,Fibrobronchoscope brush biopsy,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Fibrobronchoscope brush biopsy', 'TimesNewRomanPSMT', 10.035359999999969, (148.46, 639.35536, 298.25, 649.39072), True, False, 69, 841.92, 595.32)"
69,Pharyngeal swabs,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Pharyngeal swabs', 'TimesNewRomanPSMT', 10.035359999999969, (148.46, 622.19536, 233.09, 632.23072), True, False, 69, 841.92, 595.32)"
69,Feces,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Feces', 'TimesNewRomanPSMT', 10.035359999999969, (148.46, 604.91536, 179.06, 614.9507199999999), True, False, 69, 841.92, 595.32)"
69,Blood,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Blood', 'TimesNewRomanPSMT', 10.035359999999969, (148.46, 587.75536, 180.85999999999999, 597.79072), True, False, 69, 841.92, 595.32)"
69,Urine,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Urine', 'TimesNewRomanPSMT', 10.035359999999969, (148.46, 570.56536, 179.06, 580.60072), True, False, 69, 841.92, 595.32)"
69,+++,0,0,0,0,0,0,0,0,0,0,0,0,0,"('+++', 'TimesNewRomanPSMT', 10.035359999999969, (384.19, 690.95536, 405.55, 700.99072), True, False, 69, 841.92, 595.32)"
69,+++,0,0,0,0,0,0,0,0,0,0,0,0,0,"('+++', 'TimesNewRomanPSMT', 10.035359999999969, (384.19, 673.79536, 405.55, 683.8307199999999), True, False, 69, 841.92, 595.32)"
69,+++,0,0,0,0,0,0,0,0,0,0,0,0,0,"('+++', 'TimesNewRomanPSMT', 10.035359999999969, (384.19, 656.51536, 405.55, 666.55072), True, False, 69, 841.92, 595.32)"
69,++,0,0,0,0,0,0,0,0,0,0,0,0,0,"('++', 'TimesNewRomanPSMT', 10.035359999999969, (387.31, 639.35536, 402.43, 649.39072), True, False, 69, 841.92, 595.32)"
69,++,0,0,0,0,0,0,0,0,0,0,0,0,0,"('++', 'TimesNewRomanPSMT', 10.035359999999969, (387.31, 622.19536, 402.43, 632.23072), True, False, 69, 841.92, 595.32)"
69,+,0,0,0,0,0,0,0,0,0,0,0,0,0,"('+', 'TimesNewRomanPSMT', 10.035359999999969, (390.43, 604.91536, 399.43, 614.9507199999999), True, False, 69, 841.92, 595.32)"
69,+,0,0,0,0,0,0,0,0,0,0,0,0,0,"('+', 'TimesNewRomanPSMT', 10.035359999999969, (390.43, 587.75536, 399.43, 597.79072), True, False, 69, 841.92, 595.32)"
69,+,0,0,0,0,0,0,0,0,0,0,0,0,0,"('+', 'TimesNewRomanPSMT', 10.035359999999969, (390.43, 570.56536, 399.43, 580.60072), True, False, 69, 841.92, 595.32)"
69,"*Based on (245, 246). +++, strong; ++, moderate; +, weak.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('*Based on (245, 246). +++, strong; ++, moderate; +, weak.', 'TimesNewRomanPSMT', 9.053639999999973, (179.54, 558.4386400000001, 418.36, 567.49228), True, False, 69, 841.92, 595.32)"
69,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 536.758, 75.024, 547.666), True, False, 69, 841.92, 595.32)"
69,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 69, 841.92, 595.32)"
69,68,0,0,0,0,0,0,0,0,0,0,0,0,0,"('68', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 69, 841.92, 595.32)"
70,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 70, 841.92, 595.32)"
70,FIG1: SARS-CoV-2 virus structure,0,0,0,0,0,0,0,0,0,0,0,0,0,"('FIG1: SARS-CoV-2 virus structure', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 756.168, 256.73, 766.884), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 734.308, 75.024, 745.024), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 536.398, 75.024, 547.114), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 522.5980000000001, 75.024, 533.3140000000001), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 508.798, 75.024, 519.514), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 494.998, 75.024, 505.714), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 481.31800000000004, 75.024, 492.03400000000005), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 467.51800000000003, 75.024, 478.23400000000004), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 453.718, 75.024, 464.434), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 439.918, 75.024, 450.634), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 426.118, 75.024, 436.834), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 412.31800000000004, 75.024, 423.03400000000005), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 398.51800000000003, 75.024, 409.23400000000004), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 384.69800000000004, 75.024, 395.41400000000004), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 370.898, 75.024, 381.61400000000003), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 357.098, 75.024, 367.814), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 343.298, 75.024, 354.014), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 329.498, 75.024, 340.214), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 315.69800000000004, 75.024, 326.41400000000004), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 292.778, 75.024, 303.494), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 70, 841.92, 595.32)"
70,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (473.98, 547.558, 476.98, 558.274), True, False, 70, 841.92, 595.32)"
70,69,0,0,0,0,0,0,0,0,0,0,0,0,0,"('69', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 70, 841.92, 595.32)"
71,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 71, 841.92, 595.32)"
71,FIG  2:  S-Gene  Splits  Tree  Analysis:  Spike  (S)  glycoprotein  gene-based  phylogenetic,0,0,0,0,0,0,0,0,0,0,0,0,0,"('FIG  2:  S-Gene  Splits  Tree  Analysis:  Spike  (S)  glycoprotein  gene-based  phylogenetic', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 756.168, 526.4200000000001, 766.884), True, False, 71, 841.92, 595.32)"
71,analysis  (Splits-Tree  4.0)  of  SAR-CoV-2  isolates (39 isolates). The SARS-CoV-2 isolates,0,0,0,0,0,0,0,0,0,0,0,0,0,"('analysis  (Splits-Tree  4.0)  of  SAR-CoV-2  isolates (39 isolates). The SARS-CoV-2 isolates', 'TimesNewRomanPS-BoldMT', 10.908000000000015, (72.024, 741.268, 526.408, 752.176), False, False, 71, 841.92, 595.32)"
71,"analyzed  with  related  CoVs  from  past  human  outbreaks  and  of  animal-origin,  including",0,0,0,0,0,0,0,0,0,0,0,0,0,"('analyzed  with  related  CoVs  from  past  human  outbreaks  and  of  animal-origin,  including', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 526.396, 737.296), True, False, 71, 841.92, 595.32)"
71,"MERS-CoV, bovine coronavirus, canine coronavirus, bat_coronaviruses, Bat-SL-SARS-CoV",0,0,0,0,0,0,0,0,0,0,0,0,0,"('MERS-CoV, bovine coronavirus, canine coronavirus, bat_coronaviruses, Bat-SL-SARS-CoV', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.432, 722.416), True, False, 71, 841.92, 595.32)"
71,"and equine CoV. The analysis includes all the defined five subgenera of  Betacoronaviruses,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('and equine CoV. The analysis includes all the defined five subgenera of  Betacoronaviruses,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 696.628, 526.42, 707.548), False, False, 71, 841.92, 595.32)"
71,"namely  Sarbecovirus,  Embecovirus,  Merbecovirus,  Nobecovirus,  andHibecovirus.  The  grey",0,0,0,0,0,0,0,0,0,0,0,0,0,"('namely  Sarbecovirus,  Embecovirus,  Merbecovirus,  Nobecovirus,  andHibecovirus.  The  grey', 'TimesNewRomanPS-ItalicMT', 10.908000000000015, (72.024, 681.748, 526.384, 692.668), False, False, 71, 841.92, 595.32)"
71,area covered isolates are from the current outbreak of SARS-CoV-2 from the world over. The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('area covered isolates are from the current outbreak of SARS-CoV-2 from the world over. The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 666.748, 526.396, 677.6560000000001), True, False, 71, 841.92, 595.32)"
71,"nearest neighbors of SARS-CoV-2 are the Bat-SL-CoV, encircled in yellow color.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('nearest neighbors of SARS-CoV-2 are the Bat-SL-CoV, encircled in yellow color.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 651.868, 470.5, 662.7760000000001), True, False, 71, 841.92, 595.32)"
71,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.715999999999994, (72.024, 108.548, 75.024, 119.264), True, False, 71, 841.92, 595.32)"
71,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.715999999999994, (72.024, 85.632, 75.024, 96.348), True, False, 71, 841.92, 595.32)"
71,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.715999999999994, (72.024, 62.712, 75.024, 73.428), True, False, 71, 841.92, 595.32)"
71,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 71, 841.92, 595.32)"
71,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (468.22, 128.82799999999997, 471.22, 139.54399999999998), True, False, 71, 841.92, 595.32)"
71,70,0,0,0,0,0,0,0,0,0,0,0,0,0,"('70', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 71, 841.92, 595.32)"
72,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 72, 841.92, 595.32)"
72,"FIG 3: World Map depicting the current scenario of COVID-19. Countries,  territories",0,0,0,0,0,0,0,0,0,0,0,0,0,"('FIG 3: World Map depicting the current scenario of COVID-19. Countries,  territories', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 756.168, 526.318, 766.884), True, False, 72, 841.92, 595.32)"
72,"or regions with reported confirmed cases of  SARS-CoV-2  as of April 3, 2020. Different",0,0,0,0,0,0,0,0,0,0,0,0,0,"('or regions with reported confirmed cases of  SARS-CoV-2  as of April 3, 2020. Different', 'TimesNewRomanPS-BoldMT', 10.471679999999992, (72.024, 741.268, 526.26928, 751.984), False, False, 72, 841.92, 595.32)"
72,colors  indicate  different  geographical  regions  with  the  number  of  confirmed  cases.  The  region-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('colors  indicate  different  geographical  regions  with  the  number  of  confirmed  cases.  The  region-', 'TimesNewRomanPSMT', 10.471679999999992, (72.024, 726.97168, 523.41616, 737.44336), True, False, 72, 841.92, 595.32)"
72,wise  total  number  of  confirmed  cases  is  depicted  in  different  color  strips--meaningful,0,0,0,0,0,0,0,0,0,0,0,0,0,"('wise  total  number  of  confirmed  cases  is  depicted  in  different  color  strips--meaningful', 'TimesNewRomanPSMT', 10.471679999999992, (72.024, 712.6916799999999, 526.3, 723.1633599999999), True, False, 72, 841.92, 595.32)"
72,information on confirmed cases and deaths from different countries or regions depicted in circled,0,0,0,0,0,0,0,0,0,0,0,0,0,"('information on confirmed cases and deaths from different countries or regions depicted in circled', 'TimesNewRomanPSMT', 10.471679999999992, (72.024, 698.4116799999999, 525.7391999999999, 708.8833599999999), True, False, 72, 841.92, 595.32)"
72,balloons.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('balloons.', 'TimesNewRomanPSMT', 10.471679999999992, (72.024, 684.01168, 119.66, 694.48336), True, False, 72, 841.92, 595.32)"
72,Source:  WHO,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Source:  WHO', 'TimesNewRomanPSMT', 8.180999999999926, (72.024, 664.6360000000001, 146.013, 672.817), True, False, 72, 841.92, 595.32)"
72,19.pdf?sfvrsn=5ae25bc7_2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('19.pdf?sfvrsn=5ae25bc7_2', 'TimesNewRomanPSMT', 8.180999999999926, (72.024, 653.356, 174.35, 661.5369999999999), True, False, 72, 841.92, 595.32)"
72,https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-', 'TimesNewRomanPSMT', 8.180999999999926, (166.46, 664.6360000000001, 523.4169999999999, 672.817), True, False, 72, 841.92, 595.32)"
72,Updated,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Updated', 'TimesNewRomanPSMT', 8.180999999999926, (72.024, 634.3960000000001, 104.856, 642.577), True, False, 72, 841.92, 595.32)"
72,be,0,0,0,0,0,0,0,0,0,0,0,0,0,"('be', 'TimesNewRomanPSMT', 8.180999999999926, (448.38800000000003, 634.3960000000001, 459.15200000000004, 642.577), True, False, 72, 841.92, 595.32)"
72,https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.', 'TimesNewRomanPSMT', 8.180999999999926, (72.024, 622.3960000000001, 461.23, 630.577), True, False, 72, 841.92, 595.32)"
72,recovered,0,0,0,0,0,0,0,0,0,0,0,0,0,"('recovered', 'TimesNewRomanPSMT', 8.180999999999926, (361.55600000000004, 634.3960000000001, 399.185, 642.577), True, False, 72, 841.92, 595.32)"
72,patients,0,0,0,0,0,0,0,0,0,0,0,0,0,"('patients', 'TimesNewRomanPSMT', 8.180999999999926, (314.072, 634.3960000000001, 344.25800000000004, 642.577), True, False, 72, 841.92, 595.32)"
72,number,0,0,0,0,0,0,0,0,0,0,0,0,0,"('number', 'TimesNewRomanPSMT', 8.180999999999926, (122.03699999999999, 634.3960000000001, 151.74599999999998, 642.577), True, False, 72, 841.92, 595.32)"
72,"deaths,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('deaths,', 'TimesNewRomanPSMT', 8.180999999999926, (236.70600000000002, 634.3960000000001, 264.38, 642.577), True, False, 72, 841.92, 595.32)"
72,"cases,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('cases,', 'TimesNewRomanPSMT', 8.180999999999926, (196.03499999999997, 634.3960000000001, 219.399, 642.577), True, False, 72, 841.92, 595.32)"
72,and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('and', 'TimesNewRomanPSMT', 8.180999999999926, (281.69, 634.3960000000001, 296.774, 642.577), True, False, 72, 841.92, 595.32)"
72,can,0,0,0,0,0,0,0,0,0,0,0,0,0,"('can', 'TimesNewRomanPSMT', 8.180999999999926, (416.366, 634.3960000000001, 431.09000000000003, 642.577), True, False, 72, 841.92, 595.32)"
72,of,0,0,0,0,0,0,0,0,0,0,0,0,0,"('of', 'TimesNewRomanPSMT', 8.180999999999926, (169.053, 634.3960000000001, 178.73699999999997, 642.577), True, False, 72, 841.92, 595.32)"
72,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 294.938, 75.024, 305.84599999999995), True, False, 72, 841.92, 595.32)"
72,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 272.01800000000003, 75.024, 282.926), True, False, 72, 841.92, 595.32)"
72,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 249.09799999999998, 75.024, 260.006), True, False, 72, 841.92, 595.32)"
72,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 226.29799999999997, 75.024, 237.01399999999998), True, False, 72, 841.92, 595.32)"
72,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 203.34799999999998, 75.024, 214.064), True, False, 72, 841.92, 595.32)"
72,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 72, 841.92, 595.32)"
72,found,0,0,0,0,0,0,0,0,0,0,0,0,0,"('found', 'TimesNewRomanPSMT', 8.180999999999926, (476.45000000000005, 634.3960000000001, 499.741, 642.577), True, False, 72, 841.92, 595.32)"
72,at,0,0,0,0,0,0,0,0,0,0,0,0,0,"('at', 'TimesNewRomanPSMT', 8.180999999999926, (517.039, 634.3960000000001, 525.652, 642.577), True, False, 72, 841.92, 595.32)"
72,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (518.38, 315.218, 521.38, 326.126), True, False, 72, 841.92, 595.32)"
72,71,0,0,0,0,0,0,0,0,0,0,0,0,0,"('71', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 72, 841.92, 595.32)"
73,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 73, 841.92, 595.32)"
73,FIG 4: Bar graph and Pie chart for cases and deaths: Laboratory confirmed cases and,0,0,0,0,0,0,0,0,0,0,0,0,0,"('FIG 4: Bar graph and Pie chart for cases and deaths: Laboratory confirmed cases and', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 756.168, 526.27, 766.884), True, False, 73, 841.92, 595.32)"
73,deaths  in  China  and  the  world  over  due  to  SARS-CoV-2.  A1)  SARS-CoV-2  confirmed,0,0,0,0,0,0,0,0,0,0,0,0,0,"('deaths  in  China  and  the  world  over  due  to  SARS-CoV-2.  A1)  SARS-CoV-2  confirmed', 'TimesNewRomanPS-BoldMT', 10.908000000000015, (72.024, 741.268, 526.396, 752.176), False, False, 73, 841.92, 595.32)"
73,"cases  outside  China  where  more  than  100  deaths  have  been  reported  to  WHO  till  April  2,",0,0,0,0,0,0,0,0,0,0,0,0,0,"('cases  outside  China  where  more  than  100  deaths  have  been  reported  to  WHO  till  April  2,', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 526.0439999999999, 737.296), True, False, 73, 841.92, 595.32)"
73,2020.  A2)  Total  deaths  and  cases  in  China  only.  A3)  Number  of  total  deaths  worldwide,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2020.  A2)  Total  deaths  and  cases  in  China  only.  A3)  Number  of  total  deaths  worldwide', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 711.508, 526.354, 722.416), False, False, 73, 841.92, 595.32)"
73,outside China.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('outside China.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 696.628, 144.38, 707.5360000000001), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 340.658, 75.024, 351.566), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 317.738, 75.024, 328.64599999999996), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 294.938, 75.024, 305.84599999999995), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (72.024, 272.01800000000003, 75.024, 282.926), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999987, (72.024, 249.09799999999998, 75.024, 260.006), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 226.178, 75.024, 237.086), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 203.34799999999998, 75.024, 214.256), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 180.428, 75.024, 191.144), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 157.50799999999998, 75.024, 168.224), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 134.588, 75.024, 145.304), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 73, 841.92, 595.32)"
73,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (525.82, 360.938, 528.82, 371.84599999999995), True, False, 73, 841.92, 595.32)"
73,72,0,0,0,0,0,0,0,0,0,0,0,0,0,"('72', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 73, 841.92, 595.32)"
74,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 74, 841.92, 595.32)"
74,FIG 5: Timeline depicting the significant events that occurred during the SARS-CoV-,0,0,0,0,0,0,0,0,0,0,0,0,0,"('FIG 5: Timeline depicting the significant events that occurred during the SARS-CoV-', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 756.168, 509.77599999999995, 766.884), True, False, 74, 841.92, 595.32)"
74,2/COVID-19 virus outbreak. The timeline describes the significant events during the,0,0,0,0,0,0,0,0,0,0,0,0,0,"('2/COVID-19 virus outbreak. The timeline describes the significant events during the', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 741.268, 490.618, 752.176), False, False, 74, 841.92, 595.32)"
74,"current SARS-CoV-2 outbreak starting from December 8, 2019, and has been shown till",0,0,0,0,0,0,0,0,0,0,0,0,0,"('current SARS-CoV-2 outbreak starting from December 8, 2019, and has been shown till', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 726.388, 499.10200000000003, 737.296), True, False, 74, 841.92, 595.32)"
74,"April 2, 2020.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('April 2, 2020.', 'TimesNewRomanPSMT', 10.716000000000008, (72.024, 711.508, 142.34, 722.416), False, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 463.918, 75.024, 474.634), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 442.798, 75.024, 453.514), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 421.558, 75.024, 432.274), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 400.438, 75.024, 411.154), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 379.178, 75.024, 389.894), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 358.058, 75.024, 368.774), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 336.81800000000004, 75.024, 347.53400000000005), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 315.69800000000004, 75.024, 326.41400000000004), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 294.458, 75.024, 305.17400000000004), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 273.338, 75.024, 284.05400000000003), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000037, (72.024, 252.09799999999998, 75.024, 262.814), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 230.97799999999998, 75.024, 241.694), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 209.708, 75.024, 220.424), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 188.588, 75.024, 199.304), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 167.34799999999998, 75.024, 178.064), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 146.22799999999998, 75.024, 156.944), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 124.988, 75.024, 135.704), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.715999999999994, (72.024, 103.868, 75.024, 114.58399999999999), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.715999999999994, (72.024, 82.632, 75.024, 93.348), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 74, 841.92, 595.32)"
74,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (511.66, 484.19800000000004, 514.6600000000001, 494.91400000000004), True, False, 74, 841.92, 595.32)"
74,73,0,0,0,0,0,0,0,0,0,0,0,0,0,"('73', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 74, 841.92, 595.32)"
75,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 75, 841.92, 595.32)"
75,FIG 6: Potential transmission routes for SARS-CoV-2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('FIG 6: Potential transmission routes for SARS-CoV-2', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 750.148, 351.19, 760.864), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 533.158, 75.024, 543.874), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 511.918, 75.024, 522.634), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 490.798, 75.024, 501.514), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 469.558, 75.024, 480.274), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 448.438, 75.024, 459.154), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 427.19800000000004, 75.024, 437.91400000000004), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 406.07800000000003, 75.024, 416.79400000000004), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 384.81800000000004, 75.024, 395.53400000000005), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 363.69800000000004, 75.024, 374.41400000000004), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 342.458, 75.024, 353.17400000000004), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 321.338, 75.024, 332.05400000000003), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (72.024, 300.098, 75.024, 310.814), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 75, 841.92, 595.32)"
75,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPS-BoldMT', 10.716000000000008, (533.5, 551.638, 536.5, 562.354), True, False, 75, 841.92, 595.32)"
75,74,0,0,0,0,0,0,0,0,0,0,0,0,0,"('74', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 75, 841.92, 595.32)"
76,Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2,0,0,0,0,0,0,0,0,0,0,0,0,0,"('Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 13 April 2020                   doi:10.20944/preprints202003.0001.v2', 'Helvetica-Bold', 10.710000000000036, (8.0, 825.2969999999999, 556.7470000000001, 836.007), False, False, 76, 841.92, 595.32)"
76,FIG 7: Coronaviruses  origins. Coronavirus is the most prominent example of an emerging,0,0,0,0,0,0,0,0,0,0,0,0,0,"('FIG 7: Coronaviruses  origins. Coronavirus is the most prominent example of an emerging', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 756.168, 526.238, 767.076), False, False, 76, 841.92, 595.32)"
76,"virus that has crossed the species barrier from wild animals to humans, like SARS and MERS.",0,0,0,0,0,0,0,0,0,0,0,0,0,"('virus that has crossed the species barrier from wild animals to humans, like SARS and MERS.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 742.3480000000001, 529.33, 753.2560000000001), True, False, 76, 841.92, 595.32)"
76,The  origin  of  SARS-CoV-2  is  also  suspected  to  be  from  an  intermediate  animal  host.  The,0,0,0,0,0,0,0,0,0,0,0,0,0,"('The  origin  of  SARS-CoV-2  is  also  suspected  to  be  from  an  intermediate  animal  host.  The', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 728.548, 526.19, 739.456), True, False, 76, 841.92, 595.32)"
76,possibility of crossing the species barrier again for the fourth time cannot be ruled out.,0,0,0,0,0,0,0,0,0,0,0,0,0,"('possibility of crossing the species barrier again for the fourth time cannot be ruled out.', 'TimesNewRomanPSMT', 10.908000000000015, (72.024, 714.748, 490.06, 725.6560000000001), True, False, 76, 841.92, 595.32)"
76,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'TimesNewRomanPSMT', 10.907999999999959, (519.46, 430.918, 522.46, 441.82599999999996), True, False, 76, 841.92, 595.32)"
76,75,0,0,0,0,0,0,0,0,0,0,0,0,0,"('75', 'BCDEEE+Calibri', 11.04, (512.26, 48.864000000000004, 525.91504, 59.904), True, False, 76, 841.92, 595.32)"
76,,0,0,0,0,0,0,0,0,0,0,0,0,0,"('', 'BCDEEE+Calibri', 11.04, (72.024, 35.4, 74.51904, 46.44), True, False, 76, 841.92, 595.32)"
76,View publication stats,0,0,0,0,0,0,0,0,0,0,0,0,0,"('View publication stats', 'Helvetica', 4.624, (50.0, 4.172, 88.46000000000001, 8.796), True, False, 76, 841.92, 595.32)"
76,View publication stats,0,0,0,0,0,0,0,0,0,0,0,0,0,"('View publication stats', 'Helvetica', 4.624, (50.0, 4.172, 88.46000000000001, 8.796), True, False, 76, 841.92, 595.32)"
